Citrus Sinensis ID: 038743
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 839 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FLV4 | 872 | G-type lectin S-receptor- | yes | no | 0.983 | 0.946 | 0.681 | 0.0 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.876 | 0.886 | 0.369 | 1e-116 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.871 | 0.882 | 0.360 | 1e-115 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.848 | 0.867 | 0.348 | 1e-113 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.831 | 0.875 | 0.356 | 1e-108 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.861 | 0.829 | 0.307 | 7e-99 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.867 | 0.875 | 0.323 | 4e-96 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.867 | 0.891 | 0.316 | 8e-88 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.854 | 0.844 | 0.302 | 3e-86 | |
| Q9T058 | 849 | G-type lectin S-receptor- | no | no | 0.853 | 0.843 | 0.293 | 5e-79 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1156 bits (2990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 585/858 (68%), Positives = 682/858 (79%), Gaps = 33/858 (3%)
Query: 1 HIGLGSRLLASQ-DQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRN 59
HIGLGS+L AS+ ++AW+S NGTFA GFT DRF L IWF +LPGD T+VWS NRN
Sbjct: 29 HIGLGSKLKASEPNRAWVSANGTFAIGFTRF-KPTDRFLLSIWFAQLPGDPTIVWSPNRN 87
Query: 60 FPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPN---NQPV 116
PVTK+A+LEL+ TGNLVL+D +T +W SN+S GVE A MSESGNF+L +
Sbjct: 88 SPVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTI 147
Query: 117 WQSFLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDA 176
WQSF PSDTLLPNQPL+VSLELTS S G+YSLKMLQQ TSLSL LTYN+
Sbjct: 148 WQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKMLQQHTSLSLGLTYNI------ 201
Query: 177 ANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQN--DGDYDG 234
+ +AN SYWSGPDISNVTGDV AVLD+ GSF IVYGESS GAVYVY+N D + +
Sbjct: 202 --NLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNY 259
Query: 235 LASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKG 294
S+ T+ VLRRL+LE NGNLRLYRWDND+NGS QWVPEWAAVSNPC+IAGICG G
Sbjct: 260 NNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGICGNG 319
Query: 295 ICNLDRSKTKASCTCLPGDSKIGSD---GLCSDNSSVNGKCDPR-HRNQSSHDYRIASVQ 350
+CNLDR+K A C CLPG K+ LCSDNSS+ +C+ +RN S ++I++VQ
Sbjct: 320 VCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGS---FKISTVQ 376
Query: 351 QTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFE 410
+TNYYF E SVI N SDI+ V KCG+ CLS+C+CVASVYGLDDEKPYCW+L+SL+FGGF
Sbjct: 377 ETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLNFGGFR 436
Query: 411 DPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYY 470
DP STLFVK +N S ++ + S S R KV+VIPIV+ M +L+ LL +LLYY
Sbjct: 437 DPGSTLFVKTRANESYP-SNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGMLLYY 495
Query: 471 NVHRKRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLV 530
N+ RKR LKRA +NSLI+C +PV+FTYRDLQ T+NF+QLLG+GGFG+VYKG++ TLV
Sbjct: 496 NLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLV 555
Query: 531 AVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI 590
AVK+LDR L HGE+EF+TEVNTIGSMHHMNLVRLCGYCSE S+RLLVYE+M NGSLDKWI
Sbjct: 556 AVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWI 615
Query: 591 FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650
F S +LDW TRF IA+ATAQGIAYFHEQCRNRIIHCDIKPENILLD+NFCPKVSD
Sbjct: 616 FSS-EQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSD 674
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710
FGLAK+MGREHS VVTM+RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM
Sbjct: 675 FGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 734
Query: 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770
S DAEDFFYPGWA+KE+TNGT LK D+RL+G EEEE+++A+KVAFWCIQDEV MRPSM
Sbjct: 735 SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSM 794
Query: 771 GEVVKMLEGSAD-INTPPMPQTVLELIEEGLDHVYKAMKRDF-NQFSSFTINSST----- 823
GEVVK+LEG++D IN PPMPQT+LELIEEGL+ VY+AM+R+F NQ SS T+N+ T
Sbjct: 795 GEVVKLLEGTSDEINLPPMPQTILELIEEGLEDVYRAMRREFNNQLSSLTVNTITTSQSY 854
Query: 824 --HLSSHATCSYSSMSPR 839
SHATCSYSSMSPR
Sbjct: 855 RSSSRSHATCSYSSMSPR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1083), Expect = e-116, Method: Compositional matrix adjust.
Identities = 301/815 (36%), Positives = 433/815 (53%), Gaps = 80/815 (9%)
Query: 2 IGLGSRLLAS-QDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNF 60
I LGS + AS +Q W S N TF+ F P + + +P +WSA
Sbjct: 27 IPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP-----IWSAG--- 78
Query: 61 PVTKDAILELDTTGNLVLNDGD-TTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQS 119
V L L T+G+L L +G TT+W S + GV ++ ++G FIL + PVW S
Sbjct: 79 TVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSS 138
Query: 120 FLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANS 179
F +P+DT++ +Q T+ K L++G Y Q S +L L +N Y N
Sbjct: 139 FDNPTDTIVQSQ------NFTAGKILRSGLY----SFQLERSGNLTLRWNTSAIY--WNH 186
Query: 180 PKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQND-GDYDGLASA 238
+ S S P +S T VV++ E+ G GA VY D GD +
Sbjct: 187 GLNSSFSSNLSSPRLSLQTNGVVSIF-ESNLLG--------GAEIVYSGDYGDSN----- 232
Query: 239 TNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVP---EWAAVSNPCNIAGICGK-G 294
R L L+ +GNLR+Y + SR P W+AV + C + G CG G
Sbjct: 233 --------TFRFLKLDDDGNLRIYS-----SASRNSGPVNAHWSAV-DQCLVYGYCGNFG 278
Query: 295 ICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNY 354
IC+ + + SC D N G + S + + + T
Sbjct: 279 ICSYNDTNPICSCPSRNFD-------FVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRL 331
Query: 355 YFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDF-GGFEDPS 413
+ E + S A S C CLS+ C+ASV + D CW F G++ PS
Sbjct: 332 FTYEDDPNSE-SFFAGSSPCRANCLSSVLCLASV-SMSDGSGNCWQKHPGSFFTGYQWPS 389
Query: 414 --STLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYN 471
ST +VK+ GD +++ +V + ++ + L+ + + L++
Sbjct: 390 VPSTSYVKVCGPVVANTLERATKGD--DNNSKVHLWIVAVAVIAGLLGLVAVE-IGLWWC 446
Query: 472 VHRK--RFLKRAVENSLI--VCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDG 527
RK RF + +L+ GAPV FTY++LQ T +F + LG GGFG+VY+G L +
Sbjct: 447 CCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNR 506
Query: 528 TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLD 587
T+VAVK+L+ + GEK+F EV TI S HH+NLVRL G+CS+G +RLLVYEFM+NGSLD
Sbjct: 507 TVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLD 565
Query: 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647
++F + + L W RFNIA+ TA+GI Y HE+CR+ I+HCDIKPENIL+D+NF K
Sbjct: 566 NFLFTT--DSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAK 623
Query: 648 VSDFGLAKLMG-REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
VSDFGLAKL+ +++ ++ VRGTRGYLAPEW++N PIT K+DVYSYGM+LLE+V G+R
Sbjct: 624 VSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKR 683
Query: 707 NLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL--EGAVEEEELMRAMKVAFWCIQDEV 764
N D+S + WA++E G + D RL + V+ E++MR +K +FWCIQ++
Sbjct: 684 NFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQP 743
Query: 765 FMRPSMGEVVKMLEGSADINTPPMPQTVLELIEEG 799
RP+MG+VV+MLEG +I P P+T+ E+ G
Sbjct: 744 LQRPTMGKVVQMLEGITEIKNPLCPKTISEVSFSG 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1071), Expect = e-115, Method: Compositional matrix adjust.
Identities = 297/824 (36%), Positives = 441/824 (53%), Gaps = 93/824 (11%)
Query: 11 SQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVT-KDAILE 69
S DQ +S +GT+ GF F +G+W+ +L +T++W ANR+ V+ K++ +
Sbjct: 33 SGDQTIVSSDGTYEMGFFK-PGSSSNFYIGMWYKQL--SQTILWVANRDKAVSDKNSSVF 89
Query: 70 LDTTGNLVLNDGD--TTIWA----SNSSGAGVELATMSESGNFILYAPNN----QPVWQS 119
+ GNL+L DG+ T +W+ S SS + +E A + + GN +L + +WQS
Sbjct: 90 KISNGNLILLDGNYQTPVWSTGLNSTSSVSALE-AVLQDDGNLVLRTGGSSLSANVLWQS 148
Query: 120 FLHPSDTLLPNQPLSV------SLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGS 173
F HP DT LP + + S LTS KSL++ P SL L
Sbjct: 149 FDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLED---------PSPGLFSLEL------- 192
Query: 174 YDAANSPKAYANKS--YWS-GP-DISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQND 229
D + + K N S YWS GP + + D V + + + ++ + + Y
Sbjct: 193 -DESTAYKILWNGSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYFTYSI- 250
Query: 230 GDYDGLASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAG 289
Y+ L + R +++ +G ++ + W + G++ W W+ C +
Sbjct: 251 --YNQLN-----------VSRFVMDVSGQIKQFTW---LEGNKAWNLFWSQPRQQCQVYR 294
Query: 290 ICGK-GICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIAS 348
CG GIC+ K++ C C G + D + C + Q S
Sbjct: 295 YCGSFGICS---DKSEPFCRCPQGFRPMSQKDW--DLKDYSAGCVRKTELQCSR----GD 345
Query: 349 VQQTNYYFPEYSVIANYSDIAT---VSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLD 405
+ Q + P +A+ S++ T +S C AC +C C A Y K W L+
Sbjct: 346 INQF-FRLPNMK-LADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLN 403
Query: 406 FGGFEDPSS---TLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIG 462
ED +S ++++ ++ G+ SG S+ K ++ VL +G
Sbjct: 404 LQQLEDENSEGNIFYLRLAASDVPNVGA---SGKSN-------NKGLIFGAVLGS---LG 450
Query: 463 LLCLLLYYNVHRKRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKG 522
++ L+L + R+ +R G F+YR+LQ T NF+ LG GGFGSV+KG
Sbjct: 451 VIVLVLLVVILILRYRRRKRMRGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKG 510
Query: 523 SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582
+L D + +AVK+L+ + GEK+F TEV TIG++ H+NLVRL G+CSEGS +LLVY++M
Sbjct: 511 ALPDSSDIAVKRLEGI-SQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMP 569
Query: 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE 642
NGSLD +F + VL W RF IA+ TA+G+AY H++CR+ IIHCDIKPENILLD
Sbjct: 570 NGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDS 629
Query: 643 NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
FCPKV+DFGLAKL+GR+ S+V+T +RGTRGYLAPEW+S IT KADVYSYGM+L E+V
Sbjct: 630 QFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELV 689
Query: 703 GGRRNLDMSGDAEDFFYPGWAFKEMT-NGTPLKVADRRLEG-AVEEEELMRAMKVAFWCI 760
GRRN + S + + F+P WA +T +G + D RLEG AV+ EE+ RA KVA WCI
Sbjct: 690 SGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCI 749
Query: 761 QDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIEEGLDHVY 804
QDE RP+M +VV++LEG ++N PP P+++ L+ D V+
Sbjct: 750 QDEESHRPAMSQVVQILEGVLEVNPPPFPRSIQALVVSDEDVVF 793
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1055), Expect = e-113, Method: Compositional matrix adjust.
Identities = 276/793 (34%), Positives = 409/793 (51%), Gaps = 81/793 (10%)
Query: 18 SDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLV 77
S+N F FGF + F L I ++WSANR PV+ D GN+V
Sbjct: 50 SNNSAFGFGFVTTQDSVTLFTLSIIHKS---STKLIWSANRASPVSNSDKFVFDDNGNVV 106
Query: 78 LNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSFLHPSDTLLPNQPLSVSL 137
+ T +W ++SG + +SGN ++ + + +W+SF HP+DTL+ NQ +
Sbjct: 107 MEG--TEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGM 164
Query: 138 ELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLP-GSYDAANSPKAYANKSYWSGPD--- 193
+LTS S N +TY L S D S + + YWS +
Sbjct: 165 KLTSSPSSSN------------------MTYALEIKSGDMVLSVNSLTPQVYWSMANARE 206
Query: 194 -ISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNKSTRLTVLRRLI 252
I N G VV G+ + + V ++Q + NK T + L
Sbjct: 207 RIINKDGGVVTSSSLLGNSWRFFDQKQ---VLLWQ-------FVFSDNKDDNTTWIAVL- 255
Query: 253 LETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKG-ICNLDRSKTKASCTCLP 311
GN + + N +G+ S+ C CG +C S +K C C+
Sbjct: 256 ----GNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVC----SGSKV-CGCVS 306
Query: 312 GDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEYSVIANYSDIATV 371
G S+ SD C + + C N + +++ +Y+ Y+ +S +
Sbjct: 307 GLSRARSD--C--KTGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYA--PPFSKKTDL 360
Query: 372 SKCGDACLSNCQCVASVYGLDDEKPYCWV---LRSLDFGGFEDPSSTLFVKIMSNRSLTP 428
C + C +NC C+ + + C++ + S G ++KI S S
Sbjct: 361 DSCKEFCHNNCSCLGLFF--QNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGGG 418
Query: 429 GSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFL------KRAV 482
+ G V I VL + + + +H+++ + + +
Sbjct: 419 DNGEDDGKHFPYVVIIVVVTVFIIAVL----------IFVAFRIHKRKKMILEAPQESSE 468
Query: 483 ENSLI--VCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP 540
E++ + + G P+ F Y+DLQ T+NF+ LG GGFGSVY+G+L DG+ +AVKKL+ +
Sbjct: 469 EDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGI-G 527
Query: 541 HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV 600
G+KEF EV+ IGS+HH++LVRL G+C+EG++RLL YEF+ GSL++WIF D +
Sbjct: 528 QGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRK-KDGDVL 586
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
LDW TRFNIA+ TA+G+AY HE C RI+HCDIKPENILLD+NF KVSDFGLAKLM RE
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720
S V T +RGTRGYLAPEW++N I+ K+DVYSYGM+LLE++GGR+N D S +E +P
Sbjct: 647 QSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFP 706
Query: 721 GWAFKEMTNGTPLKVADRRLEGA-VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779
+AFK+M G + + D +++ V +E + RAMK A WCIQ+++ RPSM +VV+MLEG
Sbjct: 707 SFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEG 766
Query: 780 SADINTPPMPQTV 792
+ PP T+
Sbjct: 767 VFPVVQPPSSSTM 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1012), Expect = e-108, Method: Compositional matrix adjust.
Identities = 283/794 (35%), Positives = 396/794 (49%), Gaps = 96/794 (12%)
Query: 6 SRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTK- 64
S+++ +Q +S F GF N + LGI + +P T VW ANR PV+
Sbjct: 23 SKVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMP-TPTHVWVANRIRPVSDP 81
Query: 65 -DAILELDTTGNLVL-NDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSFLH 122
+ LEL +TG L++ N D +W +++ G + SE+GN IL + PVWQSF +
Sbjct: 82 DSSTLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFR-FSETGNLILINDDGSPVWQSFDN 140
Query: 123 PSDTLLPNQPLSVSLELTSPKSL--QNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSP 180
P+DT LP ++ +TS +SL + G+YSL++ P+ L Y
Sbjct: 141 PTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRL--SPSFNEFQLVYK----------- 187
Query: 181 KAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLAS--- 237
YWS N TG+ + E I Y +Y + Y AS
Sbjct: 188 ---GTTPYWS---TGNWTGEAFVGVPE---MTIPY-------IYRFHFVNPYTPTASFWY 231
Query: 238 --ATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGK-G 294
S L R ++ NG L+ Y WD ++ W W +PC + +CG+ G
Sbjct: 232 IVPPLDSVSEPRLTRFMVGANGQLKQYTWDPQ---TQSWNMFWLQPEDPCRVYNLCGQLG 288
Query: 295 ICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNY 354
C+ S+ C C+ G SD+ S C + + +V Y
Sbjct: 289 FCS---SELLKPCACIRGFRPRNDAAWRSDDYS--DGCRRENGDSGEKSDTFEAVGDLRY 343
Query: 355 YFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSS 414
+ V + ++ S C CL N CV GF
Sbjct: 344 ---DGDVKMSRLQVSK-SSCAKTCLGNSSCV----------------------GFYHKEK 377
Query: 415 TLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHR 474
+ KI+ +P + + S + S VV VL TLL+ L+ L +
Sbjct: 378 SNLCKILLE---SPNNLKNSKGNISKSIIILCSVVGSISVLGFTLLVPLILLKRSRKRKK 434
Query: 475 KRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVK 533
R E+ V V F++++LQ T+ F+ +G GGFG+V+KG+L G T VAVK
Sbjct: 435 TRKQD---EDGFAVLNLKV-FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVK 490
Query: 534 KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPS 593
+L+R GE EF EV TIG++ H+NLVRL G+CSE +RLLVY++M GSL ++
Sbjct: 491 RLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL--- 546
Query: 594 YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653
++L W TRF IA+ TA+GIAY HE CR+ IIHCDIKPENILLD ++ KVSDFGL
Sbjct: 547 SRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGL 606
Query: 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGD 713
AKL+GR+ S+V+ +RGT GY+APEW+S PIT KADVYS+GM LLE++GGRRN+ ++ D
Sbjct: 607 AKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSD 666
Query: 714 A--------EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVF 765
E +F+P WA +E+ G V D RL G EE+ R VA WCIQD
Sbjct: 667 TLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEE 726
Query: 766 MRPSMGEVVKMLEG 779
+RP+MG VVKMLEG
Sbjct: 727 IRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 7e-99, Method: Compositional matrix adjust.
Identities = 254/827 (30%), Positives = 413/827 (49%), Gaps = 104/827 (12%)
Query: 10 ASQDQAWISDNGTFAFG-FTPIVNIQDRFQLGIWFNELPGDR-TVVWSANRNFPVTKDAI 67
+S+ +S N F G F+P D G +F+ + D + +WS+NR+ PV+
Sbjct: 44 SSKGAFLLSRNSIFKAGLFSPG---GDDSSTGFYFSVVHVDSGSTIWSSNRDSPVSSSGT 100
Query: 68 LELDTTGNLVLNDGDTTI--WASNSSGAGVELATMSESGNFILYAPNNQPVWQSFLHPSD 125
+ L G V+ DG + I W++ + V+ ++++GN +L N +W+SF P+D
Sbjct: 101 MNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTD 160
Query: 126 TLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPKAYAN 185
+++ Q L + + L+ S + K L G D
Sbjct: 161 SIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLV--------------GESDGLMQ------ 200
Query: 186 KSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNKSTRL 245
W G + + + A +D +F + Y + + + +G + A S+
Sbjct: 201 ---WRGQNYWKLRMHIRANVDS--NFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDF 255
Query: 246 TVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGK-GICNLDRSKTK 304
V + ++++G + R+ + V E++ + C I +CGK G+CNLD +
Sbjct: 256 RVAK---MDSSGKFIVSRFSG-----KNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASEN 307
Query: 305 ASCTCLPGDSKI-GSDGLC---SDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEYS 360
SC+C P + ++ G+C S + S+ C+ R N S + + +Y+ ++
Sbjct: 308 QSCSC-PDEMRMDAGKGVCVPVSQSLSLPVSCEAR--NISYLELGLG----VSYFSTHFT 360
Query: 361 VIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGF-------EDPS 413
+ + C D C NC C+ Y ++ C++++ FG E+
Sbjct: 361 DPVEHG--LPLLACHDICSKNCSCLGVFY--ENTSRSCYLVKD-SFGSLSLVKNSPENHD 415
Query: 414 STLFVK--IMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIP-----IVLSMTLLIGLLCL 466
+VK I + PG+N G S +V++P +++++ LL C
Sbjct: 416 LIGYVKLSIRKTNAQPPGNNNRGGSSFP-----VIALVLLPCSGFFLLIALGLLWWRRCA 470
Query: 467 LLYYNVHRKRFLKRAVE------NSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVY 520
++ Y+ R++ + R S + G P F + +L+ T NF +G+GGFGSVY
Sbjct: 471 VMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVY 530
Query: 521 KGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580
KG+L D TL+AVKK+ HG +EF TE+ IG++ H NLV+L G+C+ G LLVYE+
Sbjct: 531 KGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEY 590
Query: 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640
M +GSL+K +F VL+W RF+IA+ TA+G+AY H C +IIHCD+KPENILL
Sbjct: 591 MNHGSLEKTLFSG---NGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILL 647
Query: 641 DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLE 700
++F PK+SDFGL+KL+ +E S + T +RGTRGYLAPEW++N I+ KADVYSYGM+LLE
Sbjct: 648 HDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLE 707
Query: 701 IVGGRRNLDMSGDA----ED---------------FFYPGWAFKEMTNGTPLKVADRRLE 741
+V GR+N + ED ++P +A G +++AD RLE
Sbjct: 708 LVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLE 767
Query: 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPM 788
G V +E + +++A C+ +E +RP+M VV M EGS + P M
Sbjct: 768 GRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRM 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 353 bits (905), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 272/840 (32%), Positives = 418/840 (49%), Gaps = 112/840 (13%)
Query: 2 IGLGSRLLASQDQ----AWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSAN 57
+ +G L AS+ Q +W S +G FAFGF I D F L IWF+++ D+T+VW A
Sbjct: 32 VPVGESLTASESQQISSSWRSPSGDFAFGFRKI-QPNDGFTLSIWFDKI-SDKTIVWHAQ 89
Query: 58 RNFPVT----KDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILY---- 109
T + + L G LV+ D SG V ++ GNF+L+
Sbjct: 90 AVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALSGGSVSRGRFTDDGNFVLFRDGS 149
Query: 110 APNNQPVWQSFLHPSDTLLPNQPLSVSLELTSPKSLQN--GGYYSLKMLQQPTSLSLALT 167
+++ +W SF +P+DTLLPNQ + V L+S ++ + G +SL+ L+ +L L
Sbjct: 150 EDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLR-LEDDGNLQL--- 205
Query: 168 YNLPGSYDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQ 227
++L + + A+ Y+ + Y S + N G + V +++G ++ + +N V
Sbjct: 206 HSL--NAETASESDIYS-QYYESNTNDPNNPG-IQLVFNQSGEIYVL--QRNNSRFVVKD 259
Query: 228 NDGDYDGLASATNKSTRL---TVL----RRLILETNGNLRLYRWDNDVNGSRQWVPEWAA 280
D D+ +A+ ST T++ RR++ G L DN + P+ A
Sbjct: 260 RDPDF-SIAAPFYISTGFLLSTIIPKEARRIV---GGCLLGLCRDNMCS------PDDAL 309
Query: 281 VSNPCNIAGICGKGICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDP------ 334
+ C IC G + + C C + D S+ G C P
Sbjct: 310 GNMACGYNNICSLG------NNKRPKCEC-------PERFVLKDPSNEYGDCLPDFEMQT 356
Query: 335 -RHRNQSSHD----YRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVY 389
R NQ+++ Y ++++TN+ F +Y ANY + +C +CLS+C C A ++
Sbjct: 357 CRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDE----ERCKASCLSDCLCAAVIF 412
Query: 390 GLDDEKPYCWVLRSLDFGGFEDP--SSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTK 447
G + + CW + G P S F+K+ NRS+ G+ D
Sbjct: 413 GTNRDLK-CWKKKFPLSHGERSPRGDSDTFIKV-RNRSIADVPVTGNRAKKLDW------ 464
Query: 448 VVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLKRA---VENSLIVCGAPVN---------- 494
++++ ++L+G +++ R K++ ++N G
Sbjct: 465 -----LIIACSVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLR 519
Query: 495 -FTYRDLQIRTSNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGEKEFVTE 549
FTY +L T +F + LG G FG VYKG L G VAVKKLDR+ EKEF E
Sbjct: 520 VFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNE 579
Query: 550 VNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNI 609
V IG +HH NLVRL G+C+EG ++++VYEF+ G+L ++F R R W R NI
Sbjct: 580 VKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLF----RRPRP-SWEDRKNI 634
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
A+A A+GI Y HE+C +IIHCDIKP+NILLDE + P++SDFGLAKL+ + +T +R
Sbjct: 635 AVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIR 694
Query: 670 GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729
GT+GY+APEW N PIT K DVYSYG++LLEIV ++ +D+ ++ WA+
Sbjct: 695 GTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDLE---DNVILINWAYDCFRQ 751
Query: 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMP 789
G + + E + E + R +K+A WCIQ+E MRP+M V +MLEG + PP P
Sbjct: 752 GRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNP 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (833), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 264/835 (31%), Positives = 401/835 (48%), Gaps = 107/835 (12%)
Query: 4 LGSRLLAS--QDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPG----DRTVVWSAN 57
LGS L+ + S +GTF+ GF + F +W+++ ++T+VWSAN
Sbjct: 34 LGSSLVVESYESSTLQSSDGTFSSGFYEVYT--HAFTFSVWYSKTEAAAANNKTIVWSAN 91
Query: 58 RNFPV-TKDAILELDTTGNLVLNDGD-TTIW-ASNSSGAGVELATMSESGNFILYAPNNQ 114
+ PV + + L L GN+VL D D +W A ++ GV+ A + ++GN ++
Sbjct: 92 PDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGNLVIEDSGGN 151
Query: 115 PVWQSFLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLS-LALTYNLPGS 173
VWQSF P+DT LP Q ++ + L ++ G Y + + LS L+L Y++P
Sbjct: 152 TVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRF----SDLSVLSLIYHVPQV 207
Query: 174 YDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYD 233
D YW PD N+ D + G ++ V + D
Sbjct: 208 SDI-----------YWPDPD-QNLYQDGRNQYNSTR-----LGMLTDSGVLASSDFADGQ 250
Query: 234 GLASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICG- 292
L ++ V RRL L+ +GNLRLY ND +GS W A++ PCNI G+CG
Sbjct: 251 ALVAS---DVGPGVKRRLTLDPDGNLRLYSM-NDSDGS--WSVSMVAMTQPCNIHGLCGP 304
Query: 293 KGICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSS-VNGKCDPRHRNQSSHDYRIASVQQ 351
GIC+ + T C+C PG + + VN CD R+ +S R +
Sbjct: 305 NGICHYSPTPT---CSCPPGYATRNPGNWTEGCMAIVNTTCD-RYDKRS---MRFVRLPN 357
Query: 352 TNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVY--GLDDEKPYCWVLRSLDFGGF 409
T+++ + + + S + C D C+S+C C Y G P ++ F G
Sbjct: 358 TDFWGSDQQHLLSVS----LRTCRDICISDCTCKGFQYQEGTGSCYPKAYL-----FSGR 408
Query: 410 EDPSS---TLFVKIMS----NRSLTPGSNRGSGDSSEDSETRRTKVVVIPIV-------- 454
P+S T+++K+ + + +L P S+ R K + P
Sbjct: 409 TYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGG 468
Query: 455 -LSMTLLIGLLCLLLYYNVHRKRF-----LKRAVENSLIVCGAP---------VNFTYRD 499
G + V F LKR + S + ++YR+
Sbjct: 469 ESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSYRE 528
Query: 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM 559
L T F LG G G+VYKG L D VAVKKL+ V G++ F E++ IG ++HM
Sbjct: 529 LVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVR-QGKEVFQAELSVIGRINHM 587
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
NLVR+ G+CSEGS+RLLV E+++NGSL +F + +LDW RFNIA+ A+G+AY
Sbjct: 588 NLVRIWGFCSEGSHRLLVSEYVENGSLANILFS--EGGNILLDWEGRFNIALGVAKGLAY 645
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPE 678
H +C +IHCD+KPENILLD+ F PK++DFGL KL+ R S Q V+ VRGT GY+APE
Sbjct: 646 LHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPE 705
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA-- 736
WVS+ PIT K DVYSYG++LLE++ G R ++ G ++ +++ K+
Sbjct: 706 WVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHS---MLRKLVRMLSAKLEGE 762
Query: 737 ---------DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782
D +L V + +K+A C++++ RP+M V+ L + D
Sbjct: 763 EQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTLLSADD 817
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 249/824 (30%), Positives = 387/824 (46%), Gaps = 107/824 (12%)
Query: 17 ISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVT-KDAILELDTTGN 75
+S TF GF + RF LGIW+ + D+ VVW ANR P++ + +L + GN
Sbjct: 45 VSPQKTFELGFFSPGSSTHRF-LGIWYGNIE-DKAVVWVANRATPISDQSGVLMISNDGN 102
Query: 76 LVLNDG-DTTIWASNSSGAGV----ELATMSESGNFILYAPN-NQPVWQSFLHPSDTLLP 129
LVL DG + T+W+SN + + ++ ++GNF+L + ++P+W+SF HP+DT LP
Sbjct: 103 LVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLP 162
Query: 130 NQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPKAYANKSYW 189
+ V+ P++ N + S + P+ PG+Y P W
Sbjct: 163 QMRVRVN-----PQTGDNHAFVSWRSETDPS----------PGNYSLGVDPSGAPEIVLW 207
Query: 190 SGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQ--NDGDYDGLASATNKSTRLTV 247
G + A GI +Y ++ + D G T + +V
Sbjct: 208 EGNKTRKWRS---GQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSV 264
Query: 248 LRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGK-GICNLDRSKTKAS 306
L R + NG RW+ + ++W + + C+ CGK GIC++ S
Sbjct: 265 LLRFKVLYNGTEEELRWNETL---KKWTKFQSEPDSECDQYNRCGKFGICDMKGSN--GI 319
Query: 307 CTCLPGDSKIG----SDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEYSVI 362
C+C+ G ++ S G C + + KC+ + SV+ ++ PE++++
Sbjct: 320 CSCIHGYEQVSVGNWSRG-CRRRTPL--KCERNISVGEDEFLTLKSVKLPDFEIPEHNLV 376
Query: 363 ANYSDIATVSKCGDACLSNCQCVAS--VYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKI 420
C + CL NC C A V G+ W +D FE S+L +++
Sbjct: 377 -------DPEDCRERCLRNCSCNAYSLVGGIG---CMIWNQDLVDLQQFEAGGSSLHIRL 426
Query: 421 MSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRK----R 476
SE E R+TK+ VI VL +LIG+ LLL+ +K
Sbjct: 427 AD---------------SEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGA 471
Query: 477 FLKRAVENSLIVC---------------------GAPVN------FTYRDLQIRTSNFAQ 509
+ + + S++V G VN F+ + I T++F +
Sbjct: 472 YCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCK 531
Query: 510 L--LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
LG GGFG VYKG L DG +AVK+L G EF E+ I + H NLVRL G
Sbjct: 532 ENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGC 591
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
C EG ++LVYE+M N SLD ++F + ++DW RF+I A+G+ Y H R R
Sbjct: 592 CFEGEEKMLVYEYMPNKSLDFFLFD--ETKQALIDWKLRFSIIEGIARGLLYLHRDSRLR 649
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRGYLAPEWVSNRPIT 686
IIH D+K N+LLD PK+SDFG+A++ G ++ T+ V GT GY++PE+ +
Sbjct: 650 IIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFS 709
Query: 687 VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746
VK+DVYS+G+LLLEIV G+RN + +E G+A+ T+G ++ D ++ +
Sbjct: 710 VKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSK 768
Query: 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG-SADINTPPMP 789
E +R + VA C+QD RP+M V+ MLE +A + P P
Sbjct: 769 REALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9T058|Y4119_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g11900 OS=Arabidopsis thaliana GN=At4g11900 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 245/834 (29%), Positives = 387/834 (46%), Gaps = 118/834 (14%)
Query: 17 ISDNGTFAFG-FTPIVNIQDR--FQLGIWFNELPGDRTVVWSANRNFPVTKDA---ILEL 70
+S F G FTP + D + +G+W+ + +T+VW ANR P+ DA +L++
Sbjct: 43 VSSGDIFELGLFTPTPDTYDHRNYYIGMWYRHV-SPQTIVWVANRESPLGGDASTYLLKI 101
Query: 71 DTTGNLVLNDG---------------------------DTTIWAS--NSSGAGVELATMS 101
GNL+L+D T+W++ NSS + A +
Sbjct: 102 -LDGNLILHDNISATRKSHTEGTSRRSPQKISEGNLLFHETVWSTGVNSSMSKDVQAVLF 160
Query: 102 ESGNFILY-APNNQP--VWQSFLHPSDTLLPNQPLSVSLEL-TSPKSL--QNGGYYSLKM 155
+SGN +L PN+ +WQSF HPSDT LP + + +L TS +SL + G YSL+
Sbjct: 161 DSGNLVLRDGPNSSAAVLWQSFDHPSDTWLPGGKIRLGSQLFTSWESLIDPSPGRYSLEF 220
Query: 156 LQQPTSLSLALTYNLPGSYDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVY 215
P SL +N +KSYWS +G + L F +
Sbjct: 221 --DPKLHSLVTVWN--------------RSKSYWS-------SGPLYDWLQSFKGFPELQ 257
Query: 216 GESSNGAVYVYQNDGDYDGLASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWV 275
G + + D Y + + + +R RL++ +G L W D+ + W
Sbjct: 258 GTKLS---FTLNMDESY--ITFSVDPQSRY----RLVMGVSGQFMLQVWHVDL---QSWR 305
Query: 276 PEWAAVSNPCNIAGICGK-GICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDP 334
+ N C++ CG GICN +R C C+PG + S G D++ +G C
Sbjct: 306 VILSQPDNRCDVYNSCGSFGICNENREP--PPCRCVPGFKREFSQG-SDDSNDYSGGC-- 360
Query: 335 RHRNQSSHDYRIAS--VQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLD 392
R H Y+ + N A+ T C C+++C C A Y D
Sbjct: 361 -KRETYLHCYKRNDEFLPIENMKLATDPTTASVLTSGTFRTCASRCVADCSCQA--YAND 417
Query: 393 DEKPYCWVLRSLDFGGFEDPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIP 452
K W + + + F +++ +++ +NR +E + K +V+P
Sbjct: 418 GNKCLVWTKDAFNLQQLDANKGHTFFLRLASSNISTANNR-------KTEHSKGKSIVLP 470
Query: 453 IVLSMTL-----LIGLLCLLLYYNVHRKRFLK-----RAVENSLIVCGAPVNFTY---RD 499
+VL+ + +GL C + + RK+ + R + ++ A N Y D
Sbjct: 471 LVLASLVATAACFVGLYCCI-SSRIRRKKKQRDEKHSRELLEGGLIDDAGENMCYLNLHD 529
Query: 500 LQIRTSNFA--QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH 557
+ + T++F+ + LG GGFG VYKG L +G VA+K+L + G EF EV I +
Sbjct: 530 IMVATNSFSRKKKLGEGGFGPVYKGKLPNGMEVAIKRLSKKSSQGLTEFKNEVVLIIKLQ 589
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
H NLVRL GYC EG +LL+YE+M N SLD +F S R+ LDW TR I T +G+
Sbjct: 590 HKNLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRE--LDWETRMKIVNGTTRGL 647
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG-REHSQVVTMVRGTRGYLA 676
Y HE R RIIH D+K NILLD+ PK+SDFG A++ G ++ + GT GY++
Sbjct: 648 QYLHEYSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMS 707
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736
PE+ I+ K+D+YS+G+LLLEI+ G++ + + + ++ + +
Sbjct: 708 PEYALGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYEWESWCETKGVSII 767
Query: 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQ 790
D + + EE MR + +A C+QD RP + ++V ML ++ NT P+P+
Sbjct: 768 DEPMCCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYML---SNDNTLPIPK 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 839 | ||||||
| 255545116 | 858 | ATP binding protein, putative [Ricinus c | 0.985 | 0.963 | 0.817 | 0.0 | |
| 225464707 | 857 | PREDICTED: G-type lectin S-receptor-like | 0.989 | 0.968 | 0.774 | 0.0 | |
| 357443771 | 1950 | Cysteine-rich receptor-like protein kina | 0.996 | 0.428 | 0.745 | 0.0 | |
| 356535826 | 863 | PREDICTED: G-type lectin S-receptor-like | 0.992 | 0.965 | 0.766 | 0.0 | |
| 356574526 | 863 | PREDICTED: G-type lectin S-receptor-like | 0.992 | 0.965 | 0.763 | 0.0 | |
| 449523846 | 954 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.874 | 0.744 | 0.0 | |
| 449463479 | 1030 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.809 | 0.744 | 0.0 | |
| 302143739 | 844 | unnamed protein product [Vitis vinifera] | 0.932 | 0.926 | 0.741 | 0.0 | |
| 147856526 | 1058 | hypothetical protein VITISV_016002 [Viti | 0.960 | 0.761 | 0.740 | 0.0 | |
| 75171544 | 872 | RecName: Full=G-type lectin S-receptor-l | 0.983 | 0.946 | 0.681 | 0.0 |
| >gi|255545116|ref|XP_002513619.1| ATP binding protein, putative [Ricinus communis] gi|223547527|gb|EEF49022.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1416 bits (3665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 684/837 (81%), Positives = 755/837 (90%), Gaps = 10/837 (1%)
Query: 4 LGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVT 63
LGSRLLA +D+AW+SDNGTFAFGFT N + RFQL IWF +LPGDRTVVWS NRN VT
Sbjct: 31 LGSRLLAREDRAWVSDNGTFAFGFTQADN-RHRFQLAIWFADLPGDRTVVWSPNRNSLVT 89
Query: 64 KDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILY-APNNQPVWQSFLH 122
+DA LELD TGNL+L DGDTT+W SN+S +GVE A M+ESGNF+LY + N VWQSF H
Sbjct: 90 EDASLELDATGNLILVDGDTTVWMSNTSDSGVETAVMTESGNFVLYGSSTNHSVWQSFEH 149
Query: 123 PSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPKA 182
PSDTLLPNQPL+VSLELTSPKS +GGYYSLKMLQQPTSLSLALTYNLP SYDA SP+A
Sbjct: 150 PSDTLLPNQPLTVSLELTSPKSPIDGGYYSLKMLQQPTSLSLALTYNLPESYDA--SPEA 207
Query: 183 YANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNKS 242
YAN SYW GPDISNVTGDV+AVL+EAGSFGIVYGESS+GAVYVY+NDGDY+GL+S+TN+S
Sbjct: 208 YANYSYWPGPDISNVTGDVLAVLNEAGSFGIVYGESSSGAVYVYKNDGDYNGLSSSTNQS 267
Query: 243 TRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLDRSK 302
TRL+V+RRLILE+NGNLRLYRWDNDVNGSRQWVPEWAAVSNPC+IAG+CG GICNLDRSK
Sbjct: 268 TRLSVIRRLILESNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCDIAGVCGNGICNLDRSK 327
Query: 303 TKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEYSVI 362
T ASCTCLPG SK+ + CS+NS + GKCD + NQ+S D++IA+VQQTNYYFP++SVI
Sbjct: 328 TNASCTCLPGTSKVDNGIQCSENSLLIGKCDSPNVNQTS-DFKIAAVQQTNYYFPDFSVI 386
Query: 363 ANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKIMS 422
ANYSDI TVSKCGDACLS C+CVASVYGLDDEKPYCW+L SLDFGG+EDP STLFVK+ S
Sbjct: 387 ANYSDIPTVSKCGDACLSACECVASVYGLDDEKPYCWLLGSLDFGGYEDPGSTLFVKVKS 446
Query: 423 NRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLKRAV 482
N L G SGD S S + KV+V+PIVLS+T + GLLCLLLYYNVHRKR L+RA+
Sbjct: 447 N-GLLEGDKEESGDGSGIS---KEKVLVLPIVLSVTFIFGLLCLLLYYNVHRKRALRRAM 502
Query: 483 ENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG 542
EN+LI+ GAP+NF+YRDLQI TSNF+QLLGTGGFGSVYKGSL DGTL+AVKKLD+VLPHG
Sbjct: 503 ENALILSGAPINFSYRDLQIHTSNFSQLLGTGGFGSVYKGSLSDGTLIAVKKLDKVLPHG 562
Query: 543 EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD 602
+KEF+TEVNTIGSMHHMNLVRLCGYCSEGS RLLVYEF KNGSLDKWIFPSY+ RDR+LD
Sbjct: 563 QKEFITEVNTIGSMHHMNLVRLCGYCSEGSQRLLVYEFTKNGSLDKWIFPSYNCRDRLLD 622
Query: 603 WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662
WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS
Sbjct: 623 WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 682
Query: 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW 722
VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI+GGRRNLDMS DA+DFFYPGW
Sbjct: 683 HVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIIGGRRNLDMSYDAQDFFYPGW 742
Query: 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782
AFKEMTNG P+K ADRRLEGAV+EEELMRA+KVAFWCIQDEVF RPSMGEVVKMLEGS D
Sbjct: 743 AFKEMTNGMPMKAADRRLEGAVKEEELMRALKVAFWCIQDEVFTRPSMGEVVKMLEGSMD 802
Query: 783 INTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYSSMSPR 839
INTPPMPQTVLELIEEGLDHVYKAMKR+FNQFSSFT ++TH SSHATCSYS+MSPR
Sbjct: 803 INTPPMPQTVLELIEEGLDHVYKAMKREFNQFSSFT-TATTHPSSHATCSYSTMSPR 858
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225464707|ref|XP_002275726.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1343 bits (3476), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/839 (77%), Positives = 740/839 (88%), Gaps = 9/839 (1%)
Query: 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFP 61
+GLG+RL+A +++AW+S+NGTFAFGF+P V DR+QLGIWF +LPGDRT+VWSA+RN P
Sbjct: 27 VGLGARLVAKENRAWVSENGTFAFGFSP-VESDDRYQLGIWFGQLPGDRTMVWSASRNSP 85
Query: 62 VTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSFL 121
V KDA+LELD+TGNL+L DGD T+W+SN+SG GVE A MSESGNFILY N P+WQSF
Sbjct: 86 VGKDAVLELDSTGNLLLLDGDATVWSSNTSGEGVETAYMSESGNFILYNGTNFPLWQSFS 145
Query: 122 HPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPK 181
HPSDTLLPNQPL+ S+ELTS S +GGYY+L+MLQQPTSLSL L YNLP SY S +
Sbjct: 146 HPSDTLLPNQPLTASMELTS-SSPAHGGYYTLQMLQQPTSLSLGLIYNLPDSY--ITSLQ 202
Query: 182 AYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNK 241
+YAN SYWSGPDISNVTGDVVAVLDEAGSFGI+YG SS+GAVYVY++D D GL+S+ N+
Sbjct: 203 SYANYSYWSGPDISNVTGDVVAVLDEAGSFGIMYGSSSDGAVYVYKSDTDEKGLSSSVNQ 262
Query: 242 STRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLDRS 301
+ R VLRRLILE NGNLRLYRWD+DVNG+RQWVPEWAAVSNPC+IAG+CG G+C+LDRS
Sbjct: 263 TVRPLVLRRLILEMNGNLRLYRWDDDVNGTRQWVPEWAAVSNPCDIAGVCGNGVCSLDRS 322
Query: 302 KTKASCTCLPGDSKIGSDGLCSDNSSVN-GKCDPRHRNQSSHDYRIASVQQTNYYFPEYS 360
KT ASCTCLPG SK+G G CS+NSSV+ GKCD HRN ++ +++ VQQTNYY+PE S
Sbjct: 323 KTNASCTCLPGSSKVGDSGQCSENSSVSTGKCDNNHRNSTASKLKMSIVQQTNYYYPESS 382
Query: 361 VIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKI 420
+IANYS+++ +SKCGDACLS+C CVASVYGL +EKPYCW+L SL+FGGFED SSTLFVK+
Sbjct: 383 IIANYSNMSPLSKCGDACLSDCDCVASVYGLSEEKPYCWLLNSLEFGGFEDTSSTLFVKV 442
Query: 421 MSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLKR 480
N S G+ GSGDSS+ R KV+V+PIVLSM +L+ LLC LLY+ V+R+R LKR
Sbjct: 443 GPNGS-PEGNATGSGDSSDG---LRDKVLVLPIVLSMIVLVALLCFLLYHTVYRRRALKR 498
Query: 481 AVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP 540
++E+SLIV GAP+NF+YRDLQ RT NF+QLLGTGGFGSVYKGSL DGTLVAVKKLD+VLP
Sbjct: 499 SLESSLIVSGAPMNFSYRDLQSRTGNFSQLLGTGGFGSVYKGSLSDGTLVAVKKLDKVLP 558
Query: 541 HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV 600
HGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWIFPS H RDR+
Sbjct: 559 HGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWIFPSKHCRDRL 618
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
LDW TRF+IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE
Sbjct: 619 LDWGTRFHIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 678
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720
HS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM+ DAEDFFYP
Sbjct: 679 HSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMTFDAEDFFYP 738
Query: 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780
GWAFKEM+NGT KVADRRLEGAVEEEEL RA+K FWCIQDEVFMRPSMGEVVKMLEGS
Sbjct: 739 GWAFKEMSNGTTRKVADRRLEGAVEEEELERALKTGFWCIQDEVFMRPSMGEVVKMLEGS 798
Query: 781 ADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYSSMSPR 839
+INTPPMPQTVLEL+EEGLD+VY+AMKR+FNQ S FTIN+STH SS ATCSYS+MSPR
Sbjct: 799 LEINTPPMPQTVLELMEEGLDNVYRAMKREFNQSSFFTINNSTHPSSRATCSYSTMSPR 857
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357443771|ref|XP_003592163.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355481211|gb|AES62414.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1307 bits (3382), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 630/845 (74%), Positives = 722/845 (85%), Gaps = 9/845 (1%)
Query: 1 HIGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNF 60
IGLGSRLLAS+DQ W+SDNGTFA GFTP F LGIWF LPGDRT VWS NRN
Sbjct: 1109 QIGLGSRLLASKDQVWVSDNGTFAMGFTPSKTDNHLFTLGIWFARLPGDRTFVWSPNRNS 1168
Query: 61 PVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSF 120
P++ +AILELDTTGNL+L D TIWA+N+S A VE ATMSESGNFIL+ NN P+WQSF
Sbjct: 1169 PISHEAILELDTTGNLILMDKKITIWATNTSNANVESATMSESGNFILHNINNHPIWQSF 1228
Query: 121 LHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAAN-S 179
PS+TLLPNQPL+VS ELTSPKS +GGYY+LKMLQQPTSLSLALTYNLP +Y + +
Sbjct: 1229 SQPSNTLLPNQPLTVSSELTSPKSSSHGGYYALKMLQQPTSLSLALTYNLPETYQTLDEN 1288
Query: 180 PKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASAT 239
+YAN SYW GP+ISN TG+V+AVLD+AGSFGIVYG+SS+GAVYVY+ND D GLASA
Sbjct: 1289 ESSYANYSYWQGPEISNATGEVIAVLDQAGSFGIVYGDSSDGAVYVYKNDNDDAGLASAI 1348
Query: 240 NKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLD 299
++ST LTVLRRL LE NGNLRLYRW+ DVNGS+QWV +WAAVSNPC+I GICG G+C LD
Sbjct: 1349 HQSTPLTVLRRLTLEENGNLRLYRWE-DVNGSKQWVTQWAAVSNPCDIGGICGNGVCKLD 1407
Query: 300 RSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEY 359
R+KT ASCTCLPG SK G DG C +NSS+ GKC + +RI+ VQQTNYYF E
Sbjct: 1408 RTKTNASCTCLPGTSKAGRDGQCYENSSLVGKCTNGQNENMTSKFRISMVQQTNYYFSES 1467
Query: 360 SVIANYS--DIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLF 417
S+IAN+S D++++SKCGDACLS+C CVASVYGL++E+P+CWVLRSL+FGGFED SSTLF
Sbjct: 1468 SIIANFSESDVSSLSKCGDACLSDCDCVASVYGLNEERPFCWVLRSLNFGGFEDTSSTLF 1527
Query: 418 VKIMSNRSLTP-GSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKR 476
VK+ +N S TP G + S SS+ + + K V+IPIVL M +LI LLC+LLYY+VHRKR
Sbjct: 1528 VKVRANSSWTPEGQDGSSNSSSDGMGSAKEKAVIIPIVLGMIVLIFLLCMLLYYSVHRKR 1587
Query: 477 FLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLD 536
LKR +E+SL++ GAP+NFTYR LQIRTSNF+QLLGTGGFGSVYKGSLGDGTL+AVKKLD
Sbjct: 1588 TLKREMESSLVLSGAPMNFTYRALQIRTSNFSQLLGTGGFGSVYKGSLGDGTLIAVKKLD 1647
Query: 537 RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHH 596
++LPHGEKEF+TEVNTIGSMHHMNLVRLCG+CSEG +RLLVYEFMKNGSLDKWIFPSY
Sbjct: 1648 KILPHGEKEFITEVNTIGSMHHMNLVRLCGFCSEGPHRLLVYEFMKNGSLDKWIFPSYRG 1707
Query: 597 RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656
RDR+LDW TRF+IAI TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL
Sbjct: 1708 RDRLLDWQTRFDIAINTAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 1767
Query: 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
M REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI+GGRRNLD+S DAED
Sbjct: 1768 MAREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIIGGRRNLDLSFDAED 1827
Query: 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776
FFYPGWA+KEM NG+ +KVADR L GAV+EEEL RA+K+ FWCIQD+V MRP+MGEVV++
Sbjct: 1828 FFYPGWAYKEMANGSAIKVADRSLNGAVDEEELTRALKIGFWCIQDDVSMRPTMGEVVRL 1887
Query: 777 LE--GSADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYS 834
LE GS +IN PPMPQTVLELIEEGLDHVYKAMKR++N +SSFTI S HL+SHATCS S
Sbjct: 1888 LEGQGSNNINMPPMPQTVLELIEEGLDHVYKAMKREYNHYSSFTITS--HLTSHATCSNS 1945
Query: 835 SMSPR 839
+MSPR
Sbjct: 1946 TMSPR 1950
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535826|ref|XP_003536444.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1306 bits (3381), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 645/841 (76%), Positives = 730/841 (86%), Gaps = 8/841 (0%)
Query: 1 HIGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNF 60
IGLGS+LLAS+ Q W+S+NGTFA GFTP +GIWF +LPGD T+VWS NR+
Sbjct: 29 QIGLGSQLLASKAQTWVSENGTFALGFTPAETDNRLLVIGIWFAQLPGDPTLVWSPNRDT 88
Query: 61 PVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSF 120
PV+++A LELDTTGNLVL DGDTT+W SN+SGA V+ ATMSE+GNFIL++ NN VWQSF
Sbjct: 89 PVSQEAALELDTTGNLVLMDGDTTVWTSNTSGADVQTATMSETGNFILHSTNNHSVWQSF 148
Query: 121 LHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSP 180
PSDTLLPNQ L+VS ELTS KS +GGYY+LKMLQQPTSLSLALTYNLP +Y A S
Sbjct: 149 SQPSDTLLPNQLLTVSSELTSSKSSSHGGYYALKMLQQPTSLSLALTYNLPETYQA--SD 206
Query: 181 KAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYD-GLASAT 239
++Y N SYW GPDISNVTG+V+ VLD+AGSFGIVYG+SS+GAVYVY+NDG D GL+SA
Sbjct: 207 ESYTNYSYWQGPDISNVTGEVIVVLDQAGSFGIVYGDSSDGAVYVYKNDGGDDAGLSSAV 266
Query: 240 NKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLD 299
++S LTVLRRL LE NGNLRLYRWD +VNGSRQWVP+WAAVSNPC+IAG+CG G+CNLD
Sbjct: 267 HQSAPLTVLRRLTLEKNGNLRLYRWD-EVNGSRQWVPQWAAVSNPCDIAGVCGNGVCNLD 325
Query: 300 RSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEY 359
RSKTKA+CTCLPG +K+G DG C +NSS+ GKC+ +H N +S RI++VQQTNYYF E+
Sbjct: 326 RSKTKATCTCLPGTAKVGRDGQCYENSSLVGKCNGKHENLTSQ-LRISTVQQTNYYFSEF 384
Query: 360 SVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVK 419
SVIANYSDI+ VSKCGDACL +C CVASVYGL++E+PYCWVLRSL FGGFED SSTLFVK
Sbjct: 385 SVIANYSDISNVSKCGDACLLDCDCVASVYGLNEERPYCWVLRSLSFGGFEDTSSTLFVK 444
Query: 420 IMSNRSLT-PGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFL 478
+ +N S T G GS SS+ + + K V+IP VLSM +LI LL LLLYY VHRKR L
Sbjct: 445 VRANGSWTLEGQEGGSNSSSDGMGSAKEKAVIIPTVLSMVVLIVLLSLLLYYTVHRKRTL 504
Query: 479 KRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRV 538
KR +E+SLI+ GAP+NFTYRDLQIRT NF+QLLGTGGFGSVYKGSLGDGTLVAVKKLDRV
Sbjct: 505 KREMESSLILSGAPMNFTYRDLQIRTCNFSQLLGTGGFGSVYKGSLGDGTLVAVKKLDRV 564
Query: 539 LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD 598
LPHGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWIFPSY RD
Sbjct: 565 LPHGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWIFPSYQARD 624
Query: 599 RVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658
R+LDWTTRFNIAIATAQGIAYFHEQCR+RIIHCDIKPENIL+DENFCPKVSDFGLAKLMG
Sbjct: 625 RLLDWTTRFNIAIATAQGIAYFHEQCRDRIIHCDIKPENILVDENFCPKVSDFGLAKLMG 684
Query: 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF 718
REHS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI+GGRRNLDMS AEDFF
Sbjct: 685 REHSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIIGGRRNLDMSFGAEDFF 744
Query: 719 YPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
YPGWA+KEMTNG+ +KVAD+RL GAV+EEE+ RA+KVAFWCIQDEV MRP+MGEVV++LE
Sbjct: 745 YPGWAYKEMTNGSIIKVADKRLNGAVDEEEVTRALKVAFWCIQDEVSMRPTMGEVVRLLE 804
Query: 779 GSADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYSSMSP 838
S DIN PPMPQTVLELIEEGLD VYKAMKR++NQ SSFTI S HL+SHATCS S+MSP
Sbjct: 805 DSIDINMPPMPQTVLELIEEGLDQVYKAMKREYNQSSSFTITS--HLTSHATCSNSTMSP 862
Query: 839 R 839
R
Sbjct: 863 R 863
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574526|ref|XP_003555397.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1301 bits (3367), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 641/840 (76%), Positives = 727/840 (86%), Gaps = 7/840 (0%)
Query: 1 HIGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNF 60
IGLGSRLLA + Q W+S+NGTFA GFTP F +GIWF LPGDRT+VWS NR+
Sbjct: 30 QIGLGSRLLAREAQTWVSENGTFALGFTPAETDNRLFVIGIWFARLPGDRTLVWSPNRDN 89
Query: 61 PVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSF 120
PV+++A LELDTTGNLVL DG T+W SN+SGA V+ A M+E+GNFIL+ NN VWQSF
Sbjct: 90 PVSQEAALELDTTGNLVLMDGHMTMWTSNTSGADVQTAIMAETGNFILHNSNNHSVWQSF 149
Query: 121 LHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSP 180
PSDTLLPNQ L+VS ELTS KS GGYYSLKMLQQPTSLSLALTYNLP +Y A S
Sbjct: 150 SQPSDTLLPNQLLTVSSELTSSKSSSQGGYYSLKMLQQPTSLSLALTYNLPETYQA--SD 207
Query: 181 KAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATN 240
++Y N SYW GPDISNVTG+V+AVLD+AGSFGIVYG+SS+GAVYVY+NDGD GL+SA +
Sbjct: 208 ESYTNYSYWQGPDISNVTGEVIAVLDQAGSFGIVYGDSSDGAVYVYKNDGDDAGLSSAVH 267
Query: 241 KSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLDR 300
+S LTVLRRL LE NGNLRLYRWD +VNGSRQWVP+WAAVSNPC+IAG+CG G+CNLDR
Sbjct: 268 QSAPLTVLRRLTLEKNGNLRLYRWD-EVNGSRQWVPQWAAVSNPCDIAGVCGNGVCNLDR 326
Query: 301 SKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYYFPEYS 360
SKTKA+CTCLPG SK+G DG C +NSS+ G C+ +H N +S +RI++VQQTNYYF E+S
Sbjct: 327 SKTKATCTCLPGTSKVGRDGQCYENSSLVGNCNGKHENLTSQ-FRISAVQQTNYYFSEFS 385
Query: 361 VIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKI 420
VI NYSDI+ VSKCGDACLS+C CVASVYGL++E+P+CWVLRSL FGGFED SSTLFVK+
Sbjct: 386 VITNYSDISNVSKCGDACLSDCDCVASVYGLNEERPFCWVLRSLSFGGFEDTSSTLFVKV 445
Query: 421 MSNRSLT-PGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLK 479
+N S T G GS SS+ + + K V+IP VLSM +LI LL LLLY++VHRKR LK
Sbjct: 446 RANGSWTSEGQAGGSNSSSDGMGSAKEKAVIIPTVLSMVVLIVLLSLLLYFSVHRKRTLK 505
Query: 480 RAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL 539
R +E+SLI+ GAP++FTYR+LQIRT NF+QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL
Sbjct: 506 REMESSLILSGAPMSFTYRNLQIRTCNFSQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL 565
Query: 540 PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR 599
PHGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWIFPSY RDR
Sbjct: 566 PHGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWIFPSYQGRDR 625
Query: 600 VLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659
+LDWTTRFNIAIATAQGIAYFHEQCR+RIIHCDIKPENIL+DENFCPKVSDFGLAKLMGR
Sbjct: 626 LLDWTTRFNIAIATAQGIAYFHEQCRDRIIHCDIKPENILVDENFCPKVSDFGLAKLMGR 685
Query: 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
EHS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI+GGRRNLDMS AEDFFY
Sbjct: 686 EHSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIIGGRRNLDMSFGAEDFFY 745
Query: 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779
PGWA+KEMTNG+ +KVADRRL GAV+EEEL RA+KVAFWCIQDEV MRP+MGEVV++LE
Sbjct: 746 PGWAYKEMTNGSIIKVADRRLNGAVDEEELTRALKVAFWCIQDEVSMRPTMGEVVRLLED 805
Query: 780 SADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYSSMSPR 839
S DIN PPMPQTV+ELIEEGLDHVYKAMKR++NQ SSFT+ S HL+S ATCS S+MSPR
Sbjct: 806 SIDINMPPMPQTVVELIEEGLDHVYKAMKREYNQSSSFTLTS--HLTSQATCSNSTMSPR 863
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523846|ref|XP_004168934.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1276 bits (3302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/849 (74%), Positives = 723/849 (85%), Gaps = 15/849 (1%)
Query: 1 HIGLGSRLLAS-QDQAWISDNGTFAFGFTPIV----NIQDRFQLGIWFNELPGDRTVVWS 55
IG+ SRL AS +Q W+SDN TFAFGF+P+ N+ DRF L IWF ELPGDRTV+WS
Sbjct: 111 QIGIRSRLFASDHNQVWLSDNRTFAFGFSPLSSSGDNVNDRFLLAIWFAELPGDRTVIWS 170
Query: 56 ANRNFPVTKDAILELDTTGNLVLNDGD--TTIWASNSSGAGVELATMSESGNFILYAPNN 113
ANRN PV+K+AI+ELD TGNLVL DG + +W+SN+SG G E A MSESGNFIL+
Sbjct: 171 ANRNSPVSKNAIVELDVTGNLVLTDGAAASVVWSSNTSGDGAEYAVMSESGNFILFNAER 230
Query: 114 QPVWQSFLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGS 173
PVWQSF HPSDTLLPNQPLSVSLELT+ KS +GGYY+LKMLQQ T+L LALT+NLP S
Sbjct: 231 SPVWQSFSHPSDTLLPNQPLSVSLELTTSKSPSHGGYYTLKMLQQRTTLKLALTFNLPES 290
Query: 174 YDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYD 233
Y+ P++YAN SYWS P+ISNVTG+V+AVLDE GSFG+VYG+SSNGAVYVY+ND D
Sbjct: 291 YEGL--PESYANYSYWSAPEISNVTGEVIAVLDEGGSFGVVYGDSSNGAVYVYKNDNDNG 348
Query: 234 GLASATNKS---TRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGI 290
GL+++TN+S R V+RRL LE+NGNLRLYRWD+DVNGSRQWVPEWAAVSNPC+IAGI
Sbjct: 349 GLSASTNQSIRNVRTQVVRRLTLESNGNLRLYRWDDDVNGSRQWVPEWAAVSNPCDIAGI 408
Query: 291 CGKGICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQ 350
CG GIC LD+SKT ASC+CLPG K C +NSS GKC ++ SS +RI+ VQ
Sbjct: 409 CGNGICYLDKSKTNASCSCLPGTFKDNGGSQCFENSSSVGKCGGQNHQSSSTQFRISPVQ 468
Query: 351 QTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFE 410
QTNYY+ E+SVIANYSDI TV+KCGDACL++C+CVASVYGLDDEKPYCWVLRSLDFGGFE
Sbjct: 469 QTNYYYSEFSVIANYSDINTVAKCGDACLTDCECVASVYGLDDEKPYCWVLRSLDFGGFE 528
Query: 411 DPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYY 470
D STLFVK+ SN S+ P +N G + K VIPIVLSM LIGLLCLLLYY
Sbjct: 529 DAGSTLFVKVKSNGSI-PEANGPGGGGDSSGSAKE-KATVIPIVLSMAFLIGLLCLLLYY 586
Query: 471 NVHRKRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLV 530
NV R+R +KRA+E+SLI+ GAP++FT+RDLQ+RT+NF+++LGTGGFGSVYKGSLGDGTLV
Sbjct: 587 NVRRRRAMKRAMESSLILSGAPISFTHRDLQVRTNNFSEVLGTGGFGSVYKGSLGDGTLV 646
Query: 531 AVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI 590
AVKKLDRV PHGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWI
Sbjct: 647 AVKKLDRVFPHGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWI 706
Query: 591 FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650
FPS+H++DR+LDW+TRF+IA+ TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD
Sbjct: 707 FPSHHNQDRILDWSTRFHIAVGTAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 766
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710
FGLAKLMGREHS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM
Sbjct: 767 FGLAKLMGREHSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 826
Query: 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770
S DAEDFFYPGWA+KEM N T KVADRRLEGAVEE+ELMRA+KVAFWCIQDEV RP+M
Sbjct: 827 SFDAEDFFYPGWAYKEMRNETHFKVADRRLEGAVEEKELMRALKVAFWCIQDEVVTRPTM 886
Query: 771 GEVVKMLEGSADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHAT 830
G++V+MLEGS D++ PPMPQTV+EL+EEGLD VY+AMKRD NQ SSFTINS SS AT
Sbjct: 887 GDIVRMLEGSMDVDMPPMPQTVVELVEEGLDQVYRAMKRDTNQSSSFTINSQPS-SSLAT 945
Query: 831 CSYSSMSPR 839
CS+S++SPR
Sbjct: 946 CSHSTISPR 954
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463479|ref|XP_004149461.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1275 bits (3299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/849 (74%), Positives = 723/849 (85%), Gaps = 15/849 (1%)
Query: 1 HIGLGSRLLAS-QDQAWISDNGTFAFGFTPIV----NIQDRFQLGIWFNELPGDRTVVWS 55
IG+ SRL AS +Q W+SDN TFAFGF+P+ N+ DRF L IWF ELPGDRTV+WS
Sbjct: 187 QIGIRSRLFASDHNQVWLSDNRTFAFGFSPLSSSGDNVNDRFLLAIWFAELPGDRTVIWS 246
Query: 56 ANRNFPVTKDAILELDTTGNLVLNDGD--TTIWASNSSGAGVELATMSESGNFILYAPNN 113
ANRN PV+K+AI+ELD TGNLVL DG + +W+SN+SG G E A MSESGNFIL+
Sbjct: 247 ANRNSPVSKNAIVELDVTGNLVLTDGAAASVVWSSNTSGDGAEYAVMSESGNFILFNAER 306
Query: 114 QPVWQSFLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGS 173
PVWQSF HPSDTLLPNQPLSVSLELT+ KS +GGYY+LKMLQQ T+L LALT+NLP S
Sbjct: 307 SPVWQSFSHPSDTLLPNQPLSVSLELTTSKSPSHGGYYTLKMLQQRTTLKLALTFNLPES 366
Query: 174 YDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYD 233
Y+ P++YAN SYWS P+ISNVTG+V+AVLDE GSFG+VYG+SSNGAVYVY+ND D
Sbjct: 367 YEGL--PESYANYSYWSAPEISNVTGEVIAVLDEGGSFGVVYGDSSNGAVYVYKNDNDNG 424
Query: 234 GLASATNKS---TRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGI 290
GL+++TN+S R V+RRL LE+NGNLRLYRWD+DVNGSRQWVPEWAAVSNPC+IAGI
Sbjct: 425 GLSASTNQSIRNVRTQVVRRLTLESNGNLRLYRWDDDVNGSRQWVPEWAAVSNPCDIAGI 484
Query: 291 CGKGICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQSSHDYRIASVQ 350
CG GIC LD+SKT ASC+CLPG K C +NSS GKC ++ SS +RI+ VQ
Sbjct: 485 CGNGICYLDKSKTNASCSCLPGTFKDNGGSQCFENSSSVGKCGGQNHQSSSTQFRISPVQ 544
Query: 351 QTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFE 410
QTNYY+ E+SVIANYSDI TV+KCGDACL++C+CVASVYGLDDEKPYCWVLRSLDFGGFE
Sbjct: 545 QTNYYYSEFSVIANYSDINTVAKCGDACLTDCECVASVYGLDDEKPYCWVLRSLDFGGFE 604
Query: 411 DPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYY 470
D STLFVK+ SN S+ P +N G + K VIPIVLSM LIGLLCLLLYY
Sbjct: 605 DAGSTLFVKVKSNGSI-PEANGPGGGGDSSGSAKE-KATVIPIVLSMAFLIGLLCLLLYY 662
Query: 471 NVHRKRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLV 530
NV R+R +KRA+E+SLI+ GAP++FT+RDLQ+RT+NF+++LGTGGFGSVYKGSLGDGTLV
Sbjct: 663 NVRRRRAMKRAMESSLILSGAPISFTHRDLQVRTNNFSEVLGTGGFGSVYKGSLGDGTLV 722
Query: 531 AVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI 590
AVKKLDRV PHGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWI
Sbjct: 723 AVKKLDRVFPHGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWI 782
Query: 591 FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650
FPS+H++DR+LDW+TRF+IA+ TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD
Sbjct: 783 FPSHHNQDRILDWSTRFHIAVGTAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 842
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710
FGLAKLMGREHS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM
Sbjct: 843 FGLAKLMGREHSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 902
Query: 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770
S DAEDFFYPGWA+KEM N T KVADRRLEGAVEE+ELMRA+KVAFWCIQDEV RP+M
Sbjct: 903 SFDAEDFFYPGWAYKEMRNETHFKVADRRLEGAVEEKELMRALKVAFWCIQDEVVTRPTM 962
Query: 771 GEVVKMLEGSADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHAT 830
G++V+MLEGS D++ PPMPQTV+EL+EEGLD VY+AMKRD NQ SSFTINS SS AT
Sbjct: 963 GDIVRMLEGSMDVDMPPMPQTVVELVEEGLDQVYRAMKRDTNQSSSFTINSQPS-SSLAT 1021
Query: 831 CSYSSMSPR 839
CS+S++SPR
Sbjct: 1022 CSHSTISPR 1030
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143739|emb|CBI22600.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1243 bits (3217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 608/820 (74%), Positives = 697/820 (85%), Gaps = 38/820 (4%)
Query: 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFP 61
+GLG+RL+A +++AW+S+NGTFAFGF+P V DR+QLGIWF +LPGDRT+VWSA+RN P
Sbjct: 27 VGLGARLVAKENRAWVSENGTFAFGFSP-VESDDRYQLGIWFGQLPGDRTMVWSASRNSP 85
Query: 62 VTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSFL 121
V KDA+LELD+TGNL+L DGD T+W+SN+SG GVE A MSESGNFILY N P+WQSF
Sbjct: 86 VGKDAVLELDSTGNLLLLDGDATVWSSNTSGEGVETAYMSESGNFILYNGTNFPLWQSFS 145
Query: 122 HPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPK 181
HPSDTLLPNQPL+ S+ELTS S +GGYY+L+MLQQPTSLSL L YNLP SY
Sbjct: 146 HPSDTLLPNQPLTASMELTS-SSPAHGGYYTLQMLQQPTSLSLGLIYNLPDSY------- 197
Query: 182 AYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNK 241
I+++ FGI+YG SS+GAVYVY++D D GL+S+ N+
Sbjct: 198 ------------ITSL------------HFGIMYGSSSDGAVYVYKSDTDEKGLSSSVNQ 233
Query: 242 STRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLDRS 301
+ R VLRRLILE NGNLRLYRWD+DVNG+RQWVPEWAAVSNPC+IAG+CG G+C+LDRS
Sbjct: 234 TVRPLVLRRLILEMNGNLRLYRWDDDVNGTRQWVPEWAAVSNPCDIAGVCGNGVCSLDRS 293
Query: 302 KTKASCTCLPGDSKIGSDGLCSDNSSVN-GKCDPRHRNQSSHDYRIASVQQTNYYFPEYS 360
KT ASCTCLPG SK+G G CS+NSSV+ GKCD HRN ++ +++ VQQTNYY+PE S
Sbjct: 294 KTNASCTCLPGSSKVGDSGQCSENSSVSTGKCDNNHRNSTASKLKMSIVQQTNYYYPESS 353
Query: 361 VIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKI 420
+IANYS+++ +SKCGDACLS+C CVASVYGL +EKPYCW+L SL+FGGFED SSTLFVK+
Sbjct: 354 IIANYSNMSPLSKCGDACLSDCDCVASVYGLSEEKPYCWLLNSLEFGGFEDTSSTLFVKV 413
Query: 421 MSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLKR 480
N S G+ GSGDSS+ R KV+V+PIVLSM +L+ LLC LLY+ V+R+R LKR
Sbjct: 414 GPNGS-PEGNATGSGDSSDG---LRDKVLVLPIVLSMIVLVALLCFLLYHTVYRRRALKR 469
Query: 481 AVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP 540
++E+SLIV GAP+NF+YRDLQ RT NF+QLLGTGGFGSVYKGSL DGTLVAVKKLD+VLP
Sbjct: 470 SLESSLIVSGAPMNFSYRDLQSRTGNFSQLLGTGGFGSVYKGSLSDGTLVAVKKLDKVLP 529
Query: 541 HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV 600
HGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWIFPS H RDR+
Sbjct: 530 HGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWIFPSKHCRDRL 589
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
LDW TRF+IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE
Sbjct: 590 LDWGTRFHIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 649
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720
HS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM+ DAEDFFYP
Sbjct: 650 HSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMTFDAEDFFYP 709
Query: 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780
GWAFKEM+NGT KVADRRLEGAVEEEEL RA+K FWCIQDEVFMRPSMGEVVKMLEGS
Sbjct: 710 GWAFKEMSNGTTRKVADRRLEGAVEEEELERALKTGFWCIQDEVFMRPSMGEVVKMLEGS 769
Query: 781 ADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTIN 820
+INTPPMPQTVLEL+EEGLD+VY+AMKR+FNQ S FTIN
Sbjct: 770 LEINTPPMPQTVLELMEEGLDNVYRAMKREFNQSSFFTIN 809
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147856526|emb|CAN82496.1| hypothetical protein VITISV_016002 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1243 bits (3217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/839 (74%), Positives = 712/839 (84%), Gaps = 33/839 (3%)
Query: 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFP 61
+GLG+RL+A +++AW+S+NGTFAFGF+P V DR+QLGIWF +LPGDRT+VWSA+RN P
Sbjct: 27 VGLGARLVAKENRAWVSENGTFAFGFSP-VESDDRYQLGIWFEQLPGDRTMVWSASRNSP 85
Query: 62 VTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSFL 121
V KDA+LELD+TGNL+L DGD T+W+SN+SG GVE A MSESGNFILY N P+WQSF
Sbjct: 86 VGKDAVLELDSTGNLLLLDGDATVWSSNTSGEGVETAYMSESGNFILYNGTNFPLWQSFS 145
Query: 122 HPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPK 181
HPSDTLLPNQPL+ S+ELTS S +GGYY+L+MLQQPTSLSL L YNLP SY S +
Sbjct: 146 HPSDTLLPNQPLTASMELTS-SSPAHGGYYTLQMLQQPTSLSLGLIYNLPDSY--ITSLQ 202
Query: 182 AYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNK 241
+YAN SYWSGPDISNVTGDVVAVLDEAGSFGI+YG SS+GAVYVY++D D GL+S+ N+
Sbjct: 203 SYANYSYWSGPDISNVTGDVVAVLDEAGSFGIMYGSSSDGAVYVYKSDTDEKGLSSSVNQ 262
Query: 242 STRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLDRS 301
+ R VLRRLILE NGNLRLYRWD+DVNG+RQWVPEWAAVSNPC+IAG+CG G+C+LDRS
Sbjct: 263 TVRPLVLRRLILEMNGNLRLYRWDDDVNGTRQWVPEWAAVSNPCDIAGVCGNGVCSLDRS 322
Query: 302 KTKASCTCLPGDSKIGSDGLCSDNSSVN-GKCDPRHRNQSSHDYRIASVQQTNYYFPEYS 360
KT ASCTCLPG SK+G G CS+NSSV+ GKCD HRN ++ +++ VQQTNYY+PE S
Sbjct: 323 KTNASCTCLPGXSKVGDSGQCSENSSVSXGKCDNNHRNSTASKLKMSIVQQTNYYYPESS 382
Query: 361 VIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKI 420
+IANYS+++ +SKCGDACLS+C CVASVYGL +EKPYCW+L SL+FGGFED SSTLFVK+
Sbjct: 383 IIANYSNMSPLSKCGDACLSDCDCVASVYGLSEEKPYCWLLNSLEFGGFEDTSSTLFVKV 442
Query: 421 MSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLKR 480
N S G+ GSGDSS+ R KV+V+PIVLSM +L+ LLC LLY+ V+R+R LKR
Sbjct: 443 GPNGS-PEGNATGSGDSSDG---LRDKVLVLPIVLSMIVLVALLCXLLYHTVYRRRALKR 498
Query: 481 AVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP 540
++E+SLIV GAP+NF+YRDLQ RT NF+QLLGTGGFGSVYKGSL DGTLVAVKKLD+VLP
Sbjct: 499 SLESSLIVSGAPMNFSYRDLQSRTGNFSQLLGTGGFGSVYKGSLSDGTLVAVKKLDKVLP 558
Query: 541 HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV 600
HGEKEF+TEVNTIGSMHHMNLVRLCGYCSEGS+RLLVYEFMKNGSLDKWIFPS H RDR+
Sbjct: 559 HGEKEFITEVNTIGSMHHMNLVRLCGYCSEGSHRLLVYEFMKNGSLDKWIFPSKHCRDRL 618
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
LDW TRF+IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE
Sbjct: 619 LDWGTRFHIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 678
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720
HS VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI
Sbjct: 679 HSHVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI------------------- 719
Query: 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780
EM+NGT KVADRRLEGAVEEEEL RA+K FWCIQDEVFMRPSMGEVVKMLEGS
Sbjct: 720 -----EMSNGTTRKVADRRLEGAVEEEELERALKTGFWCIQDEVFMRPSMGEVVKMLEGS 774
Query: 781 ADINTPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYSSMSPR 839
+INTPPMPQTVLEL+EEGLD+VY+AMKR+FNQ S FTIN+STH SS AT + ++ R
Sbjct: 775 LEINTPPMPQTVLELMEEGLDNVYRAMKREFNQSSFFTINNSTHPSSRATFTAAAHHQR 833
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|75171544|sp|Q9FLV4.1|Y5248_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080; Flags: Precursor gi|9758232|dbj|BAB08731.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1156 bits (2990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 585/858 (68%), Positives = 682/858 (79%), Gaps = 33/858 (3%)
Query: 1 HIGLGSRLLASQ-DQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRN 59
HIGLGS+L AS+ ++AW+S NGTFA GFT DRF L IWF +LPGD T+VWS NRN
Sbjct: 29 HIGLGSKLKASEPNRAWVSANGTFAIGFTRF-KPTDRFLLSIWFAQLPGDPTIVWSPNRN 87
Query: 60 FPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPN---NQPV 116
PVTK+A+LEL+ TGNLVL+D +T +W SN+S GVE A MSESGNF+L +
Sbjct: 88 SPVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTI 147
Query: 117 WQSFLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDA 176
WQSF PSDTLLPNQPL+VSLELTS S G+YSLKMLQQ TSLSL LTYN+
Sbjct: 148 WQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKMLQQHTSLSLGLTYNI------ 201
Query: 177 ANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQN--DGDYDG 234
+ +AN SYWSGPDISNVTGDV AVLD+ GSF IVYGESS GAVYVY+N D + +
Sbjct: 202 --NLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNY 259
Query: 235 LASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKG 294
S+ T+ VLRRL+LE NGNLRLYRWDND+NGS QWVPEWAAVSNPC+IAGICG G
Sbjct: 260 NNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGICGNG 319
Query: 295 ICNLDRSKTKASCTCLPGDSKIGSD---GLCSDNSSVNGKCDPR-HRNQSSHDYRIASVQ 350
+CNLDR+K A C CLPG K+ LCSDNSS+ +C+ +RN S ++I++VQ
Sbjct: 320 VCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGS---FKISTVQ 376
Query: 351 QTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFE 410
+TNYYF E SVI N SDI+ V KCG+ CLS+C+CVASVYGLDDEKPYCW+L+SL+FGGF
Sbjct: 377 ETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLNFGGFR 436
Query: 411 DPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSMTLLIGLLCLLLYY 470
DP STLFVK +N S ++ + S S R KV+VIPIV+ M +L+ LL +LLYY
Sbjct: 437 DPGSTLFVKTRANESYP-SNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGMLLYY 495
Query: 471 NVHRKRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLV 530
N+ RKR LKRA +NSLI+C +PV+FTYRDLQ T+NF+QLLG+GGFG+VYKG++ TLV
Sbjct: 496 NLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLV 555
Query: 531 AVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI 590
AVK+LDR L HGE+EF+TEVNTIGSMHHMNLVRLCGYCSE S+RLLVYE+M NGSLDKWI
Sbjct: 556 AVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWI 615
Query: 591 FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650
F S +LDW TRF IA+ATAQGIAYFHEQCRNRIIHCDIKPENILLD+NFCPKVSD
Sbjct: 616 FSS-EQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSD 674
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710
FGLAK+MGREHS VVTM+RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM
Sbjct: 675 FGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 734
Query: 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770
S DAEDFFYPGWA+KE+TNGT LK D+RL+G EEEE+++A+KVAFWCIQDEV MRPSM
Sbjct: 735 SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSM 794
Query: 771 GEVVKMLEGSAD-INTPPMPQTVLELIEEGLDHVYKAMKRDF-NQFSSFTINSST----- 823
GEVVK+LEG++D IN PPMPQT+LELIEEGL+ VY+AM+R+F NQ SS T+N+ T
Sbjct: 795 GEVVKLLEGTSDEINLPPMPQTILELIEEGLEDVYRAMRREFNNQLSSLTVNTITTSQSY 854
Query: 824 --HLSSHATCSYSSMSPR 839
SHATCSYSSMSPR
Sbjct: 855 RSSSRSHATCSYSSMSPR 872
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 839 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.398 | 0.403 | 0.533 | 5.7e-121 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.579 | 0.591 | 0.414 | 1.8e-116 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.703 | 0.711 | 0.385 | 7.7e-116 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.703 | 0.676 | 0.324 | 6.4e-85 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.632 | 0.639 | 0.314 | 7.4e-80 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.350 | 0.346 | 0.407 | 2.3e-78 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.613 | 0.642 | 0.305 | 1.4e-76 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.628 | 0.647 | 0.309 | 5.2e-75 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.594 | 0.620 | 0.309 | 7.6e-74 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.483 | 0.512 | 0.326 | 2.9e-73 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 917 (327.9 bits), Expect = 5.7e-121, Sum P(3) = 5.7e-121
Identities = 183/343 (53%), Positives = 245/343 (71%)
Query: 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIG 554
F+YR+LQ T NF+ LG GGFGSV+KG+L D + +AVK+L+ + GEK+F TEV TIG
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGI-SQGEKQFRTEVVTIG 541
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
++ H+NLVRL G+CSEGS +LLVY++M NGSLD +F + VL W RF IA+ TA
Sbjct: 542 TIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTA 601
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+G+AY H++CR+ IIHCDIKPENILLD FCPKV+DFGLAKL+GR+ S+V+T +RGTRGY
Sbjct: 602 RGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGY 661
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT-NGTPL 733
LAPEW+S IT KADVYSYGM+L E+V GRRN + S + + F+P WA +T +G
Sbjct: 662 LAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIR 721
Query: 734 KVADRRLEG-AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTV 792
+ D RLEG AV+ EE+ RA KVA WCIQDE RP+M +VV++LEG ++N PP P+++
Sbjct: 722 SLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSI 781
Query: 793 LELIEEGLDHVYKAMKRDFNQFSSFTINSSTHLSSHATCSYSS 835
L+ D V+ F + SS + ++S+ H++ S SS
Sbjct: 782 QALVVSDEDVVF------FTESSSSSSHNSSQNHKHSSSSSSS 818
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 967 (345.5 bits), Expect = 1.8e-116, Sum P(2) = 1.8e-116
Identities = 217/524 (41%), Positives = 309/524 (58%)
Query: 282 SNPCNIAGICGKG-ICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPRHRNQS 340
S+ C CG +C+ SK C C+ G S+ SD C + + C N +
Sbjct: 281 SDLCGTPEPCGPYYVCS--GSKV---CGCVSGLSRARSD--CK--TGITSPCKKTKDNAT 331
Query: 341 SHDYRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWV 400
+++ +Y+ Y+ +S + C + C +NC C+ + + C++
Sbjct: 332 LPLQLVSAGDGVDYFALGYA--PPFSKKTDLDSCKEFCHNNCSCLGLFF--QNSSGNCFL 387
Query: 401 ---LRSLDFGGFEDPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVXXX 457
+ S G ++KI S GS G GD+ ED VV+I +V
Sbjct: 388 FDYIGSFKTSGNGGSGFVSYIKIAST-----GS--GGGDNGEDDGKHFPYVVIIVVVTVF 440
Query: 458 XXXXXXXXXXXYYNVH-RKRFLKRAV-----ENSLI--VCGAPVNFTYRDLQIRTSNFAQ 509
+ +H RK+ + A E++ + + G P+ F Y+DLQ T+NF+
Sbjct: 441 IIAVLIFVA---FRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSV 497
Query: 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
LG GGFGSVY+G+L DG+ +AVKKL+ + G+KEF EV+ IGS+HH++LVRL G+C+
Sbjct: 498 KLGQGGFGSVYEGTLPDGSRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVRLRGFCA 556
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
EG++RLL YEF+ GSL++WIF D +LDW TRFNIA+ TA+G+AY HE C RI+
Sbjct: 557 EGAHRLLAYEFLSKGSLERWIFRK-KDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIV 615
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKA 689
HCDIKPENILLD+NF KVSDFGLAKLM RE S V T +RGTRGYLAPEW++N I+ K+
Sbjct: 616 HCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKS 675
Query: 690 DVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA-VEEEE 748
DVYSYGM+LLE++GGR+N D S +E +P +AFK+M G + + D +++ V +E
Sbjct: 676 DVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDER 735
Query: 749 LMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTV 792
+ RAMK A WCIQ+++ RPSM +VV+MLEG + PP T+
Sbjct: 736 VQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTM 779
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 958 (342.3 bits), Expect = 7.7e-116, Sum P(2) = 7.7e-116
Identities = 244/633 (38%), Positives = 352/633 (55%)
Query: 219 SNGAVYVYQND--GDYDGLASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVP 276
+NG V +++++ G + + S + R L L+ +GNLR+Y + +G
Sbjct: 205 TNGVVSIFESNLLGGAEIVYSGDYGDSN--TFRFLKLDDDGNLRIYSSASRNSGPVN--A 260
Query: 277 EWAAVSNPCNIAGICGK-GICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSSVNGKCDPR 335
W+AV C + G CG GIC+ + T C+C P + D N G C +
Sbjct: 261 HWSAVDQ-CLVYGYCGNFGICSYN--DTNPICSC-PSRN---FD-FVDVNDRRKG-CKRK 311
Query: 336 -HRNQSSHDYRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDE 394
+ S + + + T + E + S A S C CLS+ C+ASV + D
Sbjct: 312 VELSDCSGNTTMLDLVHTRLFTYEDDPNSE-SFFAGSSPCRANCLSSVLCLASV-SMSDG 369
Query: 395 KPYCWVLRSLDF-GGFEDPS--STLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVI 451
CW F G++ PS ST +VK+ GD D+ ++ +V
Sbjct: 370 SGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGD---DNNSKVHLWIVA 426
Query: 452 PIVXXXXXXXXXXXXXXYYNVHRK--RFLKRAVENSLI--VCGAPVNFTYRDLQIRTSNF 507
V ++ RK RF + +L+ GAPV FTY++LQ T +F
Sbjct: 427 VAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSF 486
Query: 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ LG GGFG+VY+G L + T+VAVK+L+ + GEK+F EV TI S HH+NLVRL G+
Sbjct: 487 KEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLIGF 545
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
CS+G +RLLVYEFM+NGSLD ++F + + L W RFNIA+ TA+GI Y HE+CR+
Sbjct: 546 CSQGRHRLLVYEFMRNGSLDNFLFTT--DSAKFLTWEYRFNIALGTAKGITYLHEECRDC 603
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMG-REHSQVVTMVRGTRGYLAPEWVSNRPIT 686
I+HCDIKPENIL+D+NF KVSDFGLAKL+ +++ ++ VRGTRGYLAPEW++N PIT
Sbjct: 604 IVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPIT 663
Query: 687 VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL--EGAV 744
K+DVYSYGM+LLE+V G+RN D+S + WA++E G + D RL + V
Sbjct: 664 SKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTV 723
Query: 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIEEGLDHVY 804
+ E++MR +K +FWCIQ++ RP+MG+VV+MLEG +I P P+T+ E+ G
Sbjct: 724 DMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTISEVSFSG----- 778
Query: 805 KAMKRDFNQFSSFTINSSTHLSSH-ATCSYSSM 836
+M + S F + T SS AT S+ +M
Sbjct: 779 NSMST--SHASMFVASGPTRSSSFSATRSFQTM 809
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 6.4e-85, Sum P(2) = 6.4e-85
Identities = 218/672 (32%), Positives = 338/672 (50%)
Query: 80 DGDTTIWASNSSGAGVELATMS--ESGNFILYAPNNQ-PVWQSFLHPSDTLLPNQPLSVS 136
D +TIW+SN TM+ G ++ +Q PVW S +L + P+ S
Sbjct: 81 DSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVW------STPVLAS-PVK-S 132
Query: 137 LELTSPKSLQNGGYYSLKMLQQ---PTSLSLALTYNLPGSYDAANSPKAYANKSYWSGPD 193
L LT +L + ++ + + PT S+ L L + S ++S +S D
Sbjct: 133 LRLTDAGNLLLLDHLNVSLWESFDFPTD-SIVLGQRLKLGMFLSGS----VSRSDFSTGD 187
Query: 194 ISNVTGDVVAVLDEAGS------FGIVYGESSNGAV-YVYQNDGDYDGLASATNKSTRLT 246
+ G+ ++ G I SN V Y+ GLA T +
Sbjct: 188 YKFLVGESDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTS---GLALMARNGTVVV 244
Query: 247 VLRRLILETNGNLRLYRWDND----VN--GSRQWVPEWAAVSNPCNIAGICGK-GICNLD 299
V R+ L + + R+ + D+ V+ + V E++ + C I +CGK G+CNLD
Sbjct: 245 V--RVALPPSSDFRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLD 302
Query: 300 RSKTKASCTCLPGDSKIGSD-GLC---SDNSSVNGKCDPRHRNQSSHDYRIASVQQTNYY 355
+ SC+C P + ++ + G+C S + S+ C+ R N S + + +Y+
Sbjct: 303 NASENQSCSC-PDEMRMDAGKGVCVPVSQSLSLPVSCEAR--NISYLELGLG----VSYF 355
Query: 356 FPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFE----D 411
++ + + C D C NC C+ Y ++ C++++ FG
Sbjct: 356 STHFTDPVEHG--LPLLACHDICSKNCSCLGVFY--ENTSRSCYLVKD-SFGSLSLVKNS 410
Query: 412 PSS-TL--FVK--IMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIP------IVXXXXXX 460
P + L +VK I + PG+N G S +V++P ++
Sbjct: 411 PENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPV-----IALVLLPCSGFFLLIALGLLW 465
Query: 461 XXXXXXXXYYNVHRKRFLKR-AVEN----SLIVCGAPVNFTYRDLQIRTSNFAQLLGTGG 515
Y ++ K+ + + E+ S + G P F + +L+ T NF +G+GG
Sbjct: 466 WRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGG 525
Query: 516 FGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575
FGSVYKG+L D TL+AVKK+ HG +EF TE+ IG++ H NLV+L G+C+ G L
Sbjct: 526 FGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLL 585
Query: 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKP 635
LVYE+M +GSL+K +F VL+W RF+IA+ TA+G+AY H C +IIHCD+KP
Sbjct: 586 LVYEYMNHGSLEKTLFSG---NGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKP 642
Query: 636 ENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYG 695
ENILL ++F PK+SDFGL+KL+ +E S + T +RGTRGYLAPEW++N I+ KADVYSYG
Sbjct: 643 ENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYG 702
Query: 696 MLLLEIVGGRRN 707
M+LLE+V GR+N
Sbjct: 703 MVLLELVSGRKN 714
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 7.4e-80, Sum P(2) = 7.4e-80
Identities = 188/598 (31%), Positives = 278/598 (46%)
Query: 246 TVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAV-SNPCNIAGICGK-GICNLDRSKT 303
T+L +L++ G++ W+ + ++W W V S C+ CG+ C + T
Sbjct: 251 TLLYHFLLDSEGSVFQRDWNVAI---QEW-KTWLKVPSTKCDTYATCGQFASCRFNPGST 306
Query: 304 KASCTCLPGDSKIGSDGLCSDNSSVNG-------KCDPRHRNQSSHDYR-IASVQQTNY- 354
C C+ G K S ++ + G +C+ R N S VQ+
Sbjct: 307 PP-CMCIRG-FKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVP 364
Query: 355 YFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYC--WVLRSLDFGGFEDP 412
+ P+ S AN D C ++CL NC C A Y D C W +D F
Sbjct: 365 HNPQRSG-ANEQD------CPESCLKNCSCTA--YSFD-RGIGCLLWSGNLMDMQEFSGT 414
Query: 413 SSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVXXXXXXXXXXXXXXYYNV 472
++++ DS T R+ V+ + ++ +
Sbjct: 415 GVVFYIRL--------------ADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIA 460
Query: 473 -HRK-----RFLKRAVE--NSLIVCGAPVN---------FTYRDLQIRTSNFA--QLLGT 513
HR+ R L +E +S V VN F ++ L + T+NF+ LG
Sbjct: 461 KHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQ 520
Query: 514 GGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573
GGFG+VYKG L +G +AVK+L R G +EFV EV I + H NLVRL G+C EG
Sbjct: 521 GGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEE 580
Query: 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDI 633
R+LVYEFM LD ++F + R+LDW TRFNI +G+ Y H R +IIH D+
Sbjct: 581 RMLVYEFMPENCLDAYLFDPV--KQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDL 638
Query: 634 KPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRGYLAPEWVSNRPITVKADVY 692
K NILLDEN PK+SDFGLA++ +V T+ V GT GY+APE+ + K+DV+
Sbjct: 639 KASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVF 698
Query: 693 SYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRA 752
S G++LLEIV GRRN D ++ +A+K G + + D + E E+ R
Sbjct: 699 SLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRC 758
Query: 753 MKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIEEGLDHVYKAMKRD 810
+ V C+QD RPS+ V+ ML S++ + P P+ + G V + + D
Sbjct: 759 VHVGLLCVQDHANDRPSVATVIWML--SSENSNLPEPKQPAFIPRRGTSEVESSGQSD 814
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 2.3e-78, Sum P(3) = 2.3e-78
Identities = 123/302 (40%), Positives = 177/302 (58%)
Query: 492 PVNFTYRDLQIRTSNFAQL--LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTE 549
PV F+ + I T++F + LG GGFG VYKG L DG +AVK+L G EF E
Sbjct: 515 PV-FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNE 573
Query: 550 VNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNI 609
+ I + H NLVRL G C EG ++LVYE+M N SLD ++F + ++DW RF+I
Sbjct: 574 IILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET--KQALIDWKLRFSI 631
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-V 668
A+G+ Y H R RIIH D+K N+LLD PK+SDFG+A++ G ++ T+ V
Sbjct: 632 IEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRV 691
Query: 669 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT 728
GT GY++PE+ +VK+DVYS+G+LLLEIV G+RN + +E G+A+ T
Sbjct: 692 VGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRS-SEHGSLIGYAWYLYT 750
Query: 729 NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG-SADINTPP 787
+G ++ D ++ + E +R + VA C+QD RP+M V+ MLE +A + P
Sbjct: 751 HGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPR 810
Query: 788 MP 789
P
Sbjct: 811 QP 812
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 600 (216.3 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 174/569 (30%), Positives = 273/569 (47%)
Query: 251 LILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGK-GICNLDRSKTKASCTC 309
L+L + G+L++ NG+ WV +N C+ G+CG G+C + C C
Sbjct: 248 LVLTSEGSLKVTHH----NGT-DWVLNIDVPANTCDFYGVCGPFGLCVMS---IPPKCKC 299
Query: 310 LPG-------DSKIGS-DGLCSDNSSV--NGKCDPRHRNQSSHDYRIASVQQTNYYFPEY 359
G + K G+ G C + + G RH N H +A+++ ++Y
Sbjct: 300 FKGFVPQFSEEWKRGNWTGGCVRRTELLCQGNSTGRHVNVF-HP--VANIKPPDFY---- 352
Query: 360 SVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVK 419
+ + +C +CL NC C+A Y ++ W +D F L ++
Sbjct: 353 ----EFVSSGSAEECYQSCLHNCSCLAFAY-INGIGCLIWNQELMDVMQFSVGGELLSIR 407
Query: 420 IMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPI-VXXXXXXXXXXXXXXYYN-VHRKRF 477
+ S+ G N + +T +V I + V +N + K
Sbjct: 408 LASSEM---GGN-------QRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVS 457
Query: 478 LKRAVENSLI---VCGAPVNFTYRDLQIRTSNFAQL--LGTGGFGSVYKGSLGDGTLVAV 532
L+ A N L V G F + ++I T+NF+ + LG GGFG VYKG L DG +AV
Sbjct: 458 LQGAWRNDLKSEDVSGLYF-FEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAV 516
Query: 533 KKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFP 592
K+L G++EF+ E+ I + H+NLVR+ G C EG RLLVYEFM N SLD +IF
Sbjct: 517 KRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFD 576
Query: 593 SYHHRDRV-LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651
S R RV +DW RF+I A+G+ Y H R RIIH D+K NILLD+ PK+SDF
Sbjct: 577 S---RKRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDF 633
Query: 652 GLAKLM-GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710
GLA++ G ++ + GT GY++PE+ + K+D YS+G+LLLE++ G +
Sbjct: 634 GLARMYEGTKYQDNTRRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRF 693
Query: 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770
S D E +A++ + D+ + E+ R +++ C+Q + RP+
Sbjct: 694 SYDKERKNLLAYAWESWCENGGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNT 753
Query: 771 GEVVKMLEGSADINTPPMPQTVLELIEEG 799
E++ ML ++D+ P P + ++G
Sbjct: 754 LELLSMLTTTSDLPLPKEPTFAVHTSDDG 782
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 600 (216.3 bits), Expect = 5.2e-75, Sum P(2) = 5.2e-75
Identities = 183/591 (30%), Positives = 277/591 (46%)
Query: 234 GLASAT-NKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAGICG 292
G S T + R + L L + G+L++ W+N GS WV + A + C++ CG
Sbjct: 239 GTGSLTYSLERRNSNLSYTTLTSAGSLKII-WNN---GSG-WVTDLEAPVSSCDVYNTCG 293
Query: 293 K-GICNLDRSKTKASCTCLPG-----D---SKIGSDGLCSDNSS----VNGKCDPRHRNQ 339
G+C RS C CL G D +K G C ++ VN + N
Sbjct: 294 PFGLCI--RSNPP-KCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNG 350
Query: 340 SSHDYRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCW 399
D +A+V+ ++Y EY + N D C CL NC C A Y ++ W
Sbjct: 351 DIFDI-VANVKPPDFY--EYLSLINEED------CQQRCLGNCSCTAFSY-IEQIGCLVW 400
Query: 400 VLRSLDFGGFEDPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVXXXXX 459
+D F TL +++ S+ GSNR K++V IV
Sbjct: 401 NRELVDVMQFVAGGETLSIRLASSE--LAGSNR-------------VKIIVASIVSISVF 445
Query: 460 XXXXXXXXXYYNVHRKRFLKRAV--ENSLIVCGA---PVNFTYRDLQIR---TSNFAQ-- 509
Y+ K+ + E S P + + D+Q T+NF+
Sbjct: 446 MILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMEN 505
Query: 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
LG GGFG VYKG+L DG +A+K+L G +EF+ E+ I + H NLVRL G C
Sbjct: 506 KLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCI 565
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
EG +LL+YEFM N SL+ +IF S + LDW RF I A G+ Y H R++
Sbjct: 566 EGEEKLLIYEFMANKSLNTFIFDSTKKLE--LDWPKRFEIIQGIACGLLYLHRDSCLRVV 623
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLM-GREHSQVVTMVRGTRGYLAPEWVSNRPITVK 688
H D+K NILLDE PK+SDFGLA++ G +H V GT GY++PE+ + K
Sbjct: 624 HRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEK 683
Query: 689 ADVYSYGMLLLEIVGGRR--NLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746
+D+Y++G+LLLEI+ G+R + + + + W + G+ L D+ + + E
Sbjct: 684 SDIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSDL--LDQDISSSGSE 741
Query: 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIE 797
E+ R +++ CIQ + RP++ +V+ ML + D+ P P +++ E
Sbjct: 742 SEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQPVFAMQVQE 792
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
Identities = 166/537 (30%), Positives = 254/537 (47%)
Query: 269 NGSRQWVPEWAAVSNPCNIAGICGK-GICNLDRSKTKASCTCLPGDSKIGSDGLCSDNSS 327
NG+ W + A +N C+I G+CG G+C + C CL G ++ N +
Sbjct: 267 NGT-DWELSYMAPANSCDIYGVCGPFGLCIVS---VPLKCKCLKGFVPHSTEEWKRGNWT 322
Query: 328 VN-GKCDPRH--RNQSSHDYRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQC 384
+ H N + D I TN P++ Y +C +CL NC C
Sbjct: 323 GGCARLTELHCQGNSTGKDVNIFH-PVTNVKLPDFY---EYESSVDAEECHQSCLHNCSC 378
Query: 385 VASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETR 444
+A Y + W +D F L +++ ++ L G N+
Sbjct: 379 LAFAY-IHGIGCLIWNQNLMDAVQFSAGGEILSIRL-AHSEL--GGNK------------ 422
Query: 445 RTKVVVIPIVXXXXXXXXXXXXXXY--YNVHRKRF-LKRAVENSLIVCGAP--VNFTYRD 499
R K++V V + Y V K + LK A N L P F
Sbjct: 423 RNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNT 482
Query: 500 LQIRTSNFA--QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH 557
+Q T+NF+ LG GGFGSVYKG L DG +AVK+L G++EF+ E+ I +
Sbjct: 483 IQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQ 542
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
H NLVR+ G C EG +LL+YEFM N SLD ++F + + +DW RF+I A+G+
Sbjct: 543 HRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDA--RKKLEVDWPKRFDIVQGIARGL 600
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-GREHSQVVTMVRGTRGYLA 676
Y H R ++IH D+K NILLDE PK+SDFGLA++ G + V GT GY++
Sbjct: 601 LYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMS 660
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736
PE+ + K+D+YS+G+LLLEI+ G + S E +A++ + +
Sbjct: 661 PEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDLL 720
Query: 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVL 793
D+ L + E+ R +++ C+Q + RP+ E++ ML ++D+ +P P V+
Sbjct: 721 DQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTFVV 777
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 2.9e-73, Sum P(3) = 2.9e-73
Identities = 140/429 (32%), Positives = 208/429 (48%)
Query: 365 YSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKIMSNR 424
Y++ C +CL NC C+A Y + W +D F L +++
Sbjct: 352 YANSVDAEGCYQSCLHNCSCLAFAY-IPGIGCLMWSKDLMDTMQFSAGGEILSIRL---- 406
Query: 425 SLTPGSNRGSGDSSEDSETRRTKVVVIPIVXXXXXXXXXXXXXXYYNVHRKRFLKRAVEN 484
S D R+ +V + + N + R
Sbjct: 407 ----------AHSELDVHKRKMTIVASTVSLTLFVILGFATFGFWRNRVKHHDAWRNDLQ 456
Query: 485 SLIVCGAPVNFTYRDLQIRTSNFA--QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG 542
S V G F +Q TSNF+ LG GGFGSVYKG L DG +AVK+L G
Sbjct: 457 SQDVPGLEF-FEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQG 515
Query: 543 EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-L 601
++EF+ E+ I + H NLVR+ G C EG +LL+YEFMKN SLD ++F S R R+ L
Sbjct: 516 KQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGS---RKRLEL 572
Query: 602 DWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-GRE 660
DW RF+I +G+ Y H R R+IH D+K NILLDE PK+SDFGLA+L G +
Sbjct: 573 DWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQ 632
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720
+ V GT GY++PE+ + K+D+YS+G+LLLEI+ G + S E
Sbjct: 633 YQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEEGKALL 692
Query: 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780
+ ++ + + D+ L+ + E+ R +++ C+Q + RP+ E++ ML +
Sbjct: 693 AYVWECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTT 752
Query: 781 ADINTPPMP 789
+D+ P P
Sbjct: 753 SDLPLPKQP 761
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FLV4 | Y5248_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6818 | 0.9833 | 0.9461 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00037801001 | SubName- Full=Chromosome undetermined scaffold_91, whole genome shotgun sequence; (857 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 839 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-24 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-23 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 4e-50
Identities = 72/201 (35%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKE--FVTEVNTIGSMHHMNLVRLC 565
+ LG+G FG+VYK G G +VAVK L + +K+ E+ + + H N+VRL
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
+ + LV E+ + G L ++ R L IA+ +G+ Y H
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHS--- 116
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV-SNRP 684
N IIH D+KPENILLDEN K++DFGLAK + + S +T GT Y+APE +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 685 ITVKADVYSYGMLLLEIVGGR 705
K DV+S G++L E++ G+
Sbjct: 176 YGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 8e-48
Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-FVTEVNTIGSMHHMNLVRLCGYC 568
LG GGFG+VY G VA+K + + E + E+ + ++H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
+ ++ LV E+ + GSL + + L I + +G+ Y H N I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHS---NGI 113
Query: 629 IHCDIKPENILLDE-NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-WVSNRPIT 686
IH D+KPENILLD N K++DFGL+KL+ + S + T+V GT Y+APE + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 687 VKADVYSYGMLLLEI 701
K+D++S G++L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-FVTEVNTIGSMHHMNLVRLCG 566
+ LG G FG VY G LVA+K + + ++E + E+ + + H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+ LV E+ + G L + R R+ + RF + Y H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARF-YLRQILSALEYLHS---K 116
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
I+H D+KPENILLDE+ K++DFGLA+ + ++ T V GT Y+APE + +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 687 VKADVYSYGMLLLEIVGGR 705
D++S G++L E++ G+
Sbjct: 175 KAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 82/282 (29%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 507 FAQLLGTGGFGSVYKGSLGDG-----TLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
+ LG G FG VYKG+L VAVK L + +EF+ E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGIA 618
+V+L G C+E ++V E+M G L Y +R + L + + A+ A+G+
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLL-----DYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG---YL 675
Y + IH D+ N L+ EN K+SDFGL++ + V+G + ++
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD---LYDDDYYKVKGGKLPIRWM 171
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735
APE + T K+DV+S+G+LL EI + E YPG + E+ LK
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEI--------FTLGEEP--YPGMSNAEVLEY--LKK 219
Query: 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777
R + EL + M C ++ RP+ E+V++L
Sbjct: 220 GYRLPKPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 41/282 (14%)
Query: 509 QLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLV 562
+ LG G FG VYKG+L G T VAVK L E+ EF+ E + + + H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
RL G C++G +V E+M G L ++ L +A+ A+G+ Y
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG---YLAPEW 679
+ +H D+ N L+ EN K+SDFGL++ + + G + ++APE
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPES 175
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739
+ + T K+DV+S+G+LL EI + + YPG + +E+ L R
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEI--------FTLGEQP--YPGMSNEEVLE---LLEDGYR 222
Query: 740 L---EGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777
L E +E ELM C + RP+ E+V+ L
Sbjct: 223 LPRPENCPDELYELMLQ------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 7e-39
Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 507 FAQLLGTGGFGSVYKGSLGD-----GTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
+ LG G FG VYKG L VAVK L + +EF+ E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+V+L G C+E +V E+M+ G L ++ L + + A+ A+G+ Y
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG---YLAP 677
+ IH D+ N L+ EN K+SDFGL++ + + RG + ++AP
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL---YDDDYYRKRGGKLPIRWMAP 172
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
E + T K+DV+S+G+LL EI + + YPG + +E+ LK
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEI--------FTLGEQP--YPGMSNEEVLEY--LKNGY 220
Query: 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777
R + EL M C ++ RP+ E+V++L
Sbjct: 221 RLPQPPNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 88/287 (30%), Positives = 128/287 (44%), Gaps = 46/287 (16%)
Query: 511 LGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMNLVRLC 565
LG G FG VYKG L G T VAVK L E K+F+ E + + H N+VRL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWI----FPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
G C+E LV E+M+ G L ++ L + AI A+G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG-----YLA 676
+ +H D+ N L+ E+ K+SDFGL+ R+ + T G ++A
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLS----RDVYDDDYYRKKTGGKLPIRWMA 175
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV- 735
PE + + T K+DV+S+G+LL EI + A YPG + +E+ +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEI--------FTLGATP--YPGLSNEEVLE----YLR 221
Query: 736 ADRRL---EGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
RL E +E ELM C Q + RP+ E+V+ LE
Sbjct: 222 KGYRLPKPEYCPDELYELML------SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+LLG G FGSVY G L+AVK L + E+ + S+ H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 566 G-YCSEGSNRLLVY-EFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAIATAQ---GI 617
G E N L ++ E++ GSL + + I T Q G+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLS-------SLLKKF----GKLPEPVIRKYTRQILEGL 114
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRGYLA 676
AY H N I+H DIK NIL+D + K++DFG AK +G + T VRGT ++A
Sbjct: 115 AYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
PE + AD++S G ++E+ G+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEFV-TEVNTIGSMHHMNLVRLC 565
+ +G G FG VY DG L +K++D + E+E EV + ++H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWI---------FPSYHHRDRVLDWTTRFNIAIATAQG 616
E +V E+ G L + I FP +++LDW + +A
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP----EEQILDWFV--QLCLA---- 115
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV--TMVRGTRGY 674
+ Y H + +I+H DIKP+NI L N K+ DFG++K++ + + T+V GT Y
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVV-GTPYY 169
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
L+PE N+P K+D++S G +L E+ +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKE---FVTEVNTIGSM-HHMNLVRL 564
+ LG G FG VY D LVA+K L + L KE F+ E+ + S+ H N+V+L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
+ + + LV E++ GSL+ + R L + I + Y H +
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 625 RNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGREHS-----QVVTMVRGTRGYLAPE 678
IIH DIKPENILLD + K+ DFGLAKL+ S + + GT GY+APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 679 WV---SNRPITVKADVYSYGMLLLEIVGGRR 706
+ S + +D++S G+ L E++ G
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G GGFG VYK G VA+K + +++ + E+ + H N+V+ Y S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY--YGS 65
Query: 570 --EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ +V EF GSL + ++ L + + +G+ Y H N
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHS---NG 118
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
IIH DIK NILL + K+ DFGL+ + TMV GT ++APE ++ +P
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMV-GTPYWMAPEVINGKPYDY 176
Query: 688 KADVYSYGMLLLEIVGGR 705
KAD++S G+ +E+ G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+G G FG V G G VAVK L + F+ E + + ++ H NLV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLG 67
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR---VLDWTTRFNIAIATAQGIAYFHEQ 623
+G+ +V E+M GSL ++ R R V+ + A+ +G+ Y E+
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYL------RSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
+H D+ N+L+ E+ KVSDFGLAK E SQ + + APE + +
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREK 174
Query: 684 PITVKADVYSYGMLLLEI 701
+ K+DV+S+G+LL EI
Sbjct: 175 KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570
LG+G FG V++G + VA+K L +++F EV + + H +L+ L CS
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIH 630
G ++ E M+ GSL ++ +VL + ++A A+G+AY EQ IH
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 631 CDIKPENILLDENFCPKVSDFGLAKLMGRE----HSQVVTMVRGTRGYLAPEWVSNRPIT 686
D+ NIL+ E+ KV+DFGLA+L+ + + + + T APE S+ +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP-YKWT----APEAASHGTFS 182
Query: 687 VKADVYSYGMLLLEIV 702
K+DV+S+G+LL E+
Sbjct: 183 TKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 76/284 (26%), Positives = 131/284 (46%), Gaps = 44/284 (15%)
Query: 509 QLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVR 563
+++G G FG V +G L VA+K L ++ +F+TE + +G H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
L G ++ +++ E+M+NGSLDK++ D + A G+ Y E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-----VRGTRGYLAPE 678
+H D+ NIL++ N KVSDFGL++ + + T +R T APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 679 WVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
++ R T +DV+S+G+++ E++ G R P W +M+N +K +
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGER-------------PYW---DMSNQDVIKAVE 222
Query: 738 R--RLEGAVE-EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
RL ++ L + M C Q + RP+ ++V L+
Sbjct: 223 DGYRLPPPMDCPSALYQLML---DCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 507 FAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRV-LPHGE-KEFVTEVNTIGSMHHMNLVR 563
L+G G FG VYKG +L G VA+K++ + K + E++ + ++ H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAIATAQ---GI 617
G + ++ E+ +NGSL + I F +A+ Q G+
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKF-----------GPFPESLVAVYVYQVLQGL 112
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
AY HEQ +IH DIK NIL ++ K++DFG+A + ++V GT ++AP
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAP 168
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGR 705
E + + +D++S G ++E++ G
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLD--RVLPHGEKEFV-TEVNTIGSMHHMNLVRLCG 566
LG G FG V G L A+K L +++ E E TE N + ++H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 567 YCS-EGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA-IATAQGIAYFHEQ 623
+ + + +L LV E+ G L + R + RF A I A + Y H
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLA--LEYLHSL 112
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
II+ D+KPENILLD + K++DFGLAK + E S+ T GT YLAPE + +
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 684 PITVKADVYSYGMLLLEIVGGR 705
D +S G+LL E++ G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 75/238 (31%), Positives = 113/238 (47%), Gaps = 25/238 (10%)
Query: 503 RTS-NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL 561
RTS + LG G FG V++G + T VAVK L + K+F+ E + + H L
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKL 63
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
++L C+ +V E MK GSL +++ R L ++A A G+AY
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
Q IH D+ N+L+ EN KV+DFGLA+++ + + + + APE
Sbjct: 121 AQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 682 NRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
++K+DV+S+G+LL EIV GR YPG MTN L+ D+
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGR-----------MPYPG-----MTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 511 LGTGGFGSVYK-GSLGDGTLVAVKKLD-RVLPHGEKE-FVTEVNTIGSMHHMNLVRLCGY 567
+G G FG+V K DG ++ K++D + EK+ V+EVN + + H N+VR
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 568 CSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLD---WTTRFNIAIATAQGIAYFH- 621
+ SN+ L V E+ + G L + I R + + W + +A + H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYECHN 123
Query: 622 -EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
N ++H D+KP NI LD N K+ DFGLAK++G + S T V GT Y++PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQL 182
Query: 681 SNRPITVKADVYSYGMLLLEI 701
++ K+D++S G L+ E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 66/200 (33%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRLCGY 567
LG G FG V+ G+ T VAVK L G + F+ E + + H LV+L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVK----TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRFNIAIATAQGIAYFHEQCR 625
CSE +V E+M GSL + + L ++A A+G+AY +
Sbjct: 70 CSEEEPIYIVTEYMSKGSL-----LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-- 122
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSN 682
IH D+ NIL+ EN K++DFGLA+L+ T G + + APE +
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANY 178
Query: 683 RPITVKADVYSYGMLLLEIV 702
T+K+DV+S+G+LL EIV
Sbjct: 179 GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 507 FAQLLGTGGFGSVYKG---SLGDGTL--VAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
++LG+G FG+VYKG G+ VA+K L + P KE + E + S+ H +
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+VRL G C S L+ + M G L ++ +H+D + N + A+G++Y
Sbjct: 71 VVRLLGICL-SSQVQLITQLMPLGCLLDYV---RNHKDN-IGSQYLLNWCVQIAKGMSYL 125
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAP 677
E+ R++H D+ N+L+ K++DFGLAKL+ + + G + ++A
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMAL 180
Query: 678 EWVSNRPITVKADVYSYGMLLLEI 701
E + +R T K+DV+SYG+ + E+
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+G G FG VY +L G L+AVK ++ P KE E+ + + H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 566 G-------------YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
G YCS G+ + E +++G R+LD I +
Sbjct: 66 GVEVHREKVYIFMEYCSGGT----LEELLEHG--------------RILDEHV---IRVY 104
Query: 613 TAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
T Q G+AY H + I+H DIKP NI LD N K+ DFG A + + + V+
Sbjct: 105 TLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 670 GTRG---YLAPEWVSNRPITVK---ADVYSYGMLLLEIVGGRR 706
G Y+APE ++ AD++S G ++LE+ G+R
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 500 LQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNT 552
+Q T + LG G FG V+ G D LVAVK L + K+F E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD-RVLDW----TTRF 607
+ + H N+V+ G C+EG ++V+E+M++G L+K F H D L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSPDSPMGEL 119
Query: 608 N------IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE- 660
IA+ A G+ Y Q +H D+ N L+ + K+ DFG M R+
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG----MSRDV 172
Query: 661 HSQVVTMVRGTR----GYLAPEWVSNRPITVKADVYSYGMLLLEI 701
++ V G ++ PE + R T ++DV+S+G++L EI
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 507 FAQLLGTGGFGSVYKGS---LGDGT--LVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMN 560
F + LG G FG V LGD T VAVK L+ +F E+ + ++ H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 561 LVRLCGYCSE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
+V+ G C + G + L+ E++ +GSL ++ HRD+ ++ + +G+
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQ-INLKRLLLFSSQICKGMD 123
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG----Y 674
Y Q R IH D+ NIL++ K+SDFGLAK++ + V+ +
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY--VKEPGESPIFW 178
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEI 701
APE + + +DV+S+G+ L E+
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-24
Identities = 41/116 (35%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 11 SQDQAWISDNGTFAFG-FTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILE 69
S Q +S F G F I +Q R I + RTVVW ANR+ P L
Sbjct: 5 SSGQTLVSSGSLFELGFFKLI--MQSRDYNLILYKGSS--RTVVWVANRDNPSGSSCTLT 60
Query: 70 LDTTGNLVLNDGD-TTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLHP 123
L + GNLV+ DG T +W+SN++ G + + + GN +LY + +WQSF +P
Sbjct: 61 LQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 35/213 (16%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE------KEFVTEVNTIGSMHHMNL 561
+LLG+G FGSVY+G +L DG AVK++ + G+ K+ E+ + + H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIA 618
V+ G E N + E + GSL K + Y + I + T Q G+
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPV-------IRLYTRQILLGLE 116
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-----VRGTRG 673
Y H++ +H DIK NIL+D N K++DFG+AK QVV +G+
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPY 166
Query: 674 YLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
++APE + + AD++S G +LE+ G+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-23
Identities = 43/119 (36%), Positives = 61/119 (51%), Gaps = 8/119 (6%)
Query: 7 RLLASQDQAWISDNGTFAFG-FTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKD 65
S Q +S N F G FT I+ I + RTVVW ANR+ PV+
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ---NDYNLILYKSSS--RTVVWVANRDNPVSDS 55
Query: 66 AILELDTTGNLVLNDGD-TTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLH 122
L L + GNLVL DGD +W+SN++GA G + + + GN ++Y + +WQSF +
Sbjct: 56 CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 40/88 (45%), Positives = 56/88 (63%), Gaps = 3/88 (3%)
Query: 49 DRTVVWSANRNFPVT-KDAILELDTTGNLVLNDGD-TTIWASNSSG-AGVELATMSESGN 105
++TVVW ANR P+T L L + GNLVL DG+ +W+SN+SG +A + + GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 106 FILYAPNNQPVWQSFLHPSDTLLPNQPL 133
+LY + + +WQSF HP+DTLLP Q
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKD 88
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 499 DLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM 556
DL+ +LG G G VYK G + A+KK+ K+ + E+ T+ S
Sbjct: 2 DLERVK-----VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC 56
Query: 557 HHMNLVRLCG-YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
+V+ G + EG + V E+M GSL + +V +A Q
Sbjct: 57 ESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL-------KKVGKIPEPV-LAYIARQ 107
Query: 616 ---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
G+ Y H + IIH DIKP N+L++ K++DFG++K++ Q T V GT
Sbjct: 108 ILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTV 164
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLE 700
Y++PE + + AD++S G+ LLE
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 33/234 (14%)
Query: 479 KRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR 537
+A ++ G P Y++L+ +G G G VYK G VA+KK+ R
Sbjct: 4 LKAALKDIVSEGDPREL-YKNLEK--------IGEGASGEVYKATDRATGKEVAIKKM-R 53
Query: 538 VLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHR 597
+ ++ + E+ + H N+V G +V E+M GSL
Sbjct: 54 LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--------- 104
Query: 598 DRVLDWT-TRFN------IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650
++ R N + QG+ Y H +IH DIK +NILL ++ K++D
Sbjct: 105 --IITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLAD 159
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
FG A + +E S+ ++V GT ++APE + + K D++S G++ +E+ G
Sbjct: 160 FGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLCG-Y 567
LG G GSV K L + ++ K P+ + K+ + E+ S +V+ G +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 568 CSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------IAIATAQGIAYF 620
E S+ + + E+ + GSLD I+ +V R IA + +G++Y
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDS-IY------KKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
H + +IIH DIKP NILL K+ DFG++ + +S T GT Y+APE +
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSFYMAPERI 175
Query: 681 SNRPITVKADVYSYGMLLLEIVGGR 705
+P ++ +DV+S G+ LLE+ R
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 507 FAQLLGTGGFGSVYK---GSLGDGT--LVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL 561
F Q LG G FGSV L D T +VAVKKL ++F E+ + S+ H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 562 VRLCGYC-SEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
V+ G C S G L LV E++ GSL ++ HR+R LD A +G+ Y
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRER-LDHRKLLLYASQICKGMEY 123
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAP 677
+ R +H D+ NIL++ K+ DFGL K++ +E+ +V + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 678 EWVSNRPITVKADVYSYGMLLLEI 701
E ++ +V +DV+S+G++L E+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
Q +G+G FG V+ G + VA+K + R E++F+ E + + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C+E S LV+EFM++G L ++ + T + + +G+AY
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
+IH D+ N L+ EN KVSDFG+ + + + T + + +PE S +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 687 VKADVYSYGMLLLEI 701
K+DV+S+G+L+ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 38/226 (16%)
Query: 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKLD--RVLPHGEKEFVT-EVNTIGSM-HHMNL 561
F +++G G F +V A+K LD +++ + ++V E + + H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 562 VRLCGYCS--EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA-IATAQGIA 618
++L Y + + N V E+ NG L ++I + + TRF A I A +
Sbjct: 65 IKL--YYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLA--LE 116
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE-------------HSQVV 665
Y H IIH D+KPENILLD++ K++DFG AK++ SQ+
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 666 TMVR------GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
R GT Y++PE ++ +P +D+++ G ++ +++ G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKE-FVTEVNTIGSMHHMNLVRLCGY 567
+ +G G FG VYKG L T VAVK LP K F+ E + H N+V+L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-LDWTTRFNIAIATAQGIAYFHEQCRN 626
C + +V E + GS ++ + + L +++ A G+ Y +
Sbjct: 61 CVQKQPIYIVMELVPGGS-----LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR----GYLAPEWVSN 682
IH D+ N L+ EN K+SDFG+++ E + T+ G + + APE ++
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 683 RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW 722
T ++DV+SYG+LL E GD YPG
Sbjct: 170 GRYTSESDVWSYGILLWETFSL-------GDTP---YPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 59/295 (20%)
Query: 511 LGTGGFGSVYKGSLGD------GTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
LG G FG VY+G T VA+K + + EF+ E + + + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRFNIAIA 612
L G S G L+V E M G L ++ + + A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM------AAE 127
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG-----REHSQVVTM 667
A G+AY + +H D+ N ++ E+ K+ DFG+ + + R+ + +
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727
VR ++APE + + T K+DV+S+G++L E+ + Y G + +E+
Sbjct: 185 VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMA----------TLAEQPYQGLSNEEV 230
Query: 728 TN----GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
G D + ELMR C Q MRP+ E+V L+
Sbjct: 231 LKFVIDG---GHLDLPENCPDKLLELMRM------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 71/282 (25%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 509 QLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVR 563
+++G G FG V++G L VA+K L ++ +F++E + +G H N++R
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI--ATAQGIAYFH 621
L G ++ +++ E+M+NG+LDK++ RD ++++ + + A G+ Y
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYL------RDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG--YLAPEW 679
+ +H D+ NIL++ N KVSDFGL++++ + T G + APE
Sbjct: 125 DM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 680 VSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
++ R T +DV+S+G+++ E++ G R P W +M+N +K +
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGER-------------PYW---DMSNHEVMKAIND 225
Query: 739 --RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
RL ++ + + + W Q + RP ++V +L+
Sbjct: 226 GFRLPAPMDCPSAVYQLMLQCW--QQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 510 LLGTGGFGSVYKGS-LGDGTLVAVKKLD-RVLPHGEKE-FVTEVNTIGSMHHMNLVRLCG 566
LG G +GSVYK L D A+K++D + E+E V E+ + S++H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+G+ +V E+ G L K I R +++ + I I +G+ HEQ
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQ--- 122
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
+I+H D+K NILL N K+ D G++K++ + ++ GT Y+APE RP +
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRPYS 179
Query: 687 VKADVYSYGMLLLEIVGGR 705
K+D++S G LL E+
Sbjct: 180 YKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 511 LGTGGFGSVYK-GSLGDGTLVAVKKLDR---VLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG GGFG V A+K + + V ++ +E + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 567 YCSEGSNRLLVY---EFMKNGSLDKWIFPSYHHRDRVL--DWTTRFNIAIATAQGIAYFH 621
Y + ++ +Y E+ G L + RDR L ++T RF IA Y H
Sbjct: 59 YRTF-KDKKYIYMLMEYCLGGELWTIL------RDRGLFDEYTARFYIACVV-LAFEYLH 110
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
II+ D+KPEN+LLD N K+ DFG AK + + T GT Y+APE +
Sbjct: 111 ---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWTFC-GTPEYVAPEIIL 165
Query: 682 NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
N+ D +S G+LL E++ GR D ED
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR--PPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 20/198 (10%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRLCGY 567
LG G FG V+ G T VA+K L + G F+ E N + + H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ----GSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
++ ++ E+M+NGSL ++ + L ++A A+G+A+ R
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFLKTPEGIK---LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSNRP 684
IH D++ NIL+ E C K++DFGLA+L+ E ++ T G + + APE ++
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLI--EDNE-YTAREGAKFPIKWTAPEAINYGT 179
Query: 685 ITVKADVYSYGMLLLEIV 702
T+K+DV+S+G+LL EIV
Sbjct: 180 FTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G +G VYK G +VA+KK L K + E+ + ++H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ LV+EFM L K I R R L + + QG+A+ H +
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLI----KDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS----QVVTMVRGTRGYLAPE-WVSN 682
I+H D+KPEN+L++ K++DFGLA+ G VV TR Y APE + +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAPELLLGD 173
Query: 683 RPITVKADVYSYGMLLLEIVGGR 705
+ + D++S G + E++ R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 68/204 (33%), Positives = 109/204 (53%), Gaps = 18/204 (8%)
Query: 509 QLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMNLVR 563
+++G G FG VY G+L G AVK L+R+ E ++F+ E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 564 LCGYC--SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
L G C SEGS L+V +MK+G L +I S H V D + A+G+ Y
Sbjct: 61 LLGICLPSEGSP-LVVLPYMKHGDLRNFI-RSETHNPTVKDL---IGFGLQVAKGMEYLA 115
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQV--VTMVRGTRGYLAPE 678
+ + +H D+ N +LDE+F KV+DFGLA+ + +E+ V T + ++A E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 679 WVSNRPITVKADVYSYGMLLLEIV 702
+ + T K+DV+S+G+LL E++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHM 559
F + LG G FG VYKG L T VA+K L + P ++EF E + + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD-----------RVLDWTTRFN 608
N+V L G C++ +++E++ +G L +++ + H D LD + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 609 IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-----GREHSQ 663
IAI A G+ Y + +H D+ N L+ E K+SDFGL++ + R S+
Sbjct: 129 IAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
+ VR ++ PE + T ++D++S+G++L EI
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 509 QLLGTGGFGSVYKGSLG----DGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSMHHMNLVR 563
+++G G FG V +G L VA+K L ++F++E + +G H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
L G ++ +++ EFM+NG+LD ++ D + A G+ Y E
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG-----YLAPE 678
+H D+ NIL++ N KVSDFGL++ + + + T G + APE
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 679 WVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMS 711
++ R T +DV+SYG+++ E++ G R DMS
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 509 QLLGTGGFGSVYKGSLGD-GTLVAVK---KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+++G G FG V D + A+K K V + + E + ++H LV L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYH--HRDRVLDWTTRFNIA-IATAQGIAYFH 621
+ N LV + + G L YH + + + +F I I A + Y H
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDL------RYHLSQKVKFSEEQVKFWICEIVLA--LEYLH 117
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
+ IIH DIKP+NILLDE ++DF +A + + T GT GY+APE +
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVLC 172
Query: 682 NRPITVKADVYSYGMLLLEIVGGRR 706
+ +V D +S G+ E + G+R
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 12/194 (6%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
LG G +G VY+G VAVK L + + +EF+ E + + H NLV+L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR-VLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ ++ EFM G+L ++ +R ++ +A + + Y +
Sbjct: 72 TREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQISSAMEYLE---KKN 124
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
IH D+ N L+ EN KV+DFGL++LM + + + APE ++ ++
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 688 KADVYSYGMLLLEI 701
K+DV+++G+LL EI
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 511 LGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
LG G FG V+ D LVAVK L + K+F E + ++ H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV----------LDWTTRFNIAIATA 614
G C EG ++V+E+MK+G L+K F H D V L + +IA A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNK--FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGTRG 673
G+ Y Q +H D+ N L+ EN K+ DFG+++ + ++ +V
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEI 701
++ PE + R T ++DV+S G++L EI
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVRLCGY 567
+LLG G FG V+KG+L D T VAVK LP K +F++E + H N+V+L G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR-VLDWTTRFNIAIATAQGIAYFHEQCRN 626
C++ +V E + G F S+ + + L A+ A G+AY +
Sbjct: 61 CTQRQPIYIVMELVPGGD-----FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK--- 112
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR----GYLAPEWVSN 682
IH D+ N L+ EN K+SDFG M R+ + G + + APE ++
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 683 RPITVKADVYSYGMLLLE 700
+ ++DV+SYG+LL E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEK-EFVTEVNTIGSMHHMNLVRLCGY 567
+G G FG V+K D + A+K++D + E+ E + E + + ++R
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ +V E+ +NG L K + R R L + I G+A+ H +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
I+H DIK N+ LD K+ D G+AKL+ + T+V GT YL+PE ++P
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNE 180
Query: 688 KADVYSYGMLLLEIVGGRRNLD 709
K+DV++ G++L E G+ D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 77/286 (26%), Positives = 133/286 (46%), Gaps = 47/286 (16%)
Query: 509 QLLGTGGFGSVYKGSL---GDGTL-VAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNL 561
+++G G FG V G L G + VA+K L + EK+ F++E + +G H N+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
+ L G ++ ++V E+M+NGSLD ++ D + A G+ Y
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG------YL 675
+ +H D+ NIL++ N KVSDFGL++++ + T TRG +
Sbjct: 124 DM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWT 176
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734
APE ++ R T +DV+SYG+++ E++ G R P W EM+N +K
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER-------------PYW---EMSNQDVIK 220
Query: 735 VADR--RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ RL ++ + + + W Q + RP ++V +L+
Sbjct: 221 AIEEGYRLPAPMDCPAALHQLMLDCW--QKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKLDR--VLPHGEKEFV-TEVNTIGSMHH 558
F + LGTG FG V +KGS G A+K L + ++ + E V E + S+ H
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA---TAQ 615
LV L G + SN LV E++ G L F S+ + RF +A AQ
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL----F-SHLRKSG------RFPEPVARFYAAQ 109
Query: 616 ---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGT 671
+ Y H I++ D+KPEN+LLD + K++DFG AK + GR + T+ GT
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLC-GT 161
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
YLAPE + ++ D ++ G+L+ E++ G
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 511 LGTGGFGSVYKGSL----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG G FGSV KG G VAVK L + G+KEF+ E + + + H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G C +G +LV E G L K++ + R + + +A A G+AY +
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYL-----KKRREIPVSDLKELAHQVAMGMAYLESK-- 114
Query: 626 NRIIHCDIKPENILL-DENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAPEWVSN 682
+H D+ N+LL + + K+SDFG+++ + G ++ + T R + APE ++
Sbjct: 115 -HFVHRDLAARNVLLVNRHQA-KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 683 RPITVKADVYSYGMLLLEIV--GGRRNLDMSG 712
+ K+DV+SYG+ L E G + +M G
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMNLVRLCGYC 568
LG G G V K G ++AVK + + K+ + E++ + + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHR--DRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+ + E+M GSLDK I R +R+L IA+A +G+ Y HE+ +
Sbjct: 69 YNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK--H 120
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
+IIH D+KP NIL++ K+ DFG++ + +S T V GT Y+APE + +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYS 177
Query: 687 VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW 722
VK+D++S G+ L+E+ GR F YP
Sbjct: 178 VKSDIWSLGLSLIELATGR-----------FPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-19
Identities = 83/299 (27%), Positives = 137/299 (45%), Gaps = 53/299 (17%)
Query: 511 LGTGGFGSVYKGS------LGDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMNLVR 563
LG G FG V K + T VAVK L E ++ ++E N + ++H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKW------IFPSY-------------HHRDRVLDWT 604
L G CS+ LL+ E+ K GSL + + PSY + +R L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 605 TRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664
+ A ++G+ Y E +++H D+ N+L+ E K+SDFGL++ + E S
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-- 182
Query: 665 VTMVRGTRG-----YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
V+ ++G ++A E + + T ++DV+S+G+LL EIV + G+ Y
Sbjct: 183 --YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV------TLGGNP----Y 230
Query: 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
PG A + + N LK R EE+ M C + E RP+ ++ K LE
Sbjct: 231 PGIAPERLFN--LLKTGYRMERPENCSEEMYNLMLT---CWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 25/201 (12%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570
LG G FG V+ G + T VAVK L + + F+ E N + ++ H LVRL ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 571 GSNRLLVYEFMKNGSL---------DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
++ E+M GSL K + P +++D++ + A+G+AY
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP------KLIDFSAQI------AEGMAYIE 120
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
R IH D++ N+L+ E+ K++DFGLA+++ + + APE ++
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 682 NRPITVKADVYSYGMLLLEIV 702
T+K+DV+S+G+LL EIV
Sbjct: 178 FGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 27/211 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMHHMNLV 562
++LG+G FG+VYKG + +G V + ++L P EF+ E + SM H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-----LDWTTRFNIAIATAQGI 617
RL G C + +L V + M +G L ++ + H+D + L+W + A+G+
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYV---HEHKDNIGSQLLLNW------CVQIAKGM 122
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-GREHSQVVTMVRGTRGYLA 676
Y E+ R++H D+ N+L+ K++DFGLA+L+ G E + ++A
Sbjct: 123 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIV--GGR 705
E + R T ++DV+SYG+ + E++ GG+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 9e-19
Identities = 84/311 (27%), Positives = 139/311 (44%), Gaps = 58/311 (18%)
Query: 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTL---VAVKKL-DRVLPHGEKEFVTEVNT 552
Y L+ F ++G G FG V K + L A+K++ + ++F E+
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 553 IGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
+ + HH N++ L G C L E+ +G+L ++ + RVL+ F IA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-----RKSRVLETDPAFAIAN 115
Query: 612 ATA----------------QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655
+TA +G+ Y ++ + IH D+ NIL+ EN+ K++DFGL++
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
Query: 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
G+E TM R ++A E ++ T +DV+SYG+LL EIV + G
Sbjct: 173 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV------SLGGTP- 223
Query: 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAV----EEEELMRAMKVAFWCIQDEVFMRPSMG 771
Y G E+ P RLE + E +LMR C +++ + RPS
Sbjct: 224 ---YCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQ------CWREKPYERPSFA 271
Query: 772 EVV----KMLE 778
+++ +MLE
Sbjct: 272 QILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD--GTLVAVK--KLDRVLPHGEKEFVTEVNTIGS 555
L ++ Q +G G FG V LGD G VAVK K D + F+ E + +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVM---LGDYRGNKVAVKCIKNDAT----AQAFLAEASVMTQ 55
Query: 556 MHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDR-VLDWTTRFNIAIAT 613
+ H NLV+L G E L +V E+M GSL ++ R R VL ++
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDV 111
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
+ + Y N +H D+ N+L+ E+ KVSDFGL K E S +
Sbjct: 112 CEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK 164
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEI 701
+ APE + + + K+DV+S+G+LL EI
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKL----DRVLPHGEKEFVT---EVNTIGSMHHMNL 561
++LG G +G+VY G G L+AVK++ VL EKE+ EV+ + S+ H+N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA-AEKEYEKLQEEVDLLKSLKHVNI 64
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
V+ G C + + + EF+ GS+ + + V T+ G+AY H
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYLH 119
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-----EHSQVVTMVRGTRGYLA 676
C ++H DIK N++L N K+ DFG A+ + HS ++ + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGR 705
PE ++ K+D++S G + E+ G+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 61/240 (25%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKEFVT-----EVNTIGSMHHMN 560
+ LG G +G VYK G +VA+KK LD E+E + E++ + + H N
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-----EEEGIPSTALREISLLKELKHPN 59
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+V+L LV+E+ L K++ R L +I +G+AY
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHSQVVTMVRGTRGYLAP 677
H +RI+H D+KP+NIL++ + K++DFGLA+ G R ++ V T Y AP
Sbjct: 115 H---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAP 167
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA----FKEMTNGTPL 733
E I + + YS +D+ W+ F EM G PL
Sbjct: 168 E------ILLGSKHYSTA------------VDI-----------WSVGCIFAEMITGKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 32/233 (13%)
Query: 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMH 557
L ++ +++G G FG+V +G G VAVK K D + F+ E + +H
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT----AQAFLEETAVMTKLH 57
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF-NIAIATAQG 616
H NLVRL G + +V E M G+L ++ R R L + ++ A+G
Sbjct: 58 HKNLVRLLGVILH-NGLYIVMELMSKGNLVNFL----RTRGRALVSVIQLLQFSLDVAEG 112
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ Y + +++H D+ NIL+ E+ KVSDFGLA++ V+ T A
Sbjct: 113 MEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----A 165
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMT 728
PE + ++ + K+DV+SYG+LL E+ GR YP + KE+
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP-----------YPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 509 QLLGTGGFGSVYK--GSLGDGTLVAVKKLDRVLP---HGEKE-------FVTEVNTIG-S 555
+ LG+G FG VYK L+A+K+++ P ++E V+EV I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 556 MHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
+ H N+VR E +V + ++ L + F S + + +NI +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ Y H++ RI+H D+ P NI+L E+ ++DFGLAK E +T V GT Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYS 180
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIV 702
PE V N P KADV+++G +L ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
+G G VY L + VA+K++D E EV + +H N+V+ Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YT 66
Query: 569 S--EGSNRLLVYEFMKNGS-LD--KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
S G LV ++ GS LD K +P LD + +G+ Y H
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPR-----GGLDEAIIATVLKEVLKGLEYLH-- 119
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFG----LAKLMGREHSQVVTMVRGTRGYLAPEW 679
N IH DIK NILL E+ K++DFG LA R T V GT ++APE
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEV 177
Query: 680 VSNRP-ITVKADVYSYGMLLLEIVGGR 705
+ KAD++S+G+ +E+ G
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLCG 566
LG G +GSVYK G +VA+K V+P E +E + E++ + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIK----VVPVEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHEQ 623
+ ++ +V E+ GS+ + ++ L T IA Q G+ Y H
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM----KITNKTL---TEEEIAAILYQTLKGLEYLH-- 116
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
N+ IH DIK NILL+E K++DFG++ + ++ T++ GT ++APE +
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 684 PITVKADVYSYGMLLLEIVGGR 705
KAD++S G+ +E+ G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRV---LPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG GGFG V + G + A KKLD+ GE+ + E + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 567 YCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
Y E + L LV M G L + Y+ + A G+ + H++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLK---YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
RI++ D+KPEN+LLD++ ++SD GLA + + + + GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 686 TVKADVYSYGMLLLEIVGGR 705
D ++ G L E++ GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 41/215 (19%)
Query: 509 QLLGTGGFGSVYKGSL--------GDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSMHHM 559
++LG G FG V SL G G +VAVK L R + E+N + +++H
Sbjct: 10 RVLGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 560 NLVRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT---- 613
N+V+ G CSE + L+ E++ GSL D+ + + +A
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSL--------------RDYLPKHKLNLAQLLLF 112
Query: 614 ----AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTM 667
+G+AY H Q IH D+ N+LLD + K+ DFGLAK + G E+ +V
Sbjct: 113 AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
+ A E + + +DV+S+G+ L E++
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 65/209 (31%), Positives = 113/209 (54%), Gaps = 20/209 (9%)
Query: 506 NFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEF-VTEVNTIGSMHHMNL 561
NF QL LG G + +VYKG + G +VA+K++ G + E++ + + H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
VRL + +LV+E+M L K++ ++ R LD T + +GIA+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYM-DTHGVR-GALDPNTVKSFTYQLLKGIAFCH 117
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG----REHSQVVTMVRGTRGYLAP 677
E NR++H D+KP+N+L+++ K++DFGLA+ G ++VVT+ Y AP
Sbjct: 118 E---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL-----WYRAP 169
Query: 678 E-WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ + +R + D++S G ++ E++ GR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 65/233 (27%), Positives = 96/233 (41%), Gaps = 50/233 (21%)
Query: 511 LGTGGFGSVYK-GSLGDGTLVAVKK--LDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G G V+K G VA+KK L R+ + + E+ + + H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHEQC 624
GS +LV E+M L + + +R L + G+AY H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL----RDEERPL---PEAQVKSYMRMLLKGVAYMHA-- 117
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
N I+H D+KP N+L+ + K++DFGLA+L E ++ + TR Y APE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE------ 170
Query: 685 ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA----FKEMTNGTPL 733
LL G R D D WA F E+ NG+PL
Sbjct: 171 ------------LLY----GARKYDPGVDL-------WAVGCIFAELLNGSPL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 18/174 (10%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT--EVNTIGSM-HHMNLVRLCG 566
LG G FGSVY + G LVA+KK+ + E E + EV ++ + H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 567 YCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRD-RVLDWTTRFNIAIATAQGIAYFHEQC 624
E ++ L V+E+M + ++ R + + +I QG+A+ H
Sbjct: 66 VFRE-NDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
++ H D+KPEN+L+ K++DFGLA+ + R V TR Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-STRWYRAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-----EVNTIGSMHHMNLVR 563
LG G + VYK G +VA+KK+ K+ + E+ + + H N++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF--NIAIATAQGIAYFH 621
L SN LV+EFM+ L+K I +D+ + T + + T +G+ Y H
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDLEKVI------KDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRGYLAP 677
N I+H D+KP N+L+ + K++DFGLA+ G + QVV TR Y AP
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRWYRAP 171
Query: 678 EWV-SNRPITVKADVYSYGMLLLE 700
E + R V D++S G + E
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 8/191 (4%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570
LG G FG V+ G+ T VA+K L + + F+ E + + H LV+L SE
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIH 630
+V E+M GSL ++ + L ++A A G+AY R +H
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 631 CDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKAD 690
D++ NIL+ EN KV+DFGLA+L+ + + APE T+K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 691 VYSYGMLLLEI 701
V+S+G+LL E+
Sbjct: 186 VWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
F + LG+G FG V+ G VA+K + R E +F+ E + + H NLV+L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C++ +V E+M NG L ++ R L ++ + + Y
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSNR 683
IH D+ N L+ E+ KVSDFGLA+ + + T +GT+ + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYS 176
Query: 684 PITVKADVYSYGMLLLEI 701
+ K+DV+S+G+L+ E+
Sbjct: 177 RFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 510 LLGTGGFGSVYKGSLGD-GTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
++G G +G V K G +VA+KK +K + EV + + H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 567 YCSEGSNRL-LVYEFMKNGSLDKW-IFPSYHHRD--RVLDWTTRFNIAIATAQGIAYFHE 622
RL LV+E+++ L+ P D R W Q IAY H
Sbjct: 68 AFRR-KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCH- 117
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-WVS 681
+ IIH DIKPENIL+ E+ K+ DFG A+ + + +T TR Y APE V
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 682 NRPITVKADVYSYGMLLLEIVGGR 705
+ DV++ G ++ E++ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLP------HGEKEFVT------EVNTIGS 555
+L+G G +G VY ++ G ++AVK+++ LP H ++ E+ T+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVE--LPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 556 MHHMNLVRLCGYCSEGSNRLLVY-EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
+ H+N+V+ G L ++ E++ GS I R + RF
Sbjct: 65 LDHLNIVQYLG-FETTEEYLSIFLEYVPGGS----IGSCLRTYGRFEEQLVRF-FTEQVL 118
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRG 673
+G+AY H + I+H D+K +N+L+D + K+SDFG++K + M ++G+
Sbjct: 119 EGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 674 YLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRR 706
++APE + + + + K D++S G ++LE+ GRR
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 511 LGTGGFGSVYKGS------LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
LG G FG V+ D LVAVK L K+F E + ++ H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-------------LDWTTRFNIAI 611
G C +G ++V+E+MK+G L+K F H D + L + +IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRG 670
A G+ Y Q +H D+ N L+ N K+ DFG+++ + ++ +V
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
++ PE + R T ++DV+S+G++L EI
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRL 564
+ +G G FG VYK +VA+K +D L E E E+ + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFH 621
G +GS ++ E+ GS + P LD T IA + G+ Y H
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPG------KLDETY---IAFILREVLLGLEYLH 115
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
E+ IH DIK NILL E K++DFG++ + S+ T V GT ++APE +
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171
Query: 682 NRPITVKADVYSYGMLLLEIVGG 704
KAD++S G+ +E+ G
Sbjct: 172 QSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
+ LG G FG V+ G+ T VAVK L + + F+ E + + H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRD---RVLDWTTRFNIAIATAQGIAYFHEQCR 625
SE +V E+M GSL ++ +D R L ++A A G+AY R
Sbjct: 71 SE-EPIYIVTEYMSKGSLLDFL------KDGEGRALKLPNLVDMAAQVAAGMAYIE---R 120
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
IH D++ NIL+ + K++DFGLA+L+ + + APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 686 TVKADVYSYGMLLLEIV 702
T+K+DV+S+G+LL E+V
Sbjct: 181 TIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 29/235 (12%)
Query: 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGE-KEFVTEVNT 552
FT DL+ +G G FG+V K GT++AVK++ + E K + +++
Sbjct: 1 FTAEDLKDLGE-----IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 553 I-GSMHHMNLVRLCGYC-SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
+ S +V+ G EG + + E M + SLDK+ Y V+ IA
Sbjct: 56 VMRSSDCPYIVKFYGALFREG-DCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
+AT + + Y E+ + IIH D+KP NILLD N K+ DFG++ + S T G
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAG 169
Query: 671 TRGYLAPEWV-SNR--PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW 722
R Y+APE + + V++DV+S G+ L E+ G+ F YP W
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK-----------FPYPKW 213
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 514 GGFGSVY---KGSLGDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRLCGY 567
G +G V+ K S GD + A+K + + + + +TE + + +V+L Y
Sbjct: 4 GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--Y 59
Query: 568 CS-EGSNRL-LVYEFMKNGSLDKWI-----FPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
S +G L LV E++ G L + R IA + Y
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV---------ARIYIA-EIVLALEYL 109
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK--LMGREHSQVVTMVR-----GTRG 673
H N IIH D+KP+NIL+D N K++DFGL+K L+ R+ + GT
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
Y+APE + + + D +S G +L E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 511 LGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
LG G FG V+ D LVAVK L ++F E + + H ++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD-RVLD-----------WTTRFNIAIA 612
G C+EG L+V+E+M++G L++ F H D ++L IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGT 671
A G+ Y +H D+ N L+ + K+ DFG+++ + ++ +V
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
++ PE + R T ++D++S+G++L EI
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 8e-17
Identities = 57/191 (29%), Positives = 85/191 (44%), Gaps = 49/191 (25%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-F-VT---EVNTIGSMHHMNLVRL 564
+G G +G VYK + G LVA+KK+ EKE F +T E+ + + H N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 565 -CGYCSEGSNRL-LVYEFMK---NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---- 615
S+G + +V+E+M G LD P +Q
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDS---PEVK---------------FTESQIKCY 105
Query: 616 ------GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT--M 667
G+ Y H N I+H DIK NIL++ + K++DFGLA+ + +S T +
Sbjct: 106 MKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 668 VRGTRGYLAPE 678
+ T Y PE
Sbjct: 163 I--TLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 509 QLLGTGGFGSVYKGSLGD-GTLVAVKKL--DRVLPHGEKE---FVTEVNTIGSMHHMNLV 562
+LLG G FG VY D G +AVK++ D P +KE E+ + ++ H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 563 RLCGYCSEGSNRLLVY-EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
+ G C L ++ E+M GS+ + + V TR +G+ Y H
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH 121
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM--VRGTRGYLAPEW 679
N I+H DIK NIL D K+ DFG +K + S M V GT +++PE
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 680 VSNRPITVKADVYSYGMLLLEIV 702
+S KADV+S G ++E++
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 37/217 (17%)
Query: 509 QLLGTGGFGSVYKGSLG--DGTL--VAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLV 562
++LG G FGSV +G L DG+ VAVK KLD +EF++E + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 563 RLCGYCSEGSNR------LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNI------A 610
+L G C E S+ +++ FMK+G L ++ S R+ + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-----RLGGLPEKLPLQTLLKFM 119
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
+ A G+ Y + IH D+ N +L E+ V+DFGL+K + R
Sbjct: 120 VDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-----DYYRQ 171
Query: 671 TR------GYLAPEWVSNRPITVKADVYSYGMLLLEI 701
R ++A E +++R T K+DV+++G+ + EI
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 81/276 (29%), Positives = 121/276 (43%), Gaps = 39/276 (14%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
LG G FG V+ G+ T VA+K L ++P F+ E + + H LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAVV 70
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
SE +V EFM GSL ++ + L ++A A G+AY R
Sbjct: 71 SE-EPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVK 688
IH D++ NIL+ +N K++DFGLA+L+ + + APE T+K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 689 ADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL---EGA 743
+DV+S+G+LL E+V R YPG M N L+ +R R+ +G
Sbjct: 184 SDVWSFGILLTELVTKGR----------VPYPG-----MVNREVLEQVERGYRMPCPQGC 228
Query: 744 VEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
E ELM+ C + + RP+ + LE
Sbjct: 229 PESLHELMKL------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 56/195 (28%), Positives = 102/195 (52%), Gaps = 14/195 (7%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570
LG G FG V+ + T VAVK + + + F+ E N + ++ H LV+L ++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRD---RVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
++ EFM GSL ++ + +++D++ + A+G+A+ + RN
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQ--RN- 122
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
IH D++ NIL+ + K++DFGLA+++ + + APE ++ T+
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 688 KADVYSYGMLLLEIV 702
K+DV+S+G+LL+EIV
Sbjct: 183 KSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKL---DRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+G G F VYK L DG +VA+KK+ + + ++ + E++ + + H N+++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
E + +V E G L + I + + R++ T + + + + H +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
RI+H DIKP N+ + K+ D GL + + + ++V GT Y++PE +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 184
Query: 687 VKADVYSYGMLLLEI 701
K+D++S G LL E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG GGFG V + + G + A KKLD+ GEK + E + ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 567 YCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
Y E L LV M G L I Y+ +R L+ + + GI + H
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHLHSM-- 114
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
I++ D+KPEN+LLD+ ++SD GLA + + + +T GT GY+APE + P
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 686 TVKADVYSYGMLLLEIVGGR 705
+ D ++ G + E+V GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 72/286 (25%), Positives = 110/286 (38%), Gaps = 48/286 (16%)
Query: 509 QLLGTGGFGSVYKG----SLGDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
+ LG G FG V +G S G VAVK L L +F+ E + S+ H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDW---TTRFNIAIATAQGIAYF 620
L G ++V E GSL + R L +T + A+ A G+ Y
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRL------RKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGL--AKLMGREHSQVVTMVRGTRGYLAPE 678
+ R IH D+ NILL + K+ DFGL A +H + ++ + APE
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
+ R + +DV+ +G+ L E+ F Y + ++ LK D+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEM---------------FTYGEEPWAGLSGSQILKKIDK 215
Query: 739 RLEGAVEEE-------ELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777
E E +M C RP+ + + L
Sbjct: 216 EGERLERPEACPQDIYNVMLQ------CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
F + LGTG FG V G VA+K + + E EF+ E + + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C++ +V E+M NG L ++ + + +G+AY +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKR----FQPSQLLEMCKDVCEGMAYLESK--- 119
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
+ IH D+ N L+D+ C KVSDFGL++ ++ E++ V R + PE +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLLYSKF 178
Query: 686 TVKADVYSYGMLLLEI 701
+ K+DV+++G+L+ E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 510 LLGTGGFGSVYKGS----LGDGT---LVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNL 561
LG+G FG VY+G+ LG G+ VAVK L + EK EF+ E + + + +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-------LDWTTRFNIAIATA 614
V+L G C + ++ E M+ G L SY RV L +I + A
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDL-----LSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDEN--FCP---KVSDFGLAKLM-----GREHSQV 664
+G Y + IH D+ N L+ E K+ DFGLA+ + R+ +
Sbjct: 117 KGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
+ VR ++APE + + T ++DV+S+G+L+ EI+
Sbjct: 174 LLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 65/212 (30%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 511 LGTGGFGSVYKGSL----GDGT--LVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVR 563
LG G FG VY+G GD VAVK L E +F+ E + +H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR--VLDWTTRFNIAIATAQGIAYFH 621
L G E R ++ E M G L ++ + +R L A A+G Y
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 622 EQCRNRIIHCDIKPENILLDENFCP------KVSDFGLAK-LMGREHSQVVTMVRGTRGY 674
E N IH DI N LL C K++DFG+A+ + + + +G R
Sbjct: 134 E---NHFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRASYYR-----KGGRAM 182
Query: 675 LAPEWVSNRP-----ITVKADVYSYGMLLLEI 701
L +W+ T K DV+S+G+LL EI
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDR---------VLPHGEKEFVTEVNTIGSMHH 558
++LG GGFG V + G + A KKL++ + EK+ + +VN+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS------ 59
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
V Y E + L LV M G L F YH + + A G+
Sbjct: 60 -RFVVSLAYAYETKDALCLVLTLMNGGDLK---FHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
H + RI++ D+KPENILLD++ ++SD GLA + Q + GT GY+AP
Sbjct: 116 EDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAP 170
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGR 705
E V N T D ++ G LL E++ G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 31/218 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-----EVNTIGSMHHMNLVRL 564
+G G +G VYKG + G +VA+KK+ R+ E+E V E++ + + H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RL--ESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWI--FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
+ S L++EF+ + L K++ P + D L + + I QGI + H
Sbjct: 65 QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH- 118
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHS-QVVTMVRGTRGYLAPE 678
R++H D+KP+N+L+D K++DFGLA+ G R ++ +VVT+ Y APE
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL-----WYRAPE 171
Query: 679 WVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
+ P + D++S G + E+ ++ L GD+E
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMA-TKKPL-FHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 509 QLLGTGGFGSVY--KGSLGDGTLVAVKKLD-RVLPHGEKEFV-TEVNTIGSMHHMNLVRL 564
+ +G G FG +Y K D +K++D +P EKE EV + M H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSY---HHRDRVLDWTTRFNIAIATAQGIAYFH 621
E +V E+ G L K I D++L W + ++ G+ + H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118
Query: 622 EQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
++ +I+H DIK +NI L +N K+ DFG+A+ + T V GT YL+PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 681 SNRPITVKADVYSYGMLLLEI 701
NRP K D++S G +L E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 50/179 (27%), Positives = 94/179 (52%), Gaps = 12/179 (6%)
Query: 527 GTLVAVKKLDRVLPHGEKEFV-TEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585
G VAVKK+D + +E + EV + H N+V + G +V EF++ G+
Sbjct: 44 GRQVAVKKMD-LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC 645
L + + + +++ + +A + +++ H Q +IH DIK ++ILL +
Sbjct: 103 LTDIVTHTRMNEEQIA------TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGR 153
Query: 646 PKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
K+SDFG + +E + ++V GT ++APE +S P + D++S G++++E+V G
Sbjct: 154 VKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 29/208 (13%)
Query: 509 QLLGTGGFGSVYKG---SLGDGTL--VAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLV 562
++LG+G FG+VYKG G+ VA+K+L + P KE + E + S+ + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-----LDWTTRFNIAIATAQGI 617
RL G C S L+ + M G L ++ H+D + L+W + A+G+
Sbjct: 73 RLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNW------CVQIAKGM 122
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GY 674
Y E+ R++H D+ N+L+ K++DFGLAKL+G + + G + +
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY--HAEGGKVPIKW 177
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIV 702
+A E + +R T ++DV+SYG+ + E++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 507 FAQLLGTGGFGSVYKG-----SLGDGTL-VAVKKLDRVLPHGEKE-FVTEVNTIGSM-HH 558
F + LG G FG V + S D + VAVK L E+E ++E+ + + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
N+V L G C+ G L++ E+ G L ++ R+ L + + A+G+A
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFL---RRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 619 YF-HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGTRGYLA 676
+ + C IH D+ N+LL K+ DFGLA+ +M + V R ++A
Sbjct: 156 FLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 677 PEWVSNRPITVKADVYSYGMLLLEI 701
PE + N T ++DV+SYG+LL EI
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 54/229 (23%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKEFVT-----EVNTIGSMHHMNLV 562
+G G +G VYK G +VA+KK L+ E E V E++ + ++H N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE-----TEDEGVPSTAIREISLLKELNHPNIV 61
Query: 563 RLCGYCSEGSNRLLVYEFM-----------KNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
RL + LV+EF+ LD + SY ++
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ-------------- 107
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHS-QVVTM 667
QGIAY H +R++H D+KP+N+L+D K++DFGLA+ G R ++ +VVT+
Sbjct: 108 -LLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 668 VRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
Y APE + +R + D++S G + E+V RR L GD+E
Sbjct: 164 -----WYRAPEILLGSRQYSTPVDIWSIGCIFAEMV-NRRPL-FPGDSE 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 59/276 (21%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 509 QLLGTGGFGS--VYKGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
++LG G FG +Y+ + D +LV K+++ R+ ++ + E+ + + H N++
Sbjct: 6 RVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
+ + + L+ E+ G+L I + ++ + ++Y H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIV---RQKGQLFEEEMVLWYLFQIVSAVSYIHK-- 119
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
I+H DIK NI L + K+ DFG++K++G E+S T+V GT Y++PE
Sbjct: 120 -AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177
Query: 685 ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG-- 742
K+D+++ G +L E++ +R D + PL + + ++G
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDAT-------------------NPLNLVVKIVQGNY 218
Query: 743 AVEEEELMRAMK-VAFWCIQDEVFMRPSMGEVVKML 777
+ + +Q + RP+ EV+
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 499 DLQIRTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKL-DRVLPHGEKEFVTEVNT 552
+L + F + LG FG +YKG L LVA+K L D P EF E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD------------RV 600
+ +HH N+V L G ++ +++E++ G L +++ H D
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--- 657
LD +IAI A G+ Y +H D+ NIL+ E K+SD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 658 --GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
R + + +R ++ PE + + +D++S+G++L EI
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 511 LGTGGFGSVYKG-SLG-----DGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
+G G FG V++ + G T+VAVK L + + +F E + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLD--------KWIFPSYHHRDRV---------LDWTTR 606
L G C+ G L++E+M G L+ + H L T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 607 FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
IA A G+AY E + +H D+ N L+ EN K++DFGL++ + +S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI---YSA--D 184
Query: 667 MVRGTRGYLAP-EWVSNRPI-----TVKADVYSYGMLLLEI 701
+ + P W+ I T ++DV++YG++L EI
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 45/244 (18%)
Query: 510 LLGTGGFGSVYKGSLGD------GTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM-HHMNL 561
LG G FG V K + VAVK L D + V+E+ + + H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWI---FPSYHHRDRVLDWTTRFNI--------A 610
+ L G C++ +V E+ +G+L ++ P + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
A+G+ + + + IH D+ N+L+ E+ K++DFGLA R+ + +
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLA----RDIHHIDYYRKT 191
Query: 671 TRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWA 723
T G L APE + +R T ++DV+S+G+LL EI GG YPG
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP------------YPGIP 239
Query: 724 FKEM 727
+E+
Sbjct: 240 VEEL 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G G V ++ G LVAVKK+D + EV + H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
G +V EF++ G+L + + + +++ + +A + ++ H Q +I
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------AVCLAVLKALSVLHAQ---GVI 138
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKA 689
H DIK ++ILL + K+SDFG + +E + ++V GT ++APE +S P +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 690 DVYSYGMLLLEIVGG 704
D++S G++++E+V G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 30/206 (14%)
Query: 509 QLLGTGGFG-SVYKGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+ +G G FG ++ S DG +K+++ ++ P +E EV + +M H N+V+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWI-------FPSYHHRDRVLDWTTRFNIAIATAQGIA 618
E N +V ++ + G L K I FP D++LDW + +A+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP----EDQILDWFVQICLALK------ 115
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR---GTRGYL 675
+ H++ +I+H DIK +NI L ++ K+ DFG+A+++ + V + R GT YL
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYL 168
Query: 676 APEWVSNRPITVKADVYSYGMLLLEI 701
+PE NRP K+D+++ G +L E+
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 510 LLGTGGFGSVYKGSLGD-GTLVAVKKL-----DRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
L+G G +G V K + G +VA+KK D+++ +K + E+ + + H NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV---KKIAMREIRMLKQLRHENLVN 64
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
L LV+EF+ + LD LD + +GI + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDD-----LEKYPNGLDESRVRKYLFQILRGIEFCH-- 117
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
+ IIH DIKPENIL+ ++ K+ DFG A+ + +V T TR Y APE +
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGD 175
Query: 684 PITVKA-DVYSYGMLLLEIVGG 704
+A D+++ G L+ E++ G
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 16/196 (8%)
Query: 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVRLCGYC 568
+G G FG V+ G L D T VAVK LP K +F+ E + H N+VRL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
++ +V E ++ G ++ L + A G+ Y +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGMEYLESKH---C 115
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR----GYLAPEWVSNRP 684
IH D+ N L+ E K+SDFG+++ E V G + + APE ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 685 ITVKADVYSYGMLLLE 700
+ ++DV+S+G+LL E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
LG G FG VYK + G L A K +D ++++ E++ + S H N+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
+N ++ EF G++D + +R L + T + + Y HE N+II
Sbjct: 73 YENNLWILIEFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV-----SNRP 684
H D+K NIL + K++DFG++ R + + + GT ++APE V +RP
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 685 ITVKADVYSYGMLLLEI 701
KADV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 509 QLLGTGGFGSVYKGSL---GDGTL--VAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLV 562
+LLG+G FG+V+KG GD VA+K + DR +E + +GS+ H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD-----RVLDWTTRFNIAIATAQGI 617
RL G C G++ LV + GSL + HRD R+L+W + A+G+
Sbjct: 73 RLLGICP-GASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNW------CVQIAKGM 122
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV-TMVRGTRGYLA 676
Y E ++H ++ NILL + +++DFG+A L+ + + + + ++A
Sbjct: 123 YYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIV 702
E + T ++DV+SYG+ + E++
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 57/294 (19%)
Query: 511 LGTGGFGSVY----KGSLGDG--TLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVR 563
LG G FG VY KG + D T VA+K ++ E+ EF+ E + + + ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKW---IFPSYHHRDRVLDWTTRFNIAIA--TAQGIA 618
L G S+G L++ E M G L + + P + + + I +A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
Y + N+ +H D+ N ++ E+F K+ DFG M R+ + +G +G L
Sbjct: 134 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 186
Query: 679 WVSNRPI-----TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
W+S + T +DV+S+G++L EI + AE ++ M+N L
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI---------ATLAEQ------PYQGMSNEQVL 231
Query: 734 KVADRRLEGAVEEE---------ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ +EG + ++ ELMR C Q MRPS E++ ++
Sbjct: 232 RFV---MEGGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRV-LPHGEKEFVT-----EVNTIGSMHHMNL 561
Q LGTG F S Y+ + GTL+AVK++ V E+E V E+ + ++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------Q 615
+R+ G E S+ L E+M GS+ +L F A+ +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSH-----------LLSKYGAFKEAVIINYTEQLLR 114
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLM-------GREHSQVVTM 667
G++Y HE N+IIH D+K N+L+D +++DFG A + G Q++
Sbjct: 115 GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL-- 169
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
GT ++APE + DV+S G +++E+ +
Sbjct: 170 --GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKE-------FVTEVNTIGSMHHM 559
L+G+G FGSVY G + G L+AVK+ L V + E+ + + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 560 NLVRLCGYCSEGSNRLLVY-EFMKNGS----LDKW-IFPSYHHRDRVLDWTTRFNIAIAT 613
N+V+ G S ++ L ++ E++ GS L+ + F R N
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR----------NFVRQI 115
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
+G+ Y H + IIH DIK NIL+D K+SDFG++K + E + + T G R
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARP 170
Query: 674 -------YLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
++APE V T KAD++S G L++E++ G+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 49/178 (27%), Positives = 92/178 (51%), Gaps = 10/178 (5%)
Query: 527 GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586
G VAVKK+D + EV + HH N+V + G +V EF++ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646
+ + + +++ + ++ + ++Y H Q +IH DIK ++ILL +
Sbjct: 107 TDIVTHTRMNEEQIA------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 647 KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
K+SDFG + +E + ++V GT ++APE +S P + D++S G++++E++ G
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 509 QLLGTGGFGSVY---KGSLGD-GTLVAVKKL--------DRVLPHGEKEFVTEVNTIGSM 556
++LG G FG V+ K + D G L A+K L DRV E++ + EVN
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN----- 56
Query: 557 HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
H +V+L Y + +L L+ +F++ G L F + +F +A A
Sbjct: 57 -HPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELAL 109
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ + H II+ D+KPENILLDE K++DFGL+K +H + GT Y+
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 165
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGG 704
APE V+ R T AD +S+G+L+ E++ G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-15
Identities = 69/275 (25%), Positives = 129/275 (46%), Gaps = 28/275 (10%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
++ G G+ YKG S+ +G VK+++ V +P +E+ +G + H N+V+L G
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS------SEIADMGKLQHPNIVKLIG 750
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C L++E+++ +L + + R L W R IAI A+ + + H +C
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL--------RNLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
++ ++ PE I++D P + L L+ + ++ Y+APE + IT
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS-----SAYVAPETRETKDIT 856
Query: 687 VKADVYSYGMLLLEIVGGRRNLDM-SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG--A 743
K+D+Y +G++L+E++ G+ D G WA ++ D + G +
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
V + E++ M +A C + RP +V+K LE
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 511 LGTGGFGSVYK-GSLGDGTLVAVKKLDRVLPHGEKEFVTE--VNTIGSMHHMN---LVRL 564
LG G GSV K + GT++A K V+ G K V + + + MH +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK----VVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHH-RDRVLDWTTRFNIAIATAQGIAYFHEQ 623
G +N + EFM GSLD+ I+ +L IA+A +G+ Y +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILG-----KIAVAVVEGLTYLYNV 122
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
+RI+H DIKP NIL++ K+ DFG++ G + + GT Y++PE +
Sbjct: 123 --HRIMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGG 177
Query: 684 PITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
TVK+DV+S G+ ++E+ G+ S +D
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 505 SNFA--QLLGTGGFGSVYKGS-LGDGTLVAVKKL---DRVLPHGEKEFVTEVNTIGSMHH 558
+NF + +G G F VY+ + L DG VA+KK+ D + + + E++ + ++H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
N+++ E + +V E G L + I + + R++ T + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
+ H + R++H DIKP N+ + K+ D GL + + + ++V GT Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 679 WVSNRPITVKADVYSYGMLLLEI 701
+ K+D++S G LL E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 507 FAQLLGTGGFGSVYKGSL---GDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSM-HHMNL 561
F ++G G FG V + + G A+K L + ++F E+ + + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRFNIA 610
+ L G C + E+ G+L ++ F H L A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
A G+ Y E+ + IH D+ N+L+ EN K++DFGL++ G E TM R
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRL 180
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
++A E ++ T K+DV+S+G+LL EIV
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 59/238 (24%), Positives = 115/238 (48%), Gaps = 27/238 (11%)
Query: 509 QLLGTGGFGSVY--KGSLGDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+++G G FG V+ + D LV +K++ +++ E + + H N++
Sbjct: 6 RVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFP---SYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
E ++V E+ G+L ++I S D +L + + +A+ H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL--------HH 116
Query: 622 EQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
+ I+H D+K +NILLD++ K+ DFG++K++ + S+ T+V GT Y++PE
Sbjct: 117 VHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVV-GTPCYISPELC 173
Query: 681 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
+P K+D+++ G +L E+ +R +A + P K + +GT ++DR
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAF----EAANL--PALVLK-IMSGTFAPISDR 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 510 LLGTGGFGSVYKGSL------GDGTLVAVKKLDRV-LPHGEKEFVTEVNTIGSMHHMNLV 562
LG G FG V+ G TLV VK L + + + EF E++ + H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV----LDWTTRFNIAIATAQGIA 618
RL G C E ++ E+ G L +++ + +++ L + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGRE---HSQVVTMVRGTRGY 674
+ R +H D+ N L+ KVS L+K + E + +R +
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----W 184
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEI 701
LAPE V + K+DV+S+G+L+ E+
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 65/228 (28%), Positives = 113/228 (49%), Gaps = 40/228 (17%)
Query: 506 NFAQL--LGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKEFVTEVNTIGSMHHMN 560
NF ++ +G G +G VYK + G +VA+KK LD + E++ + ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------ 614
+V+L + LV+EF+ + L K+ +D + I +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKF-----------MDASPLSGIPLPLIKSYLFQ 108
Query: 615 --QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHS-QVVTMV 668
QG+A+ H +R++H D+KP+N+L++ K++DFGLA+ G R ++ +VVT+
Sbjct: 109 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL- 164
Query: 669 RGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
Y APE + + + D++S G + E+V RR L GD+E
Sbjct: 165 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV-TRRAL-FPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 510 LLGTGGFGSVYKGSLGDGTL---VAVKKLDRVLPHGE-KEFVTEVNTIGSM-HHMNLVRL 564
++G G FG V K + L A+K++ + ++F E+ + + HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRFNIAIAT 613
G C L E+ +G+L ++ F + L + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
A+G+ Y ++ + IH D+ NIL+ EN+ K++DFGL++ G+E TM R
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 176
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
++A E ++ T +DV+SYG+LL EIV + G Y G E+ P
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIV------SLGGTP----YCGMTCAELYEKLPQ 226
Query: 734 KVADRRLEGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVV----KMLE 778
+ +E +LMR C +++ + RPS +++ +MLE
Sbjct: 227 GYRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 511 LGTGGFGSVYKGSLGD------GTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVR 563
LG G FG VY+G+ D T VAVK ++ E+ EF+ E + + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKW---IFPSYHHRDRVLDWTTRFNIAIAT--AQGIA 618
L G S+G L+V E M +G L + + P + T + I +A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
Y + + + +H D+ N ++ +F K+ DFG M R+ + +G +G L
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 186
Query: 679 WVSNRPI-----TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
W++ + T +D++S+G++L EI + AE ++ ++N L
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQ------PYQGLSNEQVL 231
Query: 734 K-VADRRLEGAVE--EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
K V D + E + M++ C Q MRP+ E+V +L+
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 57/228 (25%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCG 566
+++G G +G VYK G LVA+K +D + E+E E N + +H N+ G
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYG 70
Query: 567 -------------------YCSEGSNRLLVYEFMKNGSLDK--WIFPSYHHRDRVLDWTT 605
C GS LV K G K WI +Y
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI--AY----------- 117
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG----LAKLMGREH 661
I T +G+AY HE N++IH DIK +NILL +N K+ DFG L +GR +
Sbjct: 118 ---ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 662 SQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGG 704
+ + GT ++APE ++ + ++DV+S G+ +E+ G
Sbjct: 172 TFI-----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 511 LGTGGFGSVYKG---SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG+G FG+V KG VAVK K D P + E + E N + + + +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G C E + +LV E + G L+K++ + H ++ + + + G+ Y E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEE--- 113
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS--QVVTMVRGTRGYLAPEWVSNR 683
+H D+ N+LL K+SDFGL+K +G + + + T + + APE ++
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 684 PITVKADVYSYGMLLLE 700
+ K+DV+S+G+L+ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 507 FAQLLGTGGFGSVYKGSLG--DGTL-VAVKKLD-RVLPHGEKE-FVTEVNTIGSMHHMNL 561
+ LG G FGSV +G L D L VAVK + + E E F++E + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 562 VRLCGYCSEGSNR------LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT-- 613
+RL G C + +++ FMK+G L ++ S D T+ + T
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDCPQYLPTQMLVKFMTDI 121
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA-KLMGREHSQVVTMVRGTR 672
A G+ Y + IH D+ N +L+EN V+DFGL+ K+ ++ + + +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEI 701
++A E +++R T K+DV+S+G+ + EI
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVA---VKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G G FG V G G A VK+L P + F+ EV ++H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
G C E LLV EF G L ++ + ++ +A A G+ + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE-----HSQVVTMVRGTRGYLAPEW 679
+ IH D+ N L + K+ D+GLA E +R +LAPE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPEL 173
Query: 680 VSNR-------PITVKADVYSYGMLLLEI 701
V R T K++++S G+ + E+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKE-FVTEVNTIGSMHHMNLVRLCGYCS 569
LG G FG VYK + L A K+ ++ E E F+ E++ + H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
+ ++ EF G+LD + +R L + + + + H +++I
Sbjct: 73 YENKLWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVI 125
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV-----SNRP 684
H D+K NILL + K++DFG++ + T + GT ++APE V + P
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 685 ITVKADVYSYGMLLLEIVGGR 705
KAD++S G+ L+E+
Sbjct: 185 YDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRLCG-Y 567
LG G G V K L+ +KL + P + + E+ + + +V G +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
S+G + + E M GSLD+ + + + +L ++IA +G+AY E +++
Sbjct: 73 YSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQ 124
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
I+H D+KP NIL++ K+ DFG++ G+ + GTR Y++PE + +V
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 688 KADVYSYGMLLLEIVGGR 705
++D++S G+ L+E+ GR
Sbjct: 182 QSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
F + LG+G FG V+ G VA+K + E++F+ E + + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHH--RDRVLDWTTRFNIAIATAQGIAYFHEQC 624
C++ +V EFM+NG L ++ +D +L ++ +G+ Y
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLE--- 117
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
RN IH D+ N L+ KVSDFG+ + + + + + + PE +
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 685 ITVKADVYSYGMLLLEI 701
+ K+DV+S+G+L+ E+
Sbjct: 178 YSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRL 564
Q +G+G +G VYK + G LVA+K KL+ P + E + E++ + H N+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
G +V E+ GSL Y L + T +G+AY HE
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQD----IYQVTRGPLSELQIAYVCRETLKGLAYLHET- 120
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR- 683
IH DIK NILL E+ K++DFG++ + ++ + + GT ++APE +
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVER 177
Query: 684 --PITVKADVYSYGMLLLE 700
K D+++ G+ +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G G+V+ + G VA+K+++ ++ + E+ + + + N+V
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
G +V E++ GSL + + +D + Q + + H N++I
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHA---NQVI 137
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKA 689
H DIK +N+LL + K++DFG + E S+ TMV GT ++APE V+ + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 690 DVYSYGMLLLEIVGG 704
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMHHMNLV 562
++LG+G FG+VYKG + DG V + +VL P KE + E + + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-----LDWTTRFNIAIATAQGI 617
RL G C S LV + M G L ++ ++DR+ L+W + A+G+
Sbjct: 73 RLLGICLT-STVQLVTQLMPYGCLLDYV---RENKDRIGSQDLLNW------CVQIAKGM 122
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GY 674
+Y E R++H D+ N+L+ K++DFGLA+L+ + ++ G + +
Sbjct: 123 SYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY--HADGGKVPIKW 177
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIV 702
+A E + +R T ++DV+SYG+ + E++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 56/210 (26%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 501 QIRTSNFAQL--LGTGGFGSVYKGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSM 556
+++ +F ++ LG G G V+K S L+ +KL + P + + E+ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 557 HHMNLVRLCG-YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
+ +V G + S+G + + E M GSLD+ + + +++L ++IA +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIK 114
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
G+ Y E +++I+H D+KP NIL++ K+ DFG++ G+ + GTR Y+
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYM 169
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGR 705
+PE + +V++D++S G+ L+E+ GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH----HMNLVRL 564
+LG G +G VY L +A+K++ P + +V ++ ++H H N+V+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI----PERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 565 CGYCSEGSNRLLVYEFMKNGSLD-----KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
G SE + E + GSL KW P + ++ +T + +G+ Y
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQI------LEGLKY 123
Query: 620 FHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
H+ N+I+H DIK +N+L++ + K+SDFG +K + + T GT Y+APE
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPE 179
Query: 679 WVSN--RPITVKADVYSYGMLLLEIVGGR 705
+ R AD++S G ++E+ G+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDR---------VLPHGEKEFVTEVNTIGSMHH 558
++LG GGFG V + G + A KKL++ + EK+ + +VN+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR----- 60
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
V Y E + L LV M G L F Y+ + D A G+
Sbjct: 61 --FVVSLAYAYETKDALCLVLTLMNGGDLK---FHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
H R RI++ D+KPENILLD+ ++SD GLA + E + V GT GY+AP
Sbjct: 116 EDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYMAP 170
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGR 705
E V N T D + G L+ E++ G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEK----EFVTEVNT---IGSMHHMNL 561
+G G +G+VYK L G VA+KK+ +P E+ + E+ + S H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 562 VRLCGYC--SEGSNRL---LVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATA 614
VRL C L LV+E + +Y L T ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVD------QDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH---SQVVTMVRGT 671
+G+ + H +RI+H D+KP+NIL+ + K++DFGLA++ E S VVT+
Sbjct: 118 RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL---- 170
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
Y APE + D++S G + E+
Sbjct: 171 -WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 509 QLLGTGGFGSVYKGSL----GDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLV 562
+ +G G FG VY+G + VAVK K EK F+ E + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIV 70
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-LDWTTRFNIAIATAQGIAYFH 621
+L G +E + +V E G L ++ ++ + L ++ ++TA +AY
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTA--LAYLE 124
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
+ R +H DI N+L+ C K+ DFGL++ + E + + ++APE ++
Sbjct: 125 SK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 682 NRPITVKADVYSYGMLLLEI 701
R T +DV+ +G+ + EI
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G G+VY + G VA+K+++ ++ + E+ + + N+V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
G +V E++ GSL + + +D + Q + + H N++I
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHS---NQVI 137
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKA 689
H DIK +NILL + K++DFG + E S+ TMV GT ++APE V+ + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 690 DVYSYGMLLLEIVGG 704
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-13
Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 530 VAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL-VYEFMKNGS 585
VA+K L P E + F E ++H N+V L L V+E++ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DE 642
L + + D L + + +A H I+H D+KP+NI++
Sbjct: 66 LREVL-----AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 643 NFCPKVSDFGLAKLM-GREHSQVVTMVR-----GTRGYLAPEWVSNRPITVKADVYSYGM 696
KV DFG+ L+ G + V T+ R GT Y APE + P+T +D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 697 LLLEIVGGRR 706
+ LE + G+R
Sbjct: 178 IFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
++LG G G+VYK L ++AVK LD + +K+ ++E+ + ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 566 G-YCSEGSNRL-LVYEFMKNGSLD-KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
G + E NR+ + EFM GSLD P + VL IA+A +G+ Y
Sbjct: 66 GAFFVE--NRISICTEFMDGGSLDVYRKIP-----EHVLG-----RIAVAVVKGLTYLWS 113
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
+I+H D+KP N+L++ K+ DFG++ + +S T V GT Y+APE +S
Sbjct: 114 L---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISG 167
Query: 683 RPITVKADVYSYGMLLLEIVGGR 705
+ +DV+S G+ +E+ GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDR---------VLPHGEKEFVTEVNTIGSMHH 558
++LG GGFG V + G + A KKL++ + EK + +VN+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS------ 59
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
V Y E + L LV M G L F Y+ + D A G+
Sbjct: 60 -RFVVSLAYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFDEQRAIFYAAELCCGL 115
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
R RI++ D+KPENILLD+ ++SD GLA + + V GT GY+AP
Sbjct: 116 EDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGRVGTVGYMAP 170
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGR 705
E ++N T D + G L+ E++ G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 509 QLLGTGGFGSVYKGSLG----DGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
++LGTG FG + +G L VA+ L + F+ E T+G H N+VR
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
L G + G+ ++V E+M NG+LD ++ + L + A G+ Y E
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL--APEWVS 681
+H + +L++ + K+S F +L + + T + G L APE +
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 682 NRPITVKADVYSYGMLLLEIV--GGRRNLDMSG 712
+ +DV+S+G+++ E++ G R DMSG
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 28/203 (13%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLD---RVLPHGEKEFVTE--VNTIGSMHHMN---LV 562
LG+G FG V KG + K++D +VL + ++ V + + MH ++ +V
Sbjct: 3 LGSGNFGCVKKGVYK----MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAY 619
R+ G C E +LV E G L+K++ +D + T N+ Q G+ Y
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGK---KDEI----TVSNVVELMHQVSMGMKY 110
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGT--RGYLAP 677
+ +H D+ N+LL K+SDFGL+K +G + S G + AP
Sbjct: 111 LEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 678 EWVSNRPITVKADVYSYGMLLLE 700
E ++ R + ++DV+SYG+ + E
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 44/292 (15%)
Query: 511 LGTGGFGSVYKG-SLG-------DGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM-HHMN 560
LG G FG V +LG + VAVK L D + V+E+ + + H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIF----PSYHHR---DRVLDWTTRFNIAIA- 612
++ L G C++ ++ E+ G+L +++ P + RV D F ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 613 ---TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVTMV 668
A+G+ Y Q + IH D+ N+L+ EN K++DFGLA+ + ++ + T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 669 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI--VGGRRNLDMSGDAEDFFYPGWAFKE 726
R ++APE + +R T ++DV+S+G+L+ EI +GG YPG +E
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------------YPGIPVEE 247
Query: 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ LK R + A EL M+ + I RP+ ++V+ L+
Sbjct: 248 LFK--LLKEGHRMDKPANCTNELYMMMRDCWHAIPSH---RPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G G+VY + G VA+K+++ ++ + E+ + H N+V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
G +V E++ GSL + + +D + Q + + H N++I
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQVI 137
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKA 689
H DIK +NILL + K++DFG + E S+ TMV GT ++APE V+ + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 690 DVYSYGMLLLEIVGG 704
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG-YC 568
LG G FG VYK + G L A K ++ ++++ E+ + + +H +V+L G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
+G +++ EF G++D + DR L I + + Y H +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIML----ELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131
Query: 629 IHCDIKPENILLDENFCPKVSDFGLA----KLMGREHSQVVTMVRGTRGYLAPEWV---- 680
IH D+K N+LL + K++DFG++ K + R S + GT ++APE V
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 681 -SNRPITVKADVYSYGMLLLEI 701
+ P KAD++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 10/178 (5%)
Query: 527 GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586
G VAVK +D + EV + H N+V + G ++ EF++ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646
+ + + +++ + + Q + Y H Q +IH DIK ++ILL +
Sbjct: 106 TDIVSQTRLNEEQIA------TVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRV 156
Query: 647 KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
K+SDFG + ++ + ++V GT ++APE +S P + D++S G++++E+V G
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 43/230 (18%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKLDRVLPHGEKEFVT---EVN------- 551
+LG G FG V YK + G L A+K L +K + EV
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKT---GELYAIKAL-------KKGDIIARDEVESLMCEKR 51
Query: 552 ---TIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF 607
T S H LV L C + + + V E+ G L I H D + F
Sbjct: 52 IFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVF 105
Query: 608 NIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL-MGREHSQVVT 666
A G+ Y HE N+I++ D+K +N+LLD K++DFGL K MG +
Sbjct: 106 YAA-CVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRTS 159
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
GT +LAPE ++ T D + G+L+ E++ G GD E+
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES--PFPGDDEE 207
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 32/235 (13%)
Query: 510 LLGTGGFGSVYKGSL-GDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSM--HHMNLVRL 564
+LG G FG V L G L AVK K D +L + E + ++ H L +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 565 -CGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLDWT-TRFNIAIATAQGIAYF 620
C + +RL V E++ G L +H R D RF A G+ +
Sbjct: 62 HS--CFQTKDRLFFVMEYVNGGDL------MFHIQRSGRFDEPRARF-YAAEIVLGLQFL 112
Query: 621 HEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
HE+ II+ D+K +N+LLD E K++DFG+ K G + GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHI-KIADFGMCK-EGILGGVTTSTFCGTPDYIAPEI 167
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--------FYPGWAFKE 726
+S +P D ++ G+LL E++ G+ + + E F YP W KE
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKL---DRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+G G F VY+ + L D VA+KK+ + + ++ V E++ + ++H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
E + +V E G L + I + + R++ T + + + + H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMI-KYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--- 125
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
R++H DIKP N+ + K+ D GL + + + ++V GT Y++PE +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 184
Query: 687 VKADVYSYGMLLLEI 701
K+D++S G LL E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKE---FVTEVNTI-GSMHHMNLVR 563
+++G G FG V DG+ AVK L + +KE + E N + ++ H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 564 LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
L Y + + +L V +++ G L F L+ RF A A I Y H
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARF-YAAEVASAIGYLHS 114
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
II+ D+KPENILLD ++DFGL K G E + + GT YLAPE +
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 683 RPITVKADVYSYGMLLLEIVGG 704
P D + G +L E++ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 506 NFAQLLGTGGFGSVY------------KGSLGDG-----TLVAVKKL-DRVLPHGEKEFV 547
NF + LG G FG V+ K + LVAVK L + ++F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 548 TEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYH--------HRDR 599
EV + + N+ RL G C+ ++ E+M+NG L++ F H +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ--FLQKHVAETSGLACNSK 125
Query: 600 VLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659
L ++T +A A G+ Y N +H D+ N L+ +N+ K++DFG M R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES--LN-FVHRDLATRNCLVGKNYTIKIADFG----MSR 178
Query: 660 E-HSQVVTMVRGTRGYLAPEWVSNRPI-----TVKADVYSYGMLLLEI 701
+S V+G R L W++ + T K+DV+++G+ L EI
Sbjct: 179 NLYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 511 LGTGGFGSVYK-GSLGDGTLVAVKKLDRVLPHGE-KEFVTEVN-TIGSMHHMNLVRLCGY 567
LG G +G V K + GT++AVK++ + E K + +++ ++ S+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ + E M SLDK+ + + + + IA++ + + Y H +
Sbjct: 69 LFREGDVWICMEVMDT-SLDKF-YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-- 124
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV----SNR 683
+IH D+KP N+L++ N K+ DFG++ + S T+ G + Y+APE + + +
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 684 PITVKADVYSYGMLLLEIVGGR 705
VK+DV+S G+ ++E+ GR
Sbjct: 183 GYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 47/224 (20%)
Query: 507 FAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRL 564
+L+G G +G VYKG + G L A+K +D V E+E E+N + HH N+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATY 68
Query: 565 CG-------------------YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTT 605
G +C GS L+ N ++WI +Y R+
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICRE------- 119
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+G+++ H+ +++IH DIK +N+LL EN K+ DFG++ + R +
Sbjct: 120 -------ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 666 TMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGG 704
T + GT ++APE ++ + K+D++S G+ +E+ G
Sbjct: 170 TFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 22/133 (16%)
Query: 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRF------NIAIATAQGIAYFHEQCRNRIIHCD 632
E M GSLD+ VL R I+IA +G+ Y E+ ++I+H D
Sbjct: 79 EHMDGGSLDQ-----------VLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRD 125
Query: 633 IKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVY 692
+KP NIL++ K+ DFG++ G+ + GTR Y++PE + TV++D++
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIW 182
Query: 693 SYGMLLLEIVGGR 705
S G+ L+E+ GR
Sbjct: 183 SLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 65/246 (26%), Positives = 97/246 (39%), Gaps = 52/246 (21%)
Query: 501 QIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-F-VT---EVNTIG 554
++R LG G FG VYK + G +VA+KK+ L H EK+ F +T E+ +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDK----WIFPSYHHRDRVLDWTTRFNIA 610
+ H N+V L + E + + P H L +
Sbjct: 63 KLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 611 IATA--------QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM----- 657
+ +GI Y HE N I+H DIK NIL+D K++DFGLA+
Sbjct: 114 ESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 658 ---------GREHSQVVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGRRN 707
R+++ +V TR Y PE + R T D++ G + E+ R
Sbjct: 171 NPKGGGGGGTRKYTNLVV----TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
Query: 708 LDMSGD 713
L D
Sbjct: 227 LQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCGYC 568
+G G FG VYKG +VA+K +D E E + E+ + + R G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
+G+ ++ E++ GS + P L+ T I +G+ Y H + R
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSE---RK 122
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVK 688
IH DIK N+LL E K++DFG+A + + T V GT ++APE + K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 689 ADVYSYGMLLLEIVGG 704
AD++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN---LVRLCG 566
LG G +GSVYK G +A+K++ L E +F + + +H +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 567 -YCSEGSNRLLVY---EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
+ EG+ VY E+M GSLDK ++ + + + R I A +G+ + E
Sbjct: 67 AFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR-ITYAVVKGLKFLKE 120
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS- 681
+ + IIH D+KP N+L++ N K+ DFG++ G + + G + Y+APE +
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 682 -----NRPITVKADVYSYGMLLLEIVGGR 705
N TV++DV+S G+ +LE+ GR
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 34/208 (16%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLD--RVLP-------HGEKEFVTEVNTIGSMHHM 559
+GTG FG V+ A+K + V+ H EK + EV+ H
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HP 61
Query: 560 NLVRLCGYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA-IATAQG 616
++RL + +E R L + E++ G L F + R + T F + I A
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGEL----FSYLRNSGRFSNSTGLFYASEIVCA-- 113
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ Y H + I++ D+KPENILLD+ K++DFG AK + + T+ GT YLA
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC-GTPEYLA 166
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGG 704
PE + ++ D ++ G+L+ E++ G
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHM---NLVR 563
+L+G G +G+VY+G + G +VA+K ++ P + + EV + + N+ +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
G +G ++ E+ + GS+ + ++ + R + Y H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIR-----EVLVALKYIH-- 118
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN- 682
+ +IH DIK NIL+ K+ DFG+A L+ + S+ T V GT ++APE ++
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176
Query: 683 RPITVKADVYSYGMLLLEIVGG 704
+ KAD++S G+ + E+ G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDR---------VLPHGEKEFVTEVNTIGSMHH 558
++LG GGFG V + G + A K+L++ + EK+ + +VN+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS------ 59
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIF----PSYHHRDRVLDWTTRFNIAIAT 613
V Y E + L LV M G L I+ P + +R L + A
Sbjct: 60 -QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE-ERALFY------AAEI 111
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
G+ H R ++ D+KPENILLD+ ++SD GLA + + + GT G
Sbjct: 112 LCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVG 166
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
Y+APE ++N+ T+ D + G L+ E++ G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 8e-12
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G G+VY + G VA+++++ ++ + E+ + + N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
G +V E++ GSL + + +D + Q + + H N++I
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKA 689
H DIK +NILL + K++DFG + E S+ TMV GT ++APE V+ + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 690 DVYSYGMLLLEIVGG 704
D++S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCG 566
+++G G +G VYKG + G L A+K +D V E+E E+N + HH N+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 567 YCSEGS-----NRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+ S ++L LV EF GS+ + + + + DW I +G+A+
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAY--ICREILRGLAHL 137
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
H +++IH DIK +N+LL EN K+ DFG++ + R + T + GT ++APE +
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 193
Query: 681 S-----NRPITVKADVYSYGMLLLEIVGG 704
+ + ++D++S G+ +E+ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 511 LGTGGFGSVY--------KGSLGDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM-HHMN 560
LG G FG V K VAVK L D + V+E+ + + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRFNI 609
++ L G C++ ++ E+ G+L +++ F + + L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMV 668
A A+G+ Y Q + IH D+ N+L+ E+ K++DFGLA+ + ++ + T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 669 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
R ++APE + +R T ++DV+S+G+LL EI
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDR-----VL---PHGE---KEFV---TEVNTIG 554
Q LG G FG+VY LV KK VL P GE E V E +
Sbjct: 6 QRLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS 57
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
+ H +V+ E ++ E+ + LD + H + L I
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKL-EELKHTGKTLSENQVCEWFIQLL 116
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGTRG 673
G+ Y H++ RI+H D+K +NI L N K+ DFG+++ LMG + T GT
Sbjct: 117 LGVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS--CDLATTFTGTPY 170
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEI 701
Y++PE + ++ K+D++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGE-KEFVTEVNT-IGSMHHMNLVR 563
+++G G FG V DG AVK L + +L E K + E N + ++ H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 564 LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA-IATAQGIAYFH 621
L Y + +++L V +++ G L F + RF A IA+A + Y H
Sbjct: 61 L-HYSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAEIASA--LGYLH 113
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
II+ D+KPENILLD ++DFGL K G EHS+ + GT YLAPE +
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 682 NRPITVKADVYSYGMLLLEIVGG 704
+P D + G +L E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKLDR--VLPHGEKEFV-TEVNTIGSMHH 558
NF + LGTG FG V YK D VA+K+ ++ ++ + + V +E + ++H
Sbjct: 33 NFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA---TAQ 615
V L G + S LV EF+ G F ++ R++ RF + AQ
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGE-----FFTFLRRNK------RFPNDVGCFYAAQ 139
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ F I++ D+KPEN+LLD++ K++DFG AK++ ++ T+ GT Y+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEYI 195
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGG 704
APE + N AD ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 7/156 (4%)
Query: 509 QLLGTGGFGSVYKGSLGDG---TLVAVKKLD-RVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+ +G G FG V G + G V VK+L + +F+ E S+ H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
G C+E + LLV EF G L ++ D TT +A A G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
+N IH D+ N LL + K+ D+GL+ +E
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLV 562
+G+G +G V G VA+KKL R K E+ + M H N++
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 563 RLCGYCSEGSNR------LLVYEFMKNGSLDKWIFPSYHHRDRVL-DWTTRFNIAIATAQ 615
L + S+ LV M L+ + + + L D +F + +
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV------KCQKLSDDHIQF-LVYQILR 129
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
G+ Y H IIH D+KP NI ++E+ K+ DFGLA+ E + V TR Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 182
Query: 676 APEWVSNR-PITVKADVYSYGMLLLEIVGGR 705
APE + N D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 50/229 (21%)
Query: 509 QLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNL 561
+++G G FG V+ L G + A+K L + + E + + +
Sbjct: 7 KVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63
Query: 562 VRLCGYCS-EGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
V+L Y S + L LV E+M G L + +D + T RF IA +
Sbjct: 64 VKL--YYSFQDEEHLYLVMEYMPGGDLMNLLI----RKDVFPEETARFYIAELVL-ALDS 116
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH------------------ 661
H+ IH DIKP+NIL+D + K++DFGL K M +
Sbjct: 117 VHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 662 -----SQVVTMVR-----GTRGYLAPEWVSNRPITVKADVYSYGMLLLE 700
VR GT Y+APE + P ++ D +S G++L E
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 36/207 (17%)
Query: 514 GGFGSVY---KGSLGDG-TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM-----NLVRL 564
G FGSVY K S GD + +KK D + K VT V ++ + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWI-----FPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
LV E++ G I P DW ++ G+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP--------EDWAKQY--IAEVVLGVED 112
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H+ IIH DIKPEN+L+D+ K++DFGL++ G E+ + V GT YLAPE
Sbjct: 113 LHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSR-NGLENKKFV----GTPDYLAPET 164
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRR 706
+ +D +S G ++ E + G
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 509 QLLGTGGFGSVYKGSL----GDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLV 562
++LG G FGSV + L G VAVK K D +EF+ E + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 563 RLCGYC--SEGSNRL----LVYEFMKNGSLDKWIFPSYHHRDRV---LDWTTRFNIAIAT 613
+L G S RL ++ FMK+G L ++ S + L RF I IA+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA-KLMGREHSQVVTMVRGTR 672
G+ Y + IH D+ N +L+EN V+DFGL+ K+ ++ + +
Sbjct: 125 --GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
+LA E +++ T +DV+++G+ + EI+
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 507 FAQLLGTGGFGSVY-------KGSLGDGT--------LVAVKKL-DRVLPHGEKEFVTEV 550
+ LG G FG V+ LG+G LVAVK L V +F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 551 NTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKW-----IFPSYHHRDRV--LDW 603
+ + + N++RL G C ++ E+M+NG L+++ I ++ H + + +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 604 TTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663
+A+ A G+ Y +H D+ N L+ ++ K++DFG+++ + +S
Sbjct: 129 ANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSG 182
Query: 664 VVTMVRGTRGYLAPEWVSNRPI-----TVKADVYSYGMLLLEI 701
++G R L W++ I T +DV+++G+ L E+
Sbjct: 183 DYYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 510 LLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM--NLVRLCG 566
+G+G G VYK G ++AVK++ R E + + + H +V+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHH-RDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
Y S+ + E M LDK + + +L + +A + + Y E +
Sbjct: 82 YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--K 133
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVTMVRGTRGYLAPEWVSNRP 684
+ +IH D+KP NILLD + K+ DFG++ GR S+ T G Y+APE +
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 685 IT----VKADVYSYGMLLLEIVGGR 705
++ADV+S G+ L+E+ G+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 45/224 (20%)
Query: 507 FAQLLGTGGFGSV----YKGSLGDGTLVAVKKLDRVLPHGEKEFVTE--VNTIGSMHH-- 558
+ LG G +G V + + VA+KK+ V K+ + + + + + H
Sbjct: 4 LIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVF---SKKILAKRALRELKLLRHFR 59
Query: 559 ----------MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN 608
M++V + N L +YE + L + I + L T +
Sbjct: 60 GHKNITCLYDMDIVFPGNF-----NELYLYEELMEADLHQII-----RSGQPL---TDAH 106
Query: 609 IAIATAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV- 664
Q G+ Y H ++H D+KP N+L++ + K+ DFGLA+ +
Sbjct: 107 FQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
Query: 665 --VTMVRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
+T TR Y APE +S + T DV+S G +L E++G +
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRV------LPHGEKEFVTEVNTIGSMHHMNLVR 563
+G G +G+VYK G VA+K + RV LP V + + + H N+VR
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 564 LCGYCS-----EGSNRLLVYEFMKN---GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
L C+ + LV+E + LDK + P + + D +F +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDK-VPPPGLPAETIKDLMRQF------LR 119
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
G+ + H N I+H D+KPENIL+ K++DFGLA++ +T V T Y
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYR 174
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
APE + D++S G + E+ RR G++E
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEF---VTEVNTIGSMHHMNLVRLCG 566
LG GGFG V + G L A KKL++ K + + E + +H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIF------PSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
++ LV M G L I+ P + R +T + G+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-PRACFYTAQI------ISGLEHL 113
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
H+ RII+ D+KPEN+LLD + ++SD GLA + S+ GT G++APE +
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELL 169
Query: 681 SNRPITVKADVYSYGMLLLEIVGGR 705
D ++ G+ L E++ R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKL-----DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G G +G V+K + G +VA+KK D P +K + E+ + + H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNL 65
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
LV+E+ + L++ R + I T Q + + H+
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNE-----LEKNPRGVPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLM---GREHSQVVTMVRGTRGYLAPE 678
IH D+KPENIL+ + K+ DFG A+++ G +++ V TR Y APE
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV----ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 59/233 (25%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKL-----DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G G +G+V+K + +VA+K++ D +P + E+ + + H N+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELKHKNIVRL 64
Query: 565 CGYCSEGSNRLLVYEF----MK------NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
LV+E+ +K NG +D I S+ +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ---------------LL 109
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHS-QVVTM--- 667
+G+A+ H ++H D+KP+N+L+++N K++DFGLA+ G R +S +VVT+
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYR 166
Query: 668 ----VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
+ G + Y + D++S G + E+ R L D +D
Sbjct: 167 PPDVLFGAKLY-----------STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 511 LGTGGFGSV----YKGSLGD--GTLVAVKKLDRVLPHGEKEFVT----EVNTIGSMHHMN 560
LG G FG V Y GD G VAVK L P + E+ + +++H N
Sbjct: 12 LGEGHFGKVELCRYDPE-GDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHEN 67
Query: 561 LVRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
+V+ G C+E L+ EF+ +GSL +++ + + ++ + A+ +G+
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMD 123
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLA 676
Y + + +H D+ N+L++ K+ DFGL K + +E+ V + + A
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIV 702
PE + + +DV+S+G+ L E++
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 70/239 (29%), Positives = 105/239 (43%), Gaps = 38/239 (15%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
++LG G FG V L G G AVK L D VL + E + ++ N
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 566 GYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ------GI 617
YC+ + L V EF+ G L +H +D+ RF++ AT G+
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL------MFHIQDK-----GRFDLYRATFYAAEIVCGL 109
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
+ H II+ D+K +N++LD + K++DFG+ K ++ T GT Y+AP
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF----------YPGWAFKE 726
E + T D +S+G+LL E++ G+ GD ED YP W KE
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQS--PFHGDDEDELFESIRVDTPHYPRWITKE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKL-----DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G+G G+VYK G L A+K + D V ++ E+ + ++H N+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR----RQICREIEILRDVNHPNVVKC 137
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
++ EFM GSL+ + D ++A GIAY H
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEG---------THIADEQFLADVARQILSGIAYLH--- 185
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFG----LAKLMGREHSQVVTMVRGTRGYLAPEWV 680
R I+H DIKP N+L++ K++DFG LA+ M +S V GT Y++PE +
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERI 240
Query: 681 SN-----RPITVKADVYSYGMLLLEIVGGR 705
+ D++S G+ +LE GR
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 521 KGSLGDGTLVAVKKLDRV-------LP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570
+GS G LV D+ LP ++ E + M H N+V
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA 69
Query: 571 GSNRLLVYEFMKNGSLDKWI-------FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
+ +V E+ G L + I FP D +L W + + G+ + HE+
Sbjct: 70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFP----EDTILQWFVQMCL------GVQHIHEK 119
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
R++H DIK +NI L +N K+ DFG A+L+ + T V GT Y+ PE N
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 684 PITVKADVYSYGMLLLEI 701
P K+D++S G +L E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 511 LGTGGFGSVY--------KGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH----H 558
LG G FG V K T VAVK L EK+ ++ + M H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGKH 83
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRF 607
N++ L G C++ ++ E+ G+L +++ + + L +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 608 NIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVT 666
+ A A+G+ Y + + IH D+ N+L+ E+ K++DFGLA+ + ++ + T
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI--VGG 704
R ++APE + +R T ++DV+S+G+LL EI +GG
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 41/206 (19%)
Query: 519 VYKGSLGDGTLV---------AVKKLD-RVLPHGEKEFV-TEVNTIGSMHHMNLVRLCGY 567
V KGS G+ +LV +KKL+ R E++ E + + H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY-RE 66
Query: 568 CSEGSNRLL--VYEFMKNGSLDKWIFPSYHH----------RDRVLDWTTRFNIAIATAQ 615
EG + LL V F + G L YH ++V++W + A
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDL-------YHKLKEQKGKLLPENQVVEWF------VQIAM 113
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ Y HE+ I+H D+K +N+ L KV D G+A+++ + T++ GT Y+
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYM 169
Query: 676 APEWVSNRPITVKADVYSYGMLLLEI 701
+PE SN+P K+DV++ G + E+
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 76/269 (28%)
Query: 499 DLQIRTSNFAQLLGTGGFGSV----YKGS--------LGDGTLVAVKKLDRVLPHGEKEF 546
D ++ + LGTG FG V +KG+ L ++ +K++ V EK
Sbjct: 19 DFEMGET-----LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA--QEKSI 71
Query: 547 VTEVNTIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWI-----FPS----YHH 596
+ E++ H + +C + E NR+ + EF+ G L + FP+ ++H
Sbjct: 72 LMELS-----HPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 597 RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656
+ VL Y H + II+ D+KPEN+LLD KV+DFG AK
Sbjct: 125 AELVL--------------AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK- 166
Query: 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
+ + T+ GT YLAPE + ++ D ++ G+LL E + G
Sbjct: 167 --KVPDRTFTLC-GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG------------ 211
Query: 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVE 745
YP + F + TP ++ ++ L G ++
Sbjct: 212 --YPPF-FDD----TPFRIYEKILAGRLK 233
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 50/223 (22%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
+ +G+G +G V G VA+KK+ V K + E+ + + H N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL- 64
Query: 566 GYCSEGSNRLL-------------VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
+L V E M+ L K I + D F
Sbjct: 65 -------LDILRPPSPEDFNDVYIVTELMET-DLHKVI---KSPQPLTDDHIQYF----- 108
Query: 613 TAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
Q G+ Y H +IH D+KP NIL++ N K+ DFGLA+ + + + +
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 670 G--TRGYLAPE----WVS-NRPITVKADVYSYGMLLLEIVGGR 705
TR Y APE + I D++S G + E++ +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKL-----DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G G +G VYK +A+KK+ D +P + E++ + M H N+VRL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP---STAIREISLLKEMQHGNIVRL 66
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWI--FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
LV+E++ + L K + P + R++ T + I +GIAY H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIK-TYLYQIL----RGIAYCHS 120
Query: 623 QCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMG---REHS-QVVTMVRGTRGYLAP 677
R++H D+KP+N+L+D K++DFGLA+ G R + +VVT+ Y AP
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL-----WYRAP 172
Query: 678 E-WVSNRPITVKADVYSYGMLLLEIVGGR 705
E + +R + D++S G + E+V +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 509 QLLGTGGFGSVYK-GSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCG 566
+ +G G +G VYK + DG+L AVK LD + E E E N + S+ +H N+V+ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYG 86
Query: 567 --YCSE---GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
Y ++ G LV E GS+ + + + LD I G+ + H
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELV-KGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
NRIIH D+K NILL K+ DFG++ + + T V GT ++APE ++
Sbjct: 146 N---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201
Query: 682 -----NRPITVKADVYSYGMLLLEIVGG 704
+ + DV+S G+ +E+ G
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDR--VLPHGE-KEFVTEVNTI-GSMHHMNLVR 563
+++G G FG V DG AVK L + VL E K + E N + ++ H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 564 LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVL-DWTTRFNIA-IATAQGIAY 619
L Y + + +L V +F+ G L +H R+R + RF A IA+A G Y
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGEL------FFHLQRERSFPEPRARFYAAEIASALG--Y 111
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H I++ D+KPENILLD ++DFGL K G S T GT YLAPE
Sbjct: 112 LHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEV 167
Query: 680 VSNRPITVKADVYSYGMLLLEIVGG 704
+ +P D + G +L E++ G
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 511 LGTGGFGSVYKGSLGDGT--LVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCGY 567
+G G FG V+KG + + T +VA+K +D E E + E+ + + + G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHEQC 624
+G+ ++ E++ GS + R D F IA + G+ Y H +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL------RAGPFD---EFQIATMLKEILKGLDYLHSE- 120
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
+ IH DIK N+LL E K++DFG+A + + T V GT ++APE +
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177
Query: 685 ITVKADVYSYGMLLLEIVGGR-RNLDM 710
KAD++S G+ +E+ G N DM
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 30/265 (11%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVK--KLDRVLPHGEKE-FVTEVNTIG-SMHHMNLVR 563
++LG G FG V L G + A+K K D +L + + +TE + + H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 564 LCGYCSEGSNRLL-VYEFMKNGSLDKWIFPSYHHRDRVLDWT-TRFNIAIATAQGIAYFH 621
L C + +RL V E++ G L I R R D +RF A T + + H
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFDEPRSRFYAAEVTL-ALMFLH 113
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
R+ +I+ D+K +NILLD K++DFG+ K G + T GT Y+APE +
Sbjct: 114 ---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 682 NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE--------DFFYPGWAFKEMTN---G 730
D ++ G+L+ E++ G+ + + + D YP W KE +
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229
Query: 731 TPLKVADRRLEGAVEEEELMRAMKV 755
K ++RL G V + A+K
Sbjct: 230 FMTKNPNKRL-GCVASQGGEDAIKQ 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVK--KLDRVLPHGEKE-FVTEVNTIGSMHHMNLVRL 564
++LG G FG V L G L AVK K D +L + E +TE + + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 565 CGYCSEGSNRLL-VYEFMKNGSLDKWIFPSYH-HRDRVLDWT-TRFNIAIATAQGIAYFH 621
C + +RL V EF+ G L +H + R D RF A T+ + + H
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL------MFHIQKSRRFDEARARFYAAEITS-ALMFLH 113
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
++ II+ D+K +N+LLD K++DFG+ K T GT Y+APE +
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQ 169
Query: 682 NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--------FYPGW 722
D ++ G+LL E++ G + + + F YP W
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 73/287 (25%), Positives = 113/287 (39%), Gaps = 73/287 (25%)
Query: 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLD-----------------RVLPHGEK-EF 546
NF +LG G FG V G L A+K L RVL K F
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 547 VTEVNTIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTT 605
+T++++ C + +RL V E++ G L YH +
Sbjct: 63 LTQLHS---------------CFQTMDRLYFVMEYVNGGDL------MYH-----IQQVG 96
Query: 606 RFNIAIAT------AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659
+F A A G+ + H + II+ D+K +N++LD K++DFG M +
Sbjct: 97 KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG----MCK 149
Query: 660 EHSQVVTMVR---GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
E+ R GT Y+APE ++ +P D +++G+LL E++ G+ D + E
Sbjct: 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
Query: 717 F--------FYPGWAFKE---MTNGTPLKVADRRLEGAVEEEELMRA 752
F YP KE + G K +RL E +R
Sbjct: 210 FQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 499 DLQIRTSNFAQLLGTGGFGSVYKGSL-----GDGT-LVAVKKL-DRVLPHGEKEFVTEVN 551
++ + T F + LG FG VYKG L G+ T VA+K L D+ +EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 552 TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD-----------RV 600
+ H N+V L G ++ +++ + + L +++ H D
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL------- 653
L+ +I A G+ + + ++H D+ N+L+ + K+SD GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 654 --AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
KLMG + +R +++PE + ++ +D++SYG++L E+
Sbjct: 178 DYYKLMGNS----LLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 21/200 (10%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM----HHMNLVRLC 565
+G G F V K S G A+K + + E V + I ++ H N++RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 566 GYC-SEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
+ RL LV+E M D ++ R R L + + + + H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-WVSN 682
RN I H DIKPENIL+ ++ K++DFG + G T TR Y APE +++
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 683 RPITVKADVYSYGMLLLEIV 702
K D+++ G + EI+
Sbjct: 174 GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVK--KLDRVLPHGEKE-FVTEVNTIGSMHHM 559
NF +LG G FG V G L A+K K D V+ + E + E +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 560 NLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNI--AIATAQG 616
+ C + +RL V E++ G L +H +V + + A + G
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL-------MYHIQQVGKFKEPQAVFYAAEISVG 113
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR---GTRG 673
+ + H R II+ D+K +N++LD K++DFG+ K EH R GT
Sbjct: 114 LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPD 166
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
Y+APE ++ +P D ++YG+LL E++ G+ D G+ ED
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD--GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR---VLPHGEKEFVTEVNTI-GSMHHMNLVR 563
+++G G FG V + AVK L + + EK ++E N + ++ H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 564 LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRV-LDWTTRFNIA-IATAQGIAY 619
L + + +++L V +++ G L YH R+R L+ RF A IA+A G Y
Sbjct: 61 L-HFSFQTADKLYFVLDYINGGEL------FYHLQRERCFLEPRARFYAAEIASALG--Y 111
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H I++ D+KPENILLD ++DFGL K EH+ + GT YLAPE
Sbjct: 112 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEV 167
Query: 680 VSNRPITVKADVYSYGMLLLEIVGG 704
+ +P D + G +L E++ G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-----EVNTIGSMHHMN-LVR 563
+G G +G VYK G LVA+KK ++E + E++ + + +VR
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 564 LCGYCSEGSNR-----LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
L LV+E++ + L K++ + R L T + +G+A
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 619 YFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKL----MGREHSQVVTMVRGTRG 673
+ H ++ ++H D+KP+N+L+D + K++D GL + + ++VT+
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL-----W 176
Query: 674 YLAPE-WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
Y APE + + + D++S G + E+ R+ GD+E
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 42/241 (17%)
Query: 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSM--HHMNLVR 563
++LG G FG V+ L G A+K L D VL + E + S+ H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 564 LCGYCS--EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT------AQ 615
L YC+ N V E++ G L +H + +F++ AT
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDL------MFH-----IQSCHKFDLPRATFYAAEIIC 107
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK--LMGREHSQVVTMVRGTRG 673
G+ + H + I++ D+K +NILLD + K++DFG+ K ++G + GT
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPD 161
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--------FYPGWAFK 725
Y+APE + + D +S+G+LL E++ G+ + E F YP W +
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTR 221
Query: 726 E 726
E
Sbjct: 222 E 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 508 AQLLGTGGFGSVYKG-SLGDGTLVAVKKL--DRVLPHGEKEFVT---EVNTIGSMHHMNL 561
+LLG G FG VY + G +A K++ D P KE E+ + ++ H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 562 VRLCGYCSEGSNRLLV--YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
V+ G + + + L E+M GS+ + + V TR +G++Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-----QILEGMSY 121
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-------VRGTR 672
H N I+H DIK NIL D K+ DFG +K + Q + M V GT
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICMSGTGIRSVTGTP 173
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
+++PE +S KADV+S G ++E++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 511 LGTGGFGSVYKG-------SLGDGTL-VAVKKL-DRVLPHGEKEFVTEVNTIGSM-HHMN 560
LG G FG V + S D T+ VAVK L D + ++E+ + + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRFNI 609
++ L G C++ ++ E+ G+L +++ F + L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMV 668
A A+G+ Y + R IH D+ N+L+ E+ K++DFGLA+ + ++ + +
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 669 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI--VGG 704
R ++APE + +R T ++DV+S+G+L+ EI +GG
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 511 LGTGGFGSVYKGSLGDGT--LVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCGY 567
+G G FG V+KG + + T +VA+K +D E E + E+ + + + G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ + ++ E++ GS + P LD T I +G+ Y H + +
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSE---K 121
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
IH DIK N+LL E+ K++DFG+A + + T V GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 180
Query: 688 KADVYSYGMLLLEIVGG 704
KAD++S G+ +E+ G
Sbjct: 181 KADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 507 FAQLLGTGGFGSVYKGSLGD-GTLVAVKKL--DRVLPHGEKE---FVTEVNTIGSMHHMN 560
+LLG G FG VY D G +AVK++ D P KE E+ + ++ H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 561 LVRLCGYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
+V+ G + R L E M GS+ + + V T ++ I +G++
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TRKYTRQIL--EGVS 120
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-------VRGT 671
Y H N I+H DIK NIL D K+ DFG +K + Q + + V GT
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGMKSVTGT 172
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
+++PE +S KAD++S G ++E++ +
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 506 NFAQL--LGTGGFGSVY----KGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMH 557
NF L LGTG +G V+ G G L A+K L ++ +K E +T
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV---QKAKTAE-HTRTERQ 56
Query: 558 HMNLVRLCG------YCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
+ VR C Y + +L L+ +++ G L F + R+ + R IA
Sbjct: 57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL----FTHLYQREHFTESEVRVYIA 112
Query: 611 -IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
I A + + H+ II+ DIK ENILLD ++DFGL+K E +
Sbjct: 113 EIVLA--LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167
Query: 670 GTRGYLAPEWVSNRPI--TVKADVYSYGMLLLEIVGG 704
GT Y+APE + D +S G+L E++ G
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 509 QLLGTGGFGSVYKGSLGDGTL-----VAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLV 562
LL G FG ++ G L D V VK + D + E + + H N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 563 RLCGYCSEGSNRLLV-YEFMKNGSLDKWI-FPSYHHRDRVLDWTTR--FNIAIATAQGIA 618
+ C E V Y +M G+L ++ + +T+ ++AI A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLA 676
Y H + +IH DI N ++DE K++D L++ + H R + ++A
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WMA 187
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIV 702
E + N+ + +DV+S+G+LL E++
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 507 FAQLLGTGGFGSVY-----------------KGSLGDGTLVAVKKL-DRVLPHGEKEFVT 548
F + LG G FG V+ S LVAVK L + + +F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIF------PSYHHRDRVLD 602
E+ + + N++RL C ++ E+M+NG L++++ + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 603 WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662
++T +A A G+ Y +H D+ N L+ +N+ K++DFG+++ + +S
Sbjct: 129 YSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YS 182
Query: 663 QVVTMVRGTRGYLAPEWVSNRPI-----TVKADVYSYGMLLLEI 701
++G R L W+S I T +DV+++G+ L EI
Sbjct: 183 GDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 47/224 (20%)
Query: 505 SNFAQL--LGTGGFGSVYKG-SLGDGTLVAVKK--LDRVLPHGEKEFVT-----EVNTIG 554
+ F +L +G G +G VY+ G +VA+KK +D E++ + E+ +
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-----ERDGIPISSLREITLLL 61
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPS--YHHRD--RVLD-WTTRFN- 608
++ H N+V L E + LD IF Y +D +LD T F+
Sbjct: 62 NLRHPNIVEL-------------KEVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSE 107
Query: 609 -----IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHS 662
+ + +G+ Y HE IIH D+K N+LL + C K++DFGLA+ G
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
Query: 663 QVVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
+V T Y APE + T D+++ G +L E++ +
Sbjct: 165 MTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 508 AQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTI-------GSMHHM 559
+LLG G FG VY D G +AVK++ +E EVN + ++ H
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVP--FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 560 NLVRLCGYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
+V+ G + + L E+M GS+ + + V T R+ I QG+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TRRYTRQIL--QGV 119
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-------VRG 670
+Y H N I+H DIK NIL D K+ DFG +K + Q + M V G
Sbjct: 120 SYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI-----QTICMSGTGIKSVTG 171
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
T +++PE +S KADV+S ++E++
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR---EHSQVVTMVRGTR 672
G+ Y H +IH D+KP N+L++E+ ++ DFG+A+ + EH +T TR
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 673 GYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGRRNL 708
Y APE + S T D++S G + E++ GRR L
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT---EVNTIGSMHHMNLVRLCG 566
LG G + +V+KG S LVA+K++ L H E T EV+ + + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHEQ 623
+ LV+E+ LDK + + D + + N+ I Q G+AY H
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDL---KQYMDDCGNIMSMHNVKIFLYQILRGLAYCH-- 121
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHS-QVVTMVRGTRGYLAPE- 678
R +++H D+KP+N+L++E K++DFGLA+ + +S +VVT+ Y P+
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL-----WYRPPDV 175
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ + + + D++ G + E+ GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--------- 560
+G G FG VY+ D + A+K L + +KE +TIG + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA---HTIGERNILVRTLLDESPF 57
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+V L S+ LV ++M G L F R + +F IA + +
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-W 679
H+ I++ D+KPENILLD + DFGL+K ++ T GT YLAPE
Sbjct: 113 HK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVL 168
Query: 680 VSNRPITVKADVYSYGMLLLEIVGG 704
+ + T D +S G+L+ E+ G
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 54/238 (22%)
Query: 507 FAQLLGTGGFGSVYKGSL-----------------GDGTLVAVKKLDRVLPHGEK----E 545
F + LG G FG V+ + G LVAVK L P K +
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR---PDANKNARND 65
Query: 546 FVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR------ 599
F+ EV + + N++RL G C + ++ E+M+NG L++ F S HH D
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ--FLSSHHLDDKEENGN 123
Query: 600 ----------VLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVS 649
+ +++ ++A+ A G+ Y +H D+ N L+ EN K++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIA 180
Query: 650 DFGLAKLM-----GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
DFG+++ + R + V +R ++A E + T +DV+++G+ L EI+
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT---EVNTIGSMHHMNLVRLCG 566
LG G + +V+KG S LVA+K++ L H E T EV+ + ++ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHEQ 623
LV+E++ + + D + + N+ I Q G++Y H++
Sbjct: 71 IIHTERCLTLVFEYLDSDL--------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHS-QVVTMVRGTRGYLAPE- 678
+I+H D+KP+N+L++E K++DFGLA+ + +S +VVT+ Y P+
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL-----WYRPPDV 174
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ + + D++ G +L E+ GR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+G+ Y H I+H DIKP N+L++ N K+ DFGLA++ + S+ +T T+ Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 675 LAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
APE + +R T D++S G + E++G R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 41/213 (19%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLC 565
Q +G G FG V G VA+KK+ + P K E+ + + H N++ L
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 566 G-YCSEGSNRLLVYEFM--------KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQG 616
+ S + V E + + L+K F Y +G
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQ-FIQY--------------FLYQILRG 120
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ Y H ++H D+KP NIL++EN K+ DFGLA++ + + V+ TR Y A
Sbjct: 121 LKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRA 173
Query: 677 PE----WVSNRPITVKADVYSYGMLLLEIVGGR 705
PE W + V+ D++S G + E++ G+
Sbjct: 174 PEIMLTW---QKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGS 555
Y DL+ LG G G V+ D VAVKK+ P K + E+ I
Sbjct: 7 YMDLRP--------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR 58
Query: 556 MHHMNLVRLCGYCSEGSNRL--LVYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRFN--I 609
+ H N+V++ + L V + S+ +I Y D VL+
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSV--YIVQEYMETDLANVLEQGPLSEEHA 116
Query: 610 AIATAQ---GIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGRE--HSQ 663
+ Q G+ Y H ++H D+KP N+ ++ E+ K+ DFGLA+++ H
Sbjct: 117 RLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 664 VVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
++ T+ Y +P + S T D+++ G + E++ G+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 35/264 (13%)
Query: 509 QLLGTGGFGSV-YKGSLGDGTLVAVKKLDRVLPHGEKEF---VTEVNTIGSMHHMNLVRL 564
+LLG G FG V G A+K L + + + E +TE + + H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 565 CGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHH--RDRVL--DWTTRFNIAIATAQGIAY 619
Y + +RL V E++ G L + H R+RV D T + I +A + Y
Sbjct: 61 -KYSFQTKDRLCFVMEYVNGGEL-------FFHLSRERVFSEDRTRFYGAEIVSA--LDY 110
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H +I++ D+K EN++LD++ K++DFGL K G + + GT YLAPE
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEV 166
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGR---RNLDMSG-----DAEDFFYP---GWAFKEMT 728
+ + D + G+++ E++ GR N D ED +P K +
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLL 226
Query: 729 NGTPLKVADRRLEGAVEE-EELMR 751
+G +K ++RL G ++ +E+MR
Sbjct: 227 SGLLIKDPNKRLGGGPDDAKEIMR 250
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 510 LLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVT--EVNTIGSMHHMNLVRLCG 566
++G G +G V K + +VA+KK + E + T E+ + ++ N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWI-FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
LV+E+++ L+ P+ ++V + + AI H +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI---------HWCHK 118
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
N I+H DIKPEN+L+ N K+ DFG A+ + + T TR Y +PE + P
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 686 TVKADVYSYGMLLLEIVGGR 705
D++S G +L E+ G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 497 YRDLQIRTSNFAQLLGTGGFGSV-YKGSLGDGTLVAVKKLDRVLPHGEKEFVT----EVN 551
YRDL+ +G+G +G+V G VA+KKL R P + F E+
Sbjct: 17 YRDLK--------QVGSGAYGTVCSALDRRTGAKVAIKKLYR--PFQSELFAKRAYRELR 66
Query: 552 TIGSMHHMNLVRLCGYCSEGSNR------LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTT 605
+ M H N++ L + + LV FM L K + DR+
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRI----- 120
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+F + +G+ Y H IIH D+KP N+ ++E+ K+ DFGLA+ E + V
Sbjct: 121 QF-LVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYV 176
Query: 666 TMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGR 705
TR Y APE + N T D++S G ++ E++ G+
Sbjct: 177 V----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 34/84 (40%), Positives = 47/84 (55%), Gaps = 1/84 (1%)
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPI 685
+IH DIK NILL N K+ DFG +K+ S V GT Y+APE +P
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 686 TVKADVYSYGMLLLEIVGGRRNLD 709
+ KAD++S G+LL E++ +R D
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 521 KGSLGDGTLVAVKKLDRVLPHG--EKEFVTEVNTIG-----------SMHHMNLVRLCGY 567
+GS LV +KK +R+ +KE V + I + +H LV L
Sbjct: 5 RGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS- 63
Query: 568 CSEGSNRLL-VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C + +RL V E++ G L +F R + ++ I+ A + Y HE+
Sbjct: 64 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER--- 115
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
II+ D+K +N+LLD K++D+G+ K G + GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 687 VKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
D ++ G+L+ E++ GR D+ G +++
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-09
Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 217 ESSNGAVYVYQNDGDYDGLASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVP 276
E + YVY N + + T + T ++ RL L + G+L + W + S+ W
Sbjct: 16 EMQKLSYYVY-NFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFTW---IPNSQDWNL 71
Query: 277 EWAAVSNPCNIAGICGK-GICNLDRSKTKASCTCLPG 312
W+A + C++ G CG G C+++ S C C+ G
Sbjct: 72 FWSAPKDQCDVYGRCGPYGYCDVNTSPK---CNCIKG 105
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 32/239 (13%)
Query: 509 QLLGTGGFGSVYKGSLGDGT-LVAVKKL--DRVLPHGEKE--FVTEVNTIGSMHHMNLVR 563
++LG G FG V L A+K L D VL + E V + H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 564 LCGYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRFNIAIATAQGIAY 619
L +C+ + L V E++ G L +H + R + RF A G+ +
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDL------MFHIQSSGRFDEARARF-YAAEIICGLQF 111
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL-MGREHSQVVTMVRGTRGYLAPE 678
H + II+ D+K +N+LLD++ K++DFG+ K M E + GT Y+APE
Sbjct: 112 LH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE 166
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--------FYPGWAFKEMTN 729
+ + D +S+G+LL E++ G+ + E F +P W KE +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 80/343 (23%), Positives = 136/343 (39%), Gaps = 94/343 (27%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSM-HH 558
++LG G FG V + S VAVK L E K ++E+ + + +H
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70
Query: 559 MNLVRLCGYCSEGSNRLLV-YEFMKNGSLDKWI------FPSYHHR-------------- 597
+N+V L G C++ + L+V EF K G+L ++ F Y +
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 598 -----------------------------DRVLD--WTTRFNI------AIATAQGIAYF 620
+ D W + + + A+G+ +
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT-MVRGTRGYLAPEW 679
+ + IH D+ NILL EN K+ DFGLA+ + ++ V R ++APE
Sbjct: 191 ASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE-----MTNGTPLK 734
+ ++ T ++DV+S+G+LL EI +L S YPG E + +GT ++
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIF----SLGASP------YPGVQINEEFCQRLKDGTRMR 297
Query: 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777
+ E+ R M C Q + RP+ +V++L
Sbjct: 298 APE------NATPEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 511 LGTGGFGSVYKGSL---GDGTLVAVKKLDRVLPH--GEK-----EFVTEVNTIGSMHHMN 560
LG G F ++YKG L D +V + V+ G F + + + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTT-RFNIAIATAQGIAY 619
LV+L G C N ++V E++K G LD ++ HR++ + ++A A + Y
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-----HREKNNVSLHWKLDVAKQLASALHY 116
Query: 620 FHEQCRNRIIHCDIKPENILL-----DENFCP--KVSDFGLAKLMGREHSQVVTMVRGTR 672
+ +++H ++ +NIL+ +E + P K+SD G+ + +V +
Sbjct: 117 LED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI----- 168
Query: 673 GYLAPEWVSNRP--ITVKADVYSYGMLLLEI 701
++APE + N +T+ AD +S+G LLEI
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 51/194 (26%), Positives = 77/194 (39%), Gaps = 44/194 (22%)
Query: 512 GTGGFGSVYKG---SLGDGTLVAVKKLDRVLPHGEKEFVT--------EVNTIGSMHHMN 560
G G +G VYK + DG A+KK G+KE T E+ + + H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 561 LVRLCGYCSEGSNRL--LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ--- 615
+V L E +++ L++++ ++ I HR + Q
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLW--QII--KFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 616 GIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLA-------KLMGREHSQV 664
G+ Y H N ++H D+KP NIL+ E K+ D GLA K + V
Sbjct: 120 GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 665 VTMVRGTRGYLAPE 678
VT+ Y APE
Sbjct: 177 VTI-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 511 LGTGGFGSVYKG--SLGDGTLVAVKKLDRVLPHGEKEFVT---EVNTIGSMHHMNLVRLC 565
LG G + +VYKG L D LVA+K++ L H E T EV+ + + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHE 622
+ LV+E+ LDK + + D + N+ + Q G+ Y H
Sbjct: 71 DIIHTEKSLTLVFEY-----LDKDL---KQYLDDCGNSINMHNVKLFLFQLLRGLNYCH- 121
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAK---LMGREHS-QVVTMVRGTRGYLAPE 678
R +++H D+KP+N+L++E K++DFGLA+ + + +S +VVT+ Y P+
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL-----WYRPPD 174
Query: 679 -WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ + + + D++ G + E+ GR
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 493 VNFTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR---VLPHGEKEFVT 548
+N T ++ R N + + G+G +GSV G VAVKKL R + H ++ +
Sbjct: 8 LNKTIWEVPERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-R 65
Query: 549 EVNTIGSMHHMNLVRLCGYCS-----EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDW 603
E+ + M H N++ L + E N + + + L+ + ++ D
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDD 120
Query: 604 TTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663
+F I +G+ Y H IIH D+KP N+ ++E+ K+ DFGLA+ E +
Sbjct: 121 HVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 176
Query: 664 VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGR 705
V TR Y APE + N D++S G ++ E++ GR
Sbjct: 177 YV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKE-----FVTEVNTIGSMHHMNLVRL 564
+G G +G VYK D G LVA+KK V EKE + E+ + ++H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 565 CGYCSEGSNRL----------LVYEFMKN---GSLDKWI--FPSYHHRD---RVLDWTTR 606
++ + L LV+E+M + G L+ + F H + ++L+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127
Query: 607 FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
G+ Y H++ +H DIK NILL+ K++DFGLA+L E S+ T
Sbjct: 128 ---------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 667 MVRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEI 701
T Y PE + DV+S G +L E+
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 31/81 (38%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAPEWVSNRPI 685
++H D+KP N+LL+ N K+ DFGLA++ +H+ +T TR Y APE + N
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186
Query: 686 TVKA-DVYSYGMLLLEIVGGR 705
KA D++S G +L E++ R
Sbjct: 187 YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 511 LGTGGFGSVYKGS--LGDGTLVAVKKLDRV------LPHGEKEFVTEVNTIGSMHHMNLV 562
+G G +G V+K G VA+K++ RV +P V + + + H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 563 RLCGYCS-----EGSNRLLVYEFMKNG---SLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
RL C+ + LV+E + LDK P + T ++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-------VPTETIKDMMFQLL 120
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+G+ + H +R++H D+KP+NIL+ + K++DFGLA++ + + +V T Y
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 175
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEI 701
APE + D++S G + E+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 509 QLLGTGGFGSVYKGSLGDGT----LVAVKKLDRV-LPHGEKEFV---TEVNTIGSMHHMN 560
++LG GG+G V++ G + A+K L + + +K+ E N + ++ H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDR---VLDWTTRFNIA-IATAQG 616
+V L G L+ E++ G L + H +R ++ T F ++ I+ A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL-------FMHLEREGIFMEDTACFYLSEISLA-- 112
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ + H+Q II+ D+KPENILLD K++DFGL K E + T GT Y+A
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMA 168
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGG 704
PE + D +S G L+ +++ G
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK----LMGREHSQVVTMVRGTR 672
+ Y H +IH D+KP NILL+ + K++DFGLA+ L + V+T TR
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 673 GYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
Y APE + + T D++S G +L E++ G+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 50/212 (23%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 511 LGTGGFGSVYKG---SLGDG-----TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLV 562
LG G F ++KG +GD T V +K LD+ + + F + + + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
G C G ++V E++K GSLD ++ +++ + + +A A + + +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 623 QCRNRIIHCDIKPENILL-----DENFCP---KVSDFGLA-KLMGREHSQVVTMVRGTRG 673
+ H ++ +N+LL + P K+SD G++ ++ +E ++
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIP 169
Query: 674 YLAPEWVSN-RPITVKADVYSYGMLLLEIVGG 704
++ PE + N + +++ AD +S+G L EI G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 510 LLGTGGFGSVYKGSLGD-GTLVAVKKLDRV---LPHGEKEFVTE--VNTIGSMHHMNLVR 563
++G GGFG VY D G + A+K LD+ + GE + E + ++ S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 564 LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL--DWTTRFNIAIATAQGIAYF 620
Y ++L + + M G L YH + + RF A G+ +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDL------HYHLSQHGVFSEKEMRF-YATEIILGLEHM 113
Query: 621 HEQCRNR-IIHCDIKPENILLDENFCPKVSDFGLAKLMGRE--HSQVVTMVRGTRGYLAP 677
H NR +++ D+KP NILLDE+ ++SD GLA ++ H+ V GT GY+AP
Sbjct: 114 H----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAP 164
Query: 678 EWVSN-RPITVKADVYSYGMLLLEIVGG 704
E + AD +S G +L +++ G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 509 QLLGTGGFGSVY----KGSLGDGTLVAVKKLDRVLPHGEKEF---VTEVNTIGSMHHMNL 561
+LLG G FG V K + G A+K L + + + E +TE + + H L
Sbjct: 1 KLLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 562 VRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHH--RDRVL-DWTTRFNIA-IATAQG 616
L Y + +RL V E+ G L + H R+RV + RF A I +A G
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGEL-------FFHLSRERVFSEDRARFYGAEIVSALG 109
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
Y H +++ D+K EN++LD++ K++DFGL K G + GT YLA
Sbjct: 110 --YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGR 705
PE + + D + G+++ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 46/231 (19%)
Query: 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLD-----------------RVLP-HGEKEF 546
NF +LG G FG V G L A+K L RVL G+ F
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 547 VTEVNTIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTT 605
+T++++ C + +RL V E++ G L + +V +
Sbjct: 63 LTQLHS---------------CFQTMDRLYFVMEYVNGGDL-------MYQIQQVGRFKE 100
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+ A I F + II+ D+K +N++LD K++DFG+ K +
Sbjct: 101 PHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159
Query: 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
T GT Y+APE ++ +P D +++G+LL E++ G+ + G+ ED
Sbjct: 160 TFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 493 VNFTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT--- 548
VN T +L R ++ Q+ G+G +GSV G VA+KKL R P + F
Sbjct: 6 VNKTVWELPERYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIKKLSR--PFQSEIFAKRAY 62
Query: 549 -EVNTIGSMHHMNLVRLCG-YCSEGSNR-----LLVYEFMKNGSLDKWIFPSYHHRDRVL 601
E+ + M H N++ L + S S LV +M+ L K I D+V
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKV- 119
Query: 602 DWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661
++ + G+ Y H IIH D+KP N+ ++E+ K+ DFGLA+ E
Sbjct: 120 ----QY-LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171
Query: 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGR 705
+ V TR Y APE + N D++S G ++ E++ G+
Sbjct: 172 TGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 509 QLLGTGGFGSVY----KGSLGDGTLVAVKKLDRVLPHGEKEF---VTEVNTIGSMHHMNL 561
+LLG G FG V K + G A+K L + + + E VTE + + H L
Sbjct: 1 KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 562 VRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHH--RDRVL--DWTTRFNIAIATAQG 616
L Y + +RL V E+ G L + H R+RV + + I +A
Sbjct: 58 TAL-KYAFQTHDRLCFVMEYANGGEL-------FFHLSRERVFTEERARFYGAEIVSA-- 107
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ Y H + +++ DIK EN++LD++ K++DFGL K G + GT YLA
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGR 705
PE + + D + G+++ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 42/224 (18%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT---EVNTIGSMHHMNLVRLCG 566
LG G + +VYKG S G LVA+K++ L H E T E + + + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRF----NIAIATAQ---GI 617
LV+E++ D + +D N+ + Q G+
Sbjct: 71 IIHTKKTLTLVFEYL--------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK---LMGREHS-QVVTMVRGTRG 673
AY H++ R++H D+KP+N+L+ E K++DFGLA+ + + +S +VVT+
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL-----W 168
Query: 674 YLAPE-WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
Y P+ + + + D++ G + E+ GR S D ED
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 568 CSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL-DWTTRFNIAIATAQGIAYFHEQCR 625
C + ++RL LV E++ G L +F + R R L + RF A + + HE+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MF--HMQRQRKLPEEHARF-YAAEICIALNFLHER-- 115
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
II+ D+K +N+LLD + K++D+G+ K G + GT Y+APE +
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725
D ++ G+L+ E++ GR D+ D D + F+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 510 LLGTGGFGSVYKGSLGD-GTLVAVKKLDRV---LPHGEKEFVTE--VNTIGSMHHMNLVR 563
++G GGFG VY D G + A+K LD+ + GE + E + ++ S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 564 LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL--DWTTRFNIAIATAQGIAYF 620
Y ++L + + M G L YH + + RF A G+ +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDL------HYHLSQHGVFSEAEMRF-YAAEIILGLEHM 113
Query: 621 HEQCRNR-IIHCDIKPENILLDENFCPKVSDFGLAKLMGRE--HSQVVTMVRGTRGYLAP 677
H NR +++ D+KP NILLDE+ ++SD GLA ++ H+ V GT GY+AP
Sbjct: 114 H----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAP 164
Query: 678 EWVSN-RPITVKADVYSYGMLLLEIVGG 704
E + AD +S G +L +++ G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRLCG 566
+G GG+G V+ D G +VA+K++ + L E +TE + + + LV+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVL-DWTTRFNIAIATAQGIAYFHEQCR 625
+ L E++ G F + + VL + RF +A + + HE
Sbjct: 69 AFQDDEYLYLAMEYVPGGD-----FRTLLNNLGVLSEDHARFYMA-EMFEAVDALHEL-- 120
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
IH D+KPEN L+D + K++DFGL+K ++ +S V G+ Y+APE + +
Sbjct: 121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRGKG 174
Query: 685 ITVKADVYSYGMLLLEIVGG 704
D +S G +L E + G
Sbjct: 175 YDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 34/205 (16%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHG-EK--EFVTEVNTIGSMHHMNLVRLCG 566
+G G FG+VY + +VA+KK+ EK + + EV + + H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR----FNIAIATA---QGIAY 619
LV E+ + D +L+ + IA QG+AY
Sbjct: 83 CYLREHTAWLVMEYCLGSASD------------ILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H R IH DIK NILL E K++DFG A L+ +S V GT ++APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
Query: 680 V---SNRPITVKADVYSYGMLLLEI 701
+ K DV+S G+ +E+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 25/157 (15%)
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRGYLAPEWVSNRPI 685
+ IH D+ NILL EN K+ DFGLA+ + ++ V R ++APE + +R
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE-----MTNGTPLKVADRRL 740
T+++DV+S+G+LL EI +L S YPG E + GT ++ D
Sbjct: 259 TIQSDVWSFGVLLWEIF----SLGASP------YPGVKIDEEFCRRLKEGTRMRAPD--- 305
Query: 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777
E+ + M C E RP+ E+V+ L
Sbjct: 306 ---YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 509 QLLGTGGFGSV-YKGSLGDGTLVAVKKLDRVLPHGEKEF---VTEVNTIGSMHHMNLVRL 564
+LLG G FG V G A+K L + + + E +TE + + H L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 565 CGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHH--RDRVL--DWTTRFNIAIATAQGIAY 619
Y + +RL V E+ G L + H R+RV D + I +A + Y
Sbjct: 61 -KYSFQTHDRLCFVMEYANGGEL-------FFHLSRERVFSEDRARFYGAEIVSA--LDY 110
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H + +++ D+K EN++LD++ K++DFGL K ++ + + T GT YLAPE
Sbjct: 111 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 167
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGR 705
+ + D + G+++ E++ GR
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 50/188 (26%)
Query: 514 GGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-F-VT---EVNTIGSMHHMNLVRLCGY 567
G +G VY+ G +VA+KKL EKE F +T E+N + + H N+V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKM---EKEKEGFPITSLREINILLKLQHPNIVTV--- 69
Query: 568 CSE---GSNR---LLVYEFMKNGSLDKWIFPSYHHRDRVLD-WTTRFNIA------IATA 614
E GSN +V E+++ H +++ F + +
Sbjct: 70 -KEVVVGSNLDKIYMVMEYVE------------HDLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG---REHSQ-VVTMVRG 670
G+A+ H+ N I+H D+K N+LL+ K+ DFGLA+ G + ++Q VVT+
Sbjct: 117 SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL--- 170
Query: 671 TRGYLAPE 678
Y APE
Sbjct: 171 --WYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 521 KGSLGDGTLVAVKKLDRVLPHG--EKEFVTEVNTI-----------GSMHHMNLVRLCGY 567
+GS LV +KK R+ +KE V + I + +H LV L
Sbjct: 5 RGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS- 63
Query: 568 CSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVL-DWTTRF---NIAIATAQGIAYFH 621
C + +RL V EF+ G L +H R R L + RF I++A + + H
Sbjct: 64 CFQTESRLFFVIEFVSGGDL------MFHMQRQRKLPEEHARFYSAEISLA----LNFLH 113
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
E+ II+ D+K +N+LLD K++D+G+ K R T GT Y+APE +
Sbjct: 114 ER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILR 169
Query: 682 NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
D ++ G+L+ E++ GR D+ G +++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 51/224 (22%), Positives = 85/224 (37%), Gaps = 38/224 (16%)
Query: 510 LLGTGGFGSVYKGSLGD---GTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVR 563
L+G GG G VY D VA+KK+ L K F+ E + H +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 564 LCGYCSEGSNRLLVYEFMKNGSL--------DKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
+ CS+G +++ +L K + +I
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV--GAFLSIFHKICA 124
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE--------------- 660
I Y H + ++H D+KP+NILL + D+G A E
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 661 HSQVVTM--VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
+S + + GT Y+APE + P + D+Y+ G++L +++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 44/132 (33%), Positives = 65/132 (49%), Gaps = 15/132 (11%)
Query: 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA---TAQGIAYFHEQCRNRIIHCD 632
LV F+ G L +HH R RF+++ A TA+ + + +I+ D
Sbjct: 70 LVLAFINGGEL-------FHHLQR----EGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 633 IKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVY 692
+KPENILLD + DFGL KL ++ + T GT YLAPE + T D +
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAVDWW 177
Query: 693 SYGMLLLEIVGG 704
+ G+LL E++ G
Sbjct: 178 TLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 504 TSNFAQLLGTGGFGSVYK-GSLGDGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMH-HMN 560
T + +G G +G V+K + +G+ AVK LD + H ++E E N + ++ H N
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPN 76
Query: 561 LVRLCGY-----CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
+V+ G G LV E GS+ + +R+ + + I
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEALM 135
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL-AKLMGREHSQVVTMVRGTRGY 674
G+ + H N+ IH D+K NILL K+ DFG+ A+L + ++ GT +
Sbjct: 136 GLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFW 190
Query: 675 LAPEWVS-----NRPITVKADVYSYGMLLLEIVGG 704
+APE ++ + + DV+S G+ +E+ G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 507 FAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLD---RVLPHGEKEFVTEVNTIGSMHHMN 560
F+ L +G G FG+VY + + +VA+KK+ + ++ + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
++ G LV E+ + D H + L + QG+AY
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
H + +IH D+K NILL E K+ DFG A +M + V GT ++APE +
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 681 ---SNRPITVKADVYSYGMLLLEI 701
K DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCG 566
Q +G+G +G VYK +L G L AVK + ++ P + + E+ + H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA---TAQGIAYFHEQ 623
+ E+ GSL YH V + IA T QG+AY H +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQD----IYH----VTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS-- 681
+ +H DIK NILL +N K++DFG+A + ++ + + GT ++APE +
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVE 181
Query: 682 -NRPITVKADVYSYGMLLLEI 701
N D+++ G+ +E+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 20/198 (10%)
Query: 511 LGTGGFGSVYKGSLG-DGTLVAVKKLD---RVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+G G FG+VY + +VAVKK+ + ++ + EV + + H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+ LV E+ + D H + L I QG+AY H
Sbjct: 89 CYLKEHTAWLVMEYCLGSASD---LLEVHKKP--LQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV---SNR 683
+IH DIK NILL E K++DFG A +S V GT ++APE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 684 PITVKADVYSYGMLLLEI 701
K DV+S G+ +E+
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 511 LGTGGFGSVYKGSL---------GDGTLVAVKKLDRVLPHGEKE----FVTEVNTIGSMH 557
LG G +Y G L G +K + +VL ++ F + + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
H ++V L G C ++V EF++ G LD ++ H + VL +F +A A +
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM----HRKSDVLTTPWKFKVAKQLASAL 118
Query: 618 AYFHEQCRNRIIHCDIKPENILL-----DENFCP--KVSDFGLA-KLMGREHSQVVTMVR 669
+Y ++ ++H ++ +NILL D P K+SD G+ ++ R+ + V +
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIP 173
Query: 670 GTRGYLAPEWVSN-RPITVKADVYSYGMLLLEI 701
++APE V + + +++ AD +S+G L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT--EVNTIGSMHHMNLVRLC 565
Q +G+G +G VYK ++ G L A+K + L GE V E+ + H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G + EF GSL +H L + ++ T QG+ Y H + +
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQ-----DIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
+H DIK NILL +N K++DFG++ + ++ + + GT ++APE
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/209 (20%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 518 SVYKGSLGDGTLVAVKKLDRVLPH-GEK----EFVTEVNTIGSMHHMNLVRLCGYCSEGS 572
S+YKG + V ++ + H G K E+ + + N++++ G+ +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKK--FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 573 NRL----LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
+ L L+ E+ G L + + +++ L + T+ ++AI +G+ ++
Sbjct: 92 DDLPRLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN--RPIT 686
+ ++ + L+ EN+ K+ GL K++ + V + Y + + +++ T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYT 200
Query: 687 VKADVYSYGMLLLEIVGGR---RNLDMSG 712
+K D+YS G++L EI G+ NL
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 47/181 (25%)
Query: 496 TYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-F----VTE 549
Y L +G G FG V+K +VA+KK VL EKE F + E
Sbjct: 13 KYEKLAK--------IGQGTFGEVFKARHKKTKQIVALKK---VLMENEKEGFPITALRE 61
Query: 550 VNTIGSMHHMNLVRLCGYC---SEGSNR-----LLVYEFMKNGSLDKWIFPSYHHRDRVL 601
+ + + H N+V L C + NR LV+EF + H +L
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE------------HDLAGLL 109
Query: 602 DWTT-RFNIA-IATA-----QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654
+F ++ I G+ Y H RN+I+H D+K NIL+ ++ K++DFGLA
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
Query: 655 K 655
+
Sbjct: 167 R 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 1/74 (1%)
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRGYLAPEWVSNRPITV 687
IH D+ NILL EN K+ DFGLA+ + ++ V R ++APE + ++ T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 688 KADVYSYGMLLLEI 701
++DV+S+G+LL EI
Sbjct: 255 QSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 510 LLGTGGFGSV----YKGSLGDGTLVAVKKLDRVLPHGEKEFVTEV----NTIGSMHHMNL 561
++G G FG V K + G + A+KKL + EKE V V + + + +
Sbjct: 8 VIGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWV 63
Query: 562 VRLCGYCS--EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
V+L Y S + + L+ E++ G + + +D + TRF IA T I
Sbjct: 64 VKL--YYSFQDENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIA-ETILAIDS 116
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663
H+ IH DIKP+N+LLD K+SDFGL + + H
Sbjct: 117 IHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 18/151 (11%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEF--VTEVNTIGSMHHMNLVRLCGY 567
LG G + +VYKG S +G LVA+K + R+ F + E + + + H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 568 CSEGSNRLLVYEFMKNG---SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
LV+E++ +DK P H + V + + +G++Y H++
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQL------LRGLSYIHQR- 122
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAK 655
I+H D+KP+N+L+ + K++DFGLA+
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGREHSQVVTMVRGTR 672
AQG+ + +N IH D+ N+LL + K+ DFGLA+ +M + V R
Sbjct: 222 AQGMDFL--ASKN-CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEI 701
++APE + + TV++DV+SYG+LL EI
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 11/109 (10%)
Query: 597 RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656
R R L I +G+ Y H Q RIIH D+K ENI +++ + D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 657 MGREHSQVVTMVRGTRGYL---APEWVSNRPITVKADVYSYGMLLLEIV 702
V G G + APE ++ KAD++S G++L E++
Sbjct: 207 -----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
G+ Y H ++H D+KP N+LL+ N K+ DFGLA+ E +T TR Y
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYR 175
Query: 676 APEWVSN-RPITVKADVYSYGMLLLEIVGGR 705
APE + N T DV+S G + E++G +
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
GI + H IIH D+KP NI++ + K+ DFGLA+ G +V TR Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 184
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGR 705
APE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 51/233 (21%)
Query: 498 RDLQIRTSNFAQ--LLGTGGFGSV----YKGSLGDGTLVAVKKLDR--VLPHGEKEFVTE 549
L+++ +F ++G G FG V +K S + A+K L + ++ + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 550 VNTIGSMHHMN---LVRLCGYCSEGSNRLLVYEFMKNGSL----------DKW-IFPSYH 595
I M H N +V+L + +V E+M G L +KW F
Sbjct: 93 ERDI--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF---- 146
Query: 596 HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655
+T +A+ + + IH D+KP+N+LLD++ K++DFG
Sbjct: 147 -------YTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITV----KADVYSYGMLLLEIVGG 704
M GT Y++PE + ++ + D +S G+ L E++ G
Sbjct: 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 509 QLLGTGGFGSVY---KGSLGD-GTLVAVKKLDR-VLPHGEK---EFVTEVNTIGSMHHMN 560
++LGTG +G V+ K + D G L A+K L + L K TE N + +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 561 LVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF---NIAIATAQG 616
+ Y + +L L+ +++ G + F + RD + RF I +A
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEM----FTHLYQRDNFSEDEVRFYSGEIILA---- 117
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ + H + I++ DIK ENILLD ++DFGL+K E + GT Y+A
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 677 PEWVSNRPITVKA-DVYSYGMLLLEIVGGRRNLDMSGD 713
PE + + KA D +S G+L+ E++ G + G+
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 26/183 (14%)
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
LD + + A+G+++ + IH D+ NILL K+ DFGLA+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 661 HSQVVT-MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
+ VV R ++APE + N T ++DV+SYG+LL EI +L S Y
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF----SLGSSP------Y 317
Query: 720 PGW----AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
PG F +M +K R L E+ MK C + RP+ ++V+
Sbjct: 318 PGMPVDSKFYKM-----IKEGYRMLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQ 369
Query: 776 MLE 778
++E
Sbjct: 370 LIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVA---VKKLD-RVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
Q +G G FG V + T VA VK+L + EF+ + + + H N+++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFP-SYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
G C E LLV+E+ + G L ++ +H R+ L R +A A G+ + H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMH-- 116
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE-----HSQVVTMVRGTRGYLAPE 678
++ +H D+ N L + KV D+G+ +E +R +LAPE
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPE 171
Query: 679 WVSNR-------PITVKADVYSYGMLLLEI 701
V T ++V++ G+ L E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 498 RDLQIRTSNFAQLLGTGGFGSVY---KGSLGDGTLVAVKKLDR--VLPHGEKEFVTEVNT 552
+D +++ L+G G FG V + + GD + A+K + + +L F E
Sbjct: 1 KDFDVKS-----LVGRGHFGEVQVVREKATGD--IYAMKVMKKSVLLAQETVSFFEEERD 53
Query: 553 IGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
I S+ + + Y + + L LV E+ G L + + D+ + +F +A
Sbjct: 54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAE 110
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGT 671
I H+ +H DIKPEN+L+D K++DFG A + + GT
Sbjct: 111 LV-LAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
Query: 672 RGYLAPEWV------SNRPITVKADVYSYGMLLLEIVGGR 705
Y+APE + V+ D +S G++ E++ GR
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 511 LGTGGFGSVYKGSLGDGTL---VAVKKLDR---VLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G+G +GSV S D L VAVKKL R L H + + E+ + M H N++ L
Sbjct: 23 VGSGAYGSV--CSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 565 CGYCS-----EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
+ E N + + + L+ + ++ D +F I +G+ Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIV-----KCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H IIH D+KP N+ ++E+ ++ DFGLA+ E + V TR Y APE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEI 186
Query: 680 VSN-RPITVKADVYSYGMLLLEIVGGR 705
+ N D++S G ++ E++ G+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 527 GTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCS------EGSNRLLV 577
G VAVKKL R H ++ + E+ + ++H N++ L + E + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637
E M + +L + I H + LD + GI + H IIH D+KP N
Sbjct: 105 MELM-DANLCQVI-----HME--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 153
Query: 638 ILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGML 697
I++ + K+ DFGLA+ +V TR Y APE + D++S G +
Sbjct: 154 IVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCI 211
Query: 698 LLEIVGG 704
+ E+V G
Sbjct: 212 MGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNLVRLCGYC 568
LG G + +VYKG S +G LVA+K + G + E + + + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 569 SEGSNRLLVYEFMKNGSLDKWI--FPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFHEQ 623
V+E+M L +++ P H +N+ + Q G+AY H Q
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHP---------YNVRLFMFQLLRGLAYIHGQ 122
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG----REHSQVVTMVRGTRGYLAPE- 678
I+H D+KP+N+L+ K++DFGLA+ S+VVT+ Y P+
Sbjct: 123 ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL-----WYRPPDV 174
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ + D++ G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 20/198 (10%)
Query: 511 LGTGGFGSVY-KGSLGDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRLCG 566
+G G FG+VY + +VA+KK+ ++ + EV + + H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
LV E+ + D H + L I QG+AY H +
Sbjct: 93 CYLREHTAWLVMEYCLGSASD---LLEVHKKP--LQEVEIAAITHGALQGLAYLHS---H 144
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV---SNR 683
+IH DIK NILL E K++DFG A + +S V GT ++APE +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEG 199
Query: 684 PITVKADVYSYGMLLLEI 701
K DV+S G+ +E+
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 26/155 (16%)
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-LDWTTRFNIAIATAQG 616
H++L + G C GS ++V EF+++G LD + + RV + W + +A A
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL---RKEKGRVPVAW--KITVAQQLASA 129
Query: 617 IAYFHEQCRNRIIHCDIKPENIL-----LDENFCP--KVSDFGLA-KLMGREHSQVVTMV 668
++Y ++ ++H ++ +NIL L E P K+SD G++ + RE
Sbjct: 130 LSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE------- 179
Query: 669 RGTR-GYLAPEWVSN-RPITVKADVYSYGMLLLEI 701
R R ++APE V ++ AD +S+G LLEI
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 509 QLLGTGGFGSVY---KGSLGD-GTLVAVKKLDRVL----PHGEKEFVTEVNTIGSMHHMN 560
++LGTG +G V+ K S D G L A+K L + + TE + +
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 561 LVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
+ Y + +L L+ +++ G L F R+R + I + + +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERF----KEQEVQIYSGEIVLA 117
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
+ II+ DIK ENILLD N ++DFGL+K + + GT Y+AP+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 680 VS--NRPITVKADVYSYGMLLLEIVGGRRNLDMSGD 713
V + D +S G+L+ E++ G + G+
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
GI + H IIH D+KP NI++ + K+ DFGLA+ G +V TR Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 192
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGR 705
APE + D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 9/162 (5%)
Query: 547 VTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR 606
TE + + +++H ++++L G + L+ K D + + + + D
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT---DLYCYLAAKRNIAICDI--- 184
Query: 607 FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
I + + I Y HE NRIIH DIK ENI ++ + DFG A ++
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNL 708
GT APE ++ P D++S G++L E+ +L
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
GI + H IIH D+KP NI++ + K+ DFGLA+ G S ++T TR Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 185
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIV 702
APE + D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 53/234 (22%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLD----------RVLPHGEK-EFVTEVNTIGSMHHM 559
+G G FG V+ LV K+ R L EK + V EVN + + H
Sbjct: 21 IGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 560 NLVRLCGYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
N+VR +N+ L + EF G L + I Y ++ + +I +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-VDITRQLLHAL 131
Query: 618 AYFHE----QCRNRIIHCDIKPENILLDENF-----------------CPKVSDFGLAKL 656
AY H R++H D+KP+NI L K+ DFGL+K
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 657 MGRE---HSQVVTMVRGTRGYLAPEWV--SNRPITVKADVYSYGMLLLEIVGGR 705
+G E HS V GT Y +PE + + K+D+++ G ++ E+ G+
Sbjct: 192 IGIESMAHSCV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 25/156 (16%)
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR----GYLAPEWVSNRP 684
+H D+ N+L+ E K+ DFGLA+ + R+ + + +G+ ++APE + N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNL 317
Query: 685 ITVKADVYSYGMLLLEI--VGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742
T +DV+S+G+LL EI +GG ++ + FY +K R +
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTPYPELP--MNEQFY-----------NAIKRGYRMAKP 364
Query: 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
A +E+ M+ C +++ +RP ++V ++
Sbjct: 365 AHASDEIYEIMQK---CWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 58/234 (24%), Positives = 90/234 (38%), Gaps = 46/234 (19%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFV----TEVNTIGSMHHMNLVRL 564
+++G G FG V D V K+ R EKE V E + + + +V++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
+ N L+ EF+ G + + +D + + T+F IA T I H+
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIA-ETVLAIDSIHQL- 120
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGL------------------------------- 653
IH DIKP+N+LLD K+SDFGL
Sbjct: 121 --GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 654 ---AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
A+ R Q+ GT Y+APE D +S G+++ E++ G
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 503 RTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL 561
++ ++G G FG VY+ + VA+KK+ + + +E + N ++H+N+
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKN----LNHINI 121
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIF--------PSYHHRDRVLDWTTRFNIAIAT 613
+ L Y F KN +K IF P H + + R N A+
Sbjct: 122 IFLKDYYYTEC-------FKKN---EKNIFLNVVMEFIPQTVH--KYMKHYARNNHALPL 169
Query: 614 AQGIAYFHEQCR-------NRIIHCDIKPENILLDEN-FCPKVSDFGLAK-LMGREHSQV 664
Y ++ CR I H D+KP+N+L+D N K+ DFG AK L+ + S
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-- 227
Query: 665 VTMVRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGG 704
V+ + +R Y APE + T D++S G ++ E++ G
Sbjct: 228 VSYI-CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV--TMVRGTR 672
+ + Y H + H D+KP+NIL + + K+ DFGLA++ + + T TR
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 673 GYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGR 705
Y APE + T D++S G + E++ G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 44/175 (25%), Positives = 70/175 (40%), Gaps = 24/175 (13%)
Query: 542 GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHR---- 597
G K E++ + ++ H ++ L ++ + + S + P Y
Sbjct: 129 GGKTPGREIDILKTISHRAIINL------------IHAY-RWKSTVCMVMPKYKCDLFTY 175
Query: 598 -DRV--LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654
DR L I + +AY H + IIH D+K ENI LDE + DFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 655 -KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNL 708
KL + GT +PE ++ P K D++S G++L E+ L
Sbjct: 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 557 HHMNLVRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
+ N ++L Y S + + +L+ +++K+G L F ++ + + I
Sbjct: 67 DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVK-KIIRQLV 119
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPK----VSDFGLAKLMGREHSQVVTMVRG 670
+ + H ++ IIH DIK EN+L D K + D+GL K++G + G
Sbjct: 120 EALNDLH---KHNIIHNDIKLENVLYDRA---KDRIYLCDYGLCKIIGTP-----SCYDG 168
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
T Y +PE + V D ++ G+L E++ G
Sbjct: 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 617 IAYFHEQCRNRIIHCDIKPENILLD--ENFCPKVSDFGLAKLM-GREHSQVVTMVRGTRG 673
I Y H IIH DIK EN+L++ E+ C + DFG A G + + GT
Sbjct: 273 IDYIH---GEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLE 700
APE ++ P T D++S G+++ E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 548 TEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWT--T 605
+E++ + + H +V+ LL+ E+ G L+K I + R+ +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLKEHLPFQ 167
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS-QV 664
+ + + Q + E +++H D+K NI L K+ DFG +K S V
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
+ GT YLAPE + + KAD++S G++L E++
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 514 GGFGSVYKGSLG-DGTLVAVK---KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
G FG VY G + L AVK K D + + + E + + +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
+N LV E++ G + K + Y + D + I+ A + Y H R+ II
Sbjct: 75 SANNVYLVMEYLIGGDV-KSLLHIYGYFD---EEMAVKYIS-EVALALDYLH---RHGII 126
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKL-MGRE 660
H D+KP+N+L+ K++DFGL+K+ + RE
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 7/70 (10%)
Query: 353 NYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSL--DFGGFE 410
+ P+ + ++ +C +ACLSNC C A Y C + L +
Sbjct: 19 DVKLPDNAS---AITAISLEECREACLSNCSCTAYAYNNGSGG--CLLWNGLLNNLRSLS 73
Query: 411 DPSSTLFVKI 420
TL++++
Sbjct: 74 SGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 62/236 (26%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRV-LPHGEKE-----------FVT--EVNTIGS 555
LG G +G V K G +VA+KK+ + + + + F T E+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 556 MHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------I 609
+ H N++ L EG LV + M L K V+D R I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-----------VVDRKIRLTESQVKCI 124
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG----------R 659
+ G+ H + +H D+ P NI ++ K++DFGLA+ G
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 660 EHSQ--------VVTMVRGTRGYLAPEWV--SNRPITVKADVYSYGMLLLEIVGGR 705
E Q VVT+ Y APE + + + D++S G + E++ G+
Sbjct: 182 ETMQRREEMTSKVVTL-----WYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 598 DRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657
DR+ + RF IA I H+ +H DIKP+N+LLD N +++DFG M
Sbjct: 97 DRLPEDMARFYIA-EMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152
Query: 658 GREHSQVVTMVRGTRGYLAPE 678
++ + ++ GT Y++PE
Sbjct: 153 NQDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRLLV--------YEFMKNGSLDKWIFPSYHHRDRV 600
E+ +G ++H N++++ +N ++ Y FM + + D W +DR
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W-------KDRP 264
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
L TR I + Y H++ ++IH DIK ENI L+ + + DFG A +E
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
GT +PE ++ D++S G++LL+++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 64/249 (25%), Positives = 89/249 (35%), Gaps = 80/249 (32%)
Query: 510 LLGTGGFGSVY----KGSLGDGTLVAVK-----------KLDRVLPHGEKE--------- 545
LLG G G V+ KG+ G L A+K K+ RVL E+E
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVL--TEQEILATLDHPF 62
Query: 546 FVTEVNTIGSMHHMNLVRLCGYCSEGS-NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWT 604
T + + ++ LV YC G RLL + G
Sbjct: 63 LPTLYASFQTETYLCLV--MDYCPGGELFRLLQ---RQPGK----CLSEEV--------- 104
Query: 605 TRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664
RF A + Y H I++ D+KPENILL E+ +SDF L+K E V
Sbjct: 105 ARFYAAEVLL-ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160
Query: 665 VTMVR----------------------------GTRGYLAPEWVSNRPITVKADVYSYGM 696
+R GT Y+APE +S D ++ G+
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGI 220
Query: 697 LLLEIVGGR 705
LL E++ G
Sbjct: 221 LLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 34/220 (15%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL---- 564
+L+G GGFG VY+ + + + ++ + V E +++ ++ + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 565 -------------CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF--NI 609
CG + Y F+ L+K + + R+ + NI
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCR---MYYRFIL---LEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK--LMGREHSQVV-- 665
+ Y HE I H DIKPENI++D N + D+G+A ++ +H +
Sbjct: 132 MKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 666 --TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG 703
+ RGT Y + + +T + D+ S G +L+ G
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228
|
Length = 294 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVT----EVNTIGSMHHMNLVRL 564
+++G G FG V D + K+ R EKE V E + + +V++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
+ N L+ EF+ G + + +D + + T+F IA T I H+
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIA-ETVLAIDAIHQL- 120
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661
IH DIKP+N+LLD K+SDFGL + + H
Sbjct: 121 --GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G +G VYK DG L ++ G E+ + + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 570 EGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRV------LDWTTRFNIAIATAQGIAYFH 621
S+R L++++ ++ D W +H + L + ++ GI Y H
Sbjct: 69 SHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 622 EQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAKLMGREHSQVVTM--VRGTRGYL 675
N ++H D+KP NIL+ E K++D G A+L + + V T Y
Sbjct: 126 A---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 676 APE-WVSNRPITVKADVYSYGMLLLEIV 702
APE + R T D+++ G + E++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 7/77 (9%)
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR----GYLAPEWVSNRP 684
+H D+ N+LL + K+ DFGLA+ + + + V +G+ ++APE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTFLPVKWMAPESIFDNL 315
Query: 685 ITVKADVYSYGMLLLEI 701
T +DV+SYG+LL EI
Sbjct: 316 YTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 498 RDLQIRTSNF--AQLLGTGGFGSV----YKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVN 551
R LQ++ ++ +++G G FG V +K S + + K + + F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 552 TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
+ + +V+L + +V E+M G L + +Y D W + +
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNY---DVPEKWAKFYTAEV 151
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGT 671
A + H +IH D+KP+N+LLD++ K++DFG M GT
Sbjct: 152 VLA--LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206
Query: 672 RGYLAPEWVSNRP----ITVKADVYSYGMLLLEIVGG 704
Y++PE + ++ + D +S G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 17/106 (16%)
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL-------------MGR 659
T + Y H I+H D+KP+N+L+ K++DFGL+K+ + +
Sbjct: 110 TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 660 EHSQVV-TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
+ + + V GT Y+APE + + D ++ G++L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP---- 684
IH D+KP+N+LLD++ K++DFG M +E GT Y++PE + ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 685 ITVKADVYSYGMLLLEIVGG 704
+ D +S G+ L E++ G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 39/142 (27%), Positives = 58/142 (40%), Gaps = 46/142 (32%)
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL---------AKL 656
RF IA T I H + IH DIKP+NIL+D + K++DFGL +K
Sbjct: 104 RFYIAELTC-AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 657 MGR-EHSQVVTM---------------------VR-----------GTRGYLAPEWVSNR 683
+ +H + +M R GT Y+APE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 684 PITVKADVYSYGMLLLEIVGGR 705
T D +S G++L E++ G+
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCS 569
+G G +G VYK DG L ++ G E+ + + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 570 EGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------QGIAYFH 621
++R L++++ ++ D W +H + + + + GI Y H
Sbjct: 69 SHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 622 EQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAKLMGREHSQVVTM--VRGTRGYL 675
N ++H D+KP NIL+ E K++D G A+L + + V T Y
Sbjct: 126 A---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 676 APE-WVSNRPITVKADVYSYGMLLLEIV 702
APE + R T D+++ G + E++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 23/72 (31%), Positives = 32/72 (44%), Gaps = 8/72 (11%)
Query: 634 KPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYS 693
K NILL + GL KL G + R ++APE + + T KAD+YS
Sbjct: 38 KSGNILLTWD--------GLLKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYS 89
Query: 694 YGMLLLEIVGGR 705
G+ L E +
Sbjct: 90 LGITLYEALDYE 101
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 22/62 (35%), Positives = 31/62 (50%), Gaps = 14/62 (22%)
Query: 605 TRFNIA-----IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659
TRF +A I + + IH DIKP+NIL+D K+SDFGL+ +
Sbjct: 103 TRFYMAECVLAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
Query: 660 EH 661
+H
Sbjct: 154 QH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 839 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.03 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.94 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.88 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.72 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.59 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.55 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.52 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.45 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.14 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.46 | |
| PLN02236 | 344 | choline kinase | 96.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.34 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.54 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.54 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.01 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=473.15 Aligned_cols=287 Identities=46% Similarity=0.786 Sum_probs=253.4
Q ss_pred CCcccchHHHHHHhhccc--cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCccccccee
Q 038743 491 APVNFTYRDLQIRTSNFA--QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568 (839)
Q Consensus 491 ~~~~~~~~~l~~~~~~~~--~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 568 (839)
....|++.++..||.+|. +.||+|+||.||+|.+++|+.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 455699999999999998 599999999999999999999999998765433156799999999999999999999999
Q ss_pred ecCC-ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 569 SEGS-NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 569 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
.+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999 599999999999999999754221 889999999999999999999999888999999999999999999999
Q ss_pred ecccCcceecCCCCceeEEee-ccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 648 VSDFGLAKLMGREHSQVVTMV-RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
|+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+.........+..|+...
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999765431 1222222 7999999999999999999999999999999999999999876544445588999999
Q ss_pred hccCccccccccccc-CCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 727 MTNGTPLKVADRRLE-GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~-~~~~~-~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
+.++...+++|+++. ..... +++.++.++|.+|++.+|.+||+|.+|+++|+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999999987 56554 78999999999999999999999999999996544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=396.12 Aligned_cols=255 Identities=31% Similarity=0.480 Sum_probs=210.0
Q ss_pred ccccccccCCCceEEEEEeCCCcEEEEEEecccCCcc--hHHHHHHHHHhhccccCCcccccceeecCC-ceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG--EKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-NRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~~ 582 (839)
.+.+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3455699999999999999555559999997543222 458999999999999999999999999988 7999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe-eeecCCCCCcEEECCCC-ceeecccCcceecCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR-IIHCDIKPENILLDENF-CPKVSDFGLAKLMGRE 660 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 660 (839)
+|+|..+|+.. ....+++..+++++.|||+||.|||+. . ||||||||+||||+.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999643 467899999999999999999999996 5 99999999999999997 9999999999876443
Q ss_pred CceeEEeeccccceeCccccc--CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVS--NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
. ...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....... .. ..++..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~------------~~v~~~ 261 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VA------------SAVVVG 261 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HH------------HHHHhc
Confidence 2 2233467999999999999 6699999999999999999999999997544311 00 111222
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+..++......+..++.+||+.+|..||++.+++.+|+....
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22333344466678888888999999999999999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=389.73 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=220.1
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
.++......+.+.||+|.||.|+.|.++....||+|.++.. ......|.+|+++|.+|+|+|||+++|+|..+..++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 44555556678899999999999999988889999999765 34457899999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
||||+.|+|.+||.. ..+..++..+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+..
T Consensus 280 tE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999954 3567899999999999999999999995 9999999999999999999999999999976
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
.++.........-+..|.|||.+....++.|+|||||||+||||+| |+.|+......+ ..+.+
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~l 417 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELL 417 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHH
Confidence 6665555555566889999999999999999999999999999996 777765332211 12233
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+.-.+-..+..++..+.+++..||+.+|++|||++.+...|+....
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 3333344455566778888888999999999999999998876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=357.87 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=205.5
Q ss_pred cchHHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 495 ~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
++..||+. ...||+|..|+|||+.+ ++++.+|+|.+.... +...+++.+|++++++.+||+||.++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44555543 56899999999999987 468899999994332 344678999999999999999999999999888
Q ss_pred -ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 573 -NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 573 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||.+|+|+.++. ....+++...-+|+.+|++||.|||+. .+||||||||+||||+.+|++|||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ceEEeehhhcCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 5999999999999999983 336789999999999999999999974 59999999999999999999999999
Q ss_pred CcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
|.++.+-+. ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+-...+.. ..|.. +
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~----~~~~~--L---- 290 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY----LDIFE--L---- 290 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC----CCHHH--H----
Confidence 999977544 3455679999999999999999999999999999999999999996542111 01100 0
Q ss_pred ccccccccccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLEGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~-~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+..+++... +..+. ....++..++..|++.+|.+||++.|+++.
T Consensus 291 l~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 291 LCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011222110 11122 245567778888999999999999998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=398.92 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=220.7
Q ss_pred chHHHHHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCccccccee
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYC 568 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~ 568 (839)
...++......+.+.||+|+||+||+|+.. +.+.||||.++..... ...+|++|+++++.++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334566666677889999999999999763 3568999999876555 678999999999999999999999999
Q ss_pred ecCCceEEEEeeccCCChhhhcccCCCCC---------cccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEE
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHR---------DRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENIL 639 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nil 639 (839)
.+++..+||+|||..|+|.+||....... ...|+..+.+.||.|||.||.||-++ .++||||.++|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence 99999999999999999999996432211 23488999999999999999999996 9999999999999
Q ss_pred ECCCCceeecccCcceec-CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCc
Q 038743 640 LDENFCPKVSDFGLAKLM-GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDF 717 (839)
Q Consensus 640 l~~~~~~kl~DfGla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 717 (839)
|.++..|||+||||++.. ..+..+......-.++||+||.+..++||.++|||||||+||||++ |+-|+.+....+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-- 713 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-- 713 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence 999999999999999854 3333333334445789999999999999999999999999999995 888886544332
Q ss_pred cchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 718 FYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+.+.+..+++ -+.+...+..+..|+..||+.+|++||+++||-..|+....
T Consensus 714 -----VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 -----VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -----HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3333333332 23455677788999999999999999999999999986543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=357.49 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=175.6
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||+||+|++. ++..||||.+.+. .....+.+..|+++|+.++|||||++++++...+..+|||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 3556678999999999999874 5899999999655 334455688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC------CceeecccCcc
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN------FCPKVSDFGLA 654 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~------~~~kl~DfGla 654 (839)
|.+|+|.+||. ....+++.....++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|
T Consensus 91 C~gGDLs~yi~-----~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 91 CNGGDLSDYIR-----RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred CCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999994 44589999999999999999999999 699999999999999754 56899999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
+.+... ......+|++.|||||++..++|+.|+|+||+|+|||++++|+.||+...
T Consensus 163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 987632 22345679999999999999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=352.72 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=203.8
Q ss_pred HHHhhccccccccCCCceEEEEE-eCCCcEEEEEEecccCCc-------chHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPH-------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
....|.+.+.||+|+||.|-+|. ..+|+.||||++.+.... ......+|+++|++|+|||||++++++.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45567778999999999999994 568999999999653211 1223579999999999999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC---Cceeec
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN---FCPKVS 649 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~ 649 (839)
..||||||+.||+|.+++. ....+.+..-..++.|++.|+.|||++ +|+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv-----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV-----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHH-----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999985 345677777788999999999999996 99999999999999655 789999
Q ss_pred ccCcceecCCCCceeEEeeccccceeCcccccCCCC---CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 650 DFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI---TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 650 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
|||+|+..+ ....+...+||+.|.|||++.+... ..++|+||+|||||-+++|.+||........ ..++
T Consensus 322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQ 393 (475)
T KOG0615|consen 322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQ 393 (475)
T ss_pred ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHH
Confidence 999999875 3445667889999999999987643 3578999999999999999999975443220 1122
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+..++.. .......+..++.++++.++|+.||++||++.|+++.
T Consensus 394 I~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2222211 1112234556778899999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=369.71 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=208.3
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+|...+.||+|+|+.+|+++. ..|+.||+|++.+.. ....+...+|+++.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5677788999999999999977 889999999997643 233456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
|+|.+++|.+++ .+.+.+++.+...++.||+.||.|||+. +|||||||-.|+||++++++||+|||||..+.
T Consensus 98 ELC~~~sL~el~-----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELL-----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHH-----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999988 3668999999999999999999999996 89999999999999999999999999999887
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.+.... ...+|||.|+|||++....++..+||||+|||+|-||.|++||+...-.+.+ ..++.. +.
T Consensus 170 ~~~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~~------~Y 235 (592)
T KOG0575|consen 170 YDGERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKLN------EY 235 (592)
T ss_pred Cccccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHhc------Cc
Confidence 654443 4467999999999999999999999999999999999999999854322111 111111 11
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+ +........+++...|+.+|.+||++++|+..
T Consensus 236 ~~----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 SM----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cc----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11 11233345677777899999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=380.28 Aligned_cols=254 Identities=25% Similarity=0.440 Sum_probs=213.1
Q ss_pred hhccccccccCCCceEEEEEeCC----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...+.++||.|.||+|++|+++- ...||||.|+.-.. ....+|+.|+.||++..||||++|.|+....+..++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 33456799999999999998742 45899999976543 34568999999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
|||+||+|+.||. .++..+.+.++.-++.+||.||+||.+. ++|||||.++|||++.+..+|++||||++.+.
T Consensus 710 EyMENGsLDsFLR----~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 710 EYMENGSLDSFLR----QNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhCCcHHHHHh----hcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999995 3456699999999999999999999996 99999999999999999999999999999886
Q ss_pred CCCceeEEe--eccccceeCcccccCCCCCCcccEEehhHHHHHHH-hCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 659 REHSQVVTM--VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 659 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
++.....+. ..-..+|.|||.+..++++.++||||||||+||++ .|.+|+...... +...-
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIka 846 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIKA 846 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------HHHHH
Confidence 655333332 23467999999999999999999999999999988 588887432211 11222
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
++..++-..+++++..+.++++.|||.|-.+||.+.+++.+|++.
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 233334455677888999999999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.65 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=207.3
Q ss_pred HHHhhccccccccCCCceEEEE-EeCCCcEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccc-eeecCCc-eE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCG-YCSEGSN-RL 575 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~ 575 (839)
..+.+.+.++||+|.||+|||+ .+.+|..||.|.+.-. ..+....+..|+.+|++|+|||||++++ -+.+... .+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3455677889999999999999 4578999999998632 2334456899999999999999999999 4555555 89
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccC-CeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR-NRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
|||||+..|+|...+..- ....+.+++..+++++.|++.||..+|.... .-|+||||||.||+|+.+|.+||+||||+
T Consensus 97 ivmE~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999988533 3466789999999999999999999998432 24899999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+.+.....- ....+|||.||+||.+...+|+.|+||||+||++|||..-++||.+.. +-. .-+.+..+..
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~-L~~KI~qgd~-- 245 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS-LCKKIEQGDY-- 245 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH-HHHHHHcCCC--
Confidence 988654433 344679999999999999999999999999999999999999997542 111 1122222211
Q ss_pred cccccccCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 735 VADRRLEGAVE-EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 735 ~~~~~l~~~~~-~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
..++ .-....+.+++..|+..||+.||+...+++.+..
T Consensus 246 -------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1112 3445667778888999999999986666555544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.56 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=212.0
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcc-hHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
+|+....--|.++||+|.||.|.+.....+..||||+++...... .++|.+|+++|.+++|||||+++|+|..++..++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 344444456778999999999999999888999999998765443 4789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
|+|||++|+|.+||.+. ....++-...++|+.|||.||+||.+. .++||||.++|||+|.++++||+|||+++.
T Consensus 613 I~EYmEnGDLnqFl~ah---eapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAH---ELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHhcCcHHHHHHhc---cCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 99999999999999543 122255667788999999999999995 999999999999999999999999999994
Q ss_pred c-CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHH--hCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 657 M-GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 657 ~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ell--tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
+ ..+..+.....+-+++|||||.+..++++.++|||+||+.+||++ +...||....+... .+..-..+..+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcc
Confidence 4 444444455566788999999999999999999999999999987 57788864332211 11111111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
. ....+.-+...+.+++++||..+-.+||+++++...|.+.
T Consensus 764 ~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 V------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred e------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 1112233456678999999999999999999999998754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=339.78 Aligned_cols=267 Identities=27% Similarity=0.408 Sum_probs=206.8
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhc--cccCCcccccceeecCC----ceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGS--MHHMNLVRLCGYCSEGS----NRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv~ 578 (839)
..+.++||+|.||.||||.+ +++.||||++. .+....|.+|-+++.. ++|+||++++++-.... +.+||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 45678999999999999999 56999999986 3455679999888776 48999999999876655 889999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc------cCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ------CRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
||.++|+|.+|| ....++|....+|+..+++||+|||++ .+++|+|||||++||||..|+++.|+|||
T Consensus 288 ~fh~kGsL~dyL------~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYL------KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHH------HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999 456899999999999999999999974 46789999999999999999999999999
Q ss_pred cceecCCCCcee-EEeeccccceeCcccccCCC-C-----CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--h
Q 038743 653 LAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRP-I-----TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--A 723 (839)
Q Consensus 653 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~-----s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--~ 723 (839)
||..+....... ....+||.+|||||++.+.- + -.+.||||+|.|||||+++-.-++. .....+.+|.. +
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEV 440 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHh
Confidence 999886543332 22367999999999997642 2 2479999999999999998766543 22222322221 1
Q ss_pred hhhhccCcccc-cccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 724 FKEMTNGTPLK-VADRRLEGAVEE-----EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 724 ~~~~~~~~~~~-~~~~~l~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
-.+..-+.+.+ ++.++.++.++. ..+..+.+.+..||.+||+.|.|+.=|.+.+.+...
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11111111111 334444444432 456778899999999999999999999998876554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=349.59 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=209.9
Q ss_pred chHHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
.+.|+......+.+.||+|.||+||+|.+.. .||||++..... ...+.|++|+..+++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5566666666778899999999999999853 499999965443 345689999999999999999999999998877
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.+|..+|+|.+|..+|+ ..+..|+..+.++||.|||+||.|||. ++|||||||..||||.+++.|||+||||
T Consensus 463 -AIiTqwCeGsSLY~hlH----v~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLH----VQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhcc----chhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999995 345789999999999999999999999 5999999999999999999999999999
Q ss_pred ceecCCC-CceeEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 654 AKLMGRE-HSQVVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 654 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
+..-..- ..+......|...|||||+++. .+|+..+||||||+|+|||++|..||......... |.. -.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----fmV---Gr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----FMV---GR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----EEe---cc
Confidence 9764332 1222334558889999999975 57999999999999999999999999833322211 111 00
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
| .+.+++. .........+.+++..||..++++||.+.+|+.+|+....
T Consensus 608 G----~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 G----YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c----ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1 0111110 1122344566777777999999999999999998877644
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.28 Aligned_cols=239 Identities=26% Similarity=0.424 Sum_probs=198.4
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChh
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
.+-||.|+.|.||+|++ .++.||||+++.. -..+++-|++|+||||+.+.|+|......+||||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 35799999999999999 5788999987532 235788899999999999999999999999999999999999
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEe
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM 667 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 667 (839)
+.|. .++.+.-.....+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-++..... .....
T Consensus 201 ~VLk-----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 201 EVLK-----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHh-----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 9994 556788888899999999999999996 9999999999999999999999999999876443 22345
Q ss_pred eccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHH
Q 038743 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEE 747 (839)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 747 (839)
+.||..|||||++.+.+.+.|+|||||||||||||||..|+....... +.| .+-...|.-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----------GVGsNsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----------GVGSNSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----------eccCCcccccCccc
Confidence 679999999999999999999999999999999999999996433211 111 11122233333445
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 748 ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 748 ~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
++..+.-++..||+..|..||++.+++..|+-
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 55556666677999999999999999999964
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=356.48 Aligned_cols=269 Identities=27% Similarity=0.397 Sum_probs=209.7
Q ss_pred CcccchHHHHHHhhccccccccCCCceEEEEEeCC--C---cEEEEEEecc---cCCcchHHHHHHHHHhhccccCCccc
Q 038743 492 PVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGD--G---TLVAVKKLDR---VLPHGEKEFVTEVNTIGSMHHMNLVR 563 (839)
Q Consensus 492 ~~~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~--~---~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~ 563 (839)
|..-.-.+|......+.++||+|+||.||+|++.. + ..||||..+. .......+|+.|+++|+.++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 33334456666666777999999999999997743 2 2389999875 23455678999999999999999999
Q ss_pred ccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC
Q 038743 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN 643 (839)
Q Consensus 564 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~ 643 (839)
++|++......++|||+|+||+|+++|.. ....++..+++.++.+.|.||+|||+ +.+|||||.++|||++.+
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKK 298 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCC
Confidence 99999999999999999999999999943 23369999999999999999999999 599999999999999999
Q ss_pred CceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 644 FCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 644 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
..+||+||||++.-...... .....-+.+|+|||.+....++.++|||||||++||+++ |..|+.+....+
T Consensus 299 ~~vKISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------- 370 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------- 370 (474)
T ss_pred CeEEeCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------
Confidence 99999999998754311111 112245689999999999999999999999999999998 788886443221
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADI 783 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~ 783 (839)
+... ++....+...+...+..+..+...||..+|++||+|.++.+.|+.....
T Consensus 371 v~~k--------I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 371 VKAK--------IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHH--------HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1111 1111111222223344555666689999999999999999999876553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.64 Aligned_cols=255 Identities=27% Similarity=0.349 Sum_probs=200.0
Q ss_pred hccccccccCCCceEEEEEeCC-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC--ceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS--NRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~~ 581 (839)
+...+.||+|+||+||++...+ |+..|||.+........+.+.+|+++|.+++|||||+.+|...... ...+.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4456899999999999997754 8999999986553333566899999999999999999999855544 689999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecCC-
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGR- 659 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~- 659 (839)
++|+|.+++... .+ .|++..+..++.||++||+|||++ +|+||||||+||||+. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 99 PGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999432 22 699999999999999999999985 9999999999999999 79999999999987663
Q ss_pred -CCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 660 -EHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 660 -~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
..........||+.|||||++..+ ....++|||||||++.||+||++||.... ....+......+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~------- 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGRED------- 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccC-------
Confidence 222223457799999999999864 33459999999999999999999996420 0111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+.++........+++..|++.+|++|||++++++..--.
T Consensus 240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11133333445667788889999999999999999876443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=318.26 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=201.6
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+..-++|+|+||.|||.+.. +|+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|......+||+||++
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 33458999999999999874 599999999954322 224567899999999999999999999999999999999998
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
..-|+++= .....++...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+.. ..
T Consensus 85 hTvL~eLe-----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 85 HTVLHELE-----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred hHHHHHHH-----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 86655432 2345678888999999999999999995 899999999999999999999999999998865 33
Q ss_pred eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh--------hhhccCcc-
Q 038743 663 QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF--------KEMTNGTP- 732 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~- 732 (839)
...+..+.|..|.|||.+.+ .+|...+||||+||++.||++|.+.|-+..+.+..+.+.... +.+.....
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44567789999999999987 789999999999999999999999887665543322221111 11111111
Q ss_pred cccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAV-----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+.-|.....- -+.....+++++..|++.||++|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111100 0123346888999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=329.80 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=195.3
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
...+.+.++||+|+||+|++++. ++++.+|+|++++... ...+....|..+|.+++||+||+++-.+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 34456788999999999999965 5689999999976532 2345688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
+||+.||.|..+| +++..+++....-++..|+.||.|||+. +||||||||+|||||++|+++|+||||++..
T Consensus 104 ld~~~GGeLf~hL-----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHL-----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHH-----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999 4567888888888899999999999994 9999999999999999999999999999964
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
-... ......+||+.|||||++.+..|+..+|.||+|+++|||++|.+||........ .+.+..++.
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k~----- 242 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGKL----- 242 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCcC-----
Confidence 3322 233447899999999999999999999999999999999999999975443211 111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRP 768 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP 768 (839)
..... -......+++...++.+|++|.
T Consensus 243 -~~~p~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPG---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCc---cCCHHHHHHHHHHhccCHHHhc
Confidence 01111 1223345566668999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=376.64 Aligned_cols=264 Identities=27% Similarity=0.451 Sum_probs=210.7
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC--C----cEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD--G----TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
+......+.+.||+|.||.||+|.+.+ | ..||||.+.+.. .+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 444555677899999999999997743 3 259999997654 455678999999999999999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCC--CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecc
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYH--HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D 650 (839)
..++++|||++|+|..||.+.+. .....|.....+.++.|||+|+.|||+ +++|||||.++||||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999975522 225678899999999999999999999 4999999999999999999999999
Q ss_pred cCcceec-CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhc
Q 038743 651 FGLAKLM-GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMT 728 (839)
Q Consensus 651 fGla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 728 (839)
||||+.+ ..+.........-..+|||||.+..+.++.|+|||||||+||||+| |..||......+ +...+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHH
Confidence 9999943 3333332222344578999999999999999999999999999996 677775333221 111111
Q ss_pred cCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 729 NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
++ .+| ..+..+...+.+++..||+.+|++||++..+++.+..+..
T Consensus 919 ~g-------gRL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 EG-------GRL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred hC-------Ccc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11 112 2234556677899999999999999999999998876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.66 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=204.4
Q ss_pred hccccccccCCCceEEEEE-eCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC--CceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 579 (839)
++..++||+|.||.||+|+ ..+|+.||+|++.... .....-..+|+.+|++|+||||++|.+...+. ..+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 3345689999999999995 5789999999986443 33345678999999999999999999998776 68999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
||++ +|.-++. .....|+..++..++.|++.||.|+|.. +|+|||||.+|||||.+|.+||+|||||+++..
T Consensus 199 YMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 199 YMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred cccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9987 7777663 3456899999999999999999999995 999999999999999999999999999999988
Q ss_pred CCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc----------cchhhhhhhhc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF----------FYPGWAFKEMT 728 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~----------~~~~~~~~~~~ 728 (839)
......+..+-|..|.|||++.+ ..|+.+.|+||.||||.||+.|++.|.+..+.+.. .-..|....+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 77776777788999999999987 47999999999999999999999999776543211 11123321221
Q ss_pred cCc---ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 729 NGT---PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 729 ~~~---~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.-. ...-....+.+. -.......++++..+|..||.+|.|+.++++-
T Consensus 351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 100 011111122111 11123345667777899999999999998763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.67 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=202.9
Q ss_pred hccccccccCCCceEEEEE-eCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.-.++||+|.||.||+|+ ..+|+.||||+++... ..-.....+|++.|+.++|+||+.+++++...+..-||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 4445789999999999995 4679999999996432 122456899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+. +|+..|. .+...|....+..++.++++||+|||+ +.|+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus 84 ~t-dLe~vIk----d~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 84 PT-DLEVVIK----DKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred cc-cHHHHhc----ccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 75 8988884 456788999999999999999999999 499999999999999999999999999999987655
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-----hhhccC-----
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF-----KEMTNG----- 730 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~----- 730 (839)
...... +-|..|.|||.+.+ +.|+...||||.|||+.||+-|.+-|.+..+.+.......+. +.|.+-
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 544333 57899999998876 679999999999999999999987776655443221111111 011100
Q ss_pred -cccc-cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 -TPLK-VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 -~~~~-~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.... .-.+.+.. .-......+++++..++..+|.+|.+++|++++
T Consensus 235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000 00111111 122334456888889999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.78 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred ccccccCCCceEEEE-EeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
-++||+|+.|.||.+ +..+++.||||++........+-+.+|+.+|...+|+|||.++..+...+++++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 358999999999999 4567899999999776555556688999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
.+.+ ....+++.++..|+.++++||+|||.. +|||||||..|||++.+|.+||+|||++..+....... .
T Consensus 358 TDvV------t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR-~ 427 (550)
T KOG0578|consen 358 TDVV------TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR-S 427 (550)
T ss_pred hhhh------hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc-c
Confidence 9988 345699999999999999999999995 99999999999999999999999999999876655433 4
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
..+||+.|||||++....|..|.||||||++++||+-|.+||-...... +...+...-. + .-....
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~-----P--~lk~~~ 493 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGT-----P--KLKNPE 493 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCC-----C--CcCCcc
Confidence 4569999999999999999999999999999999999999995432211 1111111100 1 111223
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.....+.++..+||+.|+++||++.|+++.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 344557778888999999999999999763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=323.88 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=204.1
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...|++..+||.|..++||+|.. +.++.||||++.-.. ....+.+++|+..|..++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 34577888999999999999965 678999999995432 2335789999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
||.+||+.+.+... -...+++..+..|+.++++||.|||++ +.||||||+.||||+.+|.+||+|||.+-.+..
T Consensus 105 fMa~GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999654 234589999999999999999999995 999999999999999999999999998876544
Q ss_pred CCcee---EEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 660 EHSQV---VTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 660 ~~~~~---~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
..... .....||+.|||||++.. ..|+.|+||||||+...||.+|..||......+. ....+ .+.+..
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tL-qn~pp~ 251 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTL-QNDPPT 251 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHh-cCCCCC
Confidence 33222 145689999999999643 5799999999999999999999999964322110 00111 111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..-..+..+-.......+.+++..|++.||.+|||++++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111111112223367778888999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=384.17 Aligned_cols=268 Identities=25% Similarity=0.466 Sum_probs=212.6
Q ss_pred cchHHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 495 ~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
+++.++... ....++||+|+||.||+|.. .++..||||++..... ....|++.+++++|||||+++|+|.+...
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 444554432 34456899999999999986 5789999999865422 22356888999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++|+|.+++. .++|..+.+|+.|||+||+|||+++.++|+||||||+||+++.++.+++. ||.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 999999999999999983 37899999999999999999997767899999999999999999988876 666
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
+...... ....+++.|||||++.+..++.++|||||||++|||++|+.|++..... ......|+..........
T Consensus 829 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 829 PGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLD 902 (968)
T ss_pred ccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchh
Confidence 5433221 1225789999999999999999999999999999999999999643322 223444544433333344
Q ss_pred ccccccccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 734 KVADRRLEG--AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 734 ~~~~~~l~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+|+.+.. ....++...+.+++.+||+.+|++||+|.||+++|+....
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 455665533 3455777889999999999999999999999999987643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=347.51 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=200.7
Q ss_pred HHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecCC-
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGS- 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~- 572 (839)
...+.+.++||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +||||++++++|....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 34567788999999999999964 2356899999965432 2345689999999999 8999999999887644
Q ss_pred ceEEEEeeccCCChhhhcccCCCC--------------------------------------------------------
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHH-------------------------------------------------------- 596 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 596 (839)
..++||||+++|+|.++|......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999998532100
Q ss_pred -CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee-EEeeccccce
Q 038743 597 -RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGY 674 (839)
Q Consensus 597 -~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y 674 (839)
....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 023478888999999999999999994 99999999999999999999999999998653322211 2233467889
Q ss_pred eCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHH
Q 038743 675 LAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAM 753 (839)
Q Consensus 675 ~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 753 (839)
+|||++.+..++.++||||||+++|||++ |+.||......+. ....+..+.. .. .+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-----~~----~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR-----MR----APENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC-----CC----CCCCCCHHHH
Confidence 99999999999999999999999999997 9999864332110 1111111111 01 1112234578
Q ss_pred HHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 754 KVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 754 ~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+++.+||+.+|++||+|.+|+++|+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.19 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=204.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+.|.+.||.|+|++|++|+. ..++.+|||++.+... ...+-...|-.+|.+| .||.|++|+-.|.++..+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 456889999999999999954 5799999999976532 2234567888899999 8999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.++|. +-..|++.....++.+|+.||+|||+. +||||||||+|||||++|++||+|||-|+.+.
T Consensus 154 e~A~nGdll~~i~-----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 154 EYAPNGDLLDLIK-----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EecCCCcHHHHHH-----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999994 457899999999999999999999995 99999999999999999999999999999886
Q ss_pred CCCce---------e---EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 659 REHSQ---------V---VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 659 ~~~~~---------~---~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
..... . ....+||..|.+||++.....+..+|+|+||||||.|+.|++||....+.. .+++
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-------iFqk 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-------IFQK 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-------HHHH
Confidence 43222 1 134789999999999999999999999999999999999999997544321 1121
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+. -++- ++++...+.+.+++.+.|..||.+|+|..++.+.
T Consensus 299 I~------~l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQ------ALDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH------Hhcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 1122 2233333556677777899999999999888775
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.71 Aligned_cols=245 Identities=18% Similarity=0.284 Sum_probs=196.5
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcc---hHHHHHHHHHhhccccCCcccccceeec----CCceEEEEeec
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG---EKEFVTEVNTIGSMHHMNLVRLCGYCSE----GSNRLLVYEFM 581 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~~ 581 (839)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999997653333 3567899999999999999999999876 45678999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++. ....+++...+.++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHh-----hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999994 335688999999999999999999973 378899999999999999999999999998654322
Q ss_pred ceeEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+..+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-------~~~i~~~~-------- 238 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-------YDLIINKN-------- 238 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcC--------
Confidence 12357889999999976 6899999999999999999999999974322110 11110000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+......+.+++.+||+.+|++||+|.+|++.|+..
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 01111112344577888899999999999999999999754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.68 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=223.6
Q ss_pred CcccchHHHHHHhhccccccccCCCceEEEEEeCC-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec
Q 038743 492 PVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570 (839)
Q Consensus 492 ~~~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 570 (839)
.+...-.|+........++||-|.||.||.|.++. .-.||||.++.. .-...+|+.|+.+|+.++|||+|+|+|+|..
T Consensus 256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred cCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 33446677777777788899999999999999865 568999999765 3456799999999999999999999999999
Q ss_pred CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecc
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D 650 (839)
+...|||.|||.+|+|.+||... .+..+.-..++.+|.||+.||.||.. +.+|||||.++|+|+.++..+||+|
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeec
Confidence 99999999999999999999644 44566777889999999999999998 5999999999999999999999999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
|||++++..+.........-.+.|.|||-+....++.|+|||+|||+||||.| |..|+-+..-.
T Consensus 409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------------- 473 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------- 473 (1157)
T ss_pred cchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---------------
Confidence 99999997766655554556788999999999999999999999999999985 77776432211
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+++....+.+-+..+...+.+++..||+.+|.+||++.|+-+.|+.+
T Consensus 474 -qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 474 -QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred -HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 11234444445555666778889999999999999999999999988754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.33 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=204.7
Q ss_pred HhhccccccccCCCceEEEEE-eCCCcEEEEEEecccCCcch-HHHHHHHHHhhccc-cCCcccccceeecCC-ceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMH-HMNLVRLCGYCSEGS-NRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lv~ 578 (839)
..|...++||.|.||.||+|+ ..+|+.||||++++.....+ --=++|++.|.+|+ ||||++|..++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 456677899999999999995 46789999999977644322 22468999999998 999999999998888 999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
|||+. +|.+++. .+++.|++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+||...
T Consensus 90 E~Md~-NLYqLmK----~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 90 EFMDC-NLYQLMK----DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred Hhhhh-hHHHHHh----hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 99965 8888884 3578999999999999999999999995 99999999999999999999999999999764
Q ss_pred CCCceeEEeeccccceeCccccc-CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-----hhhccC-c
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF-----KEMTNG-T 731 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~-~ 731 (839)
.. ...+..+.|+.|.|||++. ...|+.+.||||+|||++||.+-++.|-+..+.+...-...+. +.+.++ .
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 32 3356677899999999775 5789999999999999999999998886655432211111111 111111 0
Q ss_pred ccccccccccC-------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLEG-------AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~-------~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+...+.-++.. ..-......+++++..|+..||.+|||+++.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00011111100 0112356678899999999999999999999986
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.60 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=201.8
Q ss_pred HHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
...+.+.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +||||++++++|.++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44567789999999999999963 346689999996432 23345688999999999 89999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCC----------------------------------------------------------
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYH---------------------------------------------------------- 595 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 595 (839)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998853210
Q ss_pred ------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 596 ------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 596 ------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0123578899999999999999999984 9999999999999999999999999999876443222
Q ss_pred e-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 664 V-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 664 ~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..+.+..+. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~---------~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGY---------R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCc---------c
Confidence 1 122345678999999999999999999999999999998 8888854321110 011111111 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|++||+|.+|+++|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001111234577888999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=327.63 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=202.6
Q ss_pred HHHhhccccccccCCCceEEEEEeC----CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
....+.+.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++.+++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4456778899999999999999753 367899999875432 23456899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||.+.
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 83 IVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999999842 234688999999999999999999985 99999999999999999999999999876
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
..............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~--- 225 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGF--- 225 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC---
Confidence 542222111122335678999999999999999999999999999775 999986432211 011111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+......+.+++..||+.+|.+||++.++.+.|...
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111222345678888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=328.97 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=202.9
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||+||||+- .+.+.||+|.+.+..+ ...+.+.+|++++++++|||||.+++.++...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 45667899999999999965 4689999999976533 23456899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
.+ +|..+| ..+..+.+..+..|+.+++.||.|||+ ++|+|||+||+||||+..+.+|++|||+|+.+.. .
T Consensus 84 ~g-~L~~il-----~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 84 VG-DLFTIL-----EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hh-hHHHHH-----HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 87 999999 466789999999999999999999999 5999999999999999999999999999998764 3
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
....+.+.||+.|||||+..+++|+..+|+||+||||||+.+|++||-...-. . ..+.+.. |+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------~-Lv~~I~~-------d~v-- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------Q-LVKSILK-------DPV-- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------H-HHHHHhc-------CCC--
Confidence 34456778999999999999999999999999999999999999999522110 0 0011111 111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+......+..++...++.||.+|-+..+++..
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122445567777778899999999999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.89 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=199.9
Q ss_pred HHhhccccccccCCCceEEEEEeCC-----------------CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCccc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD-----------------GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVR 563 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 563 (839)
...+.+.++||+|+||.||++...+ +..||+|.+..... ....+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456678899999999999997532 34799999865432 23457999999999999999999
Q ss_pred ccceeecCCceEEEEeeccCCChhhhcccCCC--------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeee
Q 038743 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYH--------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629 (839)
Q Consensus 564 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 629 (839)
+++++.+....++||||+++|+|.+++..... .....+++..+++++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998843211 1123578889999999999999999995 899
Q ss_pred ecCCCCCcEEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh--CCC
Q 038743 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG--GRR 706 (839)
Q Consensus 630 H~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt--G~~ 706 (839)
||||||+|||+++++.+||+|||+++......... .....++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998654332221 223345788999999998899999999999999999987 455
Q ss_pred CCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 707 NLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 707 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
||....... ........+..... .. ....+......+.+++.+||+.+|++||+|.+|.+.|++
T Consensus 241 p~~~~~~~~---~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQ---VIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHH---HHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 665322111 11111111110000 00 000111233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.39 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=202.3
Q ss_pred HHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCCc-chHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
+....+.+.+.||+|+||.||++.. .++..||||++...... ....+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3445677889999999999999863 23458999999754322 235688999999999 899999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCC--------------------------------------------------------
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYH-------------------------------------------------------- 595 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 595 (839)
...++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998853210
Q ss_pred ---------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee-E
Q 038743 596 ---------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV-V 665 (839)
Q Consensus 596 ---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~ 665 (839)
.....+++.++++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 0123578888999999999999999994 99999999999999999999999999998654332221 1
Q ss_pred EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
....++..|||||++.+..++.++||||||+++|||++ |+.||........ .......+ .....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~---------~~~~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRG---------YQMSR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcc---------cCccC
Confidence 22345678999999999999999999999999999997 9999864322111 00111111 00001
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111234577888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=331.93 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=202.2
Q ss_pred HHHhhccccccccCCCceEEEEEe-CCCcEEEEEEeccc----CC-cchHHHHHHHHHhhccc-cCCcccccceeecCCc
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV----LP-HGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSN 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 573 (839)
....|.+.+.||+|+||+|++|.. .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345677889999999999999965 56899999977553 11 23445678999999998 9999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-CceeecccC
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFG 652 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfG 652 (839)
.++||||+.+|+|.+++. ....+.+.+...++.|++.|++|||+. +|+||||||+|||+|.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~-----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV-----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999994 346788899999999999999999995 99999999999999999 999999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCC-CC-CcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP-IT-VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
++.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... ....+..+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKG 238 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcC
Confidence 999874 2223455678999999999999977 85 89999999999999999999998532111 11111111
Q ss_pred cccccccccccCCCCHHH-HHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEE-LMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~-~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. + .++.-. ...+..++.+|++.+|.+|+++.++++
T Consensus 239 ~--------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 E--------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred C--------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 0 111111 456778888999999999999999983
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.45 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=206.5
Q ss_pred HHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+....+.+.+.||+|++|.||+|...+++.||+|.++.. ....+++.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 344567788999999999999999878889999998654 2345679999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999998432 245689999999999999999999984 999999999999999999999999999987653
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
...........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~-------- 220 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQG-------- 220 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC--------
Confidence 22221122223467999999999999999999999999999999 999886432111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.....+......+.+++.+|++.+|.+||+|.++++.|++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 -YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0001112234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.42 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=204.7
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
...+.+.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+.+....+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3456678899999999999999888899999998653 233567899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999998532 345678889999999999999999984 99999999999999999999999999998765433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
........++..|+|||++....++.++||||||+++|||++ |+.||....... ....+.... ..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-----~~-- 223 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY-----RM-- 223 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC-----CC--
Confidence 222223345678999999998889999999999999999998 999986432111 111111110 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.........+.+++.+|++.+|++||+++++.++|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 --PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.70 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=201.2
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.+.+.||+|+||.||++...++..+|+|.+... .....++..|+.++++++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45667899999999999999988889999988643 33456789999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 84 GCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999988432 23588999999999999999999984 9999999999999999999999999999865433222
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+..+.. ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~--~~~~---- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGFR--LYRP---- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCC--CCCC----
Confidence 2223345678999999998889999999999999999999 899986432211 1111111110 0011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
......+.+++.+||+.+|++||+|.++++.|.
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112345789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.78 Aligned_cols=249 Identities=32% Similarity=0.525 Sum_probs=191.9
Q ss_pred cccccccCCCceEEEEEeC-----CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 507 FAQLLGTGGFGSVYKGSLG-----DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.||.|.||.||+|.+. .+..|+||.++..... ..++|.+|++.+.+++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999875 2578999999654332 367899999999999999999999999988889999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.++|... ....+++.+++.|+.||++||.|||+. +++|+||+++|||+++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999543 346789999999999999999999995 8999999999999999999999999999877322
Q ss_pred Cce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 661 HSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 661 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ..........|+|||.+....++.++||||||+++|||++ |+.|+......+ ....+.++..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~------ 223 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQR------ 223 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEE------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccc------
Confidence 222 2223457789999999999989999999999999999999 678875331110 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
...+......+.+++..||+.+|++||+|.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222344577888899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.95 Aligned_cols=275 Identities=23% Similarity=0.372 Sum_probs=208.6
Q ss_pred cchHHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhc--cccCCcccccceeecCC
Q 038743 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGS--MHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 495 ~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~ 572 (839)
+-.+.....+..+.+.||+|.||+||+|++ -|+.||||++.. .+++.+.+|.++++. |+|+||+.+++.-....
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 344445556667788999999999999999 689999999963 456779999999887 49999999998765443
Q ss_pred ----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhh-----ccCCeeeecCCCCCcEEECCC
Q 038743 573 ----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE-----QCRNRIIHCDIKPENILLDEN 643 (839)
Q Consensus 573 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~dlk~~Nill~~~ 643 (839)
.++||.+|.++|||.+|| ....++-...++++..+|.||++||- +.++.|.|||||+.|||+..+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL------~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYL------NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred CceEEEEEeeecccCCcHHHHH------hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 678999999999999999 44689999999999999999999996 457889999999999999999
Q ss_pred CceeecccCcceecCCCCcee---EEeeccccceeCcccccCC----CC--CCcccEEehhHHHHHHHhCCCCCCCCCCC
Q 038743 644 FCPKVSDFGLAKLMGREHSQV---VTMVRGTRGYLAPEWVSNR----PI--TVKADVYSYGMLLLEIVGGRRNLDMSGDA 714 (839)
Q Consensus 644 ~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~--s~~~DV~S~Gvvl~elltG~~p~~~~~~~ 714 (839)
+.+.|+|+|||-......... ....+||.+|||||++... .+ -..+||||||.|+||+...-.- .+-.
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~---ggi~ 429 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES---GGIV 429 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc---CCEe
Confidence 999999999998765543322 3456799999999998642 22 2469999999999999854311 1111
Q ss_pred CCccchhhhh--hhhccCcccc-cccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 715 EDFFYPGWAF--KEMTNGTPLK-VADRRLEGAV-----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 715 ~~~~~~~~~~--~~~~~~~~~~-~~~~~l~~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+.+.+|.+.+ ....-+.+.+ +-..++++.+ +.+.+..+.+++..||..+|..|-|+-.+.+.|.+..+
T Consensus 430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2222222111 1111111111 2233344333 34788999999999999999999999999999877654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.02 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=202.1
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCC
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
.+.||+|.||.||||.. ..++.||+|++.-.. .....+.+.|+.++.+++|+||.+++|.+..+..+.++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 46899999999999965 568999999996543 3334678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeE
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 665 (839)
+.+.|. .+..+++..+.-|+.++..||.|||.+ +.+|||||+.|||+..+|.+||+|||++-.+.......
T Consensus 98 v~~lL~-----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 98 VLDLLK-----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hhhhhc-----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 999983 445568888889999999999999996 89999999999999999999999999998876655444
Q ss_pred EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCC
Q 038743 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 745 (839)
...+||+.|||||++....|+.|+||||||++.+||.+|.+|+....... ..-++.+.-.+...
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccc
Confidence 56779999999999998899999999999999999999999986443211 11111111112222
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 746 ~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
......+.+++..|+..+|+.||++.++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2334457778888999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=299.60 Aligned_cols=196 Identities=29% Similarity=0.392 Sum_probs=175.2
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+++.+.||.|+||+|.+++.+ +|..+|+|++++..-- ..+...+|.++|+.+.||+++++++.+.+.+..+|||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 355789999999999999764 5889999999764322 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
.+||.|..+|. +.+.+++....-+|.+|+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 126 v~GGElFS~Lr-----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 126 VPGGELFSYLR-----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred cCCccHHHHHH-----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999994 456899999999999999999999994 9999999999999999999999999999976432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
..+.+||+.|+|||.++..++..++|.|||||++|||+.|..||....
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 556789999999999999999999999999999999999999996443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.82 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=202.6
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+-|.|.+|++ .+|+.+|||++.+... .....+.+|+.+|+.+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 56788999999999999976 6799999999976532 2234578999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|.|.++|. +...|.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||.++.+||+|||||.+-.
T Consensus 94 v~gGELFdylv-----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 94 VPGGELFDYLV-----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred cCCchhHHHHH-----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 99999999994 557889999999999999999999996 99999999999999999999999999998632
Q ss_pred CceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
........+|.+.|.|||++.+.+| ..++||||.||||+.||+|+.||+...-. -...++..|..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-------~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-------VLLLKVQRGVF------- 229 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCcc-------
Confidence 2334556789999999999999998 57999999999999999999999833211 01112222211
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+.+......+.+++.+|+..||.+|-|++||++.
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122333446677778999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.02 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=200.1
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--------------cchHHHHHHHHHhhccccCCcccccce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--------------HGEKEFVTEVNTIGSMHHMNLVRLCGY 567 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~ 567 (839)
-+|.+.+.||+|.||.|-+|.. .+++.||||++.+... ...+...+|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 4566778999999999999965 5799999999964311 012467899999999999999999999
Q ss_pred eec--CCceEEEEeeccCCChhhhcccCCCCCccc-CChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 568 CSE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 568 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
..+ .+..|||+|||..|.+...= .... |+..+.++++.+++.||+|||.+ +||||||||+|+||+++|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 865 46899999999999875422 3344 99999999999999999999998 999999999999999999
Q ss_pred ceeecccCcceecCCCCc----eeEEeeccccceeCcccccCCC----CCCcccEEehhHHHHHHHhCCCCCCCCCCCCC
Q 038743 645 CPKVSDFGLAKLMGREHS----QVVTMVRGTRGYLAPEWVSNRP----ITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~ 716 (839)
++||+|||.+..+..... .......||+.|||||...++. .+.+.||||+||+||.|+.|+.||......+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999987622111 1123367999999999987733 35789999999999999999999964332111
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+ ..++...+.....++.-+.+.+++.++|+.||++|-+..+|.....-.
T Consensus 328 -------~--------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 328 -------F--------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred -------H--------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 1 123333333333445667788899999999999999999998876543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.33 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=196.8
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+...+.||+|+||.||++.. .+++.||||.+.... ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 44567899999999999976 578999999986432 22234578999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|..++... ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999998887432 234688999999999999999999994 9999999999999999999999999999875332
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~---------- 220 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED---------- 220 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc----------
Confidence 1 223446899999999999999999999999999999999999999754321100 0000001000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
....+......+.+++.+||+.+|.+||+ ++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01112223345678888899999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.06 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=203.8
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
...+.+.+.||+|+||.||+|... .++.||+|.+... .....++.+|++++.+++|+||+++++++......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345667889999999999999764 5889999998654 33456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 84 MTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999998432 234688999999999999999999984 9999999999999999999999999999876443
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ ....+...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~--------- 221 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKG--------- 221 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC---------
Confidence 2222222234668999999999999999999999999999998 888886432111 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+......+.+++.+|++.+|++||+|.+++++|+..
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111122235577888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=317.09 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=207.6
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.++||.|+||.||+|...+++.+|+|.+.........++..|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 45667889999999999999988899999999976655456678999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++... ....+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 86 KGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999542 345689999999999999999999984 899999999999999999999999999987643222
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. .....++..|+|||.+....++.++||||||++++||++ |+.||......+ ....... ...
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~---------~~~ 222 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQITA---------GYR 222 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHh---------CCc
Confidence 1 223346778999999998899999999999999999998 899986433211 0111111 011
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11122334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.50 Aligned_cols=252 Identities=24% Similarity=0.426 Sum_probs=201.8
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||+|+..++..+|||.+... .....++.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 346678899999999999998877778999998644 2335679999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++... ...+++..++.++.||+.||+|||+. +++|+||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999998432 23689999999999999999999984 999999999999999999999999999986644322
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 219 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLR--------- 219 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCC---------
Confidence 22222345678999999998889999999999999999998 999986432211 1111111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
...+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011112456788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=340.84 Aligned_cols=257 Identities=23% Similarity=0.251 Sum_probs=210.4
Q ss_pred hccccccccCCCceEEEEEeCCC-cEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccce-eec------CCceE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDG-TLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGY-CSE------GSNRL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~~ 575 (839)
..+.++|.+|||+.||.+....+ ..+|+|++-...+...+.+.+|+++|++|+ |+|||.+++. ... .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34578999999999999987665 999999997666777788999999999996 9999999993 221 24678
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
|.||||++|.|-++|.... ...|++.++++|+.|+++|+++||.. .++|||||||-+||||..++..||||||.|.
T Consensus 119 lLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 9999999999999996542 23499999999999999999999985 6789999999999999999999999999997
Q ss_pred ecCCCCcee--E------EeeccccceeCcccc---cCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh
Q 038743 656 LMGREHSQV--V------TMVRGTRGYLAPEWV---SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 656 ~~~~~~~~~--~------~~~~gt~~y~aPE~~---~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 724 (839)
..-...... . -...-|+.|.|||++ .+.++++|+|||+|||+||-|+....||+..+..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 543222111 0 112368999999987 5788999999999999999999999999855432
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCCC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADIN 784 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~~ 784 (839)
.|+.........+....++..||..||+++|.+||++-+|+..+..+...+
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 233444333334577888999999999999999999999999998776543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.59 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=203.6
Q ss_pred HhhccccccccCCCceEEEEEeCC------CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD------GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
..+.+.+.||+|+||.||+|.... ...||+|.+..... ....++.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 355678899999999999997633 25799999864432 23456899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCC-----------cccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHR-----------DRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
++|||+++|+|.+++....... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 9999999999999985432111 15688899999999999999999994 999999999999999999
Q ss_pred ceeecccCcceecCCCCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 645 CPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986533222 12233456788999999998899999999999999999998 999986432211
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
....+..+. ....+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 235 ~~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111111 111223345668889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.10 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=199.0
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||+|+.. +++.||||++.... ......+..|++++..++||||+++++++.+....++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 567789999999999999875 58999999996532 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 83 VPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999983 334688899999999999999999995 999999999999999999999999999986543
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.... ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~--~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYWK--ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhcc--ccccCCC
Confidence 22334689999999999999999999999999999999999999965432111 01110000 0000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...........+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000001223456788888999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.15 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=201.5
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCc-chHHHHHHHHHhhccc-cCCcccccceeecCCc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSN 573 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 573 (839)
...+.+.++||+|+||.||+|+.. .+..||||++...... ....+.+|++++.++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 344567789999999999999752 2347999999654332 2356899999999995 9999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCC----------------------------------------------------------
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYH---------------------------------------------------------- 595 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 595 (839)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998854210
Q ss_pred ---------------------------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC
Q 038743 596 ---------------------------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE 642 (839)
Q Consensus 596 ---------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~ 642 (839)
.....+++..++.++.||++||+|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 0113477888899999999999999984 9999999999999999
Q ss_pred CCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccch
Q 038743 643 NFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 643 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 720 (839)
++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 9999999999998654322211 222346788999999999999999999999999999997 8888864321110
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.......+. ....+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 349 --~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 --FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 011111110 0111122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.98 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=205.0
Q ss_pred HHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
...++.+.+.||+|+||.||+|... +++.||||.++..... ....+.+|++++.+++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 3456778899999999999999763 3478999999765443 35679999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCC---------CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 574 RLLVYEFMKNGSLDKWIFPSY---------HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
.++||||+++++|.++|.... ......+++..+..++.||+.||+|||+. +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 999999999999999985431 12234578899999999999999999984 999999999999999999
Q ss_pred ceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 645 CPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------- 232 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------- 232 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------
Confidence 9999999999865332211 1223345788999999999999999999999999999998 999986433211
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.......+... ..+......+.+++..||+.+|++||++.||++.|+
T Consensus 233 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 VIECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 01111111110 111123355788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.98 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=200.3
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.+.+.||+|+||.||++...++..+|+|.+... .....++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35677899999999999998877788999998643 22345788999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++... ...+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999998432 33688999999999999999999995 8999999999999999999999999999865432222
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ........ ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSAGY---------RL 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHcCC---------cC
Confidence 1122224567999999999999999999999999999998 8888864332110 11111110 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
..+......+.+++.+||+.+|++||+|.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111123456888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.96 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=192.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+++.++||+|+||.||+++. .+|..+|+|++++.... ..+..+.|-.+|....+|+||+|+..|.+.+.+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 34567999999999999965 56999999999876433 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC-
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR- 659 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~- 659 (839)
++||++..+|. +...|++......+.+++-|+.-||+. ++|||||||+|+|||..|++||+||||+.-+..
T Consensus 223 lPGGD~mTLL~-----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 223 LPGGDMMTLLM-----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred cCCccHHHHHH-----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999993 556888888888889999999999996 999999999999999999999999999953311
Q ss_pred ----------------------CCce----e-------------------EEeeccccceeCcccccCCCCCCcccEEeh
Q 038743 660 ----------------------EHSQ----V-------------------VTMVRGTRGYLAPEWVSNRPITVKADVYSY 694 (839)
Q Consensus 660 ----------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~ 694 (839)
+... . ....+|||.|||||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 112469999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 038743 695 GMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS 769 (839)
Q Consensus 695 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt 769 (839)
|||+||||.|.+||......+. ++.+..-+ ..+..........+..++|.+|+. ||++|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQET-------YRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999976543321 12111100 001111111222567788888888 9999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=289.03 Aligned_cols=263 Identities=23% Similarity=0.266 Sum_probs=209.0
Q ss_pred HhhccccccccCCCceEEEEE-eCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC-----ceEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-----NRLL 576 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 576 (839)
..|.+.+.||+|||.-||+++ +.++..+|+|++.-...++.+..++|++..++++|||++++++++..+. +.||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 456778899999999999996 5788999999997666677788999999999999999999999986543 4899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
+++|...|+|.+.+... ..++..+++.+++.|+.+|.+||++||+. .++++||||||.|||+.+.+.++|.|||.+..
T Consensus 101 l~Pyy~~Gsl~d~i~~~-k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERL-KIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EeehhccccHHHHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999998543 23556899999999999999999999995 23599999999999999999999999999976
Q ss_pred cCCCCcee--------EEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 657 MGREHSQV--------VTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 657 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
..-.-... ...-.-|..|.|||.+. +..+++++|||||||+||+|+.|..||+......+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-------- 250 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-------- 250 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--------
Confidence 53211100 11234688899999885 456889999999999999999999999744321110
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
-...+....+...-.....+.+.+++.+|++.||.+||++.+++..++..
T Consensus 251 -----laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 -----LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 00112222222222233667899999999999999999999999988754
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.45 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=172.2
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...+.+.+.||+|+||.||++... ++..||+|.+..... .....+.+|++++.+++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345667789999999999999764 688999999865422 234568999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLK-----EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999984 234688899999999999999999984 3699999999999999999999999999976533
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 21 2234689999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=326.52 Aligned_cols=242 Identities=22% Similarity=0.276 Sum_probs=193.7
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||+|+||.||++.. .+|+.||||+++... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 568999999996532 223356788999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 9999884 345788999999999999999999995 99999999999999999999999999997532221 12
Q ss_pred EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+. .. +
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~------~~----~ 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE------IR----F 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC------CC----C
Confidence 234569999999999999999999999999999999999999996432111 001111110 01 1
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
+......+.+++.+||+.+|++|| ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 112234567888899999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.08 Aligned_cols=241 Identities=21% Similarity=0.262 Sum_probs=191.1
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999764 58899999986432 23345688999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQ-----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 99984 334688999999999999999999995 99999999999999999999999999998643222 1223
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .......+.. ..+.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-------~~~~~~~~~~----------~~~~ 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-------MYRKILQEPL----------RFPD 214 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCC----------CCCC
Confidence 4568999999999999999999999999999999999999996432111 1111111100 1111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.....+.+++.+||+.+|.+||++..+.+.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 2234567888899999999998654444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=320.65 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=198.0
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 567789999999999999874 58899999986432 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+++.|..+.. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 83 EKNMLELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred CCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9987765541 234688899999999999999999985 99999999999999999999999999998764433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc--------chhhhhhhhccC-cc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF--------YPGWAFKEMTNG-TP 732 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~-~~ 732 (839)
........|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ++......+... ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 323334568999999999999899999999999999999999999997543211100 000000000000 00
Q ss_pred cccccccccC------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEG------AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~------~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.....+.... .........+.+++.+|++.+|++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000112345888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=325.55 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=198.2
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 574 (839)
+......|.++||+|.||+|+++.+ .+++.+|||++++.. .+..+..+.|.+++... +||.|+.++.++...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3344556789999999999999977 468899999998754 34455678898888877 599999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+.||++..+. ....+++....-++..|+.||+|||+ ++||+||||-+|||||.+|.+||+||||+
T Consensus 445 ~fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccc
Confidence 9999999999954444 45689999999999999999999999 59999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+..-.. ...+++..||+.|||||++.+..|+..+|.|||||+||||+.|..||.+.++.+.+ ..+.
T Consensus 516 Ke~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-------dsI~------ 581 (694)
T KOG0694|consen 516 KEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-------DSIV------ 581 (694)
T ss_pred cccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHh------
Confidence 864322 22466788999999999999999999999999999999999999999866544321 1110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
.|.. .++.-...+.+.|+.+.+..+|++|..+
T Consensus 582 -~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 -NDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -cCCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0111 1122233456677777899999999987
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.48 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=202.5
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
...+.+.+.||+|+||.||++...++..||+|.+.... .....+.+|+.++.+++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 34567788999999999999998888899999987543 23567999999999999999999999875 45689999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++..+..++.+++.||+|||+. +++||||||+||++++++.++|+|||++..+....
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999998532 234688999999999999999999994 89999999999999999999999999998764433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+ .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~ 220 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERG---------Y 220 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC---------C
Confidence 222222335678999999988899999999999999999999 888886432111 11111110 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
....+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111122334568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.84 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=202.7
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.++||+|+||.||+|...+...||+|+++.. ....+++.+|+.++.+++||||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 457788999999999999998877778999999753 2335678999999999999999999998754 56899999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++... ....+++..+..++.|+++||+|||+ ++++||||||+||++++++.+||+|||+++.+.....
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999432 23467899999999999999999998 4999999999999999999999999999987654332
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~---------~ 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY---------R 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC---------C
Confidence 22223346778999999998899999999999999999999 888885432111 011111100 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+....+.+++.+|++.+|++||++.+++++|++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111223445678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.02 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=205.2
Q ss_pred HHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+...++.+.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4456778889999999999999998889999999987542 33567899999999999999999999864 467899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999988532 345688999999999999999999984 999999999999999999999999999987653
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
..........++..|+|||++....++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~------- 220 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGY------- 220 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCC-------
Confidence 33222223346778999999998889999999999999999999 999996433211 011111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...........+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001111223468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.15 Aligned_cols=245 Identities=23% Similarity=0.281 Sum_probs=196.7
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677889999999999999774 68899999986431 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++. ....+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLR-----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999984 334678888889999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.++..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~------ 232 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL------ 232 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc------
Confidence 322 23468999999999999999999999999999999999999996432110 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~~ 776 (839)
..+......+.+++.+||+.+|.+||+ +++++..
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112234678888999999999996 5666543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=329.86 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=205.0
Q ss_pred cccccccCCCceEEEEEe-CCCc----EEEEEEeccc-CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 507 FAQLLGTGGFGSVYKGSL-GDGT----LVAVKKLDRV-LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
-.++||+|+||+||+|.+ ++|+ +||+|++... ..+...+++.|+-+|.+++||||++|+|+|.... ..||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 356999999999999965 5544 7999998554 3455689999999999999999999999998766 8899999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
|+.|+|.+|+.. .+..+--...+.+..|||+||.|||++ +++||||.++|||+.+-..+||.|||+++.+..+
T Consensus 779 mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999953 455778889999999999999999996 9999999999999999999999999999988665
Q ss_pred CceeE-EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 661 HSQVV-TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 661 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
..... ....-.+.|||-|.+....|+.++|||||||.+||++| |..|++.....+.. +++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHHhc
Confidence 54432 22334678999999999999999999999999999995 88898765433321 11111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+-.-++.....+..++.+||..|+..||+++++...+...
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 111223455667788999999999999999999999887654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.95 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=213.5
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC---Cc--EEEEEEeccc-CCcchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD---GT--LVAVKKLDRV-LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
+..+...+.++||.|.||.||+|.+.+ |+ .||||..+.. .....+.|+.|..+|+.++||||++|+|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 444445567899999999999997632 33 6999999764 34556779999999999999999999999987 56
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++|||.++-|.|..||. .+...|+......++.||..+|+|||+ +.++||||.++|||+...-.+||+|||+
T Consensus 465 ~WivmEL~~~GELr~yLq----~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQ----QNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHH----hccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccch
Confidence 789999999999999994 345678889999999999999999999 5999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHH-hCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
++.+..+.....+...-++.|||||.+..+.++.++|||-|||++|||+ .|..||.+-...+ .
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------V 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------V 601 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------e
Confidence 9998877776666666788999999999999999999999999999998 5899997543221 1
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+...-+...++.++..+..+..+||..+|.+||++.++...|..+
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 112222223345566777888999999999999999999998887543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.40 Aligned_cols=260 Identities=24% Similarity=0.383 Sum_probs=202.0
Q ss_pred HHHhhccccccccCCCceEEEEEe-----CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
....+.+.+.||+|+||.||+|.. ..+..||+|.+..... ....++.+|+.++++++||||+++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 345567789999999999999974 3467899999975332 2335788999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCC------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC
Q 038743 575 LLVYEFMKNGSLDKWIFPSYH------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE 642 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~ 642 (839)
++||||+++++|.+++..... .....+++.+.+.++.|++.||+|||+. +++||||||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999842210 0123578899999999999999999985 9999999999999999
Q ss_pred CCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccch
Q 038743 643 NFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 643 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 720 (839)
++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 999999999999865432221 1223345678999999988889999999999999999998 88888543211
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+....... ...+......+.+++.+|++.+|.+||++.+|.++|..
T Consensus 234 -~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -EVIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 01111111111 01111223457788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=326.86 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=201.1
Q ss_pred HHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeec-CC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE-GS 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~ 572 (839)
...+.+.++||+|+||.||+|.. .+++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34577889999999999999954 2357899999865432 2234678899999999 89999999998864 45
Q ss_pred ceEEEEeeccCCChhhhcccCCCC--------------------------------------------------------
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHH-------------------------------------------------------- 596 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 596 (839)
..+++|||+++++|.++|......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988532110
Q ss_pred CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee-EEeecccccee
Q 038743 597 RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYL 675 (839)
Q Consensus 597 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 675 (839)
....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 013688999999999999999999984 99999999999999999999999999998764322221 23345677899
Q ss_pred CcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHH
Q 038743 676 APEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMK 754 (839)
Q Consensus 676 aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (839)
|||++.+..++.++|||||||++|||++ |+.||......+. .......+.. ...+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCHHHHH
Confidence 9999999999999999999999999997 9999864322111 0011111110 0111223456788
Q ss_pred HHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 755 VAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 755 l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
++.+||+.+|++||++.+|+++|+...
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=323.61 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=199.3
Q ss_pred HHHhhccccccccCCCceEEEEEeC-CCc----EEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG-DGT----LVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
....+...+.||+|+||.||+|.+. +++ .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3445667789999999999999753 343 48999986543 23456789999999999999999999999764 57
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++++||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 84 ~~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 84 QLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 799999999999999843 234688899999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 655 KLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 655 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+.+....... .....++..|+|||++.+..++.++||||||+++|||++ |+.||+.....+ . ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~-~~~~~~~~- 228 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------I-SSILEKGE- 228 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHhCCC-
Confidence 9765433222 122234678999999999999999999999999999997 999986432111 0 01111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+......+.+++.+||+.+|++||++.+++..|....
T Consensus 229 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 229 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011112345778889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=287.78 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=204.3
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...++.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+-..++.+|+++-..|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 34467899999999999999764 57799999996542 233567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||.+.|+|...|.+. ....+++.....++.|+|.||.|+|. +.+|||||||+|+|++.++..||+|||-+-.-.
T Consensus 102 Eya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999532 45678889999999999999999998 699999999999999999999999999987542
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
........||..|.+||+..+..++.+.|+|++|++.||++.|.+||+.....+.+ +++.. .++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY-------krI~k---~~~~~- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY-------KRIRK---VDLKF- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH-------HHHHH---ccccC-
Confidence 23345567999999999999999999999999999999999999999755422211 11111 11111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+......+.+++..|+..+|.+|.+..||++.
T Consensus 242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22334456788889999999999999999764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.38 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=201.8
Q ss_pred HhhccccccccCCCceEEEEEeCC----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+|.... ...||||.++.... ....+|.+|+.++.+++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 345678899999999999997742 45899999865432 2345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.+
T Consensus 84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999843 234789999999999999999999984 9999999999999999999999999999977
Q ss_pred CCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC----
Confidence 5222221 222345678999999999999999999999999999997 998885332111 011111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+......+.+++.+|++.+|++||++.+|+++|+..
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112345678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.73 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=206.3
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...+.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.++.+++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 344567789999999999999642 35679999987655445567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 576 LVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
+||||+++++|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999853210 1224588999999999999999999984 999999999999999999
Q ss_pred ceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 645 CPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 233 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 9999999999765432221 1223446788999999999999999999999999999998 999985432211
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+....+.... ........+.+++.+||+.+|++||++.+|+++|+....
T Consensus 234 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111111 111233467889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.13 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=173.5
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
+....|.+.++||+|+||.||++... +++.+|+|.+..... .....+.+|++++.+++||||+++++++.+....++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34456778899999999999999774 688899998865422 2345689999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++. ....+++.....++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 99999999999984 234578889999999999999999974 37999999999999999999999999999765
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
.... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 155 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 3221 22346899999999999989999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.01 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=193.7
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
++||+|+||.||++.. .+++.||||++.+.. ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 468999999996532 223456888999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|..++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 9998883 345688999999999999999999985 99999999999999999999999999987542221 12
Q ss_pred EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+ +..+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~------~~~~p~-- 216 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILME------DIKFPR-- 216 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccC------CccCCC--
Confidence 2345699999999999999999999999999999999999999964321110 0111000 011111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
.....+.+++.+|++.+|.+|| ++.++++.
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 --TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2234567888899999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=319.51 Aligned_cols=243 Identities=21% Similarity=0.257 Sum_probs=195.3
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 556789999999999999764 68999999985432 12345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 83 VPGGELFSYLR-----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999984 334688899999999999999999995 9999999999999999999999999999865432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......+..
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~-------- 215 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL-------- 215 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc--------
Confidence 1 23458999999999999999999999999999999999999996432211 1111111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~~ 776 (839)
..+......+.+++.+|++.+|.+||+ ++++++.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111112345678888999999999995 7776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.02 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=198.5
Q ss_pred hhccccccccCCCceEEEEEe-----CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec--CCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 576 (839)
.+.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|++++.+++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 455678999999999999974 3578999999876655556688999999999999999999998743 346889
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
|+||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 v~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 85 VMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999842 234589999999999999999999985 999999999999999999999999999987
Q ss_pred cCCCCceeE--EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 657 MGREHSQVV--TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 657 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
......... ....++..|+|||.+.+..++.++||||||+++|||++|..++.......................+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 643322111 112234569999999988999999999999999999998876532211000000000000000000001
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.+...............+.+++.+||+.+|++||||.+|++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111122335688899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=304.85 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=208.2
Q ss_pred HHHhhccccccccCCCceEEEEE-eCCCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
....|+|.+.||+|.||.|-++. ...|+.||||.+++.... +...+++|+++|..|+||||+.++.+|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34567888999999999999995 478999999999765433 34467899999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||..+|.|.+|+ .....|++.+..+++.||..|+.|+|. ++++|||||.+|||||+++++||+||||+-+
T Consensus 131 vMEYaS~GeLYDYi-----Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYI-----SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHH-----HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999 456789999999999999999999998 5999999999999999999999999999988
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
+... .....++|.+.|.+||++.+.+| ....|-|||||+||.|+.|.-||++.+... ..+++..|...
T Consensus 203 y~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYr-- 271 (668)
T KOG0611|consen 203 YADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYR-- 271 (668)
T ss_pred hccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhccccc--
Confidence 7432 23456789999999999999998 478999999999999999999998654321 11122222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.++.+....-++.|++-.+|++|.|+.+|...-
T Consensus 272 ---------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ---------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122334456788999999999999999998864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.62 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=197.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcc-hHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChh
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
++||+|+||.||+|...+++.+|+|.+....... ...+.+|++++.+++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998889999999987554322 346889999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEe
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM 667 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 667 (839)
+++.. ....+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRK----KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 98842 234578999999999999999999984 99999999999999999999999999997643322222222
Q ss_pred eccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
..++..|+|||++.+..++.++||||||+++||+++ |..||....... .......+. ....+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGY---------RMSCPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---------CCCCCC
Confidence 334677999999998999999999999999999998 998986432111 111111110 011112
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.....+.+++.+|++.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.44 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=199.2
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC--CcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD--GTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++..++||||+++++++.++...
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 445567788999999999999997533 3689999985432 22345688999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 107 ~lv~Ey~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLR-----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 99999999999999984 335688999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 179 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~-- 245 (340)
T PTZ00426 179 KVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII-- 245 (340)
T ss_pred eecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC--
Confidence 876432 23356999999999999988999999999999999999999999643221 11111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
.+.... ...+.+++.+|++.+|.+|+ +++++++.
T Consensus 246 ----~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011112 23456788889999999995 88888765
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.14 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=204.8
Q ss_pred HHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...+.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.++.+++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 34566778999999999999974 234579999987654455667999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCC--------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 576 LVYEFMKNGSLDKWIFPSYH--------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
+||||+++++|.++|..... .....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999853211 1223589999999999999999999985 999999999999999999999
Q ss_pred ecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhh
Q 038743 648 VSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 648 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 725 (839)
|+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 9999999865332211 1223345778999999999999999999999999999998 898886432211 111
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+.... ... .....+.+++.+|++.+|.+||++.+|++.|+...
T Consensus 234 ~i~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111110 111 12345788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.52 Aligned_cols=265 Identities=22% Similarity=0.390 Sum_probs=203.4
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCcc-hHHHHHHHHHhhccc-cCCcccccceee
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMH-HMNLVRLCGYCS 569 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~g~~~ 569 (839)
.++....+.+.++||+|+||.||+|++. .++.||||+++...... ...+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3444555667789999999999999753 34689999997543332 346889999999997 999999999999
Q ss_pred cCCceEEEEeeccCCChhhhcccCCC------------------------------------------------------
Q 038743 570 EGSNRLLVYEFMKNGSLDKWIFPSYH------------------------------------------------------ 595 (839)
Q Consensus 570 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 595 (839)
.....++|+||+++|+|.++|+....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999864311
Q ss_pred ---------------------------------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCC
Q 038743 596 ---------------------------------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPE 636 (839)
Q Consensus 596 ---------------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~ 636 (839)
.....+++..++.++.||+.||+|||+ ++++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence 011346778889999999999999998 49999999999
Q ss_pred cEEECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCC
Q 038743 637 NILLDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDA 714 (839)
Q Consensus 637 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~ 714 (839)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999865332211 1122346788999999998889999999999999999998 88888543211
Q ss_pred CCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 715 EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+. ....+..+. ....+......+.+++..||+.+|.+||+|++|++.|+..
T Consensus 349 ~~------~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQ------FYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH------HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 10 011111110 0111112235677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.68 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=199.4
Q ss_pred ccccccccCCCceEEEEEe-----CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecC--CceEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLV 577 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 577 (839)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678999999999988653 4578999999865432 3456788999999999999999999988653 457899
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~~~l~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 87 MEYVPLGSLRDYLP------KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ecCCCCCCHHHHHH------HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999983 23589999999999999999999984 9999999999999999999999999999876
Q ss_pred CCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... .....++..|+|||.+....++.++||||||++++||++|+.|+......... ...............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhh
Confidence 4322211 11223566799999999888999999999999999999999998543211000 00000000000111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
++.......+......+.+++..||+.+|++||+|++|+++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222111122223345688889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.46 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=193.9
Q ss_pred ccccCCCceEEEEEe---CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 510 LLGTGGFGSVYKGSL---GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
.||+|+||.||+|.+ .+++.+|+|+++.... ...+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 3578999999864432 23457899999999999999999999885 45678999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||.||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999983 334688999999999999999999985 89999999999999999999999999998765433221
Q ss_pred E--EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 665 V--TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 665 ~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~--------- 216 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGER--------- 216 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC---------
Confidence 1 12234578999999988889999999999999999998 999996432211 0111111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+......+.+++.+||+.+|++||+|.+|++.|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11112233457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.07 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=194.5
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999976 4789999998864432 3345789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee-E
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV-V 665 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~ 665 (839)
.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.......... .
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999842 234688999999999999999999985 99999999999999999999999999997643221111 1
Q ss_pred EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
.....+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ...... .......
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~---------~~~~~~~ 217 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIE---------QGVRLPC 217 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHH---------cCCCCCC
Confidence 11123467999999999999999999999999999997 888885322110 001110 0011111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
+......+.+++.+|++.+|++||++.+|+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2223456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.43 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=200.7
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||++....+..+|+|.+... ....+.+.+|++++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 446777899999999999999877778999988643 233467889999999999999999998875 456889999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999532 234578999999999999999999985 899999999999999999999999999987643322
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......+ ..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~ 221 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERG---------YR 221 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------CC
Confidence 22223346678999999998899999999999999999999 898886432211 01111111 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122234567888899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.66 Aligned_cols=241 Identities=24% Similarity=0.281 Sum_probs=192.2
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999976 468999999996532 223346778999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 151 (323)
T cd05595 81 ELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence 9988883 345689999999999999999999985 99999999999999999999999999987532221 12
Q ss_pred EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+. ..+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~~~~~~------~~~p~-- 216 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEE------IRFPR-- 216 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCC------CCCCC--
Confidence 2335689999999999999999999999999999999999999964322110 01110000 01111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
.....+.+++.+||+.+|.+|| ++.++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2234567888889999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=338.65 Aligned_cols=251 Identities=20% Similarity=0.241 Sum_probs=199.2
Q ss_pred hccccccccCCCceEEEEEeC-C-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-D-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 677889999999999999653 3 67899997754433444567889999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.++|.... .....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 149 GGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999885321 2334688889999999999999999995 999999999999999999999999999987654322
Q ss_pred e-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 Q-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+.. .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~----~---- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKY----D---- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC----C----
Confidence 1 2334569999999999999999999999999999999999999996432111 0111111110 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122345778889999999999999999865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.46 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=200.2
Q ss_pred HHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
....+.+.+.||+|+||.||+|... .+..||||++..... ....++.+|+.++..++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455777889999999999999652 356899999864322 234568899999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCC-----CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHH-----RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
.++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998532111 123467888999999999999999984 9999999999999999999999
Q ss_pred cccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhh
Q 038743 649 SDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 649 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999997653322211 112345778999999999999999999999999999998 688885432111 0111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
..+.... ..+......+.+++.+|++.+|++||++.|++++|++
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 0111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.55 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=189.0
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||++.. .+++.||+|++++.. ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999976 467899999997542 22334577888888776 899999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 99988873 335688999999999999999999995 999999999999999999999999999975322211
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCC--ccchhhhhhhhccCccccccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED--FFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+..+.......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------
Confidence 22345689999999999999999999999999999999999999964322111 1111111121111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
.++......+.+++.+||+.+|++||+.
T Consensus 223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122223456788889999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.25 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=189.3
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.++||+|+||.||+++. .+++.||||++..... .....+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 4567899999999999976 4689999999864322 2345689999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 157 GSLEGTH---------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9986533 345677889999999999999995 999999999999999999999999999987643221
Q ss_pred eEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||....... |...... +. .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~------~~-~ 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCA------IC-M 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHH------Hh-c
Confidence 1233468999999998743 234568999999999999999999997322111 1000000 00 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.............+.+++.+||+.+|++||++.||++.
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112234457888899999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.68 Aligned_cols=254 Identities=19% Similarity=0.240 Sum_probs=197.5
Q ss_pred HHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
....+.+.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456777889999999999999764 68899999986421 2233457889999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++|+|.+++. ...++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999883 23577888888999999999999995 999999999999999999999999999987
Q ss_pred cCCCCceeEEeeccccceeCcccccCC----CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNR----PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~ 264 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKN 264 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCC
Confidence 644332223345699999999998653 47899999999999999999999997433211 1111111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFM--RPSMGEVVKM 776 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~~v~~~ 776 (839)
.+...........+.+++..|++.+|.+ ||++.++++.
T Consensus 265 ------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000001112345677888899988987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.53 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=196.2
Q ss_pred hhccccccccCCCceEEEEEeC-CCc----EEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGT----LVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
.+.+.+.||+|+||.||+|... +++ .+++|.+..... ....++..|+..++++.||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4456689999999999999763 444 478888754322 223567888889999999999999998864 557889
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
+||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 87 TQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999942 235689999999999999999999984 8999999999999999999999999999876
Q ss_pred CCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . .+.+..+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~--~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGER--L 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCc--C
Confidence 433221 2233457788999999999999999999999999999998 999986432211 0 011111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+. .....+.+++.+|+..+|++||++.|+++.|.....
T Consensus 231 ~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0111 112346778889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.65 Aligned_cols=263 Identities=20% Similarity=0.252 Sum_probs=194.7
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.++||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 466778999999999999976 468899999986432 223456789999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 86 DS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred Cc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 75 89888732 234578889999999999999999995 99999999999999999999999999998653222
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh--------hhhhhhcc-Cc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG--------WAFKEMTN-GT 731 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~ 731 (839)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...... ..+..... ..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1 1223457899999998865 568999999999999999999999996543221110000 00000000 00
Q ss_pred ccccccccccCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 PLKVADRRLEGAV----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 ~~~~~~~~l~~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......+...... .......+.+++.+|++.+|.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001111100000 0011235678899999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.08 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=198.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||++... +++.||||++.... ......+..|++++..++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 3567789999999999999774 68999999986432 2334568899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 82 YMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999842 25788999999999999999999994 999999999999999999999999999987644
Q ss_pred CC----------------------------ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 660 EH----------------------------SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 660 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11123356899999999999999999999999999999999999999754
Q ss_pred CCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 038743 712 GDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-MGEVVKM 776 (839)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-~~~v~~~ 776 (839)
.... ....+.... ..+...........+.+++..|++ +|.+||+ +.++++.
T Consensus 234 ~~~~-------~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE-------TYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH-------HHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3211 011111000 000000000123456677788997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.02 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=190.8
Q ss_pred hhccccccccCCCceEEEEEe--CCCcEEEEEEecccCC--cchHHHHHHHHHhhcc---ccCCcccccceee-----cC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL--GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSM---HHMNLVRLCGYCS-----EG 571 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~ 571 (839)
.|.+.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++..+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 356778999999999999976 3468899999864322 2234566777776665 6999999999885 34
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||++ ++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 56899999996 6898888432 234588999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-----hh
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF-----KE 726 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~ 726 (839)
|+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....+.+......... ..
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 999876433 22334568999999999998899999999999999999999999997654321110000000 00
Q ss_pred hccC--cccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 727 MTNG--TPLKVADRRLEG---AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 727 ~~~~--~~~~~~~~~l~~---~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+... ............ .........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000000000000 000112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.34 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=201.3
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCcc-hHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.+.+.||+|+||.||+|... +++.||||+++...... ...+..|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 345667789999999999999763 25789999997543322 35688999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCC-----------CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC
Q 038743 575 LLVYEFMKNGSLDKWIFPSY-----------HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN 643 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~ 643 (839)
++++||+++++|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||.|||++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999984211 11224578888999999999999999985 99999999999999999
Q ss_pred CceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchh
Q 038743 644 FCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPG 721 (839)
Q Consensus 644 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 721 (839)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 99999999999865432221 1233446789999999988889999999999999999998 887875432111
Q ss_pred hhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 722 WAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.......+.. ...+......+.+++..|++.+|++||++.+|+..|+.
T Consensus 235 -~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -VIEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 01122234457788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.58 Aligned_cols=251 Identities=21% Similarity=0.269 Sum_probs=195.4
Q ss_pred hccccccccCCCceEEEEEe----CCCcEEEEEEecccC----CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (839)
+.+.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+..|+.++.++ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45678999999999999865 368899999986431 12234578899999999 5999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 82 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 82 LILDYVSGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999884 335688999999999999999999985 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.+............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK----- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc-----
Confidence 6544333333445699999999999875 4789999999999999999999999644322110 001111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
.++.+ +......+.+++.+|++.+|++|| +++++++.
T Consensus 226 -~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111 112234567788899999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.25 Aligned_cols=192 Identities=23% Similarity=0.266 Sum_probs=166.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 466788999999999999965 568999999753 2357899999999999999999999999999999999985
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
++|..++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 -~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 167 -TDLYCYLA-----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred -CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 68888773 334688999999999999999999995 999999999999999999999999999976433322
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+-.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 233445799999999999999999999999999999999999988743
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=318.04 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=192.9
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||.||++... +++.||||++++.. ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999764 68899999997532 22234578899999888 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 99998883 335789999999999999999999985 99999999999999999999999999987432211 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCC--CccchhhhhhhhccCccccccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE--DFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ......+..+....... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~- 224 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC-
Confidence 2234568999999999999999999999999999999999999997433221 11111111221111110 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPS------MGEVVK 775 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt------~~~v~~ 775 (839)
+......+.+++.+|++.+|.+||+ +.++++
T Consensus 225 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 ---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122345678888999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.88 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=191.6
Q ss_pred cccccCCCceEEEEEe----CCCcEEEEEEecccC----CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.||+|+||.||+++. .+++.||||+++... ......+..|+.++..++||||+++++++..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999986431 12234578899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+.+.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999883 334677888888999999999999995 9999999999999999999999999999754322
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .......+..
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~-------- 217 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL-------- 217 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 21 2233568999999999999889999999999999999999999996432211 1111111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
..+......+.+++.+|++.+|++|| ++.++++
T Consensus 218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234567888999999999999 7887766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.08 Aligned_cols=243 Identities=22% Similarity=0.282 Sum_probs=193.1
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||+|+||.||++.. .+++.||+|++.... .....++..|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 578999999996532 223356788999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|..++. ....+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9998883 345789999999999999999999973 4899999999999999999999999999875432221 2
Q ss_pred EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+. ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~------~~~p~~- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEE------IRFPRT- 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCC------CCCCCC-
Confidence 2334699999999999999999999999999999999999999964322110 01110000 011111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
....+.+++.+|++.+|++|+ ++.++++.
T Consensus 219 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 ---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 233467788889999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.21 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=194.1
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
...+.+.+.||+|+||.||+++.. +++.+|+|.+.+.. ......+.+|+.++..++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 345677889999999999999774 58899999986421 22334578899999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++. ...+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++...
T Consensus 122 ~Ey~~gg~L~~~l~------~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 122 MEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999883 23578888999999999999999995 9999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCC----CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNR----PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+....
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------~~~i~~~~-- 263 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------YSKIMDHK-- 263 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC--
Confidence 54333233455699999999998754 378999999999999999999999964332110 11111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVF--MRPSMGEVVKM 776 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~--~RPt~~~v~~~ 776 (839)
..+...........+.+++..|++..+. .||++.++++.
T Consensus 264 ----~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 ----NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000001112233455666778875554 38899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.80 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=202.7
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
...+.+.+.||+|+||.||++... ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 344567789999999999999763 23689999986532 22345688999999999 89999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCC-----------CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC
Q 038743 574 RLLVYEFMKNGSLDKWIFPSY-----------HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE 642 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~ 642 (839)
.+++|||+++|+|..++.... ......+++..++.++.||+.||+|||+ ++|+||||||+|||+++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 999999999999999985321 0234578999999999999999999998 49999999999999999
Q ss_pred CCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccch
Q 038743 643 NFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 643 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 720 (839)
++.+||+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----- 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-----
Confidence 9999999999998764432211 222335678999999999999999999999999999997 888875322111
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+....+. ....+......+.+++.+|++.+|++||||.++++.|+..
T Consensus 243 --~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 --LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111111 1111223345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=309.28 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=198.6
Q ss_pred ccccccccCCCceEEEEEeCC----CcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCc------
Q 038743 506 NFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN------ 573 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 573 (839)
.+.+.||+|+||.||+|.... +..||+|+++... .....++.+|++.+..++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456889999999999997632 3689999986432 2234578999999999999999999998866554
Q ss_pred eEEEEeeccCCChhhhcccCCC-CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYH-HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
.++++||+++|+|..++..... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 7999999999999998854321 1234688999999999999999999985 99999999999999999999999999
Q ss_pred cceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 653 LAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 653 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
+++.+....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC
Confidence 998764332221 122335678999999998999999999999999999999 888885432211 01111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.. ...+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 011223345688889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.77 Aligned_cols=262 Identities=18% Similarity=0.198 Sum_probs=193.6
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcc--hHHHHHHHHHhhccccCCcccccceee--cCCceEEEEee
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHG--EKEFVTEVNTIGSMHHMNLVRLCGYCS--EGSNRLLVYEF 580 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~ 580 (839)
...+.|++|.||.||+|+. .+++.||+|+++-..... .-...+|+.+|.+++|||||.+-.+.. +-+..||||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 3456899999999999966 578999999996432111 124689999999999999999988764 34579999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
|+. +|..+|.. ..+.+...+..-+..|+++||+|||. +.|+|||||++|+|+...|.+||+|||||+.++..
T Consensus 159 ~Eh-DLksl~d~----m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 159 VEH-DLKSLMET----MKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHh-hHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 987 88888843 34688899999999999999999999 49999999999999999999999999999998765
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh----hhhhhccC----c
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW----AFKEMTNG----T 731 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~----~~~~~~~~----~ 731 (839)
. ...+..+-|..|.|||++.+ ..|+...|+||+|||+.||+++++.|.+.........+.. +.+....+ .
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 23455567999999999887 5699999999999999999999999876654322111000 00000000 0
Q ss_pred ------ccccccccccCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 ------PLKVADRRLEGAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ------~~~~~~~~l~~~~~~~-~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.....-..++..+... ..+.-.++....+..||.+|-|+++.++.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000001111111111 12334456666899999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.11 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=208.0
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccceeecCCc-eEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN-RLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~ 578 (839)
..|...+++|+|+||.++..+.+ ++..+++|.+.-. .....+....|+.++++++|||||.+.+.+.+.+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 34667789999999999999763 5789999998533 23334468899999999999999999999998888 99999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
+|++||+|.+.|... ++..+.+..+.+++.||+.|+.|||+ +.|+|||||+.|||++.+..+||+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999543 46788999999999999999999997 699999999999999999999999999999987
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.+... ...+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|....... .+.+ +...
T Consensus 158 ~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~k---------i~~~ 221 (426)
T KOG0589|consen 158 PEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILK---------INRG 221 (426)
T ss_pred Cchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHH---------Hhhc
Confidence 76532 345679999999999999999999999999999999999999997543221 1111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.....+......+..++..|++.+|..||++.+++.+
T Consensus 222 -~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 -LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223444556667788888999999999999999876
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=306.97 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=203.7
Q ss_pred HHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+..+.+.+.+.||+|+||.||++...++..+|+|.+... ......+.+|++++++++|+||+++.+++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345567788999999999999999878888999988643 2234678999999999999999999999887 77899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999998432 345678899999999999999999984 999999999999999999999999999986643
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
..........++..|+|||++....++.++||||||+++||+++ |+.||....... ....+..+..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~------ 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYR------ 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCC------
Confidence 32222223345678999999998889999999999999999998 899986432111 0111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
..........+.+++.+|++.+|++||++.+|+++|+.
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112233467888999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.42 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=201.2
Q ss_pred HhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
..+.+.++||+|+||.||++... ++..+|+|.+..........+.+|++++.+++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34456789999999999999642 356899999876655556789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCC----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCce
Q 038743 577 VYEFMKNGSLDKWIFPSYH----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
+|||+++++|.+++..... .....+++..++.++.||+.||+|||+. +++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999853211 1113588999999999999999999985 99999999999999999999
Q ss_pred eecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhh
Q 038743 647 KVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 647 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 724 (839)
||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------I 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------H
Confidence 999999998654322211 122335678999999999999999999999999999998 8988853322110 0
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.....+.. ...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111100 00111223457788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=307.75 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=205.2
Q ss_pred HHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
....+.+.++||+|+||.||++...+++.||||.+... ....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34556778899999999999999888889999998754 33456799999999999999999999999998999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999532 335689999999999999999999984 8999999999999999999999999999876532
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.........++..|+|||.+.+..++.++||||||++++|+++ |+.||....... .......+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~--------- 220 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERG--------- 220 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------
Confidence 2222222334568999999998899999999999999999998 999985432111 11111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.....+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001111224467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.15 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=193.3
Q ss_pred ccccCCCceEEEEEeC---CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCC
Q 038743 510 LLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
.||+|+||.||+|.+. .+..||+|++..... ...+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 355799999865432 22456899999999999999999999885 457899999999999
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeE
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 665 (839)
|.+++.. ....+++..+++++.||+.||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9999842 234689999999999999999999985 999999999999999999999999999986543322211
Q ss_pred --EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 666 --TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 666 --~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
....++..|+|||.+....++.++||||||+++||+++ |+.||....... ....+..+. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 217 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGK---------RL 217 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC---------CC
Confidence 11223578999999988889999999999999999996 999986432211 011111111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+......+.+++..||+.+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12223345677888899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=324.79 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=190.6
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++.+++||||+++++++.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 45667899999999999965 568899999996432 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 83 IPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999984 334678888889999999999999995 9999999999999999999999999998643211
Q ss_pred Cce----------------------------------------------eEEeeccccceeCcccccCCCCCCcccEEeh
Q 038743 661 HSQ----------------------------------------------VVTMVRGTRGYLAPEWVSNRPITVKADVYSY 694 (839)
Q Consensus 661 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~ 694 (839)
... ......||+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 0123469999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHh--ccccCCCCCCCHHH
Q 038743 695 GMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFW--CIQDEVFMRPSMGE 772 (839)
Q Consensus 695 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~--Cl~~~p~~RPt~~~ 772 (839)
||++|||++|+.||......+.. ...........+ + ....++.+ +.+++.+ |+..++..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~--~-~~~~~s~~----~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHI--P-PQVKLSPE----AVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHccccccCC--C-CCCCCCHH----HHHHHHHHccCcccccCCCCHHH
Confidence 99999999999999644321110 000000000000 0 00112333 3344433 66778888999999
Q ss_pred HHHH
Q 038743 773 VVKM 776 (839)
Q Consensus 773 v~~~ 776 (839)
++..
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.79 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=200.4
Q ss_pred hhccccccccCCCceEEEEEeC-CC---cEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DG---TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+...+.||+|+||.||+|... ++ ..+|+|.++... .....++..|++++.+++||||+++.+++......++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4556789999999999999874 23 379999986543 233457899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 86 EYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999842 235688999999999999999999985 89999999999999999999999999998764
Q ss_pred CCCceeEE--eeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 659 REHSQVVT--MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 659 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
........ ....+..|+|||++....++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~---- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF---- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC----
Confidence 33222211 1223467999999998889999999999999999997 999985432111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...........+.+++.+|++.+|++||+|.+|++.|++.
T Consensus 228 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111112345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.68 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=200.3
Q ss_pred hccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
+.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.++..++||||+++++.+......+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 345688999999999999652 235799998865432 2345688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCC-------------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 578 YEFMKNGSLDKWIFPSYH-------------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
+||+++|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 999999999998753211 1224588999999999999999999984 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAED 716 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 716 (839)
|+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~- 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER- 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 99999999999999998653322211 222345678999999988889999999999999999998 999885432111
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.+...... .....+......+.+++.+|++.+|++||++.++++.|++..
T Consensus 238 ------~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 ------LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111111 111111223346788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=316.41 Aligned_cols=240 Identities=23% Similarity=0.309 Sum_probs=187.2
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||+|... +++.||||+++... ......+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 57899999986532 22234456677776654 899999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 99998883 234688899999999999999999995 99999999999999999999999999998643222 2
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+.... + .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~------~----~ 214 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDR------P----H 214 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------C----C
Confidence 2334568999999999999999999999999999999999999997443211 011111100 1 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMG-EVV 774 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-~v~ 774 (839)
.+......+.+++.+||+.+|.+||++. +++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111233456788889999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=316.90 Aligned_cols=237 Identities=25% Similarity=0.345 Sum_probs=185.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHH-HhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVN-TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||.||+++. .+++.||+|++.+.. .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999977 468899999986432 122334555554 57788999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+....+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 99988873 335678888889999999999999984 99999999999999999999999999987532221 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ .+ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~--------~~--~ 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHK--------PL--Q 214 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcC--------CC--C
Confidence 2234568999999999999999999999999999999999999996432111 01111111 00 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMG 771 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~ 771 (839)
.+......+.+++.+|++.+|.+||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1222344577889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.44 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=190.2
Q ss_pred cccccCCCceEEEEEeCC---CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSLGD---GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 45799998865432 23457889999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|.++|..........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999543222334567778889999999999999984 99999999999999999999999999997543322211
Q ss_pred -EEeeccccceeCcccccCC-------CCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 665 -VTMVRGTRGYLAPEWVSNR-------PITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 665 -~~~~~gt~~y~aPE~~~~~-------~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+.. .....+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-------TYTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-------HHHhhcccCCC
Confidence 1234467889999988642 35789999999999999996 99999643221110 00000111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.++.+... ....+.+++..|+ .+|++||++.+|+..|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 1223556667798 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.01 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=195.9
Q ss_pred cccccccCCCceEEEEEeCCC-c--EEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------CceE
Q 038743 507 FAQLLGTGGFGSVYKGSLGDG-T--LVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNRL 575 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 575 (839)
+.++||+|+||.||+|...+. + .||+|.++... ......+.+|++++..++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 567899999999999987543 2 69999886532 23345788999999999999999999987432 3568
Q ss_pred EEEeeccCCChhhhcccCC-CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 576 LVYEFMKNGSLDKWIFPSY-HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++|||+++|+|.+++.... ......+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999874321 12335688999999999999999999984 9999999999999999999999999999
Q ss_pred eecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 655 KLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 655 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+.+....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 8764332211 122345678999999999999999999999999999999 788886432211 1111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.. ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 1112234578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=308.16 Aligned_cols=255 Identities=25% Similarity=0.469 Sum_probs=199.3
Q ss_pred HhhccccccccCCCceEEEEEeCC-C---cEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD-G---TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+|.... + ..||||.+.... .....+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 456778999999999999997643 3 369999987542 23346799999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999842 234688999999999999999999985 9999999999999999999999999999865
Q ss_pred CCCCcee--EEeec--cccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 658 GREHSQV--VTMVR--GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 658 ~~~~~~~--~~~~~--gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
....... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||....... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~-- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQD-- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC--
Confidence 4322211 11111 2457999999999999999999999999999886 999986432111 00111000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+.+....+.+++..||+.+|++||+|.+|+.+|+..
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011112234577889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.01 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=188.6
Q ss_pred ccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC-----ceEEEEeec
Q 038743 508 AQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-----NRLLVYEFM 581 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~e~~ 581 (839)
.+++|.|+||.||+|.+. +++.||||+.-... +.--+|+.+|+.+.|||||+|+-++.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 468999999999999874 47899999874332 23347899999999999999998885432 345899999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-CceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~~~~~~ 660 (839)
|. +|..++..- ...+..++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus 105 P~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 87 888888431 12345677777888999999999999995 99999999999999965 99999999999988655
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh-----hhhhccCcc--
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA-----FKEMTNGTP-- 732 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~-- 732 (839)
..... ..-|+-|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+...........-+ .+.+.....
T Consensus 180 epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 44432 235788999999887 57999999999999999999999999765432211000000 011111110
Q ss_pred cccccccccC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 733 LKVADRRLEG-----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 733 ~~~~~~~l~~-----~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+...+.+.. -.........++++.++++.+|.+|.++.|++..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111111111 1222344567888889999999999999988754
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=315.87 Aligned_cols=242 Identities=22% Similarity=0.281 Sum_probs=191.1
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||.||+|+.. +++.||||++.... ......+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999764 57899999986532 22334577888888866 899999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 151 (321)
T cd05591 81 GDLMFQIQ-----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-V 151 (321)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-c
Confidence 99998883 335688999999999999999999995 99999999999999999999999999997543222 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~------~---- 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV------L---- 214 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC------C----
Confidence 2234568999999999999999999999999999999999999997443211 1111111110 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRP-------SMGEVVKM 776 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RP-------t~~~v~~~ 776 (839)
.+......+.+++..|++.+|++|| ++.++++.
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111224567788889999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.88 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=201.1
Q ss_pred HhhccccccccCCCceEEEEEeCC-----------------CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD-----------------GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRL 564 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 564 (839)
..+.+.+.||+|+||.||++...+ +..||+|.+..... ....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 456778999999999999987642 24689999865432 335678899999999999999999
Q ss_pred cceeecCCceEEEEeeccCCChhhhcccCCCC------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHH------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 565 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
++++......++++||+++++|.++|...... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 99999999999999999999999998543211 223689999999999999999999985 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh--CCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG--GRRNLDMSGDAE 715 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 715 (839)
+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999999999865432221 2233446788999999998889999999999999999998 667775322111
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
. ............. ......+......+.+++.+|++.+|++||+|.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 V---IENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 0 0000000000000 0000111122356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.05 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=200.5
Q ss_pred HhhccccccccCCCceEEEEEeC----CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+|... .+..+|+|.++.... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667889999999999999763 234799999865332 2345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||++..+
T Consensus 84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999842 234688999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCceeEEe--eccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 658 GREHSQVVTM--VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 658 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.......... ..++..|+|||++.+..++.++||||||+++||+++ |+.||......+. .....++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~~~~~--- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-------IKAIEEGY--- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-------HHHHhCCC---
Confidence 5433222221 223568999999999899999999999999999886 9999864322110 11111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...........+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011112234577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.85 Aligned_cols=265 Identities=20% Similarity=0.323 Sum_probs=198.4
Q ss_pred HHhhccccccccCCCceEEEEEeCC---------------CcEEEEEEecccC-CcchHHHHHHHHHhhccccCCccccc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD---------------GTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLC 565 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 565 (839)
...+.+.+.||+|+||.||++.... ...||+|.++... ......+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4466778899999999999986532 2358999986542 22345689999999999999999999
Q ss_pred ceeecCCceEEEEeeccCCChhhhcccCCC-------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYH-------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 566 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
+++......++||||+++++|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999843210 1112468889999999999999999985 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh--CCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG--GRRNLDMSGDAE 715 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 715 (839)
++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765332211 1222345778999999998899999999999999999998 556665332211
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
. .....+..... ........+......+.+++.+|++.+|++||+|.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V---IENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0 00000000000 000000111122357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.88 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=190.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||++.. .+++.||+|++++... ...+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999976 4578999999975422 2234578899998888 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 81 GDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 99998873 335689999999999999999999995 99999999999999999999999999997532211 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.............+..+....... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~--- 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI--- 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC---
Confidence 233456999999999999999999999999999999999999999654332222112222222211110 11
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
+......+.+++.+|++.+|.+||++
T Consensus 223 -p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 -PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11123446788888999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.82 Aligned_cols=251 Identities=20% Similarity=0.235 Sum_probs=196.5
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||+||++.. .+++.||+|+++.... ...+.+.+|+.++..++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 56778999999999999976 4689999999965322 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~~~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 83 QPGGDLLSLLNR----YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999842 234688999999999999999999995 9999999999999999999999999999876544
Q ss_pred CceeEEeeccccceeCccccc------CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVS------NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+.... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~--~ 226 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQ--R 226 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCC--C
Confidence 433334456899999999986 4567899999999999999999999996433211 011111100 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
... ..........+.+++..|++ +|.+||++.++++.
T Consensus 227 ~~~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLK----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccC----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 00011123345667777897 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.02 Aligned_cols=238 Identities=25% Similarity=0.308 Sum_probs=190.3
Q ss_pred cccccCCCceEEEEEe----CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++.+++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3688999999965321 223457789999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999883 334689999999999999999999995 999999999999999999999999999986543222
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~---------- 215 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL---------- 215 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC----------
Confidence 2334568999999999999889999999999999999999999996432111 0111111110
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGE 772 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~ 772 (839)
..+......+.+++.+||+.+|++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111122345667888899999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=333.92 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=199.0
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC-------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------- 572 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 572 (839)
..|.+.+.||+|+||+||+++. .+++.||||++.... ......+.+|+..+..++|+||+++...+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4677889999999999999965 578999999986432 233456889999999999999999887765432
Q ss_pred -ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 573 -NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 573 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
..++||||+++|+|.++|.... .....+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence 3679999999999999985432 2345788999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 652 GLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 652 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
|+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......+
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~~~~~~~ 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VMHKTLAG 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhcC
Confidence 999876433222 2234569999999999999999999999999999999999999996432111 11111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. + ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 261 ~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 0 1112233457788889999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=322.87 Aligned_cols=263 Identities=20% Similarity=0.281 Sum_probs=192.6
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC-----CceEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRLL 576 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 576 (839)
|.+.++||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 55678999999999999975 468999999986432 22345688999999999999999999987543 34799
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+. ++|.+++. ....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 v~e~~~-~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 82 VFELME-SDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEecCC-CCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999995 68988883 334689999999999999999999995 999999999999999999999999999986
Q ss_pred cCCCCce--eEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhh
Q 038743 657 MGREHSQ--VVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAF 724 (839)
Q Consensus 657 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~ 724 (839)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... +....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4322211 1234568999999999876 6789999999999999999999999965432110000 00000
Q ss_pred hhhccCcccccc---cccccCCCC---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 KEMTNGTPLKVA---DRRLEGAVE---EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ~~~~~~~~~~~~---~~~l~~~~~---~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+........+ .+....... ......+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 000000000 0112356788999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=313.18 Aligned_cols=262 Identities=25% Similarity=0.398 Sum_probs=200.0
Q ss_pred hhccccccccCCCceEEEEEeCC-Cc--EEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGD-GT--LVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+.+.+.||+|+||.||+|...+ +. .+++|.++... ....+.+.+|+.++.++ +||||+++++++.+....++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35677899999999999997743 33 57888886432 23345788999999999 7999999999999999999999
Q ss_pred eeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 579 EFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
||+++++|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence 99999999999854211 1123588899999999999999999984 999999999999999999999
Q ss_pred ecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhh
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
|+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 160 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~~ 230 (297)
T cd05089 160 IADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYEK 230 (297)
T ss_pred ECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999998643211 11111223567999999999899999999999999999997 999986432111 1111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCCCCC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTP 786 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~~~p 786 (839)
...+ .....+......+.+++.+|++.+|.+||++.++++.|+.......+
T Consensus 231 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 LPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 01111112234577899999999999999999999999876654433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=313.93 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=205.9
Q ss_pred ccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChhh
Q 038743 510 LLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDK 588 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 588 (839)
+||+|.||+||-|+. .+...+|||-+.........-+..|+.+-++|+|.|||+++|.|.++...-+.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 899999999999965 4566899999976655556678999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCcccC--ChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCceeecccCcceecCCCCceeE
Q 038743 589 WIFPSYHHRDRVL--DWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQVV 665 (839)
Q Consensus 589 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~ 665 (839)
+|... =.++ ++.++-.+..||++||.|||+ +.|+|||||-.||||+ -.|.+||+|||-++.+..-. ...
T Consensus 662 LLrsk----WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~T 733 (1226)
T KOG4279|consen 662 LLRSK----WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCT 733 (1226)
T ss_pred HHHhc----cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-ccc
Confidence 99432 2344 677788889999999999999 4999999999999996 57899999999998764322 223
Q ss_pred EeeccccceeCcccccCC--CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 666 TMVRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
....||..|||||++..+ .|..++|||||||.+.||.||++||-..+..... +..+---...+.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------------MFkVGmyKvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------------MFKVGMYKVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------hhhhcceecCCC
Confidence 456699999999999764 5899999999999999999999999654432211 011111223345
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCCCCCCCCCCc
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGSADINTPPMP 789 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~~~~~~p~~p 789 (839)
++.+....+..++++|+.++|.+||+++++++- |+-....+.|+.+
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 677778888999999999999999999999753 3333333444443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=314.29 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=205.2
Q ss_pred HHHHhhccccccccCCCceEEEEEe--------CCCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceee
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL--------GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCS 569 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 569 (839)
+....+.+.+.||+|+||.||++.. .++..||+|.+.... .....++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4455677889999999999999964 134579999986542 23346789999999999 8999999999999
Q ss_pred cCCceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 570 EGSNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 570 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
.....++||||+++|+|.++|..... .....+++..+..++.||++||.|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999854311 1124578889999999999999999984 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAED 716 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 716 (839)
|+++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 99999999999999998764332221 222345678999999999899999999999999999998 777775322111
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADI 783 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~ 783 (839)
..+.+..+.. ...+......+.+++.+||+.+|++||+|.+|++.|++...+
T Consensus 248 ------~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ------LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ------HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111110 011122345677889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.76 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=192.7
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||+|+||+||++.. .+++.||+|.+..... .....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999976 4688999999864321 2234578899999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
..++.... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 98874321 2345689999999999999999999995 999999999999999999999999999986543222 123
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... .+..... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-------~~~~~----~~~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------KELKQ----RILNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-------HHHHH----hhcccCC--CCcc
Confidence 346899999999999999999999999999999999999999643321100 00000 0001100 1122
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
.....+.+++..|++.+|++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2345577888899999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.39 Aligned_cols=251 Identities=26% Similarity=0.458 Sum_probs=200.2
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.+.+.||+|+||.||++...+++.+|+|.+... .....++..|++++.+++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 45677899999999999998877889999998644 23356799999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++.. ....+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 84 GCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999998842 234578899999999999999999985 8999999999999999999999999999865433222
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......++.+|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+ .....+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~--~~~~~~~--- 224 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAG--FRLYKPR--- 224 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCC--CCCCCCC---
Confidence 2222235678999999998899999999999999999998 999986432111 01111111 0011111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.65 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=197.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+...++||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 45678999999999999976 468999999986432 12234577899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 82 MNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred cCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999888432 234689999999999999999999994 9999999999999999999999999999875432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ......+.. .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~----------~ 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE----------D 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh----------c
Confidence 21 22345899999999999889999999999999999999999999753321100 000000000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
....+......+.+++..|++.+|.+|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112223445677889999999999999 77787553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.00 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=202.7
Q ss_pred HHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
....+.+.+.||+|+||.||+|... .+..||+|.+..... ....++.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3445667789999999999999763 246899999864432 334578899999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCC-----CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHH-----RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
.++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+ .+++||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999998543211 12357889999999999999999998 49999999999999999999999
Q ss_pred cccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhh
Q 038743 649 SDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 649 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKF 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHH
Confidence 999999865433221 1223346788999999998889999999999999999998 888885432211 1111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+... ..+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111110 1111224567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.91 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=187.9
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||.||+++.. +++.||||++.+.. ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 58899999986432 23345677888888776 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~-----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 99998884 335688999999999999999999985 99999999999999999999999999987542221 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~ 214 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------V 214 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------C
Confidence 2334568999999999999999999999999999999999999997433211 1111111110 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
.+......+.+++.+|++.+|.+||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111123456788889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.37 Aligned_cols=199 Identities=25% Similarity=0.338 Sum_probs=170.7
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||+||++.. .+++.||||++.+.. ......+..|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 45678999999999999966 468999999996532 12234678899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 83 LPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999984 345789999999999999999999995 9999999999999999999999999999754321
Q ss_pred Cc----------------------------------eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC
Q 038743 661 HS----------------------------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 661 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred CCCCC
Q 038743 707 NLDMS 711 (839)
Q Consensus 707 p~~~~ 711 (839)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=319.16 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=198.4
Q ss_pred HHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecC-C
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG-S 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 572 (839)
...+.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45677889999999999999963 3578999999965432 2345688999999999 789999999988654 5
Q ss_pred ceEEEEeeccCCChhhhcccCCCC--------------------------------------------------------
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHH-------------------------------------------------------- 596 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 596 (839)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999988532100
Q ss_pred ------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce-eEEeec
Q 038743 597 ------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ-VVTMVR 669 (839)
Q Consensus 597 ------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 669 (839)
....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 013467888899999999999999985 9999999999999999999999999999865332211 122234
Q ss_pred cccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHH
Q 038743 670 GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEE 748 (839)
Q Consensus 670 gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 748 (839)
++..|+|||.+.+..++.++||||||+++|||++ |..||........ .......+... ..+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCC---------CCCCCC
Confidence 5678999999999999999999999999999997 8888854321110 01111111100 001111
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 749 LMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 749 ~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
...+.+++..||+.+|++||++.+|++.|+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 235788899999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.87 Aligned_cols=241 Identities=23% Similarity=0.315 Sum_probs=189.2
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||+||+|... +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999774 57899999996532 22334566777777764 899999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++. ....+++.+...++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05619 81 GDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A 151 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence 99999883 234688899999999999999999995 99999999999999999999999999997532211 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+... .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~------~~~~--- 215 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMD------NPCY--- 215 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------CCCC---
Confidence 2234568999999999999999999999999999999999999996432111 11111110 0111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMG-EVVK 775 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-~v~~ 775 (839)
+......+.+++.+|++.+|.+||++. ++.+
T Consensus 216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 -PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111233467888899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.25 Aligned_cols=240 Identities=24% Similarity=0.370 Sum_probs=187.3
Q ss_pred cccccCCCceEEEEEeCC-------------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 509 QLLGTGGFGSVYKGSLGD-------------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358999886654444557889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc-------eee
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC-------PKV 648 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~-------~kl 648 (839)
+||||+++|+|..++.. ....+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999988842 234689999999999999999999984 9999999999999987664 899
Q ss_pred cccCcceecCCCCceeEEeeccccceeCccccc-CCCCCCcccEEehhHHHHHHH-hCCCCCCCCCCCCCccchhhhhhh
Q 038743 649 SDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 649 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
+|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+......+. ..
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~ 220 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ER 220 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HH
Confidence 999998754322 1234778899999886 567899999999999999998 57777753221110 00
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
...+.. . . .......+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYEGQC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHhcCc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 001000 0 0 0112345678889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.35 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=201.6
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||++.. .|+.||+|.+..... ..+++.+|+.++.+++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4566788999999999999987 478999999976533 46689999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 84 KGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999998432 223689999999999999999999995 999999999999999999999999999986632211
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
....+..|+|||.+....++.++||||||++++|+++ |+.||....... .......+. .
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGY---------R 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC---------C
Confidence 2234667999999998889999999999999999997 998885332110 111111110 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+......+.+++.+|++.+|++||++.+++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112234567888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.66 Aligned_cols=257 Identities=26% Similarity=0.356 Sum_probs=197.9
Q ss_pred HhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
..+.+.+.||+|+||.||+|... .+..||+|.+..... .....+..|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 34566789999999999999774 356899998864432 23456899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCC--CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC---ceeecc
Q 038743 576 LVYEFMKNGSLDKWIFPSYH--HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---CPKVSD 650 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~D 650 (839)
+||||+++++|.+++..... .....+++..++.++.||+.||+|||+. +++||||||+|||++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999854321 1223689999999999999999999995 899999999999998654 699999
Q ss_pred cCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhc
Q 038743 651 FGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMT 728 (839)
Q Consensus 651 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 728 (839)
||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+. .....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~ 235 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------MEFVT 235 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHH
Confidence 99998763322111 112223568999999999999999999999999999997 9999864322110 01111
Q ss_pred cCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 729 NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
... ....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 01111222356778899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.91 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=189.5
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHh---hccccCCcccccceeecCCceEEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTI---GSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+.+.||+|+||.||++.. .+++.||||++++.. ....+.+..|++++ ..++||||+++++++......++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 4568899999999999976 468999999996432 22234566666554 5678999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 82 EYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred cCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999988873 34689999999999999999999995 99999999999999999999999999987532
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..+. .
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~------~ 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDE------V 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------C
Confidence 221 12234568999999999999999999999999999999999999996432211 011111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
.. +......+.+++.+|++.+|.+||+ +.++++
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11 1112345678889999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.34 Aligned_cols=262 Identities=20% Similarity=0.317 Sum_probs=199.8
Q ss_pred HhhccccccccCCCceEEEEEe-----CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecC--Cce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNR 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 574 (839)
.++.+.+.||+|+||.||++++ .++..||+|.++... ......+.+|+.++++++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4456678899999999999974 357899999986543 22345789999999999999999999998775 568
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 999999999999999842 22368999999999999999999998 49999999999999999999999999999
Q ss_pred eecCCCCce--eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCC-C-------ccchhhhh
Q 038743 655 KLMGREHSQ--VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE-D-------FFYPGWAF 724 (839)
Q Consensus 655 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~-~-------~~~~~~~~ 724 (839)
+.+...... ......++..|+|||++.+..++.++||||||+++|||++++.|........ . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876433221 1223456778999999998889999999999999999999887653221100 0 00000000
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+. ...........+.+++.+|++.+|++||++.++++.|+..
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011110 0111122345788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.17 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=201.2
Q ss_pred HHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
...+.+.+.||+|+||.||++.. ..+..||||+++.... .....+.+|+.+++++ +||||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 34567788999999999999964 2345899999875432 2235688999999999 79999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++|+|.+++... ....+++.++..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999998432 223489999999999999999999984 999999999999999999999999999
Q ss_pred ceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 654 AKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 654 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
++.+....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... ......+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcCC
Confidence 98654332211 122345778999999999999999999999999999998 99998643321110 01111110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
....+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 262 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 001111123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.92 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=199.4
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCc----EEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGT----LVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...+.+.++||+|+||+||+|+. .+++ .||+|+++.... ....++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 34456678999999999999975 4454 489999865432 335678899999999999999999999875 4578
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 99999999999999843 234688999999999999999999994 99999999999999999999999999998
Q ss_pred ecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
.+....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||+...... +. ..+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~- 229 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGER- 229 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCc-
Confidence 765432221 112235678999999999999999999999999999998 888886432111 00 01111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADI 783 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~ 783 (839)
...+......+.+++..||+.+|++||++.++++.|+.....
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011112334577889999999999999999999999766443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.08 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=201.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|++|.||++.. .+++.|++|.+... ......++.+|++++++++||||+++++++.+....++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 45678999999999999976 46899999998543 2334567889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.+....
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 82 ENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999998532 24578899999999999999999998 499999999999999999999999999998765432
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ......|++.|+|||++.+..++.++||||||++++||++|+.||...... ........+..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~--------- 218 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVF--------- 218 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC---------
Confidence 2 123345788999999999999999999999999999999999999643311 01111111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+||+.+|++||+|.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122334568889999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.58 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=199.0
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
...+.+.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++.+..+...++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34567788999999999999976 57889999999755444456788999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 88 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999884 234678999999999999999999985 9999999999999999999999999999866432
Q ss_pred CceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.. ......|+..|+|||.+. ...++.++||||||+++|||++|+.|+......+... ..... ....
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~ 228 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQP 228 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCC
Confidence 21 122345888999999884 3457889999999999999999999985332211100 00000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
+.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11100 112234677888999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.92 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=202.9
Q ss_pred HHhhccccccccCCCceEEEEEeCC-----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeec-CCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD-----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 574 (839)
...+.+.++||+|+||.||+|...+ +..|++|++..... .....+.+|+.++.+++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4456778899999999999998755 78899999865432 234568899999999999999999998766 5778
Q ss_pred EEEEeeccCCChhhhcccCCCC---CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHH---RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
++++||+++++|.++|...... ....+++.++..++.||+.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998543111 125689999999999999999999984 9999999999999999999999999
Q ss_pred CcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 652 GLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 652 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ + ...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M----AAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHc
Confidence 9998664333222 122346778999999998899999999999999999998 999986432111 0 011111
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+. ...........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 0001111234578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.88 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=203.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++||||+++++++.+....++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 456788999999999999976 478999999875422 2223468899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++.... .....++...+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 83 LADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999998884321 1334678889999999999999999984 999999999999999999999999999987643
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+. ..+.... .+
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~-----~~- 226 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCD-----YP- 226 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCC-----CC-
Confidence 2221 123458889999999998889999999999999999999999985332110 0000 1111000 01
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111123345678889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.48 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=197.9
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCc--EEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGT--LVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (839)
...+.+.+.||+|+||.||+|... ++. .+|+|.+.... .....++.+|++++.++ +||||+++++++.+....++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 345667889999999999999764 444 46888776432 23345788999999999 89999999999999999999
Q ss_pred EEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc
Q 038743 577 VYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC 645 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~ 645 (839)
||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+. +++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999854321 1123688999999999999999999984 9999999999999999999
Q ss_pred eeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhh
Q 038743 646 PKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 646 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 724 (839)
+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+ ..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 233 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HH
Confidence 9999999986422111 1111234667999999988889999999999999999998 999986432211 01
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+. ....+......+.+++.+|++.+|++||++.+++++|+..
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111110 0001111234577899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.27 Aligned_cols=237 Identities=27% Similarity=0.354 Sum_probs=185.8
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHH-HhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVN-TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||+||+|.. .+++.||||++.... .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999977 468999999986432 122334555554 46778999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 99999883 345688889999999999999999995 99999999999999999999999999987532211 2
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKP------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC------CCCCCC
Confidence 2334568999999999999999999999999999999999999996432111 011111111 011111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMG 771 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~ 771 (839)
....+.+++.+|++.+|.+||++.
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ----ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234577888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.10 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=199.2
Q ss_pred HhhccccccccCCCceEEEEEeC-----------------CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-----------------DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRL 564 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 564 (839)
..+.+.+.||+|+||.||++... +...||+|++.... .....++.+|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34677889999999999998532 23479999987542 2334678999999999999999999
Q ss_pred cceeecCCceEEEEeeccCCChhhhcccCCCC------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHH------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 565 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
++++......++||||+++|+|.+++...... ....+++.++..++.||+.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998543211 123578889999999999999999995 899999999999
Q ss_pred EECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh--CCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG--GRRNLDMSGDAE 715 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 715 (839)
|+++++.++|+|||+++.+....... .....++..|+|||....+.++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998653322211 122334678999999888899999999999999999998 667775332211
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.. ........... ..... ..+......+.+++.+||+.+|.+||+|.+|++.|+.
T Consensus 242 ~~---~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI---ENTGEFFRDQG-RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHhhcc-ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 00000000000 00000 0111223567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.79 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=195.0
Q ss_pred cccccCCCceEEEEEeCC----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999996522 36899999875543 24567899999999999999999999876 4578999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.++|.. ...+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999943 23688999999999999999999985 8999999999999999999999999999876433222
Q ss_pred eE--EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 664 VV--TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 664 ~~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGERL------- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCcC-------
Confidence 11 11224568999999999999999999999999999998 999986432211 01111111100
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
..+......+.+++.+|++.+|++||++.+|++.|++..
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.79 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=193.6
Q ss_pred cccccCCCceEEEEEeCC-Cc--EEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLGD-GT--LVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||+|...+ +. .+|+|.+.... ......+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998744 43 57889886432 23345788999999999 899999999999999999999999999
Q ss_pred CChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 584 GSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 584 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
|+|.+++..... .....+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999854311 122357899999999999999999998 499999999999999999999999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
++...... ........+..|+|||++....++.++||||||++++||++ |+.||....... .......+.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCCC
Confidence 98632211 11112234567999999988899999999999999999997 999985432111 111111110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...........+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011112234577899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.36 Aligned_cols=269 Identities=22% Similarity=0.327 Sum_probs=203.2
Q ss_pred HhhccccccccCCCceEEEEEeC-----CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeec--CCce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-----DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNR 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 574 (839)
..+.+.+.||+|+||.||++.+. +++.||||.+...... ...++.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34556789999999999999863 3689999999765332 45679999999999999999999999877 6688
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 9999999999999999432 3368999999999999999999998 49999999999999999999999999999
Q ss_pred eecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-cchhhhhhhhccCc
Q 038743 655 KLMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-FYPGWAFKEMTNGT 731 (839)
Q Consensus 655 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 731 (839)
.......... .....++..|+|||.+.+..++.++||||||++++||++|+.|+......... ..+.. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ--GQMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc--ccccHHH
Confidence 8765322211 11223556799999999889999999999999999999999988543221100 00000 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+.+........+......+.+++.+|++.+|++||+|.+|+++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0111111111111222335688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.02 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=192.3
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||+|+||.||++.. .+|+.+|+|.+.... ......+..|++++.+++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999976 468999999986422 12234566799999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
..++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 9887432 334588999999999999999999994 99999999999999999999999999998764322 223
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......... .. ........ .+... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~-~~~~~~~~--------~~~~~-~~ 220 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EE-LKRRTLED--------EVKFE-HQ 220 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HH-HHHHhhcc--------ccccc-cc
Confidence 456899999999999988999999999999999999999998643221100 00 00000000 00000 01
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.....+.+++..||+.+|++||++.|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 12334678888899999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.97 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=202.7
Q ss_pred HHHHhhccccccccCCCceEEEEEeC--------CCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceee
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG--------DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCS 569 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 569 (839)
+....+.+.+.||+|+||.||++... +...+|+|.+.... .....++..|+.++..+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34456788899999999999999642 23579999997542 23345688899999999 7999999999999
Q ss_pred cCCceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 570 EGSNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 570 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
.....++||||+++|+|.+++..... .....+++.++++++.||+.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999954311 1224588999999999999999999984 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAED 716 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 716 (839)
|++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~- 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence 99999999999999997653321111 112234568999999999899999999999999999998 888885322110
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.......+. ....+......+.+++..|++.+|++||+|.+|++.|+...
T Consensus 251 ------~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 ------LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ------HHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111111 11112223456778899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.41 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=192.6
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4667889999999999999774 688999999865432 22346788999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+ ++|.+++.. ....++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 86 H-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred C-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 6 677777732 234578888999999999999999995 99999999999999999999999999997543222
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-c----------chhhhhhh---
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-F----------YPGWAFKE--- 726 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~----------~~~~~~~~--- 726 (839)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.... . ...|....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 11223457899999998865 45889999999999999999999999754321100 0 00000000
Q ss_pred -hccCcccccccccccCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 727 -MTNGTPLKVADRRLEGAVE-EEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 727 -~~~~~~~~~~~~~l~~~~~-~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.............+....+ ......+.+++.+|++.+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000000 001235668888999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.16 Aligned_cols=259 Identities=20% Similarity=0.336 Sum_probs=203.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.+.||+|+||.||++.. .+++.+|||.+..... ....++.+|+.++..++||||+++++++.+....+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 456678999999999999975 5789999998864322 223578899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++.... .....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 83 LADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999884321 2345688999999999999999999985 999999999999999999999999999886643
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
... ......++..|+|||++.+..++.++||||||+++|||++|..||........ .. .+... ....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~~-----~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL-CKKIE-----QCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HH-hhhhh-----cCCCCC
Confidence 222 12234588899999999998999999999999999999999999864321100 00 00100 000111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+ ........+.+++.+|++.+|++||||.+|++++++.
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1112345677888899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.24 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=194.7
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCC-----ceEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-----NRLLV 577 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 577 (839)
.+.+.||+|+||.||++.. .+++.||||++..... ...+++.+|++++..++||||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4567899999999999976 5789999999865322 23457889999999999999999999998776 78999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
+||+. ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~e~~~-~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 83 TELMQ-SDLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eeccc-cCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99997 57877773 345689999999999999999999995 9999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh----------h----
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG----------W---- 722 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~----------~---- 722 (839)
............+++.|+|||.+.+. .++.++|||||||++|||++|+.||............. +
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 44333333344578999999998774 57999999999999999999999997543221100000 0
Q ss_pred --hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 --AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 --~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+..... ..................+.+++.+|++.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0000000000111124567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.97 Aligned_cols=239 Identities=24% Similarity=0.347 Sum_probs=185.8
Q ss_pred ccccCCCceEEEEEeCC-------------------------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccc
Q 038743 510 LLGTGGFGSVYKGSLGD-------------------------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 564 (839)
.||+|+||.||+|.+.. ...||+|++.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999865444444578899999999999999999
Q ss_pred cceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 565 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
+++|.+....++||||+++|+|..++.. ....+++..++.++.||++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 9999999999999999999999998842 234688999999999999999999984 999999999999997643
Q ss_pred -------ceeecccCcceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHH-hCCCCCCCCCCCC
Q 038743 645 -------CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAE 715 (839)
Q Consensus 645 -------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~ 715 (839)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4799999988643221 12246788999998875 56899999999999999995 7898886433211
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.. . .... ...+... ....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 230 ~~---~----~~~~-------~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KE---R----FYEK-------KHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---H----HHHh-------ccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 0 0000 0001111 1235778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.17 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=192.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||+||+++. .+++.||||++.... ......+.+|+.++..++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 45678999999999999976 468999999996431 22334578899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~g~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 83 LPGGDMMTLLM-----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCcHHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999984 234689999999999999999999995 9999999999999999999999999999765321
Q ss_pred Cce-------------------------------------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh
Q 038743 661 HSQ-------------------------------------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG 703 (839)
Q Consensus 661 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt 703 (839)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0012358999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 038743 704 GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS---MGEVVKM 776 (839)
Q Consensus 704 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt---~~~v~~~ 776 (839)
|+.||......+. ...+..... .+. .... ......+.+++.+|+. +|.+|++ +.++++.
T Consensus 235 G~~Pf~~~~~~~~-------~~~i~~~~~-~~~---~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET-------YRKIINWKE-TLQ---FPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH-------HHHHHcCCC-ccC---CCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999964332110 011100000 000 0000 0112345566666886 8999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.45 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=187.7
Q ss_pred cccccCCCceEEEEEeCC---CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSLGD---GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||+|+||.||+|...+ ...+|+|.+..... ....++.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 45788888754322 23456889999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|.++|...........++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999654322234456788899999999999999995 99999999999999999999999999987543222111
Q ss_pred -EEeeccccceeCcccccC-------CCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 665 -VTMVRGTRGYLAPEWVSN-------RPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 665 -~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ............+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVREQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhhccCccC
Confidence 122345678999998743 456889999999999999999 777875332111 0111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
..+.+.. .....+.+++..|+ .+|++||++++|+++|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222221 22234455666688 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=301.16 Aligned_cols=258 Identities=21% Similarity=0.346 Sum_probs=205.1
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4667889999999999999875 78999999885321 2234578999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++... ......+++.++..++.+++.||+|||+. +|+||||+|+||+++.++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 83 LADAGDLSRMIKHF-KKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCCHHHHHHHh-cccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999988532 12345688999999999999999999995 999999999999999999999999999986543
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+..+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~-------- 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCD-------- 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCC--------
Confidence 3221 22345888999999999889999999999999999999999998533211 000 001111110
Q ss_pred ccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~-~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+. .....+.+++.+|++.+|++||++.+|+++|+..
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 011111 3345677889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=291.51 Aligned_cols=266 Identities=21% Similarity=0.277 Sum_probs=196.1
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCC-cccccceeecCC------ce
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMN-LVRLCGYCSEGS------NR 574 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~ 574 (839)
+...++||+|+||+||+|+. .+|+.||+|++.-.... ......+|+.++.+++|+| ||+|++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44456799999999999965 57899999999654332 2345789999999999999 999999998777 78
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
+||+||+.. +|..++...... ...++...+..++.||++||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~-~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKK-PQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEeecc-cHHHHHHhcccc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 899999855 899998543211 14566688999999999999999996 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
+.+.-+.. ..+...+|..|.|||++.+. .|+...||||+|||+.||++++..|.+..+...............+..+.
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 97653322 23445588999999999886 79999999999999999999998887655422110000000000000000
Q ss_pred c---cccccc-----c--CCCCH---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 734 K---VADRRL-----E--GAVEE---EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 734 ~---~~~~~l-----~--~~~~~---~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. +.+-.. . ..... .......+++.+|++.+|.+|.+++..+++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 001000 0 00001 111467788999999999999999999876
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.17 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=196.9
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChh
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeE-E
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV-T 666 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~ 666 (839)
+++.. ....+++..++.++.+++.+|+|||+. +++||||||+|||++.++.+||+|||++........... .
T Consensus 81 ~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRK----KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99843 234678889999999999999999984 999999999999999999999999999986542211111 1
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCC
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 745 (839)
...++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........ .....+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~ 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESG---------YRMPAP 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcC---------CCCCCC
Confidence 2234567999999998899999999999999999999 788875432111 00111000 001111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 746 ~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
......+.+++.+|++.+|++||++.||++.|+.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 2234467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.44 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=191.7
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||++... +++.||||++++.. ......+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999774 57899999996532 22344577888888877 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQ-----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 99998883 334689999999999999999999985 999999999999999999999999999875322211
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~ 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------R 214 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------C
Confidence 2233468999999999999999999999999999999999999996433111 1111111110 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSM-----GEVVKM 776 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~-----~~v~~~ 776 (839)
.+......+.+++.+||+.+|.+||++ .++++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111223456788899999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.78 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=196.4
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee-cCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS-EGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~ 581 (839)
..+.+.+.||+|+||.||++.. .+..||+|.++.. ...+.+.+|+.++++++|+|++++++++. +....++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4567788999999999999987 4788999998643 23457899999999999999999999764 556789999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999998532 234588999999999999999999985 99999999999999999999999999988643322
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ . ......+.
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~-~~~~~~~~--------- 216 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------V-VPRVEKGY--------- 216 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHhcCC---------
Confidence 12234568999999999899999999999999999997 998885322110 0 01111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...........+.+++.+|++.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011112234567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.26 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=199.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
++.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 456678899999999999975 5689999999976555555678899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~------~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 101 GGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999883 23578899999999999999999995 999999999999999999999999999876533221
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||......... ......+. +.+
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~------~~~-- 236 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT------PEL-- 236 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCC------CCC--
Confidence 1 22345888999999999888999999999999999999999999643321110 00000000 000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1112233457788899999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=297.98 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=197.5
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec-----CCceEEEEe
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-----GSNRLLVYE 579 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~e 579 (839)
.+.||+|+||.|..+.. .+|+.||||++.+.. ....++..+|+++++.++|+||+.+.+.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 47899999999999965 578999999997433 3345678899999999999999999998855 457899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
+| ..+|...|. .++.|+......++.||++||+|+|+. +|+||||||+|+|++.+..+||+|||+|+....
T Consensus 107 lM-etDL~~iik-----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 107 LM-ETDLHQIIK-----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred HH-hhHHHHHHH-----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence 99 568988883 445588888999999999999999996 999999999999999999999999999998754
Q ss_pred CC-ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------hhhhhcc
Q 038743 660 EH-SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------AFKEMTN 729 (839)
Q Consensus 660 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~ 729 (839)
.. ....+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|+..|-+....+...++.. ....+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 31 222466778999999998765 6899999999999999999999999977654332211111 1111111
Q ss_pred Ccccccccccc-cCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 730 GTPLKVADRRL-EGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 730 ~~~~~~~~~~l-~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
......+.... ....+ +..-...++++.++|..||.+|+|++|.++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111000000 00000 1223456788888999999999999998764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=317.85 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=195.2
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
+....+.+.+.||+|+||.||++... +++.+|+|++.+.. ......+.+|+.++..++||||+++++.+.++...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 33456777889999999999999774 68899999985421 222345788999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++. ...++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 120 lv~Ey~~gg~L~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 120 MVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999883 23578888889999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCC----CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNR----PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
..............||+.|+|||++... .++.++|||||||++|||++|+.||....... ....+....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~ 263 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHK 263 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC
Confidence 7654333233445699999999998754 37899999999999999999999997432211 111111110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHh
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFM--RPSMGEVVKML 777 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~~v~~~L 777 (839)
. .+...........+.+++..|++..+.+ ||++.++++..
T Consensus 264 ~------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 N------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 0000001122344566777788744433 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.99 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=189.1
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcccc-CCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHH-MNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 579 (839)
+.+.+.||+|+||.||+|... +++.||||++.... ......+..|++++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999764 57899999986532 2334567889999999866 568889999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 82 YVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred CCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999884 334678899999999999999999995 999999999999999999999999999875322
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~------~~ 219 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHN------VS 219 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------CC
Confidence 11 12334569999999999999999999999999999999999999996433211 011111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
+ +......+.+++.+|++.+|.+||+.
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 Y----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 11123456788889999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.54 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=189.6
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+.+.+.||+|+||.||+|... +++.||||.+.+.. ......+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456789999999999999764 57899999986532 12234567788888777 68999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 82 YVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred CCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999998883 334688999999999999999999995 999999999999999999999999999975432
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~-------- 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHN-------- 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC--------
Confidence 21 12234568999999999999999999999999999999999999997433211 011111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
. ..+......+.+++.+|++.+|.+|++.
T Consensus 218 ~--~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 V--AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 1112233456788899999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.86 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=197.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-----cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-----HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
+...+.||+|++|.||++.. .+++.||+|.+..... .....+.+|++++.+++||||+++++++.+....++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 55678999999999999976 4689999999854321 12346888999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++. ....+++.....++.|++.||.|||+. +|+||||+|+||++++++.++|+|||+++...
T Consensus 84 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 84 EYMPGGSVKDQLK-----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EECCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999884 234678888999999999999999995 99999999999999999999999999998654
Q ss_pred CCCceeE--EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 659 REHSQVV--TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 659 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
....... ....++..|+|||++.+..++.++||||||+++|||++|+.||........ .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~---------~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKI---------A 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHH---------h
Confidence 3222211 234578899999999998899999999999999999999999863321110 0000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
........+......+.+++..||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001111222234456788889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.77 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=205.2
Q ss_pred HHHHHhhccccccccCCCceEEEEEeC--------CCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCccccccee
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLG--------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYC 568 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 568 (839)
++....+.+.+.||+|+||.||++... .+..||+|.+..... ...+++.+|++++.++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 444556788899999999999999641 124799998865422 2346789999999999 899999999999
Q ss_pred ecCCceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
.+....++++||+++|+|.++|..... .....+++.+++.++.||+.||+|||+ ++|+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 999999999999999999999854211 123468899999999999999999998 499999999999
Q ss_pred EEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCC
Q 038743 638 ILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAE 715 (839)
Q Consensus 638 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 715 (839)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998654322111 122334568999999999999999999999999999998 888875332111
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCC
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADI 783 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~ 783 (839)
....+..+.. ...+......+.+++.+|++.+|.+||+|.++++.|+.....
T Consensus 245 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 -------LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111110 011112234677889999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.96 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=196.8
Q ss_pred cccccCCCceEEEEEeCC--C--cEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLGD--G--TLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|++|.||+|...+ + ..||||.+..... ...+.+..|+.++.+++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 3 3699999976654 456689999999999999999999999988 889999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++.... ...+++...+.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999985431 1568999999999999999999998 49999999999999999999999999999876442221
Q ss_pred e--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 664 V--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 664 ~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...... .. ..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~-~~-----~~- 219 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-------LKKIDK-EG-----ER- 219 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHh-cC-----Cc-
Confidence 1 123457789999999999999999999999999999998 9999863321110 000000 00 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
...+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011123456778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.51 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=188.4
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||.||+|... +++.||+|.++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999774 68899999996532 22344567788877754 899999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~i~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 151 (316)
T cd05620 81 GDLMFHIQ-----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DN 151 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CC
Confidence 99998883 234688899999999999999999995 9999999999999999999999999998743211 12
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+..... .+.+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~------~~~~~~- 217 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVD------TPHYPR- 217 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------CCCCCC-
Confidence 2344568999999999999999999999999999999999999996432211 11111111 011111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMG-EVV 774 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-~v~ 774 (839)
.....+.+++.+|++.+|.+||++. +++
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 ---WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1223466788889999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.13 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=199.8
Q ss_pred HHhhccccccccCCCceEEEEEeCC----CcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
...+.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4456678899999999999997643 2479999886554 2344578999999999999999999998875 55789
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++|+|.+++.. ....+++..++.++.+++.||+|||+. +++|+||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999999943 234589999999999999999999984 999999999999999999999999999987
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.............++..|+|||.+....++.++||||||++++|+++ |+.||......+. ...+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~-- 227 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGERL-- 227 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCcC--
Confidence 64432222223334568999999988889999999999999999996 9999864432110 0111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+......+.+++.+|+..+|++||++.++++.|++.
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01112234677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.92 Aligned_cols=199 Identities=24% Similarity=0.319 Sum_probs=168.5
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.++||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++.+.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 45678999999999999976 568899999986432 12235688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. +...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 83 IPGGDMMSLLI-----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999884 234678888889999999999999995 9999999999999999999999999997533110
Q ss_pred Cc----------------------------------------------eeEEeeccccceeCcccccCCCCCCcccEEeh
Q 038743 661 HS----------------------------------------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSY 694 (839)
Q Consensus 661 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~ 694 (839)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00112468999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCC
Q 038743 695 GMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 695 Gvvl~elltG~~p~~~~ 711 (839)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.98 Aligned_cols=200 Identities=24% Similarity=0.319 Sum_probs=169.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
|.+.+.||+|+||.||+++. .+++.||||++.+.. ......+.+|++++.+++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 56678999999999999976 468999999986432 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 83 IPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999984 334678888889999999999999995 9999999999999999999999999998533110
Q ss_pred Cc------------------------------------------eeEEeeccccceeCcccccCCCCCCcccEEehhHHH
Q 038743 661 HS------------------------------------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698 (839)
Q Consensus 661 ~~------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl 698 (839)
.. .......||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 001124699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 038743 699 LEIVGGRRNLDMSG 712 (839)
Q Consensus 699 ~elltG~~p~~~~~ 712 (839)
|||++|+.||....
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=303.23 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=194.9
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.++||+|+||.||+|.. .+++.||+|.+.... .....++.+|++++.+++||||+++++++......++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45667899999999999965 578899999986432 3334578899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 83 GGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 99996543 457788889999999999999995 99999999999999999999999999998654321
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...........+.-......... .+.+.
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~- 221 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP- 221 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC-
Confidence 2234688999999999999999999999999999999999999965332221111100001100000 01110
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.......+.+++.+|++.+|++||+++++++.-
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 111234577888999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=284.39 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=198.6
Q ss_pred HhhccccccccCCCceEEEEE-eCCCcEEEEEEec--ccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 503 RTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..+.+.++||+|.|+.||+.. .++|+.+|+|++. +....+.+++.+|+++.+.|+||||++|...+.+....+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 446677899999999999984 4679999999874 3334466789999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeecccCccee
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKL 656 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~ 656 (839)
+|.|++|..-|. .+...++...-..+.||+++|.|+|. ++|||||+||+|+||. ...-+||+|||+|..
T Consensus 91 ~m~G~dl~~eIV-----~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 91 LVTGGELFEDIV-----AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred cccchHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999987663 23567777888899999999999999 5999999999999994 344689999999998
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
++ .........|||+|||||++...+|+..+|||+.|||||-|+.|..||.+...... .+.+..+.. -+
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-------ye~I~~g~y--d~ 231 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YEQIKAGAY--DY 231 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-------HHHHhcccc--CC
Confidence 76 33344456799999999999999999999999999999999999999975432211 111111111 01
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+++.-. ...+....++.+|+..||.+|-|+.|.++.
T Consensus 232 ~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111111 223345677788999999999999988653
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.44 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=200.2
Q ss_pred HhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
..+.+.+.||+|+||.||++... ++..||+|++..... ....++.+|+.++.+++||||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 34566789999999999999763 467899999865432 33467899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCC-----------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 576 LVYEFMKNGSLDKWIFPSYH-----------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
+||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 99999999999999853211 1123578889999999999999999984 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAED 716 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 716 (839)
|+++++.+||+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~- 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE- 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999865332211 1122234667999999998999999999999999999997 888875322111
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.......+... ..+......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 241 ------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111110 0111234568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.80 Aligned_cols=242 Identities=26% Similarity=0.323 Sum_probs=188.0
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHH-HhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVN-TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||++.. .+|+.||+|++.... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999975 568999999986432 222345556655 46778999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 99998883 345688999999999999999999984 99999999999999999999999999987532211 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~------~~~~- 217 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPL------VLRP- 217 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCc------cCCC-
Confidence 2234568999999999999999999999999999999999999996432111 1111111110 0111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.....+.+++.+|++.+|.+||++.+.++.
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 123456678888999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.87 Aligned_cols=199 Identities=24% Similarity=0.315 Sum_probs=169.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
|.+.+.||+|+||.||++.. .+++.||||++.+.. ......+.+|++++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 45678999999999999965 578999999985431 22345688899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 83 LPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999984 335678888899999999999999995 9999999999999999999999999999643211
Q ss_pred Cce----------------------------------------------eEEeeccccceeCcccccCCCCCCcccEEeh
Q 038743 661 HSQ----------------------------------------------VVTMVRGTRGYLAPEWVSNRPITVKADVYSY 694 (839)
Q Consensus 661 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~ 694 (839)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012359999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCC
Q 038743 695 GMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 695 Gvvl~elltG~~p~~~~ 711 (839)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (377)
T cd05629 235 GAIMFECLIGWPPFCSE 251 (377)
T ss_pred chhhhhhhcCCCCCCCC
Confidence 99999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.80 Aligned_cols=259 Identities=24% Similarity=0.296 Sum_probs=202.5
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
|....+.+.+.||+|+||+||++.. .+++.||+|++.... ....+.+.+|++++..++||||+++++++......++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3445667788999999999999976 468899999885432 33356789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++. ....+++.....++.+++.||.|||+. .+++||||||+||++++++.++|+|||++...
T Consensus 82 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 82 MEFMDCGSLDRIYK-----KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred EecCCCCCHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 99999999998883 234688999999999999999999973 37999999999999999999999999998754
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-----cchhhhhhhhccCcc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-----FYPGWAFKEMTNGTP 732 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~ 732 (839)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ....+...
T Consensus 155 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 224 (284)
T cd06620 155 INSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ------- 224 (284)
T ss_pred hhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-------
Confidence 2221 12346899999999998889999999999999999999999999754432110 00011000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
+................+.+++.+|++.+|++||++.||+++.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 225 --IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000000000112345677888899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.24 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=200.0
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456777889999999999999653 245899998864422 2234678899999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCC-----CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeec
Q 038743 575 LLVYEFMKNGSLDKWIFPSYH-----HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVS 649 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~ 649 (839)
++||||+++|+|.+++..... .....+.+..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999953211 0123456778889999999999999984 99999999999999999999999
Q ss_pred ccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhh
Q 038743 650 DFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 650 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 99999865332211 1122335678999999999999999999999999999998 788875422111 00111
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
..+... ..+......+.+++.+|++.+|++||+|.++++.|++..
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111000 011122356888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.46 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=200.5
Q ss_pred HHhhccccccccCCCceEEEEEeC--------CCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG--------DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
...+.+.+.||+|+||.||++... ....+|+|++.... .....++..|++++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 345667899999999999999642 24579999987542 23345688999999999 699999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
...+++|||+++|+|.+++..... .....+++.++..++.||+.||.|||+. +++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999854211 1234688999999999999999999984 99999999999999
Q ss_pred CCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCcc
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFF 718 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 718 (839)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998664322211 122234567999999999999999999999999999999 888885332111
Q ss_pred chhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 719 YPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.......+.. ...+......+.+++.+|++.+|++||++.++++.|+..
T Consensus 245 ----~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 ----LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred ----HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111 011122234577889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=311.88 Aligned_cols=200 Identities=22% Similarity=0.276 Sum_probs=170.9
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||+++.. +++.||+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 567789999999999999764 67899999986421 22234578899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 83 YVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred CCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999942 234678888999999999999999985 9999999999999999999999999999876544
Q ss_pred CceeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
.........|++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 3333344569999999999875 56789999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=307.42 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=208.1
Q ss_pred HHhhccccccccCCCceEEEEEeCC-CcEEEEEEecccCCcc---hHHHHHHHHHhhccc-cCCcccccceeecCCceEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHG---EKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 576 (839)
...|.+.+.||+|.||.||+++.+. |+.+|+|.+.+..... .....+|+.+|+++. |||||.+.+.+......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3457778999999999999997754 9999999997654432 357899999999998 9999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC----CCceeecccC
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE----NFCPKVSDFG 652 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~----~~~~kl~DfG 652 (839)
|||++.+|.|.+.|... .+++.....++.||+.+++|||+. +|+||||||+|+|+.. ++.+|++|||
T Consensus 114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999998532 388999999999999999999995 9999999999999953 3579999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
++..... ........||+.|+|||++....|+..+||||+||++|.|++|..||......+... .+..+..
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 9998766 445677889999999999999999999999999999999999999998665433211 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
......-+.....+.+++..++..+|.+|+|+.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122223345566778888999999999999999985
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.43 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=202.0
Q ss_pred hccccccccCCCceEEEEEeC--CCc--EEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG--DGT--LVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..+.++||+|.||.|++|.+. .|+ .||||.+...... ...+|++|+.+|.+|+|+|+++|+|+..+ ...+||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 345679999999999999773 344 6999999755433 56789999999999999999999999988 78899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
.++.|+|.+.|++. ....|-.....+++.|||.||.||... ++|||||.++|+||-..-.+||+||||.+-++.
T Consensus 191 LaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999652 445677888899999999999999995 999999999999999999999999999997754
Q ss_pred CCce-eEE-eeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 660 EHSQ-VVT-MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 660 ~~~~-~~~-~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
.... .+. ...-...|.|||.+..+.++.++|||+|||.||||++ |..||-+.... .+.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhc
Confidence 3332 222 2335677999999999999999999999999999996 66676543221 112233
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
|..-+-..+..+.+++.+++..||.++|++|||+..+.+.
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 3322333455677889999999999999999999999743
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=298.67 Aligned_cols=251 Identities=31% Similarity=0.459 Sum_probs=201.1
Q ss_pred cccccCCCceEEEEEeCC----CcEEEEEEecccCCcc-hHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||++.... +..||+|.+....... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997754 7899999997654333 56789999999999999999999999999999999999999
Q ss_pred CChhhhcccCCC----CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 584 GSLDKWIFPSYH----HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 584 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
++|.+++..... .....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999853210 0136789999999999999999999994 999999999999999999999999999987654
Q ss_pred CCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 660 EHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 660 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
... .......++..|+|||.+....++.++||||||++++||++ |+.||......+ ..+....+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 321 11233457889999999988899999999999999999999 699986542111 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
....+......+.+++.+|++.+|.+||++.++++.|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01111222456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.98 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=192.4
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
...||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 35899999999999975 46788999998765555566899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccC--ChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecCCCCce
Q 038743 587 DKWIFPSYHHRDRVL--DWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~ 663 (839)
.+++... ...+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 93 ~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 93 SALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred HHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 9998532 1234 7788889999999999999984 9999999999999976 67999999999976543221
Q ss_pred eEEeeccccceeCcccccCC--CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
......|+..|+|||++... .++.++||||||+++|||++|+.||......... .+.... ....
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~-----------~~~~ 230 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGM-----------FKIH 230 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhh-----------hccC
Confidence 12233578999999998664 3789999999999999999999998643221100 000000 0001
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+......+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1122233455778889999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.59 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=197.1
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.+.||+|+||.||++.. .++..+|+|.+..... ....++.+|++++.+++||||+++++++.++...++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 45678999999999999976 4678899998864422 223568899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++. ....+++..+..++.||++||.|||+. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 83 GGSLDQVLK-----KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999984 235688899999999999999999973 379999999999999999999999999987543221
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC------------
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG------------ 730 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 730 (839)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 123458899999999988889999999999999999999999985432111000000000000000
Q ss_pred -----cccccccccc---cCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 731 -----TPLKVADRRL---EGAVE-EEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 731 -----~~~~~~~~~l---~~~~~-~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
...++.+... ....+ ......+.+++.+|++.+|++||++.+|++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 00000 01234578999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.47 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=187.7
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHH-HhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVN-TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||++... +++.||+|++.... .....++..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999764 57889999986432 122234455544 46778999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++. ....+.......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~ 151 (325)
T cd05602 81 GELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-G 151 (325)
T ss_pred CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-C
Confidence 99999884 334577788888999999999999995 99999999999999999999999999997543221 1
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~------~~~-- 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPL------QLK-- 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCc------CCC--
Confidence 2334569999999999999999999999999999999999999996432211 0111111100 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
......+.+++.+|++.+|.+||++.+.+..+.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 217 --PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 122345677888899999999999875544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.12 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=197.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 344557899999999999976 457899999986443 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLK------PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999999883 34688999999999999999999984 99999999999999999999999999998654322
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ...... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~---------~~ 218 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKN---------SP 218 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcC---------CC
Confidence 1 122345788999999999989999999999999999999999998633221100 000000 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..........+.+++.+|++.+|++||+|.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122234567788899999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.56 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=192.9
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecC------CceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG------SNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~ 575 (839)
.+.+.+.||+|+||.||+|.. .+++.||+|++... .....++..|+.++.++ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 345567899999999999976 45889999998654 34456788999999998 799999999998653 4578
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
++|||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.
T Consensus 86 iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999999998532 335688999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||......... ......
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-------~~~~~~ 231 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FLIPRN 231 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HHHhcC
Confidence 6543221 223355889999999986 346788999999999999999999999633211100 000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. ...+. .......+.+++.+||+.+|.+||++.++++
T Consensus 232 ~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 P-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00000 1112245778889999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=298.04 Aligned_cols=238 Identities=24% Similarity=0.397 Sum_probs=187.2
Q ss_pred cccccCCCceEEEEEeCCCc-----------EEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 509 QLLGTGGFGSVYKGSLGDGT-----------LVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
+.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875432 5888877544322 6788999999999999999999999988 788999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-------ceeecc
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-------CPKVSD 650 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-------~~kl~D 650 (839)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999998432 22688999999999999999999985 999999999999999888 799999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCC--CCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhh
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
||++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+.. ...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~ 219 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFY 219 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHH
Confidence 999986543 1223466789999999876 78999999999999999999 46666533211100 000
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.... .. +......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 220 ~~~~-------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQH-------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcCC-------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 0011156788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.96 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=187.1
Q ss_pred cccccCCCceEEEEEeCCC---cEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSLGDG---TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.++..++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 356677765432 234567999999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC-ce
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH-SQ 663 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~~ 663 (839)
+|.+++..... ....+.+..+..++.||++||+|||+. +++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999954311 123456677889999999999999985 89999999999999999999999999986432111 11
Q ss_pred eEEeeccccceeCcccccC-------CCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 664 VVTMVRGTRGYLAPEWVSN-------RPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
......++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .......+....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIKDQQVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhhccccc
Confidence 1223457889999998753 245789999999999999997 466775322211 1111111222233
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.++.+....+ ..+.+++..|| .+|++||+|++|++.|.
T Consensus 230 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3443333322 34556777799 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.61 Aligned_cols=191 Identities=26% Similarity=0.265 Sum_probs=164.0
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..+...++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 4566789999999999999775 47899999642 2346789999999999999999999999999999999995
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
++|.+++.. ....+++.+++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 244 -~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 244 -SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred -CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 688888742 234689999999999999999999985 999999999999999999999999999987643322
Q ss_pred e-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCC
Q 038743 663 Q-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNL 708 (839)
Q Consensus 663 ~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~ 708 (839)
. ......||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 2 123456999999999999999999999999999999999988765
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=300.24 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=188.8
Q ss_pred cccccCCCceEEEEEeC----CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceee-cCCceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCS-EGSNRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~ 582 (839)
+.||+|+||.||+|... +...||+|++.... ....+.+..|+.+++.++||||+++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 24579999985432 233457889999999999999999999775 4556889999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++.. ....+.+..++.++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999842 223467788899999999999999984 999999999999999999999999999986533221
Q ss_pred ee---EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCC-CCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 663 QV---VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR-RNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 663 ~~---~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.. .....++..|+|||.+.+..++.++||||||+++|||++|. .|+......+ .. .....+.. .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~----~~~~~~~~-----~ 221 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT----VYLLQGRR-----L 221 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCCC-----C
Confidence 11 12234577899999998889999999999999999999964 4554221100 00 01111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+......+.+++..||+.+|++||++.+|++.|+..
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=310.98 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=189.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 579 (839)
+++.+.||+|+||.||++.. .+++.||+|++.+.. ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 46778999999999999976 468999999986432 223356778888888875 6778889999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 82 YVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred CCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999883 334689999999999999999999985 999999999999999999999999999875432
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+.....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~------- 218 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV------- 218 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 211 1233458999999999999999999999999999999999999996432211 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223456788889999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=309.85 Aligned_cols=200 Identities=22% Similarity=0.280 Sum_probs=170.4
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 3567789999999999999764 58999999986421 2234558889999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 82 YYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred cCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999842 234688889999999999999999995 999999999999999999999999999986644
Q ss_pred CCceeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 33333334569999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.54 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=200.2
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..+.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4566778999999999999975 579999999997654455567889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999883 24578889999999999999999985 99999999999999999999999999998654332
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.. .....+++.|+|||.+.+..++.++||||||+++||+++|+.||.......... .....+. +.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~------~~-- 234 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------PE-- 234 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCC------CC--
Confidence 21 223457889999999999889999999999999999999999996543221100 0000000 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+......+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011222344677889999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=301.78 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=199.0
Q ss_pred hhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.+...+.||+|+||.||+|+.. +.+.|++|.+...... ...++.+|++++++++|+||+++++++.+....++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 3445678999999999999763 3467999988654332 34679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCC----cccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 577 VYEFMKNGSLDKWIFPSYHHR----DRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
||||+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999985332111 12689999999999999999999985 89999999999999999999999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
+++..............++..|+|||.+.+...+.++||||||++++||++ |..||....+.. .......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~ 235 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGK 235 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCC
Confidence 987543322222223346778999999988889999999999999999998 778885332211 011111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.. ..........+.+++.+|++.+|++||++.+++++|.
T Consensus 236 ~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10 0111123346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=300.35 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=198.1
Q ss_pred hccccccccCCCceEEEEEeCC--CcEEEEEEecccC----------CcchHHHHHHHHHhhc-cccCCcccccceeecC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGD--GTLVAVKKLDRVL----------PHGEKEFVTEVNTIGS-MHHMNLVRLCGYCSEG 571 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~ 571 (839)
+.+.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4556789999999999998754 6889999875321 1223457778888765 7999999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...+++|||+++++|.+++... ......+++..++.++.|++.||.|||+. .+++|+||+|+|||++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999887432 12345688899999999999999999963 47999999999999999999999999
Q ss_pred CcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ......++.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhcc
Confidence 9998765433 2334568899999999999889999999999999999999999986332110 001111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
. .+ .........+.+++.+|++.+|++||++.||..++++
T Consensus 230 ~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 Y----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 00 0011123457788889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.49 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=195.6
Q ss_pred cccccCCCceEEEEEeCC-------CcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGD-------GTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997642 3579999886542 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCC--CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-----ceeecccCc
Q 038743 581 MKNGSLDKWIFPSYHH--RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-----CPKVSDFGL 653 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-----~~kl~DfGl 653 (839)
+++++|.+++...... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999543111 234578999999999999999999984 899999999999999877 899999999
Q ss_pred ceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 654 AKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 654 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-------HHHHHhcCC
Confidence 9765332211 1122345678999999999999999999999999999998 999985332111 001111100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001112234567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.88 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=193.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4666789999999999999764 678999999864432 23346788999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 87 DK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 75 78877732 234578889999999999999999995 99999999999999999999999999997653322
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------hhhhhccCcc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------AFKEMTNGTP 732 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~ 732 (839)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....... .+..+.....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1 1223457889999998865 5689999999999999999999999965432211100000 0000000000
Q ss_pred -cccccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 -LKVADRRLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 -~~~~~~~l~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...-.+.... .........+.+++.+|++.+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000112334678889999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.56 Aligned_cols=240 Identities=23% Similarity=0.392 Sum_probs=187.1
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGD--------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996532 235888888655444456788999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc--------eeecccC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC--------PKVSDFG 652 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~--------~kl~DfG 652 (839)
+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999843 234688999999999999999999984 9999999999999987765 5999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCC-CCCCCCCCCCCccchhhhhhhhccC
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGR-RNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
++...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... .....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~-- 218 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFY-- 218 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHH--
Confidence 88754321 22457888999999986 45799999999999999999995 4443221110 00000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
... ...+......+.+++..||+.+|++||+++++++.|+
T Consensus 219 ------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ------EDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------Hcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0111122345788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=303.60 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=194.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+...++||+|+||.||++.. .+++.||||.+...... ....+..|+.++.+++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 44567899999999999966 46889999998653222 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999988432 234588999999999999999999984 9999999999999999999999999999765322
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....... . .....
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~----~-~~~~~ 224 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVK----E-VQEEY 224 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhh----h-hhhhc
Confidence 21 123468999999999999999999999999999999999999997533211000 0000000 0 00011
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
.......+.+++..||+.+|.+||+ +.|+++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112334678888899999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=332.05 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=199.1
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.++||+|+||.||+|... +++.||||++...... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3567789999999999999764 5899999999654322 23568999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCC------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 580 FMKNGSLDKWIFPSYH------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
|+++|+|.+++..... .....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999998853211 1123456778899999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCc-----------------eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCC
Q 038743 654 AKLMGREHS-----------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716 (839)
Q Consensus 654 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~ 716 (839)
++....... .......||+.|||||.+.+..++.++|||||||++|||++|+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 987621110 001124699999999999999999999999999999999999999964322110
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhcCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-SMGEVVKMLEGS 780 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~~v~~~L~~~ 780 (839)
. ... . +.++... ....+....+.+++.+|++.+|++|| +++++++.|+..
T Consensus 240 ~------~~~----~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 240 S------YRD----V---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h------hhh----h---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000 0 0000000 00012234567888999999999996 677777777654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.01 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=195.9
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++.+++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4567789999999999999976 6788999998643 2345789999999999999999999998654 5799999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 82 KGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999998532 23467899999999999999999998 499999999999999999999999999997643221
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ......+ ..
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~---------~~ 215 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------V-KECVEKG---------YR 215 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------H-HHHHhCC---------CC
Confidence 11234567999999998899999999999999999997 999886332111 0 0111111 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
..........+.+++.+|++.+|++||++.+|++.|++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11112234567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.18 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=199.8
Q ss_pred hhccccccccCCCceEEEEEeCC-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.+.||+|+||.||+|...+ ++.+++|.+..... ..++.+|++++++++||||+++++++.+....++++||++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 45667889999999999998754 78999999865422 6789999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 82 AGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999842 345789999999999999999999985 999999999999999999999999999987644321
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ....... .+. .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~--~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKP-----PPT--L 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCC-----CCC--C
Confidence 223345788999999999999999999999999999999999998643321110 0000000 000 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+......+.+++.+|++.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223346788889999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.27 Aligned_cols=199 Identities=23% Similarity=0.321 Sum_probs=160.8
Q ss_pred ccccccCCCceEEEEEeC---CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec--CCceEEEEeecc
Q 038743 508 AQLLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNRLLVYEFMK 582 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 582 (839)
.++||+|+||+||+|... +++.||+|.+... .....+.+|++++.+++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999764 4678999998643 223467899999999999999999998854 456789999986
Q ss_pred CCChhhhcccCC----CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE----CCCCceeecccCcc
Q 038743 583 NGSLDKWIFPSY----HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLA 654 (839)
Q Consensus 583 ~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla 654 (839)
+ +|.+++.... ......+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 7777763211 11223588889999999999999999995 99999999999999 46678999999999
Q ss_pred eecCCCCce--eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 655 KLMGREHSQ--VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 655 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
+.+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543221 1234568999999999877 468999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.91 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=191.5
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+...+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++.+++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 34557899999999999976 4688999999865322 2234577899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999888432 234689999999999999999999984 9999999999999999999999999999765322
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 156 ~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05632 156 E--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE--------- 221 (285)
T ss_pred C--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc---------
Confidence 1 122346899999999999999999999999999999999999999643221100 00001111000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMG 771 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~ 771 (839)
..........+.+++..|++.+|++||++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011112233467788889999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=301.35 Aligned_cols=240 Identities=26% Similarity=0.344 Sum_probs=192.8
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCcch---HHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.||.|+||.||.++. .+.+.||||++.-.-.+.. .++..|++.|.+++|||++.+-|++..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 4699999999999965 5788999999965444333 4688999999999999999999999999999999999965
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+-.++|. -..+++.+.++..|+.+.+.||+|||++ +.||||||+.||||++.|.|||+|||.|.+..+.
T Consensus 111 SAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 111 SASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred cHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 5555552 2356888999999999999999999996 8999999999999999999999999999876543
Q ss_pred EEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 665 VTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
..++|||.|||||++. .+.|+-|+||||||++..||.-.++|+-....-. +.-++.... .|.+.
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNe-----sPtLq 246 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNE-----SPTLQ 246 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcC-----CCCCC
Confidence 3467999999999885 4789999999999999999999998874322100 111111111 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+....+..++-.|++.-|.+|||.+++++.
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34556677888888999999999999998764
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.06 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=199.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.+.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 55677899999999999965 57899999999765445566789999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|..++. ...+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 101 GSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999883 33589999999999999999999995 9999999999999999999999999998865433221
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......... ........ +.+ .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-------~~~~~~~~-----~~~--~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGT-----PEL--Q 236 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCC-----ccc--C
Confidence 22345888999999999988999999999999999999999999654321110 00000000 000 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111223356778889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=322.28 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=187.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecC--------Cce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--------SNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~ 574 (839)
.|.+.++||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 466788999999999999976 46889999988532 22345799999999999999998876321 246
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGL 653 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGl 653 (839)
++||||+++ +|.+++... ......+++..+..++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||+
T Consensus 143 ~lvmE~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHY-ARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEecCCc-cHHHHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 689999985 676665321 12345788999999999999999999995 999999999999998664 799999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh-----hhhh
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA-----FKEM 727 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-----~~~~ 727 (839)
++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........ ...+
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 986543221 223457999999998876 46899999999999999999999999754322110000000 0000
Q ss_pred c--cCccc-----ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 728 T--NGTPL-----KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 728 ~--~~~~~-----~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. ..... .+....+...++......+.+++.+||+.+|.+|||+.|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00000 0000111111112233567889999999999999999998854
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.16 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=170.1
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.++||+|+||.||+++.. +++.+|+|++.+.. ......+..|+.++..++|+||+++++++.+....++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 3566789999999999999875 47889999985421 1223457889999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 y~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 82 YYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred ccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999942 234688889999999999999999995 999999999999999999999999999976543
Q ss_pred CCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 3333333456999999999986 346889999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.84 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=196.1
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.+.+.||+|+||.||+|... ++..+++|.+..........+.+|++++..++||||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999775 4778999998655444556788999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|..++.. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999988742 235689999999999999999999995 999999999999999999999999999976532211
Q ss_pred eEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
......++..|+|||++. +..++.++|||||||++|||++|+.||......+. ... ........+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~-- 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLK-IAKSEPPTLA-- 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHH-HhhcCCCCCC--
Confidence 123345889999999884 34578899999999999999999999864321110 000 0000000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.+......+.+++.+||+.+|.+||++.++++.-
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1111234577888999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.10 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=199.2
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+...+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++.+....++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 445678999999999999764 58899999986442 2335678899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++. ...+++.+...++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~i~------~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 86 GGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999883 2357888999999999999999998 4999999999999999999999999999987643321
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.......... ........
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCC
Confidence 1223457889999999998889999999999999999999999986433211100 00011112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233455678889999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.24 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=198.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.+.||+|+||.||++.. .+++.+|+|.++... ....+.+..|+.+++.++|+||+++++.+......+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 45678999999999999976 468899999985432 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++... ....++....+.++.||+.||.|||+. +|+|+||||+||++++++.++|+|||++..+.....
T Consensus 82 ~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 82 GGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999988422 344678899999999999999999985 999999999999999999999999999986643222
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... . ......+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~--------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------L-ILKVCQGSYK--------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------H-HHHHhcCCCC---------
Confidence 1223458889999999999899999999999999999999999996432110 0 0111111110
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+......+.+++.+||+.+|++||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111223457788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.36 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=196.8
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcch--HHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||+||+++.. +++.+|+|.+........ ....+|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356789999999999999775 466899999976533222 23456999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.++|. ....+++..+..++.||++||++||+. +|+|+||||+||++++++.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-EN 151 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-ST
T ss_pred cccccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cc
Confidence 9999999994 356789999999999999999999995 99999999999999999999999999998652 22
Q ss_pred ceeEEeeccccceeCccccc-CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
........++..|+|||++. +...+.++||||+|+++++|++|..|+......... ......... ..... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~----~~~~~~~~~---~~~~~-~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL----EIIEKILKR---PLPSS-S 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH----HHHHHHHHT---HHHHH-T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh----hhhhhcccc---ccccc-c
Confidence 22334556899999999998 888999999999999999999999999744100000 000000000 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.........+.+++..|++.+|++||++.++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011267888899999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.12 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=198.5
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456788999999999999764 68899999986543 3334578899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 83 GGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999832 2789999999999999999999985 899999999999999999999999999987754322
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......++..|+|||++.+..++.++||||||+++|||++|+.||........ ......... +.+..
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~-----~~~~~ 220 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNP-----PSLEG 220 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCC-----CCCcc
Confidence 22334578899999999998899999999999999999999999964331110 011111110 11111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. .....+.+++.+|++.+|++||+++++++.
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 023457788899999999999999999773
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.20 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=195.6
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcc---------hHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHG---------EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
+.+.+.||+|+||.||+|.. .+++.+|+|.+....... .+.+.+|+.++.+++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 44677899999999999976 468899999886443221 14578899999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++|+||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHH-----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999983 234678889999999999999999984 9999999999999999999999999999
Q ss_pred eecCCCCce-----eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 655 KLMGREHSQ-----VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 655 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
+........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~ 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------IFKIGE 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------HHHHhc
Confidence 876422111 11223578899999999998899999999999999999999999964322110 000000
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+ ..+......+.+++.+||+.+|.+||++.+|++
T Consensus 227 -----~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 112223456778888999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.91 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=189.1
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhcc---ccCCcccccceeec-----CCc
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSM---HHMNLVRLCGYCSE-----GSN 573 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 573 (839)
|.+.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.++.++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 45678899999999999976 46899999998653222 223566777776665 79999999998764 345
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++ +|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred EEEEEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 7899999984 888887432 234588999999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc-chhh----hhhhhc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF-YPGW----AFKEMT 728 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-~~~~----~~~~~~ 728 (839)
++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .... ....+.
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 987643221 223457899999999999899999999999999999999999986543211100 0000 000000
Q ss_pred cC-c-cccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 729 NG-T-PLKVADRRLE---GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 729 ~~-~-~~~~~~~~l~---~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. . ......+... .....+....+.+++.+|++.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0 0000000000 0011122345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.46 Aligned_cols=251 Identities=21% Similarity=0.268 Sum_probs=196.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.++..++||||+++++.+......++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 556678999999999999976 4688999999875544444568889999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 90 ~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 90 GGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999883 234688999999999999999999995 999999999999999999999999999976543221
Q ss_pred eeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+......... .... ... ...+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~-~~~---~~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMT-KSN---FQPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhh-ccC---CCCCc
Confidence 123346899999999874 456889999999999999999999998533221110 0000 000 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..... .....+.+++.+|++.+|++||++.+|++
T Consensus 231 ~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 10000 11234678889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.15 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=199.6
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCc----EEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGT----LVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...+.+.+.||+|+||.||+|... +++ .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 345567789999999999999764 233 689998865533 334678899999999999999999999987 7889
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999999843 234589999999999999999999994 99999999999999999999999999998
Q ss_pred ecCCCCceeE-EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQVV-TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
.......... ....++..|+|||.+....++.++||||||+++||+++ |+.||+.....+ ....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~- 229 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER- 229 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCC-
Confidence 7653322211 11223568999999988899999999999999999998 999986432211 0111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
...+......+.+++.+||..+|++||++.++++.|+...
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 --------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0011112235678888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=278.71 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=197.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC----cch----HHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP----HGE----KEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~----~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
.+.-.+.||+|..++|.+... .+|+..|+|++..... ... +.-..|+.+|+++ .||+|+++.++++....
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 345567899999999998855 5688999999853221 112 2356799999998 79999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++|+|.|+.|.|.++|. ....+++....+|+.|+..|+.|||.. .|+||||||+|||+|++.++||+|||+
T Consensus 98 ~FlVFdl~prGELFDyLt-----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLT-----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhcccchHHHHhh-----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 999999999999999993 557899999999999999999999994 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccC------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhh
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSN------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
++.+.+ .......+||++|+|||.+.. ..|+...|+|+.|||+|.|+.|.+||..... ....+.+
T Consensus 170 a~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~I 240 (411)
T KOG0599|consen 170 ACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMI 240 (411)
T ss_pred eeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHH
Confidence 997643 233456789999999998853 4588999999999999999999999852110 0111222
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+|+.. ....--.+......+++.+|++.||.+|-|.+|++..
T Consensus 241 meGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222211 1111112345567788999999999999999998753
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.61 Aligned_cols=261 Identities=21% Similarity=0.192 Sum_probs=195.2
Q ss_pred HHhhccccccccCCCceEEEEEeC---CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...+.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 345778899999999999999653 3578999987542 34568999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
|++. ++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 166 e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9986 68888872 345789999999999999999999995 99999999999999999999999999998664
Q ss_pred CCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhc-------cC
Q 038743 659 REHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT-------NG 730 (839)
Q Consensus 659 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 730 (839)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................+.+. ..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43222 22345699999999999999999999999999999999999999965432210000000000000 00
Q ss_pred ccccc------ccccccCCCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKV------ADRRLEGAVE-------EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~------~~~~l~~~~~-------~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+ .......... ......+..++.+|++.+|++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0000000000 0112346678889999999999999999775
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.99 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=196.2
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC-----CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
+.+.+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345678999999999999875 78999999985432 123457889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++. ....+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 82 ELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999983 234588999999999999999999985 99999999999999999999999999998754
Q ss_pred CCCceeEEeeccccceeCcccccCCC-CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||....... ..........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~------ 219 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKE------ 219 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhccc------
Confidence 332 223445888999999987776 8999999999999999999999986432111 0011000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+......+.+++.+||+.+|++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01112223355678888999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.02 Aligned_cols=190 Identities=23% Similarity=0.312 Sum_probs=161.8
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++.+++||||+++++++.+....++|+||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 35677889999999999999774 5778999975432 2456899999999999999999999999999999998
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
. ++|.+++.. ....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 140 S-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred C-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 5 688888742 345789999999999999999999995 99999999999999999999999999997532211
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCC
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNL 708 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~ 708 (839)
......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123346899999999999999999999999999999999876555
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.35 Aligned_cols=198 Identities=23% Similarity=0.327 Sum_probs=159.8
Q ss_pred cccccCCCceEEEEEeC---CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee--cCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS--EGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~~ 583 (839)
.+||+|+||.||+|+.. ++..||+|.+... .....+.+|++++.+++||||+++++++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 3578999998653 22346789999999999999999999884 35677899999875
Q ss_pred CChhhhcccCC----CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE----CCCCceeecccCcce
Q 038743 584 GSLDKWIFPSY----HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAK 655 (839)
Q Consensus 584 gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla~ 655 (839)
+|.+++.... ......+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 6766663211 11234578889999999999999999995 99999999999999 567899999999998
Q ss_pred ecCCCCce--eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 656 LMGREHSQ--VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 656 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76543222 1233468999999999876 458999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.82 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=195.9
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCCc------chHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
+...+.||+|+||.||+|...+++.+|||.+...... ....+.+|++++++++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 3456789999999999998888999999988643211 1245888999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++. +...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++....
T Consensus 82 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 82 EFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred ecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999983 224578899999999999999999985 89999999999999999999999999997643
Q ss_pred CCC-----ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 659 REH-----SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 659 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
... ........|+..|+|||++.+..++.++||||||++++||++|+.||......... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~--- 223 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-------FYIGAH--- 223 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-------HHhhhc---
Confidence 211 11122345889999999999988999999999999999999999999643211100 000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+. .+......+..++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RGLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111 12223445678889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.86 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=196.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4667789999999999999774 588999999976555556778999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|..++.+ ....+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 93 GGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999888742 234689999999999999999999985 99999999999999999999999999987543221
Q ss_pred eeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.......++..|+|||++. ...++.++||||||+++|||++|+.||....... ..........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~----- 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEP----- 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------HHHHHhcCCC-----
Confidence 1123345788999999885 3457889999999999999999999986432110 0011111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+.. ..+......+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 011122345778889999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.20 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=200.6
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|+.++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45678999999999999865 568899999985432 334567889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 82 NGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred CCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999998432 245688999999999999999999985 89999999999999999999999999998764433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. .....+...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~-~~~~~~~~~-------- 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LV-VKIVQGNYT-------- 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHcCCCC--------
Confidence 2 2233458899999999998889999999999999999999999986432211 01 111111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.........+.+++.+|++.+|.+||++.++++.+
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01122344577888899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=309.19 Aligned_cols=240 Identities=22% Similarity=0.257 Sum_probs=182.7
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhcc---ccCCcccccceeecCCceEEEEeeccC
Q 038743 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSM---HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 511 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
||+|+||+||+|+. .+++.||||++.+... .....+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999976 4689999999864321 1223355566666654 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 99998883 345688999999999999999999995 999999999999999999999999999975422211
Q ss_pred eEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 664 VVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+..+.. .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV------RFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC------CCCC
Confidence 12345689999999998764 58999999999999999999999996432111 1111111110 0111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPS----MGEVVK 775 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt----~~~v~~ 775 (839)
. .....+.+++.+||+.+|.+||+ +.++++
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 12234567888899999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.99 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=194.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCc----EEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGT----LVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
.+...+.||+|+||.||+|.. .+++ .||+|.+..... ....++.+|+.++..++||||++++|++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 334567899999999999975 3444 578998865432 2234688999999999999999999998754 56799
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
+||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 87 ~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 87 TQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999842 234678899999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~--- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEKGER--- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCC---
Confidence 4322211 122335678999999999999999999999999999997 888886432111 00 11111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..........+.+++..||..+|++||+|.++++.|+..
T Consensus 230 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000111234577889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=297.92 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=197.4
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++||||+++++.+......++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567789999999999999875 68999999886432 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|..++... .....+++..+..++.+|+.||.|||+. .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 82 DAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999988432 1134689999999999999999999974 489999999999999999999999999997653221
Q ss_pred ceeEEeeccccceeCcccccCC------CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNR------PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||......... ........+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~---- 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF----AQLSAIVDGD---- 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH----HHHHHHhhcC----
Confidence 1223478899999988554 3588999999999999999999999643211100 0001111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+......+.+++.+|++.+|++||++.+++..
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111223345567788999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.89 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=187.8
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-----cchHHHHHHHHHhhccccCCcccccceeec--CCceEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-----HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNRLL 576 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 576 (839)
+...+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 44568999999999999976 4688999998854321 123458889999999999999999998865 356789
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
++||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 84 FMEYMPGGSVKDQLK-----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999984 234578899999999999999999985 899999999999999999999999999986
Q ss_pred cCCCCc--eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 657 MGREHS--QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 657 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~----- 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQ----- 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcC-----
Confidence 532111 112234578899999999998899999999999999999999999964321110 0000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+ ..+......+..+ .+|+..+|++||+|+||++
T Consensus 225 ~~~~----~~~~~~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNP----QLPSHISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC----CCchhcCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 0011 1111112223333 4788899999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=313.32 Aligned_cols=199 Identities=25% Similarity=0.336 Sum_probs=170.2
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||++... +++.||||++.... ......+..|+.++.+++||||+++++.+.+....++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999764 68999999986432 22345678899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++.....++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 83 ~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 83 LPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999984 345688999999999999999999994 9999999999999999999999999998754321
Q ss_pred Cc----------------------------------eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC
Q 038743 661 HS----------------------------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 661 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113469999999999999999999999999999999999999
Q ss_pred CCCCC
Q 038743 707 NLDMS 711 (839)
Q Consensus 707 p~~~~ 711 (839)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 99644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.43 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=196.2
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
++.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3556789999999999999875 5899999998643222 245688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|..+.. ....+++.++..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 82 VDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred CCccHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999988763 233589999999999999999999985 9999999999999999999999999999875433
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-c-------chhhhhhhhccCc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-F-------YPGWAFKEMTNGT 731 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~-------~~~~~~~~~~~~~ 731 (839)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. . +............
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 22 2223457889999998875 45788999999999999999999988643321100 0 0000000000000
Q ss_pred cc-ccccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 PL-KVADRRLEGA-----VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 ~~-~~~~~~l~~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. ....+..... ........+.+++.+||+.+|++||+|.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0000000000 01123456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=293.01 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=197.7
Q ss_pred cccccccCCCceEEEEEeCC-----CcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 507 FAQLLGTGGFGSVYKGSLGD-----GTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.||.|+||.||++...+ +..||+|++...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999997743 488999999655433 456899999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 83 MEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred cCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999998432 112289999999999999999999995 9999999999999999999999999999876543
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.........++..|+|||.+.+..++.++||||||++++||++ |+.||....... .......+..
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~------- 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYR------- 222 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCC-------
Confidence 2222222337789999999988889999999999999999998 788876422110 0111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
..........+.+++.+|++.+|++|||+.++++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011111344677899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=303.52 Aligned_cols=199 Identities=18% Similarity=0.198 Sum_probs=163.6
Q ss_pred cccccccC--CCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 507 FAQLLGTG--GFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 507 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.++||+| +|++||++.. .+|+.||+|++..... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999966 5789999999865422 22345778999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999998432 234588999999999999999999985 99999999999999999999999998654332111
Q ss_pred ce------eEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 662 SQ------VVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 662 ~~------~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 10 0112346778999999876 46899999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.71 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=194.5
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChh
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
..||+|+||.||++.. .++..||||.+........+.+.+|+.++..++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5799999999999976 468899999986554445567889999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEe
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM 667 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 667 (839)
+++. ...+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......... ...
T Consensus 108 ~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 177 (292)
T cd06658 108 DIVT------HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKS 177 (292)
T ss_pred HHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cce
Confidence 9883 23578999999999999999999995 9999999999999999999999999999765432221 223
Q ss_pred eccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHH
Q 038743 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEE 747 (839)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 747 (839)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ...+.+.. ...
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~-----~~~~~~~~--~~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRD-----NLPPRVKD--SHK 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-----cCCCcccc--ccc
Confidence 4588999999999888899999999999999999999999864322110 011100 01111111 011
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 748 ELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 748 ~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+..++.+|++.+|.+|||++++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22346677788999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=293.11 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=200.7
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.+.||.|+||.||++.. .+++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 456778999999999999976 4578999999976555556789999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++.. ....+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 84 GGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999998842 225688999999999999999999985 999999999999999999999999999986543221
Q ss_pred eeEEeeccccceeCcccccCC---CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR---PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
......++..|+|||.+... .++.++||||||+++|||++|+.||......... ...... ......
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-------~~~~~~---~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-------FLISKS---NFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhc---cCCCcc
Confidence 12234578899999999776 8899999999999999999999998643321110 000000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+ .........+.+++.+||+.+|.+||++.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.09 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=195.3
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++++..+...++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34799999999999976 46899999998654444556788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
..++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 106 ~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 106 TDIVS------QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHh------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 98772 34688999999999999999999985 899999999999999999999999999876543222 122
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...|+..|+|||++.+..++.++||||||++++||++|+.||......+. ...+........ ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~-------~~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPKL-------KNAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccCCCCc-------cccC
Confidence 34588999999999988899999999999999999999999864322110 011111100000 0011
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.....+.+++..|++.+|++||++.+|++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122346778888999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.32 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=206.4
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+++..+||+|+||.||++.+ ..|+.||||.+.- ..+..++..|+.++++...|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 45567999999999999966 4699999998854 45678899999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|++.+.+. .+++.|.+.++..++...++||+|||.. .-||||||+.||||+-+|.+||+|||.|..+.+....
T Consensus 113 GSiSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 113 GSISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CcHHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999984 4678999999999999999999999996 6799999999999999999999999999877554443
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCC-CccchhhhhhhhccCcccccccccccC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE-DFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
. ..+.||+.|||||++..-.|..++||||||+...||..|++|+.....-. .+.+| .. +....
T Consensus 186 R-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--------T~-------PPPTF 249 (502)
T KOG0574|consen 186 R-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--------TK-------PPPTF 249 (502)
T ss_pred h-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--------CC-------CCCCC
Confidence 3 44569999999999999999999999999999999999999996433211 11111 11 11111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+.+....+-+++..|+-..|++|-|+.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2244556778889999999999999999888764
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=292.13 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=198.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||.||++.. .+++.||+|++.... ....+++.+|+.++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 45678999999999999965 468999999986432 233457899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++.+++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 82 EGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999988432 234578899999999999999999984 99999999999999999999999999998764322
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.. .....|++.|+|||++.+..++.++||||||++++||++|+.||...... ...... ..+..
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~--------- 218 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKI-IRGSY--------- 218 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHH-hcCCC---------
Confidence 11 12334788999999999999999999999999999999999998632211 111111 11110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+|++.+|++||+|.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01122334567888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.96 Aligned_cols=264 Identities=20% Similarity=0.267 Sum_probs=193.9
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 34667789999999999999764 68899999986432 22334678899999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
++ ++|.+++.. ....+++..+..++.||++||+|||+. +|+|+||||+|||+++++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 588888742 234678899999999999999999994 9999999999999999999999999999764332
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhhhhhccCc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAFKEMTNGT 731 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~~~~~~~ 731 (839)
.. ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ....+..+....
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 21 1222346889999998865 4578899999999999999999999965432110000 000000000000
Q ss_pred -ccccccccccCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 -PLKVADRRLEGA----VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 -~~~~~~~~l~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......+..... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000 00112335678899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.67 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=198.6
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.+.+.+.||+|+||.||+|... +++.||||.++... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3567789999999999999775 58899999986432 22346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
++++.|..++. ....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99877776552 234588999999999999999999985 9999999999999999999999999999876554
Q ss_pred CceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhhhhhc-cC
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAFKEMT-NG 730 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~~~~-~~ 730 (839)
.........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.... +......+. ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 33233345578899999999888 889999999999999999999999864432110000 000000000 00
Q ss_pred cc-----ccccccc-ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TP-----LKVADRR-LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~-----~~~~~~~-l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. ....+.. .....+......+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0000000 000011122566888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.47 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=196.0
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++|+||+++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 556788999999999999875 58999999985432 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+++.|..++. ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 83 DHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred CccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988763 234689999999999999999999995 99999999999999999999999999998764432
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch-----hhhh--hh-hccCcc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP-----GWAF--KE-MTNGTP 732 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-----~~~~--~~-~~~~~~ 732 (839)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... .+.. .. +.....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 1223347788999999876 56789999999999999999999999654322110000 0000 00 000000
Q ss_pred -cccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 -LKVADRRLEGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 -~~~~~~~l~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.....+......+ ......+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000 112356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=296.90 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=197.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.+.||.|+||.||++... +++.+|+|.+..........+..|++++++++||||+++++.+......++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 3667788999999999999774 688999999875544455678999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 86 GGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999998842 234689999999999999999999995 999999999999999999999999999876533222
Q ss_pred eeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....... ....+.....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----- 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-------VLLKILKSEP----- 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-------HHHHHhcCCC-----
Confidence 223345889999999875 3457889999999999999999999986432111 0011111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+.+ ..+......+.+++..||+.+|.+||++.+|++.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111223456778889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.95 Aligned_cols=263 Identities=24% Similarity=0.262 Sum_probs=195.7
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc-----chHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH-----GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
+.+.+.||+|+||.||+|.. .+++.||||.+...... ....+..|++++.+++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 45667899999999999976 46899999999654322 2345778999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+ +|+|.+++... ...+++..+..++.||++||.|||+. +|+|+||||+|||++.++.+||+|||+++...
T Consensus 82 e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 82 EFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred ccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 999 99999998432 23689999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh-----hhhhhcc-Cc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW-----AFKEMTN-GT 731 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~-----~~~~~~~-~~ 731 (839)
.... ......++..|+|||.+.+ ..++.++||||||++++||++|..+|....+.+......- ....+.. ..
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 4322 1222346788999998865 4678999999999999999999877754332110000000 0000000 00
Q ss_pred ccccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLEGAV-----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
............. .......+.+++.+|++.+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000011 11234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=305.98 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=191.5
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC------c
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------N 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 573 (839)
..|.+.+.||+|+||.||++.. .+++.||||++.... .....++.+|+.++..++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4567788999999999999976 468999999986432 233456889999999999999999999886443 4
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++ +|...+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 7999999975 5555552 2477888899999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc-------ch--hh--
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF-------YP--GW-- 722 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-------~~--~~-- 722 (839)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+ .+
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97643221 1233468999999999999999999999999999999999999997543211000 00 00
Q ss_pred ----hhhhhccCc-------cccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 ----AFKEMTNGT-------PLKVADRRLE---GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 ----~~~~~~~~~-------~~~~~~~~l~---~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+.... ..+....... ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0000000000 00011123457788999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.65 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=200.2
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..+.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++.+......++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4566778999999999999965 468899999986544445567899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999983 23578889999999999999999985 99999999999999999999999999987654332
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.. .....+++.|+|||.+....++.++||||||+++||+++|+.||........... ....+.. .
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~--------~ 234 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP--------E 234 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCC--------C
Confidence 22 2234588899999999888899999999999999999999999965432211100 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..........+.+++..||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223456778889999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.40 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=193.1
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|++|.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456688999999999999774 68999999986432 222356889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+ ++|.+++... .....+++..+..++.||+.||+|||+. +++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 82 S-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred C-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 7 6888887432 2235789999999999999999999985 99999999999999999999999999998654322
Q ss_pred ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc--------chhhhhhhhccC-c
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF--------YPGWAFKEMTNG-T 731 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~-~ 731 (839)
.......+++.|+|||.+.+. .++.++||||||++++||++|+.||.......... ...-.+...... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112223468899999988654 57899999999999999999999997543211000 000000000000 0
Q ss_pred ccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 PLKVADRRLEG---AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 ~~~~~~~~l~~---~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
........... .........+.+++.+|++.+|++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000012345678899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=291.91 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=196.9
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+..|+.++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 45568999999999999976 46889999998654332 4567899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ....+++..+..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 82 SGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCcHHHHHh-----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999984 234578889999999999999999985 99999999999999999999999999998765433
Q ss_pred ceeE---EeeccccceeCcccccCCC---CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 662 SQVV---TMVRGTRGYLAPEWVSNRP---ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 662 ~~~~---~~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.... ....++..|+|||++.+.. ++.++||||||++++|+++|+.||........ .... ...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~---- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFH-VGAGH---- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHH-HhcCC----
Confidence 2221 1345788999999998766 89999999999999999999999964321110 0000 00000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+.+.. .......+.+++.+|++.+|.+||++.+++.
T Consensus 224 -~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001100 0112445678889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=291.43 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=207.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
-|++.+.||+|.|..|-++++ -+|+.||||++.+.... ....+..|++.|+.++|||||+|+.+...+..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 366778999999999999965 47999999999765332 345789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE-CCCCceeecccCcceecCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL-DENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill-~~~~~~kl~DfGla~~~~~ 659 (839)
-.+|+|.+||.. ....+++....+++.||+.|+.|+|+. .++||||||+||.+ .+-|-+||.|||++-.+.+
T Consensus 99 GD~GDl~DyImK----He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 99 GDGGDLFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred cCCchHHHHHHh----hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999953 456788899999999999999999995 99999999999876 5678999999999987643
Q ss_pred CCceeEEeeccccceeCcccccCCCCC-CcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPIT-VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.+..+..+|...|-|||++.+..|+ ++.||||||||||.|++|+.||+...+.+.. ..++|=
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC 234 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC 234 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence 3345667899999999999998886 6899999999999999999999866655432 112332
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. -.++.-....+.+++..|++.||.+|.+.+|++..
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2 12344556678899999999999999999999865
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=307.07 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=192.7
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------Cc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SN 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 573 (839)
..|.+.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 4567788999999999999975 468899999996532 22345688999999999999999999987543 35
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++ +|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 7999999975 6666662 2477888999999999999999984 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc---------chhhhh
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF---------YPGWAF 724 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~---------~~~~~~ 724 (839)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.+ .
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 249 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF-M 249 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-H
Confidence 98654321 1233468999999999999999999999999999999999999996543211100 0000 0
Q ss_pred hhhc-------cCcc-------cccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 KEMT-------NGTP-------LKVADRRL---EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ~~~~-------~~~~-------~~~~~~~l---~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+. .... ..+....+ ...........+.+++.+|++.||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 00000000 000111123467889999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=290.80 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=196.8
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec-CCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 580 (839)
|.+.+.||+|++|.||++... +++.||+|++.... ....+.+..|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567789999999999999764 57899999986432 2334568899999999999999999988764 4457899999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++.++..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 82 ~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 82 CEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999998532 234689999999999999999999984 9999999999999999999999999999876432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. ......+++.|+|||.+.+..++.++||||||++++||++|+.||...... ... .....+..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~-~~~~~~~~-------- 219 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLV-YRIIEGKL-------- 219 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHH-HHHHhcCC--------
Confidence 22 223345889999999999999999999999999999999999998643211 111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122334567889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=328.17 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=197.2
Q ss_pred chHHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec--
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-- 570 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-- 570 (839)
...+.....|.+.+.||+|+||+||++.. ..++.||+|.+.... ......+..|+.++.+|+|||||++++++.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 33455566788889999999999999976 457789999886432 2234568899999999999999999998754
Q ss_pred CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc----CCeeeecCCCCCcEEECC----
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC----RNRIIHCDIKPENILLDE---- 642 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~iiH~dlk~~Nill~~---- 642 (839)
....+|||||+++|+|.++|.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 456899999999999999985321 12346899999999999999999999842 135999999999999964
Q ss_pred -------------CCceeecccCcceecCCCCceeEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCC
Q 038743 643 -------------NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRN 707 (839)
Q Consensus 643 -------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p 707 (839)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 34589999999987643221 233468999999999864 4588999999999999999999999
Q ss_pred CCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 708 LDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
|....... .....+.... .+.. ......+.+++..||+.+|.+||++.+++.
T Consensus 243 F~~~~~~~------qli~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANNFS------QLISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCcHH------HHHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 96432211 0111111110 0100 112345778888999999999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=294.85 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=195.2
Q ss_pred ccccccccCCCceEEEEEeC----CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC------c
Q 038743 506 NFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------N 573 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 573 (839)
.+.++||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999753 36899999986542 233456889999999999999999999886532 2
Q ss_pred eEEEEeeccCCChhhhcccCCC-CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYH-HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
.++++||+++|+|..++..... .....+++.....++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 4788999999999988753321 122357888999999999999999998 499999999999999999999999999
Q ss_pred cceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 653 LAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 653 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
+++......... .....++..|++||.+....++.++||||||+++|||++ |+.||......+ . .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHcC
Confidence 998654322111 122335678999999998899999999999999999999 888875332111 0 0111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.. + .........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 232 ~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 00112345788899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=284.07 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=202.8
Q ss_pred hhccccccccCCCceEEEEEeCC-CcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..++.+.||.|.-|+||++++.+ +..+|+|++.+.. .....+...|.+||+.++||.|+.|+..++..+..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 33456789999999999998854 5899999997654 3334567889999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
||+||+|..++. .+.++.+++....-++..++-||+|||-. |||.|||||+||||.++|++-|+||.|+.....
T Consensus 158 yCpGGdL~~Lrq---kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQ---KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHh---hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999998874 34678899999999999999999999996 999999999999999999999999998853310
Q ss_pred ---------------------------------CCc----------------------eeEEeeccccceeCcccccCCC
Q 038743 660 ---------------------------------EHS----------------------QVVTMVRGTRGYLAPEWVSNRP 684 (839)
Q Consensus 660 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 684 (839)
... ......+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0011246899999999999999
Q ss_pred CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCC
Q 038743 685 ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEV 764 (839)
Q Consensus 685 ~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p 764 (839)
.+.++|.|+|||+||||+.|+.||.+....+.+ ..++-..+...-.++....+.++|...|..||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999999876654322 12222222222223445667788888999999
Q ss_pred CCCCC----HHHHHH
Q 038743 765 FMRPS----MGEVVK 775 (839)
Q Consensus 765 ~~RPt----~~~v~~ 775 (839)
.+|-. +.||.+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 666654
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=294.09 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=193.8
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc----------chHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH----------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.||+|+||.||+|.. .+++.||+|.++..... ..+.+.+|+.++.+++||||+++++++......
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 3467899999999999965 46899999987532110 123578899999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||+|+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999842 24688899999999999999999985 9999999999999999999999999999
Q ss_pred eecCCCCcee-EEeeccccceeCcccccCCC--CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 655 KLMGREHSQV-VTMVRGTRGYLAPEWVSNRP--ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 655 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
+......... .....|+..|+|||.+.... ++.++||||||+++||+++|+.||......+. ..+ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFK-LGNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHH-hhccc
Confidence 8654322211 23345889999999987654 89999999999999999999999853221110 000 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+.. .........+.+++..|++.+|++||+|.+|++.
T Consensus 229 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0001111 1112234567788889999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.58 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=194.0
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceee-----cCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCS-----EGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~ 575 (839)
.++.+.+.||+|+||.||++.. .+++.+|+|.++.. .....++.+|+.++.++ +||||+++++++. .+...+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 3456678999999999999976 46889999988643 22345688899999999 6999999999874 345689
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++++|.+++.... .....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++
T Consensus 97 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCcee
Confidence 9999999999999874321 2335678889999999999999999985 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+......... ......
T Consensus 173 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-------~~~~~~ 244 (286)
T cd06638 173 QLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-------FKIPRN 244 (286)
T ss_pred ecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-------hhcccc
Confidence 6643221 1223458999999998853 45788999999999999999999998643221100 000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
......++ ......+.+++.+|++.+|++||++.||++.+
T Consensus 245 ~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 PPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00001111 11123577889999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.07 Aligned_cols=261 Identities=23% Similarity=0.257 Sum_probs=192.1
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC------Cc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SN 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 573 (839)
..|.+.+.||+|+||.||++.. ..++.||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 4566778999999999999965 4688999999965422 2335678899999999999999999987543 35
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++ +|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 7999999975 5666552 2478888999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc---------chhhhh
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF---------YPGWAF 724 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~---------~~~~~~ 724 (839)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.+..
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98653321 1233468999999999999999999999999999999999999996543111000 000000
Q ss_pred ------hhhccC--ccccccccc-----c---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 ------KEMTNG--TPLKVADRR-----L---EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ------~~~~~~--~~~~~~~~~-----l---~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+.+. ....+..+. + ...........+.+++.+|++.+|++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000000000 0 000111223567889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.38 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=198.5
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 56678999999999999976 468999999986543 223467899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+++|.+++... ...+++.++..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 -~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 82 -PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred -CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99999988432 35689999999999999999999985 99999999999999999999999999998765443
Q ss_pred ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhhhccC-c
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKEMTNG-T 731 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~-~ 731 (839)
........++..|+|||.+.+. .++.++||||||++++||++|+.+|....+....... ...+....+- .
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2223345688999999988654 4689999999999999999998877543321100000 0000000000 0
Q ss_pred cccccccccc----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLE----GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~----~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+..+... .....+....+.+++.+|++.+|.+||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00011223678889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.44 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=190.1
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--C---cchHHHHHHHHHhhccccCCcccccceeecC--CceEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--P---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLL 576 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 576 (839)
+.+.+.||+|+||.||+|.. .+++.||||.+.... . ...+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 45678999999999999976 458999999885321 1 1234678899999999999999999988663 46789
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
+|||+++++|.+++. ....+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 84 FMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 999999999999884 224578888999999999999999985 899999999999999999999999999986
Q ss_pred cCCCCc--eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 657 MGREHS--QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 657 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~------ 222 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIA------ 222 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHh------
Confidence 532211 11223458889999999988889999999999999999999999986332111 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
........+......+..++.+|+. +|++||++++|++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 --TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0001112233344556677777885 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.36 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=197.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 355667899999999999976 468899999886432 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~------~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLE------PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999883 2368899999999999999999998 499999999999999999999999999998654322
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ......... .
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 218 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNN---------P 218 (277)
T ss_pred h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCC---------C
Confidence 1 1223457889999999988889999999999999999999999986432111 000011110 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..........+.+++.+|++.+|.+||+|.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11112233457788899999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=301.76 Aligned_cols=197 Identities=27% Similarity=0.407 Sum_probs=168.6
Q ss_pred hhccccccccCCCceEEEE-EeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-c-----CCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-H-----MNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l 576 (839)
+|.+.+.||+|+||.|.|+ +..+++.||||++++. ..-..+...|+++|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6788899999999999999 5677999999999865 333456778999999986 3 389999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC--CCceeecccCcc
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--NFCPKVSDFGLA 654 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla 654 (839)
|+|.+.. +|.++|... +-..|+...+..|+.||+.||.+||+ .+|||+||||+||||.+ .-.+||+|||.+
T Consensus 266 VfELL~~-NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhhhh-hHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999854 999999644 44568999999999999999999998 49999999999999964 347999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
......- ....-++-|.|||++.+.+|+.+.||||||||+.||++|.+.|-+..
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 8754322 24446778999999999999999999999999999999987776544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.44 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=195.7
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccc---cCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e 579 (839)
|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....++.+|+.++++++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44567899999999999976 578999999986542 333457889999999986 9999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++. ...+++.....++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 83 YAEGGSVRTLMK------AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred cCCCCcHHHHHH------ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999883 23688999999999999999999985 999999999999999999999999999987654
Q ss_pred CCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..... ..+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KPP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CCC
Confidence 332 2233468899999998875 457899999999999999999999996433211100 00000 001
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+... .....+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 133457788889999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.45 Aligned_cols=250 Identities=25% Similarity=0.285 Sum_probs=196.5
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||++... +++.||+|.+...... ..+.+..|++++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 556788999999999999775 4899999999654322 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+.+++|.+++... ....+++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 83 CPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred cCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999988422 345789999999999999999999985 9999999999999999999999999998754321
Q ss_pred Cce----------------------------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 661 HSQ----------------------------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 661 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0112357889999999999889999999999999999999999996433
Q ss_pred CCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 038743 713 DAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS----MGEVVK 775 (839)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt----~~~v~~ 775 (839)
.... ... +................+.+++.+|++.+|++||+ +.+++.
T Consensus 237 ~~~~-------~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET-------FSN--------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH-------HHH--------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 000 11111111111114566888999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=291.91 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=198.6
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.+.||+|+||.||++... +++.||+|.+.... .....++.+|++++++++||||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 455678999999999999775 68999999986543 2345678999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++... ...++...+..++.|++.||+|||+. .+++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999998432 25788899999999999999999982 3899999999999999999999999999876533222
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
.. ..++..|+|||++.+..++.++||||||++++||++|+.||......... .. ...+....+.. .
T Consensus 157 ~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~-~~~~~~~~~~~---------~ 222 (265)
T cd06605 157 KT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IF-ELLQYIVNEPP---------P 222 (265)
T ss_pred hc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HH-HHHHHHhcCCC---------C
Confidence 11 55888999999999999999999999999999999999999644321110 00 00111111100 0
Q ss_pred CCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 743 AVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 743 ~~~~~-~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..... ....+.+++..|++.+|++||++.+++..
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 34457788899999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=304.94 Aligned_cols=257 Identities=23% Similarity=0.274 Sum_probs=189.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC------Cce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 574 (839)
.|.+.+.||+|+||.||++.. .+++.||||++..... .....+.+|++++.+++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 455678999999999999975 5688999999865322 2235677899999999999999999987543 456
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++++|++ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 96 ~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 96 YLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 8999987 788988772 34688999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc-c-------hhhhhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF-Y-------PGWAFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-~-------~~~~~~ 725 (839)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... . ......
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 223458999999999877 578999999999999999999999996432111000 0 000000
Q ss_pred hhccCcccccccccccCCCCH--------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGTPLKVADRRLEGAVEE--------EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~--------~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+.......... .+. ..+. .....+.+++.+|++.+|.+|||+.++++.
T Consensus 242 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 000 0000 012246788999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.26 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=197.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC------cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP------HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
+...+.||+|+||.||++.. .+++.||+|.+..... ...+.+..|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34567899999999999975 5789999999864321 1235688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCccee
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKL 656 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~ 656 (839)
+||+++++|.+++. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++ .+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 82 VEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EeccCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999984 234688899999999999999999995 999999999999998775 599999999987
Q ss_pred cCCCCce---eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 657 MGREHSQ---VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 657 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
+...... ......++..|+|||.+.+..++.++||||+|++++||++|+.||......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~-------- 222 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFK-------- 222 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHH--------
Confidence 6433111 112345788999999998888999999999999999999999998643221111 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..........+......+.+++.+|++.+|++||++.++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 -IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001112233344566788999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=321.22 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=205.2
Q ss_pred HHHHHhhccccccccCCCceEEEEEeC--------CCcEEEEEEecccCCc-chHHHHHHHHHhhcc-ccCCccccccee
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLG--------DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSM-HHMNLVRLCGYC 568 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~ 568 (839)
++......+.+.||+|.||.|++|.+. ....||||+++..... ..+.+..|+++|..+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333444456679999999999999752 1457999999765433 456799999999998 799999999999
Q ss_pred ecCCceEEEEeeccCCChhhhcccCC---------CCCc--ccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSY---------HHRD--RVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
......++|+||+..|+|.+||.... .... ..|.....+.++.|||.||+||++. ++|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997654 1111 2388999999999999999999995 89999999999
Q ss_pred EEECCCCceeecccCcceecCCCCceeEEeec--cccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCC
Q 038743 638 ILLDENFCPKVSDFGLAKLMGREHSQVVTMVR--GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDA 714 (839)
Q Consensus 638 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~ 714 (839)
||+.++..+||+|||+|+...+.......... -...|||||.+....|+.|+|||||||+||||++ |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999965554444333222 3566999999999999999999999999999996 56666431101
Q ss_pred CCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 715 EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.-..+.+++|. +...+......+.+++..||+.+|++||++.++++.|+.
T Consensus 529 ------~~l~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 ------EELLEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred ------HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11122333322 112233345566788888999999999999999999986
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.74 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=202.3
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.+.||+|++|.||++... +++.||||++..... ....++.+|+..+.+++|+||+++++++......++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 456789999999999999775 489999999876543 345679999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhh-ccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE-QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+++|.+++.. ...+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 83 GGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999942 2578999999999999999999998 6 99999999999999999999999999998764433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||........... ........ .
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~----~~~~~~~~---------~ 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL----MQAICDGP---------P 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH----HHHHhcCC---------C
Confidence 22 1234578899999999999999999999999999999999999965432110000 01111100 0
Q ss_pred CCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~-~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+.. ....+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 34578888899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=305.73 Aligned_cols=245 Identities=27% Similarity=0.407 Sum_probs=192.5
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEe--cccC--CcchHHHHHHHHHhhccccCCcccccceeecCCc--eEEEEe
Q 038743 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKL--DRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN--RLLVYE 579 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l--~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv~e 579 (839)
|..+||+|+|-+||||.. .+|..||--.+ ++.. +.....|..|+.+|+.|+||||++++....+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 456899999999999965 35666764433 2222 3334679999999999999999999999877655 788999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMG 658 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~ 658 (839)
.|..|+|..|+. +.+.++.+.+..++.||++||.|||++ .++|||||||..||+|+. .|.|||+|+|||.+..
T Consensus 124 L~TSGtLr~Y~k-----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRK-----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHH-----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999994 456788889999999999999999996 689999999999999975 5899999999999876
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
...... +.|||.|||||+.. ..|...+||||||++++||+|+..|+...... ....+++..|....-+
T Consensus 198 ~s~aks---vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl-- 265 (632)
T KOG0584|consen 198 KSHAKS---VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAAL-- 265 (632)
T ss_pred ccccce---eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHh--
Confidence 544332 67999999999776 88999999999999999999999999644322 1223333333221111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+. ...+.++|.+|+.. ..+||++.|+++.
T Consensus 266 ---~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 ---SKVK---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---hccC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1111 23466788889999 9999999999863
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=290.30 Aligned_cols=260 Identities=25% Similarity=0.306 Sum_probs=197.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecC--CceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 580 (839)
+.+.+.||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 44567999999999999987 4688999999865432 3456789999999999999999999988653 468999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++.... .....++...+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 83 CEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred cCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999998874321 2345678889999999999999999995 9999999999999999999999999998754322
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||......... .... ...........+.+ ..
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~-~~ 232 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIEL-LSYIVNMPNPELKD-EP 232 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHH-HHHHhcCCchhhcc-CC
Confidence 21 2334788999999999999999999999999999999999999754321000 0000 01111101101100 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. .......+.+++.+||+.+|.+||||.||++.
T Consensus 233 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 01234567899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=287.21 Aligned_cols=247 Identities=22% Similarity=0.382 Sum_probs=196.4
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+.+.||+|+||.||++.. .+++.+|||.+.... ......+.+|++++++++||||+++++.+......++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 45678999999999999966 468899999986432 233567889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-CceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~~~~~~ 660 (839)
++++|.+++... ....+++..+..++.+++.||+|||+. +++|+||||+||+++++ ..+||+|||++......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 82 PGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999532 244588999999999999999999995 99999999999999854 46899999999876432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .... ...+..
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~-~~~~~~-------- 218 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLK-IMSGTF-------- 218 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHH-HHhcCC--------
Confidence 21 122457889999999998889999999999999999999999986432211 1111 111100
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+......+.+++.+||+.+|++|||+.++++
T Consensus 219 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 -APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111123445778899999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-33 Score=317.41 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=186.2
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc------cCCcccccceeecC-Cce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH------HMNLVRLCGYCSEG-SNR 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~-~~~ 574 (839)
..|.+.++||+|+||+||+|.. ..++.||||+++.. .....++..|+.++..++ |++++++++++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 4566788999999999999976 46889999999653 222345566777776665 44588888888654 568
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC----------
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---------- 644 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---------- 644 (839)
++|||++ +++|.+++. ....+++..+..|+.||+.||.|||+. .+||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIM-----KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EEEEecc-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence 8899887 778888874 234689999999999999999999973 4899999999999998765
Q ss_pred ------ceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc
Q 038743 645 ------CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF 718 (839)
Q Consensus 645 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 718 (839)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998864322 1234568999999999999999999999999999999999999997654321111
Q ss_pred chhhhhh----hhcc----Ccccccccc--cccCCC---------------CHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 038743 719 YPGWAFK----EMTN----GTPLKVADR--RLEGAV---------------EEEELMRAMKVAFWCIQDEVFMRPSMGEV 773 (839)
Q Consensus 719 ~~~~~~~----~~~~----~~~~~~~~~--~l~~~~---------------~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v 773 (839)
....... .+.. .....+.+. .+.... .......+++++.+||+.||++|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 0000000 0000 000000000 000000 00123457789999999999999999999
Q ss_pred HH
Q 038743 774 VK 775 (839)
Q Consensus 774 ~~ 775 (839)
++
T Consensus 436 L~ 437 (467)
T PTZ00284 436 TT 437 (467)
T ss_pred hc
Confidence 87
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=290.53 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=199.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec--CCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e 579 (839)
|.+.+.||.|+||.||++.. .+++.||+|.+.... ....+.+..|++++++++||||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 45678899999999999965 568899999986432 2234568889999999999999999997753 456789999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc--CCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC--RNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|+++++|.+++... ......+++..++.++.||+.||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 82 ~~~~~~L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 82 YCEGGDLAQLIQKC-KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hccCCCHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999998532 123457899999999999999999999332 359999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ..+....+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------ 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGK------ 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhcCC------
Confidence 543321 223458899999999999889999999999999999999999997433110 011111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+......+.+++.+|++.+|++||++.+|++.
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112223344677889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=288.10 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=199.9
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+.+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+++++.++|+||+++++.+......++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 356778999999999999975 468899999986432 234567899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++.... ....+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 82 SGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999985321 124688999999999999999999985 99999999999999999999999999998665432
Q ss_pred ce---eEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 662 SQ---VVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 662 ~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.. ......|+..|+|||.+... .++.++||||||+++|||++|+.||......+.. ....... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-------~~~~~~~-----~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-------MLTLQND-----P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH-------HHHhcCC-----C
Confidence 22 12334588999999998877 7899999999999999999999999643321100 0000000 0
Q ss_pred ccccCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAV-EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+.+.... .......+.+++.+|++.+|++||++.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111 0123456778888999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=292.49 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=192.0
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeec------CCce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE------GSNR 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~ 574 (839)
..+.+.+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.++.++ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 3456678999999999999976 56889999998543 23345688899999998 79999999999853 4578
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
+++|||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+|+||||+||++++++.++|+|||++
T Consensus 95 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 9999999999999988432 234577888899999999999999995 9999999999999999999999999998
Q ss_pred eecCCCCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.......... ....
T Consensus 169 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-------~~~~ 240 (282)
T cd06636 169 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPR 240 (282)
T ss_pred hhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-------hHhh
Confidence 76532211 122345888999999876 3467889999999999999999999996432211100 0000
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. .+.+ ........+.+++..||+.+|.+||++.|+++
T Consensus 241 ~~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NP-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000 01122346788899999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=293.06 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=192.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.++.+++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 45678899999999999976 468999999986432 222356788999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+ ++|.+++.. ....+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 82 ~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 82 D-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred C-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 7 578777632 234689999999999999999999995 99999999999999999999999999998654322
Q ss_pred ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc---------chhhhhhhhc---
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF---------YPGWAFKEMT--- 728 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~---------~~~~~~~~~~--- 728 (839)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+..... .....+....
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1 12233578899999988764 47899999999999999999999874332211000 0000000000
Q ss_pred cCccccccccccc-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 729 NGTPLKVADRRLE-GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 729 ~~~~~~~~~~~l~-~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
............. ..........+.+++.+|++.+|.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000 0001122356678899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=294.28 Aligned_cols=246 Identities=26% Similarity=0.299 Sum_probs=192.4
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.+.||+|+||.||+|... +++.||+|.+..... ...+++.+|++++..++||||+++.+++.+....++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3566789999999999999764 689999999854322 223568899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|++ |+|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++.....
T Consensus 96 ~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 96 YCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 997 567666632 234689999999999999999999985 999999999999999999999999999976533
Q ss_pred CCceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
.. ...++..|+|||.+. ...++.++||||||+++|||++|+.||........ . ........
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~-~~~~~~~~---- 231 (307)
T cd06607 168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNDS---- 231 (307)
T ss_pred CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------H-HHHhcCCC----
Confidence 21 235788999999874 45688999999999999999999999864321110 0 00000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
+.+ ........+.+++.+||+.+|++||+|.+|+...
T Consensus 232 -~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 -PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000 0112345678889999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=294.76 Aligned_cols=278 Identities=23% Similarity=0.313 Sum_probs=209.0
Q ss_pred hccccccccCCCceEEEEEeCC-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+++.-.||-|+||.||++...+ +-..|-|.+.-........|+-|++||+...||+||+|++.+..++.++|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3455679999999999997654 445677888766666677899999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|-++..+.. -++.|.+.++.-++.|++.||.|||+. .|||||||+.|||++-+|.++|+|||.+-..... .+
T Consensus 114 GAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 114 GAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred chHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 999988743 467899999999999999999999995 9999999999999999999999999998643221 12
Q ss_pred eEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
....+.||+.|||||++. ..+|+.++||||||+.|.||.-+.+|..... |..+.-.+....+..++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKSePPTLlq- 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSEPPTLLQ- 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhcCCCcccC-
Confidence 234567999999999875 4789999999999999999999988864221 111111121111111222
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCCCCCCCchhhHHHhhhchhhHHHhhh
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIEEGLDHVYKAMK 808 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~ 808 (839)
+......+.++..+|+..+|..||++.++++.=-- -..|.. ..+...+.+....+.+++.
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv---~~~~Sn-K~ireLlAEakAeV~EEve 317 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV---QNAPSN-KMIRELLAEAKAEVQEEVE 317 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc---ccCCcc-hHHHHHHHHHHHHHHHHhh
Confidence 12334456677778999999999999999764211 112222 4455555555555554444
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=291.20 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=195.5
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
.+.||+|++|.||++.. .+++.+++|++........+.+.+|+.++..++||||+++++++......++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46999999999999975 56889999998654444456788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
.+++.. ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++......... ..
T Consensus 104 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~ 173 (285)
T cd06648 104 TDIVTH------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RK 173 (285)
T ss_pred HHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cc
Confidence 998832 4688899999999999999999995 9999999999999999999999999988765432221 22
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .......... +.+.. ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~~~--~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNLP-----PKLKN--LH 239 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHhcCC-----CCCcc--cc
Confidence 3458899999999998889999999999999999999999986432111 0111111100 00100 11
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.....+.+++.+|++.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 12346788899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=293.01 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=195.8
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC--CceEEEEee
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLVYEF 580 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 580 (839)
.+.+.||.|+||.||+|+.. +++.+|+|++.... ......+.+|++++.+++|+|++++++++.+. ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999775 58899999997653 22345688999999999999999999999887 899999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++ +|.+++.. ....+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 82 ~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 82 MDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 975 88888742 225789999999999999999999985 8999999999999999999999999999877554
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhhhcc--
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKEMTN-- 729 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~-- 729 (839)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ...+..+..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3322333456888999998765 46789999999999999999999999654321100000 000000000
Q ss_pred ----CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 ----GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ----~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..........+...........+.+++..|++.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000111111112557889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=292.12 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=192.0
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+.+.||+|++|.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4566789999999999999764 6899999998654322 2345778999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++ +|.+++.. ....+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 86 DT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 85 89888742 234678899999999999999999985 99999999999999999999999999987543211
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCC-ccch--------hhhhhhhccC-
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED-FFYP--------GWAFKEMTNG- 730 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~--------~~~~~~~~~~- 730 (839)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .... ...+......
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1 1122246788999998875 5688999999999999999999999964431100 0000 0000000000
Q ss_pred ---c-ccccc-cccccCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 ---T-PLKVA-DRRLEGAV-EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ---~-~~~~~-~~~l~~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. ..... ...+.... .......+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000 00000000 0011256678899999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=290.68 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=189.9
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHH-hhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNT-IGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|+||.||++... +|+.||+|+++... .....++..|+.. ++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999764 68999999986543 2334456667665 55568999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+ |+|.+++.... .....+++..++.++.||+.||+|||+. .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 68888774322 2335789999999999999999999983 389999999999999999999999999998653321
Q ss_pred ceeEEeeccccceeCcccccC----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... .. ......+. .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~--~~~~~~~~-----~ 225 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----QQ--LKQVVEEP-----S 225 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH----HH--HHHHHhcC-----C
Confidence 1223457889999998865 456889999999999999999999985322110 00 00000110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+.+. .......+.+++.+|++.+|++||++.+|++
T Consensus 226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 0112345778888999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=292.86 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=191.2
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 3456899999999999976 458999999986432 234457889999999996 9999999999999999999999986
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
. +|.++...........+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 554433111111335688999999999999999999974 4899999999999999999999999999976533221
Q ss_pred eeEEeeccccceeCcccccCC---CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR---PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.....|+..|+|||.+.+. .++.++||||||+++|||++|+.||...... .. .......+. .+.
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~-----~~~ 230 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FD-QLTQVVKGD-----PPI 230 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HH-HHhhhcCCC-----CCc
Confidence 1223578899999998776 6899999999999999999999998633210 00 000110010 111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+...........+.+++.+|++.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112344567889999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=294.10 Aligned_cols=253 Identities=24% Similarity=0.279 Sum_probs=195.6
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+...+.||+|+||.||+++. .+++.||+|++..... ....++.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44567899999999999976 4688999999864322 2234688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
++ |+|.+++.. ....+++.++..++.||+.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 97 477776632 234689999999999999999999985 9999999999999999999999999998754332
Q ss_pred CceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
....|+..|+|||++. .+.++.++||||||+++|||++|+.||........ ........
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~------ 240 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNE------ 240 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhcc------
Confidence 2235788999999874 45789999999999999999999999864321110 00110000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINT 785 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~~~ 785 (839)
............+.+++.+|++.+|.+||++.+|++.+.-....+.
T Consensus 241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 0001111233457788899999999999999999987655444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=291.01 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=193.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecC-----CceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG-----SNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~l 576 (839)
.+.+.+.||+|+||.||++.. .+++.+|+|.+... .....++.+|+.++.++ +|||++++++++... ...++
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 355677999999999999976 56889999998653 22345678899999998 899999999998653 35899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
|+||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..
T Consensus 102 v~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 102 VLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 999999999999884321 2345688999999999999999999985 999999999999999999999999999986
Q ss_pred cCCCCceeEEeeccccceeCcccccCC-----CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNR-----PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
....... .....|+..|+|||.+... .++.++||||||+++|||++|+.||........ ........
T Consensus 178 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-------~~~~~~~~ 249 (291)
T cd06639 178 LTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-------LFKIPRNP 249 (291)
T ss_pred ccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-------HHHHhcCC
Confidence 5432211 1234578899999988653 368999999999999999999999864322110 00111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+.+ ..+....+.+++.+|++.+|++||++.++++.
T Consensus 250 ~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 250 PPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 11233457889999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=287.51 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=197.6
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||.|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999875 589999999965322 3356789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 82 LLGGDLRYHLS-----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999983 224788999999999999999999985 8999999999999999999999999999865433
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......|+..|+|||.+....++.++||||||+++|+|++|+.||....... .......... .
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~ 217 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------A 217 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------c
Confidence 2 2233458889999999998889999999999999999999999997543211 1111111110 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSM--GEVV 774 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~--~~v~ 774 (839)
....+......+.+++.+|++.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122233667788899999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=289.30 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=195.1
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||+|+||.||++... +++.+|+|.+..... .....+.+|++++.+++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999865432 3345788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc----
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS---- 662 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~---- 662 (839)
.+++.. ...+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 999842 23689999999999999999999985 999999999999999999999999999876433211
Q ss_pred ---eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 663 ---QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 663 ---~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.......++..|+|||.+.....+.++||||||++++||++|+.||......+ .......+.
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~-------- 217 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGK-------- 217 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC--------
Confidence 12233457889999999988889999999999999999999999986433111 011111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
............+.+++.+|++.+|.+||++.+|.+.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000000124567788899999999999999888777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=294.37 Aligned_cols=267 Identities=19% Similarity=0.220 Sum_probs=194.9
Q ss_pred hccccccccCCCceEEEEEeC---CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecC--CceEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG---DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLL 576 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 576 (839)
+.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456788999999999999764 47899999997632 23345678899999999999999999999888 78999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC----CCceeecccC
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE----NFCPKVSDFG 652 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~----~~~~kl~DfG 652 (839)
||||+++ +|.+++..........++...+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 666666433222334788899999999999999999985 8999999999999999 9999999999
Q ss_pred cceecCCCCce--eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--h----
Q 038743 653 LAKLMGREHSQ--VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--A---- 723 (839)
Q Consensus 653 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--~---- 723 (839)
+++........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 99876443221 1223457889999998766 4589999999999999999999999975543221000000 0
Q ss_pred hhhhc-----------cC-cccccccccccCCCC---------H--HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 724 FKEMT-----------NG-TPLKVADRRLEGAVE---------E--EELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 724 ~~~~~-----------~~-~~~~~~~~~l~~~~~---------~--~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+. +. ......+.......+ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00 000000000000000 0 22346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=293.95 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=197.0
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||++... .++.||+|.+..... .....+.+|++++..++||||+++++.+..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999764 578999999865421 2235678999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 83 VEGGDCATLLK-----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred CCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999983 234688999999999999999999984 9999999999999999999999999998742111
Q ss_pred Cc--------------eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 661 HS--------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 661 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
.. .......++..|+|||.+....++.++||||||+++|||++|+.||......+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 00 00112357889999999988889999999999999999999999986332111 1111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+. ...+... ......+.+++.+|++.+|++||++.++.+.|+..
T Consensus 228 ~~~~~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDD---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcc---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11110 0111111 12234567889999999999999988888877653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=286.44 Aligned_cols=242 Identities=23% Similarity=0.294 Sum_probs=192.4
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||.|+||.||+++.. +++.+|+|.+..... ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999875 489999999865322 2345789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
.+++. +...+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILR-----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 99984 234588899999999999999999994 99999999999999999999999999998764432 122
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...++..|+|||.+.+..++.++|+||||+++|||++|+.||....... .. .... +.+.......+.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~--------~~~~~~~~~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----ME-IYND--------ILKGNGKLEFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HH-HHHH--------HhccCCCCCCCc
Confidence 3457889999999988889999999999999999999999996443210 00 0111 111011111222
Q ss_pred HHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
.....+.+++..||+.+|++||+ +.|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 22456888999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=290.33 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=192.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+...+.||.|+||.||+|+. .+++.||||++.... ......+.+|++++.+++||||+++++++.+....++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 34567899999999999976 468999999986432 222356889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
. ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 82 H-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred c-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 6 6888888432 345688999999999999999999985 99999999999999999999999999987654322
Q ss_pred ceeEEeeccccceeCcccccCCC-CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc-chh-------hhhh---hhcc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF-YPG-------WAFK---EMTN 729 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-~~~-------~~~~---~~~~ 729 (839)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.......... ... ..+. .+.+
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 11 22234678899999887644 6889999999999999999999996443211000 000 0000 0000
Q ss_pred --CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 --GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 --~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..........+.. ........+.+++.+|++.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 00111234668899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=290.36 Aligned_cols=241 Identities=25% Similarity=0.329 Sum_probs=194.0
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 566789999999999999764 68999999986432 12345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....++...+..++.||+.||.|||+ .+++|+||+|+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 83 VPGGELFSHLR-----KSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred CCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999984 33578899999999999999999999 49999999999999999999999999999876443
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||...... ...+....+..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-------- 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV-------- 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc--------
Confidence 22345889999999998888999999999999999999999998643311 01111111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVV 774 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~ 774 (839)
..+......+.+++.+||+.+|.+|| ++++++
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11112235667888899999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=314.54 Aligned_cols=204 Identities=19% Similarity=0.255 Sum_probs=158.8
Q ss_pred HHHhhccccccccCCCceEEEEEeCC--CcEEEEEEe--------------cc---cCCcchHHHHHHHHHhhccccCCc
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLGD--GTLVAVKKL--------------DR---VLPHGEKEFVTEVNTIGSMHHMNL 561 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni 561 (839)
....|.+.+.||+|+||+||++.... +...++|.+ .+ ........+.+|+.++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34568888999999999999986532 222222211 00 011223457899999999999999
Q ss_pred ccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC
Q 038743 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD 641 (839)
Q Consensus 562 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~ 641 (839)
+++++++...+..++|+|++. ++|.+++..................++.||+.||+|||+. +|+||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 5677766433211122233556778999999999999995 999999999999999
Q ss_pred CCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCC
Q 038743 642 ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNL 708 (839)
Q Consensus 642 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~ 708 (839)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999877544333333456999999999999999999999999999999999988543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=291.93 Aligned_cols=263 Identities=20% Similarity=0.260 Sum_probs=191.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhcc-ccCCcccccceeecCCc-----eE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN-----RL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~ 575 (839)
+.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++..+ +||||+++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 55678999999999999976 4689999998854322 2235688899999999 56999999999877665 89
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcc
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLA 654 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla 654 (839)
+||||+++ +|.+++..........+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 888887543222245689999999999999999999985 9999999999999998 899999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC---
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG--- 730 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 730 (839)
+.+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||.......... -....+...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL---HIFKLLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHhCCCChh
Confidence 865332211 112246788999998865 467999999999999999999999996543211000 000000000
Q ss_pred cccc---ccc----cccc----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLK---VAD----RRLE----GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~---~~~----~~l~----~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.... ..+ +... ....+.....+.+++.+|++.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000 0000 0000123455778899999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=289.46 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=197.9
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.+.+.||+|+||.||+|... +++.|++|++..... ....+.+|++.+.+++|+|++++++.+......++|+||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 455678999999999999876 688999999975433 456789999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 100 GSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 9999999432 1378999999999999999999998 4999999999999999999999999999875543221
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .............
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~------- 237 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LFLITTKGIPPLK------- 237 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCCCCc-------
Confidence 12233478899999999988899999999999999999999999863322110 0000000000000
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
........+.+++.+|++.+|.+||++.+|++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011123457788999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=286.80 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=195.6
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCC------ce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGS------NR 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~ 574 (839)
..+.+.+.||+|+||.||+|... +++.+++|++.... ....++.+|+.++.++ .|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 34667789999999999999874 57899999986542 3346789999999999 7999999999996644 48
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence 99999999999999884321 1245788999999999999999999985 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
........ ......|+..|+|||.+.. ..++.++||||||++++||++|+.||........ ......
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~ 232 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-------LFKIPR 232 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-------HHHhhc
Confidence 76543222 2233458889999998753 3467899999999999999999999963321110 001111
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
... +.+ .........+.+++.+|+..+|++|||+.+|++
T Consensus 233 ~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 011 111223456788999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=281.65 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=199.7
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+...+.||+|++|.||++... +++.+++|++.........++.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 345678999999999999875 6889999999765444567899999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++... ...+++..+..++.|++.+|+|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 82 GSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999998432 25789999999999999999999994 999999999999999999999999999987654332
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
.....++..|+|||.+....++.++||||||++++||++|+.|+......... .......... +..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~-----~~~- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-------FKIATNGPPG-----LRN- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcCCCC-----cCc-
Confidence 23445888999999999888999999999999999999999998643211100 0000000000 000
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.......+.+++.+|++.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111356788889999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=297.09 Aligned_cols=202 Identities=29% Similarity=0.464 Sum_probs=173.0
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecC------CceEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNRLLV 577 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv 577 (839)
.-.+.||+|+||.||+|+. ..|+.||||.+.+... ...+...+|++++++++|+|||++++.-.+. +..++|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3457899999999999984 6799999999976543 3345688999999999999999999886543 467899
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC--C--CCceeecccCc
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD--E--NFCPKVSDFGL 653 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~--~--~~~~kl~DfGl 653 (839)
||||.+|||...|... .....|++.+.+.++.+++.||.|||+ ++|+||||||.||++- + .-.-||+|||.
T Consensus 96 mEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999654 355789999999999999999999998 5999999999999982 3 33579999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCC
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDA 714 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~ 714 (839)
|+.+.... ......||..|++||+... +.|+..+|.|||||++||.+||..||......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99875443 5667789999999999984 88999999999999999999999999766544
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=290.41 Aligned_cols=263 Identities=19% Similarity=0.232 Sum_probs=194.1
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecC--CceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 578 (839)
.+.+.+.||.|+||.||+|... +++.+|+|.++..... ....+.+|+.++.+++||||+++++++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4666789999999999999875 5889999998643222 223567899999999999999999998777 8999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++ +|.+++.. ....+++..+..++.||+.||+|||+. +++|+||||+|||++.++.+||+|||++..+.
T Consensus 86 e~~~~-~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 86 EYVEH-DLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hhcCc-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99974 89888742 223689999999999999999999985 99999999999999999999999999998765
Q ss_pred CCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc-c-------hhhhhhhh--
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF-Y-------PGWAFKEM-- 727 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-~-------~~~~~~~~-- 727 (839)
.... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||.......... + ....+..+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 4321 12233468889999988764 46899999999999999999999996543211000 0 00000000
Q ss_pred ----ccCcccccccccccCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 728 ----TNGTPLKVADRRLEGAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 728 ----~~~~~~~~~~~~l~~~~~~~-~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
............+...++.. ....+.+++..|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000001111111111111 2455778888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=284.51 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=196.7
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456788999999999999774 57899999985431 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 660 (839)
++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 82 DGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999988432 234578999999999999999999985 999999999999999875 4699999999876433
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. ......|++.|+|||++.+..++.++||||||++++||++|+.||...... ....... .+. ..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~----~~--- 220 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGY----FA--- 220 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-ccc----CC---
Confidence 22 223345889999999998888999999999999999999999998633211 1111111 111 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.........+.+++.+|++.+|++||++.+|++.
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111223457788899999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=287.40 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=184.8
Q ss_pred ccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHh---hccccCCcccccceeecCCceEEEEeecc
Q 038743 510 LLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTI---GSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..++ ...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999976 4689999999864321 1122344444333 33479999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLS-----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 999999884 334689999999999999999999995 89999999999999999999999999997653322
Q ss_pred eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.....|+..|+|||.+.. ..++.++||||||++++||++|+.||.......... . .... ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~-~~~~---------~~~~ 215 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----I-DRMT---------LTVN 215 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----H-HHHh---------hcCC
Confidence 122458999999998864 568999999999999999999999996443221100 0 0000 0011
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
...+......+.+++..|++.+|.+|| +++++++.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112223345677888899999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=288.83 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=194.1
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChh
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
.+||+|+||.||++.. .+++.||||++..........+.+|+.++..++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 6799999999999977 578999999986544445567899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEe
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM 667 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 667 (839)
+++. ...+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 106 ~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 106 DIVT------HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9873 23578899999999999999999995 999999999999999999999999999876543221 1233
Q ss_pred eccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHH
Q 038743 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEE 747 (839)
Q Consensus 668 ~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 747 (839)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... ..+.+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~-----~~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDN-----LPPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhh-----CCcccCC--ccc
Confidence 4588999999999888899999999999999999999999864322110 0001000 0000000 011
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 748 ELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 748 ~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+.+++.+||+.+|.+||++.+|++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23346678888999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=289.84 Aligned_cols=261 Identities=25% Similarity=0.301 Sum_probs=192.5
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.||.|++|.||+|.. .+|+.||+|++.... ......+.+|++++++++|||++++++++.++...+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4567899999999999976 479999999986432 2223568899999999999999999999999999999999995
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
++|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 -~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 82 -LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred -cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 6899988432 224689999999999999999999984 999999999999999999999999999976543221
Q ss_pred eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-cch-------hhhhhhhccC-c-
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-FYP-------GWAFKEMTNG-T- 731 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~~~-------~~~~~~~~~~-~- 731 (839)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||....+.... ... ...+...... .
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 1223468899999987664 5789999999999999999999999644321100 000 0000000000 0
Q ss_pred ---ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 ---PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 ---~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......... ..........+.+++.+|++.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0001112346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=289.87 Aligned_cols=266 Identities=23% Similarity=0.250 Sum_probs=193.3
Q ss_pred HHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC-----
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS----- 572 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 572 (839)
....+.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++.+++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3455677889999999999999874 58899999986432 222346788999999999999999999987655
Q ss_pred -----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 573 -----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 573 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 66666632 234689999999999999999999995 999999999999999999999
Q ss_pred ecccCcceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh----
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW---- 722 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~---- 722 (839)
|+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||..............
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999998765433222222345778999998765 4578999999999999999999999964332110000000
Q ss_pred ----hhhhhccCcc------cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 723 ----AFKEMTNGTP------LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 723 ----~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+..+.+... ............ ......+.+++..||+.+|.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 000000000000 012345788889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=297.73 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=191.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecC-----CceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 576 (839)
.+.+.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 466778999999999999965 578999999986432 22345678899999999999999999987654 35799
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
|+||+.+ +|..++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~-~l~~~~------~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 86 VQELMET-DLYKLI------KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred Eehhccc-CHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 9999975 777766 234689999999999999999999995 999999999999999999999999999987
Q ss_pred cCCCCcee--EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC---
Q 038743 657 MGREHSQV--VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG--- 730 (839)
Q Consensus 657 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 730 (839)
........ .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHH
Confidence 54322211 123457899999998755 56899999999999999999999999643211100 0000000000
Q ss_pred ccccccccc-------c--cCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKVADRR-------L--EGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~~~~~-------l--~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+.+.. . ....+ ......+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0 00000 1123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=289.46 Aligned_cols=263 Identities=20% Similarity=0.235 Sum_probs=190.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++..++|+||+++.+++..+...++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 355678999999999999975 4688999999865432 22346789999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
. ++|.+++.. ....+.+..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||+++......
T Consensus 86 ~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 86 H-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred c-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 6 677776632 224567888889999999999999985 89999999999999999999999999997643222
Q ss_pred ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh---------hhhhc--c
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA---------FKEMT--N 729 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~--~ 729 (839)
.. .....++..|+|||++.+. .++.++||||||+++|||++|+.||+...+........|. +..+. .
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 QT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 11 1223468899999998764 5788999999999999999999999754321100000000 00000 0
Q ss_pred CcccccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 GTPLKVADRRLEGAV-----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
............... .......+.+++.+|++.+|.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0011345667889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.11 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=200.3
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC--CceEEEEee
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLVYEF 580 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 580 (839)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+.+. ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 45678999999999999875 689999999865432 3456789999999999999999999999888 889999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 83 VSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred cCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999842 23889999999999999999999994 9999999999999999999999999999876544
Q ss_pred Cce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
... ......++..|+|||.+.....+.++||||||++++||++|+.||....... ..... . ....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~--------~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYK-I--------GSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHh-c--------cccC
Confidence 321 1233458889999999998889999999999999999999999997544110 00000 0 0001
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.....+......+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122233567888899999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=321.13 Aligned_cols=245 Identities=28% Similarity=0.435 Sum_probs=195.3
Q ss_pred ccccccCCCceEEEEE-eCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 508 AQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
...||.|.||.||-+. .++|+..|+|-+.-.. ....+...+|+.++..|+|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 3589999999999995 5679999999874322 334456889999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|.+.+ ..++.+++.....+..|++.|++|||++ +||||||||.||||+.+|.+|++|||.|..+.......
T Consensus 1320 sLa~ll-----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1320 SLASLL-----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred cHHHHH-----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999998 3556777777788899999999999997 99999999999999999999999999999775542111
Q ss_pred ---EEeeccccceeCcccccCC---CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-hhhccCccccccc
Q 038743 665 ---VTMVRGTRGYLAPEWVSNR---PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF-KEMTNGTPLKVAD 737 (839)
Q Consensus 665 ---~~~~~gt~~y~aPE~~~~~---~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 737 (839)
.....||+.|||||++.+. ....++||||+|||++||+||++||...+.. |+. -++..|.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh------ 1458 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGH------ 1458 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccC------
Confidence 2345799999999999763 4567899999999999999999999643321 211 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.++++......-.+++.+|++.||++|-++.|+++.
T Consensus 1459 ---~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ---KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 122333344555678888999999999888777654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=295.92 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=192.9
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC-----CceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 575 (839)
.|.+.+.||+|+||+||++.. .+++.||||.+.... ......+.+|+.++..++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 355677999999999999975 568999999986532 23345678899999999999999999988654 3579
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+|+||+. ++|.+++. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 86 lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 86 IVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 9999996 68888873 335688999999999999999999984 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh--------hhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA--------FKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 726 (839)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||............... ...
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 664322 22233457889999998765 56899999999999999999999999643211100000000 000
Q ss_pred hccCcccccc-------cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MTNGTPLKVA-------DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~~~~~~~~~-------~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.........+ +.... .........+.+++.+|++.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 00000 0011234567889999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=296.31 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=193.5
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhcc-ccCCcccccceeecC--CceEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG--SNRLL 576 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~l 576 (839)
..+.+.+.||+|+||.||+|... +++.+|||++.... ......+.+|+.++.++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667789999999999999764 68899999985432 23345677899999999 999999999988643 46899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||++ ++|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 87 v~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 87 VFEYME-TDLHAVIR------ANILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred Eecccc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999997 58988873 2277889999999999999999998 4999999999999999999999999999986
Q ss_pred cCCCCc----eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------h
Q 038743 657 MGREHS----QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------A 723 (839)
Q Consensus 657 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~ 723 (839)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12233458899999998765 5678999999999999999999999964332111000000 0
Q ss_pred hhhhccCccccccc----ccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 724 FKEMTNGTPLKVAD----RRL--EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 724 ~~~~~~~~~~~~~~----~~l--~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+.......+++ ... ...........+.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000110 000 000011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=288.36 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=180.1
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC----CcEEEEEEecccCCcch-----------HHHHHHHHHhhccccCCcccc
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLPHGE-----------KEFVTEVNTIGSMHHMNLVRL 564 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 564 (839)
+....+.+.++||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 334567788999999999999998754 34566665432211110 112233345566789999999
Q ss_pred cceeecCC----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 565 CGYCSEGS----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 565 ~g~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
++++.... ..++++|++.. ++.+.+. .....++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99765543 34667776543 5555542 122356778889999999999999985 99999999999999
Q ss_pred CCCCceeecccCcceecCCCCce------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCC
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQ------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDA 714 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~ 714 (839)
+.++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999876432211 122346999999999999999999999999999999999999999755322
Q ss_pred CCccc-hhh-hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 715 EDFFY-PGW-AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 715 ~~~~~-~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
..... ... ....+.. ..+.... ....+.+++..|++.+|++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHE--------GKIKIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHHhhh--------hhhccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11100 000 0011111 1111111 1344667777799999999999999998874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-34 Score=274.59 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=192.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhc-cccCCcccccceeecCCceEEEEeeccCCC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGS-MHHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
..||.|+||+|+|-.+ +.|+.+|||+++.... .+.++++.|.+...+ -++||||+++|.+..+...++.||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 4799999999999966 5699999999976543 456678889886554 589999999999999999999999995 47
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeE
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 665 (839)
|+.+....+......+++..+-+|...++.||.||.+. ..|||||+||+|||||..|.+||||||++..+.... ..
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--Ak 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--AK 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--Hh
Confidence 77664332233556788888889999999999999986 689999999999999999999999999997654322 23
Q ss_pred EeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 666 TMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
+.-.|...|||||.+.. ..|+.++||||||+.|+|+.||+.|+..-... ......+..+....+..+ .
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------feql~~Vv~gdpp~l~~~----~ 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------FEQLCQVVIGDPPILLFD----K 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------HHHHHHHHcCCCCeecCc----c
Confidence 34468889999999864 35899999999999999999999998632210 000111112221111111 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
-..+....+.+++..|+..+..+||...++.++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 122345667888888999999999999998764
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=286.71 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=196.0
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEeccc--CCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...|.+.++||+||.+.||++...+.+.+|+|++... ..+....|..|+..|.+| .|.+||+|++|-..+..+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4456677899999999999999988899999987433 234456799999999999 5999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||- .-+|..+|... .....+| .+..+..|++.++.++|++ +|||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 440 E~G-d~DL~kiL~k~---~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKK---KSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhc---cCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 985 45899988432 2233445 6777899999999999997 999999999999985 4689999999999887
Q ss_pred CCCceeE-EeeccccceeCcccccCC-----------CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 659 REHSQVV-TMVRGTRGYLAPEWVSNR-----------PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 659 ~~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
.+..... ....||+.||+||.+... ..+.++||||+|||||+|+.|+.||.... ..|+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a--- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA--- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH---
Confidence 7665553 345799999999988532 25689999999999999999999996211 0111
Q ss_pred hccCcccccccccccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MTNGTPLKVADRRLEGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~-~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
++..+.++.-.-+++. ..-..+++++..||+.||++||+..+|++.
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233444433222211 111228888999999999999999999763
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=285.77 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=187.6
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||+|+||+||++.. .+|+.||+|.+.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999965 468999999986432 12234567899999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++...... ....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 152 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIK 152 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccc
Confidence 9998533 224688999999999999999999995 9999999999999999999999999999765431 1122
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...++..|+|||.+.+..++.++||||||++++||++|+.||......... ..+.... .. .....+.
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~----~~--~~~~~~~ 219 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------EELKRRT----LE--MAVEYPD 219 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------HHHHhcc----cc--ccccCCc
Confidence 345788999999998888999999999999999999999999644321100 0000000 00 0011112
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGE 772 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~ 772 (839)
.....+.+++..||+.+|.+||+..+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 22445778889999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=287.00 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=196.5
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.||+|++|.||++... +++.+++|++...... ....+..|+.++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999774 6889999998654322 34578899999999999999999999999999999999997
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+ +|.+++.. ....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 82 ~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 82 T-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 5 88887742 235789999999999999999999995 99999999999999999999999999998775543
Q ss_pred eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhhhcc---C
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKEMTN---G 730 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~---~ 730 (839)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..... ...+..+.+ .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 122234578889999998876 7899999999999999999999998644321110000 000000000 0
Q ss_pred cccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADRRL--EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~~l--~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......+... ...........+.+++..||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000 00111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=312.43 Aligned_cols=245 Identities=28% Similarity=0.400 Sum_probs=181.3
Q ss_pred ccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecC--------------
Q 038743 508 AQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-------------- 571 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------------- 571 (839)
.++||+||||.|||++.+ ||+.+|||++.-.. ........+|++.+++|+|||||+++....+.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 358999999999999653 89999999996543 22334688999999999999999986542110
Q ss_pred --------------------------------------------------------------------------------
Q 038743 572 -------------------------------------------------------------------------------- 571 (839)
Q Consensus 572 -------------------------------------------------------------------------------- 571 (839)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred -------------------------CceEEEEeeccCCChhhhcccCCCCCcccC-ChhhHHHHHHHHHHHhHHhhhccC
Q 038743 572 -------------------------SNRLLVYEFMKNGSLDKWIFPSYHHRDRVL-DWTTRFNIAIATAQGIAYFHEQCR 625 (839)
Q Consensus 572 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l-~~~~~~~i~~~ia~~L~yLH~~~~ 625 (839)
..+||-||||+.-.|++++.... .. .....++++.+|+.||+|+|++
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEGLaYIH~~-- 716 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEGLAYIHDQ-- 716 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHHHHHHHhC--
Confidence 12367788888888877774321 11 3567789999999999999997
Q ss_pred CeeeecCCCCCcEEECCCCceeecccCcceecC-----------------CCCceeEEeeccccceeCcccccCC---CC
Q 038743 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMG-----------------REHSQVVTMVRGTRGYLAPEWVSNR---PI 685 (839)
Q Consensus 626 ~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~ 685 (839)
+||||||||.||+||++..+||+|||+|+... .......+...||.-|+|||++.+. +|
T Consensus 717 -giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 -GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred -ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 89999999999999999999999999998721 0111123456799999999999764 59
Q ss_pred CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCC
Q 038743 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVF 765 (839)
Q Consensus 686 s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~ 765 (839)
+.|+|+||+||||+||+ .||....+.. .+...++.+.+..- ..+..++...-.+++.|++++||.
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERA------SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHH------HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCc
Confidence 99999999999999999 4454322210 11122222221110 223345556667899999999999
Q ss_pred CCCCHHHHHH
Q 038743 766 MRPSMGEVVK 775 (839)
Q Consensus 766 ~RPt~~~v~~ 775 (839)
+|||+.|++.
T Consensus 861 kRPtA~eLL~ 870 (1351)
T KOG1035|consen 861 KRPTATELLN 870 (1351)
T ss_pred cCCCHHHHhh
Confidence 9999999965
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=294.72 Aligned_cols=265 Identities=20% Similarity=0.297 Sum_probs=194.7
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec----CCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----GSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 575 (839)
..+.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 3456678999999999999975 468999999986542 2334567889999999999999999998753 35689
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+. ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 85 VVMDLME-SDLHHIIH-----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEehhh-hhHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 9999996 68988883 234589999999999999999999984 99999999999999999999999999998
Q ss_pred ecCCCCcee---EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhh
Q 038743 656 LMGREHSQV---VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWA 723 (839)
Q Consensus 656 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~ 723 (839)
......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 664322211 223468889999998865 4689999999999999999999999965432110000 0000
Q ss_pred hhhhccCcccccccc-cccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 724 FKEMTNGTPLKVADR-RLEGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 724 ~~~~~~~~~~~~~~~-~l~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.............+. ....... ......+.+++.+|++.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000000 0000111 1234668889999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=292.58 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=199.7
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC-----ceEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-----NRLL 576 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 576 (839)
+.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999875 48999999997653 334467899999999999999999999998775 7899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
+|||++ ++|.+++. ....+++..+..++.+|+.||+|||+. +|+||||||.|||++.++.++|+|||++..
T Consensus 82 v~e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 82 VTELME-TDLHKVIK-----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred Eecchh-hhHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 999998 48888883 234789999999999999999999995 999999999999999999999999999987
Q ss_pred cCCCCc--eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh-----h---hhh
Q 038743 657 MGREHS--QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG-----W---AFK 725 (839)
Q Consensus 657 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~-----~---~~~ 725 (839)
...... .......++..|+|||.+.+. .++.++||||||++++||++|+.||......+...... . .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 654321 112334578899999999887 88999999999999999999999996544211000000 0 000
Q ss_pred hhccCcccccccc-cccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCC
Q 038743 726 EMTNGTPLKVADR-RLEGA-----VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGS 780 (839)
Q Consensus 726 ~~~~~~~~~~~~~-~l~~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~ 780 (839)
..........+.. ..... ........+.+++.+||+.+|.+||++.++++. +++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000000000 00000 011134567889999999999999999999985 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=283.78 Aligned_cols=197 Identities=30% Similarity=0.430 Sum_probs=173.6
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.-++||+|+||.||-... .+|+.+|.|++.+.. .+++.-.++|-.++.+++.+.||.+--.+...+.++||+..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 346999999999999965 569999999996543 3445557899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
||+|.-+|.+. ....+++...+-++.+|+.||++||.+ .||.|||||+|||||+.|+++|+|.|||..+...
T Consensus 269 GGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-- 340 (591)
T KOG0986|consen 269 GGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-- 340 (591)
T ss_pred CCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC--
Confidence 99999999643 457899999999999999999999996 9999999999999999999999999999876443
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
+.....+||.+|||||++.++.|+...|.||+||+||||+.|+.||...
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 2334447999999999999999999999999999999999999999643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=286.87 Aligned_cols=262 Identities=18% Similarity=0.156 Sum_probs=190.0
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCC
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
.+.+|.|+++.|+++.. +++.||||++... .....+.+..|++++++++|+||+++++++.+....+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666655 7899999998654 23345679999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc---
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS--- 662 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~--- 662 (839)
|.+++... ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99998532 234578888999999999999999995 999999999999999999999999999875532111
Q ss_pred ---eeEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc------cchhhhhh-hh--c
Q 038743 663 ---QVVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF------FYPGWAFK-EM--T 728 (839)
Q Consensus 663 ---~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~------~~~~~~~~-~~--~ 728 (839)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||......... ..+.+... .. .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 11223457788999999876 45889999999999999999999999754321100 00000000 00 0
Q ss_pred cCcccc----ccccc----ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 729 NGTPLK----VADRR----LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 729 ~~~~~~----~~~~~----l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...... ..++. ............+.+++.+||+.+|++||+++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 00000 0111122334567889999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=263.16 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=190.7
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeeccC
Q 038743 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+...||.|..|.|++.++ ..|..+|||.+.+.. ....+++++.++++..-+ +|+||+.+|||.......+.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 345799999999999977 458999999997654 334466778888777664 99999999999999999999998843
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
.++.+|.. -..++.+..+=++...+++||.||.+. .+|||||+||+|||+|+.|++||||||++..+-+. .
T Consensus 176 -C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--k 246 (391)
T KOG0983|consen 176 -CAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--K 246 (391)
T ss_pred -HHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc--c
Confidence 45555532 234577888888999999999999985 69999999999999999999999999999876443 3
Q ss_pred eEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
..+...|.+.|||||.+.- ..|+.++||||||+.|+||.||+.||......-. +...+.+..+ +.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~eP-----P~L 315 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEEP-----PLL 315 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcCC-----CCC
Confidence 3455679999999999864 4688999999999999999999999976543210 1111111111 222
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
... ......+.++...|++.|+.+||...++++.
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 211 1134557778888999999999999998764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=294.17 Aligned_cols=261 Identities=22% Similarity=0.255 Sum_probs=192.9
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------Cc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SN 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 573 (839)
..+...+.||+|+||.||++.. .+++.||||.+.... .....++.+|+.++.+++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 4566778999999999999975 478999999986432 22345678899999999999999999987543 35
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+. ++|.+.+. ..++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred EEEEEeccC-CCHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 799999996 47877762 1278888999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc---------cchhh--
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF---------FYPGW-- 722 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~---------~~~~~-- 722 (839)
++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ....+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 987643221 22335788999999999999999999999999999999999999644311000 00000
Q ss_pred ----hhhhhccCc-------ccccccccc----cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 ----AFKEMTNGT-------PLKVADRRL----EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 ----~~~~~~~~~-------~~~~~~~~l----~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
......... ..++....+ ...........+.+++.+|++.+|++||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000111100 001111335567899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.57 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=194.7
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.+.||.|++|.||+|+.. +|+.||||.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999874 6889999998654322 34567889999999999999999999999999999999998
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+ +|.+++... .....+++..+..++.||+.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~-~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 82 K-DLKKYMDTH--GVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred c-cHHHHHHhc--CCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 5 888887432 1234689999999999999999999985 899999999999999999999999999976533221
Q ss_pred eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhhhccCcc-
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKEMTNGTP- 732 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~- 732 (839)
......++..|++||.+.+. .++.++||||||+++|||++|+.||......+..... ...++.+.....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 11223468899999988664 5789999999999999999999999754322110000 000000000000
Q ss_pred c----ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 L----KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~----~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. ...+... ....+.....+.+++.+|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000000 0011122456778899999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.20 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=196.9
Q ss_pred hccccccccCCCceEEEEEe----CCCcEEEEEEecccC----CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (839)
+.+.+.||+|+||.||++.. .+++.||||.+.+.. ....+.+..|+.++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45678899999999999964 357899999986432 12235688999999999 6999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++. ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 82 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 82 LILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEecCCCCcHHHHHh-----hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999884 23468889999999999999999998 499999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCC--CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRP--ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
.+............|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...... +....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~-~~~~~---- 226 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEIS-RRILK---- 226 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHH-HHHHc----
Confidence 76443332233345889999999987654 7889999999999999999999985322110 000110 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
... ..+......+.+++.+|++.+|++|||+.+|.+.|+-
T Consensus 227 --~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 --SKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --cCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001 1111223456788889999999999999999888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=285.53 Aligned_cols=258 Identities=20% Similarity=0.245 Sum_probs=190.1
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccc-cCCcccccceeecC--CceEEEEee
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEG--SNRLLVYEF 580 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~ 580 (839)
.+.+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.++.++. |+||+++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4567899999999999976 4689999999865422 22334567888898885 99999999999887 889999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
++ |+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 82 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 82 MD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred CC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 97 578777732 234689999999999999999999995 9999999999999999 99999999999866432
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc---------cchhhhhhhhccC
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF---------FYPGWAFKEMTNG 730 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~---------~~~~~~~~~~~~~ 730 (839)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.. ....+ .......
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKS 229 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccc
Confidence 22 122347889999997654 56789999999999999999999999654321100 00000 0011100
Q ss_pred cccccccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADRRLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~~l~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.......+.... .........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 001123567889999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=289.02 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=191.0
Q ss_pred HhhccccccccCCCceEEEEEeCC-CcEEEEEEecccC-CcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEe
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 579 (839)
..+.+.+.||+|+||.||+|...+ ++.||||.++... .....++..|+.++.+.. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 345678899999999999998864 8999999996543 223456777887777764 9999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+. .+|+||||+|+||++++++.+||+|||++..+..
T Consensus 95 ~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 467666532 234788999999999999999999973 4899999999999999999999999999976543
Q ss_pred CCceeEEeeccccceeCcccccCCC----CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRP----ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ........+...
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~-- 237 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------EVLTKILQEEPP-- 237 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------HHHHHHhcCCCC--
Confidence 222 12234788999999987653 7899999999999999999999986422110 000111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.+.. .......+.+++.+|++.+|++||++.++++.-
T Consensus 238 ---~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 ---SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000 001234578888999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=289.22 Aligned_cols=261 Identities=19% Similarity=0.231 Sum_probs=189.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCC--------
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-------- 572 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 572 (839)
.+.+.+.||+|+||.||++.. .+++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 466778999999999999976 4689999999854322 22335678999999999999999999986654
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..++||||+.+ +|.+++.. ....+++.++..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 35999999975 78777732 234689999999999999999999995 99999999999999999999999999
Q ss_pred cceecCCCCce---eEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhc
Q 038743 653 LAKLMGREHSQ---VVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT 728 (839)
Q Consensus 653 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 728 (839)
++..+...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432221 12234578889999988664 478999999999999999999999865432111000000000000
Q ss_pred -----cC-------------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 729 -----NG-------------TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 729 -----~~-------------~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. .........+... .....+.+++.+|++.+|.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000000011000 11235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.54 Aligned_cols=244 Identities=22% Similarity=0.217 Sum_probs=187.9
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHh-hccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTI-GSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||+|.. .+++.||||.+.+.... ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999976 46899999998653211 122344555443 445899999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++. ....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999984 234688899999999999999999995 999999999999999999999999999876432
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....... .......+... ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~ 215 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEE 215 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCc
Confidence 123357889999999988889999999999999999999999996432211 11111111100 0011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
........+.+++.+|++.+|++||++.++.+.|.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11123456788999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=280.54 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=200.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|+||.||++.. .+++.+|+|.+.... .....++..|++++++++|+||+++.+++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 45678899999999999965 468899999986532 233456788999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||+|.||++++++.+||+|||+++.....
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 82 PFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred CCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999985421 1235688999999999999999999984 9999999999999999999999999999876543
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+ + ......+ ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~----~~~~~~~---------~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---L----RYKVQRG---------KY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcC---------CC
Confidence 1222457889999999999999999999999999999999999996432110 0 0011111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12223445668899999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=290.02 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=191.0
Q ss_pred cccccC--CCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTG--GFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
..||+| +||+||++.. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356766 8999999976 5799999999864322 2235688999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999988532 22358888999999999999999998 49999999999999999999999999865433211111
Q ss_pred e------EEeeccccceeCcccccCC--CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-------cchhhhh----
Q 038743 664 V------VTMVRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-------FYPGWAF---- 724 (839)
Q Consensus 664 ~------~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-------~~~~~~~---- 724 (839)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||......... .+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 0112345679999998763 5789999999999999999999999654321100 0000000
Q ss_pred ---hhh----------------ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 ---KEM----------------TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ---~~~----------------~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
... .......+.+..+...........+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000001111122222233456778999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.46 Aligned_cols=265 Identities=20% Similarity=0.249 Sum_probs=191.8
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecC--CceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 577 (839)
..+.+.+.||+|+||.||+|.. .+|+.||+|.++..... ....+.+|+.++.+++|+||+++++++.+. +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 3466778999999999999976 46899999998643221 223567899999999999999999998654 568999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+.+ +|.+++.. ....+++.++..++.||++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 87 ~e~~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 87 MEYCEQ-DLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EecCCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999974 78888742 235689999999999999999999995 8999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhhhc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKEMT 728 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~ 728 (839)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... ...+..+.
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 54321 1222335788999998865 56799999999999999999999999644322110000 00000000
Q ss_pred cCcccccc--cccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 729 NGTPLKVA--DRRLEGAV---EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 729 ~~~~~~~~--~~~l~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
........ ........ .......+.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 00000000 00123456778899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=280.35 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=191.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEeccc-----CCcchHHHHHHHHHhhccccCCcccccceeecC--CceEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV-----LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLL 576 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 576 (839)
+.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 56678999999999999976 46899999987432 122335688999999999999999999998664 45789
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
++||+++++|.+++. ....+++.....++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 84 FVEYMPGGSIKDQLK-----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEeCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 999999999999883 223578888999999999999999985 999999999999999999999999999986
Q ss_pred cCCCCc--eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 657 MGREHS--QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 657 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
...... .......++..|+|||++.+..++.++||||||++++||++|+.||........ ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-------- 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKI-------- 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHH--------
Confidence 532111 112234588999999999988899999999999999999999999863321110 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.........+......+.+++..|++ +|..||+..+++.
T Consensus 222 -~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 -ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00001112233344557778888999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=287.61 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=190.1
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.+.+.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 3566789999999999999764 688999999854322 2335688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~ 659 (839)
++ ++|.+++... ....+++.....++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 83 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 83 LD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 96 5787776322 223457788889999999999999984 9999999999999985 56799999999976543
Q ss_pred CCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc------
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP------ 732 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 732 (839)
... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+.............+...
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 211 1122346889999998866 45789999999999999999999999654321110000000000000000
Q ss_pred ccc--ccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKV--ADRRLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~--~~~~l~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
... ..+.... .........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000000 001122345778999999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=278.43 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=201.4
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|+||.||++... +++.||+|++..... ....++.+|+++++.++|||++++++.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456678999999999999774 588999999865432 44567889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++.... .....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 82 DGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred CCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999985431 1246789999999999999999999995 99999999999999999999999999998765443
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.......|++.|+|||.+....++.++||||||+++++|++|+.||....... ..........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKILKGQY--------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHhcCCC---------
Confidence 22233468889999999998899999999999999999999999986432110 1111111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111233457788889999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=281.92 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=193.6
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.||+|+||+||+|... +++.||||++..... .......+|+..+.+++ |+||+++++++.+....++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 46688999999999999875 478999999865432 22334567899999998 999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++... ....+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 88998888432 234789999999999999999999984 999999999999999999999999999986643221
Q ss_pred eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc----------chhhhhhhhccCc
Q 038743 663 QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF----------YPGWAFKEMTNGT 731 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~----------~~~~~~~~~~~~~ 731 (839)
.....++..|+|||.+.. ..++.++||||||++++||++|+.||.......... -..|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123457889999998754 567999999999999999999999986443211100 0001000000000
Q ss_pred cccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLE---GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~---~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+..... ..........+.+++.+|++.+|++||+++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001124568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=280.25 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=190.5
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhcc---ccCCcccccceeecCCc-----e
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSM---HHMNLVRLCGYCSEGSN-----R 574 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 574 (839)
.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++.++ +|+||+++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999875 4899999999643222 123566777776655 69999999999988776 8
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
+++|||+.+ +|.+++... ....+++..+..++.||++||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred EEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999974 888887432 223689999999999999999999995 8999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-------hhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF-------KEM 727 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-------~~~ 727 (839)
..+..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..... ..+
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhc
Confidence 87643321 12234788899999999999999999999999999999999998654322110 00000 000
Q ss_pred ccCcc--ccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 728 TNGTP--LKVADRRLE---GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 728 ~~~~~--~~~~~~~l~---~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..... ......... ..........+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 000000000 0111223456778999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=284.01 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=192.0
Q ss_pred hccccccccCCCceEEEEEe----CCCcEEEEEEecccCC----cchHHHHHHHHHhhcc-ccCCcccccceeecCCceE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLP----HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (839)
+.+.+.||+|+||.||++.. .+|+.||+|++..... ...+++.+|++++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45678999999999999975 4689999999864321 2235678899999999 6999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+|+||+++++|.+++. ....+.+..+..++.||+.||.|||+. +++||||+|+|||+++++.+||+|||+++
T Consensus 82 lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 82 LILDYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999984 234678888999999999999999984 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCC--CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
..............|+..|+|||.+... .++.++||||||+++|||++|+.||........ ..... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~-~~~~~~--- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEIS-RRILKS--- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHH-HHhhcc---
Confidence 7644333333345588999999998753 468899999999999999999999864322111 00111 000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
.+ ..+......+.+++..|++.+|++|| ++.+++.
T Consensus 228 ---~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 11122334567888899999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.10 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=198.0
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+.+.||+|++|.||++... +++.|++|.+..... .....+.+|++++.+++|+|++++++++.+....+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999764 678999999976543 34467899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 82 ENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCcHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999883 235789999999999999999999984 99999999999999999999999999998765433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.. .....++..|+|||.+.+..++.++||||||++++||++|+.|+........ .+ .. .... .
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~--~~-~~~~-----~---- 216 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LF--RI-VQDD-----H---- 216 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HH--HH-hccC-----C----
Confidence 21 2334578899999999888899999999999999999999999864321100 00 00 0000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+......+..++.+|++.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1111222456778889999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=280.79 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=184.3
Q ss_pred ccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHH---HhhccccCCcccccceeecCCceEEEEeecc
Q 038743 510 LLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVN---TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.||+|+||.||++.. .+++.||+|.+.+... .....+..|.. .+....||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 4588999999865321 11223444443 3444579999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|..++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 999998883 334689999999999999999999995 899999999999999999999999999976533221
Q ss_pred eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... ...... .....+
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~------~~~~~~- 218 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TMAVEL- 218 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhh------ccCCCC-
Confidence 234589999999998754 68999999999999999999999996543211100 000000 001111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
+......+.+++.+|++.+|.+|| ++.++++
T Consensus 219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 112235677888899999999999 8889875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=284.73 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=192.1
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+...+.||+|+||.||+|.. .+++.+|+|.+.... .....++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3455567899999999999976 467899999985421 222346788999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 578776632 234578999999999999999999985 99999999999999999999999999998654
Q ss_pred CCCceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... .......+..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~--- 231 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES--- 231 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhhcCC---
Confidence 32 2235788999999875 3567889999999999999999999985322110 0000100000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
+.. ........+.+++.+||+.+|++||++.+|++....
T Consensus 232 --~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 --PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred --CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 000 111233456788899999999999999999887543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.30 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=197.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.+.+.+.||+|.|++|.+|+. .++..||||.+++..-. ....+.+|+++|..++|||||+++.+...+..+++||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 456678999999999999976 46899999999765322 234588999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
..+|.+.++|.+. ..........+..|+..+++|||+. .|+|||||++||||+.++.+||+|||++..+..
T Consensus 137 a~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 137 ASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred ccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999532 2334477788999999999999995 999999999999999999999999999998752
Q ss_pred CceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
........|++.|.|||++.+..+ ..++|+||+|++||-|++|..||++..-.+ +.+. ++...
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------Lr~r----vl~gk 271 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------LRPR----VLRGK 271 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------ccch----heeee
Confidence 333456779999999999999776 589999999999999999999998654221 1111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
++- +.-....+-+++.+.+-.+|.+|++++++.+.-
T Consensus 272 ~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 272 YRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ecc--cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111 111122345667778899999999999998763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=274.12 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=199.1
Q ss_pred ccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeec-CCceEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNRLLV 577 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv 577 (839)
.+..++-+|.||.||+|.+ .+.+.|-+|.++.... -....+..|...+..+.|||+.++.+++.+ ....+.+
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 3455899999999999944 4456788888865432 234568889999999999999999999865 5678899
Q ss_pred EeeccCCChhhhcccC---CCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 578 YEFMKNGSLDKWIFPS---YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
|.++.-|+|+.||... .....+.+...+...++.|++.||+|||.+ ++||.||.++|++||+..++||+|=.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence 9999999999999622 123446788889999999999999999996 9999999999999999999999999999
Q ss_pred eecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 655 KLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 655 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+.+-+.+.+ ....-..+..||+||.+.+..|+.++|||||||+||||+| |+.|+...+..+ ....+++|.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ylkdGy- 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYLKDGY- 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHHhccc-
Confidence 865443322 2333446788999999999999999999999999999995 888876433222 111222221
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
++. -+.+++.++..++.-||...|++||++++++.-|.+
T Consensus 516 ------Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 516 ------RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ------eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 121 233455667788888999999999999999998864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=263.74 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=198.8
Q ss_pred chHHHHHHhhccccccccCCCceEEEE-EeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
+++|+..-| .+.||+|+|+.|--+ .+.+|..+|||++.+..........+|++++.+. .|+||++|+.+++++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 355554444 357999999999988 4678999999999888777788899999999998 59999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC---ceeecc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---CPKVSD 650 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~D 650 (839)
.|||||-|.||+|..+| ++.+.+++.+..++..+||.||.|||. ++|.||||||+|||-..-. -+||+|
T Consensus 151 FYLVfEKm~GGplLshI-----~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHI-----QKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred EEEEEecccCchHHHHH-----HHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeec
Confidence 99999999999999998 356789999999999999999999999 5999999999999985433 489999
Q ss_pred cCcceecCC--C----CceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc
Q 038743 651 FGLAKLMGR--E----HSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719 (839)
Q Consensus 651 fGla~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~ 719 (839)
|.|..-... + ........+|+..|||||+.. ...|+.+.|.||||||||-|++|..||.+.....-
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--- 299 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--- 299 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---
Confidence 998864321 1 112234567999999999773 24689999999999999999999999977654321
Q ss_pred hhhhhhhhccCcccc-ccccccc--CCCCHHH----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 720 PGWAFKEMTNGTPLK-VADRRLE--GAVEEEE----LMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 720 ~~~~~~~~~~~~~~~-~~~~~l~--~~~~~~~----~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.|...+.-. ...+ ++...-. -+++.++ .....+++...+..++.+|.++.+|+.
T Consensus 300 -GWdrGe~Cr-~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 -GWDRGEVCR-VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -CccCCCccH-HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 121110000 0000 1111001 1223222 223344555567799999999999887
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=290.05 Aligned_cols=258 Identities=22% Similarity=0.277 Sum_probs=191.5
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEecccCCcc--------------hHHHHHHHHHhhccccCCcccccceeecC
Q 038743 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHG--------------EKEFVTEVNTIGSMHHMNLVRLCGYCSEG 571 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 571 (839)
+.+.||.|+||.||+|.. .+++.||||.+....... ...+.+|++++.+++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 456899999999999975 468999999986432211 12477899999999999999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 99999999997 68988883 334688899999999999999999984 9999999999999999999999999
Q ss_pred CcceecCCCC-------------ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc
Q 038743 652 GLAKLMGREH-------------SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF 717 (839)
Q Consensus 652 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 717 (839)
|+++...... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....+.+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9998764111 1111223467889999998764 4789999999999999999999999754422110
Q ss_pred cchhhhhhhhccCc---cc------------ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 718 FYPGWAFKEMTNGT---PL------------KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 718 ~~~~~~~~~~~~~~---~~------------~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
......+.... .. ....+... .........+.+++..|++.+|++||++.+++..-
T Consensus 244 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 ---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred ---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 00000000000 00 00000000 00111245577899999999999999999998753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=281.67 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=197.6
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 579 (839)
|.+.+.||+|+||.||++... +++.||+|++.... ....+.+..|+.++.+++ ||||+++++++......++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 566789999999999999764 68999999986532 223456889999999998 9999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 83 YAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred CCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999984 234799999999999999999999985 999999999999999999999999999987644
Q ss_pred CCc-------------------eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch
Q 038743 660 EHS-------------------QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 660 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 720 (839)
... .......++..|+|||.+....++.++||||||++++|+++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 321 11233457889999999988889999999999999999999999997443111
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM----GEVVK 775 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~----~~v~~ 775 (839)
..+.... .....+......+.+++.+|++.+|.+||++ +++++
T Consensus 230 --~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 --TFQKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011100 0111222224567889999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=289.60 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=189.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------CceE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNRL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 575 (839)
+.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 44567999999999999975 568999999986532 22234688999999999999999999998654 3468
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 97 lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 97 LVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 99999864 666554 23578899999999999999999995 89999999999999999999999999997
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------hhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------AFKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~ 726 (839)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 166 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 643221 22346788999999876 4689999999999999999999999975331110000000 0000
Q ss_pred hccCccccccc--ccc-cCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCCCC
Q 038743 727 MTNGTPLKVAD--RRL-EGAV---EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGSAD 782 (839)
Q Consensus 727 ~~~~~~~~~~~--~~l-~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~~~ 782 (839)
+.......... +.. .... .......+.+++.+|++.+|.+||++.+++.. ++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000 000 0000 00123457789999999999999999999954 655544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=274.60 Aligned_cols=239 Identities=21% Similarity=0.292 Sum_probs=181.8
Q ss_pred ccccc--cccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeec
Q 038743 506 NFAQL--LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 506 ~~~~~--lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+. ||+|+||.||++.. .+++.+|+|.+...... +. |+.....+ +||||+++++.+...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 59999999999975 46888999998643211 11 22222222 7999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 660 (839)
++++|.+++. ....+++.++..++.||++||.|||+. +++||||||+||+++.++ .++|+|||+++.....
T Consensus 92 ~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 92 KDGDLFDLLK-----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred CCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999984 223789999999999999999999995 899999999999999988 9999999999865432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ...++..|+|||++.+..++.++||||||++++||++|+.||...... ......+.... . ...
T Consensus 164 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~--------~~~ 227 (267)
T PHA03390 164 S-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--Q--------KKL 227 (267)
T ss_pred c-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--c--------ccC
Confidence 2 235788999999999989999999999999999999999999733221 11111111000 0 000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPS-MGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-~~~v~~ 775 (839)
.........+.+++..|++.+|.+||+ ++++++
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 --PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111123445778888999999999995 688864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.90 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=187.2
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.||+|+||+||+|+. .+++.||+|++..... .....+.+|+++++.++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 46799999999999976 4688999999864322 223467889999999999999999999999999999999996
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++.. ....+++.++..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 105 ~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 105 GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 577776632 234688999999999999999999985 999999999999999999999999999864322
Q ss_pred eEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.....|+..|+|||++. ...++.++||||||+++|||++|+.|+........ ...... ......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~-~~~~~~----- 240 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NDSPTL----- 240 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh-cCCCCC-----
Confidence 12345788999999984 45688999999999999999999999864322110 000000 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
........+.+++.+|++.+|.+||++.+++..
T Consensus 241 ---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122346778889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=261.86 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=174.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcch---HHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..+|.++||+|.||.|.+.+- ..++.+|+|++++...... ..-+.|-++|+..+||.+..|--.+...+.+++|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 346788999999999999965 4689999999987643333 345678899999999999999988999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|..||.|.-+| .+.+.+++....-+...|+.||.|||+. +||.||||.+|.|||.+|++||+||||++.--
T Consensus 249 yanGGeLf~HL-----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 249 YANGGELFFHL-----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EccCceEeeeh-----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999888 4567888877777889999999999995 99999999999999999999999999998532
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
.....+...+||+.|+|||++....|..+.|.|.+|||+|||++|+.||....
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 22334567889999999999999999999999999999999999999996443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=277.44 Aligned_cols=260 Identities=26% Similarity=0.326 Sum_probs=194.5
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+.++++++|+||+++++++.+....++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34578999999999999775 58999999997653 2234568899999999999999999999999999999999998
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
++|.+++... ...+++..+..++.+++.||+|||+. +|+||||+|+||++++++.+||+|||+++.......
T Consensus 82 -~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 82 -MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred -cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 5899998432 24689999999999999999999995 899999999999999999999999999987643322
Q ss_pred eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc--------chhhhhhhhccC---
Q 038743 663 QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF--------YPGWAFKEMTNG--- 730 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~--- 730 (839)
......++..|+|||.+.+. .++.++||||||++++||++|+.||......+... .....+..+..-
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223356789999998776 88999999999999999999999986543211000 000000000000
Q ss_pred --cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 --TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 --~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
........... ...+.....+.+++..|++.+|++||++.+|+.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 000112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.90 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=189.9
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCC-------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------- 572 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 572 (839)
..+.+.+.||+|+||.||+|... +++.+|||++...... ....+.+|++++.+++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45667889999999999999764 6899999998543222 2345788999999999999999999875433
Q ss_pred -ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 573 -NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 573 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
..++|+||+.+ +|...+.. ....+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999875 66666632 234689999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCce----------eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc-
Q 038743 652 GLAKLMGREHSQ----------VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY- 719 (839)
Q Consensus 652 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~- 719 (839)
|+++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865432211 1123456888999998765 4588999999999999999999999865432110000
Q ss_pred -------hhhhhhhh---ccC---cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 720 -------PGWAFKEM---TNG---TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 720 -------~~~~~~~~---~~~---~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+..+ ... .......+.+... .......+.+++.+|++.+|.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 000 0000000000000 0112256788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=289.17 Aligned_cols=263 Identities=21% Similarity=0.246 Sum_probs=190.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecC-----------
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG----------- 571 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 571 (839)
.+.+.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 456678999999999999976 56899999998665555567789999999999999999999876543
Q ss_pred ---CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCcee
Q 038743 572 ---SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPK 647 (839)
Q Consensus 572 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~k 647 (839)
...++||||++ ++|.+++. ...+++.....++.||+.||.|||+. +|+||||||+||+++ +++.+|
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58888773 23588899999999999999999985 999999999999997 556789
Q ss_pred ecccCcceecCCCCcee--EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--
Q 038743 648 VSDFGLAKLMGREHSQV--VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW-- 722 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~-- 722 (839)
|+|||+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..............
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998654322111 122357889999997654 5688999999999999999999999964432111000000
Q ss_pred h------hhhhccCcccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 A------FKEMTNGTPLKVADRRLEGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 ~------~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. .....................+ ......+.+++..|++.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0000000000000000000000 1123457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.15 Aligned_cols=205 Identities=23% Similarity=0.306 Sum_probs=170.5
Q ss_pred hhccccccccCCCceEEEEEeC---C--CcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeec-CCceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG---D--GTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 575 (839)
.|+....||+|.||.||+|.-. + ...+|||+++.... .-.....+|+.+++.++||||+.|..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3566788999999999999442 2 23799999965422 123457899999999999999999998877 78899
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC----Cceeeccc
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN----FCPKVSDF 651 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~----~~~kl~Df 651 (839)
|++||.+. +|...|+-..+...+.++...+..|+.||+.|+.|||+ +.|+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999877 78787765545566789999999999999999999999 699999999999999766 99999999
Q ss_pred CcceecCCCCcee--EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 652 GLAKLMGREHSQV--VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 652 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
|+++++...-... ...++-|..|.|||++.+ ..||.+.|||+.|||+.||++-.+.|....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999986644333 345667999999999887 579999999999999999999988886543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=274.35 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=192.2
Q ss_pred hccccccccCCCceEEEEEeCC-CcEEEEEEecccC-----CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
|.+.+.||+|+||.||++.... +..+++|.++... .....++..|+.++.+++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5677899999999999997643 4556666654321 223345778999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++... ......+++..+..++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 82 EYCEGRDLDCKLEEL-KHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EeCCCCCHHHHHHHH-hhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999888532 12345789999999999999999999984 9999999999999975 569999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ...+.
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~-~~~~~------- 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLR-IVEGP------- 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-HHcCC-------
Confidence 3221 223345788999999998888999999999999999999999998532211 00111 11110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+......+.+++.+|++.+|++||++.++++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11122334456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=286.11 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=188.3
Q ss_pred hccccccccCCCceEEEEEeC-C--CcEEEEEEecccCC--cchHHHHHHHHHhhcc-ccCCcccccceeec----CCce
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-D--GTLVAVKKLDRVLP--HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE----GSNR 574 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 574 (839)
+.+.+.||+|+||.||++... . +..||+|++..... ...+.+.+|+.++.++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456789999999999999764 3 77999999864322 2245688899999999 59999999987543 2456
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++++||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 82 YLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 78888886 68988883 345688999999999999999999985 9999999999999999999999999999
Q ss_pred eecCCCCce---eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc--------chhh
Q 038743 655 KLMGREHSQ---VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF--------YPGW 722 (839)
Q Consensus 655 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~ 722 (839)
+.+...... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223468999999998765 568999999999999999999999986543211000 0000
Q ss_pred hhhhhccCccccccc-------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 AFKEMTNGTPLKVAD-------RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~-------~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+.......... ..+. .........+.+++.+|++.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 0000 0001123467789999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=269.72 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=192.0
Q ss_pred HHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
.+.....+|..+||+|+||.|.++.- .+.+.+|||++++.... +.+--+.|-++|+.. +-|.++++..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45666778999999999999999955 45789999999765422 222345677788776 67899999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
+|+||||+.+|+|--+| ++-..+.+....-+|..||-||-+||+. +||.||||..|||||.+|.+||+|||+
T Consensus 425 LyFVMEyvnGGDLMyhi-----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHI-----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred eeeEEEEecCchhhhHH-----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence 99999999999997777 3445677888888999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
++.-- ..........||+.|+|||++..++|...+|.|||||+||||+.|+.||++.++.+.+ +.
T Consensus 497 cKEni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~a------- 561 (683)
T KOG0696|consen 497 CKENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QA------- 561 (683)
T ss_pred ccccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HH-------
Confidence 98421 1223355678999999999999999999999999999999999999999977654322 11
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS 769 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt 769 (839)
+.+... .++.....+.+.+...-+...|.+|..
T Consensus 562 -I~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 -IMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 122211 122223334445555567788888753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=270.22 Aligned_cols=236 Identities=27% Similarity=0.319 Sum_probs=190.1
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 511 LGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999774 5899999998654322 345788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 666 (839)
.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 81 FSHLS-----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 99984 234689999999999999999999994 99999999999999999999999999998764332 1223
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
...++..|+|||.+.+...+.++|+||||+++||+++|+.||....... ....... .. ...+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~--------~~--~~~~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-------IYEKILK--------DP--LRFPE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhc--------CC--CCCCC
Confidence 4457889999999988889999999999999999999999996432210 0011110 00 11112
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHH
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGE 772 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~ 772 (839)
.....+.+++.+|++.+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22456778899999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=276.22 Aligned_cols=237 Identities=28% Similarity=0.441 Sum_probs=189.2
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
.++||.|.||+||-|++ ++|+.||||++.+.. ...+.++++|+.+|++++||.||.+.-.|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 35899999999999976 579999999997643 44567799999999999999999999999999999999999855
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC---CceeecccCcceecCCCC
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN---FCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DfGla~~~~~~~ 661 (839)
++.+.|.. .....|++..-.-++.||+.||+|||.. +|+|+||||+||||... -++||||||+|++++...
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 55555533 2456788888888999999999999994 99999999999999643 379999999999986543
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCC------ccchhhhhhhhccCccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED------FFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 735 (839)
- ...++||+.|+|||+++.+.|...-|+||.|||+|--++|..||+...+..+ +.+|.-.|
T Consensus 722 F--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW----------- 788 (888)
T KOG4236|consen 722 F--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW----------- 788 (888)
T ss_pred h--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch-----------
Confidence 2 3456799999999999999999999999999999999999999975443221 11222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVV 774 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~ 774 (839)
.+.....++++...+|..-.+|-+...-+
T Consensus 789 ----------~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 ----------SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ----------hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 12233456667777887888887766544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.75 Aligned_cols=258 Identities=24% Similarity=0.278 Sum_probs=189.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC------ce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------NR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 574 (839)
.|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++.+++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 355678999999999999965 578999999985432 222346889999999999999999999886543 45
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+ +++|.+++. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 8999998 779988873 34688999999999999999999985 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc--------cchhhhhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--------FYPGWAFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~ 725 (839)
....... ....+++.|+|||.+.+ ..++.++||||||++++++++|+.||......... ..+.....
T Consensus 166 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8653321 22357889999998876 46889999999999999999999999744321100 00000000
Q ss_pred hhccCccccccc--cccc----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 726 EMTNGTPLKVAD--RRLE----GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 726 ~~~~~~~~~~~~--~~l~----~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+.......... +... ..........+.+++.+|++.+|++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000 0001112335778999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=278.77 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=189.9
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec-CCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 580 (839)
|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+..|+.++.+++||||+++.+++.. ....++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 55678999999999999965 478999999885432 2234568899999999999999999998865 5678999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+ +++|.+++. ...+++.....++.||++||+|||+. +|+||||+|+|||+++++.+||+|||++......
T Consensus 92 ~-~~~L~~~~~------~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 92 L-GTDLHRLLT------SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred h-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 8 568988873 33577888889999999999999995 9999999999999999999999999999754322
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc--------chhhhhhhhccCc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF--------YPGWAFKEMTNGT 731 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~~ 731 (839)
. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .+.-....+..+.
T Consensus 162 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 M----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred c----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 1 22346788999998766 578999999999999999999999996433110000 0000001111111
Q ss_pred ccccccc-cccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADR-RLEGAVEE-----EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~-~l~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..++... ......+. .....+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111000 00011111 123567888999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.45 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=192.7
Q ss_pred HHhhccccccccCCCceEEEE-EeCCCcEEEEEEecccC--Ccch-----HHHHHHHHHhhccccCCcccccceee-cCC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGE-----KEFVTEVNTIGSMHHMNLVRLCGYCS-EGS 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~--~~~~-----~~~~~E~~~l~~l~h~niv~l~g~~~-~~~ 572 (839)
...|-+..+||+|+|+.||++ .+...+.||||+-.-.. .... +...+|.++-+.|.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 344445678999999999999 56778899999863221 1111 34678999999999999999999985 566
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeec
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVS 649 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~ 649 (839)
..+-|+|||+|.+|+.||. ..+.+++.+...|+.||+.||.||.+. +++|||-||||.||||- .-|.+||.
T Consensus 542 sFCTVLEYceGNDLDFYLK-----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK-----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHH-----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 7889999999999999993 557889999999999999999999985 57999999999999994 45789999
Q ss_pred ccCcceecCCCCce------eEEeeccccceeCcccccC----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc
Q 038743 650 DFGLAKLMGREHSQ------VVTMVRGTRGYLAPEWVSN----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719 (839)
Q Consensus 650 DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~ 719 (839)
||||++++..+... ......||..|++||.+.- ..++.|+||||.|||+|..+.|+.||.......+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--- 692 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--- 692 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---
Confidence 99999999765443 2456789999999998753 3578999999999999999999999975432211
Q ss_pred hhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 038743 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEV 773 (839)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v 773 (839)
.+.+..+...-. +.....+........++.+||+..-++|-...++
T Consensus 693 ------ILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 ------ILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred ------HHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 111111111100 1111112223345567888999999998765544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=285.06 Aligned_cols=258 Identities=23% Similarity=0.264 Sum_probs=187.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------CceE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNRL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 575 (839)
+.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 44567899999999999965 578999999986532 22245678899999999999999999987543 3467
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
++++++ +++|.+++. ...+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 99 lv~~~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 99 LVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred EEehhc-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence 777776 789988772 23588999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAFKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~~ 726 (839)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... +......
T Consensus 169 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 169 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 64322 223457889999998876 5688999999999999999999999854332110000 0000000
Q ss_pred hccCccccc---ccccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MTNGTPLKV---ADRRLEGAV---EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~~~~~~~~---~~~~l~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+........ +........ .......+.+++.+|++.+|.+||++.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 000000000 00123457789999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=285.28 Aligned_cols=258 Identities=23% Similarity=0.270 Sum_probs=190.4
Q ss_pred hccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCc------eE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN------RL 575 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 575 (839)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 556789999999999999774 58899999986432 2233567789999999999999999998866554 89
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+|+||+ +++|.+++. ...+++..+..++.||++||.|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 97 lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 97 LVTHLM-GADLNNIVK------CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence 999998 669988883 24689999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAFKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~~ 726 (839)
..... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||........... +.-....
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 65432 223357888999998865 4678999999999999999999999964332110000 0000000
Q ss_pred hccCcccccccc---cccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MTNGTPLKVADR---RLEGAV---EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~~~~~~~~~~~---~l~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+........+.. ...... .......+.+++.+|++.+|.+|||+.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 000000 01124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=281.55 Aligned_cols=238 Identities=23% Similarity=0.263 Sum_probs=189.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+...+|.|+|+.|-++.. .+++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.++|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 456677899999999999965 57899999999765 22344566665555 7999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE-CCCCceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL-DENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill-~~~~~~kl~DfGla~~~~~~ 660 (839)
.++-|.+.++. .+.+. .++..|+.+|+.++.|||++ +++||||||+|||+ ++.++++|+|||.++...++
T Consensus 399 ~g~ell~ri~~-----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 399 DGGELLRRIRS-----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred cccHHHHHHHh-----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99988777732 22233 77788999999999999996 99999999999999 69999999999999977654
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
....+-|..|.|||++....++.++|+||||++||||++|+.||....... .....+ .
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i------------~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRI------------Q 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhh------------c
Confidence 223356889999999999999999999999999999999999997543320 011111 1
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+.++........+++.+|||.+|.+||+|.++...
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 222223444556778888999999999999998653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=253.36 Aligned_cols=283 Identities=20% Similarity=0.300 Sum_probs=200.2
Q ss_pred cccccccCCCceEEEEEeC-CCcEEEEEEec--ccCCcchHHHHHHHHHhhccccCCcccccceeec--------CCceE
Q 038743 507 FAQLLGTGGFGSVYKGSLG-DGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--------GSNRL 575 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~~~ 575 (839)
-..+||+|.||+||+|+.. +|+.||+|+.- +....-.....+|+++|..++|+|++.++..|.. ....+
T Consensus 21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 3468999999999999764 57888998752 2111222457899999999999999999999853 23579
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
|||.+|+. +|.-+|. .....++..++.+++.++..||.|+|. +.|+|||+||.|+||+.++.+||+|||+++
T Consensus 101 lVf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 99999976 7777772 344678899999999999999999998 499999999999999999999999999998
Q ss_pred ecCCCCce---eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------h
Q 038743 656 LMGREHSQ---VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------A 723 (839)
Q Consensus 656 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~ 723 (839)
.+...... ..+..+-|..|.+||.+.+ +.++.+.|||.-|||+.||++|.+-+.+........++.. +
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76433222 1344556999999998876 5799999999999999999999988876543321111110 1
Q ss_pred hhhhccCcc-------------cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCCCCCCCc-
Q 038743 724 FKEMTNGTP-------------LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMP- 789 (839)
Q Consensus 724 ~~~~~~~~~-------------~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~~~p~~p- 789 (839)
|....+-.+ ...+..++..-...+ ..++++...+..||.+|+.+.+++...- +-..|.|
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~---~a~dLle~ll~~DP~kR~~ad~alnh~~----F~kdp~pq 325 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDD---EALDLLEKLLKLDPTKRIDADQALNHDF----FWKDPMPQ 325 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCCh---hHHHHHHHHhccCcccCcchHhhhchhh----hhcCCcch
Confidence 111000000 011111111111112 3455666689999999999999976432 2334555
Q ss_pred hhhHHHhhhchhhHH
Q 038743 790 QTVLELIEEGLDHVY 804 (839)
Q Consensus 790 ~~~~~~~~~~~~~~~ 804 (839)
.++.++++...++..
T Consensus 326 anl~~ml~t~~~s~f 340 (376)
T KOG0669|consen 326 ANLQDMLSTHLQSMF 340 (376)
T ss_pred hhHHHHHHHhHHHHH
Confidence 556666666655544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=253.10 Aligned_cols=243 Identities=23% Similarity=0.218 Sum_probs=188.1
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeec----CCceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE----GSNRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~~ 582 (839)
++||-|-.|.|..... .+++.+|+|++... ...++|+++--.. .|||||.+++++.+ ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 5899999999999965 57899999998543 2456777765444 69999999998754 567889999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeecccCcceecCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~~~~ 659 (839)
||.|...+.+ .....+.+.+.-.|+.||+.|+.|||+. .|.||||||+|+|.. .+..+||+|||+|+.-..
T Consensus 143 GGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 143 GGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred chHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999998843 3556799999999999999999999996 999999999999995 456799999999986433
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
........-|+.|.|||++....|+...|+||+||++|-|++|.+||-...... ++.-....+..+.
T Consensus 217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq-------- 283 (400)
T KOG0604|consen 217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ-------- 283 (400)
T ss_pred --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC--------
Confidence 233445667999999999999999999999999999999999999996443211 1111111111111
Q ss_pred ccCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 740 LEGAVEE----EELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 740 l~~~~~~----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
-.++. ...+...+++...|..+|.+|.|+.+++..=
T Consensus 284 --y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 284 --YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred --ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 11221 2344555677778899999999999998753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=263.91 Aligned_cols=221 Identities=20% Similarity=0.131 Sum_probs=174.4
Q ss_pred CCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChhhhccc
Q 038743 514 GGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFP 592 (839)
Q Consensus 514 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 592 (839)
|.||.||++.. .+++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999966 568899999986532 334455555566799999999999999999999999999999998842
Q ss_pred CCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEeecccc
Q 038743 593 SYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672 (839)
Q Consensus 593 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 672 (839)
...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...... .....++.
T Consensus 79 -----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 79 -----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred -----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 23588999999999999999999984 9999999999999999999999999988655432 12234567
Q ss_pred ceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHH
Q 038743 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRA 752 (839)
Q Consensus 673 ~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 752 (839)
.|+|||.+....++.++||||+|+++|||++|+.|+........ . .... ..+......+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~-----~~~~----~~~~~~~~~~ 205 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T-----HTTL----NIPEWVSEEA 205 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c-----cccc----CCcccCCHHH
Confidence 89999999888899999999999999999999988753211100 0 0000 0111223456
Q ss_pred HHHHHhccccCCCCCCCHHH
Q 038743 753 MKVAFWCIQDEVFMRPSMGE 772 (839)
Q Consensus 753 ~~l~~~Cl~~~p~~RPt~~~ 772 (839)
.+++.+|++.+|++||++.+
T Consensus 206 ~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHccCCHHHhcCCCc
Confidence 78889999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=293.86 Aligned_cols=200 Identities=22% Similarity=0.275 Sum_probs=176.7
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
...+.+.++||+|+||.|..+++ .+++.+|.|++.+.. .....-|..|-.+|..-+.+-|+++.-.|.+..++|||
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 44566788999999999999987 468899999998742 33445689999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
||||+||+|-.+|.. .+ .+++....-++..|+.||.-||+. |+|||||||.|||||..|++||+|||.+-.+
T Consensus 154 MdY~pGGDlltLlSk----~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSK----FD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EecccCchHHHHHhh----cC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999932 22 678777778888999999999996 9999999999999999999999999999988
Q ss_pred CCCCceeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
..+..-.....+|||.|++||++.. +.|...+|.||+||++|||+.|..||.
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 8777777777889999999999852 578999999999999999999999995
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=299.59 Aligned_cols=144 Identities=25% Similarity=0.367 Sum_probs=126.9
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.++||+|+||.||+|... +++.||||++..... .....+..|+.++..++||||+++++++......+||||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4567789999999999999775 689999999864322 123568899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
|+++++|.+++. ....+++...+.++.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~-----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLH-----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999984 234578888999999999999999985 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=280.03 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=203.6
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeec-----CCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE-----GSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~~ 575 (839)
.+..|.++||.|.+|.||+++. ++++..|+|++... ....++...|.++++.+ +|||++.++|++.. ++.++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 3456788999999999999965 57899999998654 45566788899999888 79999999999853 57899
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
||||||.+||..+++.... +..+.|..+..|+..++.||.+||. +.+||||||-.|||++.++.+||.|||++.
T Consensus 98 LVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeee
Confidence 9999999999999986653 7889999999999999999999998 599999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
.+...... .....||+.|||||++.. ..|+..+|+||||++..||--|.+|+.......... .+..
T Consensus 172 QldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-------~IpR- 242 (953)
T KOG0587|consen 172 QLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPR- 242 (953)
T ss_pred eeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-------cCCC-
Confidence 76543333 234569999999999965 347889999999999999999999986443321110 0000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.|...-..+......+.+++..|+..+-.+||++.++++.
T Consensus 243 ------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 ------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111112245667788899999999999999999888653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=258.80 Aligned_cols=238 Identities=27% Similarity=0.361 Sum_probs=190.8
Q ss_pred CCceEEEEEeC-CCcEEEEEEecccCCcc-hHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChhhhccc
Q 038743 515 GFGSVYKGSLG-DGTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFP 592 (839)
Q Consensus 515 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 592 (839)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 48999999997654444 67899999999999999999999999999999999999999999999843
Q ss_pred CCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEeecccc
Q 038743 593 SYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672 (839)
Q Consensus 593 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 672 (839)
. ..+++..++.++.+++++|.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 2 2388999999999999999999995 99999999999999999999999999998765432 223345788
Q ss_pred ceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHH
Q 038743 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRA 752 (839)
Q Consensus 673 ~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 752 (839)
.|++||.+....++.++|||+||++++||++|..||....... ...+......... ..........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-------ccccccCCHHH
Confidence 9999999998889999999999999999999999986422111 0011111110000 00000033568
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 038743 753 MKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 753 ~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 88999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=258.35 Aligned_cols=270 Identities=20% Similarity=0.269 Sum_probs=204.6
Q ss_pred ccchHHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-c-C----Ccccccc
Q 038743 494 NFTYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-H-M----NLVRLCG 566 (839)
Q Consensus 494 ~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~g 566 (839)
-+...|.....+.+...+|+|.||.|-+.-. ..+..||||+++.... -.+..+-|+++++++. + | .+|++.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 4566777778888899999999999999944 4589999999976532 2345678999999993 2 2 3788888
Q ss_pred eeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-----
Q 038743 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD----- 641 (839)
Q Consensus 567 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~----- 641 (839)
++.-..+.++|+|.+ |-|+.+||.+. .-..+....+..|+.|++++++|||+ ++++|-||||+|||+-
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 899999999999987 55899999532 45678889999999999999999999 5999999999999992
Q ss_pred ---------------CCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC
Q 038743 642 ---------------ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 642 ---------------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
++..+||+|||.|+.-.... ..++.|..|.|||++.+..++.++||||+||||.|+.+|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 13458999999998644333 45567999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCc--------cchhhhhhhh------ccCcc-----------ccccccc----ccCCCCHHHHHHHHHHHH
Q 038743 707 NLDMSGDAEDF--------FYPGWAFKEM------TNGTP-----------LKVADRR----LEGAVEEEELMRAMKVAF 757 (839)
Q Consensus 707 p~~~~~~~~~~--------~~~~~~~~~~------~~~~~-----------~~~~~~~----l~~~~~~~~~~~~~~l~~ 757 (839)
.|....+.+.. .+|....... ..+++ ..+.++. ........+...+.+++.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 99776644321 1222111111 01100 0000000 011223466778999999
Q ss_pred hccccCCCCCCCHHHHHH
Q 038743 758 WCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 758 ~Cl~~~p~~RPt~~~v~~ 775 (839)
.++..||.+|+|+.|.+.
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=275.09 Aligned_cols=261 Identities=19% Similarity=0.186 Sum_probs=175.7
Q ss_pred HHhhccccccccCCCceEEEEEe-----------------CCCcEEEEEEecccCCcchH--------------HHHHHH
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-----------------GDGTLVAVKKLDRVLPHGEK--------------EFVTEV 550 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~--------------~~~~E~ 550 (839)
...+.+.++||+|+||+||+|.. .+++.||||++........+ .+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 33456778999999999999954 23568999998643222222 234567
Q ss_pred HHhhccccCCc-----ccccceeec--------CCceEEEEeeccCCChhhhcccCCC-------------------CCc
Q 038743 551 NTIGSMHHMNL-----VRLCGYCSE--------GSNRLLVYEFMKNGSLDKWIFPSYH-------------------HRD 598 (839)
Q Consensus 551 ~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~ 598 (839)
.++.+++|.++ ++++++|.. ....+|||||+++++|.++|+.... ...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766654 677888753 3568999999999999999864211 011
Q ss_pred ccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcc
Q 038743 599 RVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678 (839)
Q Consensus 599 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 678 (839)
..+++..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++.+............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2456778899999999999999985 8999999999999999999999999999765432222222233578999999
Q ss_pred cccCCC----------------------CCCcccEEehhHHHHHHHhCCC-CCCCCCCCC------Cccchhhhhhhhcc
Q 038743 679 WVSNRP----------------------ITVKADVYSYGMLLLEIVGGRR-NLDMSGDAE------DFFYPGWAFKEMTN 729 (839)
Q Consensus 679 ~~~~~~----------------------~s~~~DV~S~Gvvl~elltG~~-p~~~~~~~~------~~~~~~~~~~~~~~ 729 (839)
.+.... ...+.||||+||+++||++|.. |+....... ......| +....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhhcc
Confidence 875422 1234799999999999999875 654221100 0011111 11111
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEV---FMRPSMGEVVK 775 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p---~~RPt~~~v~~ 775 (839)
... +- ...........+++.+++..+| .+|+|++|+++
T Consensus 459 ~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 11 1111223445666777777655 78999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=283.38 Aligned_cols=261 Identities=18% Similarity=0.171 Sum_probs=165.9
Q ss_pred HhhccccccccCCCceEEEEEeC-C----CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccce------eecC
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-D----GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY------CSEG 571 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~ 571 (839)
..+.+.++||+|+||.||+|.+. + +..||||++..... .+.+..| .+....+.+++.++.. +..+
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 45667789999999999999874 4 68999998864321 1111111 1122223333332222 2456
Q ss_pred CceEEEEeeccCCChhhhcccCCCC---------------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCC
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHH---------------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPE 636 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~ 636 (839)
...++||||+++++|.+++...... .........+..++.||+.||+|||+. +|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence 7899999999999999988532100 000112234567999999999999995 9999999999
Q ss_pred cEEECC-CCceeecccCcceecCCCCceeEEeeccccceeCcccccCC----------------------CCCCcccEEe
Q 038743 637 NILLDE-NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR----------------------PITVKADVYS 693 (839)
Q Consensus 637 Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~DV~S 693 (839)
|||+++ ++.+||+|||+++.+............+++.|||||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 68999999999986644333333455689999999965322 2345679999
Q ss_pred hhHHHHHHHhCCCCCCCCCCC-------CCccchhhhhhhhccCcccccccccccCCC--CHHHHHHHHHHHHhccccCC
Q 038743 694 YGMLLLEIVGGRRNLDMSGDA-------EDFFYPGWAFKEMTNGTPLKVADRRLEGAV--EEEELMRAMKVAFWCIQDEV 764 (839)
Q Consensus 694 ~Gvvl~elltG~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~l~~~Cl~~~p 764 (839)
|||+||||+++..+.+..... ....+..|. ...... ..+.+...+ .........+++.+|++.||
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR--KLVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH--Hhhccc----cchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999987665321100 000111110 000000 000000000 00112234578899999999
Q ss_pred CCCCCHHHHHHH
Q 038743 765 FMRPSMGEVVKM 776 (839)
Q Consensus 765 ~~RPt~~~v~~~ 776 (839)
.+|||+.++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=225.41 Aligned_cols=194 Identities=24% Similarity=0.372 Sum_probs=162.2
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
.++||+|.||+||+|+. ++++.||+|+++-.. ..-.....+|+-+++.++|.|||++++....+...-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 46899999999999975 568999999985332 22345789999999999999999999999999999999999954
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
+|..|.. .-...++......++.|+++||.|+|++ .+.||||||.|.||+.+|+.||+|||+++-++-+-..
T Consensus 86 dlkkyfd----slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 86 DLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred HHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 7777662 2455788889999999999999999996 8999999999999999999999999999987654322
Q ss_pred EEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHh-CCCCCCC
Q 038743 665 VTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVG-GRRNLDM 710 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~ellt-G~~p~~~ 710 (839)
.+..+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++.|-+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 2334468999999998875 58999999999999999995 4444443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=232.78 Aligned_cols=197 Identities=26% Similarity=0.416 Sum_probs=165.2
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccCC
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
...||+|++|.|-+-++ .+|+..|+|++.... .+..+..++|+.+..+. .+|.+|.++|....+...++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 35799999999999876 679999999996544 34456788999887665 899999999999999999999999954
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
||+.|-.+.. ..+..+.+..+=+||..+.+||.|||++ ..+||||+||+||||+.+|++||||||++..+.+.-.
T Consensus 130 Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-- 204 (282)
T KOG0984|consen 130 SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-- 204 (282)
T ss_pred hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence 7877654332 3566788888999999999999999997 7899999999999999999999999999987644322
Q ss_pred EEeeccccceeCcccccC----CCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 665 VTMVRGTRGYLAPEWVSN----RPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~----~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
.+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 233457888999998853 4799999999999999999999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-29 Score=265.30 Aligned_cols=238 Identities=24% Similarity=0.277 Sum_probs=190.9
Q ss_pred cccccccCCCceEEEEEeCCCc-EEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGT-LVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
....||-|+||.|-++..+... .+|+|++++.. ...++....|-++|...+.|.||+++-.+.+....||.||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3458999999999999885443 48999886643 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
||.|...|. .+..++..+..-++..+.+|++|||.. +||.|||||+|.+||.+|-+||.|||+|+.++. .
T Consensus 504 GGElWTiLr-----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g 573 (732)
T KOG0614|consen 504 GGELWTILR-----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--G 573 (732)
T ss_pred Cchhhhhhh-----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc--C
Confidence 999999993 445788888888899999999999994 999999999999999999999999999998754 3
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
..+-..+||+.|.|||++.+...+.++|.||||+++|||++|++||...+.-..+.++- .| +|. -
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-------kG-----id~---i 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-------KG-----IDK---I 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-------hh-----hhh---h
Confidence 34567889999999999999999999999999999999999999998665433322211 11 010 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPS 769 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt 769 (839)
.++........+++.+....+|.+|..
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112222333455666667789999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=263.52 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=185.9
Q ss_pred chHHHHHHhhc---c--ccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccc
Q 038743 496 TYRDLQIRTSN---F--AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCG 566 (839)
Q Consensus 496 ~~~~l~~~~~~---~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g 566 (839)
.|..|+.+.-+ | .+.||-|+||+|.++.. ++...+|.|.|++.. +........|..||+....+.||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 45555554432 3 34799999999999954 556789999997643 233456788999999999999999999
Q ss_pred eeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCce
Q 038743 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 567 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
.|.+.+.+|+||+|++||++-.+|. +-..+.+....-++..++.|+++.|.. ++|||||||.|||||.+|.+
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLI-----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHH-----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCce
Confidence 9999999999999999999999884 345677777777778899999999996 99999999999999999999
Q ss_pred eecccCcceecC---------C--C---C-----------------------ce----eEEeeccccceeCcccccCCCC
Q 038743 647 KVSDFGLAKLMG---------R--E---H-----------------------SQ----VVTMVRGTRGYLAPEWVSNRPI 685 (839)
Q Consensus 647 kl~DfGla~~~~---------~--~---~-----------------------~~----~~~~~~gt~~y~aPE~~~~~~~ 685 (839)
||.||||+.-+. . . + .+ .....+||+.|+|||++....+
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999996441 0 0 0 00 0112469999999999999999
Q ss_pred CCcccEEehhHHHHHHHhCCCCCCCCCCCCC-ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHH
Q 038743 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAED-FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKV 755 (839)
Q Consensus 686 s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 755 (839)
+..+|.||.|||||||+.|+.||......+. +.+..| ...++-......+.+....+.++
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHHH
Confidence 9999999999999999999999965443332 112222 22334444455666666666666
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=274.99 Aligned_cols=242 Identities=25% Similarity=0.345 Sum_probs=182.5
Q ss_pred cccccCCCce-EEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 509 QLLGTGGFGS-VYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 509 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
+++|.|+-|+ ||+|.+ +|+.||||++-. .-..-..+|+..++.- .|||||++++.-.++...|+..|.|. -+|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 4799998875 699999 789999998842 2234567899999888 69999999988889999999999995 499
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-----CCceeecccCcceecCCCC
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-----NFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~~~~~~ 661 (839)
++++... ........-...+.+..|++.||++||+. +||||||||.||||+. ..+++|+|||+++.+....
T Consensus 590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999653 01111111144567889999999999995 9999999999999965 3579999999999876544
Q ss_pred cee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhC-CCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 662 SQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG-RRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 662 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... .....||-+|+|||.+....-+.++||||+|||+|+.++| .+||......+. ..+........+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~L~- 736 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVHLE- 736 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceeeec-
Confidence 332 4556799999999999998889999999999999999987 899964332110 0000000000011
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. .++ ...+++..++.++|..||++.+|+.
T Consensus 737 ---~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 ---PL--PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---cC--chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 111 6678888899999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=243.49 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=170.9
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...+.++||+|+|.+|.++++ ++.+.+|+|++++..-. +..-.+.|-.++.+. +||.+|.+..++..+..+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 345678999999999999987 45789999999765322 222356677777665 7999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|--++ ++.+.|++....-+...|.-||.|||+. +||.||||..|||||..|.+||.|||+++.--
T Consensus 331 eyv~ggdlmfhm-----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 331 EYVNGGDLMFHM-----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEecCcceeeeh-----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999997766 4667888888888889999999999996 99999999999999999999999999998643
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
. .....+...||+.|+|||.+++..|....|.|++||+++||+.|+.||+.-.
T Consensus 403 ~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 403 G-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred C-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 2 2334567889999999999999999999999999999999999999997654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=234.86 Aligned_cols=193 Identities=27% Similarity=0.412 Sum_probs=164.6
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC-----CceEEEEe
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRLLVYE 579 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e 579 (839)
.+.||-|+||.||-.+. .+|+.||+|++.+... ...+.+.+|++++...+|.|++..++...-. .+.|++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46899999999999976 5799999999865432 2346788999999999999999998877543 35677888
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
.|.. +|.+.|. ....|+-..+.-+..||++||+|||+. +|.||||||.|.|++.+..+||+|||+++....
T Consensus 138 LmQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 138 LMQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 8854 8888774 445677777788999999999999995 999999999999999999999999999999877
Q ss_pred CCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
+....++..+-|..|.|||.+.+ +.|+.+.||||.|||+.||+..+..|.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 77777777778999999999987 579999999999999999998877664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=229.16 Aligned_cols=211 Identities=33% Similarity=0.538 Sum_probs=182.0
Q ss_pred cccCCCceEEEEEeCC-CcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChhh
Q 038743 511 LGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDK 588 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 588 (839)
||+|.+|.||++...+ ++.+++|++...... ....+.+|++.+..++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 899999999755332 34679999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecCCCCceeEEe
Q 038743 589 WIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGREHSQVVTM 667 (839)
Q Consensus 589 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~ 667 (839)
++... ...+++..+..++.+++++|++||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 98422 14688999999999999999999995 9999999999999999 89999999999987654321 1223
Q ss_pred eccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCH
Q 038743 668 VRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746 (839)
Q Consensus 668 ~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 746 (839)
..+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4477889999999887 889999999999999998
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 747 ~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577888889999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-27 Score=210.88 Aligned_cols=98 Identities=47% Similarity=0.717 Sum_probs=70.4
Q ss_pred CCcEEEeeCCCCCCCC---CeEEEEecCCcEEEeCC-CeeEEEe-cCCCCc--eeEEEEeccccEEEecCCCCceeeccc
Q 038743 49 DRTVVWSANRNFPVTK---DAILELDTTGNLVLNDG-DTTIWAS-NSSGAG--VELATMSESGNFILYAPNNQPVWQSFL 121 (839)
Q Consensus 49 ~~tvVW~ANr~~pv~~---~~~l~l~~~G~Lvl~~~-~~~vWst-~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFD 121 (839)
++||||+|||+.|+.. ..+|.|+.||+|+|.+. +..||+| ++.+.+ ...|+|+|+|||||++..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 3799999999999943 37999999999999995 4789999 555443 677999999999999999999999999
Q ss_pred CCCccccCCCCcccce------eeccCCccC
Q 038743 122 HPSDTLLPNQPLSVSL------ELTSPKSLQ 146 (839)
Q Consensus 122 ~PTDTlLpg~~l~~~~------~L~s~~s~~ 146 (839)
|||||+||||+|+.+. .|+||++..
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~ 111 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNT 111 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS-
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCC
Confidence 9999999999998632 267776653
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=219.32 Aligned_cols=194 Identities=18% Similarity=0.337 Sum_probs=163.4
Q ss_pred HhhccccccccCCCceEEEEE-eCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecC--CceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEG--SNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~ 578 (839)
..|++.+++|+|.+++||.|. ..+.+.++||+++.. ..+.+.+|+++|..|. ||||++|++...+. ....||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 346677899999999999995 567899999999744 4567899999999996 99999999998764 4678999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceec
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLM 657 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~ 657 (839)
||+.+.+...+. ..|+...+...+.++++||.|+|+. ||.|||+||.|++||. .-.++|+|+|+|.++
T Consensus 115 E~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 115 EYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 999998887654 3567778888999999999999996 9999999999999985 457999999999987
Q ss_pred CCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
.+... ....+.+..|..||++.. ..|+..-|+|||||+|.+|+..+.||-...
T Consensus 184 Hp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 184 HPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 55433 233446778999998865 568999999999999999999999995443
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=202.20 Aligned_cols=110 Identities=35% Similarity=0.603 Sum_probs=96.8
Q ss_pred cCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-CCeeEEEec
Q 038743 11 SQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND-GDTTIWASN 89 (839)
Q Consensus 11 ~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~-~~~~vWst~ 89 (839)
.++++|+|++|.|++|||.+..+. .++++|||.+++ +++||.||++.|....+.|.|+.||+|+|.| ++.+||+|+
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q~-~dgnlv~~~~~~--~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~ 81 (116)
T cd00028 5 SSGQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGSS--RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSN 81 (116)
T ss_pred CCCCEEEeCCCcEEEecccCCCCC-CeEEEEEEeCCC--CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEec
Confidence 458999999999999999886532 488999998853 7899999999996667899999999999998 567899999
Q ss_pred CCC-CceeEEEEeccccEEEecCCCCceeecccCC
Q 038743 90 SSG-AGVELATMSESGNFILYAPNNQPVWQSFLHP 123 (839)
Q Consensus 90 ~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD~P 123 (839)
+.+ .+..+|+|+|+|||||++.++.++|||||||
T Consensus 82 ~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 82 TTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred ccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 865 5666799999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=243.95 Aligned_cols=192 Identities=25% Similarity=0.317 Sum_probs=162.4
Q ss_pred cccccccCCCceEEEEEeCC-CcEEEEEEecccCC--------cchHHHHHHHHHhhccc---cCCcccccceeecCCce
Q 038743 507 FAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLP--------HGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 574 (839)
..+.+|+|+||.|+.+.++. ...|+||.+.+... ...-..-.|+.+|..++ |+||++++++|++.+..
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35689999999999998754 56899999865321 11123557999999997 99999999999999999
Q ss_pred EEEEeec-cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 575 LLVYEFM-KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 575 ~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
||++|-. ++-+|.++| .....+++.+...|..||+.|+++||++ +|||||||-+||.++.+|-+||+|||.
T Consensus 645 yl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred EEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 9999965 456888888 3556789999999999999999999997 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCC
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
+..... ......+||.+|.|||++.+.+| ...-|||++|++||.++....||-
T Consensus 717 aa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876432 23456789999999999999887 567899999999999998887763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=228.38 Aligned_cols=197 Identities=31% Similarity=0.498 Sum_probs=170.6
Q ss_pred ccccccccCCCceEEEEEeCC-CcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 506 NFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999998865 899999999765444 567889999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCccc-CChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 584 GSLDKWIFPSYHHRDRV-LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
++|.+++... .. +++..+..++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||++........
T Consensus 82 ~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 82 GDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999998432 22 78999999999999999999995 999999999999999999999999999987754431
Q ss_pred eeEEeeccccceeCcccc-cCCCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 663 QVVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
.......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334577889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=217.59 Aligned_cols=251 Identities=19% Similarity=0.304 Sum_probs=185.0
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccce-eecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGY-CSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lv~e~ 580 (839)
.|++.+.||+|.||.+-++++. ..+.+|+|.+... ....++|.+|...--.| .|.||+.-+.. +...+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4678899999999999999874 5788999988765 34567899998875555 69999987765 5666788899999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE-C-CCCceeecccCcceecC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL-D-ENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill-~-~~~~~kl~DfGla~~~~ 658 (839)
+|.|+|..-+ ....+.+..-.+++.|++.||.|+|+ +.++|||||.+|||| + +...+||+|||+.+..+
T Consensus 104 aP~gdL~snv------~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 104 APRGDLRSNV------EAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred Cccchhhhhc------CcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999998877 33456777788899999999999999 599999999999999 3 34589999999987543
Q ss_pred CCCceeEEeeccccceeCcccccCC-----CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNR-----PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
. ......-+..|.+||..... ...+.+|||.||++++.+++|+.||.-.. ....+.|-+..+..+...
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhcccCc
Confidence 2 12223345679999977542 34678999999999999999999997221 122344555555554433
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
.+ |+.-.. ..++++++..+-+.+++++|--..++.++-
T Consensus 248 ~~--P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 AL--PKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cC--chhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 111112 233455666667889999996555555543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=222.05 Aligned_cols=254 Identities=23% Similarity=0.249 Sum_probs=183.9
Q ss_pred cccccCCCceEEEE-EeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------CceEEEEe
Q 038743 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNRLLVYE 579 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~e 579 (839)
+.+|.|.- .|.-+ ..-.+++||+|++.... ....+...+|...+..++|+||++++.++.-. .+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 46777777 44444 23358899999985442 23346788999999999999999999998643 46799999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
+|. .+|...+. -.++-..+..|..|+..|++|||+. +|+||||||+||++..+..+||.|||+|+.-+.
T Consensus 102 ~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 102 LMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCc
Confidence 995 47877773 3466778889999999999999994 999999999999999999999999999986543
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc----------------chhhh
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF----------------YPGWA 723 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~----------------~~~~~ 723 (839)
+ -..+....|..|.|||++.+..+.+.+||||.||++.||++|+..|.+......+. +..-+
T Consensus 171 ~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 171 D--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred c--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 3 34566778999999999999889999999999999999999998886543211110 00000
Q ss_pred hhhhccC-c-----ccccc-cccccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 724 FKEMTNG-T-----PLKVA-DRRLEG--AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 724 ~~~~~~~-~-----~~~~~-~~~l~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....... + ..+++ |..... +.+......+..++.++|-.+|++|-+.+++++.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000 0 00000 100000 1112234456678888999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=240.62 Aligned_cols=251 Identities=22% Similarity=0.240 Sum_probs=194.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|++.+.+|.|.+|.|||++. ..++..|||+++-.......-...|+-+++.-+|||||.++|-+...+..+++||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 456778999999999999965 5789999999987656666677889999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|++.-+ -...+++.++...+....+||+|||+. +=+|||||-.|||+++.+.+|++|||.+-.+...-.
T Consensus 96 ggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 96 GGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred CCcccceee-----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999998764 345788999999999999999999996 779999999999999999999999999876644332
Q ss_pred eeEEeeccccceeCcccc---cCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWV---SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~---~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
+. ....||+.|||||+. +.+.|..++|||+.|+...|+---+.|...... .+.+.-......-.+.
T Consensus 168 Kr-ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----------mr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 168 KR-KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----------MRALFLMTKSGFQPPT 236 (829)
T ss_pred hh-hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----------HHHHHHhhccCCCCCc
Confidence 22 234599999999977 357799999999999999999877766532111 1111000000111112
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+... ....+.+-+++..|+..+|++||+++.+++
T Consensus 237 lkDk--~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCC--ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2221 122344555666699999999999987654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=225.34 Aligned_cols=143 Identities=26% Similarity=0.371 Sum_probs=116.1
Q ss_pred CCcccchHHHHH-HhhccccccccCCCceEEEE-EeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-----c---CC
Q 038743 491 APVNFTYRDLQI-RTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-----H---MN 560 (839)
Q Consensus 491 ~~~~~~~~~l~~-~~~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~n 560 (839)
+-......|... ..|.+.++||-|.|++||++ ...+.+.||+|+.+.. ..=.+..+.|+++|++++ | ..
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 333445566666 78888999999999999999 5567889999998654 222345778999999883 3 36
Q ss_pred cccccceee----cCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCC
Q 038743 561 LVRLCGYCS----EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPE 636 (839)
Q Consensus 561 iv~l~g~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~ 636 (839)
||+|+++|. .+.+.+||+|++ |-+|..+|... .-+.+....+..|+.||+.||.|||..| +|||-||||+
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPE 217 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPE 217 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcc
Confidence 999999985 467999999998 55788887543 4567888999999999999999999985 9999999999
Q ss_pred cEEE
Q 038743 637 NILL 640 (839)
Q Consensus 637 Nill 640 (839)
|||+
T Consensus 218 NvLl 221 (590)
T KOG1290|consen 218 NVLL 221 (590)
T ss_pred eeee
Confidence 9999
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=192.61 Aligned_cols=108 Identities=35% Similarity=0.638 Sum_probs=95.5
Q ss_pred cCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeCC-CeeEEEec
Q 038743 11 SQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDG-DTTIWASN 89 (839)
Q Consensus 11 ~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~~-~~~vWst~ 89 (839)
..+++|+|++|.|++|||.+.. ..++++|||+..+ +++||+||++.|+..++.|.|..||+|+|.+. +.+||+|+
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~--q~dgnlV~~~~~~--~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~ 80 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLIM--QNDYNLILYKSSS--RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSN 80 (114)
T ss_pred CCCCEEecCCCcEeeeccccCC--CCCEEEEEEECCC--CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEec
Confidence 4589999999999999998864 3578999999853 78999999999998778999999999999984 66899999
Q ss_pred CC-CCceeEEEEeccccEEEecCCCCceeecccC
Q 038743 90 SS-GAGVELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 90 ~~-~~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
+. +.+..+|+|+|+|||||++..+.++||||||
T Consensus 81 t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 81 TTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 85 5566679999999999999999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-25 Score=228.78 Aligned_cols=214 Identities=22% Similarity=0.254 Sum_probs=178.9
Q ss_pred eeCCCcccchHHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc------cCC
Q 038743 488 VCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH------HMN 560 (839)
Q Consensus 488 ~~~~~~~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~n 560 (839)
-..+-..+.+.|+....|.+.-..|+|-|++|.+|.. ..|+.||||++.+. ....+.=+.|+++|.+|+ ..+
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence 3445556788899999999999999999999999965 44889999999765 334455678999999994 447
Q ss_pred cccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 561 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
.++|+-.|...++++||+|-+ .-+|.++|..- .....|....+..++.|+.-||..|... +|+|.||||.|||+
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKy--G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY--GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHh--CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEe
Confidence 899999999999999999987 44888888543 3556788889999999999999999985 99999999999999
Q ss_pred CCC-CceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 641 DEN-FCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 641 ~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
++. ..+||||||.|....... .+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|-+.
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 875 568999999998764432 33444567899999999999999999999999999999999888553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=265.94 Aligned_cols=196 Identities=18% Similarity=0.276 Sum_probs=140.3
Q ss_pred cccc-CCccccccee-------ecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCC
Q 038743 555 SMHH-MNLVRLCGYC-------SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626 (839)
Q Consensus 555 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 626 (839)
.++| .||++++++| .+....++++||+ +++|.++|.. ....+++.+++.++.||++||+|||+.
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 4556 6888888887 2334667788887 6699999942 245689999999999999999999985
Q ss_pred eeeecCCCCCcEEECC-------------------CCceeecccCcceecCCCCc---------------eeEEeecccc
Q 038743 627 RIIHCDIKPENILLDE-------------------NFCPKVSDFGLAKLMGREHS---------------QVVTMVRGTR 672 (839)
Q Consensus 627 ~iiH~dlk~~Nill~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~ 672 (839)
+|+||||||+||||+. ++.+||+|||+++....... .......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 45677777777764321000 0011235888
Q ss_pred ceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHH
Q 038743 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRA 752 (839)
Q Consensus 673 ~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 752 (839)
.|||||++.+..++.++|||||||+||||++|..|+..... ....+.. ..+.+.. .......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~----~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRH----RVLPPQI-----LLNWPKE 241 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHH----hhcChhh-----hhcCHHH
Confidence 99999999999999999999999999999999887642110 0001100 0111110 1123345
Q ss_pred HHHHHhccccCCCCCCCHHHHHHH
Q 038743 753 MKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 753 ~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..++.+||+.+|.+||+|.||++.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 677888999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=209.24 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=189.5
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEec--ccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..++..+|.+...|+.|+|++.. ..+++|++. .......++|..|.-.++...||||++++|.|....+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34556789999999999999954 456667773 333444567999999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+.|+|...|++. .....+-.+..+++.+||+|++|||+. .+-|..--|.++.|+||++.+++|+- +-+++.-..
T Consensus 270 p~gslynvlhe~---t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE- 343 (448)
T ss_pred cchHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec-
Confidence 999999999753 566788899999999999999999996 23344456899999999999998852 111111000
Q ss_pred ceeEEeeccccceeCcccccCCCCC---CcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPIT---VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
....-.+.||+||.++..+.+ .++|+|||+++||||.|...||.....-+. + ..+.-+
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------------g--mkiale 404 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------------G--MKIALE 404 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------------h--hhhhhc
Confidence 111235789999999876654 579999999999999999999964332111 0 112222
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.++..+++.....+.+++.-|+.+||.+||.+..|+-.|+..
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 333444555555667777779999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=212.88 Aligned_cols=194 Identities=24% Similarity=0.337 Sum_probs=160.1
Q ss_pred ccccccccCCCceEEEEEeC----CCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEee
Q 038743 506 NFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
...++||+|.|++||++.+. ..+.||+|.+.... ......+|+++|..+ -+.||+++.+++..++...+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 34579999999999999653 46789999986542 344688999999998 599999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~ 659 (839)
++.-...+++. .++...+...+..+..||+++|. ++||||||||+|+|.+. .+.-.|.|||+|.....
T Consensus 117 ~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 117 FEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred cCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999888873 46688899999999999999999 59999999999999974 45678999999972210
Q ss_pred CC---------------------------------c----------eeEEeeccccceeCcccccC-CCCCCcccEEehh
Q 038743 660 EH---------------------------------S----------QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYG 695 (839)
Q Consensus 660 ~~---------------------------------~----------~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~G 695 (839)
.. . .......||+||.|||++.. ..-+.+.||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00123469999999998876 4568999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 038743 696 MLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 696 vvl~elltG~~p~~~~~ 712 (839)
||++.+++++.||-...
T Consensus 266 VI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAK 282 (418)
T ss_pred ceeehhhccccccccCc
Confidence 99999999999995443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=202.17 Aligned_cols=166 Identities=22% Similarity=0.214 Sum_probs=123.3
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++.. .+..+++.+++.++.||+.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc--
Confidence 688888842 245799999999999999999999996 3 999999999999999 99998764422
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
..|++.|||||++.+..++.++|||||||++|||++|+.||........ . ...+....... ++.. ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~-~~~~~~~~~~~--~~~~-~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----I-LEILLNGMPAD--DPRD-RS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----H-HHHHHHHhccC--Cccc-cc
Confidence 2588999999999999999999999999999999999999864322110 0 00110000000 0000 00
Q ss_pred CCHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 744 VEEEEL--MRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 744 ~~~~~~--~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...... ..+.+++.+|++.+|.+||++.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111112 258899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-22 Score=211.72 Aligned_cols=163 Identities=18% Similarity=0.186 Sum_probs=126.0
Q ss_pred HHhhccccccccCCCceEEEEEeC--CCcEEEEEEecccC-----CcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG--DGTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...|.+.+.||+|+||+||+|... +++.||||++.... ......|.+|++++.+++|+|+++.+.. ....
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 345777889999999999999764 57788999875331 1124568999999999999999853322 2457
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCC-CCCcEEECCCCceeecccCc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDI-KPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DfGl 653 (839)
+|||||+++++|.... .. ....++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+
T Consensus 94 ~LVmE~~~G~~L~~~~------~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 94 GLVRGWTEGVPLHLAR------PH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred EEEEEccCCCCHHHhC------cc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 9999999999996321 00 0146788999999999995 9999999 99999999999999999999
Q ss_pred ceecCCCCcee-------EEeeccccceeCcccccC
Q 038743 654 AKLMGREHSQV-------VTMVRGTRGYLAPEWVSN 682 (839)
Q Consensus 654 a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 682 (839)
++.+....... .....++..|+|||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99875433111 134568889999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-22 Score=216.24 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=195.1
Q ss_pred hhccccCCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecC
Q 038743 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCD 632 (839)
Q Consensus 553 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 632 (839)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|..+..+..+|++||+|||.. +-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeee
Confidence 3568899999999999999999999999999999999953 467899999999999999999999995 2339999
Q ss_pred CCCCcEEECCCCceeecccCcceecCCC-CceeEEeeccccceeCcccccCC-------CCCCcccEEehhHHHHHHHhC
Q 038743 633 IKPENILLDENFCPKVSDFGLAKLMGRE-HSQVVTMVRGTRGYLAPEWVSNR-------PITVKADVYSYGMLLLEIVGG 704 (839)
Q Consensus 633 lk~~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DV~S~Gvvl~elltG 704 (839)
++++|+++|..+.+||+|||+....... .........-...|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999999876431 11112222345679999998763 257889999999999999999
Q ss_pred CCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCCC
Q 038743 705 RRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADIN 784 (839)
Q Consensus 705 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~~ 784 (839)
+.||......... .+ ....+.. .......|.+.... +....++.++..||..+|.+||++++|-..++......
T Consensus 155 ~~~~~~~~~~~~~--~e-ii~~~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP--DE-IILRVKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cCccccccccCCh--HH-HHHHHHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9999765433321 01 1111111 11112222222111 33336888999999999999999999999998766543
Q ss_pred --CCCCchhhHHHhhhchhhHHHhhhccCCcccceeecCCc
Q 038743 785 --TPPMPQTVLELIEEGLDHVYKAMKRDFNQFSSFTINSST 823 (839)
Q Consensus 785 --~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ss~ 823 (839)
....-+.+..+++.+.+.+++.+++.+.+...++.++..
T Consensus 229 ~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~ 269 (484)
T KOG1023|consen 229 SSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDT 269 (484)
T ss_pred cccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHH
Confidence 235667888999999999999888876666655554444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=200.87 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=187.2
Q ss_pred hhccccccccCCCceEEEEEeCCC--cEEEEEEecccCCcchHHHHHHHHHhhcccc----CCccccccee-ecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDG--TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH----MNLVRLCGYC-SEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 576 (839)
.+.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566788999999999999976443 5788888765433333368888888888863 5788888888 47778899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-----Cceeeccc
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-----FCPKVSDF 651 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-----~~~kl~Df 651 (839)
||+.+ |.+|.++.... ..+.++..+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.||
T Consensus 99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99876 77998876332 257899999999999999999999995 99999999999999754 46999999
Q ss_pred Ccce--ecCCCCce------e-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh
Q 038743 652 GLAK--LMGREHSQ------V-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 652 Gla~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 722 (839)
|+++ .+...... . ....+||..|++++.+.+...+.+.|+||++.++.|++.|..||.........
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~----- 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK----- 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-----
Confidence 9999 33222211 1 23456999999999999999999999999999999999999998544322110
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+........... .....+.+...+.+. +-..+..++|....+...|+..
T Consensus 247 --~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 --SKFEKDPRKLLTDR--FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred --HHHHHHhhhhcccc--ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHH
Confidence 00000000001110 112233344444443 4557889999999998887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-21 Score=191.01 Aligned_cols=198 Identities=23% Similarity=0.314 Sum_probs=168.6
Q ss_pred hccccccccCCCceEEEEE-eCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeecc
Q 038743 505 SNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
+.+.++||+|.||.++.|+ +-++++||||.-...+ ..-++..|.+..+.| ..++|...+-|-.++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 5678899999999999994 5689999999764432 233577888888888 5799999998889999999999987
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-----CCceeecccCcceec
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-----NFCPKVSDFGLAKLM 657 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~~ 657 (839)
|.||+++. .-.++.++..++..+|.|++.-++|+|+. .+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 107 GPSLEDLF----D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 GPSLEDLF----DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred CcCHHHHH----HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77898876 24678999999999999999999999995 9999999999999953 346899999999988
Q ss_pred CCCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 658 GREHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 658 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
.+..... .....||.+||+-....++.-+.+.|+-|+|.++.+.|.|..||.+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 6654433 234569999999999999999999999999999999999999997654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=184.26 Aligned_cols=259 Identities=19% Similarity=0.228 Sum_probs=190.5
Q ss_pred HHHhhccccccccCCCceEEEEE-eCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 578 (839)
....+.+.++||.|+||.+|.|. ..+|+.||||.-++...+ -++..|.++...|+ ...|..+..+..++..-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34556788999999999999995 578999999987654333 35778999999996 478899999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCcce
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGLAK 655 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~ 655 (839)
+.+ +.+|++++. -..+.++..+.+.++-|++.-++|+|.. ++|||||||+|+|..- ...+.|+|||+|+
T Consensus 91 dLL-GPsLEdLfn----fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN----FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ecc-CccHHHHHH----HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 987 778988762 3567899999999999999999999995 9999999999999853 3468899999999
Q ss_pred ecCCCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 656 LMGREHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 656 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
.+.+..... .....||.+|.+-....+..-+.+.|+-|+|.+|.++..|..||.+....... ...+++.+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~----QKyEkI~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK----QKYEKISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH----HHHHHHHH
Confidence 875433322 23456999999988888888899999999999999999999999765432110 01112222
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
.++. ..-..+...++. ++.-.+.-|-..--++-|...-+.+++.
T Consensus 239 kK~s-~~ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 239 KKMS-TPIEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred hhcC-CCHHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 2111 111122222332 2333344477777777777665555543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=166.89 Aligned_cols=109 Identities=27% Similarity=0.678 Sum_probs=79.0
Q ss_pred ccccccCCCCCCcccCceEEeeccCCcceeeeccCCCccEEEEecCCCccccccccccccccceeEEEEEecCCcEEEEE
Q 038743 184 ANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNKSTRLTVLRRLILETNGNLRLYR 263 (839)
Q Consensus 184 ~~~~yW~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 263 (839)
||++.|+|..+++.+.+... ..+. |.|..+....+.++. ..+.++++|++||++|++|+|.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~-----~~~~-----------~~fv~~~~e~~~t~~---~~~~s~~~r~~ld~~G~l~~~~ 61 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSN-----SLYN-----------YSFVSNNEEVYYTYS---LSNSSVLSRLVLDSDGQLQRYI 61 (110)
T ss_pred CCccccCCeEECCccccccc-----ceeE-----------EEEEECCCeEEEEEe---cCCCceEEEEEEeeeeEEEEEE
Confidence 57899999888877754311 1111 222222222112211 1234688999999999999999
Q ss_pred eecCCCCCCCceeeccccCCCCccccccc-ccccccCCCCCCCceeecCCCCcCC
Q 038743 264 WDNDVNGSRQWVPEWAAVSNPCNIAGICG-KGICNLDRSKTKASCTCLPGDSKIG 317 (839)
Q Consensus 264 w~~~~~~~~~W~~~~~~p~d~Cd~yg~CG-~g~C~~~~~~~~~~C~Cl~Gf~~~~ 317 (839)
|+ +..+.|.+.|.+|.|+||+|+.|| +|+|+.+. .|.|+||+||+|++
T Consensus 62 w~---~~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~~---~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 62 WN---ESTQSWSVFWSAPKDQCDVYGFCGPNGICNSNN---SPKCSCLPGFEPKN 110 (110)
T ss_pred Ee---cCCCcEEEEEEecccCCCCccccCCccEeCCCC---CCceECCCCcCCCc
Confidence 95 457789999999999999999999 69998654 67899999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.8e-19 Score=190.98 Aligned_cols=261 Identities=27% Similarity=0.367 Sum_probs=194.0
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCCc---chHHHHHHHHHhhccccC-CcccccceeecCCceEEEEee
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHM-NLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345678999999999999886 88999999665433 256799999999999888 799999999777778999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcceecCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLMGR 659 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~ 659 (839)
+.+++|.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||+++.+..
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999776322110 3688889999999999999999995 899999999999999988 799999999986654
Q ss_pred CCce-----eEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 660 EHSQ-----VVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 660 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
.... ......|+..|+|||.+.+ .......|+|++|++++++++|..|+....... ........+....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc---cHHHHHHHHHhcC
Confidence 3322 2355679999999999987 678999999999999999999999965433210 0000111111000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. .................+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000000002223456777888999999999999987764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=179.00 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=108.0
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCc--c-------hHH-----------------HHHHHHHhhccccCCc
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH--G-------EKE-----------------FVTEVNTIGSMHHMNL 561 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 561 (839)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998888999999999643211 1 111 2349999999988877
Q ss_pred ccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHh-hhccCCeeeecCCCCCcEEE
Q 038743 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF-HEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 562 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~dlk~~Nill 640 (839)
.....+.. ...+|||||+++++|...+. ....++......++.|++.+|.|| |+ .+|+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 44333222 23489999999987765431 234678889999999999999999 56 489999999999999
Q ss_pred CCCCceeecccCcceecC
Q 038743 641 DENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~ 658 (839)
+ ++.++|+|||++....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=181.44 Aligned_cols=174 Identities=11% Similarity=0.124 Sum_probs=135.2
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHH---------HHHHHHHhhccccCCccccccee
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKE---------FVTEVNTIGSMHHMNLVRLCGYC 568 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~g~~ 568 (839)
.++....+...++||.|+||.||+... ++..+|||.+........+. +.+|++.+.++.|++|..+..++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 455566777889999999999999766 57789999997554333322 67899999999999999998885
Q ss_pred ecC--------CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 569 SEG--------SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 569 ~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
... ...+|+|||++|.+|.++.. ++. ....+++.+|..||+. +++|||+||+||++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 532 35789999999999987641 111 3466999999999995 99999999999999
Q ss_pred CCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHH
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ell 702 (839)
+.++ ++|+|||.......+... ..++....+..++|+|+||+.+.-+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9988 999999988754322111 11344556778999999999987664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-20 Score=212.65 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=182.7
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccc--CCcchH----HHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV--LPHGEK----EFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~----~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..++|.|++|.|+.... ...+..+.|..... ...... .+..|..+-..++|||++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 56899999997777743 33444444433210 111111 245677777788999999988888887777777999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++ +|..++. ....+...++..+..|+..|++|||+. +|.|||||++|++++.++.+||+|||.+..+.-.
T Consensus 403 ~~~-Dlf~~~~-----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 403 CPY-DLFSLVM-----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred ccH-HHHHHHh-----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 999 9999883 224677788889999999999999996 9999999999999999999999999999887554
Q ss_pred Cce---eEEeeccccceeCcccccCCCCCC-cccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 661 HSQ---VVTMVRGTRGYLAPEWVSNRPITV-KADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 661 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~-~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
... ......|...|+|||.+.+..|.. ..||||.|+++..|++|+.||.......... . ..... .+.-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~----~~~~~---~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K----TNNYS---DQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h----hhccc---cccc
Confidence 443 345677999999999999988864 6899999999999999999996544322211 0 00000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...-...+......+...++.++++.+|.+|-||++|++.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000011122345566778889999999999999999764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=172.14 Aligned_cols=142 Identities=18% Similarity=0.153 Sum_probs=110.6
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcc--------------------------hHHHHHHHHHhhccccCCc
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG--------------------------EKEFVTEVNTIGSMHHMNL 561 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 561 (839)
...||+|+||.||+|...+|+.||||++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999988789999999986542110 1123578899999999987
Q ss_pred ccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC
Q 038743 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD 641 (839)
Q Consensus 562 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~ 641 (839)
.....+... ..+|||||++++++...+. ....++......++.+++.+|.+||+. .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE
Confidence 554444332 3489999999886543321 223567788899999999999999982 3999999999999999
Q ss_pred CCCceeecccCcceecCC
Q 038743 642 ENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 642 ~~~~~kl~DfGla~~~~~ 659 (839)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-19 Score=201.10 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=181.7
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccC-CcchHHHHHHHHH--hhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL-PHGEKEFVTEVNT--IGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
...+.+.||.+.|=+|.+++.++|. |+||++-+.. ....+.|.++++- ...++|||.+++.-.....+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566789999999999999998888 9999985544 3344555554443 4455899999998887778888999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec--C
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--G 658 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~--~ 658 (839)
+.+ +|.+.| ..+..|...+..-|+.|++.||..+|.. +|+|||||.+||||+.-.-+.|+||.--+.. .
T Consensus 103 vkh-nLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VKH-NLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hhh-hhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 865 787777 3456677888889999999999999995 9999999999999999888999999877532 1
Q ss_pred CCCc----eeEEeeccccceeCcccccC----------CC-CCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 659 REHS----QVVTMVRGTRGYLAPEWVSN----------RP-ITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 659 ~~~~----~~~~~~~gt~~y~aPE~~~~----------~~-~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
.+.. ......+.-..|+|||.+.. .. .+++-||||+||++.||++ |+++|+... .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------L 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------L 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------H
Confidence 1111 11333445567999998743 12 5788999999999999996 577775321 0
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
. ..+.+. ....+.+...++ -..+.++++.|++.||.+|-+++++++.-.+..
T Consensus 245 ~--aYr~~~--~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 245 L--AYRSGN--ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred H--hHhccC--ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 0 000010 000000000111 114667888899999999999999999876654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-18 Score=164.95 Aligned_cols=184 Identities=16% Similarity=0.069 Sum_probs=138.0
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEecccCCcch----HHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeec
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGE----KEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
....|++|+||+||.+.- .+.+++.+.+........ ..+.+|+++|.+|+ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356899999999998766 678888887765432111 24789999999994 5889999886 4569999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCC-CCCcEEECCCCceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDI-KPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
.|.+|...+. . ....++.|++++|.++|+. +|+|||| ||.|||++.++.++|+|||++......
T Consensus 81 ~G~~L~~~~~-----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 81 AGAAMYQRPP-----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred cCccHHhhhh-----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999865431 0 1235778999999999995 9999999 799999999999999999999865433
Q ss_pred Cce----e--------EEeeccccceeCcccccCC-CCC-CcccEEehhHHHHHHHhCCCCCCC
Q 038743 661 HSQ----V--------VTMVRGTRGYLAPEWVSNR-PIT-VKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 661 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
... . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 210 0 0112357778888754332 223 567889999999999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=191.34 Aligned_cols=198 Identities=23% Similarity=0.272 Sum_probs=159.9
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc---cCCcccccceeecCCce
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 574 (839)
-++....+.+.+.||+|+||.||+|...+|+.||||+-+..... +|.--.+++.+|+ -+-|..+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34445566778899999999999999888999999987654332 2333334444554 23444555555667888
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-------CCCcee
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-------ENFCPK 647 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-------~~~~~k 647 (839)
+||+||.+.|+|.+++. ..+.++|.....++.|+++.++.||.. +|||+||||+|+||. +..-++
T Consensus 770 ~lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred eeeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 99999999999999994 567899999999999999999999996 999999999999993 344689
Q ss_pred ecccCcceecCCCCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC
Q 038743 648 VSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 648 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
|+|||.+-.+.-... .......+|-.+-.+|+..+++++...|-|.|+.+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999976543322 34666778999999999999999999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=162.95 Aligned_cols=134 Identities=19% Similarity=0.231 Sum_probs=103.2
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-----ccCCcccccceeecCC---c-eEEEE
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-----HHMNLVRLCGYCSEGS---N-RLLVY 578 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lv~ 578 (839)
.+.||+|+||.||. ++.....+||++........+++.+|++++..+ .||||++++|++.+.. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35899999999996 443333479988654444567899999999999 5799999999998764 3 23789
Q ss_pred ee--ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHh-HHhhhccCCeeeecCCCCCcEEECC----CCceeeccc
Q 038743 579 EF--MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI-AYFHEQCRNRIIHCDIKPENILLDE----NFCPKVSDF 651 (839)
Q Consensus 579 e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~dlk~~Nill~~----~~~~kl~Df 651 (839)
|| +++|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||
T Consensus 85 e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 668999999932 234444 35677888777 999995 9999999999999974 347999995
Q ss_pred Ccc
Q 038743 652 GLA 654 (839)
Q Consensus 652 Gla 654 (839)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-17 Score=170.28 Aligned_cols=231 Identities=22% Similarity=0.292 Sum_probs=145.6
Q ss_pred cccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccc----------cCCcccccceee---
Q 038743 507 FAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMH----------HMNLVRLCGYCS--- 569 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~g~~~--- 569 (839)
..+.||.|+++.||.++.. +++.+|||+..... ....+++.+|.-.+..+. |-.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4568999999999999875 58999999984322 233456777766555532 222222222221
Q ss_pred ------cCC--------ceEEEEeeccCCChhhhcc---cCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecC
Q 038743 570 ------EGS--------NRLLVYEFMKNGSLDKWIF---PSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCD 632 (839)
Q Consensus 570 ------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 632 (839)
... +.+++|+-+ .++|.+++. ... .....+....++.+..|+++.+++||+. +++|+|
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-QTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-cccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 235667766 557777642 221 1134556677788889999999999996 999999
Q ss_pred CCCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccC--------CCCCCcccEEehhHHHHHHHhC
Q 038743 633 IKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN--------RPITVKADVYSYGMLLLEIVGG 704 (839)
Q Consensus 633 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DV~S~Gvvl~elltG 704 (839)
|||+|+|++.+|.++|+||+.....+... .....+..|.+||.... -.++.+.|.|++|+++|.|+||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999998877644321 11335577999997644 2478899999999999999999
Q ss_pred CCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCC
Q 038743 705 RRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMR 767 (839)
Q Consensus 705 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~R 767 (839)
+.||+........ .| .+ ..+. +..+.+..++...++.+|.+|
T Consensus 247 ~lPf~~~~~~~~~---~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP---EW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS---GG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc---cc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999754322111 00 11 1222 556667778888999999887
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=161.34 Aligned_cols=142 Identities=17% Similarity=0.168 Sum_probs=108.7
Q ss_pred hccccccccCCCceEEEEE--eCCCcEEEEEEecccCCc------------------------chHHHHHHHHHhhcccc
Q 038743 505 SNFAQLLGTGGFGSVYKGS--LGDGTLVAVKKLDRVLPH------------------------GEKEFVTEVNTIGSMHH 558 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h 558 (839)
+.+.+.||+|+||.||+|. ..+|+.||||++...... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 578999999998643210 01235689999999975
Q ss_pred CC--cccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe-eeecCCCC
Q 038743 559 MN--LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR-IIHCDIKP 635 (839)
Q Consensus 559 ~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~dlk~ 635 (839)
.. +.+++++ ...++||||+++++|..++. ....+...+...++.||+.+|++||+. + |+||||||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 33 3344432 23589999999988876542 123345556778999999999999996 7 99999999
Q ss_pred CcEEECCCCceeecccCcceecCC
Q 038743 636 ENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 636 ~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
+||+++ ++.++|+|||++...+.
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999876443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.1e-17 Score=180.27 Aligned_cols=186 Identities=26% Similarity=0.319 Sum_probs=154.4
Q ss_pred ccccCCCceEEEEE----eCCCcEEEEEEecccCCcc--hHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeecc
Q 038743 510 LLGTGGFGSVYKGS----LGDGTLVAVKKLDRVLPHG--EKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
++|+|.||.|++.+ .+.|..+|.|.+.+..... ......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999873 2457788888886543211 114566788888886 9999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|.|...+. ....+++.........++-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 81 gg~lft~l~-----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLS-----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccc-----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988773 445666666667778889999999994 999999999999999999999999999987543322
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
. .||..|||||++. .....+|-||||++.+||++|..||..
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2 6899999999988 678899999999999999999999975
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-16 Score=157.31 Aligned_cols=134 Identities=19% Similarity=0.270 Sum_probs=112.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCc--------chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH--------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|++++..++|++++....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 7788999986543211 123577899999999999998888787777889999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
+++++|.+++... .. .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988321 11 7889999999999999995 999999999999999 78899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=153.13 Aligned_cols=137 Identities=17% Similarity=0.134 Sum_probs=107.2
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCCc----------------------chHHHHHHHHHhhccccCC--
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH----------------------GEKEFVTEVNTIGSMHHMN-- 560 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h~n-- 560 (839)
+.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5567899999999999998888999999987532100 0113567888888888874
Q ss_pred cccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 561 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
++..++ ....++||||+++++|..... ......++.+++.++.++|+. +|+||||||.||++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 234589999999999876541 034457889999999999995 99999999999999
Q ss_pred CCCCceeecccCcceecCC
Q 038743 641 DENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~ 659 (839)
++++.++|+|||++.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.4e-16 Score=158.93 Aligned_cols=197 Identities=22% Similarity=0.255 Sum_probs=136.7
Q ss_pred ccCCcccccceeec---------------------------CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHH
Q 038743 557 HHMNLVRLCGYCSE---------------------------GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNI 609 (839)
Q Consensus 557 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 609 (839)
+|||||++.++|.+ ....|+||.-.+. +|.++|. .+..+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~------~~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW------TRHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh------cCCCchHHHHHH
Confidence 79999999887754 2456788876544 8888884 335667778889
Q ss_pred HHHHHHHhHHhhhccCCeeeecCCCCCcEEE--CCCC--ceeecccCcceecCCCC-----ceeEEeeccccceeCcccc
Q 038743 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILL--DENF--CPKVSDFGLAKLMGREH-----SQVVTMVRGTRGYLAPEWV 680 (839)
Q Consensus 610 ~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill--~~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~ 680 (839)
+.|+++|+.|||.+ +|.|||+|+.|||| |+|+ .+.|+|||.+---.... ........|...-||||+.
T Consensus 347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999997 99999999999998 4554 46889999875322211 1112234578889999988
Q ss_pred cCCCC------CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHH
Q 038743 681 SNRPI------TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMK 754 (839)
Q Consensus 681 ~~~~~------s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 754 (839)
...+- -.|+|.|+.|.+.||++....||...++.. +... ...+-.-+ ..+......+.+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~~r--------~Yqe~qLP----alp~~vpp~~rq 488 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LDTR--------TYQESQLP----ALPSRVPPVARQ 488 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---echh--------hhhhhhCC----CCcccCChHHHH
Confidence 65331 258999999999999999999996422110 0000 00000111 222333445667
Q ss_pred HHHhccccCCCCCCCHHHHHHHhc
Q 038743 755 VAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 755 l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
++...++.+|.+||+..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 777789999999999877666653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=177.13 Aligned_cols=133 Identities=17% Similarity=0.263 Sum_probs=108.8
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEE-ecccCCc-------chHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKK-LDRVLPH-------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.||+|+||+||+|.+.+.. +++|+ +.+.... ....+.+|++++..++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 4678999999999999885544 44443 3221111 1245889999999999999998888887777889999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998872 3567999999999999995 99999999999999 6778999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.6e-17 Score=174.34 Aligned_cols=123 Identities=24% Similarity=0.444 Sum_probs=107.5
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..++.|++|...+|.+||... ......++...+.++.|++.|+.| ++.+|+|+||.||++..+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 578999999999999999543 244567788899999999999999 289999999999999999999999999
Q ss_pred cceecCCCC-----ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh
Q 038743 653 LAKLMGREH-----SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG 703 (839)
Q Consensus 653 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt 703 (839)
+........ ....+...||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998765544 233556779999999999999999999999999999999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.5e-16 Score=154.28 Aligned_cols=130 Identities=19% Similarity=0.281 Sum_probs=106.6
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccC-Cc-------chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVL-PH-------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.||+|+||.||+|.+ ++..|++|...... .. ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 67889999864322 11 1245778999999999888766666666677789999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
++++|.+++... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887321 10 7899999999999995 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.5e-14 Score=142.44 Aligned_cols=138 Identities=20% Similarity=0.162 Sum_probs=97.4
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcc--hHH----------------------HHHHHHHhhccccCC--c
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG--EKE----------------------FVTEVNTIGSMHHMN--L 561 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i 561 (839)
.+.||+|+||.||+|...+++.||||++....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986432111 111 124555555554332 3
Q ss_pred ccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC
Q 038743 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD 641 (839)
Q Consensus 562 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~ 641 (839)
.+.+++ ...++||||++++.+....... .... .....++.+++.++.++|.. .+|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE
Confidence 333332 2468999999996543221111 0011 56778999999999999983 3899999999999999
Q ss_pred CCCceeecccCcceecC
Q 038743 642 ENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 642 ~~~~~kl~DfGla~~~~ 658 (839)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=134.53 Aligned_cols=134 Identities=20% Similarity=0.188 Sum_probs=114.1
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcccc--CCcccccceeecCCceEEEEeeccCCC
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH--MNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999854 7899999865432 4578999999999976 589999988888888999999999887
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 80 ~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7432 4566778899999999999986556899999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=142.12 Aligned_cols=134 Identities=20% Similarity=0.182 Sum_probs=103.5
Q ss_pred cccc-cCCCceEEEEEeCCCcEEEEEEecccC-------------CcchHHHHHHHHHhhccccCCc--ccccceeecCC
Q 038743 509 QLLG-TGGFGSVYKGSLGDGTLVAVKKLDRVL-------------PHGEKEFVTEVNTIGSMHHMNL--VRLCGYCSEGS 572 (839)
Q Consensus 509 ~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~ 572 (839)
..|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4788 8999999999884 7789999874310 1123457889999999998875 66776654322
Q ss_pred c----eEEEEeeccC-CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 573 N----RLLVYEFMKN-GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 573 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
. .++|+|++++ .+|.+++.. ..++. ..+.+|+.+|.+||+. +|+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 2599999997 689888732 22332 2467899999999995 999999999999999988999
Q ss_pred ecccCccee
Q 038743 648 VSDFGLAKL 656 (839)
Q Consensus 648 l~DfGla~~ 656 (839)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=165.99 Aligned_cols=162 Identities=23% Similarity=0.312 Sum_probs=114.7
Q ss_pred ccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
.+.|..|++|.||..++. ..+++|+|+-++.. +.+- ++.....|.+| |+=
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence 468999999999999875 36788885432221 1110 22222333333 232
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC-----
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----- 661 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~----- 661 (839)
...+.. -..+. .+++.+++|||+ .+|+|||+||.|.+|+.-|.+|+.|||+.+......
T Consensus 139 ~tllk~-----~g~lP--------vdmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 139 ATLLKN-----IGPLP--------VDMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhccc-----CCCCc--------chhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 222311 11111 223789999999 599999999999999999999999999997542110
Q ss_pred -------cee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCC
Q 038743 662 -------SQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDA 714 (839)
Q Consensus 662 -------~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~ 714 (839)
.+. ...++||+.|+|||++..+.|...+|.|++|+|+||.+-|..||.+....
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 011 23467999999999999999999999999999999999999999866433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.7e-14 Score=161.22 Aligned_cols=254 Identities=23% Similarity=0.276 Sum_probs=181.1
Q ss_pred hhccccccccCCCceEEEEEeC--CCcEEEEEEecccC--CcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG--DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 3556677999999999988653 34566777665432 111223445777767775 999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhh-hccCCeeeecCCCCCcEEECCCC-ceeecccCccee
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH-EQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKL 656 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~ 656 (839)
+|..++++.+.+.. ......+....-....|+..++.|+| + .++.|+||||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred Cccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999887731 11114455566678899999999999 5 5999999999999999999 999999999998
Q ss_pred cCC-C-CceeEEeecc-ccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 657 MGR-E-HSQVVTMVRG-TRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 657 ~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+.. . .........| ++.|+|||...+. ......|+||.|+++.-+++|..|++........ +..|..... .
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~~---~- 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNKG---R- 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccccc---c-
Confidence 766 2 2233455667 9999999998884 4578899999999999999999999765543321 111211110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..............++...++..+|..|.+.+++..
T Consensus 250 -------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000001112223445556677789999988777643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.1e-12 Score=143.12 Aligned_cols=141 Identities=21% Similarity=0.225 Sum_probs=98.5
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcc----------------------------------------hHHHHH
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG----------------------------------------EKEFVT 548 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~ 548 (839)
+.||.|++|.||+|++.+|+.||||+.+...... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4799999999999999999999999985432110 012445
Q ss_pred HHHHhhccc----cCCccccccee-ecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHH-HhHHhhh
Q 038743 549 EVNTIGSMH----HMNLVRLCGYC-SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ-GIAYFHE 622 (839)
Q Consensus 549 E~~~l~~l~----h~niv~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~ 622 (839)
|++.+.+++ |.+-+.+-..+ ......+|||||++|++|.+++... ...+ .+..++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCC---CHHHHHHHHHHHHHHHHHh
Confidence 555555542 22222222222 2234679999999999998876321 0111 34567777766 4677887
Q ss_pred ccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 623 ~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
. +++|+|+||.||+++.++.++|+|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=131.92 Aligned_cols=154 Identities=20% Similarity=0.337 Sum_probs=117.3
Q ss_pred HHhhccccCCcccccceeecC-----CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccC
Q 038743 551 NTIGSMHHMNLVRLCGYCSEG-----SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625 (839)
Q Consensus 551 ~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 625 (839)
.-|-++-|.|||++..|..+. ....++.|||..|+|..+|.... .....+......+++.||..||.|||+ |.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 345556799999999988653 45689999999999999996542 344567777788999999999999998 57
Q ss_pred CeeeecCCCCCcEEECCCCceeecccCcceec---CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHH
Q 038743 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLM---GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702 (839)
Q Consensus 626 ~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ell 702 (839)
++|+|+++..+-|++..++-+||.--.-...- ............+.++|.|||+-.....+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999998887532211100 000001122334778999999887778889999999999999998
Q ss_pred hCCC
Q 038743 703 GGRR 706 (839)
Q Consensus 703 tG~~ 706 (839)
-+..
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 7763
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.1e-12 Score=100.11 Aligned_cols=64 Identities=20% Similarity=0.362 Sum_probs=48.9
Q ss_pred CCccceeeeecccccCCccceeccccCCcChHHHHHhhcCCCceeEEEeecCCCCCeEEEeeeccCC
Q 038743 341 SHDYRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFG 407 (839)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~y~~~~~~~~C~~~~~~~~~ 407 (839)
.++++|.+++++++ |++.......+ .++++|+++||+||||+||+|.+..++++|++|.+.+++
T Consensus 2 ~~~d~F~~l~~~~~--p~~~~~~~~~~-~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 2 GSGDGFLKLPNMKL--PDFDNAIVDSS-VSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred cCCCEEEEECCeeC--CCCcceeeecC-CCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 45678999998887 55433222233 589999999999999999999753477999999877664
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.5e-11 Score=115.68 Aligned_cols=130 Identities=16% Similarity=0.063 Sum_probs=96.6
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcc-cccceeecCCceEEEEeeccCCChh
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLV-RLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
+.|+.|.++.||+++.. ++.+++|....... ....+..|++++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999874 77899998754321 233567899999988665554 444433 33468999999998875
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc--CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC--RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 112346788999999999852 23469999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.3e-11 Score=129.77 Aligned_cols=254 Identities=20% Similarity=0.223 Sum_probs=179.7
Q ss_pred HHHHHHhhcccccccc--CCCceEEEEEe---CCCcEEEEEEecccCC--cchHHHHHHHHHhhcc-ccCCcccccceee
Q 038743 498 RDLQIRTSNFAQLLGT--GGFGSVYKGSL---GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSM-HHMNLVRLCGYCS 569 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 569 (839)
.+.......+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+.....+ .|+|.++......
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 4455556677889999 99999999977 4578899998543322 3333445666666666 5999999888888
Q ss_pred cCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHH----HhHHhhhccCCeeeecCCCCCcEEECCC-C
Q 038743 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ----GIAYFHEQCRNRIIHCDIKPENILLDEN-F 644 (839)
Q Consensus 570 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~dlk~~Nill~~~-~ 644 (839)
..+..++-.|++. .+|..+.+. ....+.....+.+..+... ||..+|.. .++|-|+||.||++..+ .
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cCCcceeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 8889999999875 688777643 3344566667777777777 99999994 99999999999999999 8
Q ss_pred ceeecccCcceecCCCCcee----EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch
Q 038743 645 CPKVSDFGLAKLMGREHSQV----VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 720 (839)
..+++|||+...++...... .....|...|++||... +.++.++|+|++|.+.+|..++.+.....- ..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~ 333 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NS 333 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CC
Confidence 89999999999886544221 12235788899999754 457889999999999999999887654221 11
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.|. ++..+- +..++.......+...+..+++.+|..|++.+.++..
T Consensus 334 ~W~--~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 SWS--QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred Ccc--cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 221 111111 1111111112223336667899999999988777653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.6e-11 Score=133.24 Aligned_cols=141 Identities=18% Similarity=0.192 Sum_probs=88.4
Q ss_pred cccccCCCceEEEEEeCC-CcEEEEEEecccCCcc----------------------------------h------HHHH
Q 038743 509 QLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHG----------------------------------E------KEFV 547 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----------------------------------~------~~~~ 547 (839)
+.||.|++|.||+|++.+ |+.||||+++...... . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 489999999999999987 9999999996432100 0 1134
Q ss_pred HHHHHhhccc----cCCcccccceeec-CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHH-hHHhh
Q 038743 548 TEVNTIGSMH----HMNLVRLCGYCSE-GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQG-IAYFH 621 (839)
Q Consensus 548 ~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH 621 (839)
+|+..+.+++ +.+.+.+=.++.+ ....+|||||++|+.+.++-.- .....+ +..++...++. +..++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l----~~~g~d---~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL----RAAGTD---MKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH----HhcCCC---HHHHHHHHHHHHHHHHH
Confidence 4444444442 3222222222222 3467899999999999774210 011111 11222222221 12223
Q ss_pred hccCCeeeecCCCCCcEEECCCC----ceeecccCcceecCC
Q 038743 622 EQCRNRIIHCDIKPENILLDENF----CPKVSDFGLAKLMGR 659 (839)
Q Consensus 622 ~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfGla~~~~~ 659 (839)
. .+++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 4999999999999999888 999999999987754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=111.18 Aligned_cols=142 Identities=20% Similarity=0.264 Sum_probs=109.2
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCC-cchHHHHHHHHHhhcccc--CCcccccceeecCC---ceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHH--MNLVRLCGYCSEGS---NRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~e~~~ 582 (839)
+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887778999999754322 134578899999999865 44577777766543 5689999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc---------------------------------------
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ--------------------------------------- 623 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 623 (839)
+.+|.+.+. ...++...+..++.+++++|++||+.
T Consensus 84 G~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLL------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 998876552 12456667777888888888888852
Q ss_pred --------------cCCeeeecCCCCCcEEECC--CCceeecccCccee
Q 038743 624 --------------CRNRIIHCDIKPENILLDE--NFCPKVSDFGLAKL 656 (839)
Q Consensus 624 --------------~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~ 656 (839)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-09 Score=101.16 Aligned_cols=131 Identities=20% Similarity=0.283 Sum_probs=101.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEe-cccCCcc-------hHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKL-DRVLPHG-------EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l-~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..+++|+-+.+|.+.+- |.++++|.- .+..... .....+|++++.+++--.|...+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999773 444666653 3332222 13467899999998766666656667788899999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
.++..|.++|... +..++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888321 35678888888899999 4999999999999998765 99999999975
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.1e-09 Score=105.56 Aligned_cols=138 Identities=17% Similarity=0.158 Sum_probs=97.0
Q ss_pred cccccCCCceEEEEEeCC-------CcEEEEEEecccC----------C------------cchHHH----HHHHHHhhc
Q 038743 509 QLLGTGGFGSVYKGSLGD-------GTLVAVKKLDRVL----------P------------HGEKEF----VTEVNTIGS 555 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~----------~------------~~~~~~----~~E~~~l~~ 555 (839)
-.||.|--+.||.|.-.+ +..+|||+.+-.. . ...+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999997643 4799999874210 0 001122 379999988
Q ss_pred ccc--CCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHh-hhccCCeeeecC
Q 038743 556 MHH--MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF-HEQCRNRIIHCD 632 (839)
Q Consensus 556 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~d 632 (839)
+.. -++.+++++ ...+|||||+.+..+..-.. .+..++..+...+..+++.+|..| |. .+|+|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 853 455566654 56789999998754422110 122344445667889999999999 66 4999999
Q ss_pred CCCCcEEECCCCceeecccCcceecCC
Q 038743 633 IKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 633 lk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|++.|||++ ++.+.|+|||.+.....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999997 46799999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.3e-09 Score=119.08 Aligned_cols=231 Identities=15% Similarity=0.169 Sum_probs=146.7
Q ss_pred EeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCC
Q 038743 523 SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD 602 (839)
Q Consensus 523 ~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~ 602 (839)
+..++.+|.|...+...........+-++.++.++||||++++.........|||.|-+. .|..++. .+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk--------~l~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK--------ELG 102 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH--------HhH
Confidence 445788899988876544233446777889999999999999999999999999999864 3444442 122
Q ss_pred hhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccC
Q 038743 603 WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682 (839)
Q Consensus 603 ~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 682 (839)
....--.+.||+.||.|||+. .+++|++|.-..|++++.|..||++|.++.......... ....---.|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~-~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA-KSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc-ccchhhhcccChhhcCc
Confidence 445556788999999999986 589999999999999999999999999886543222100 00011123455554322
Q ss_pred CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc-cchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccc
Q 038743 683 RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF-FYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQ 761 (839)
Q Consensus 683 ~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~ 761 (839)
.. -..|.|-||++++|++.|..+- ..+.... ..+. ...++.-+.+. ........ .++.+..|..
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~~~~--~~~~~~~~~ipk---------~~~~~~~k~~~-~~~~~r~n-~~~~~~~~~~ 244 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGSLLT--KTDLSNTGKIPK---------ALIELYCKKLG-ATELKRPN-KLRFILECRL 244 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcccCc--chhhhccCccch---------hHHHHHHHHhc-cccccccc-hhhHHHHHHh
Confidence 21 3469999999999999983221 1111000 0000 00001100110 00011111 4556666777
Q ss_pred cCCCCCCCHHHHHHHhcCCC
Q 038743 762 DEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 762 ~~p~~RPt~~~v~~~L~~~~ 781 (839)
..+--|=-+-+++..|++..
T Consensus 245 ~~gff~n~fvd~~~fLeel~ 264 (690)
T KOG1243|consen 245 LGGFFRNDFVDTLLFLEELR 264 (690)
T ss_pred ccccccchHHHHHHHHHhcc
Confidence 77777777788888887653
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-09 Score=92.97 Aligned_cols=71 Identities=20% Similarity=0.377 Sum_probs=52.5
Q ss_pred cceeeeecccccCCccceeccccCCcChHHHHHhhcCCCceeEEEeecCCCCCeEEEeeeccCCCccC--CCCceEEEEe
Q 038743 344 YRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSLDFGGFED--PSSTLFVKIM 421 (839)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~y~~~~~~~~C~~~~~~~~~g~~~--~~~~lylkl~ 421 (839)
+.|..+++++++ ++.... ...++++|+++||+||+|+||+|. +++++|++|...+.+.... ++.++|+|++
T Consensus 12 ~~f~~~~~~~~~--~~~~~~---~~~s~~~C~~~Cl~nCsC~a~~~~--~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLP--DNASAI---TAISLEECREACLSNCSCTAYAYN--NGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCC--Cchhhh---ccCCHHHHHHHHhcCCCcceeeec--CCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 578888877774 333211 335899999999999999999997 3468999998877765432 3478999973
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-09 Score=120.79 Aligned_cols=192 Identities=24% Similarity=0.307 Sum_probs=145.8
Q ss_pred hccccccccCCCceEEEEEe--CCCcEEEEEEecccCCcchHH--HHHHHHHhhcc-ccCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQLLGTGGFGSVYKGSL--GDGTLVAVKKLDRVLPHGEKE--FVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.++...||.|.|+.|++... .++..+++|.+.+.......+ -..|+-+...+ .|.++++....+..-+..++=-|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 44566899999999999854 467899999886654433322 24555555555 58888888877777788889999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-CceeecccCcceecC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMG 658 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~~~~ 658 (839)
|++++++...+ .....++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.+..+.
T Consensus 347 ~~~~~s~~l~~-----~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 347 FCEGGSSSLRS-----VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred hhcCcchhhhh-----HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999987766 234578888999999999999999998 599999999999999876 788999999986421
Q ss_pred CCCceeEEeeccccce-eCcccccCCCCCCcccEEehhHHHHHHHhCCCC
Q 038743 659 REHSQVVTMVRGTRGY-LAPEWVSNRPITVKADVYSYGMLLLEIVGGRRN 707 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p 707 (839)
-. .......+..| .+++......+-.+.|++|||.-+.|.+++..-
T Consensus 419 ~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 419 FS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ee---cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 11 11111223334 356666677888999999999999999988743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=96.00 Aligned_cols=142 Identities=21% Similarity=0.327 Sum_probs=102.9
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEE-ecccCCc-------chHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKK-LDRVLPH-------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...|-+|+-+.|+++.+ .|+...||. +.+..+. ..+...+|++.+.+++--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 35788999999999998 567666664 3333222 23457889999998865555544456667777789999
Q ss_pred eccC-CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC---ceeecccCcce
Q 038743 580 FMKN-GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---CPKVSDFGLAK 655 (839)
Q Consensus 580 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~ 655 (839)
|+++ .++.+++.... ...........++..|-+.+.-||. ++|||+||..+||+|..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~---~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM---EDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHc---cCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9987 57888875331 1111222236788899999999998 5999999999999996443 46899999986
Q ss_pred e
Q 038743 656 L 656 (839)
Q Consensus 656 ~ 656 (839)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.6e-09 Score=85.70 Aligned_cols=67 Identities=13% Similarity=0.146 Sum_probs=48.0
Q ss_pred CccceeeeecccccCCccceeccccCCcChHHHHHhhcC---CCceeEEEeecCCCCCeEEEeeecc-CCC--ccCCCCc
Q 038743 342 HDYRIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLS---NCQCVASVYGLDDEKPYCWVLRSLD-FGG--FEDPSST 415 (839)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~y~~~~~~~~C~~~~~~~-~~g--~~~~~~~ 415 (839)
....|..+.+++ .|+... .+++||+++|++ ||||+||+|... +.+|++|...+ .+. +.+.+.+
T Consensus 7 ~~g~fl~~~~~k--lpd~~~-------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 7 SAGTTLIKIALK--IKTTKA-------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred cCCeEEEeeccc--CCcccc-------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccCCCce
Confidence 344566555555 466543 488999999999 999999999732 35798887776 543 3444678
Q ss_pred eEEE
Q 038743 416 LFVK 419 (839)
Q Consensus 416 lylk 419 (839)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.7e-08 Score=104.05 Aligned_cols=171 Identities=16% Similarity=0.230 Sum_probs=130.8
Q ss_pred CceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee----cCCceEEEEeeccC-CChhhh
Q 038743 516 FGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS----EGSNRLLVYEFMKN-GSLDKW 589 (839)
Q Consensus 516 fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~~ 589 (839)
-.+.||+.. -||..+++|++.....+.......-++.++++.|.|+|++..++. ....+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888854 589999999995443333333455678899999999999998876 34578999999986 678776
Q ss_pred cccCCCC----------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 590 IFPSYHH----------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 590 l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
-+..... ....+.+..+|.++.|++.||.++|+. |+.-+-|.+++||++.+.+++|+..|+..+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6543222 234567889999999999999999996 888899999999999999999999888876654
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRN 707 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p 707 (839)
+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 331 1111 12466888899999999999754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=93.26 Aligned_cols=126 Identities=22% Similarity=0.241 Sum_probs=82.9
Q ss_pred eEEEEEeCCCcEEEEEEecccC--------------C-------cc-----hHHHHHHHHHhhccccC--Ccccccceee
Q 038743 518 SVYKGSLGDGTLVAVKKLDRVL--------------P-------HG-----EKEFVTEVNTIGSMHHM--NLVRLCGYCS 569 (839)
Q Consensus 518 ~Vy~~~~~~~~~vavK~l~~~~--------------~-------~~-----~~~~~~E~~~l~~l~h~--niv~l~g~~~ 569 (839)
.||.|..++|..+|||..+... . .. .....+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999874210 0 00 12357899999999755 45666544
Q ss_pred cCCceEEEEeecc--CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHh-hhccCCeeeecCCCCCcEEECCCCce
Q 038743 570 EGSNRLLVYEFMK--NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF-HEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 570 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
....|||||++ +..+..+. ...++......++.+++..+..+ |. .+|+|+||.+.|||++++ .+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-------~~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-------DVDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-------HCGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred --eCCEEEEEecCCCccchhhHH-------hccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 24579999998 55554432 11222445667888888866664 56 599999999999999988 89
Q ss_pred eecccCcceecC
Q 038743 647 KVSDFGLAKLMG 658 (839)
Q Consensus 647 kl~DfGla~~~~ 658 (839)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.9e-09 Score=119.54 Aligned_cols=197 Identities=21% Similarity=0.247 Sum_probs=136.6
Q ss_pred ccccccCCCceEEEEEeC-CCcEEEEEEecc---cCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 508 AQLLGTGGFGSVYKGSLG-DGTLVAVKKLDR---VLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+-+-+|.++.++.++-. .|...++|.... ......+....+-.++-..+||-+++..--+.-.....|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 346777888888776432 232233333221 1111122233333333334567777665555667888999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC----
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR---- 659 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~---- 659 (839)
++|...|+.. ..++.......+..+.+.+.|||.. .+.|+|++|.|+|+..++..+++|||.....+-
T Consensus 889 ~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 889 GDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CCchhhhhcC-----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999888543 2444444455666788899999984 589999999999999999999999984432210
Q ss_pred -----------------C---------CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 660 -----------------E---------HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 660 -----------------~---------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
. .........||+.|.+||.+.+......+|.|++|++++|.++|..||+...
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0011223569999999999999999999999999999999999999997543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.8e-07 Score=97.38 Aligned_cols=139 Identities=14% Similarity=0.019 Sum_probs=98.7
Q ss_pred cccCCCceEEEEEeCCCcEEEEEEecccCC-----------cchHHHHHHHHHhhccccCCcc--cccceeec-----CC
Q 038743 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVLP-----------HGEKEFVTEVNTIGSMHHMNLV--RLCGYCSE-----GS 572 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~niv--~l~g~~~~-----~~ 572 (839)
+-.-....|++..+ +|+.+.||+...... .....+.+|.+.+.++...+|. +++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333345777777 678899997743221 1112478999999888544443 44555543 23
Q ss_pred ceEEEEeeccCC-ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-------CC
Q 038743 573 NRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-------NF 644 (839)
Q Consensus 573 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-------~~ 644 (839)
..+||+|++++. +|.+++... .....+...+..++.+++..++-||+. +|+|+|++++|||++. +.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 568999999986 898887321 123345567778999999999999995 9999999999999975 56
Q ss_pred ceeecccCccee
Q 038743 645 CPKVSDFGLAKL 656 (839)
Q Consensus 645 ~~kl~DfGla~~ 656 (839)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.3e-06 Score=88.94 Aligned_cols=196 Identities=14% Similarity=0.148 Sum_probs=127.6
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccce----e--ecC-CceEEEE
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGY----C--SEG-SNRLLVY 578 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~----~--~~~-~~~~lv~ 578 (839)
....||+|+-+.+|-.--- +. -+-|+..........+. +..|... .||-+..-+.+ . -++ ...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999954221 12 23466654433222222 2233333 45543321111 0 111 2245666
Q ss_pred eeccCC-ChhhhcccC-CCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 579 EFMKNG-SLDKWIFPS-YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 579 e~~~~g-sL~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
..+.+- ....++... .++.-...+|...++.+..+|.+.+-||++ +.+-+|+.++|+|+.+++.+.|.|-..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 666553 233333221 222334678999999999999999999996 889999999999999999999988554333
Q ss_pred cCCCCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhC-CCCCCCCC
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGG-RRNLDMSG 712 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG-~~p~~~~~ 712 (839)
- .........+|...|.+||.-. +..-+...|.|.||+++++++.| ++||.+..
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 2 2233445567899999999654 33456789999999999999987 99997653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-06 Score=88.40 Aligned_cols=136 Identities=19% Similarity=0.140 Sum_probs=94.8
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccC----------------------CcchHHHHHHHHHhhccccC--C
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL----------------------PHGEKEFVTEVNTIGSMHHM--N 560 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 560 (839)
+.+.++||.|--+.||.|..+.|.++|||.-+--. -.......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34678999999999999999999999999642100 00112367888999888644 5
Q ss_pred cccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 561 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
+.+.+++ +.-.+||||.++-.|... .++....-.|+..|+.-+.-+-. .+|||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 6665543 456899999998666331 11223333344444444443333 499999999999999
Q ss_pred CCCCceeecccCcceec
Q 038743 641 DENFCPKVSDFGLAKLM 657 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~ 657 (839)
+++|.+.++||-.+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.5e-08 Score=107.67 Aligned_cols=152 Identities=19% Similarity=0.341 Sum_probs=100.8
Q ss_pred HHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee--------EEeeccccceeCccccc
Q 038743 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV--------VTMVRGTRGYLAPEWVS 681 (839)
Q Consensus 610 ~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 681 (839)
+.+++.||.|+|.+ .++||++|.|++|.++..+..||+.|+.+.......... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44566999999987 799999999999999999999999999886543311111 11123456799999999
Q ss_pred CCCCCCcccEEehhHHHHHHH-hCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhcc
Q 038743 682 NRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCI 760 (839)
Q Consensus 682 ~~~~s~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl 760 (839)
....+.++|+||+|+++|-+. .|+.-++.......+.+.. . ..+.-.......++. ++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----~----~~~~~~~~~s~~~p~----el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----N----LLNAGAFGYSNNLPS----ELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----c----ccccccccccccCcH----HHHHHHHHHh
Confidence 988999999999999999999 5555554433222111100 0 000000111122333 3444444568
Q ss_pred ccCCCCCCCHHHHHHH
Q 038743 761 QDEVFMRPSMGEVVKM 776 (839)
Q Consensus 761 ~~~p~~RPt~~~v~~~ 776 (839)
..++..||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 8999999987776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.1e-06 Score=81.29 Aligned_cols=138 Identities=19% Similarity=0.189 Sum_probs=102.7
Q ss_pred cccCCCceEEEEEeCCCcEEEEEEecccC------CcchHHHHHHHHHhhccccCC--cccccceeec-----CCceEEE
Q 038743 511 LGTGGFGSVYKGSLGDGTLVAVKKLDRVL------PHGEKEFVTEVNTIGSMHHMN--LVRLCGYCSE-----GSNRLLV 577 (839)
Q Consensus 511 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lv 577 (839)
-|+||-+-|++-.+ +|+.+-+|+-.+.. +.+...|.+|...|.++..-+ +.+++ ++.. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46788889999888 44579999875321 445678999999999985333 44444 3322 1235789
Q ss_pred EeeccC-CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc--eeecccCcc
Q 038743 578 YEFMKN-GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC--PKVSDFGLA 654 (839)
Q Consensus 578 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DfGla 654 (839)
+|-+++ -+|.+++.+. .-...+...+..+..+|++.++-||+. ++.|+|+-+.|||++.++. ++++||.-+
T Consensus 104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997764 5888887321 123456777889999999999999995 9999999999999986666 999999877
Q ss_pred ee
Q 038743 655 KL 656 (839)
Q Consensus 655 ~~ 656 (839)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 63
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.5e-06 Score=87.59 Aligned_cols=107 Identities=21% Similarity=0.225 Sum_probs=82.9
Q ss_pred hHHHHHHHHHhhccccC--CcccccceeecCC----ceEEEEeeccCC-ChhhhcccCCCCCcccCChhhHHHHHHHHHH
Q 038743 543 EKEFVTEVNTIGSMHHM--NLVRLCGYCSEGS----NRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615 (839)
Q Consensus 543 ~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 615 (839)
.....+|...+.++... ..++.+++..... ..++|+|++++. +|.+++... ..++......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 34678888888887533 3455566655432 358999999984 899988421 12566778889999999
Q ss_pred HhHHhhhccCCeeeecCCCCCcEEECCCC---ceeecccCcceec
Q 038743 616 GIAYFHEQCRNRIIHCDIKPENILLDENF---CPKVSDFGLAKLM 657 (839)
Q Consensus 616 ~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~~~ 657 (839)
.++-||+. +|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999995 999999999999998877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.6e-06 Score=97.69 Aligned_cols=142 Identities=17% Similarity=0.232 Sum_probs=91.2
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcch------------------------------H----------HHHH
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGE------------------------------K----------EFVT 548 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~------------------------------~----------~~~~ 548 (839)
+.|+.++-|.||+|++++|+.||||+.+....... + ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999999864211100 0 1334
Q ss_pred HHHHhhccc-----cCCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc
Q 038743 549 EVNTIGSMH-----HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623 (839)
Q Consensus 549 E~~~l~~l~-----h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 623 (839)
|...+.+++ .+++.-..=|..-.....|+|||++|-.+.+...- +...++. ..++..++++ |+.+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l----~~~g~d~---k~ia~~~~~~--f~~q~ 281 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL----KSAGIDR---KELAELLVRA--FLRQL 281 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH----HhcCCCH---HHHHHHHHHH--HHHHH
Confidence 444444431 23322111122234678999999999988887421 1223342 2334333332 11111
Q ss_pred cCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 624 ~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
.+.++.|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 113899999999999999999999999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-05 Score=82.14 Aligned_cols=142 Identities=15% Similarity=0.187 Sum_probs=84.9
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC--cccccceeecCCceEEEEeeccCCC-
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--LVRLCGYCSEGSNRLLVYEFMKNGS- 585 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 585 (839)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 24567788875432 3445788999998886443 4667777777777789999999963
Q ss_pred hhhhcccC-----------------CCCCc-ccCChhhHH-HHHH----------HHHH-HhHHhhhc-cCCeeeecCCC
Q 038743 586 LDKWIFPS-----------------YHHRD-RVLDWTTRF-NIAI----------ATAQ-GIAYFHEQ-CRNRIIHCDIK 634 (839)
Q Consensus 586 L~~~l~~~-----------------~~~~~-~~l~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~iiH~dlk 634 (839)
+...+... .|.-. .......+. .+.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111100 01000 000000000 0000 0001 11222211 12457899999
Q ss_pred CCcEEECCCCceeecccCccee
Q 038743 635 PENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 635 ~~Nill~~~~~~kl~DfGla~~ 656 (839)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.8e-06 Score=91.04 Aligned_cols=140 Identities=19% Similarity=0.260 Sum_probs=90.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcc-------------------------------------hHHHHHHHH
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-------------------------------------EKEFVTEVN 551 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 551 (839)
+.||.-+.|.||+|++++|+.||||+-+...... +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5899999999999999999999999875432111 012444554
Q ss_pred Hhhcc----ccCC------cccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhh
Q 038743 552 TIGSM----HHMN------LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621 (839)
Q Consensus 552 ~l~~l----~h~n------iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 621 (839)
-..+. .|-+ |.+++- .-...+.|+||||+|..+.+.-. -....++-.. |+..+.++ |++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~----i~~~gi~~~~---i~~~l~~~--~~~ 315 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDA----IDKRGISPHD---ILNKLVEA--YLE 315 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHH----HHHcCCCHHH---HHHHHHHH--HHH
Confidence 33332 3444 333322 22357899999999988877531 1223344443 33333332 222
Q ss_pred hccCCeeeecCCCCCcEEECC----CCceeecccCcceecCC
Q 038743 622 EQCRNRIIHCDIKPENILLDE----NFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 622 ~~~~~~iiH~dlk~~Nill~~----~~~~kl~DfGla~~~~~ 659 (839)
.-...|++|+|=+|.||+++. ++.+.+.|||+......
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 211238999999999999983 67899999999986644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.9e-05 Score=76.63 Aligned_cols=138 Identities=20% Similarity=0.271 Sum_probs=91.2
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccCCc-------------------chHH-----HHHHHHHhhccc--cCCccc
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH-------------------GEKE-----FVTEVNTIGSMH--HMNLVR 563 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~-----~~~E~~~l~~l~--h~niv~ 563 (839)
.|..|--+.||+|.-.++..+|||+....... ..++ ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 57788889999998888999999998532211 0111 235666666652 334444
Q ss_pred ccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC
Q 038743 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN 643 (839)
Q Consensus 564 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~ 643 (839)
.+++. +-.|||||+....+. .....+..+...+...+..++++.+.-|-.. .++||+||..-|||+. +
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~p-----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLP-----APRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceeec----CCeEEEEeccCCCCC-----CCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence 44432 447999998654211 0111222222224566677777777777663 4899999999999999 8
Q ss_pred CceeecccCcceecCC
Q 038743 644 FCPKVSDFGLAKLMGR 659 (839)
Q Consensus 644 ~~~kl~DfGla~~~~~ 659 (839)
+.+.|+|++.|.....
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8899999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.1e-05 Score=75.76 Aligned_cols=141 Identities=16% Similarity=0.166 Sum_probs=91.7
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHH---------HHHHHHhhccccC---Cccccc
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEF---------VTEVNTIGSMHHM---NLVRLC 565 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h~---niv~l~ 565 (839)
+++....+...+++-......|.+-.. +|+.+++|.........++.| .+++..+.+++.. ..+.++
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 344455555666777777777877777 678899998765433333222 2334434444322 222222
Q ss_pred ceee-----cCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 566 GYCS-----EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 566 g~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
.+.. -....+|+|||++|-.|.++. .++. .++..|+++|.-||+. |+.|+|.+|.|+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEE
Confidence 2222 224557899999998886643 1111 3556788889999996 99999999999999
Q ss_pred CCCCceeecccCccee
Q 038743 641 DENFCPKVSDFGLAKL 656 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~ 656 (839)
++++ +++.||+..+.
T Consensus 169 ~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKRM 183 (229)
T ss_pred ECCc-EEEEECccccc
Confidence 9665 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.00 E-value=9e-05 Score=66.49 Aligned_cols=102 Identities=25% Similarity=0.396 Sum_probs=67.8
Q ss_pred cCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEee-CCCCCCCCCeEEEEecCCcEEEeC-CCeeEEEe
Q 038743 11 SQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSA-NRNFPVTKDAILELDTTGNLVLND-GDTTIWAS 88 (839)
Q Consensus 11 ~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~A-Nr~~pv~~~~~l~l~~~G~Lvl~~-~~~~vWst 88 (839)
+.++++.+.+|.+.|-|...++ |-| |+. ..++||.. +........+.+.|..+|||||.| .+.+||+|
T Consensus 9 n~~~p~~~~s~~~~L~l~~dGn------Lvl-~~~---~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S 78 (114)
T PF01453_consen 9 NRNSPLTSSSGNYTLILQSDGN------LVL-YDS---NGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQS 78 (114)
T ss_dssp -TTEEEEECETTEEEEEETTSE------EEE-EET---TTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred ccccccccccccccceECCCCe------EEE-EcC---CCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEee
Confidence 4567787766999999976552 444 333 35679999 434443356799999999999998 67789999
Q ss_pred cCCCCceeEEEEec--cccEEEecCCCCceeecccCCC
Q 038743 89 NSSGAGVELATMSE--SGNFILYAPNNQPVWQSFLHPS 124 (839)
Q Consensus 89 ~~~~~~~~~a~Lld--sGNlVl~~~~~~~lWQSFD~PT 124 (839)
.. ....+...+++ .||++ ......+.|.|=+.|+
T Consensus 79 f~-~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 FD-YPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TT-SSS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred cC-CCccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 43 33445566666 88888 7666788999877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.5e-05 Score=77.58 Aligned_cols=142 Identities=15% Similarity=0.110 Sum_probs=85.6
Q ss_pred cccCCC-ceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeeccCCChhh
Q 038743 511 LGTGGF-GSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDK 588 (839)
Q Consensus 511 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 588 (839)
|-.|.. ..||+.... +..+.||+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344444 889999774 4788889875432 345778888888873 4445677777766667899999999987764
Q ss_pred hccc---------------CCCC---CcccCCh--hhHHHHHH--------------------HHHHHhHHhhh----cc
Q 038743 589 WIFP---------------SYHH---RDRVLDW--TTRFNIAI--------------------ATAQGIAYFHE----QC 624 (839)
Q Consensus 589 ~l~~---------------~~~~---~~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~----~~ 624 (839)
.... ..+. ....+.. ..++.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 3210 0000 0001110 00000000 01111122211 11
Q ss_pred CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 625 ~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
...++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35689999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.1e-05 Score=77.49 Aligned_cols=144 Identities=16% Similarity=0.123 Sum_probs=84.9
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccC--Ccccccceeec---CCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM--NLVRLCGYCSE---GSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~---~~~~~lv~e~~~~ 583 (839)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468899999999999977 68999987543 3456788898888888533 34566664432 3346899999999
Q ss_pred CChhh----------------hc---ccCCCCCcccCChhh---------HHH------------HHHHHHH-HhHHhhh
Q 038743 584 GSLDK----------------WI---FPSYHHRDRVLDWTT---------RFN------------IAIATAQ-GIAYFHE 622 (839)
Q Consensus 584 gsL~~----------------~l---~~~~~~~~~~l~~~~---------~~~------------i~~~ia~-~L~yLH~ 622 (839)
..+.. .| +... .....+.+.. ... ....+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 88877 11 1110 0001111100 000 0112222 3334443
Q ss_pred c----cCCeeeecCCCCCcEEEC-CCCceeecccCccee
Q 038743 623 Q----CRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKL 656 (839)
Q Consensus 623 ~----~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~ 656 (839)
. ....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 246799999999999999 666668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.6e-06 Score=93.27 Aligned_cols=183 Identities=17% Similarity=0.100 Sum_probs=133.2
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC-cccccceeecCCceEEEEeeccCC-C
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN-LVRLCGYCSEGSNRLLVYEFMKNG-S 585 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~g-s 585 (839)
-+-+++|++++++|.+-...+.+.++.+.. ..+..-++++|.+.+||| .++.++-+..+....++++++..+ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 356788999999988764444444554432 245677889999999999 777777778888889999999877 3
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCceeE
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 665 (839)
-...+. .....+...+...+...-+++|+|||+. .=+|+| ||+..+ ...|..||+....+.+.. ..
T Consensus 322 ~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 322 SALEMT----VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred ccccCC----hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 222111 1223444455556667778899999984 348888 777665 678999999988765543 23
Q ss_pred EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
....+++.++|||......+..+.|+|++|+-..++--|-+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 44568999999999999999999999999987777776666643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.3e-05 Score=76.15 Aligned_cols=104 Identities=20% Similarity=0.263 Sum_probs=81.1
Q ss_pred HHHHHhhcccc-CCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCC
Q 038743 548 TEVNTIGSMHH-MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626 (839)
Q Consensus 548 ~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 626 (839)
.|.-+++.+++ +++++++|+|- .++|.||...+++...-.. -..-...+|..|.+||.++++.+.+|++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57778888865 69999999993 4789999987765321000 00112468999999999999999999985545
Q ss_pred eeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 627 ~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
.+.-.|++++|+-+++++.+|+.|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6788999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.6e-05 Score=71.59 Aligned_cols=53 Identities=28% Similarity=0.561 Sum_probs=42.3
Q ss_pred EEEEecCCcEEEeCCC--eeEEEecCCCC--ceeEEEEeccccEEEecCCCCceeec
Q 038743 67 ILELDTTGNLVLNDGD--TTIWASNSSGA--GVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 67 ~l~l~~~G~Lvl~~~~--~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.+..+|+||+.+.. .+||++++... ....+.|.++|||||++.++.++|||
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 3455688999999853 68999997422 22568999999999999989999998
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.84 E-value=1.9e-05 Score=71.42 Aligned_cols=53 Identities=28% Similarity=0.564 Sum_probs=42.0
Q ss_pred EEEec-CCcEEEeCC--CeeEEEecCCC--CceeEEEEeccccEEEecCCCCceeecc
Q 038743 68 LELDT-TGNLVLNDG--DTTIWASNSSG--AGVELATMSESGNFILYAPNNQPVWQSF 120 (839)
Q Consensus 68 l~l~~-~G~Lvl~~~--~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSF 120 (839)
+.+.. +|+||+.+. ..+||++|+.. .....+.|.++|||||++.++.++|||=
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~ 81 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSN 81 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEec
Confidence 34455 899999874 36899999743 3444689999999999999999999974
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0003 Score=86.05 Aligned_cols=79 Identities=11% Similarity=0.300 Sum_probs=58.0
Q ss_pred ccccccCCCceEEEEEeCCC---cEEEEEEecccC-CcchHHHHHHHHHhhccc-cCCc--ccccceeecC---CceEEE
Q 038743 508 AQLLGTGGFGSVYKGSLGDG---TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMH-HMNL--VRLCGYCSEG---SNRLLV 577 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv 577 (839)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|.+++..+. |.++ .+++++|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35789999999999887654 467788764321 223456889999999995 6665 7778888764 467899
Q ss_pred EeeccCCCh
Q 038743 578 YEFMKNGSL 586 (839)
Q Consensus 578 ~e~~~~gsL 586 (839)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00021 Score=59.25 Aligned_cols=58 Identities=22% Similarity=0.424 Sum_probs=39.6
Q ss_pred ceeeeecccccCCccceeccccCCcChHHHHHhhcC-CCceeEEEeecCCCCCeEEEee-eccCCC
Q 038743 345 RIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLS-NCQCVASVYGLDDEKPYCWVLR-SLDFGG 408 (839)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~y~~~~~~~~C~~~~-~~~~~g 408 (839)
.|..++++.++ +..... ....++++|++.|++ +|+|.||+|.. ++..|++|. ..+.+.
T Consensus 5 ~f~~~~~~~l~--~~~~~~--~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~ 64 (78)
T smart00473 5 CFVRLPNTKLP--GFSRIV--ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDA 64 (78)
T ss_pred eeEEecCccCC--CCccee--EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccc
Confidence 45566666654 222111 123589999999999 99999999973 678999887 444333
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0008 Score=66.62 Aligned_cols=127 Identities=17% Similarity=0.259 Sum_probs=88.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccC----------------CcchHHHHHHHHHhhccc------cCCcccccc
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL----------------PHGEKEFVTEVNTIGSMH------HMNLVRLCG 566 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~g 566 (839)
..||+|+.-.|| .++++....||++.... ....++..+|+.....+. +..|.+++|
T Consensus 7 ~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 579999999988 45667778889886543 122456777777666665 889999999
Q ss_pred eeecCCceEEEEeeccC------CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 567 YCSEGSNRLLVYEFMKN------GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 567 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
+.......-+|+|.+.+ -+|.+++. ...++. . +...+-+-..||-+ ..|+.+|++|.||++
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~------~~~~~~-~---~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK------EGGLTE-E---LRQALDEFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH------cCCccH-H---HHHHHHHHHHHHHH---cCCeecCCCcccEEE
Confidence 99999999999998753 35666662 223333 2 23333344456665 389999999999999
Q ss_pred CCC---C-ceeecc
Q 038743 641 DEN---F-CPKVSD 650 (839)
Q Consensus 641 ~~~---~-~~kl~D 650 (839)
..+ . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00058 Score=70.43 Aligned_cols=74 Identities=12% Similarity=0.159 Sum_probs=45.0
Q ss_pred cccccCCCc-eEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccC---CcccccceeecC---CceEEEEeec
Q 038743 509 QLLGTGGFG-SVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM---NLVRLCGYCSEG---SNRLLVYEFM 581 (839)
Q Consensus 509 ~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lv~e~~ 581 (839)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 356766665 58875 23467776543 22345788899988877421 234444433322 2348899999
Q ss_pred cCCChhh
Q 038743 582 KNGSLDK 588 (839)
Q Consensus 582 ~~gsL~~ 588 (839)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9977754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=70.28 Aligned_cols=76 Identities=8% Similarity=0.095 Sum_probs=56.2
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcccc---CCcccccceeecC---CceEEEEeec
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH---MNLVRLCGYCSEG---SNRLLVYEFM 581 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lv~e~~ 581 (839)
.+.||.|..+.||+....+++ +++|..+.. .....+..|.+.++.+.. ..+.+++++|..+ +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 457999999999999876664 666764321 123478899999888842 4677888877543 5689999999
Q ss_pred cCCCh
Q 038743 582 KNGSL 586 (839)
Q Consensus 582 ~~gsL 586 (839)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00065 Score=71.08 Aligned_cols=140 Identities=12% Similarity=0.072 Sum_probs=79.7
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEeeccCCChhh
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYEFMKNGSLDK 588 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~~ 588 (839)
.+..|-...+|+... +++.+++|........-.....+|.+++..+....+ .++++... ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456788889999884 567888887643322211235778888888854433 33443332 368999999877643
Q ss_pred h-----------------cccCCCCCcccCChhhHH-HHHHH---------HHHHhHHhhhc-----cCCeeeecCCCCC
Q 038743 589 W-----------------IFPSYHHRDRVLDWTTRF-NIAIA---------TAQGIAYFHEQ-----CRNRIIHCDIKPE 636 (839)
Q Consensus 589 ~-----------------l~~~~~~~~~~l~~~~~~-~i~~~---------ia~~L~yLH~~-----~~~~iiH~dlk~~ 636 (839)
- |+.. ......++...+. ....+ +...+..+... ....++|+|+.|.
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQ-PRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 2 1111 0011122221111 11101 11112222111 1246899999999
Q ss_pred cEEECCCCceeecccCccee
Q 038743 637 NILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 637 Nill~~~~~~kl~DfGla~~ 656 (839)
||++++++ ++|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00095 Score=73.33 Aligned_cols=75 Identities=17% Similarity=0.191 Sum_probs=53.3
Q ss_pred cccccCCCceEEEEEeCCC-cEEEEEEecccC-------CcchHHHHHHHHHhhccc---cCCcccccceeecCCceEEE
Q 038743 509 QLLGTGGFGSVYKGSLGDG-TLVAVKKLDRVL-------PHGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv 577 (839)
+.||.|.+..||++...+| +.|+||.-.... +.....+..|.+.|..+. ...+++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 589999853211 123456677888777762 2356666655 44668899
Q ss_pred EeeccCCC
Q 038743 578 YEFMKNGS 585 (839)
Q Consensus 578 ~e~~~~gs 585 (839)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00091 Score=68.94 Aligned_cols=74 Identities=18% Similarity=0.140 Sum_probs=48.6
Q ss_pred cccccCCCceEEEEEeCC--CcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEeeccCCC
Q 038743 509 QLLGTGGFGSVYKGSLGD--GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
+.|..|-...+|+....+ ++.+++|+..... .......+|+.++..+...++ +++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457788888999998764 6789999765432 112234578888888854444 34443332 247999999877
Q ss_pred hh
Q 038743 586 LD 587 (839)
Q Consensus 586 L~ 587 (839)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.001 Score=65.25 Aligned_cols=125 Identities=25% Similarity=0.382 Sum_probs=88.5
Q ss_pred HhhccccccccCCC-ceEEEEEeCCCcEEEEEEecccC-----------C----------cchHHHHHHHHHhhccc---
Q 038743 503 RTSNFAQLLGTGGF-GSVYKGSLGDGTLVAVKKLDRVL-----------P----------HGEKEFVTEVNTIGSMH--- 557 (839)
Q Consensus 503 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~-----------~----------~~~~~~~~E~~~l~~l~--- 557 (839)
+..+|.+.||.|.- |.||++++ +|+.+|+|.+.... . .-...|..|.+.+++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 66788899999999 99999999 67899999942110 0 01124889999999884
Q ss_pred cCCc--ccccceeecC------------------CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHh
Q 038743 558 HMNL--VRLCGYCSEG------------------SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617 (839)
Q Consensus 558 h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L 617 (839)
+..+ |+.+||..-. ..+.||.||++... ....+-+.+|.+-|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQIRDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccchhHHHHHHHHH
Confidence 4456 8888887211 12356777665422 11223456677778
Q ss_pred HHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 618 ~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
..+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 888884 9999999999986 4589999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00071 Score=64.05 Aligned_cols=129 Identities=19% Similarity=0.223 Sum_probs=84.6
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCccc-ccceeecCCceEEEEeeccCCC
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVR-LCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lv~e~~~~gs 585 (839)
..+.|++|.+|.||+|.+ .|..+|+|+-... .....+..|++++..+.-.++.+ ++.| +.-.+.|||..|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence 356899999999999999 4558899987543 33567899999999887665543 3333 22244599999888
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCC-CCcEEECCCCceeecccCcceec
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIK-PENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk-~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|.+.-.. .+- +-...+++. +|.-+. .+|-|+.|. |...+|-.+..+.|+||.-|+.-
T Consensus 99 L~~~~~~--------~~r----k~l~~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG--------GDR----KHLLRVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc--------ccH----HHHHHHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8664411 011 223344444 343332 488888876 44444444448999999998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0026 Score=68.18 Aligned_cols=143 Identities=15% Similarity=0.153 Sum_probs=85.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC--ccccccee------ecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--LVRLCGYC------SEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~e~ 580 (839)
+.|..|....+|+....+ ..+++|+... ....+...|++++..+.+.. +++++... ...+..++|++|
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 467778888999987644 4688898754 23445667888777774332 44444321 223456899999
Q ss_pred ccCCChhhh--------------cccCC---CC---CcccCChhhHH----------HHHHHHHHHhHHhhh----ccCC
Q 038743 581 MKNGSLDKW--------------IFPSY---HH---RDRVLDWTTRF----------NIAIATAQGIAYFHE----QCRN 626 (839)
Q Consensus 581 ~~~gsL~~~--------------l~~~~---~~---~~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~~ 626 (839)
++|..+... |+... .. ......|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 999776431 11100 00 00111222211 011123334444443 1234
Q ss_pred eeeecCCCCCcEEECCCCceeecccCcce
Q 038743 627 RIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 627 ~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
.++|+|+.|.|||++++..+.|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 69999999999999998778899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00087 Score=54.84 Aligned_cols=34 Identities=24% Similarity=0.590 Sum_probs=28.7
Q ss_pred cChHHHHHhhcCCCceeEEEeecCCCCCeEEEeeec
Q 038743 369 ATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRSL 404 (839)
Q Consensus 369 ~~~~~C~~~Cl~nCsC~A~~y~~~~~~~~C~~~~~~ 404 (839)
.+.++|++.|+.||+|.||.|. .....|+++...
T Consensus 25 ~s~~~Cq~~C~~~~~C~afT~~--~~~~~C~lk~~~ 58 (73)
T cd01100 25 SSAEQCQAACTADPGCLAFTYN--TKSKKCFLKSSE 58 (73)
T ss_pred CCHHHHHHHcCCCCCceEEEEE--CCCCeEEcccCC
Confidence 4789999999999999999997 446889976553
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0069 Score=65.21 Aligned_cols=144 Identities=15% Similarity=0.177 Sum_probs=82.5
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccC--Cccccccee------ecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM--NLVRLCGYC------SEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~------~~~~~~~lv~e~ 580 (839)
+.++.|....+|+....++ .+++|+.... ....+...|++++..|... .+.+++... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4677787789999876555 5778876542 1234455667777666322 234444322 123456899999
Q ss_pred ccCCChhhh--------------cccCCC---CC----cccCChhhHH------------HHHHHHHHHhHHhhh----c
Q 038743 581 MKNGSLDKW--------------IFPSYH---HR----DRVLDWTTRF------------NIAIATAQGIAYFHE----Q 623 (839)
Q Consensus 581 ~~~gsL~~~--------------l~~~~~---~~----~~~l~~~~~~------------~i~~~ia~~L~yLH~----~ 623 (839)
++|..+... |+.... .. ...-.|.... .....+.+.+++|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 998654311 111000 00 0011121111 011123344555542 2
Q ss_pred cCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 624 ~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
...+++|+|+++.||+++.++...|.||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34689999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.004 Score=66.93 Aligned_cols=143 Identities=20% Similarity=0.182 Sum_probs=83.5
Q ss_pred cccccCCCceEEEEEeCC-------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGD-------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~ 580 (839)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345667777899988765 5789999875432 223456778888887753333 345555432 358999
Q ss_pred ccCCChhhh-c----------------ccCCCCC-cc---cCC--hhhHHH--------------------------HHH
Q 038743 581 MKNGSLDKW-I----------------FPSYHHR-DR---VLD--WTTRFN--------------------------IAI 611 (839)
Q Consensus 581 ~~~gsL~~~-l----------------~~~~~~~-~~---~l~--~~~~~~--------------------------i~~ 611 (839)
++|..+... + +...... .. ... |..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776542 1 1111110 00 000 111100 111
Q ss_pred HHHHHhHHhhh------ccCCeeeecCCCCCcEEECCC----CceeecccCccee
Q 038743 612 ATAQGIAYFHE------QCRNRIIHCDIKPENILLDEN----FCPKVSDFGLAKL 656 (839)
Q Consensus 612 ~ia~~L~yLH~------~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~ 656 (839)
.+.+.+..|.. .....++|+|+.+.|||++++ +.++|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134578999999999999985 7899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0083 Score=64.98 Aligned_cols=143 Identities=13% Similarity=0.111 Sum_probs=77.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC--cccccce------eecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--LVRLCGY------CSEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~e~ 580 (839)
+.|+.|....+|+.+..+| .+++|+... ....+...|+.++..|...+ +.+.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 3567788889999987555 688898752 12233444555555553222 2233321 1224457899999
Q ss_pred ccCCChhhh--------------cccCCCC------CcccCCh-hhHHHH------------H-HHHHHHhHHhhh----
Q 038743 581 MKNGSLDKW--------------IFPSYHH------RDRVLDW-TTRFNI------------A-IATAQGIAYFHE---- 622 (839)
Q Consensus 581 ~~~gsL~~~--------------l~~~~~~------~~~~l~~-~~~~~i------------~-~~ia~~L~yLH~---- 622 (839)
++|..+... |+..... ....+.| .....- . ..+...+..+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 998754321 1111000 0011111 111111 1 111112233321
Q ss_pred ccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 623 ~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
....++||+|++|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 124589999999999999977666899999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.012 Score=62.16 Aligned_cols=72 Identities=18% Similarity=0.352 Sum_probs=47.0
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc---ccCCcccccceeecCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM---HHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.|+.|....+|+.+ .+++.+.||.-.. .....|..|..-|+.| .--.+++++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 478889999999988 5788899998752 2334578888877777 3446778888887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.029 Score=59.20 Aligned_cols=31 Identities=32% Similarity=0.561 Sum_probs=26.0
Q ss_pred CeeeecCCCCCcEEECCCCc-eeecccCccee
Q 038743 626 NRIIHCDIKPENILLDENFC-PKVSDFGLAKL 656 (839)
Q Consensus 626 ~~iiH~dlk~~Nill~~~~~-~kl~DfGla~~ 656 (839)
..++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.024 Score=61.83 Aligned_cols=142 Identities=20% Similarity=0.181 Sum_probs=80.3
Q ss_pred ccccCCCceEEEEEeCC-----CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcc-cccceeecCCceEEEEeeccC
Q 038743 510 LLGTGGFGSVYKGSLGD-----GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLV-RLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.|-.|-.-.+|+....+ ++.|++|+...... ..-.-..|..++..+...++. ++++.+..+ .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44457778899987543 36789998755432 222346788888888554443 455655433 58999987
Q ss_pred CChhhh-----------------cccCCCCCcc-cCChhhHHHHHHH-----------------HHHHhHHh----hh-c
Q 038743 584 GSLDKW-----------------IFPSYHHRDR-VLDWTTRFNIAIA-----------------TAQGIAYF----HE-Q 623 (839)
Q Consensus 584 gsL~~~-----------------l~~~~~~~~~-~l~~~~~~~i~~~-----------------ia~~L~yL----H~-~ 623 (839)
.+|... +|+....... ..-|.++.++..+ +...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776422 1111000001 1112222222111 11112222 21 2
Q ss_pred cCCeeeecCCCCCcEEECC-CCceeecccCccee
Q 038743 624 CRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKL 656 (839)
Q Consensus 624 ~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~ 656 (839)
....++|+|+++.|||+++ ++.++|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2347899999999999986 47899999988753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0042 Score=74.43 Aligned_cols=197 Identities=18% Similarity=0.173 Sum_probs=127.9
Q ss_pred HHHHHHHhhccccCCcccccceeecCCceE----EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhh
Q 038743 546 FVTEVNTIGSMHHMNLVRLCGYCSEGSNRL----LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621 (839)
Q Consensus 546 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 621 (839)
...|+..+..+.|+|++.++.|..+....- +..|++..-++...+ ..-..++..+.+.+..++..||+|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-----q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-----QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-----hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 345777788889999999999876654433 234667776776666 23456777888889999999999999
Q ss_pred hccCCeeeecCCCCC---cEEECCCCceeec--ccCcceecCCCCceeEEeeccccceeCcccccCCCCC--CcccEEeh
Q 038743 622 EQCRNRIIHCDIKPE---NILLDENFCPKVS--DFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT--VKADVYSY 694 (839)
Q Consensus 622 ~~~~~~iiH~dlk~~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~~DV~S~ 694 (839)
+. ...|.-|..+ +...+.++...++ ||+..+.+........ ..-+..+.+||......+. ...|+|.+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHH
Confidence 95 4444444444 4444566667776 8888876543222211 1123456788877665544 44799999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 038743 695 GMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVV 774 (839)
Q Consensus 695 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~ 774 (839)
|..+..+..|..+-..... +..+++. .... .+......|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~~~------------------~~~~l~~-----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV------------------PVSLLDV-----LSTS---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccc------------------hhhhhcc-----ccch---hhhhhhhhhcchhhhhccchhhhh
Confidence 9999999988754321110 0011111 1111 344555669999999999999998
Q ss_pred HHhc
Q 038743 775 KMLE 778 (839)
Q Consensus 775 ~~L~ 778 (839)
...-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 7653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0056 Score=63.51 Aligned_cols=134 Identities=16% Similarity=0.113 Sum_probs=89.1
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEeccc--C-------C-------------cchHHHHHHHHHhhccc-cC-C
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRV--L-------P-------------HGEKEFVTEVNTIGSMH-HM-N 560 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~-------~-------------~~~~~~~~E~~~l~~l~-h~-n 560 (839)
+.+.++||-|--+.||.+...+|++.++|.-.-- + + -..-...+|...|..|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999999999999853210 0 0 01123456777887774 22 2
Q ss_pred cccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 561 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
+.+.+++ ...++|||++.+-.|...- ...+..++..-+ ..-+.-|.. .++||+|..--||++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~--------~v~d~~~ly~~l---m~~Iv~la~---~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVR--------HVEDPPTLYDDL---MGLIVRLAN---HGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeee--------ecCChHHHHHHH---HHHHHHHHH---cCceecccchheeEE
Confidence 3344433 4558899999888875432 122333333322 223334444 499999999999999
Q ss_pred CCCCceeecccCccee
Q 038743 641 DENFCPKVSDFGLAKL 656 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~ 656 (839)
+++..++++||-....
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999975543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.046 Score=58.12 Aligned_cols=143 Identities=17% Similarity=0.259 Sum_probs=79.8
Q ss_pred cCCCceEEEEEeCCCcEEEEEEecc--cCCcchHHHHHHHHHhhcccc--CCcccccceeecCC--ceEEEEeeccCCCh
Q 038743 513 TGGFGSVYKGSLGDGTLVAVKKLDR--VLPHGEKEFVTEVNTIGSMHH--MNLVRLCGYCSEGS--NRLLVYEFMKNGSL 586 (839)
Q Consensus 513 ~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lv~e~~~~gsL 586 (839)
.|..-.+|+.... +++++++ ... ..........+|.++|+.+.- .-+.+.++.|.++. ..+.||+|++|..+
T Consensus 35 ~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 35 GGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred CCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 3433344444432 7778888 321 112233455677777777632 33455677787766 77999999998544
Q ss_pred hhhcccCCCC---------------------------------CcccCChhhHHHHHH--------HHHHHhHHhhhc--
Q 038743 587 DKWIFPSYHH---------------------------------RDRVLDWTTRFNIAI--------ATAQGIAYFHEQ-- 623 (839)
Q Consensus 587 ~~~l~~~~~~---------------------------------~~~~l~~~~~~~i~~--------~ia~~L~yLH~~-- 623 (839)
.+.+...... .++.-.|...++.+. ....-..+|++.
T Consensus 113 ~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p 192 (321)
T COG3173 113 WSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRP 192 (321)
T ss_pred cCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCC
Confidence 4333211000 000011111111000 011223344432
Q ss_pred ---cCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 624 ---CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 624 ---~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
....++|+|+++.|++|+...-+-|.||+++.+-
T Consensus 193 ~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 193 PWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1356999999999999998888999999999764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.075 Score=58.40 Aligned_cols=80 Identities=11% Similarity=0.102 Sum_probs=53.1
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCC-------cchHHHHHHHHHhhccc---cCCcccccceeecCCceEEE
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP-------HGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv 577 (839)
.+.||-|....||+...+ +..++||+-..... .....-..|.+.|..+. ...+++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357899999999998864 56799998642111 13334445566665553 347778888777 456889
Q ss_pred EeeccC--CChhhhc
Q 038743 578 YEFMKN--GSLDKWI 590 (839)
Q Consensus 578 ~e~~~~--gsL~~~l 590 (839)
|||+++ ..|.+-|
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3455544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.058 Score=58.18 Aligned_cols=79 Identities=15% Similarity=0.096 Sum_probs=50.1
Q ss_pred ccccCCCceEEEEEeCCC-cEEEEEEecccC-------CcchHHHHHHHHHhhccc--cCC-cccccceeecCCceEEEE
Q 038743 510 LLGTGGFGSVYKGSLGDG-TLVAVKKLDRVL-------PHGEKEFVTEVNTIGSMH--HMN-LVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~--h~n-iv~l~g~~~~~~~~~lv~ 578 (839)
.||-|....||++..++| +.|+||.-.... +-...+..-|.+.|.... .|. +++++ +.+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 579999999999998765 589999763211 223345556777766552 343 34443 34556677999
Q ss_pred eeccC-CChhhhc
Q 038743 579 EFMKN-GSLDKWI 590 (839)
Q Consensus 579 e~~~~-gsL~~~l 590 (839)
|+++. ..|++.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99855 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.083 Score=56.09 Aligned_cols=139 Identities=18% Similarity=0.231 Sum_probs=94.6
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccC---------Ccch------------H-----HHHHHHHHhhccccCCccc
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVL---------PHGE------------K-----EFVTEVNTIGSMHHMNLVR 563 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~------------~-----~~~~E~~~l~~l~h~niv~ 563 (839)
.|..|--+.||.+.-.+|..+|||+.+... -.++ + -...|++-|.+|+.-.|..
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 688899999999999999999999874211 0000 0 1345777777775544432
Q ss_pred ccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC
Q 038743 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN 643 (839)
Q Consensus 564 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~ 643 (839)
.--.. -..-.|||+|+..-... ........++......+-.+++.-|.-|-+.| ++||.||.--|+|+.+
T Consensus 231 PePIl--Lk~hVLVM~FlGrdgw~-----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 231 PEPIL--LKNHVLVMEFLGRDGWA-----APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCcee--eecceEeeeeccCCCCc-----CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence 11111 13457999998643321 11224456677778888888999999888875 7899999999999864
Q ss_pred CceeecccCcceecC
Q 038743 644 FCPKVSDFGLAKLMG 658 (839)
Q Consensus 644 ~~~kl~DfGla~~~~ 658 (839)
|.+.|+|.+.+-...
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 579999988775443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.051 Score=54.88 Aligned_cols=31 Identities=32% Similarity=0.429 Sum_probs=22.1
Q ss_pred CeeeecCCCCCcEEE-CCCCceeecccCccee
Q 038743 626 NRIIHCDIKPENILL-DENFCPKVSDFGLAKL 656 (839)
Q Consensus 626 ~~iiH~dlk~~Nill-~~~~~~kl~DfGla~~ 656 (839)
..++|.|+.+.|||+ +.++.++|+||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.18 Score=54.33 Aligned_cols=138 Identities=20% Similarity=0.263 Sum_probs=82.5
Q ss_pred CCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC------cccccce----eecCCceEEEEeeccCC
Q 038743 515 GFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN------LVRLCGY----CSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 515 ~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~----~~~~~~~~lv~e~~~~g 584 (839)
.-..+|+....+|+. ++|..... ....+...|+..+..|.-.. |..+-|- ...+...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789998877777 88887654 34556777777777763222 2222221 22223778899999998
Q ss_pred Chhh-hc--------------ccC----C--C-CCcccCChh-------------hHHHHHHHHHHHhHHhhh----ccC
Q 038743 585 SLDK-WI--------------FPS----Y--H-HRDRVLDWT-------------TRFNIAIATAQGIAYFHE----QCR 625 (839)
Q Consensus 585 sL~~-~l--------------~~~----~--~-~~~~~l~~~-------------~~~~i~~~ia~~L~yLH~----~~~ 625 (839)
.+.. .. +.. . + .....+.|. .-.....++...+..+++ ...
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 100 0 0 011123333 111233344444444443 222
Q ss_pred Ce---eeecCCCCCcEEECCCCc-eeecccCcce
Q 038743 626 NR---IIHCDIKPENILLDENFC-PKVSDFGLAK 655 (839)
Q Consensus 626 ~~---iiH~dlk~~Nill~~~~~-~kl~DfGla~ 655 (839)
.. +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999998875 8999999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.067 Score=58.43 Aligned_cols=81 Identities=12% Similarity=0.103 Sum_probs=52.0
Q ss_pred ccccccCCCceEEEEEeCC-CcEEEEEEecccC------CcchHHHHHHHHHhhccc--cCC-cccccceeecCCceEEE
Q 038743 508 AQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVL------PHGEKEFVTEVNTIGSMH--HMN-LVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~--h~n-iv~l~g~~~~~~~~~lv 577 (839)
.+.||-|.-..||++..++ ++.|+||.-.... +-...+..-|.+.|+... .|. +++++ +.+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 3578999999999998753 5689999763221 223455666777776652 443 44454 3455677889
Q ss_pred EeeccC-CChhhhc
Q 038743 578 YEFMKN-GSLDKWI 590 (839)
Q Consensus 578 ~e~~~~-gsL~~~l 590 (839)
||+++. ..|++.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 999854 2344443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 839 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-57 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 422 bits (1087), Expect = e-142
Identities = 126/295 (42%), Positives = 175/295 (59%), Gaps = 6/295 (2%)
Query: 490 GAPVNFTYRDLQIRTSNFAQ--LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-EKEF 546
G F+ R+LQ+ + NF+ +LG GGFG VYKG L DGTLVAVK+L G E +F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 547 VTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR 606
TEV I H NL+RL G+C + RLLVY +M NGS+ + + LDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKR 133
Query: 607 FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
IA+ +A+G+AY H+ C +IIH D+K NILLDE F V DFGLAKLM + + V T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG--DAEDFFYPGWAF 724
VRGT G++APE++S + K DV+ YG++LLE++ G+R D++ + +D W
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779
+ + D L+G ++EE+ + ++VA C Q RP M EVV+MLEG
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-121
Identities = 105/293 (35%), Positives = 159/293 (54%), Gaps = 7/293 (2%)
Query: 495 FTYRDLQIRTSNF--AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNT 552
DL+ T+NF L+G G FG VYKG L DG VA+K+ G +EF TE+ T
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
+ H +LV L G+C E + +L+Y++M+NG+L + ++ S + W R I I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRLEICIG 147
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-GREHSQVVTMVRGT 671
A+G+ Y H + IIH D+K NILLDENF PK++DFG++K + + + T+V+GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731
GY+ PE+ +T K+DVYS+G++L E++ R + S E WA + NG
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADIN 784
++ D L + E L + A C+ RPSMG+V+ LE + +
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-118
Identities = 96/299 (32%), Positives = 149/299 (49%), Gaps = 24/299 (8%)
Query: 495 FTYRDLQIRTSNFAQ--------LLGTGGFGSVYKGSLGDGTLVAVKKL----DRVLPHG 542
F++ +L+ T+NF + +G GGFG VYKG + + T VAVKKL D
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 543 EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD 602
+++F E+ + H NLV L G+ S+G + LVY +M NGSL + L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLS 131
Query: 603 WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE-H 661
W R IA A GI + HE IH DIK NILLDE F K+SDFGLA+ +
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG 721
+ + + + GT Y+APE + IT K+D+YS+G++LLEI+ G +D + +
Sbjct: 189 TVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--D 245
Query: 722 WAFKEMTNGTPL-KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779
+ + D+++ + + VA C+ ++ RP + +V ++L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-72
Identities = 75/311 (24%), Positives = 124/311 (39%), Gaps = 33/311 (10%)
Query: 493 VNFTYRDLQIRTSNF--AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEV 550
V+ +L ++ ++ G FG V+K L VAVK + EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEV 69
Query: 551 NTIGSMHHMNLVRLCGYCSEGSN----RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR 606
++ M H N+++ G G++ L+ F + GSL ++ + V+ W
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNEL 123
Query: 607 FNIAIATAQGIAYFHE-------QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659
+IA A+G+AY HE + I H DIK +N+LL N ++DFGLA
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 660 EHSQVVTMVR-GTRGYLAPE-----WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGD 713
S T + GTR Y+APE R ++ D+Y+ G++L E+ D D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 714 A-----EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAM-KVAFWCIQDEVFMR 767
E+ + ++M K L ++ M + + C + R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 768 PSMGEVVKMLE 778
S G V + +
Sbjct: 304 LSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 79/305 (25%), Positives = 133/305 (43%), Gaps = 44/305 (14%)
Query: 497 YRDLQIRTS--NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGE--KEFVTEVNT 552
D+ I N + +G G FG+V++ G+ VAVK L H E EF+ EV
Sbjct: 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
+ + H N+V G ++ N +V E++ GSL + + LD R ++A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYD 145
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
A+G+ Y H I+H ++K N+L+D+ + KV DFGL++L GT
Sbjct: 146 VAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTP 203
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732
++APE + + P K+DVYS+G++L E+ ++ P + + P
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ-------------P---WGNL---NP 244
Query: 733 LKVA------DRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782
+V +RLE + ++ C +E + RPS ++ +L
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEG------CWTNEPWKRPSFATIMDLLRPLIK 298
Query: 783 INTPP 787
PP
Sbjct: 299 SAVPP 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-57
Identities = 70/327 (21%), Positives = 119/327 (36%), Gaps = 54/327 (16%)
Query: 493 VNFTYRDLQIRTSNF--AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEV 550
+ + + N +L+G G +G+VYKGSL D VAVK + F+ E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEK 56
Query: 551 N--TIGSMHHMNLVRLCGYCSEGS-----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDW 603
N + M H N+ R + LLV E+ NGSL K++ DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDW 110
Query: 604 TTRFNIAIATAQGIAYFHE------QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657
+ +A + +G+AY H + I H D+ N+L+ + +SDFGL+ +
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 658 GR-------EHSQVVTMVRGTRGYLAPE-------WVSNRPITVKADVYSYGMLLLEIVG 703
E GT Y+APE + D+Y+ G++ EI
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 704 GRRNLDMSGDAEDFFYPGWAFKEMTNGTP------LKVADRRL-----EGAVEEEELMRA 752
+L ++ F+ P + V+ + E E +R+
Sbjct: 231 RCTDLFPGESVPEYQMA---FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 753 M-KVAFWCIQDEVFMRPSMGEVVKMLE 778
+ + C + R + + +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 53/294 (18%)
Query: 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM 556
Y+++++ +++G G FG V K VA+K+++ K F+ E+ + +
Sbjct: 7 YKEIEVE-----EVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRV 58
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV--LDWTTRFNIAIATA 614
+H N+V+L G C LV E+ + GSL + H + + + + +
Sbjct: 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL----HGAEPLPYYTAAHAMSWCLQCS 112
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
QG+AY H +IH D+KP N+LL K+ DFG A + +T +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAA 168
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
++APE + K DV+S+G++L E++ R+ P F E+ G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK-------------P---FDEI-GGPAF 211
Query: 734 KVA-----DRRL---EGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
++ R + + E LM C + RPSM E+VK++
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-56
Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 47/291 (16%)
Query: 507 FAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE-------KEFVTEVNTIGSMHH 558
+ + +G GGFG V+KG + D ++VA+K L GE +EF EV + +++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
N+V+L G +V EF+ G L + + + W+ + + + A GI
Sbjct: 83 PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL----LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 619 YFHEQCRNRIIHCDIKPENILLDE-----NFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
Y I+H D++ NI L C KV+DFGL+ ++ V+ + G
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQ 191
Query: 674 YLAPE--WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731
++APE T KAD YS+ M+L I+ G + +++ ++
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-----------PFDEYSYGKIKFIN 240
Query: 732 PLKVADRRL---EGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
++ R E ++ C + RP +VK L
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIEL------CWSGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-56
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 46/315 (14%)
Query: 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569
LG G FG K + G ++ +K+L R ++ F+ EV + + H N+++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRII 629
+ + E++K G+L I D W+ R + A A G+AY H II
Sbjct: 78 KDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 630 HCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ-------------VVTMVRGTRGYLA 676
H D+ N L+ EN V+DFGLA+LM E +Q V G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGWAFKEMTNGTPL 733
PE ++ R K DV+S+G++L EI+G + G+ + P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP 250
Query: 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG---SADINTPPMPQ 790
+ C + RPS ++ LE + P PQ
Sbjct: 251 SFF-----------PIT------VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
Query: 791 TVLELIEEGLDHVYK 805
LE ++ G Y+
Sbjct: 294 --LEQLDRGFWETYR 306
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-54
Identities = 75/294 (25%), Positives = 117/294 (39%), Gaps = 57/294 (19%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKL----DRVLPHGEKEFVTEVNTIGSMHHMNLV 562
+++G GGFG VY+ G VAVK D + + E + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
L G C + N LV EF + G L++ + + + N A+ A+G+ Y H+
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 623 QCRNRIIHCDIKPENILLDE--------NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+ IIH D+K NIL+ + N K++DFGLA+ H G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAW 180
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734
+APE + + +DV+SYG+LL E++ G P F+ + L
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEV-------------P---FRGI---DGLA 221
Query: 735 VA------DRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
VA L E +LM C + RPS ++ L
Sbjct: 222 VAYGVAMNKLALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-52
Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 51/290 (17%)
Query: 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
Q +G+G FG+VYKG GD VAVK L P + F EV + H+N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
GY + +V ++ + SL + H + + +IA TA+G+ Y H +
Sbjct: 85 FMGYSTAP-QLAIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVTMVRGTRGYLAPE---W 679
IIH D+K NI L E+ K+ DFGLA R S + G+ ++APE
Sbjct: 140 ---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA--- 736
+ P + ++DVY++G++L E++ G+ + + N +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ----------------LPYSNINNRDQIIEMVGR 240
Query: 737 -DRRLEGAVEEE-------ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ + LM C++ + RPS ++ +E
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 47/287 (16%)
Query: 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVR 563
NF L G ++KG G + VK L ++F E + H N++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 564 LCGYCSE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
+ G C + L+ +M GSL + + + V+D + A+ A+G+A+ H
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
I + ++++DE+ ++S + S ++APE +
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQ 181
Query: 682 NRP---ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG-TPLKVAD 737
+P AD++S+ +LL E+V P F +++N +KVA
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREV-------------P---FADLSNMEIGMKVAL 225
Query: 738 RRL-----EGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
L G +LM+ C+ ++ RP +V +LE
Sbjct: 226 EGLRPTIPPGISPHVSKLMKI------CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-51
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 61/305 (20%)
Query: 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGE--KEFVTEVNTI 553
+ L+I +L+G G FG VY G G+ VA++ +D + + K F EV
Sbjct: 32 FEQLEIG-----ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAY 83
Query: 554 GSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT 613
H N+V G C + ++ K +L + VLD IA
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV----RDAKIVLDVNKTRQIAQEI 139
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR----EHSQVVTMVR 669
+G+ Y H + I+H D+K +N+ D ++DFGL + G + +
Sbjct: 140 VKGMGYLHAK---GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 670 GTRGYLAPE---------WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720
G +LAPE P + +DV++ G + E+
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--------------- 240
Query: 721 GWAFKEMTNGTPLKVADRRL-----EGAVEEE--ELMRAMKVAFWCIQDEVFMRPSMGEV 773
W FK + + + + +E +++ C E RP+ ++
Sbjct: 241 -WPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLF------CWAFEQEERPTFTKL 293
Query: 774 VKMLE 778
+ MLE
Sbjct: 294 MDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-48
Identities = 70/313 (22%), Positives = 127/313 (40%), Gaps = 52/313 (16%)
Query: 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFV--TEVNTIG 554
+ +Q+ + +G G +G V+ G G VAVK E + TE+
Sbjct: 36 AKQIQM-----VKQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTV 86
Query: 555 SMHHMNLVRLCGYCSEGSNR----LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
M H N++ +G+ L+ ++ +NGSL ++ + LD + +A
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLA 140
Query: 611 IATAQGIAYFHE-----QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV- 664
++ G+ + H Q + I H D+K +NIL+ +N ++D GLA + ++V
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 665 --VTMVRGTRGYLAPE------WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
GT+ Y+ PE ++ + AD+YS+G++L E+ R G E+
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA---RRCVSGGIVEE 257
Query: 717 FFYPGWAFKEMTNGTP------LKVADRRL----EGAVEEEELMRAM-KVAFWCIQDEVF 765
+ P + ++ P V ++L +E +R M K+ C
Sbjct: 258 YQLP---YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 766 MRPSMGEVVKMLE 778
R + V K L
Sbjct: 315 SRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 67/312 (21%), Positives = 126/312 (40%), Gaps = 52/312 (16%)
Query: 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFV--TEVNTIGS 555
RD+ + + +G G +G V++GS G VAVK EK + TE+
Sbjct: 8 RDITL-----LECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVM 58
Query: 556 MHHMNLVRLCGYCSEGSNR----LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
+ H N++ + L+ + + GSL ++ + LD + I +
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVL 112
Query: 612 ATAQGIAYFHE-----QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV- 665
+ A G+A+ H Q + I H D+K +NIL+ +N ++D GLA + + +Q+
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 666 --TMVRGTRGYLAPEWVSNRPITV------KADVYSYGMLLLEIVGGRRNLDMSGDAEDF 717
GT+ Y+APE + + D++++G++L E+ R + +G ED+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA---RRMVSNGIVEDY 229
Query: 718 FYPGWAFKEMTNGTP------LKVADRRL----EGAVEEEELMRAM-KVAFWCIQDEVFM 766
P F ++ P V + + + ++ K+ C
Sbjct: 230 KPP---FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSA 286
Query: 767 RPSMGEVVKMLE 778
R + + K L
Sbjct: 287 RLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 68/313 (21%), Positives = 125/313 (39%), Gaps = 54/313 (17%)
Query: 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTE--VNTIGS 555
R + + + +G G FG V++G G VAVK E+ + E +
Sbjct: 42 RTIVL-----QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVM 92
Query: 556 MHHMNLVRLCGYCSEGSNR----LLVYEFMKNGSLDKWIFPSYHH-RDRVLDWTTRFNIA 610
+ H N++ ++ + LV ++ ++GSL + + + +A
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL-------FDYLNRYTVTVEGMIKLA 145
Query: 611 IATAQGIAYFHE-----QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV- 664
++TA G+A+ H Q + I H D+K +NIL+ +N ++D GLA +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 665 --VTMVRGTRGYLAPE------WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716
GT+ Y+APE + + +AD+Y+ G++ EI R + G ED
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHED 262
Query: 717 FFYPGWAFKEMTNGTP------LKVADRRL----EGAVEEEELMRAM-KVAFWCIQDEVF 765
+ P + ++ P V +++L + E +R M K+ C
Sbjct: 263 YQLP---YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 766 MRPSMGEVVKMLE 778
R + + K L
Sbjct: 320 ARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-38
Identities = 71/286 (24%), Positives = 114/286 (39%), Gaps = 47/286 (16%)
Query: 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+ +G G FG V+ G L D TLVAVK + + P + +F+ E + H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSY-HHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
G C++ +V E ++ G ++ L T + A G+ Y +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFL-----TFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY----LAPEW 679
IH D+ N L+ E K+SDFG+++ V G R APE
Sbjct: 233 ---CCIHRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGLRQVPVKWTAPEA 286
Query: 680 VSNRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
++ + ++DV+S+G+LL E G YP ++N + ++
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASP-----------YPN-----LSNQQTREFVEK 330
Query: 739 --RL---EGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
RL E + LM C E RPS + + L+
Sbjct: 331 GGRLPCPELCPDAVFRLME------QCWAYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 79/284 (27%), Positives = 122/284 (42%), Gaps = 45/284 (15%)
Query: 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG G +G VY+G VAVK L + +EF+ E + + H NLV+L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
G C+ ++ EFM G+L Y + + +A + + Y ++
Sbjct: 283 GVCTREPPFYIITEFMTYGNLL-----DYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG----REHSQVVTMVRGTRGYLAPEW 679
IH ++ N L+ EN KV+DFGL++LM H+ ++ T APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APES 390
Query: 680 VSNRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
++ ++K+DV+++G+LL EI G YPG ++ L D
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQV---YELLEKDY 436
Query: 739 RLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
R+E G E+ ELMRA C Q RPS E+ + E
Sbjct: 437 RMERPEGCPEKVYELMRA------CWQWNPSDRPSFAEIHQAFE 474
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 82/291 (28%), Positives = 120/291 (41%), Gaps = 40/291 (13%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG G FG V+ G+ T VA+K L + + F+ E + + H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
SE +V E+M GSL ++ + L ++A A G+AY
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
+H D++ NIL+ EN KV+DFGLA+L+ + + APE T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 687 VKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL--- 740
+K+DV+S+G+LL E+ GR YPG M N L +R R+
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP-----------YPG-----MVNREVLDQVERGYRMPCP 403
Query: 741 EGAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQ 790
E +LM C + E RP+ + LE D T PQ
Sbjct: 404 PECPESLHDLMC------QCWRKEPEERPTFEYLQAFLE---DYFTSTEPQ 445
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 61/291 (20%), Positives = 120/291 (41%), Gaps = 36/291 (12%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
+ LG G FG V G VAVK L + + E+ + +++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 561 LVRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
+V+ G C+E L+ EF+ +GSL +++ ++++ ++ + A+ +G+
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNK-INLKQQLKYAVQICKGMD 140
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYL 675
Y + + +H D+ N+L++ K+ DFGL K + + T+ +
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVFWY 196
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
APE + + +DV+S+G+ L E++ + M+ + +MT +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG---QMTVTRLV 253
Query: 734 KVADR--RLEGAVE--EE--ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
RL +E +LMR C + + R S +++ E
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQLMRK------CWEFQPSNRTSFQNLIEGFE 298
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-35
Identities = 72/282 (25%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+ LG G FG V+ + T VAVK + + + F+ E N + ++ H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
++ ++ EFM GSL ++ + + A+G+A+ ++
Sbjct: 251 VVTK-EPIYIITEFMAKGSLLDFLK---SDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 303
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG---YLAPEWVSNR 683
IH D++ NIL+ + K++DFGLA+++ T G + + APE ++
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 684 PITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL 740
T+K+DV+S+G+LL+EIV GR YPG M+N ++ +R R+
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP-----------YPG-----MSNPEVIRALERGYRM 404
Query: 741 ---EGAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
E EE +M C ++ RP+ + +L+
Sbjct: 405 PRPENCPEELYNIMM------RCWKNRPEERPTFEYIQSVLD 440
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 82/291 (28%), Positives = 120/291 (41%), Gaps = 40/291 (13%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG G FG V+ G+ T VA+K L + + F+ E + + H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
SE +V E+M GSL ++ + L ++A A G+AY
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM--- 382
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
+H D++ NIL+ EN KV+DFGLA+L+ + + APE T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 687 VKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RLE-- 741
+K+DV+S+G+LL E+ GR YPG M N L +R R+
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP-----------YPG-----MVNREVLDQVERGYRMPCP 486
Query: 742 -GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQ 790
E +LM C + E RP+ + LE D T PQ
Sbjct: 487 PECPESLHDLMC------QCWRKEPEERPTFEYLQAFLE---DYFTSTEPQ 528
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 507 FAQLLGTGGFGSVYKGSLGDG-----TLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
++LG+G FG+VYKG VA+K+L + P KE + E + S+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+ RL G C S L+ + M G L ++ + N + A+G+ Y
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAP 677
++ R++H D+ N+L+ K++DFGLAKL+G E G + ++A
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMAL 188
Query: 678 EWVSNRPITVKADVYSYGMLLLEIV 702
E + +R T ++DV+SYG+ + E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 47/296 (15%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL 561
+ LG G FGSV G LVAVK+L P +++F E+ + ++H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 562 VRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
V+ G + LV E++ +G L ++ HR R LD + + +G+ Y
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRAR-LDASRLLLYSSQICKGMEY 142
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL---- 675
+ R +H D+ NIL++ K++DFGLAKL+ + V G
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV---REPGQSPIFW 196
Query: 676 -APEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
APE +S+ + ++DV+S+G++L E+ ++ P F M
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----------CSPSAEFLRMMGCERD 246
Query: 734 KVADRRLEGAVEE-----------EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
A RL +EE E+ MK C RPS + L+
Sbjct: 247 VPALSRLLELLEEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 299
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 43/282 (15%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+ LG+G FG V G VAVK + + E EF E T+ + H LV+ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
CS+ +V E++ NG L ++ + L+ + + +G+A+
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESH--- 123
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSNR 683
+ IH D+ N L+D + C KVSDFG+ + + GT+ + APE
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 684 PITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL 740
+ K+DV+++G+L+ E+ G+ Y TN + + RL
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP-----------YDL-----YTNSEVVLKVSQGHRL 224
Query: 741 E---GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
A + ++M + C + RP+ +++ +E
Sbjct: 225 YRPHLASDTIYQIMYS------CWHELPEKRPTFQQLLSSIE 260
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 43/282 (15%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
F Q +G+G FG V+ G + VA+K + R E++F+ E + + H LV+L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C E + LV EFM++G L ++ + + T + + +G+AY E
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 123
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSNR 683
+IH D+ N L+ EN KVSDFG+ + + T GT+ + +PE S
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 684 PITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL 740
+ K+DV+S+G+L+ E+ G+ Y +N ++ RL
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP-----------YEN-----RSNSEVVEDISTGFRL 224
Query: 741 E---GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
A ++M C ++ RP+ +++ L
Sbjct: 225 YKPRLASTHVYQIMNH------CWRERPEDRPAFSRLLRQLA 260
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 42/293 (14%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
+ LG G FG V G G +VAVK L P + E++ + +++H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 561 LVRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
+++ G C + LV E++ GSL ++ + A +G+A
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMA 148
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL--- 675
Y H Q IH D+ N+LLD + K+ DFGLAK + H G
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV---REDGDSPVF 202
Query: 676 --APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731
APE + +DV+S+G+ L E++ + E +MT
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG---QMTVLR 259
Query: 732 PLKVADR--RLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
++ +R RL E LM+ C + E RP+ ++ +L+
Sbjct: 260 LTELLERGERLPRPDKCPAEVYHLMKN------CWETEASFRPTFENLIPILK 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL 561
F Q LG G FGSV G +VAVKKL ++F E+ + S+ H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 562 VRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGI 617
V+ G C R L+ E++ GSL Y H++R +D +G+
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLR-----DYLQKHKER-IDHIKLLQYTSQICKGM 127
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY--- 674
Y + R IH D+ NIL++ K+ DFGL K++ + V+
Sbjct: 128 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEFFKVKEPGESPIF 182
Query: 675 -LAPEWVSNRPITVKADVYSYGMLLLEIV 702
APE ++ +V +DV+S+G++L E+
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRL 564
+ +G G F VY+ L DG VA+KK+ K + E++ + ++H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHR-----DRVLDWTTRFNIAIATAQGIAY 619
E + +V E G L + I + V + + + +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------LCSALEH 151
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H + R++H DIKP N+ + K+ D GL + + + ++V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRR 706
+ K+D++S G LL E+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 63/283 (22%), Positives = 116/283 (40%), Gaps = 45/283 (15%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
F + LGTG FG V G VA+K + + E EF+ E + ++ H LV+L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C++ ++ E+M NG L ++ + + + Y +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK--- 139
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH--SQVVTM--VRGTRGYLAPEWVSN 682
+ +H D+ N L+++ KVSDFGL++ + + S V + VR + PE +
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMY 195
Query: 683 RPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--R 739
+ K+D++++G+L+ EI G+ Y TN + + R
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP-----------YER-----FTNSETAEHIAQGLR 239
Query: 740 L---EGAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
L A E+ +M + C ++ RP+ ++ +
Sbjct: 240 LYRPHLASEKVYTIMYS------CWHEKADERPTFKILLSNIL 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
Q LG GGFG V++ + D A+K++ ++ + EV + + H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 567 YCSEGSN---------RLLVY---EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
E + ++ +Y + + +L W+ + + + +I + A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIA 128
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR----- 669
+ + + H + ++H D+KP NI + KV DFGL M ++ + +
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 670 ------GTRGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
GT+ Y++PE + + K D++S G++L E+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 49/291 (16%)
Query: 506 NFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMN 560
+F +++G G FG VY G+L G AVK L+R+ GE +F+TE + H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 561 LVRLCGYCSEGSN-RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
++ L G C L+V +MK+G L +I + + A+G+ Y
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL---- 675
+ + +H D+ N +LDE F KV+DFGLA+ M + + V G
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVK 197
Query: 676 --APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731
A E + + T K+DV+S+G+LL E++ G YP ++T
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------YPDVNTFDITV-- 243
Query: 732 PLKVADRRLEGAVE--EE--ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ RRL + E+M C + MRPS E+V +
Sbjct: 244 -YLLQGRRLLQPEYCPDPLYEVMLK------CWHPKAEMRPSFSELVSRIS 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL 561
F Q LG G FGSV G +VAVKKL ++F E+ + S+ H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 562 VRLCGYCSEGSNR--LLVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGI 617
V+ G C R L+ E++ GSL Y H++R +D +G+
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLR-----DYLQKHKER-IDHIKLLQYTSQICKGM 158
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG------T 671
Y + R IH D+ NIL++ K+ DFGL K++ ++ G
Sbjct: 159 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702
APE ++ +V +DV+S+G++L E+
Sbjct: 216 ----APESLTESKFSVASDVWSFGVVLYELF 242
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-33
Identities = 70/282 (24%), Positives = 112/282 (39%), Gaps = 47/282 (16%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
Q +G G FG V G G VAVK + + F+ E + + + H NLV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 567 YCSEGSNRL-LVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
E L +V E+M GSL Y VL ++ + + Y
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLV-----DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
+H D+ N+L+ E+ KVSDFGL K V+ T APE + +
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 361
Query: 684 PITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL 740
+ K+DV+S+G+LL EI GR YP + + ++ ++
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP-----------YPR-----IPLKDVVPRVEKGYKM 405
Query: 741 E---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ G ++M+ C + RP+ ++ + LE
Sbjct: 406 DAPDGCPPAVYDVMKN------CWHLDAATRPTFLQLREQLE 441
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 19/206 (9%)
Query: 507 FAQLLGTGGFGSVYKGSL----GDGTLVAVKKL---DRVLPHGEKEFVTEVNTIGSMHHM 559
+ LG G FG V +G G VAVK L P +F+ EVN + S+ H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
NL+RL G +V E GSL + T A+ A+G+ Y
Sbjct: 82 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLA 676
+ R IH D+ N+LL K+ DFGL + + + M + + A
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCA 192
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIV 702
PE + R + +D + +G+ L E+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEF-VTEVNTIGSMHHMNLVRLC 565
Q +G G FG S DG +K+++ + E+E EV + +M H N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHR---DRVLDWTTRFNIAIATAQGIAYFHE 622
E + +V ++ + G L K I D++LDW + + + H+
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLALKHVHD 143
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
+ +I+H DIK +NI L ++ ++ DFG+A+++ + GT YL+PE N
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 683 RPITVKADVYSYGMLLLEIVGGRR 706
+P K+D+++ G +L E+ +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKH 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 509 QLLGTGGFGSVYKGSL---GDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVR 563
+ LG+G FG+V KG VAVK K + P + E + E N + + + +VR
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
+ G C + +LV E + G L+K Y ++R + + + G+ Y E
Sbjct: 83 MIGICE-AESWMLVMEMAELGPLNK-----YLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG------TRGYLAP 677
+H D+ N+LL K+SDFGL+K + + + G AP
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----AP 189
Query: 678 EWVSNRPITVKADVYSYGMLLLEIV 702
E ++ + K+DV+S+G+L+ E
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
++LG+G FG+V+KG V +K + D+ + + IGS+ H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+VRL G C S+ LV +++ GSL + L N + A+G+ Y
Sbjct: 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHV----RQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAP 677
E ++H ++ N+LL +V+DFG+A L+ + Q++ + ++A
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186
Query: 678 EWVSNRPITVKADVYSYGMLLLEIV 702
E + T ++DV+SYG+ + E++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 507 FAQLLGTGGFGSVYKGSL----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNL 561
+++G+G G V G L VA+K L ++F++E + +G H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
+RL G + G ++V E+M+NGSLD ++ D + G+ Y
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG------TRGYL 675
+ +H D+ N+L+D N KVSDFGL++++ + T G T
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT---- 221
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIV 702
APE ++ R + +DV+S+G+++ E++
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 511 LGTGGFGSVYKGSL---GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG G FGSV +G VA+K L +E + E + + + +VRL G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C +LV E G L K++ + + + + + G+ Y E+
Sbjct: 78 VCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG------TRGYLAPEWV 680
+H D+ N+LL K+SDFGL+K +G + S G APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 681 SNRPITVKADVYSYGMLLLEIV 702
+ R + ++DV+SYG+ + E +
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEAL 207
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+L+G+GGFG V+K DG +K++ + ++ EV + + H+N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 568 ----------------CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
S+ + EF G+L++WI R LD +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALELFE 129
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGT 671
+G+ Y H ++I+ D+KP NI L + K+ DFGL + ++ T +GT
Sbjct: 130 QITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGT 184
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEI 701
Y++PE +S++ + D+Y+ G++L E+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAEL 214
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 47/285 (16%)
Query: 507 FAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG G +G VY+G VAVK L + +EF+ E + + H NLV+L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
G C+ ++ EFM G+L Y + + +A + + Y ++
Sbjct: 76 GVCTREPPFYIITEFMTYGNLL-----DYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWV 680
IH D+ N L+ EN KV+DFGL++LM T G + + APE +
Sbjct: 131 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESL 184
Query: 681 SNRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR- 738
+ ++K+DV+++G+LL EI G YPG + ++ ++
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP-----------YPG-----IDLSQVYELLEKD 228
Query: 739 -RLE---GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
R+E G E+ ELMRA C Q RPS E+ + E
Sbjct: 229 YRMERPEGCPEKVYELMRA------CWQWNPSDRPSFAEIHQAFE 267
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 56/299 (18%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+ LG G FG V+ G T VAVK L + F+ E N + + H LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
++ ++ E+M+NGSL + L ++A A+G+A+ E+
Sbjct: 76 VVTQ-EPIYIITEYMENGSLV-----DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLM------GREHSQVVTMVRGTRGYLAPE 678
IH D++ NIL+ + K++DFGLA+L+ RE ++ ++ T APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWT----APE 180
Query: 679 WVSNRPITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
++ T+K+DV+S+G+LL EIV GR YPG MTN ++ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP-----------YPG-----MTNPEVIQNLE 224
Query: 738 R--RLE---GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQ 790
R R+ EE +LMR C ++ RP+ + +LE D T Q
Sbjct: 225 RGYRMVRPDNCPEELYQLMR------LCWKERPEDRPTFDYLRSVLE---DFFTATEGQ 274
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 511 LGTGGFGSVYKGSL----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+G G FG V G L VA+K L ++F+ E + +G H N++RL
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G ++ ++V E+M+NGSLD ++ D + A G+ Y +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSN 682
+H D+ NIL++ N KVSDFGL +++ + + RG + + +PE ++
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 683 RPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--R 739
R T +DV+SYG++L E++ G R Y M+N +K D R
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP-----------YWE-----MSNQDVIKAVDEGYR 268
Query: 740 L---EGAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLEL 795
L +LM C Q + RP ++V +L+ I P + +
Sbjct: 269 LPPPMDCPAALYQLML------DCWQKDRNNRPKFEQIVSILD--KLIRNPGSLKIITSA 320
Query: 796 IEEGLDHVYKAMKRDFNQFSS 816
+ + D F +
Sbjct: 321 AARPSNLLLDQSNVDITTFRT 341
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 9/205 (4%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEF-VTEVNTIGSMHHMNLVRLC 565
+GTG +G K DG ++ K+LD + EK+ V+EVN + + H N+VR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 566 G-YCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
+ L +V E+ + G L I + LD + + H +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 624 --CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
+ ++H D+KP N+ LD K+ DFGLA+++ + S T V GT Y++PE ++
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 682 NRPITVKADVYSYGMLLLEIVGGRR 706
K+D++S G LL E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 507 FAQLLGTGGFGSVYKGSLGDG-----TLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
++LG+G FG+VYKG VA+K+L + P KE + E + S+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+ RL G C S L+ + M G L ++ + N + A+G+ Y
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAP 677
++ R++H D+ N+L+ K++DFGLAKL+G E G + ++A
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMAL 188
Query: 678 EWVSNRPITVKADVYSYGMLLLEIV 702
E + +R T ++DV+SYG+ + E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 506 NFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMN 560
+F +++G G FG VY G+L G AVK L+R+ GE +F+TE + H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 561 LVRLCGYCSEGSN-RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
++ L G C L+V +MK+G L +I + + A+G+ +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL---- 675
+ + +H D+ N +LDE F KV+DFGLA+ M + ++ T L
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKW 262
Query: 676 -APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732
A E + + T K+DV+S+G+LL E++ G YP ++T
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------YPDVNTFDITV--- 307
Query: 733 LKVADRRLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ RRL E+M C + MRPS E+V +
Sbjct: 308 YLLQGRRLLQPEYCPDPLYEVMLK------CWHPKAEMRPSFSELVSRIS 351
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 507 FAQLLGTGGFGSVYKGSL-----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMN 560
+++G G FG VYKG L VA+K L +F+ E +G H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
++RL G S+ +++ E+M+NG+LDK++ +D + A G+ Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAP 677
+H D+ NIL++ N KVSDFGL++++ + + G + + AP
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAP 219
Query: 678 EWVSNRPITVKADVYSYGMLLLEIV 702
E +S R T +DV+S+G+++ E++
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVM 244
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 56/219 (25%), Positives = 82/219 (37%), Gaps = 32/219 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
Q LG GGF V L DG A+K++ +E E + +H N++RL Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 568 CSEGSNR----LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF------NIAIATAQGI 617
C L+ F K G+L I +R+ D + + +G+
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEI-------ERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS--------QVVTMVR 669
H + H D+KP NILL + P + D G Q R
Sbjct: 148 EAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 670 GTRGYLAPEWV---SNRPITVKADVYSYGMLLLEIVGGR 705
T Y APE S+ I + DV+S G +L ++ G
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 507 FAQLLGTGGFGSVYKGSLGDG----TLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHMNL 561
+++G G FG VY G D A+K L R+ + F+ E + ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 562 VRLCGYCSEGSNRLL-VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+ L G + +M +G L ++I R + + A+G+ Y
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL----- 675
EQ + +H D+ N +LDE+F KV+DFGLA+ + + V+ R
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKW 194
Query: 676 -APEWVSNRPITVKADVYSYGMLLLEIV 702
A E + T K+DV+S+G+LL E++
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 507 FAQLLGTGGFGSVYKGSL----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNL 561
++LG G FG VY+G G+ VAVK +++F++E + ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
V+L G E ++ E G L ++ L T ++ + +AY
Sbjct: 76 VKLIGIIEEEP-TWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPE 678
+H DI NIL+ C K+ DFGL++ + E TR +++PE
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPE 184
Query: 679 WVSNRPITVKADVYSYGMLLLEIV 702
++ R T +DV+ + + + EI+
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEIL 208
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 18/211 (8%)
Query: 503 RTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHM 559
R F +G G F +VYKG VA + ++ + F E + + H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85
Query: 560 NLVRLCGYC---SEGSNRLLVY-EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
N+VR +G +++ E M +G+L +Y R +V+ + +
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLK-----TYLKRFKVMKIKVLRSWCRQILK 140
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
G+ + H IIH D+K +NI + K+ D GLA L ++ ++ GT +
Sbjct: 141 GLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVI-GTPEF 196
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
+APE + DVY++GM +LE+
Sbjct: 197 MAPE-MYEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDR--VLPHG-EKEFVTEVNTIGSMHHMNLVRLC 565
LG G FG+VY ++A+K L + + G E + EV + H N++RL
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
GY + + L+ E+ G++ + + + T I A ++Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT-ELANALSYCH---S 127
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
R+IH DIKPEN+LL K++DFG + S+ + GT YL PE + R
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLC-GTLDYLPPEMIEGRMH 184
Query: 686 TVKADVYSYGMLLLEIVGGR 705
K D++S G+L E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 511 LGTGGFGSVYKGSL----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+G G FG V++G VA+K + ++F+ E T+ H ++V+L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G +E + ++ E G L ++ R LD + A + +AY +
Sbjct: 83 GVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPEWVSN 682
R +H DI N+L+ N C K+ DFGL++ M + ++APE ++
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINF 191
Query: 683 RPITVKADVYSYGMLLLEIV 702
R T +DV+ +G+ + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 54/293 (18%)
Query: 507 FAQLLGTGGFGSVYKGSL--------GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH 558
F + LG G F ++KG T V +K LD+ + + F + + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
+LV G C G +LV EF+K GSLD ++ ++ + +A A +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMH 127
Query: 619 YFHEQCRNRIIHCDIKPENILLD--------ENFCPKVSDFGLAKLMGREHSQVVTM-VR 669
+ E +IH ++ +NILL K+SD G++ + ++ +
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQERIP 182
Query: 670 GTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEM 727
PE + N + D +S+G L EI GG + +
Sbjct: 183 WV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-----------LSA-----L 222
Query: 728 TNGTPLKVADR--RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ L+ + +L A + EL + C+ E RPS +++ L
Sbjct: 223 DSQRKLQFYEDRHQLP-APKAAELANLIN---NCMDYEPDHRPSFRAIIRDLN 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 43/215 (20%), Positives = 73/215 (33%), Gaps = 21/215 (9%)
Query: 509 QLLGTGGFGSVYKGSLGD------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLV 562
LLG G F VY+ + GD +K P + + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
+ + +LV E G+L I + ++V+ + A+ I H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 623 QCRNRIIHCDIKPENILLDENFCP-----------KVSDFGLAKLMGR-EHSQVVTMVRG 670
IIH DIKP+N +L F + D G + M + T
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
T G+ E +SN+P + D + + ++ G
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-31
Identities = 62/284 (21%), Positives = 109/284 (38%), Gaps = 42/284 (14%)
Query: 507 FAQLLGTGGFGSVYKGSL----GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNL 561
+ +G G FG V++G VA+K + ++F+ E T+ H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
V+L G +E + ++ E G L ++ R LD + A + +AY
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR---GYLAPE 678
+ R +H DI N+L+ N C K+ DFGL++ M + ++APE
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 679 WVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
++ R T +DV+ +G+ + EI+ G + + G + N + +
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP-----------FQG-----VKNNDVIGRIE 606
Query: 738 R--RLEGAVE-EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
RL L M C + RP E+ L
Sbjct: 607 NGERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 647
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 77/319 (24%), Positives = 117/319 (36%), Gaps = 56/319 (17%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHM 559
+ LG G FG VY+G + VAVK L + E +F+ E I +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHH--RDRVLDWTTRFNIAIATAQGI 617
N+VR G + R ++ E M G L ++ + + L ++A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 618 AYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
Y E N IH DI N LL K+ DFG+A+ + R +G
Sbjct: 154 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAM 206
Query: 675 L-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEM 727
L PE T K D +S+G+LL EI G YP + +E+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------------YPSKSNQEV 254
Query: 728 TNGTPLKVAD-RRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE---G 779
V R++ +M C Q + RP+ +++ +E
Sbjct: 255 LE----FVTSGGRMDPPKNCPGPVYRIMTQ------CWQHQPEDRPNFAIILERIEYCTQ 304
Query: 780 SADINTPPMPQTVLELIEE 798
D+ +P L+EE
Sbjct: 305 DPDVINTALPIEYGPLVEE 323
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 511 LGTGGFGSVYKGSL---GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG G FGSV +G VA+K L +E + E + + + +VRL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C +LV E G L K++ + + + + + G+ Y E+
Sbjct: 404 VCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG------TRGYLAPEWV 680
+H ++ N+LL K+SDFGL+K +G + S G APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 681 SNRPITVKADVYSYGMLLLEIV 702
+ R + ++DV+SYG+ + E +
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEAL 533
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 509 QLLGTGGFGSVYKGSLGDGTL---VAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLV 562
LG GG +VY D L VA+K + E K F EV+ + H N+V
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
+ E LV E+++ +L ++I L T N GI + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH- 128
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
RI+H DIKP+NIL+D N K+ DFG+AK + V GT Y +PE
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 683 RPITVKADVYSYGMLLLEIVGGRR 706
D+YS G++L E++ G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEP 210
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+LG G FG V K + D A+KK+ ++EV + S++H +VR
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 568 CSEGSNRL-------------LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
E N + + E+ +NG+L I ++ R W +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQIL 126
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV--------- 665
+ ++Y H Q IIH D+KP NI +DE+ K+ DFGLAK + R +
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 666 -----TMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLE 700
+ + GT Y+A E + K D+YS G++ E
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 47/282 (16%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
Q +G G FG V G G VAVK + + F+ E + + + H NLV+L G
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 567 YCSEGSNRL-LVYEFMKNGSLDKWIFPSY--HHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
E L +V E+M GSL Y VL ++ + + Y
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLV-----DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
+H D+ N+L+ E+ KVSDFGL K V+ T APE + +
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 189
Query: 684 PITVKADVYSYGMLLLEIV-GGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR--RL 740
+ K+DV+S+G+LL EI GR YP + + ++ ++
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP-----------YPR-----IPLKDVVPRVEKGYKM 233
Query: 741 E---GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ G E+M+ C + MRPS ++ + LE
Sbjct: 234 DAPDGCPPAVYEVMK------NCWHLDAAMRPSFLQLREQLE 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 56/207 (27%), Positives = 78/207 (37%), Gaps = 27/207 (13%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSM-HHMNLVRL 564
LG G +G V+K S DG L AVK+ P + EV + + H VRL
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWI------FPSYHHRDRVLDWTTRFNIAIATAQGIA 618
EG L E SL + P +V + T +A
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE----AQVWGYLRD------TLLALA 171
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
+ H ++H D+KP NI L K+ DFGL +G G Y+APE
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPE 226
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ ADV+S G+ +LE+
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 72/326 (22%), Positives = 121/326 (37%), Gaps = 58/326 (17%)
Query: 507 FAQLLGTGGFGSVYKGSL----GDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMN 560
++LG G FGSV + L G VAVK K D + +EF+ E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 561 LVRLCGYCSEGSNR------LLVYEFMKNGSLDKWI-FPSYHHRDRVLDWTTRFNIAIAT 613
+ +L G + +++ FMK+G L ++ L T +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
A G+ Y + IH D+ N +L E+ V+DFGL++ + +G
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD----YYRQGCAS 199
Query: 674 YL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKE 726
L A E +++ TV +DV+++G+ + EI+ G Y G E
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP------------YAGIENAE 247
Query: 727 MTNGTPLKVAD-RRLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE--- 778
+ N + RL+ E +LM C + RPS + LE
Sbjct: 248 IYN----YLIGGNRLKQPPECMEEVYDLMYQ------CWSADPKQRPSFTCLRMELENIL 297
Query: 779 GSADINTPPMPQTVLELIEEGLDHVY 804
G + + + + E H +
Sbjct: 298 GHLSVLSTSQDPLYINI-ERAHHHHH 322
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+LG G +G VY G L + +A+K++ + E+ + H N+V+ G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 568 CSEGSNRLLVYEFMKNGSLD---KWIFPSYHHRDRVLDWTTRFNIAIATAQ---GIAYFH 621
SE + E + GSL + + ++ I T Q G+ Y H
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT--------IGFYTKQILEGLKYLH 139
Query: 622 EQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
+ +I+H DIK +N+L++ + K+SDFG +K + + T GT Y+APE +
Sbjct: 140 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEII 195
Query: 681 --SNRPITVKADVYSYGMLLLEIVGGRR 706
R AD++S G ++E+ G+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 75/318 (23%), Positives = 116/318 (36%), Gaps = 54/318 (16%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHM 559
+ LG G FG VY+G + VAVK L + E +F+ E I +H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR--FNIAIATAQGI 617
N+VR G + R ++ E M G L ++ + + ++A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 618 AYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
Y E N IH DI N LL K+ DFG+A+ + R +G
Sbjct: 195 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAM 247
Query: 675 L-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEM 727
L PE T K D +S+G+LL EI G YP + +E+
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------------YPSKSNQEV 295
Query: 728 TNGTPLKVADRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE---GS 780
+ R++ +M C Q + RP+ +++ +E
Sbjct: 296 LE---FVTSGGRMDPPKNCPGPVYRIMTQ------CWQHQPEDRPNFAIILERIEYCTQD 346
Query: 781 ADINTPPMPQTVLELIEE 798
D+ +P L+EE
Sbjct: 347 PDVINTALPIEYGPLVEE 364
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDR--VLPHG-EKEFVTEVNTIGSMHHMNLVRLC 565
LG G FG+VY + ++A+K L + + G E + E+ + H N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA-IATAQGIAYFHEQC 624
Y + L+ EF G L K + R + + + +A A + Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADA--LHYCH--- 131
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
++IH DIKPEN+L+ K++DFG + + TM GT YL PE + +
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMC-GTLDYLPPEMIEGKT 188
Query: 685 ITVKADVYSYGMLLLEIVGGR 705
K D++ G+L E + G
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGM 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 53/296 (17%)
Query: 507 FAQLLGTGGFGSVYKGSL----GDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMN 560
++LG G FGSV +G+L G VAVK KLD +EF++E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 561 LVRLCGYCSEGSNR-----LLVYEFMKNGSLDKWIFPSYHHRD-RVLDWTTRFNIAIATA 614
++RL G C E S++ +++ FMK G L ++ S + + T + A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
G+ Y + +H D+ N +L ++ V+DFGL+K + +G
Sbjct: 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD----YYRQGRIAK 210
Query: 675 L-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEM 727
+ A E +++R T K+DV+++G+ + EI G YPG EM
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP------------YPGVQNHEM 258
Query: 728 TNGTPLKVAD-RRLEG----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ + RL+ E E+M + C + + RP+ + LE
Sbjct: 259 YD----YLLHGHRLKQPEDCLDELYEIMYS------CWRTDPLDRPTFSVLRLQLE 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLC- 565
+ LGTGGFG V + G VA+K+ + L +E E+ + ++H N+V
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 566 -----GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+ LL E+ + G L K++ + L + + + Y
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 621 HEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
HE NRIIH D+KPENI+L + K+ D G AK + + V GT YLAP
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYLAP 192
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGRR 706
E + + TV D +S+G L E + G R
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 31/210 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G FG V++ G AVKK+ L E E+ + +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVE---ELVACAGLSSPRIVPLYGA 118
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAIATAQ---GIAYFH 621
EG + E ++ GSL + ++ Q G+ Y H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQ-----------LIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 622 EQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAKLMGREHSQVVTM----VRGTRGYLA 676
+ RI+H D+K +N+LL + + DFG A + + + + GT ++A
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
PE V +P K D++S ++L ++ G
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDR---VLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
LLG G F VY+ S+ G VA+K +D+ + EV + H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD-WTTRFNIA-IATAQGIAYFHEQ 623
Y + + LV E NG +++++ +R + R + I T + Y H
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITG--MLYLH-- 129
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
+ I+H D+ N+LL N K++DFGLA + H + T+ GT Y++PE +
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 684 PITVKADVYSYGMLLLEIVGGR 705
+++DV+S G + ++ GR
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 37/271 (13%), Positives = 79/271 (29%), Gaps = 54/271 (19%)
Query: 480 RAVENSLIVCGAPVNF-TYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR 537
V SL G P + + RT +LG + + G V
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 538 VLPHGEKE----------------------------FVTEVNTIGSMHHMNLVRLCGYCS 569
F+ + + ++R+
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 570 EGS--NRLLVYEFMK--NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
+ +R +Y M+ + + + S+ + L R + + + +A H
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLH---H 224
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR-- 683
++H ++P +I+LD+ ++ F G +RG+ PE + R
Sbjct: 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRAT 279
Query: 684 ---------PITVKADVYSYGMLLLEIVGGR 705
+T D ++ G+++ I
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 58/299 (19%)
Query: 507 FAQLLGTGGFGSVYKGSL---GDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSM-HHMNL 561
F ++G G FG V K + G A+K++ + +F E+ + + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKW-----------IFPSYHHRDRVLDWTTRFNIA 610
+ L G C L E+ +G+L + F + L + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
A+G+ Y ++ + IH D+ NIL+ EN+ K++DFGL+ R V+
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS----RGQE---VYVKK 198
Query: 671 TRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWA 723
T G L A E ++ T +DV+SYG+LL EIV GG Y G
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------------YCGMT 246
Query: 724 FKEMTNGTPLKVADRRLE---GAVEEE-ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
E+ RLE +E +LMR C +++ + RPS +++ L
Sbjct: 247 CAELYE---KLPQGYRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLN 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 33/221 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSM-HHMNLVRL 564
+ +G+G FGSV+K DG + A+K+ + L E+ + EV + H ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
+E + L+ E+ GSL I + ++ + +G+ Y H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQVGRGLRYIHSM- 134
Query: 625 RNRIIHCDIKPENILLDENFCP-------------------KVSDFGLAKLMGREHSQVV 665
++H DIKP NI + P K+ D G + +
Sbjct: 135 --SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 191
Query: 666 TMVRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
G +LA E N KAD+++ + ++ G
Sbjct: 192 ----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 72/317 (22%), Positives = 130/317 (41%), Gaps = 56/317 (17%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEK-EFVTEVNTIGSMHHM 559
++ LG G FG VY+G T VA+K ++ E+ EF+ E + + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----FPSYHHRDRVLDWTTRFNIAIATA 614
++VRL G S+G L++ E M G L ++ + + + +A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
G+AY + + +H D+ N ++ E+F K+ DFG+ + + +G +G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGL 201
Query: 675 L-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEM 727
L +PE + + T +DV+S+G++L EI + Y G + +++
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP------------YQGLSNEQV 249
Query: 728 TNGTPLKVADR-RLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782
V + L+ + ELMR C Q MRPS E++ ++ +
Sbjct: 250 LR----FVMEGGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIISSIK---E 296
Query: 783 INTPPMPQTVLELIEEG 799
P + EE
Sbjct: 297 EMEPGFREVSFYYSEEN 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN 560
+ LG G FG V+ D LVAVK L K+F E + ++ H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSL-----------DKWIFPSYHHRDRVLDWTTRFNI 609
+V+ G C +G ++V+E+MK+G L + L + +I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
A A G+ Y Q +H D+ N L+ N K+ DFG+++ +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYRV 191
Query: 670 GTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV 702
G L PE + R T ++DV+S+G++L EI
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEK-EFVTEVN---TIGSM 556
F + LG G FG V + + VAVK L EK ++E+ +G
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-- 107
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSL---------DKWIFPSYHHRDRVLDWTTRF 607
H N+V L G C+ G L++ E+ G L P++ +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 608 NIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM 667
+ + AQG+A+ + IH D+ N+LL K+ DFGLA+ + +
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----NY 220
Query: 668 VRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV 702
+ L APE + + TV++DV+SYG+LL EI
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 30/219 (13%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHM 559
F + LG FG VYKG L VA+K L D+ +EF E + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKW-----------IFPSYHHRDRVLDWTTRFN 608
N+V L G ++ +++ + +G L ++ L+ +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 609 IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMV 668
+ A G+ Y ++H D+ N+L+ + K+SD GL + +
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YYK 185
Query: 669 RGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV 702
L APE + ++ +D++SYG++L E+
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 509 QLLGTGGFGSVYKGSLGDGTL---VAVKKLDRVLPHGEKEFVT----EVNTIGSMHHMNL 561
++LG GG V+ D VAVK L L F E +++H +
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAI 74
Query: 562 VRLCGY---CSEGSNRLLVY---EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
V + Y +E L Y E++ +L + H + + + Q
Sbjct: 75 VAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQ 127
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT---MVRGTR 672
+ + H +N IIH D+KP NI++ KV DFG+A+ + + VT V GT
Sbjct: 128 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTA 183
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
YL+PE + ++DVYS G +L E++ G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-29
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 30/214 (14%)
Query: 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVT----EVNT-IGSMHHMN 560
+LG G G++ + D VAVK++ E + EV S H N
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEHPN 79
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
++R + + + E +L +++ +D + T G+A+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC-AATLQEYV----EQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 621 HEQCRNRIIHCDIKPENILLDE-----NFCPKVSDFGLAKLMGREHSQVVTM--VRGTRG 673
H I+H D+KP NIL+ +SDFGL K + V GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 674 YLAPE---WVSNRPITVKADVYSYGMLLLEIVGG 704
++APE T D++S G + ++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG GGF ++ + A K + + L PH ++ E++ S+ H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G+ + +V E + SL + R + + R+ G Y H R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY-YLRQIVLGCQYLH---R 159
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
NR+IH D+K N+ L+E+ K+ DFGLA + + + + GT Y+APE +S +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH 218
Query: 686 TVKADVYSYGMLLLEIVGGR 705
+ + DV+S G ++ ++ G+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 510 LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG GGF ++ + A K + + L PH ++ E++ S+ H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G+ + +V E + SL + R + + R+ G Y H R
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY-YLRQIVLGCQYLH---R 133
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
NR+IH D+K N+ L+E+ K+ DFGLA + + + + GT Y+APE +S +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH 192
Query: 686 TVKADVYSYGMLLLEIVGGR 705
+ + DV+S G ++ ++ G+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 78/352 (22%), Positives = 134/352 (38%), Gaps = 68/352 (19%)
Query: 467 LLYYNVHRKRFLKRAVENSLIVCGAPVNFTYRDLQI-------RTS-NFAQLLGTGGFGS 518
+ YY+ H +L G + +L R + LG G FG
Sbjct: 25 MGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQ 84
Query: 519 VYKGSL--------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYC 568
V T VAVK L + ++E+ + + H N++ L G C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 569 SEGSNRLLVYEFMKNGSL-----------DKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
++ ++ E+ G+L ++ + H+ + L + A A+G+
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL-- 675
Y + + IH D+ N+L+ E+ K++DFGLA+ + + T G L
Sbjct: 205 EYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYKKTTNGRLPV 257
Query: 676 ---APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWAFKEMTNG 730
APE + +R T ++DV+S+G+LL EI GG YPG +E+
Sbjct: 258 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------------SPYPGVPVEELFK- 304
Query: 731 TPLKVADRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
L R++ E +MR C RP+ ++V+ L+
Sbjct: 305 --LLKEGHRMDKPSNCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLD 348
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSM--HHMNLVRL 564
+ +G+GG V++ + A+K L+ + E+ + + H ++RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
Y +V E N L+ W+ + + +D R + + + H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQ-- 126
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV-TMVRGTRGYLAPEWVSNR 683
+ I+H D+KP N L+ + K+ DFG+A M + + VV GT Y+ PE + +
Sbjct: 127 -HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 684 P-----------ITVKADVYSYGMLLLEIVGGR 705
I+ K+DV+S G +L + G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 73/306 (23%), Positives = 120/306 (39%), Gaps = 63/306 (20%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVN---TIGSM 556
F + LG G FG V + + VAVK L + ++E+ +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-- 84
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSL-------------DKWIFPSYHHRDRVLDW 603
+HMN+V L G C+ G L++ E+ G L K + LD
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 604 TTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663
+ + A+G+A+ + IH D+ NILL K+ DFGLA+ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-- 199
Query: 664 VVTMVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAED 716
V L APE + N T ++DV+SYG+ L E+ G M D++
Sbjct: 200 --NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 717 FFYPGWAFKEMTNGTPLKVADRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGE 772
+K + G R+ A E ++M+ C + RP+ +
Sbjct: 257 ------FYKMIKEG-------FRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQ 297
Query: 773 VVKMLE 778
+V+++E
Sbjct: 298 IVQLIE 303
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 82/310 (26%), Positives = 132/310 (42%), Gaps = 67/310 (21%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHM 559
+ LG G FG V K + T VAVK L + P ++ ++E N + ++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSL-------------------DKWIFPSYHHRDRV 600
++++L G CS+ LL+ E+ K GSL + H +R
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
L + A +QG+ Y E +++H D+ NIL+ E K+SDFGL++ + E
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 661 HSQVVTMVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGD 713
+ V+ ++G + A E + + T ++DV+S+G+LL EIV GG
Sbjct: 204 D----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--------- 250
Query: 714 AEDFFYPGWAFKEMTNGTPLKVAD-RRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRP 768
YPG + + N + R+E EE LM C + E RP
Sbjct: 251 ---NPYPGIPPERLFN----LLKTGHRMERPDNCSEEMYRLMLQ------CWKQEPDKRP 297
Query: 769 SMGEVVKMLE 778
++ K LE
Sbjct: 298 VFADISKDLE 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 74/321 (23%), Positives = 127/321 (39%), Gaps = 63/321 (19%)
Query: 507 FAQLLGTGGFGSVYKGSL--------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM- 556
+ LG G FG V + VAVK L D + V+E+ + +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSL-----------DKWIFPSYHHRDRVLDWTT 605
H N++ L G C++ ++ E+ G+L ++ + + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+ A+G+ Y Q + IH D+ N+L+ EN K++DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID---- 211
Query: 666 TMVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFF 718
+ T G L APE + +R T ++DV+S+G+L+ EI GG
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG------------SP 259
Query: 719 YPGWAFKEMTNGTPLKVADRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVV 774
YPG +E+ L R++ E +MR C RP+ ++V
Sbjct: 260 YPGIPVEELFK---LLKEGHRMDKPANCTNELYMMMRD------CWHAVPSQRPTFKQLV 310
Query: 775 KMLEGSADINTPPMPQTVLEL 795
+ L+ I T + L+L
Sbjct: 311 EDLD---RILTLTTNEEYLDL 328
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 48/230 (20%), Positives = 95/230 (41%), Gaps = 28/230 (12%)
Query: 494 NFTYRDLQIRTSNFA--QLLGTGGFGSVYKGSLGDGTLVAVK--KLDRVLPHGEKEFVTE 549
N ++ + ++ ++ + +G+GG V++ + A+K L+ + E
Sbjct: 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 550 VNTIGSMHHMNL--VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF 607
+ + + + +RL Y +V E N L+ W+ + + +D R
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERK 130
Query: 608 NIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-GREHSQVVT 666
+ + + H+ + I+H D+KP N L+ + K+ DFG+A M S V
Sbjct: 131 SYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 186
Query: 667 MVRGTRGYLAPEWVSNRP-----------ITVKADVYSYGMLLLEIVGGR 705
GT Y+ PE + + I+ K+DV+S G +L + G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 73/303 (24%), Positives = 115/303 (37%), Gaps = 63/303 (20%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN 560
LG G FG V+ D LVAVK L ++F E + + H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLD----------KWIFPSYHHRDRVLDWTTRFNIA 610
+VR G C+EG L+V+E+M++G L+ K + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
A G+ Y +H D+ N L+ + K+ DFG+++ + +S G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYY-RVG 217
Query: 671 TRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFFYPGWA 723
R L PE + R T ++DV+S+G++L EI G + + +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP------------WYQLS 265
Query: 724 ----FKEMTNGTPLKVADRRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
+T G R LE E +MR C Q E R S+ +V
Sbjct: 266 NTEAIDCITQG-------RELERPRACPPEVYAIMRG------CWQREPQQRHSIKDVHA 312
Query: 776 MLE 778
L+
Sbjct: 313 RLQ 315
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM-HH 558
+ LG G FG V + VAVK L + + ++E+ + + HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 559 MNLVRLCGYCS-EGSNRLLVYEFMKNGSL-----------DKWIFPSYHHRDRVLDWTTR 606
+N+V L G C+ G +++ EF K G+L + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 607 FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
+ A+G+ + + + IH D+ NILL E K+ DFGLA+ + ++
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 203
Query: 667 MVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV 702
VR L APE + +R T+++DV+S+G+LL EI
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 24/261 (9%), Positives = 55/261 (21%), Gaps = 43/261 (16%)
Query: 480 RAVENSLIVCGAPVNF-TYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLD- 536
AV ++ A + R + L G V+ + A+K
Sbjct: 38 EAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM 97
Query: 537 --RVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC-------------------------- 568
+ + +
Sbjct: 98 GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157
Query: 569 SEGSNRLLVYEFMKNGSLDKWI--FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+N LL+ L+ + + + A
Sbjct: 158 YAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SK 213
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV--SNRP 684
++H P+N+ + + + D +G Y E++ S
Sbjct: 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----TRGPASSVPVTYAPREFLNASTAT 269
Query: 685 ITVKADVYSYGMLLLEIVGGR 705
T + + G+ + +
Sbjct: 270 FTHALNAWQLGLSIYRVWCLF 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 23/213 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRV-LPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+LG G +V++G G L A+K + + + E + ++H N+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 567 YCSEGSNRL--LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
E + R L+ EF GSL + L + + G+ + E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 625 RNRIIHCDIKPENILL----DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-- 678
N I+H +IKP NI+ D K++DFG A+ + + Q V++ GT YL P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMY 187
Query: 679 ------WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ D++S G+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 69/305 (22%), Positives = 122/305 (40%), Gaps = 62/305 (20%)
Query: 507 FAQLLGTGGFGSVYKGSL--------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSM- 556
+ LG G FG V + VAVK L D + V+E+ + +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSL-----------DKWIFPSYHHRDRVLDWTT 605
H N++ L G C++ ++ E+ G+L ++ + + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+ A+G+ Y Q + IH D+ N+L+ EN K++DFGLA+ +
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID---- 257
Query: 666 TMVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMSGDAEDFF 718
+ T G L APE + +R T ++DV+S+G+L+ EI GG
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG------------SP 305
Query: 719 YPGWAFKEMTNGTPLKVAD-RRLE---GAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEV 773
YPG +E+ + + R++ E +MR C RP+ ++
Sbjct: 306 YPGIPVEELFK----LLKEGHRMDKPANCTNELYMMMRD------CWHAVPSQRPTFKQL 355
Query: 774 VKMLE 778
V+ L+
Sbjct: 356 VEDLD 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 50/205 (24%), Positives = 77/205 (37%), Gaps = 18/205 (8%)
Query: 509 QLLGTGGFGSVYKGSLGDGTL---VAVKKLDRVLPHGEKEFVT----EVNTIGSMHHMNL 561
+L+G GG G VY+ D VA+K + L + F T E T G + ++
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHV 96
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
V + + + + L + R L I + H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML-----RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
H D+KPENIL+ + + DFG+A E + GT Y+APE S
Sbjct: 152 ---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 682 NRPITVKADVYSYGMLLLEIVGGRR 706
T +AD+Y+ +L E + G
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSP 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 23/213 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCG 566
+LG G +V++G G L A+K + + + E + ++H N+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 567 YCSEGSNRL--LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
E + R L+ EF GSL + L + + G+ + E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 625 RNRIIHCDIKPENILL----DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-- 678
N I+H +IKP NI+ D K++DFG A+ + + Q V++ GT YL P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMY 187
Query: 679 ------WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ D++S G+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 34/224 (15%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCG 566
++L GGF VY+ +G G A+K+L + + EV + + H N+V+ C
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 567 YCSEGSNR--------LLVYEFMKNGSLDKWIFPSYHHR---DRVLDWTTRFNIAIATAQ 615
S G LL+ E K ++ D VL I T +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL------KIFYQTCR 147
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT--------- 666
+ + H Q + IIH D+K EN+LL K+ DFG A + +
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 667 --MVRGTRGYLAPE---WVSNRPITVKADVYSYGMLLLEIVGGR 705
T Y PE SN PI K D+++ G +L + +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 72/316 (22%), Positives = 117/316 (37%), Gaps = 78/316 (24%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVN---TIGSM 556
F ++LG+G FG V + G VAVK L ++ + ++E+ +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-- 106
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSL------------------DKWIFPSYHHRD 598
H N+V L G C+ L++E+ G L +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 599 RVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658
VL + A A+G+ + + +H D+ N+L+ K+ DFGLA+ +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 659 REHSQVVTMVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV--GGRRNLDMS 711
+ V L APE + T+K+DV+SYG+LL EI G
Sbjct: 224 SDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV------- 272
Query: 712 GDAEDFFYPGWA-----FKEMTNGTPLKVADRRLE---GAVEE-EELMRAMKVAFWCIQD 762
YPG +K + NG +++ A EE +M++ C
Sbjct: 273 -----NPYPGIPVDANFYKLIQNG-------FKMDQPFYATEEIYIIMQS------CWAF 314
Query: 763 EVFMRPSMGEVVKMLE 778
+ RPS + L
Sbjct: 315 DSRKRPSFPNLTSFLG 330
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNL--VRL 564
+ +G+GG V++ + A+K L+ + E+ + + + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
Y +V E N L+ W+ + + +D R + + + H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQ-- 173
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLM-GREHSQVVTMVRGTRGYLAPEWVSNR 683
+ I+H D+KP N L+ + K+ DFG+A M S V G Y+ PE + +
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 684 P-----------ITVKADVYSYGMLLLEIVGGR 705
I+ K+DV+S G +L + G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 38/222 (17%)
Query: 511 LGTGGFGSVYKGSLG--DGTLVAVKKLDRVLPHGEKEFVT-----------------EVN 551
L G F + L D A+KK ++ L +++F E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 552 TIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
I + + + G + ++YE+M+N S+ K+ + ++T I +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD---EYFFVLDKNYTCFIPIQV 152
Query: 612 AT------AQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+Y H + I H D+KP NIL+D+N K+SDFG ++ M ++
Sbjct: 153 IKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIK 208
Query: 666 TMVRGTRGYLAPEWVSNRPITV--KADVYSYGMLLLEIVGGR 705
GT ++ PE+ SN K D++S G+ L +
Sbjct: 209 GSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-27
Identities = 50/242 (20%), Positives = 88/242 (36%), Gaps = 53/242 (21%)
Query: 489 CGAPVNFT------------YRDLQIRTSNFAQLLGTGGFGSVYKG---SLGDGTLVAVK 533
CG+P +F Y + GG G +Y ++ +G V +K
Sbjct: 62 CGSPYSFLPQLNPGDIVAGQYE--------VKGCIAHGGLGWIYLALDRNV-NGRPVVLK 112
Query: 534 KLDRVLPHGEKEFVT----EVNTIGSMHHMNLVRLCGYCSEGSNRL-----LVYEFMKNG 584
L + G+ E E + + H ++V++ + +V E++
Sbjct: 113 GL---VHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169
Query: 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644
SL + + + L + ++Y H +++ D+KPENI+L E
Sbjct: 170 SLKR-------SKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQ 219
Query: 645 CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
K+ D G + + GT G+ APE V P TV D+Y+ G L +
Sbjct: 220 -LKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLD 272
Query: 705 RR 706
Sbjct: 273 LP 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-27
Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 33/219 (15%)
Query: 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNT-IGSMHHMNLVRL 564
++LG G G+V G VAVK R+L + E+ S H N++R
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVK---RMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA--TAQGIAYFHE 622
+ + E N +L + + + I++ A G+A+ H
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 623 QCRNRIIHCDIKPENILLD-------------ENFCPKVSDFGLAKLMGREHSQVVTMVR 669
+IIH D+KP+NIL+ EN +SDFGL K + S T +
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 670 ---GTRGYLAPE-------WVSNRPITVKADVYSYGMLL 698
GT G+ APE + R +T D++S G +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 33/265 (12%), Positives = 73/265 (27%), Gaps = 43/265 (16%)
Query: 480 RAVENSLIVCGAPVNF-TYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR 537
V SL G P + + RT +LG + + G V
Sbjct: 54 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 113
Query: 538 VLPHGEKE----------------------------FVTEVNTIGSMHHMNLVRLCGYCS 569
F+ + + ++R+
Sbjct: 114 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 173
Query: 570 EGS--NRLLVYEFMK--NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
+ +R +Y M+ + + + S+ + L R + + + +A H
Sbjct: 174 DMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLH---H 229
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP- 684
++H ++P +I+LD+ ++ F G + A +
Sbjct: 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQH 289
Query: 685 ----ITVKADVYSYGMLLLEIVGGR 705
+T D ++ G+ + I
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 495 FTYRDLQIRTSNFAQL------LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV 547
+ + ++++ + LG+G FG V++ G + K ++ P +
Sbjct: 37 YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 96
Query: 548 TEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF 607
E++ + +HH L+ L + +L+ EF+ G L F DR+ +
Sbjct: 97 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----F------DRIAAEDYKM 146
Query: 608 NIAIATA------QGIAYFHEQCRNRIIHCDIKPENILL--DENFCPKVSDFGLAKLMGR 659
+ A +G+ + HE + I+H DIKPENI+ + K+ DFGLA +
Sbjct: 147 SEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-- 201
Query: 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYG----MLL 698
++V + T + APE V P+ D+++ G +LL
Sbjct: 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKL-DRVLPHGEKEFVTEVNTIGSMHHM 559
+ + +G G FG V++ T+VAVK L + + +F E + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSL-------------------DKWIFPSYHHRDRV 600
N+V+L G C+ G L++E+M G L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
L + IA A G+AY E+ + +H D+ N L+ EN K++DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 661 HSQVVTMVRGTRGYL-----APEWVSNRPITVKADVYSYGMLLLEIV 702
+ PE + T ++DV++YG++L EI
Sbjct: 228 D----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 492 PVNFTYRDLQIRTSNFAQL--------LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHG 542
P F +R + + LG G FG V+K G +A K +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 543 EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD 602
++E E++ + + H NL++L ++ +LV E++ G L F DR++D
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----F------DRIID 179
Query: 603 WTTRFNIAIATA------QGIAYFHEQCRNRIIHCDIKPENILL--DENFCPKVSDFGLA 654
+ +GI + H+ I+H D+KPENIL + K+ DFGLA
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYG----MLL 698
+ + + + + GT +LAPE V+ ++ D++S G MLL
Sbjct: 237 RRY--KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 507 FAQLLGTGGFGSVYKG-SLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVR 563
+ LG+G +G V A+K + V + + EV + + H N+++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------IAIATAQGI 617
L + + N LV E K G L F D ++ +FN I G+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGEL----F------DEIIH-RMKFNEVDAAVIIKQVLSGV 149
Query: 618 AYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
Y H+ I+H D+KPEN+LL +++ K+ DFGL+ + E+ + + GT Y
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYY 204
Query: 675 LAPEWVSNRPITVKADVYSYGMLL 698
+APE V + K DV+S G++L
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G G V G VAVK +D + EV + H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAI---ATAQGIAYFH 621
G ++ EF++ G+L D V R N IA A Q +AY H
Sbjct: 111 YLVGEELWVLMEFLQGGALT----------DIVS--QVRLNEEQIATVCEAVLQALAYLH 158
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
+IH DIK ++ILL + K+SDFG + ++ + ++V GT ++APE +S
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVIS 214
Query: 682 NRPITVKADVYSYGMLLLEIVGG 704
+ D++S G++++E+V G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR---VLPHGEKEFVTEVNTIGSMHHMNL 561
++LG G FG V G AVK + + ++ + EV + + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------IAIATAQ 615
++L + + LV E G L F D ++ RF+ I
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL----F------DEIIS-RKRFSEVDAARIIRQVLS 137
Query: 616 GIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
GI Y H+ +I+H D+KPEN+LL ++ ++ DFGL+ E S+ + GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTA 192
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLL 698
Y+APE V + K DV+S G++L
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 25/266 (9%)
Query: 511 LGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
LG G G V+K S G ++A K + + P + + E+ + + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------IAIATAQGIAYFHE 622
+ E M GSLD+ VL R ++IA +G+ Y E
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-----------VLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
+ ++I+H D+KP NIL++ K+ DFG++ + S + V GTR Y++PE +
Sbjct: 150 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQG 204
Query: 683 RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742
+V++D++S G+ L+E+ GR + E G + TP +
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 743 AVEEEELMRAMKVAFWCIQDEVFMRP 768
+ R F + V P
Sbjct: 265 NKFGMD-SRPPMAIFELLDYIVNEPP 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE--FVTEVNTIGSMHHMNLVRLC 565
+ +G G G+VY + G VA+++++ L K+ + E+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAI---ATAQGIAY 619
G +V E++ GSL D V T + IA Q + +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSL----------TDVVT--ETCMDEGQIAAVCRECLQALEF 131
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H N++IH DIK +NILL + K++DFG + E S+ TMV GT ++APE
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 187
Query: 680 VSNRPITVKADVYSYGMLLLEIVGG 704
V+ + K D++S G++ +E++ G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 49/206 (23%), Positives = 80/206 (38%), Gaps = 32/206 (15%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVK-----KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G G F V + G AVK K ++ E + + H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD---WTTRFNIAIATA------Q 615
S +V+EFM L ++ ++ A+A+ +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADL----C------FEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 616 GIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
+ Y H+ N IIH D+KP +LL + + K+ FG+A +G V GT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLL 698
++APE V P DV+ G++L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 69/328 (21%), Positives = 121/328 (36%), Gaps = 51/328 (15%)
Query: 380 SNCQCVASVYGLDDEKPYCWVLRSLDFGGFEDPSSTLFVKIMSNRSLTPGSNRGSGDSSE 439
+ ++ GL K Y + + + + G P + L PG R +
Sbjct: 61 KSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEP------TAPVLIPGDERKRRRGYD 114
Query: 440 DSETRRTKVVVIPIVLSMTLLIGLLCLLLYYNVHRKRFLKRAVENSLIVCGAPVNFTYRD 499
E + + + Y+ + K+ + + V Y
Sbjct: 115 VDEQGKIVRGKGTVSSN-------------YDNYVFDIWKQYYPQPVEIKHDHVLDHY-- 159
Query: 500 LQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH 558
+ + LGTG FG V++ G A K + ++ E+ T+ + H
Sbjct: 160 ------DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA---- 614
LV L + + +++YEFM G L F ++V D + + A
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGEL----F------EKVADEHNKMSEDEAVEYMRQ 263
Query: 615 --QGIAYFHEQCRNRIIHCDIKPENILLDENFCP--KVSDFGLAKLMGREHSQVVTMVRG 670
+G+ + HE N +H D+KPENI+ K+ DFGL + + Q V + G
Sbjct: 264 VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTG 318
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLL 698
T + APE +P+ D++S G+L
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLV 562
N +LG G FG V K AVK ++ + EV + + H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------IAIATAQG 616
+L + S+ +V E G L F D ++ RF+ I G
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL----F------DEIIK-RKRFSEHDAARIIKQVFSG 133
Query: 617 IAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
I Y H+ I+H D+KPENILL +++ K+ DFGL+ + + + GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAY 188
Query: 674 YLAPEWVSNRPITVKADVYSYGMLL 698
Y+APE V K DV+S G++L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 59/249 (23%), Positives = 95/249 (38%), Gaps = 40/249 (16%)
Query: 468 LYYNVHRKRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGD 526
++++ H + EN N Y L + LG G F V + S
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFY-ILTSKE------LGRGKFAVVRQCISKST 53
Query: 527 GTLVAVK--KLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583
G A K K R E + E+ + ++ L S +L+ E+
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113
Query: 584 GSLDKWIFPSYHHRDRVLD-WTTRFNIAIATA------QGIAYFHEQCRNRIIHCDIKPE 636
G + F L + +G+ Y H+ N I+H D+KP+
Sbjct: 114 GEI----F------SLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQ 160
Query: 637 NILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYS 693
NILL K+ DFG+++ + H+ + + GT YLAPE ++ PIT D+++
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 694 YG----MLL 698
G MLL
Sbjct: 219 IGIIAYMLL 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ LG G +GSVYK G +VA+K++ + +E + E++ + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAI---ATAQGIAYFH 621
+ ++ +V E+ GS+ D + IA +T +G+ Y H
Sbjct: 93 YFKNTDLWIVMEYCGAGSVS----------DIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
R IH DIK NILL+ K++DFG+A + ++ T++ GT ++APE +
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 682 NRPITVKADVYSYGMLLLEIVGG 704
AD++S G+ +E+ G
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEG 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 27/203 (13%)
Query: 506 NFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+G G +G V G A KK+ + F E+ + S+ H N++RL
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------QGIA 618
+ ++ LV E G L F +RV+ F + A +A
Sbjct: 72 YETFEDNTDIYLVMELCTGGEL----F------ERVVH-KRVFRESDAARIMKDVLSAVA 120
Query: 619 YFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
Y H+ + H D+KPEN L + K+ DFGLA + +++ GT Y+
Sbjct: 121 YCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYV 175
Query: 676 APEWVSNRPITVKADVYSYGMLL 698
+P+ V + D +S G+++
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV-TEVNTIGSMHHMNLVR 563
F + LG+G FG V+ G +K +++ E + E+ + S+ H N+++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTT---RFNIAIATA------ 614
+ + N +V E + G L +R++ +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGEL----L------ERIVSAQARGKALSEGYVAELMKQMM 134
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGT 671
+AYFH ++H D+KPENIL + K+ DFGLA+L + + T GT
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGT 189
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLL 698
Y+APE V R +T K D++S G+++
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 506 NFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
F ++LG+G F V+ G L A+K + + + E+ + + H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF------NIAIATAQGIA 618
++ LV + + G L F DR+L+ + + +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGEL----F------DRILE-RGVYTEKDASLVIQQVLSAVK 120
Query: 619 YFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
Y HE N I+H D+KPEN+L +EN ++DFGL+K+ E + +++ GT GY+
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYV 174
Query: 676 APEWVSNRPITVKADVYSYGMLL 698
APE ++ +P + D +S G++
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 40/215 (18%)
Query: 507 FAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR-------------VLPHGEKEFVTEVNT 552
+ LG+G +G V + A+K + + + +E E++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---- 608
+ S+ H N+++L + LV EF + G L F +++++ +F+
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----F------EQIIN-RHKFDECDA 148
Query: 609 --IAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQ 663
I GI Y H+ I+H DIKPENILL + K+ DFGL+
Sbjct: 149 ANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDY 203
Query: 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698
+ GT Y+APE V + K DV+S G+++
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 502 IRTSNFAQL------LGTGGFGSVYKG-SLGDGTLVAVK-----KLDRVLPHGEKEFV-T 548
+ LG+G F V K G A K + +E +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD--WTTR 606
EV+ + + H N++ L ++ +L+ E + G L F D + +
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----F------DFLAQKESLSE 114
Query: 607 FNIAIATAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCP----KVSDFGLAKLMGR 659
Q G+ Y H +I H D+KPENI+L + P K+ DFGLA +
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYG----MLL 698
E + GT ++APE V+ P+ ++AD++S G +LL
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 498 RDLQIRTSNFAQL--LGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE-KEFVTEVNTI 553
+ + L +G G +GSV K G ++AVK++ + E K+ + +++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 554 -GSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
S +V+ G + + E M + S DK+ Y D V+ I +A
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
T + + + E +IIH DIKP NILLD + K+ DFG++ + S T G R
Sbjct: 134 TVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCR 189
Query: 673 GYLAPE----WVSNRPITVKADVYSYGMLLLEIVGGR 705
Y+APE S + V++DV+S G+ L E+ GR
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 31/207 (14%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV-TEVNTIGSMHHMNLVR 563
A+ LG G FG V++ K + ++ V E++ + H N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILH 65
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAIATAQ---GI 617
L ++++EF+ + F +R+ N I Q +
Sbjct: 66 LHESFESMEELVMIFEFISGLDI----F------ERINTSAFELNEREIVSYVHQVCEAL 115
Query: 618 AYFHEQCRNRIIHCDIKPENILL--DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ H + I H DI+PENI+ + K+ +FG A+ + + ++ Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYY 170
Query: 676 APEWVSNRPITVKADVYSYG----MLL 698
APE + ++ D++S G +LL
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLL 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 45/215 (20%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 500 LQIRTSNFAQL--LGTGGFGSVYKGS-LGDGTLVAVKKLDRVL-PHGEKEFVTEVNTI-G 554
++++ + + LG G +G V K + G ++AVK++ + +K + +++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
++ V G + + E M + SLDK + + + + IA++
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+ + + H + +IH D+KP N+L++ K+ DFG++ + + G + Y
Sbjct: 120 KALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPY 175
Query: 675 LAPE----WVSNRPITVKADVYSYGMLLLEIVGGR 705
+APE ++ + +VK+D++S G+ ++E+ R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 506 NFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLV 562
N +LG G FG V K AVK ++ + EV + + H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN------IAIATAQG 616
+L + S+ +V E G L F D ++ RF+ I G
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL----F------DEIIK-RKRFSEHDAARIIKQVFSG 133
Query: 617 IAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRG 673
I Y H+ + I+H D+KPENILL +++ K+ DFGL+ + + + GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAY 188
Query: 674 YLAPEWVSNRPITVKADVYSYGMLL 698
Y+APE V K DV+S G++L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 37/209 (17%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVK-----KLDRVLPHGEKEFV-TEVNTIGSMHHMNLVR 563
LG+G F V K G G A K +L +E + EVN + + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------QGI 617
L ++ +L+ E + G L F D + + AT G+
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL----F------DFLAE-KESLTEDEATQFLKQILDGV 121
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCP----KVSDFGLAKLMGREHSQVVTMVRGTRG 673
Y H RI H D+KPENI+L + P K+ DFG+A + E + GT
Sbjct: 122 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPE 176
Query: 674 YLAPEWVSNRPITVKADVYSYG----MLL 698
++APE V+ P+ ++AD++S G +LL
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 502 IRTSNFAQL------LGTGGFGSVYKG-SLGDGTLVAVK-----KLDRVLPHGEKEFV-T 548
+ LG+G F V K G A K + +E +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD--WTTR 606
EV+ + + H N++ L ++ +L+ E + G L F D + +
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----F------DFLAQKESLSE 114
Query: 607 FNIAIATAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCP----KVSDFGLAKLMGR 659
Q G+ Y H +I H D+KPENI+L + P K+ DFGLA +
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYG----MLL 698
E + GT ++APE V+ P+ ++AD++S G +LL
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEF---VTEVNTIGSMHHMNLVRL 564
+++G+G V VA+K+++ L + + E+ + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 565 CGYCS--EGSNRLLVYEFMKNGSLD---KWIFPSYHHRDRVLDWTTRFNIAI---ATAQG 616
Y S LV + + GS+ K I H+ VLD +T IA +G
Sbjct: 79 --YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST---IATILREVLEG 133
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR----GTR 672
+ Y H +N IH D+K NILL E+ +++DFG++ + VR GT
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 673 GYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGRR-NLDMSGDAEDFFYPGWA-FKEMTN 729
++APE + R KAD++S+G+ +E+ G P + N
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP--------PMKVLMLTLQN 242
Query: 730 GTPLKVADRRLEGAVEEEELMRAMKVAF-----WCIQDEVFMRPS 769
P LE V+++E+++ +F C+Q + RP+
Sbjct: 243 DPP------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 43/224 (19%)
Query: 502 IRTSNFAQL------LGTGGFGSVYKG-SLGDGTLVAVK-----KLDRVLPHGEKEFV-T 548
R N LG+G F V K G A K + +E +
Sbjct: 4 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN 608
EV+ + + H N++ L ++ +L+ E + G L F D + +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----F------DFLAE-KESLT 112
Query: 609 IAIATA------QGIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAKLMG 658
AT G+ Y H +I H D+KPENI+L K+ DFGLA +
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI- 168
Query: 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYG----MLL 698
+ + GT ++APE V+ P+ ++AD++S G +LL
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 45/214 (21%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLDR---------VLPHGEKEFVTEVNTIGSMHHM- 559
LG G V + AVK +D + + + EV+ I + +
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD-I--LRKVS 81
Query: 560 ---NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA-- 614
N+++L + LV++ MK G L F D + + +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGEL----F------DYLTE-KVTLSEKETRKIM 130
Query: 615 ----QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
+ I H+ I+H D+KPENILLD++ K++DFG + + ++ + G
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVC-G 185
Query: 671 TRGYLAPE------WVSNRPITVKADVYSYGMLL 698
T YLAPE ++ + D++S G+++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 32/230 (13%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIGSMHH 558
++LG GGFG V+ K + G L A KKL R+ + E + +H
Sbjct: 188 LDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA---TA 614
+V L Y E L LV M G + +H V + F A TA
Sbjct: 245 RFIVSL-AYAFETKTDLCLVMTIMNGGDI-------RYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 615 Q---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGT 671
Q G+ + H+ II+ D+KPEN+LLD++ ++SD GLA + ++ GT
Sbjct: 297 QIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
Query: 672 RGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR---RNLDMSGDAEDFF 718
G++APE + D ++ G+ L E++ R R + ++
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 504 TSNFAQ------LLGTGGFGSVYKGS-LGDGTLVAVKKLD-RVLPHGEKEFV-TEVNTIG 554
++ F+ LG G F V + G A K ++ + L + + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
+ H N+VRL E S LV++ + G L F + ++ ++ A A+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----F------EDIVA-REFYSEADASH 109
Query: 615 ------QGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVV 665
+ IAY H N I+H ++KPEN+LL + K++DFGLA + S+
Sbjct: 110 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAW 164
Query: 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698
GT GYL+PE + P + D+++ G++L
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 24/225 (10%)
Query: 491 APVNFTYRDLQIRTSNFAQL------LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE 543
+PV +Q ++ +L +G G FG V+KG +VA+K +D E
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 544 KE-FVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD 602
E E+ + + + G + + ++ E++ GS + LD
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLD 117
Query: 603 WTTRFNIAI---ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659
T IA +G+ Y H + IH DIK N+LL E+ K++DFG+A +
Sbjct: 118 ETQ---IATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
+ T V GT ++APE + KAD++S G+ +E+ G
Sbjct: 172 TQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-23
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 507 FAQLLGTGGFGSVYKGS-LGDGTLVAVKKLD-RVLPHGEKEFV-TEVNTIGSMHHMNLVR 563
+ LG G F V + + G A ++ + L + + + E + H N+VR
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------QGI 617
L SE + L+++ + G L F + ++ ++ A A+ + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGEL----F------EDIVA-REYYSEADASHCIQQILEAV 123
Query: 618 AYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+ H+ ++H ++KPEN+LL + K++DFGLA + E GT GY
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGY 179
Query: 675 LAPEWVSNRPITVKADVYSYGMLL 698
L+PE + P D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 49/257 (19%), Positives = 84/257 (32%), Gaps = 65/257 (25%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEFVTEVNTIGSMHHMNLVRL-- 564
Q +G GGFG V++ + D A+K++ ++ + EV + + H +VR
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 565 -------CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD----WTTRFNIAIAT 613
+ E L E + + R +D T + ++
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 614 AQGIAYFH-EQCRNR--------------------------------------IIHCDIK 634
+ Y + CR ++H D+K
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK 191
Query: 635 PENILLDENFCPKVSDFGLAKLM-----------GREHSQVVTMVRGTRGYLAPEWVSNR 683
P NI + KV DFGL M T GT+ Y++PE +
Sbjct: 192 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN 251
Query: 684 PITVKADVYSYGMLLLE 700
+ K D++S G++L E
Sbjct: 252 NYSHKVDIFSLGLILFE 268
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 55/238 (23%), Positives = 84/238 (35%), Gaps = 51/238 (21%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVK-----KLDRVLPHGEKEFVTEVNTIGSMHHMNLV 562
+G G +G V + A+K K+ ++ P + TEV + +HH N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTRFNIAIATA------- 614
RL + LV E G L DK + + I
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 615 ---------------------------QGIAYFHEQCRNRIIHCDIKPENILL--DENFC 645
+ Y H Q I H DIKPEN L +++F
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208
Query: 646 PKVSDFGLAKLMGREHSQVVTMVR---GTRGYLAPE--WVSNRPITVKADVYSYGMLL 698
K+ DFGL+K + ++ + GT ++APE +N K D +S G+LL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 61/253 (24%), Positives = 103/253 (40%), Gaps = 42/253 (16%)
Query: 474 RKRFLKRAVENSLIVCGAPVN--FTYRDL-----QIRTSNFAQ------LLGTGGFGSVY 520
++R L NS I N F + DL + LG+G G V
Sbjct: 96 KRRPLN---NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVK 152
Query: 521 KG-SLGDGTLVAVKKLDR--------VLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG 571
VA++ + + TE+ + ++H ++++ + +
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DA 211
Query: 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHC 631
+ +V E M+ G L + + ++ T + + Y HE N IIH
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEA----TCK-LYFYQMLLAVQYLHE---NGIIHR 263
Query: 632 DIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE---WVSNRPI 685
D+KPEN+LL +E+ K++DFG +K++G E S + T+ GT YLAPE V
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPEVLVSVGTAGY 321
Query: 686 TVKADVYSYGMLL 698
D +S G++L
Sbjct: 322 NRAVDCWSLGVIL 334
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLD--RVLPHGEKEFV-TEVNTIGSMHHMNL 561
F ++LG G F +V L A+K L+ ++ + +V E + + + H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLD-WTTRFNIA-IATAQGIAY 619
V+L + + KNG L Y + D TRF A I +A + Y
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL----L-KYIRKIGSFDETCTRFYTAEIVSA--LEY 145
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV--TMVRGTRGYLAP 677
H IIH D+KPENILL+E+ +++DFG AK++ E Q + V GT Y++P
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSP 201
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGR 705
E ++ + +D+++ G ++ ++V G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEK--EFVTEVNTIGSMHHMNLVRLC 565
LG G FG VYK + G L A K ++ E+ +++ E+ + + H +V+L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN---IAI---ATAQGIAY 619
G ++ EF G++D +L+ I + + + +
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVD----------AIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H RIIH D+K N+L+ +++DFG++ + + + + GT ++APE
Sbjct: 133 LHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 680 VSNRPIT-----VKADVYSYGMLLLEIVGG 704
V + KAD++S G+ L+E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 507 FAQLLGTGGFGSVYKGS-LGDGTLVAVKKLD-RVLPHGEKEFV-TEVNTIGSMHHMNLVR 563
+ LG G F V + G A K ++ + L + + + E + H N+VR
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA------QGI 617
L E S LV++ + G L F + ++ ++ A A+ + I
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGEL----F------EDIVA-REFYSEADASHCIQQILESI 141
Query: 618 AYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
AY H N I+H ++KPEN+LL + K++DFGLA + S+ GT GY
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGY 196
Query: 675 LAPEWVSNRPITVKADVYSYGMLL 698
L+PE + P + D+++ G++L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIGSMHHMNL 561
++LG GGFG V + G + A KKL R+ + E + ++ +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 562 VRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLD-WTTRFNIA-IATAQGIA 618
V L Y E + L LV M G L I YH F A I +
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCG--LE 300
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
H RI++ D+KPENILLD++ ++SD GLA + E + V GT GY+APE
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV-GTVGYMAPE 355
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGR 705
V N T D ++ G LL E++ G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNT-----IGSMHHM--- 559
++G G V + G AVK ++ E + EV + +
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 560 -NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF------NIAIA 612
+++ L S LV++ M+ G L F D + + +I +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGEL----F------DYLTE-KVALSEKETRSIMRS 208
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
+ +++ H N I+H D+KPENILLD+N ++SDFG + + ++ + GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELC-GTP 263
Query: 673 GYLAPE------WVSNRPITVKADVYSYGMLL 698
GYLAPE ++ + D+++ G++L
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 507 FAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG G VY+ G A+K L + + +K TE+ + + H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT------AQGIAY 619
+ LV E + G L F DR+++ ++ A + +AY
Sbjct: 115 EIFETPTEISLVLELVTGGEL----F------DRIVE-KGYYSERDAADAVKQILEAVAY 163
Query: 620 FHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
HE N I+H D+KPEN+L + K++DFGL+K++ EH ++ V GT GY A
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCA 218
Query: 677 PEWVSNRPITVKADVYSYG 695
PE + + D++S G
Sbjct: 219 PEILRGCAYGPEVDMWSVG 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 506 NFAQLLGTGGFGSVYKGS-LGDGTLVAVKKLD-RVLPHGEKE-------FVTEVNTIGSM 556
++ LG+G G V VA+K + R G TE+ + +
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA-- 614
+H ++++ + + + +V E M+ G L F D+V+ R A
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGEL----F------DKVVG-NKRLKEATCKLYF 120
Query: 615 ----QGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTM 667
+ Y HE N IIH D+KPEN+LL +E+ K++DFG +K++G E S + T+
Sbjct: 121 YQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL 176
Query: 668 VRGTRGYLAPE---WVSNRPITVKADVYSYGMLL 698
GT YLAPE V D +S G++L
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSMH-HMNLVRLCGY 567
+G+G G V+K G ++AVK++ R K + +++ + H +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
++ + E M +K + + +A + + Y E+ +
Sbjct: 93 FITNTDVFIAMELM-GTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-----WVSN 682
+IH D+KP NILLDE K+ DFG++ + + G Y+APE +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 683 RPITVKADVYSYGMLLLEIVGGR 705
++ADV+S G+ L+E+ G+
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 38/217 (17%)
Query: 502 IRTSNFAQL---------LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVN 551
++ S F Q LG G F K AVK + + E E+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEIT 57
Query: 552 TIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN-- 608
+ H N+V+L + + LV E + G L F +R+ F+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----F------ERIKK-KKHFSET 106
Query: 609 ----IAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREH 661
I +++ H+ ++H D+KPEN+L ++N K+ DFG A+L ++
Sbjct: 107 EASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698
+ T T Y APE ++ D++S G++L
Sbjct: 164 QPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCG 566
Q LG G +G V + VAVK +D E + E+ ++H N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 567 YCSEGSNRLLVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTR--FNIAIATAQGIAYFHEQ 623
+ EG+ + L E+ G L D+ + + + F+ +A G+ Y H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMA---GVVYLH-- 122
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAPEWVS 681
I H DIKPEN+LLDE K+SDFGLA + + M GT Y+APE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 682 NRPIT-VKADVYSYGMLLLEIVGGR 705
R DV+S G++L ++ G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRL 564
+ +G G FG+VY + + +VA+KK+ ++ + EV + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI---ATAQGIAYFH 621
G LV E+ + D + L IA QG+AY H
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQ---EVEIAAVTHGALQGLAYLH 171
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
+IH D+K NILL E K+ DFG A +M + + V GT ++APE +
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFV-GTPYWMAPEVIL 223
Query: 682 NR---PITVKADVYSYGMLLLEIVGG 704
K DV+S G+ +E+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVR--- 563
+L+G G +G VYKG + G L A+K +D V E+E E+N + HH N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 564 --LCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL--DWTTRFNIAI---ATAQ 615
+ ++L LV EF GS+ I + L +W IA +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEW-----IAYICREILR 140
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
G+++ H+ +++IH DIK +N+LL EN K+ DFG++ + R + T + GT ++
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 196
Query: 676 APEWVSNRPIT-----VKADVYSYGMLLLEIVGG 704
APE ++ K+D++S G+ +E+ G
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 77/273 (28%), Positives = 113/273 (41%), Gaps = 72/273 (26%)
Query: 499 DLQIRTSNFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEF---VT---E 549
D++ R + +L LG G F +VYK +VA+KK+ ++ E + T E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALRE 62
Query: 550 VNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNI 609
+ + + H N++ L SN LV++FM+ L+ I VL +
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII----KDNSLVLTPSHIKAY 117
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVV 665
+ T QG+ Y H ++ I+H D+KP N+LLDEN K++DFGLAK G + QVV
Sbjct: 118 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 666 TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGW 722
TR Y APE LL G R +DM W
Sbjct: 175 -----TRWYRAPE------------------LLF---GARMYGVGVDM-----------W 197
Query: 723 A----FKEMTNGTPLKVADRRLEGAVEEEELMR 751
A E+ P L G + ++L R
Sbjct: 198 AVGCILAELLLRVPF------LPGDSDLDQLTR 224
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 43/228 (18%)
Query: 492 PVNFTYRDLQIRTSNFAQ------LLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEK 544
V+ + L + F +G G + + AVK +D+ +
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64
Query: 545 EFVTEVNTIGSMHHM----NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV 600
E I + N++ L +G +V E MK G L D++
Sbjct: 65 E-------IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----L------DKI 107
Query: 601 LDWTTRFN------IAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCP-KVSD 650
L F+ + + + Y H Q ++H D+KP NIL N ++ D
Sbjct: 108 LR-QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICD 163
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698
FG AK + E+ ++T T ++APE + + D++S G+LL
Sbjct: 164 FGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCG 566
Q LG G +G V + VAVK +D E + E+ ++H N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 567 YCSEGSNRLLVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTR--FNIAIATAQGIAYFHEQ 623
+ EG+ + L E+ G L D+ + + + F+ +A G+ Y H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMA---GVVYLH-- 122
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAPEWVS 681
I H DIKPEN+LLDE K+SDFGLA + + M GT Y+APE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 682 NRPIT-VKADVYSYGMLLLEIVGGR 705
R DV+S G++L ++ G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 44/234 (18%)
Query: 488 VCGAPVNFTYRDLQIRTSNFA-------QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL 539
+ + ++ + + Q+LG G G V + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS- 65
Query: 540 PHGEKEFVTEVNTIG-SMHHMNLVRLCGYCSEGSNR----LLVYEFMKNGSLDKWIFPSY 594
+ EV+ + ++V + + L++ E M+ G L F
Sbjct: 66 ----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----F--- 114
Query: 595 HHRDRVLD-WTTRFNIAIAT------AQGIAYFHEQCRNRIIHCDIKPENILL---DENF 644
R+ + F A I + H I H D+KPEN+L +++
Sbjct: 115 ---SRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168
Query: 645 CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698
K++DFG AK + + T T Y+APE + D++S G+++
Sbjct: 169 VLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 1e-20
Identities = 40/212 (18%), Positives = 71/212 (33%), Gaps = 31/212 (14%)
Query: 512 GTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT----EVNTIGSMHHMNLVRLCG 566
G +V G V V++++ L E VT E++ +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSKLFNHPNIVPY-- 91
Query: 567 YCS--EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI---ATAQGIAYFH 621
+ + +V FM GS I H ++ IA + + Y H
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELA---IAYILQGVLKALDYIH 145
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR------GTRGYL 675
+H +K +IL+ + +S M + + +L
Sbjct: 146 ---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 676 APEWVSNRPI--TVKADVYSYGMLLLEIVGGR 705
+PE + K+D+YS G+ E+ G
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 498 RDLQIRTSNFAQL--LGTGGFGSVY----KGSLGDGTLVAVKKLDR---VLPHGEKEFVT 548
++ + ++F+ +G GGFG VY + G + A+K LD+ + GE +
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALN 238
Query: 549 EVN---TIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD- 602
E + + +V + Y ++L + + M G L YH + V
Sbjct: 239 ERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL------HYHLSQHGVFSE 291
Query: 603 WTTRFNIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661
RF A I + + H +++ D+KP NILLDE+ ++SD GLA ++
Sbjct: 292 ADMRFYAAEIILG--LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
Query: 662 SQVVTMVRGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGR 705
V GT GY+APE + AD +S G +L +++ G
Sbjct: 347 PH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 65/259 (25%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGSMHHMNLVRL 564
+G G +G V+K + G +VA+KK L + + E+ + + H NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
LV+E+ + ++ + R + +I T Q + + H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITWQTLQAVNFCH--- 119
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRGYLAPEWV 680
++ IH D+KPENIL+ ++ K+ DFG A+L+ +V TR Y +PE
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-----TRWYRSPE-- 172
Query: 681 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA----FKEMTNGTPLKVA 736
+ V Y +D+ WA F E+ +G PL
Sbjct: 173 ----LLVGDTQYGPP------------VDV-----------WAIGCVFAELLSGVPL--- 202
Query: 737 DRRLEGAVEEEELMRAMKV 755
G + ++L K
Sbjct: 203 ---WPGKSDVDQLYLIRKT 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHM 559
++LG G FG V+ L A+K L + E + + ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 560 NLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRFNIA-IATAQ 615
+V+L Y + +L L+ +F++ G L F ++ + +F +A +A A
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL----F--TRLSKEVMFTEEDVKFYLAELALA- 138
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ + H II+ D+KPENILLDE K++DFGL+K + + GT Y+
Sbjct: 139 -LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYM 193
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGR 705
APE V+ R T AD +S+G+L+ E++ G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 72/265 (27%)
Query: 505 SNFAQL--LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGSMH 557
+ +L +G G +G VYK G +VA+K+ + E E + T E++ + +H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKR---IRLDAEDEGIPSTAIREISLLKELH 77
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
H N+V L LV+EFM+ L K + L + +G+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL----DENKTGLQDSQIKIYLYQLLRGV 132
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRG 673
A+ H ++RI+H D+KP+N+L++ + K++DFGLA+ G +VV T
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLW 184
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGWA----FKE 726
Y AP+ +L+ G ++ ++D+ W+ F E
Sbjct: 185 YRAPD------------------VLM---GSKKYSTSVDI-----------WSIGCIFAE 212
Query: 727 MTNGTPLKVADRRLEGAVEEEELMR 751
M G PL G ++++L +
Sbjct: 213 MITGKPL------FPGVTDDDQLPK 231
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 53/233 (22%), Positives = 85/233 (36%), Gaps = 50/233 (21%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDR------------VLPHGEKEFVTEVNTIGS 555
+G G +G V + D T A+K L + P G +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 556 M--------------HHMNLVRLCGYC---SEGSNRL-LVYEFMKNGSLDKWIFPSYHHR 597
H N+V+L + L +V+E + G +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----M-EVPTL 131
Query: 598 DRVLDWTTR--FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655
+ + R F I GI Y H +IIH DIKP N+L+ E+ K++DFG++
Sbjct: 132 KPLSEDQARFYFQDLIK---GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITV---KADVYSYGMLLLEIVGGR 705
+ + V GT ++APE +S DV++ G+ L V G+
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT-EVNTIGSMHHMNLVRLCG 566
+ +G+G FG LVAVK ++R E V E+ S+ H N+VR
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF-- 81
Query: 567 Y-CSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA---Q---GIA 618
L ++ E+ G L + +R+ + RF+ A Q G++
Sbjct: 82 KEVILTPTHLAIIMEYASGGEL----Y------ERICN-AGRFSEDEARFFFQQLLSGVS 130
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCP--KVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
Y H +I H D+K EN LLD + P K+ DFG +K HSQ + V GT Y+A
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIA 185
Query: 677 PEWVSNRPIT-VKADVYSYGMLLLEIVGGR 705
PE + + ADV+S G+ L ++ G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIGSMHHMNL 561
+ +G G FG V + A+K + + + E V E+ + + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 562 VRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH--HRDRVLDWTTRFNIA-IATAQGI 617
V L Y + + +V + + G L YH + T + I + A +
Sbjct: 78 VNL-WYSFQDEEDMFMVVDLLLGGDL----R--YHLQQNVHFKEETVKLFICELVMA--L 128
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
Y Q RIIH D+KP+NILLDE+ ++DF +A ++ +Q+ TM GT+ Y+AP
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMA-GTKPYMAP 183
Query: 678 EWVSNRPI---TVKADVYSYGMLLLEIVGGRR 706
E S+R + D +S G+ E++ GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDR----VLPHGEKEFVTEVNTIGSMHHMNLVR 563
LLG G +G V + AVK L + +P+GE E+ + + H N+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 564 LCGY---CSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR--FNIAIATAQGI 617
L +E ++ +V E+ G + + R F I G+
Sbjct: 71 L--VDVLYNEEKQKMYMVMEYCVCGMQE--ML-DSVPEKRFPVCQAHGYFCQLID---GL 122
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLA 676
Y H I+H DIKP N+LL K+S G+A+ + + +G+ +
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 677 PEWVSNR-----PITVKADVYSYGMLLLEIVGGR 705
PE + K D++S G+ L I G
Sbjct: 180 PEIANGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 64/259 (24%), Positives = 97/259 (37%), Gaps = 65/259 (25%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGSMHHMNLVRL 564
+G G +G V K + G +VA+KK L + + V E+ + + H NLV L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKK---FLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
C + LV+EF+ + ++ + LD+ GI + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDL----ELFPNGLDYQVVQKYLFQIINGIGFCH--- 141
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRGYLAPEWV 680
+ IIH DIKPENIL+ ++ K+ DFG A+ + +V TR Y APE
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-----TRWYRAPE-- 194
Query: 681 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA----FKEMTNGTPLKVA 736
+ V Y +D+ WA EM G PL
Sbjct: 195 ----LLVGDVKYGKA------------VDV-----------WAIGCLVTEMFMGEPL--- 224
Query: 737 DRRLEGAVEEEELMRAMKV 755
G + ++L M
Sbjct: 225 ---FPGDSDIDQLYHIMMC 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 72/268 (26%)
Query: 506 NFAQL--LGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGSMHH 558
+ L +G G +G VYK G A+KK + E E + T E++ + + H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKK---IRLEKEDEGIPSTTIREISILKELKH 59
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
N+V+L +LV+E + L K + + L+ T + + GIA
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL----DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRGY 674
Y H R++H D+KP+N+L++ K++DFGLA+ G ++V T Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWY 166
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGWA----FKEM 727
AP+ +L+ G ++ +D+ W+ F EM
Sbjct: 167 RAPD------------------VLM---GSKKYSTTIDI-----------WSVGCIFAEM 194
Query: 728 TNGTPLKVADRRLEGAVEEEELMRAMKV 755
NGTPL G E ++LMR ++
Sbjct: 195 VNGTPL------FPGVSEADQLMRIFRI 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 48/216 (22%), Positives = 80/216 (37%), Gaps = 44/216 (20%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM----NLVR 563
+LG G V +L AVK +++ H EV ++ N++
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM---LYQCQGHRNVLE 75
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT------AQGI 617
L + E LV+E M+ GS+ + FN A+ A +
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSI----L------SHIHK-RRHFNELEASVVVQDVASAL 124
Query: 618 AYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLM-------GREHSQVVTM 667
+ H I H D+KPENIL ++ K+ DF L + +++T
Sbjct: 125 DFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 668 VRGTRGYLAPE-----WVSNRPITVKADVYSYGMLL 698
G+ Y+APE + D++S G++L
Sbjct: 182 C-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 60/283 (21%), Positives = 104/283 (36%), Gaps = 95/283 (33%)
Query: 505 SNFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGSM 556
+ ++ LG G +G VYK VA+K++ R+ E+E V T EV+ + +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RL--EHEEEGVPGTAIREVSLLKEL 90
Query: 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRFNIAIA-- 612
H N++ L L++E+ D + +D ++ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYA--------------ENDLKKYMDKNPDVSMRVIKS 136
Query: 613 ----TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP-----KVSDFGLAKLMGREH-- 661
G+ + H R +H D+KP+N+LL + K+ DFGLA+ G
Sbjct: 137 FLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 662 --SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAED 716
+++ T Y PE +LL G R ++D+
Sbjct: 194 FTHEII-----TLWYRPPE------------------ILL---GSRHYSTSVDI------ 221
Query: 717 FFYPGWA----FKEMTNGTPLKVADRRLEGAVEEEELMRAMKV 755
W+ + EM TPL G E ++L + +V
Sbjct: 222 -----WSIACIWAEMLMKTPL------FPGDSEIDQLFKIFEV 253
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIGSMHHMNL 561
+ + LGTG FG V G A+K L +V+ + E E + +++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRFNIA-IATAQGIA 618
V+L + SN +V E++ G + F H R R + RF A I
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM----F--SHLRRIGRFSEPHARFYAAQIVLT--FE 155
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
Y H +I+ D+KPEN+L+D+ +V+DFG AK R + T+ GT LAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLC-GTPEALAPE 208
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGR 705
+ ++ D ++ G+L+ E+ G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR-------VLPHGEKEFVTEVNTIGSMHHM- 559
LLG+GGFGSVY G + D VA+K +++ LP+G + EV + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP-MEVVLLKKVSSGF 107
Query: 560 -NLVRLCGYCSEGSNRLLVYEFMKN-GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
++RL + + +L+ E + L +I R + + R + + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELAR-SFFWQVLEAV 162
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ H ++H DIK ENIL+D N K+ DFG L+ GTR Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 216
Query: 677 PEWVSNRPIT-VKADVYSYGMLLLEIVGGR 705
PEW+ A V+S G+LL ++V G
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 50/211 (23%), Positives = 79/211 (37%), Gaps = 42/211 (19%)
Query: 507 FAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM----NL 561
+Q+LG G G V + + A+K L + EV ++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVEL---HWRASQCPHI 117
Query: 562 VRLCGYC----SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF-------NIA 610
VR+ + L+V E + G L F R+ D + I
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGEL----F------SRIQDRGDQAFTEREASEIM 167
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTM 667
+ + I Y H I H D+KPEN+L N K++DFG AK H+ + T
Sbjct: 168 KSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTP 223
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLL 698
T Y+APE + D++S G+++
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGEKEFVTEVNT-IGSM-------H 557
LLG GGFG+V+ G L D VA+K + R VL + +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGS--LDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
H ++RL + +LV E D + + + +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-----EKGPLGEGPSR-CFFGQVVA 150
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
I + H ++H DIK ENIL+D C K+ DFG L+ E GTR Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DFD-GTRVY 204
Query: 675 LAPEWVSNRPIT-VKADVYSYGMLLLEIVGGR 705
PEW+S + A V+S G+LL ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 28/185 (15%)
Query: 506 NFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGSMH 557
+ +L +G G +G+V+K + +VA+K+ V + E V + E+ + +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELK 59
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
H N+VRL LV+EF L K+ + LD + +G+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLLKGL 114
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRG 673
+ H ++H D+KP+N+L++ N K+++FGLA+ G ++VV T
Sbjct: 115 GFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLW 166
Query: 674 YLAPE 678
Y P+
Sbjct: 167 YRPPD 171
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G F V + G VA+K +D+ + P ++ EV + ++H N+V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 568 -CSEGSNRL-LVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
E L L+ E+ G + D + R+ + R + + Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLV-----AHGRMKEKEAR-SKFRQIVSAVQYCH--- 131
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
+ RI+H D+K EN+LLD + K++DFG + ++ G Y APE +
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPYAAPELFQGKK 189
Query: 685 IT-VKADVYSYGMLLLEIVGGR 705
+ DV+S G++L +V G
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGS 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 7e-19
Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 69/266 (25%)
Query: 505 SNFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEF-VT---EVNTIGSMH 557
S F QL LG G + +VYKG + G VA+K+ V E+ T E++ + +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE---VKLDSEEGTPSTAIREISLMKELK 61
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-FPSYHHRDRVLDWTTRFNIAIATAQG 616
H N+VRL + LV+EFM + L K++ + + R L+ QG
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTR 672
+A+ H N+I+H D+KP+N+L+++ K+ DFGLA+ G S+VV T
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-----TL 172
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGWA----FK 725
Y AP+ +L+ G R ++D+ W+
Sbjct: 173 WYRAPD------------------VLM---GSRTYSTSIDI-----------WSCGCILA 200
Query: 726 EMTNGTPLKVADRRLEGAVEEEELMR 751
EM G PL G +EE+L
Sbjct: 201 EMITGKPL------FPGTNDEEQLKL 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 64/264 (24%), Positives = 106/264 (40%), Gaps = 72/264 (27%)
Query: 506 NFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEF-VT---EVNTIGSMHH 558
+ +L LG G + +VYKG S LVA+K+ + E+ T EV+ + + H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKE---IRLEHEEGAPCTAIREVSLLKDLKH 59
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
N+V L + LV+E++ L +++ +++ +G+A
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLRGLA 114
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH----SQVVTMVRGTRGY 674
Y H R +++H D+KP+N+L++E K++DFGLA+ ++VV T Y
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWY 166
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGWA----FKEM 727
P+ +LL G +DM W F EM
Sbjct: 167 RPPD------------------ILL---GSTDYSTQIDM-----------WGVGCIFYEM 194
Query: 728 TNGTPLKVADRRLEGAVEEEELMR 751
G PL G+ EE+L
Sbjct: 195 ATGRPL------FPGSTVEEQLHF 212
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGEKEFVT-EVNTIGSMHHMNLVRL 564
LG G FG V G G VAVK L+R + + E+ + H ++++L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 565 CGY-CSEGSNRL-LVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTR--FNIAIATAQGIAY 619
Y +V E++ G L D RV + R F ++ + Y
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILS---AVDY 126
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H R+ ++H D+KPEN+LLD + K++DFGL+ +M + + T G+ Y APE
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEV 181
Query: 680 VSNRPIT-VKADVYSYGMLLLEIVGGR 705
+S R + D++S G++L ++ G
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGEKEF-VTEVNTIGSMHH 558
+ +LLG G FG V K + G A+K L + ++ E +TE + + H
Sbjct: 151 EYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRFNIA-IATA 614
L L Y + +RL V E+ G L F +H R+RV RF A I +A
Sbjct: 208 PFLTAL-KYSFQTHDRLCFVMEYANGGEL----F--FHLSRERVFSEDRARFYGAEIVSA 260
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+ Y H + +++ D+K EN++LD++ K++DFGL K ++ + + T GT Y
Sbjct: 261 --LDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEY 315
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
LAPE + + D + G+++ E++ GR
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIGSMHH 558
+ LGTG FG V+ + + G A+K L + V+ + E E + + H
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD--RVLDWTTRFNIA-IATAQ 615
++R+ G + ++ ++++ G L F R R + +F A + A
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL----F--SLLRKSQRFPNPVAKFYAAEVCLA- 118
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
+ Y H II+ D+KPENILLD+N K++DFG AK T+ GT Y+
Sbjct: 119 -LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYTLC-GTPDYI 170
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGR 705
APE VS +P D +S+G+L+ E++ G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 492 PVNFTYRDLQIRTSNFAQL--LGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGE 543
P + +++ +F L +G G FG V K + + A+K L +L E
Sbjct: 61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAE 117
Query: 544 KEFV-TEVNTIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL 601
E + + + + L Y + N L LV ++ G L + DR+
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLP 173
Query: 602 DWTTRFNIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
+ RF +A + A I H+ +H DIKP+NIL+D N +++DFG + +
Sbjct: 174 EEMARFYLAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVK-----ADVYSYGMLLLEIVGGR 705
+ ++ GT Y++PE + D +S G+ + E++ G
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 30/232 (12%)
Query: 492 PVNFTYRDLQIRTSNFAQL--LGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGE 543
P+ ++++++ +F L +G G F V K + G + A+K + +L GE
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGE 104
Query: 544 KEFV-TEVNTIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL 601
E + + + + +L + + N L LV E+ G L + +R+
Sbjct: 105 VSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIP 160
Query: 602 DWTTRFNIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660
RF +A I A I H +H DIKP+NILLD +++DFG + +
Sbjct: 161 AEMARFYLAEIVMA--IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVY-------SYGMLLLEIVGGR 705
+ + GT YL+PE + Y + G+ E+ G+
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 53/207 (25%), Positives = 81/207 (39%), Gaps = 19/207 (9%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGEKEFVT------EVNTIGSMHHM 559
LG+G FG V+ V VK + + VL E E+ + + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
N++++ LV E +G LD +F R+ + I + Y
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLAS-YIFRQLVSAVGY 145
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
IIH DIK ENI++ E+F K+ DFG A + T GT Y APE
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPEV 200
Query: 680 VSNRP-ITVKADVYSYGMLLLEIVGGR 705
+ P + +++S G+ L +V
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIGSMHH 558
++ +LLG G FG V K + G A+K L + ++ E TE + + H
Sbjct: 8 DYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 559 MNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRFNIA-IATA 614
L L Y + +RL V E+ G L F +H R+RV RF A I +A
Sbjct: 65 PFLTAL-KYAFQTHDRLCFVMEYANGGEL----F--FHLSRERVFTEERARFYGAEIVSA 117
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY 674
+ Y H +++ DIK EN++LD++ K++DFGL K + + + T GT Y
Sbjct: 118 --LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEY 171
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
LAPE + + D + G+++ E++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 498 RDLQIRTSNFAQL--LGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGEKEFV-T 548
RDL+++ ++ + +G G FG V K + + A+K L ++ + F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHH--RDRVLDWTT 605
E + + + +V+L Y + L +V E+M G L + V +
Sbjct: 119 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-------VNLMSNYDVPEKWA 170
Query: 606 RFNIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV 664
RF A + A + H IH D+KP+N+LLD++ K++DFG M +E
Sbjct: 171 RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 665 VTMVRGTRGYLAPEWVSNRPITVK----ADVYSYGMLLLEIVGGR 705
GT Y++PE + ++ D +S G+ L E++ G
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKL--DRVLPHGEKEFV---TEVNTIGSM 556
++LG GG+G V+ G + A+K L ++ + K+ E N + +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEV 78
Query: 557 HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRFNIA-IA 612
H +V L Y + +L L+ E++ G L F R+ + T F +A I+
Sbjct: 79 KHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----F--MQLEREGIFMEDTACFYLAEIS 131
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
A + + H+ II+ D+KPENI+L+ K++DFGL K + + T GT
Sbjct: 132 MA--LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTI 185
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
Y+APE + D +S G L+ +++ G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGEKEFVT-EVNTIGSMHHMNLVRL 564
LG G FG V G G VAVK L+R + + E+ + H ++++L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 565 CGY-CSEGSNRL-LVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTR--FNIAIATAQGIAY 619
Y + + +V E++ G L D R+ + +R F ++ G+ Y
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFDYIC-----KNGRLDEKESRRLFQQILS---GVDY 131
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H R+ ++H D+KPEN+LLD + K++DFGL+ +M + + T G+ Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEV 186
Query: 680 VSNRP-ITVKADVYSYGMLLLEIVGGR 705
+S R + D++S G++L ++ G
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 61/276 (22%), Positives = 98/276 (35%), Gaps = 83/276 (30%)
Query: 505 SNFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNT--------- 552
S + + +G G +G+VYK G VA+K V +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS---VRVPNGGGGGGGLPISTVREVALL 65
Query: 553 --IGSMHHMNLVRL----CGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTT 605
+ + H N+VRL ++ ++ LV+E + L ++ L T
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAET 121
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH---S 662
++ +G+ + H N I+H D+KPENIL+ K++DFGLA++ +
Sbjct: 122 IKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFY 719
VV T Y APE +LL +DM
Sbjct: 179 VVV-----TLWYRAPE------------------VLL----QSTYATPVDM--------- 202
Query: 720 PGWA----FKEMTNGTPLKVADRRLEGAVEEEELMR 751
W+ F EM PL G E ++L +
Sbjct: 203 --WSVGCIFAEMFRRKPL------FCGNSEADQLGK 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIG-SMHHMN 560
+F +++G G FG V + AVK L +L E++ + +E N + ++ H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 561 LVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRFNIA-IATAQG 616
LV L + + +++L V +++ G L F YH R+R RF A IA+A
Sbjct: 101 LVGL-HFSFQTADKLYFVLDYINGGEL----F--YHLQRERCFLEPRARFYAAEIASA-- 151
Query: 617 IAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLA 676
+ Y H I++ D+KPENILLD ++DFGL K +S T GT YLA
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLA 207
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGR 705
PE + +P D + G +L E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 50/234 (21%)
Query: 492 PVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEV 550
P +Y D ++ +G G FG VY+ L D G LVA+KK VL + E+
Sbjct: 51 PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKN-REL 98
Query: 551 NTIGSMHHMNLVRLCGY-CSEGSNRL-----LVYEFM--------KNGSLDKWIFPSYHH 596
+ + H N+VRL + S G + LV +++ ++ S K P +
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 597 RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAK 655
+ + +AY H I H DIKP+N+LLD + K+ DFG AK
Sbjct: 159 K----------LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 656 LMGREH---SQVVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
+ R S + +R Y APE + T DV+S G +L E++ G+
Sbjct: 206 QLVRGEPNVSYIC-----SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 101/284 (35%)
Query: 505 SNFAQL--LGTGGFGSVYKG--SLGDGTLVAVKKLDRVLPHGEKEFV--T---EVNTIGS 555
+ + +G G +G V+K G VA+K+ V +E + + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRH 67
Query: 556 MH---HMNLVRL----CGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRD--RVLDWTT 605
+ H N+VRL ++ +L LV+E + +D LD
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV--------------DQDLTTYLDKVP 113
Query: 606 RFNIAIATA--------QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657
+ T +G+ + H +R++H D+KP+NIL+ + K++DFGLA++
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 658 GREH---SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMS 711
+ S VV T Y APE +LL +D+
Sbjct: 171 SFQMALTSVVV-----TLWYRAPE------------------VLL----QSSYATPVDL- 202
Query: 712 GDAEDFFYPGWA----FKEMTNGTPLKVADRRLEGAVEEEELMR 751
W+ F EM PL G+ + ++L +
Sbjct: 203 ----------WSVGCIFAEMFRRKPL------FRGSSDVDQLGK 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 41/295 (13%), Positives = 78/295 (26%), Gaps = 70/295 (23%)
Query: 509 QLLGTGGFGSVYKGSLGDGTL---VAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLV 562
G ++ D L VA+ +D + +E ++ + + +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
R+ + L+V E+++ GSL + D + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAH- 146
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
R + P + VS G L +
Sbjct: 147 --RAGVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA---- 179
Query: 683 RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742
+ D+ G L ++ R W E + L A+R G
Sbjct: 180 ---NPQDDIRGIGASLYALLVNR----------------WPLPEAGVRSGLAPAERDTAG 220
Query: 743 AVEEEELMRAM------KVAFWCIQDEVFMRPS--MGEVVKMLEGSADINTPPMP 789
E + VA +Q + +R + + +++ AD P
Sbjct: 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 41/231 (17%)
Query: 490 GAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVT- 548
G Y + ++ +G G FG V++ L + VA+KK VL +K F
Sbjct: 35 GEQREIAYTNCKV--------IGNGSFGVVFQAKLVESDEVAIKK---VLQ--DKRFKNR 81
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRL------LVYEFMKNGSLDKWIFPSYHHRDRVLD 602
E+ + + H N+V L + ++ LV E++ ++ + H ++
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQ 136
Query: 603 WTTRFNIAIATAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAKLMG 658
I + Q +AY H I H DIKP+N+LLD K+ DFG AK++
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
Query: 659 REH---SQVVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
S + +R Y APE + T D++S G ++ E++ G+
Sbjct: 194 AGEPNVSYIC-----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 41/222 (18%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKL--------DRVLPH--GEKEFVTEVN 551
++LGTG +G V+ G L A+K L + H E++ + +
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 552 TIGSMHHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHH--RDRVLD-WTTRF 607
LV L Y + +L L+ +++ G L + H + +
Sbjct: 117 -----QSPFLVTLH-YAFQTETKLHLILDYINGGEL-------FTHLSQRERFTEHEVQI 163
Query: 608 NIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL-MGREHSQVV 665
+ I A + + H+ II+ DIK ENILLD N ++DFGL+K + E +
Sbjct: 164 YVGEIVLA--LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 666 TMVRGTRGYLAPEWV--SNRPITVKADVYSYGMLLLEIVGGR 705
GT Y+AP+ V + D +S G+L+ E++ G
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKL--DRVLPHGEKEFV-TEVNTIG-SMH 557
++LG G FG V +K + A+K L D VL + E E + +
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 558 HMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRFNIA-IAT 613
H L + + L V E++ G L YH D F A I
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL----M--YHIQSCHKFDLSRATFYAAEIIL 129
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
+ + H I++ D+K +NILLD++ K++DFG+ K ++ T GT
Sbjct: 130 G--LQFLHS---KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC-GTP 182
Query: 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
Y+APE + + D +S+G+LL E++ G+
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDR--VLPHGEKEFVT-EVNTIGSMHHMNLVRL 564
+ LG G FG V + VA+K + R + V E++ + + H ++++L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 565 CGY-CSEGSNRL-LVYEFMKNGSL-DKWIFPSYHHRDRVLDWTTR--FNIAIATAQGIAY 619
Y + +V E+ G L D + + R+ + R F I I Y
Sbjct: 75 --YDVITTPTDIVMVIEYA-GGELFDYIV-----EKKRMTEDEGRRFFQQIIC---AIEY 123
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H R++I+H D+KPEN+LLD+N K++DFGL+ +M + + + T G+ Y APE
Sbjct: 124 CH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEV 178
Query: 680 VSNRPIT-VKADVYSYGMLLLEIVGGR 705
++ + + DV+S G++L ++ GR
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 67/283 (23%), Positives = 106/283 (37%), Gaps = 91/283 (32%)
Query: 503 RTSNFAQL--LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-F-VT---EVNTIG 554
S + +L +G G FG V+K G VA+KK VL EKE F +T E+ +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQ 71
Query: 555 SMHHMNLVRLCGYCSEGSNRL--------LVYEFMKN---GSLDKWIFPSYHHRDRVLDW 603
+ H N+V L C ++ LV++F ++ G L +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--------NVLVKFTL 123
Query: 604 TTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH-- 661
+ + G+ Y H RN+I+H D+K N+L+ + K++DFGLA+
Sbjct: 124 SEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 662 ------SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSG 712
++VV T Y PE LLL G R +D+
Sbjct: 181 QPNRYTNRVV-----TLWYRPPE------------------LLL---GERDYGPPIDL-- 212
Query: 713 DAEDFFYPGWA----FKEMTNGTPLKVADRRLEGAVEEEELMR 751
W EM +P+ ++G E+ +L
Sbjct: 213 ---------WGAGCIMAEMWTRSPI------MQGNTEQHQLAL 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 42/219 (19%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM----- 556
NF +LG G FG V KG+ L AVK L +K+ V + + +
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGT---DELYAVKIL-------KKDVVIQDDDVECTMVEKR 72
Query: 557 ------HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRF 607
L +L C + +RL V E++ G L YH + F
Sbjct: 73 VLALPGKPPFLTQL-HSCFQTMDRLYFVMEYVNGGDL------MYHIQQVGRFKEPHAVF 125
Query: 608 NIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
A IA + + II+ D+K +N++LD K++DFG+ K + T
Sbjct: 126 YAAEIAIG--LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
GT Y+APE ++ +P D +++G+LL E++ G+
Sbjct: 181 FC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 58/278 (20%), Positives = 95/278 (34%), Gaps = 79/278 (28%)
Query: 511 LGTGGFGSVYKG---SLGDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+G G +G VYK D A+K+++ + E+ + + H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM---SACREIALLRELKHPNVISLQK 85
Query: 567 YCSEGSNRL--LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA------TAQGIA 618
++R L++++ D W +H + + + GI
Sbjct: 86 VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 619 YFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAKLMG-------REHSQVVTM 667
Y H N ++H D+KP NIL+ E K++D G A+L VV
Sbjct: 143 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 197
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR---NLDMSGDAEDFFYPGWA- 723
T Y APE LLL G R +D+ WA
Sbjct: 198 ---TFWYRAPE------------------LLL---GARHYTKAIDI-----------WAI 222
Query: 724 ---FKEMTNGTPL---KVADRRLEGAVEEEELMRAMKV 755
F E+ P+ + D + ++L R V
Sbjct: 223 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM----- 556
F ++LG G FG V K + G L AVK L +K+ + + + +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKET---GDLYAVKVL-------KKDVILQDDDVECTMTEKR 75
Query: 557 ------HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRF 607
+H L +L C + +RL V EF+ G L +H + R D RF
Sbjct: 76 ILSLARNHPFLTQL-FCCFQTPDRLFFVMEFVNGGDL------MFHIQKSRRFDEARARF 128
Query: 608 NIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
A I +A + + H+ II+ D+K +N+LLD K++DFG+ K T
Sbjct: 129 YAAEIISA--LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
GT Y+APE + D ++ G+LL E++ G
Sbjct: 184 FC-GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM----- 556
+ +++G G + V K + + A+K + +KE V + I +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVV-------KKELVNDDEDIDWVQTEKH 61
Query: 557 ------HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRF 607
+H LV L C + +RL V E++ G L +H R R L RF
Sbjct: 62 VFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGGDL----M--FHMQRQRKLPEEHARF 114
Query: 608 NIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
A I+ A + Y HE II+ D+K +N+LLD K++D+G+ K R T
Sbjct: 115 YSAEISLA--LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
GT Y+APE + D ++ G+L+ E++ GR
Sbjct: 170 FC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 44/221 (19%)
Query: 509 QLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEF----VTEVNTIGSMHHMNLVR 563
++ G G FG+V G G VA+KK V+ F + + + +HH N+V+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQD--PRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 564 LCGY-CSEGSNRL------LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA---- 612
L Y + G +V E++ P HR R +A
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYV----------PDTLHR--CCRNYYRRQVAPPPILI 131
Query: 613 ------TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAKLMGREHSQVV 665
+ I H N + H DIKP N+L++E K+ DFG AK + V
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 666 TMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
+ +R Y APE + N+ T D++S G + E++ G
Sbjct: 191 YIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 506 NFAQLLGTGGFGSVY----KGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM----- 556
+ +++G G + V K + + A++ + +KE V + I +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKT---DRIYAMRVV-------KKELVNDDEDIDWVQTEKH 104
Query: 557 ------HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRF 607
+H LV L C + +RL V E++ G L +H R R L RF
Sbjct: 105 VFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGGDL----M--FHMQRQRKLPEEHARF 157
Query: 608 NIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
A I+ A + Y HE II+ D+K +N+LLD K++D+G+ K R T
Sbjct: 158 YSAEISLA--LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
GT Y+APE + D ++ G+L+ E++ GR
Sbjct: 213 FC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 42/219 (19%)
Query: 506 NFAQLLGTGGFGSV----YKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM----- 556
NF +LG G FG V KG+ L AVK L +K+ V + + +
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGT---DELYAVKIL-------KKDVVIQDDDVECTMVEKR 393
Query: 557 ------HHMNLVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYH-HRDRVLD-WTTRF 607
L +L C + +RL V E++ G L YH + F
Sbjct: 394 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL------MYHIQQVGRFKEPHAVF 446
Query: 608 NIA-IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVT 666
A IA + + II+ D+K +N++LD K++DFG+ K + T
Sbjct: 447 YAAEIAIG--LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
Query: 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
GT Y+APE ++ +P D +++G+LL E++ G+
Sbjct: 502 FC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 41/216 (18%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVK---KLDRVLPHGEKE--FVTEVNTIGSMHHMNLV 562
+++G G FG V K VA+K R +E + + + MN++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 563 RLCGY-------C--SE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
+ C E N +YE +K F R A
Sbjct: 163 HMLENFTFRNHICMTFELLSMN---LYELIKKNKFQG--FSLPLVR----------KFAH 207
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP--KVSDFGLAKLMGREHSQVVTMVR 669
+ Q + H +NRIIHCD+KPENILL + KV DFG + + +
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ--- 261
Query: 670 GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
+R Y APE + + D++S G +L E++ G
Sbjct: 262 -SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVK---KLDRVLPHGEKE-----FVTEVNTIGSMH-- 557
+ LG G F +V+ + + T VA+K E E V + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 558 HMNLVRLCGY----CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT 613
++++L + G + ++V+E + +L I + R + I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI---KKYEHRGIPLIYVKQISKQL 140
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILLDENFCP------KVSDFGLAKLMGREHSQVVTM 667
G+ Y H +C IIH DIKPEN+L++ P K++D G A ++ +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
TR Y +PE + P AD++S L+ E++ G
Sbjct: 198 ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 40/165 (24%), Positives = 59/165 (35%), Gaps = 34/165 (20%)
Query: 507 FAQLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRL 564
+Q+LG G G V + A+K L + EV ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 565 CGYC----SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRF-------NIAIAT 613
+ L+V E + G L F R+ D + I +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGEL----F------SRIQDRGDQAFTEREASEIMKSI 126
Query: 614 AQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAK 655
+ I Y H I H D+KPEN+L N K++DFG AK
Sbjct: 127 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 39/220 (17%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVT-----------EVNTIGSMH 557
+ + +G +G+V G +G VA+K++ + G + E+ + H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 558 HMNLVRL----CGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
H N++ L + ++L LV E M+ L + I H + V+ + +I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQRIVI---SPQHIQYF 139
Query: 613 TAQ---GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-- 667
G+ HE ++H D+ P NILL +N + DF LA RE +
Sbjct: 140 MYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLA----REDTADANKTH 192
Query: 668 -VRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGR 705
V R Y APE V + T D++S G ++ E+ +
Sbjct: 193 YV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 12/155 (7%)
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
+G++ RL S S+ + K+ S + L +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
A+G+ + + + IH D+ NILL E K+ DFGLA+ + ++ VR
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGD 254
Query: 673 GYL-----APEWVSNRPITVKADVYSYGMLLLEIV 702
L APE + +R T+++DV+S+G+LL EI
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 21/166 (12%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSM-HH 558
+ LG G FG V + VAVK L H E + ++E+ + + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 559 MNLVRLCGYCSEGSNRLLV-YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
+N+V L G C++ L+V EF K G+L ++ + R +G
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------------RSKRNEFVPYKTKGA 133
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663
+ + I D+K + + S F K + +
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
+G+G +GSV G VA+KKL R K E+ + M H N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 566 -----GYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
LV FM L K + + + ++ + +G+ Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM------GLKFSEEKIQY-LVYQMLKGLKY 141
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H ++H D+KP N+ ++E+ K+ DFGLA+ E + V TR Y APE
Sbjct: 142 IHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 194
Query: 680 V-SNRPITVKADVYSYGMLLLEIVGGR 705
+ S D++S G ++ E++ G+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRL- 564
+ +G+G G V VA+KKL R + K E+ + ++H N++ L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 565 -----CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
E + LV E M + +L + I + + + + GI +
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVI------QMELDHERMSY-LLYQMLCGIKH 179
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H IIH D+KP NI++ + K+ DFGLA+ G ++T TR Y APE
Sbjct: 180 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEV 234
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGR 705
+ D++S G ++ E+V +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
+ +G+G G V VA+KKL R + K E+ + ++H N++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 566 G-YCSEGSNRL-----LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
+ + S +V E M + +L + I + + + + GI +
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELM-DANLCQVI------QMELDHERMSY-LLYQMLCGIKH 142
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H IIH D+KP NI++ + K+ DFGLA+ S ++T TR Y APE
Sbjct: 143 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 197
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGR 705
+ D++S G ++ E++ G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 49/256 (19%), Positives = 90/256 (35%), Gaps = 62/256 (24%)
Query: 492 PVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEV 550
+ Y + LGTG FG V + + G A+KK VL + E+
Sbjct: 4 TSSKKYSLGKT--------LGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKN-REL 51
Query: 551 NTIGSMHHMNLVRL-CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD----------- 598
+ + + H+N+++L + + G + + + ++
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 599 --------------RVLDWTTRFNIAIATAQ----------GIAYFHEQCRNRIIHCDIK 634
+VL R +I + + H I H DIK
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIK 168
Query: 635 PENILLDENFCP-KVSDFGLAKLMGREH---SQVVTMVRGTRGYLAPEWV-SNRPITVKA 689
P+N+L++ K+ DFG AK + + + +R Y APE + T
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-----SRFYRAPELMLGATEYTPSI 223
Query: 690 DVYSYGMLLLEIVGGR 705
D++S G + E++ G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
Q +G+G +G+V G VA+KKL R K E+ + M H N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 566 -----GYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
+ LV FM L K + +++ + +F + +G+ Y
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQF-LVYQMLKGLRY 143
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H IIH D+KP N+ ++E+ K+ DFGLA+ E + V TR Y APE
Sbjct: 144 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----TRWYRAPEV 196
Query: 680 V-SNRPITVKADVYSYGMLLLEIVGGR 705
+ + T D++S G ++ E++ G+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 39/216 (18%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVK---KLDRVLPHGEKE--FVTEVNTIGSMHHMNLV 562
L+G G FG V K + VA+K L + E + +N + +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 563 RLCGY-------C--SE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
L + C E N +Y+ ++N + F TR A
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYN---LYDLLRNTN-----FRGVSLN------LTR-KFAQ 164
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP--KVSDFGLAKLMGREHSQVVTMVR 669
+ + IIHCD+KPENILL K+ DFG + +G+ Q +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ--- 220
Query: 670 GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
+R Y +PE + P + D++S G +L+E+ G
Sbjct: 221 -SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 36/209 (17%)
Query: 511 LGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRL--CG 566
LG G + V++ + + V VK L P +K+ E+ + ++ N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWI--FPSYHHRD---RVLDWTTRFNIAIATAQGIAYFH 621
LV+E + N + Y R +L + + Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 622 EQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAKLMGREHSQVVTM-VR-GTRGYLAPE 678
I+H D+KP N+++D ++ D+GLA + VR +R + PE
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPE 200
Query: 679 -WVSNRPITVKADVYSYGMLLLEIVGGRR 706
V + D++S G +L ++ +
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 52/233 (22%), Positives = 82/233 (35%), Gaps = 59/233 (25%)
Query: 509 QLLGTGGFGSVYKG--SLGDGTLVAVK---KLDRVLPHGEKE--FVTEVNTIGSMHHMNL 561
LG G FG V + + VA+K + + E + ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 562 VRLCGY-------C--SE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
V + + C E G N +EF+K + +P H R ++A
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQP--YPLPHVR----------HMA 129
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP-------------------KVSDF 651
+ + HE N++ H D+KPENIL + +V+DF
Sbjct: 130 YQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG 704
G A H+ +V TR Y PE + DV+S G +L E G
Sbjct: 187 GSATFDHEHHTTIVA----TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 40/180 (22%), Positives = 60/180 (33%), Gaps = 59/180 (32%)
Query: 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKP 635
+V+E + + L KWI + L I QG+ Y H +CR IIH DIKP
Sbjct: 122 MVFEVLGH-HLLKWI---IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 636 ENILL-------------------------------------------------DENFCP 646
ENILL E
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 647 KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
K++D G A + + ++ + TR Y + E + AD++S + E+ G
Sbjct: 236 KIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 3e-11
Identities = 42/216 (19%), Positives = 72/216 (33%), Gaps = 20/216 (9%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQ 118
+ + NLVL D D +WASN++GA A + G ++ N W
Sbjct: 21 QSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWS 80
Query: 119 SFLHPSD-----TLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGS 173
S S L P++ +++ N G + S N P +
Sbjct: 81 SGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQT 140
Query: 174 YDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVY--VYQNDG- 230
+A +S P ++ D VL + + G V Q +G
Sbjct: 141 L--------HATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGR 192
Query: 231 ----DYDGLASATNKSTRLTVLRRLILETNGNLRLY 262
+A T+ ++R +L+ + NL +Y
Sbjct: 193 MDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIY 228
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 4e-08
Identities = 21/86 (24%), Positives = 33/86 (38%), Gaps = 1/86 (1%)
Query: 41 IWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-AT 99
I ++ D L ++T NLVL D D +W++N++G G A
Sbjct: 127 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 186
Query: 100 MSESGNFILYAPNNQPVWQSFLHPSD 125
+ +G + N VW S S
Sbjct: 187 LQPNGRMDVLTNQNIAVWTSGNSRSA 212
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM---VRGTR 672
G+ Y H ++H D+KP N+LL+ K+ DFGLA++ +H + V TR
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATR 195
Query: 673 GYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
Y APE ++++ T D++S G +L E++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
+G+G +GSV G VAVKKL R K E+ + M H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 566 -----GYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVL-DWTTRFNIAIATAQGIA 618
E N + LV M L+ + + + L D +F + +G+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIV------KCQKLTDDHVQF-LIYQILRGLK 146
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
Y H IIH D+KP N+ ++E+ K+ DFGLA+ E + V TR Y APE
Sbjct: 147 YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPE 199
Query: 679 WV-SNRPITVKADVYSYGMLLLEIVGGR 705
+ + D++S G ++ E++ GR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 53/228 (23%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKL---DRVLPHGEKEFVTEVNTIGSMHHMNLVRL 564
+ LG GG G V+ VA+KK+ D K + E+ I + H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKV 73
Query: 565 -------------CGYCSEGSNRL-LVYEFM--------KNGSLDKWIFPSYHHRDRVLD 602
N + +V E+M + G L + H R
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-----EHAR----- 123
Query: 603 WTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP-KVSDFGLAKLMGREH 661
+G+ Y H ++H D+KP N+ ++ K+ DFGLA++M +
Sbjct: 124 -----LFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 662 SQVVTM---VRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
S + + T+ Y +P +S T D+++ G + E++ G+
Sbjct: 176 SHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-10
Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 7/74 (9%)
Query: 47 PGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVE-LATMSESGN 105
+ + + + T NLVL D + IWA+N+ G G A + G
Sbjct: 19 ATESLEILFGTHVY------RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGV 72
Query: 106 FILYAPNNQPVWQS 119
++ N VWQS
Sbjct: 73 LVVITNENVTVWQS 86
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-07
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 51 TVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGAGVE-LATMSESGNFIL 108
+W+ N + L G LV+ + T+W S +G + + N ++
Sbjct: 49 NPIWATNT-GGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 109 YAPNNQPVWQS 119
Y +W +
Sbjct: 108 Y---GDALWAT 115
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 58/229 (25%), Positives = 84/229 (36%), Gaps = 59/229 (25%)
Query: 509 QLLGTGGFGSVYKG--SLGDGTLVAVK---KLDRVLPHGEKE--FVTEVNTIGSMHHMNL 561
LG G FG V + G VAVK +DR E + +NT
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 562 VRLCGY-------C--SE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
V++ + C E G + Y+F+K F H R +A
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLP--FRLDHIR----------KMA 124
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP-------------------KVSDF 651
+ + + H N++ H D+KPENIL ++ KV DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLE 700
G A HS +V+ TR Y APE + + DV+S G +L+E
Sbjct: 182 GSATYDDEHHSTLVS----TRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 2e-10
Identities = 35/230 (15%), Positives = 67/230 (29%), Gaps = 51/230 (22%)
Query: 485 SLIVCG--APVNFTYRDLQIRTSNFAQL--LGTGGFGSVYKGSLGDGTLVAVKKL----- 535
S+ C PV F++ + T + +G G FG V++ D T VA+K +
Sbjct: 1 SMGECSQKGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGP 56
Query: 536 ---DRVLPHGEKEFVTEV---------NTIGSMHHMNLVRLCG-YCSEG---SNRLLVYE 579
+ +E + E+ + + L +C +G L ++
Sbjct: 57 DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
Query: 580 FMKNGSLDKWIFPSY--------------------HHRDRVLDWTTRFNIAIATAQGIAY 619
+ P + R ++ T +I +A
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
R H D+ N+LL + K+ K + +
Sbjct: 177 AEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 50/234 (21%), Positives = 86/234 (36%), Gaps = 65/234 (27%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-----HHMNLV 562
+ +G G FG V + + AVK + R + + E + + + ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 563 RLCGY-------C--SE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAI 611
+ G C E G + +YE + + + F + I
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNG--FHIEDIK----------LYCI 144
Query: 612 ATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP------------------------- 646
+ + Y + + H D+KPENILLD+ +
Sbjct: 145 EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 647 KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLE 700
K+ DFG A H ++ TR Y APE + N V +D++S+G +L E
Sbjct: 202 KLIDFGCATFKSDYHGSIIN----TRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 49/225 (21%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVT----EVNTIGSMHHMNLVR 563
LLG G +G V + G +VA+KK++ P + F E+ + H N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 564 LCG-YCSEGSNRL----LVYEFM--------KNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
+ + ++ E M L H +
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-----DHIQ----------YFI 118
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
T + + H + +IH D+KP N+L++ N KV DFGLA+++ +
Sbjct: 119 YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 671 ---------TRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGR 705
TR Y APE +++ + DV+S G +L E+ R
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-09
Identities = 19/66 (28%), Positives = 31/66 (46%), Gaps = 1/66 (1%)
Query: 55 SANRNFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-ATMSESGNFILYAPNN 113
+ V L + N VL D +WASN+ G G T+ +GN ++Y +N
Sbjct: 11 FTGHSLEVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSN 70
Query: 114 QPVWQS 119
+ +WQ+
Sbjct: 71 RVIWQT 76
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 6/78 (7%)
Query: 49 DRTVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGAGVE-LATMSESGNF 106
VW++N L L GNLV+ D IW + ++G + + + N
Sbjct: 37 SGKPVWASNTGGL-GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNV 95
Query: 107 ILYAPNNQPVWQSFLHPS 124
++Y VW + P+
Sbjct: 96 VIY---GPVVWATGSGPA 110
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-09
Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 5/77 (6%)
Query: 46 LPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNS-SGAGVELATMSES 103
L T VW++N K L + GN V+ D + ++WAS+S G G + + E
Sbjct: 33 LYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQED 92
Query: 104 GNFILYAPNNQPVWQSF 120
GN ++Y +W +
Sbjct: 93 GNVVIY---GSDIWSTG 106
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-09
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL--ATMSESGNFILYAPNNQPV 116
+ + NLVL D T++WASN+ G + A + GNF++Y + +
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSL 73
Query: 117 WQS 119
W S
Sbjct: 74 WAS 76
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (139), Expect = 3e-09
Identities = 40/293 (13%), Positives = 72/293 (24%), Gaps = 47/293 (16%)
Query: 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRF-QLGIWFNELPGDRTVVWSANRNF 60
+ L S Q +S N F N+ + +W RN
Sbjct: 17 LPAYQTL--SAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQ-PFSSTIPLRNK 73
Query: 61 P----VTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPV 116
LD + D + + SN L + + GN +L
Sbjct: 74 KAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLV-LQDDGNIVLVDSLALWN 132
Query: 117 WQSFLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDA 176
+ + + L+ EL G + L NL +Y
Sbjct: 133 GTPAIPLVPGAIDSLLLAPGSELVQGVVYGAG----------ASKLVFQGDGNL-VAYGP 181
Query: 177 ANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLA 236
+ W+ + G G +V + N ++
Sbjct: 182 NGAA-------TWN----AGTQGKGAVRAVFQGDGNLVVYGAGNAVLW-----------H 219
Query: 237 SATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSNPCNIAG 289
S T L L+ NG++ + + V + P + +
Sbjct: 220 SHTGGHAS----AVLRLQANGSIAILD-EKPVWARFGFQPTYRHIRKINPDQK 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 40/192 (20%), Positives = 71/192 (36%), Gaps = 33/192 (17%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGEKEFVT-----EVNTIGSMHHMNLV 562
L+GTG +G V + + +VA+KK+ RV E E+ + ++H ++V
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVV 115
Query: 563 RL----CGYCSEGSNRL-LVYEFMKNGSLDKWI-----FPSYHHRDRVLDWTTRFNIAIA 612
++ E + L +V E + K H + +
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIK----------TLLYN 164
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTR 672
G+ Y H I+H D+KP N L++++ KV DFGLA+ + + + R
Sbjct: 165 LLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 673 GYLAPEWVSNRP 684
Sbjct: 222 EDDMNLVTFPHT 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 56/264 (21%), Positives = 94/264 (35%), Gaps = 45/264 (17%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
L+G G +G VY VA+KK++R+ K + E+ + + ++RL
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 566 GYCSEGSNRL-----LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ---GI 617
+V E + L K L T +I G
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA-DSDLKKLF-----KTPIFL---TEEHIKTILYNLLLGE 142
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG------- 670
+ HE + IIH D+KP N LL+++ KV DFGLA+ + E +
Sbjct: 143 NFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 671 --------------TRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
TR Y APE + + T D++S G + E++ ++
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 716 DFFYPGWAFKEMTNGTPLKVADRR 739
+PG + ++ K +
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEK 283
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 35/154 (22%), Positives = 61/154 (39%), Gaps = 21/154 (13%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G FG +++G +L + VA+K P E+ T G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYYF 74
Query: 568 CSEGSNRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
EG + +LV + + G SL+ + + T A + HE+
Sbjct: 75 GQEGLHNVLVIDLL--GPSLED-LLDLCGRK---FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 627 RIIHCDIKPENILLDENFCPK-----VSDFGLAK 655
+++ DIKP+N L+ V DFG+ K
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 17/70 (24%), Positives = 31/70 (44%), Gaps = 2/70 (2%)
Query: 51 TVVWSANRNFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVE-LATMSESGNFILY 109
VW++ +L++ GNLV+ G IWASN++ + N ++Y
Sbjct: 38 RAVWASGT-NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY 96
Query: 110 APNNQPVWQS 119
+N +W +
Sbjct: 97 DNSNNAIWAT 106
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 63/237 (26%)
Query: 509 QLLGTGGFGSVYKGS-LGDGTLVAVKKLDRVLPHG--------EKEFVTEVNTIGSMHHM 559
+ LG G +G V+K G +VAVKK+ + E +TE++ H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-----GHE 69
Query: 560 NLVRLCG-YCSEGSNRL-LVYEFM--------KNGSLDKWIFPSYHHRDRVLDWTTRFNI 609
N+V L ++ + LV+++M + L+ H + +
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP-----VHKQ----------YV 114
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
+ I Y H ++H D+KP NILL+ KV+DFGL++ +
Sbjct: 115 VYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 670 G--------------------TRGYLAPEW-VSNRPITVKADVYSYGMLLLEIVGGR 705
TR Y APE + + T D++S G +L EI+ G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 36/170 (21%), Positives = 60/170 (35%), Gaps = 34/170 (20%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHG----EKEF------VTEVNTIGS 555
+ +G+GGFG +Y A K++ +G E +F +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 556 MHHMNL-----VRLCGY--CSEGSNRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRF 607
++ G S R +V E + G L K ++ +T
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-----ISGQNGTFKKSTVL 154
Query: 608 NIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV--SDFGLAK 655
+ I + Y HE N +H DIK N+LL +V +D+GL+
Sbjct: 155 QLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 38/155 (24%), Positives = 57/155 (36%), Gaps = 23/155 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G G FG + G +L VA+K + P E+ + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 568 CSEGSNRLLVYEFMKNG-SL-DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G +V E + G SL D + DR T IAI + Y H +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDL-----CDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 626 NRIIHCDIKPENILLDENFCPKVS-----DFGLAK 655
+I+ D+KPEN L+ DF LAK
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-08
Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVE-LATMSESGNFILYAPNNQPVW 117
F + + NLVL D D IWA+N+ G +M GN ++Y+P N P+W
Sbjct: 14 EFLNNGRYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIW 73
Query: 118 QS 119
S
Sbjct: 74 AS 75
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 17/76 (22%), Positives = 31/76 (40%), Gaps = 6/76 (7%)
Query: 46 LPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGAGVE-LATMSES 103
L +W+ N + + L + + GNLV+ IWASN+ G + + +
Sbjct: 33 LYDVDKPIWATNT-GGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKD 91
Query: 104 GNFILYAPNNQPVWQS 119
N ++Y W +
Sbjct: 92 RNVVIY---GTARWAT 104
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 26/172 (15%), Positives = 49/172 (28%), Gaps = 35/172 (20%)
Query: 509 QLLGTGGFGSVYKG---------SLGDGTLVAVK-------------KLDRVLPHGEKEF 546
G +Y+ S ++K R +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 547 VTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTT 605
++ + + + G + R LV + G SL VL +
Sbjct: 108 WKKLYSTPLLA-IPTCMGFG-VHQDKYRFLVLPSL--GRSLQS-ALDVSPKH--VLSERS 160
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV--SDFGLAK 655
+A + + HE N +H ++ ENI +D +V + +G A
Sbjct: 161 VLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-08
Identities = 19/62 (30%), Positives = 25/62 (40%), Gaps = 1/62 (1%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-ATMSESGNFILYAPNNQPVW 117
+ L + NLV IWASN+ G T+ GN ++Y NN VW
Sbjct: 15 HSLQAGAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVW 74
Query: 118 QS 119
S
Sbjct: 75 GS 76
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 16/73 (21%), Positives = 31/73 (42%), Gaps = 6/73 (8%)
Query: 49 DRTVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGAGVE-LATMSESGNF 106
+ +W++N + L L + GNLV+ D + +W S G + + + G F
Sbjct: 37 NGRQIWASNTDRR-GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRF 95
Query: 107 ILYAPNNQPVWQS 119
++Y +W
Sbjct: 96 VIY---GPVLWSL 105
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 33/171 (19%), Positives = 60/171 (35%), Gaps = 33/171 (19%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKL--DRVLPH---------------GEKEFVTEVN 551
+G GGFG +Y + V +V P + E + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 552 TIGSMHHMNLVRLCGYCSEGSN----RLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTR 606
+ ++ + + G N R ++ + G L K I+ + T
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IY---EANAKRFSRKTV 154
Query: 607 FNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV--SDFGLAK 655
+++ + Y HE + +H DIK N+LL+ +V D+GLA
Sbjct: 155 LQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 15/62 (24%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-ATMSESGNFILYAPNNQPVW 117
K+ L + NLVL W SN+ G G ++ G I+ + + +W
Sbjct: 19 GRLTAKNHQLVMQGDCNLVLYG-GKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIW 77
Query: 118 QS 119
S
Sbjct: 78 SS 79
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-06
Identities = 17/73 (23%), Positives = 32/73 (43%), Gaps = 6/73 (8%)
Query: 49 DRTVVWSANRNFPVTKDAILELDTTGNLVL-NDGDTTIWASNSSGAGVELA-TMSESGNF 106
W +N + L L+ G L++ +D TIW+S SS E + + G
Sbjct: 40 GGKYGWQSNT-HGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFG 98
Query: 107 ILYAPNNQPVWQS 119
++Y P ++++
Sbjct: 99 VIYGP---AIFET 108
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 23/154 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G+G FG +Y G + G VA+K + P E + + +R CG
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVGIPTIRWCG- 74
Query: 568 CSEGSNRLLVYEFMKNG-SL-DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
+EG ++V E + G SL D + F R T +A I Y H +
Sbjct: 75 -AEGDYNVMVMELL--GPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 626 NRIIHCDIKPENILL----DENFCPKVSDFGLAK 655
IH D+KP+N L+ N + DFGLAK
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-07
Identities = 18/64 (28%), Positives = 25/64 (39%), Gaps = 3/64 (4%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTT--IWASNSSGAGVEL-ATMSESGNFILYAPNNQP 115
T+D L + NLVL G T +W S +SG G + SG +
Sbjct: 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT 78
Query: 116 VWQS 119
V+ S
Sbjct: 79 VFVS 82
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 15/74 (20%), Positives = 33/74 (44%), Gaps = 6/74 (8%)
Query: 48 GDRTVVWSANRNFPVTKDAILELDTTGNLVL-NDGDTTIWASNSSGAGVE-LATMSESGN 105
+VW + + + + L +G L + +D T++ SN+ G + + + +G
Sbjct: 42 SKTNIVWESGTSGR-GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQ 100
Query: 106 FILYAPNNQPVWQS 119
++Y P VW +
Sbjct: 101 AVVYGP---AVWST 111
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-ATMSESGNFILYAPNNQPVW 117
D L + NLVL +G+ W SN++ G + T+++ G ++ + VW
Sbjct: 16 GHLKNGDFDLVMQDDCNLVLYNGN---WQSNTANNGRDCKLTLTDYGELVIKNGDGSTVW 72
Query: 118 QS 119
+S
Sbjct: 73 KS 74
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 18/68 (26%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 54 WSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGA-GVELATMSESGNFILYAP 111
W +N +D L L G LV+ +GD +T+W S + G A + G +++ P
Sbjct: 40 WQSN-TANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP 98
Query: 112 NNQPVWQS 119
V++
Sbjct: 99 ---SVFKI 103
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 19/152 (12%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVK--KLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+G+G FG +Y G ++ VA+K + P E + + VR G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE-SKIYRILQGGTGIPNVRWFG- 72
Query: 568 CSEGSNRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
EG +LV + + G SL+ ++ R L T +A + + H +
Sbjct: 73 -VEGDYNVLVMDLL--GPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 627 RIIHCDIKPENILLDENFCPK---VSDFGLAK 655
+H DIKP+N L+ + DFGLAK
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-06
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 59 NFPVTKDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-ATMSESGNFILYAPN-NQPV 116
N + A + NLVL + + SN+ G GV+ ++ G +++ N N PV
Sbjct: 15 NQLSYESAAFVMQGDCNLVLYNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPV 73
Query: 117 WQS 119
W
Sbjct: 74 WVY 76
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-05
Identities = 15/76 (19%), Positives = 29/76 (38%), Gaps = 9/76 (11%)
Query: 49 DRTVVWSANRNFPVTKDAILELDTTGNLVL--NDGDTTIWASNSSGAGVE---LATMSES 103
+ + +N + D L L+ G L + + +T +W S V AT+
Sbjct: 36 NEAGGFQSNTH-GRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 104 GNFILYAPNNQPVWQS 119
+ +Y P +W +
Sbjct: 95 QHVTIYGP---AIWST 107
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-05
Identities = 90/563 (15%), Positives = 152/563 (26%), Gaps = 170/563 (30%)
Query: 211 FGIVYGESSNGAVYVYQNDG---DYDGLASATNKSTRLTVLRRLILETNGNLRLYRWDND 267
F + + V + + +Y L S R + + + RLY DN
Sbjct: 68 FWTLLSKQEEM-VQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD-RLYN-DNQ 124
Query: 268 V----NGSRQWVPEWA---AVSN--PCNIAGICGKGICNLDRSKTK-ASCTCLPGDSKIG 317
V N SR P A+ P I G KT A CL K+
Sbjct: 125 VFAKYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGS----GKTWVALDVCL--SYKVQ 177
Query: 318 SD----------GLCSDNSSV-------NGKCDPRHRNQSSHD----YRIASVQQT-NYY 355
C+ +V + DP ++S H RI S+Q
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 356 F--PEYS----VIANYSDIATVSKCGDACLSNCQ--------CVASVYGLDDEKPYCWVL 401
Y V+ N + +A +C+ V
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAW----NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 402 RSLDFGGFEDPSSTLFVKIMSNRSLTPGSNRGSGDSSEDSETRRTKVVVIPIVLSM--TL 459
S+ D +L +K + R + R + P LS+
Sbjct: 294 HSMTLT--PDEVKSLLLKYLDCRP---------------QDLPREVLTTNPRRLSIIAES 336
Query: 460 LIGLLCLLLYY---------------------NVHRKRFLKRAV--ENSLIVCGAP---- 492
+ L + +RK F + +V ++ I P
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI----PTILL 392
Query: 493 ----VNFTYRDLQIRTSNFAQ--LLGTGGFGSVYKGSLGDGTLVAVKKLD--RVLPHGEK 544
+ D+ + + + L+ S S+ L KL+ L H +
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYLELKVKLENEYAL-H--R 447
Query: 545 EFVTEVNT---------------------IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583
V N IG HH+ + + L + F++
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG--HHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-E 642
K I R W +I Q Y + I D K E ++
Sbjct: 506 ----K-I------RHDSTAWNASGSILNTLQQLKFY-----KPYICDNDPKYERLVNAIL 549
Query: 643 NFCPKVSDFGLAKLMGREHSQVV 665
+F PK+ L+ +++ ++
Sbjct: 550 DFLPKIE----ENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 90/530 (16%), Positives = 160/530 (30%), Gaps = 152/530 (28%)
Query: 50 RTVVWSANRNFP---VT--------KDAILELDTTGNLVLNDGDTTIWASNSSGAG--VE 96
R +++ N+ F V+ + A+LEL N+++ DG G+G
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI-DGVL--------GSGKTW- 165
Query: 97 LATMSESGNFILYAPNNQPVWQSFLH---PSDTLLPNQPLSVSLE---------LTSPKS 144
+A + + + W + + P L Q L ++ ++ K
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 145 LQNGGYYSLKMLQQ----PTSLSLALTYNLPGSYDAANSPKAYANKSYWSGPDIS----N 196
+ L+ L + L L L + KA W+ ++S
Sbjct: 226 RIHSIQAELRRLLKSKPYENCL-LVL--------LNVQNAKA------WNAFNLSCKILL 270
Query: 197 VTGD--VVAVLDEAGSFGIVYGESSNGAVYVYQNDGDYDGLASATNKSTRLTVLRRLILE 254
T V L A + I S D L + R L R +L
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMT----LTPDEVKSLLLKYLD--CRPQDLPREVLT 324
Query: 255 TN--------GNLR--LYRWDNDVNGSRQWVPEWAAVSNPCNIAGICGKGICNLDRSKTK 304
TN ++R L WDN W V+ + I + L+ ++ +
Sbjct: 325 TNPRRLSIIAESIRDGLATWDN-----------WKHVNCD-KLTTIIESSLNVLEPAEYR 372
Query: 305 A---SCTCLPGDSKIGSDGLC--------SDNSSVNGKC--------DPRHRNQSSHD-Y 344
+ P + I + L SD V K P+ S Y
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 345 RIASVQQTNYYFPEYSVIANYSDIATVSKCGDACLSNCQCVASVYGLDDEKPYCWV---L 401
V+ N Y S++ +Y+ + D + D+ Y + L
Sbjct: 433 LELKVKLENEYALHRSIVDHYN--IPKTFDSDDLIPPY---------LDQYFYSHIGHHL 481
Query: 402 RSLDFGGFEDPSSTLFV-------KIMSNRSLTPGSNRGS-GDSSEDSETRRTKVVVIPI 453
++++ +F+ KI T + GS ++ + + + I
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKI--RHDSTAWNASGSILNTLQQLKFYKPY-----I 534
Query: 454 VLSMTLLIGLLCLLLYYNVHRKRFLKRAVENSLIVCGAPVNFTYRDL-QI 502
+ L+ +L FL + EN LI Y DL +I
Sbjct: 535 CDNDPKYERLVNAIL-------DFLPKIEEN-LICS------KYTDLLRI 570
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 839 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.79 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.78 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.72 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.71 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.5 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.49 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.38 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.37 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.35 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.3 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.27 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.89 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.86 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.76 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.69 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.62 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.54 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.53 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.73 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.32 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 91.52 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.45 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.8 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.25 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 82.76 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=446.58 Aligned_cols=269 Identities=19% Similarity=0.329 Sum_probs=216.7
Q ss_pred cchHHHHHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccce
Q 038743 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGY 567 (839)
Q Consensus 495 ~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~ 567 (839)
..+.|+...+..|.++||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 4555666777889999999999999999862 468999999965433 345689999999999999999999999
Q ss_pred eecCCceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCC
Q 038743 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPE 636 (839)
Q Consensus 568 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~ 636 (839)
|.+....+||||||++|+|.++|..... .....++|.+++.|+.|||+||+|||+. +||||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCcccc
Confidence 9999999999999999999999954321 1234689999999999999999999995 8999999999
Q ss_pred cEEECCCCceeecccCcceecCCCCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCC
Q 038743 637 NILLDENFCPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDA 714 (839)
Q Consensus 637 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~ 714 (839)
||||++++.+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987644322 22345679999999999999999999999999999999998 89999754321
Q ss_pred CCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 715 EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+ ....+..+.. ...+......+.+++.+||+.+|++||||.||++.|+...+
T Consensus 255 ~-------~~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 255 D-------VVEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp H-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred H-------HHHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1 1122222211 11222334567889999999999999999999999986543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=445.82 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=205.2
Q ss_pred HhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
....+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+....+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34456789999999999999864 478999999987655666789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCC----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCce
Q 038743 577 VYEFMKNGSLDKWIFPSYH----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
|||||++|+|.++|..... .....++|.+++.|+.|||+||+|||+. +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999965321 1234699999999999999999999995 89999999999999999999
Q ss_pred eecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhh
Q 038743 647 KVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 647 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 724 (839)
||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999999976443322 2345679999999999999999999999999999999998 899996433211 11
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+..+.. ...+......+.+++.+||+.+|++||||.||++.|+.+.+
T Consensus 271 ~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 22222211 11122233457788999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=441.32 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=211.3
Q ss_pred HHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
....+.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3345667889999999999999863 4788999999876555667899999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCC--------CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCce
Q 038743 575 LLVYEFMKNGSLDKWIFPSY--------HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
+||||||++|+|.++|.... ......++|.+++.|+.|||.||+|||+. +||||||||+||||++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999996421 12345799999999999999999999995 99999999999999999999
Q ss_pred eecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhh
Q 038743 647 KVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 647 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 724 (839)
||+|||+|+......... .....||+.|||||++.+..++.++|||||||+||||+| |+.||......+ ..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 240 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VI 240 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 999999998765433332 233568999999999999999999999999999999998 899997433211 11
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
..+..+.. ...+......+.+++.+||+.+|++||||++|++.|+...
T Consensus 241 ~~i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 241 ECITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22222211 1112223456788899999999999999999999998643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=430.28 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=201.0
Q ss_pred HHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
|+......+.++||+|+||+||+|++.+ .||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3444455678899999999999999853 59999986443 2334679999999999999999999999865 56899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
|||||++|+|.++|.. ....++|.+++.|+.|||.||+|||+. +||||||||+||||++++.+||+|||+|+.
T Consensus 109 VmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999953 345799999999999999999999995 999999999999999999999999999987
Q ss_pred cCCCCc-eeEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 657 MGREHS-QVVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 657 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
...... .......||+.|||||++.+ .+|+.++|||||||+||||+||+.||....... .....+..+
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~-- 253 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRG-- 253 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTT--
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC--
Confidence 654332 23455679999999999964 468999999999999999999999997433211 111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+.+ ...+......+.+++.+||+.+|++||||.||++.|+..
T Consensus 254 --~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 254 --YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp --CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred --CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111 111223345677888999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=425.29 Aligned_cols=269 Identities=23% Similarity=0.279 Sum_probs=201.0
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC----ceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS----NRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 579 (839)
++.+.++||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.. ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 455678999999999999998 68999999996431 12223445667778899999999999997653 5799999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-----CCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC-----RNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
||++|+|.++|. ...++|..+++++.|+|+||+|||+++ .++||||||||+||||+.++++||+|||++
T Consensus 82 y~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999994 346899999999999999999999852 458999999999999999999999999999
Q ss_pred eecCCCCcee---EEeeccccceeCcccccCC------CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc----hh
Q 038743 655 KLMGREHSQV---VTMVRGTRGYLAPEWVSNR------PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY----PG 721 (839)
Q Consensus 655 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~----~~ 721 (839)
+......... .....||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 9775443322 2345799999999999764 367899999999999999999988864433221100 00
Q ss_pred hhhhhhccCcccccccccccCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 722 WAFKEMTNGTPLKVADRRLEGA-VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+........+++.+... .+.+....+.+++.+||+.+|++||||.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011111000111122222211 1235667888999999999999999999999999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=416.23 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=204.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.++||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..+||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 356678999999999999976 4699999999976555566778999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++. ...+++.++..++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 155 gg~L~~~l~------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 155 GGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999983 34689999999999999999999995 999999999999999999999999999998754432
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
. .....||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+..+.. +.+.
T Consensus 226 ~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~-----~~~~- 291 (346)
T 4fih_A 226 R-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLP-----PRLK- 291 (346)
T ss_dssp C-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSSC-----CCCS-
T ss_pred c-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCC-----CCCC-
Confidence 2 344679999999999999999999999999999999999999996432211 1111111111 0110
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
........+.+++.+||+.||++|||+.|+++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01122345678888999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=423.92 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=209.9
Q ss_pred HHHHHhhccccccccCCCceEEEEEeCC------CcEEEEEEecccCCc-chHHHHHHHHHhhccc-cCCcccccceeec
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLGD------GTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMH-HMNLVRLCGYCSE 570 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 570 (839)
|+....+.+.+.||+|+||+||+|.+.. ++.||||++...... ..++|.+|++++.+++ |||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 4555667788999999999999997532 468999999765433 3467999999999995 5999999999976
Q ss_pred C-CceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 571 G-SNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 571 ~-~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
. ...+||||||++|+|.++|..... .....+++..++.++.|||+||+|||+. +||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence 4 568999999999999999964311 1234689999999999999999999995 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAED 716 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 716 (839)
||++++.+||+|||+|+.+...... ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999977554433 3345679999999999999999999999999999999998 999997543221
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+.++.. ...+......+.+++.+||+.+|++||||.+|++.|+..
T Consensus 296 -----~~~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 -----EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp -----HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11122222211 111222234577888999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=411.19 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=198.8
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.+.++||+|+||+||+|+. .+|+.||||+++... ...+|+.++++++|||||++++++.+++..+||||||++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 45667899999999999976 569999999996432 234799999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcceecCCCCc
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~~~~~ 662 (839)
|+|.++|. ....+++.....++.||+.||+|||+. +||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 135 g~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 135 GSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999994 345799999999999999999999995 999999999999999987 699999999998754332
Q ss_pred ee----EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 663 QV----VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 663 ~~----~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.. .....||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ..+..+... -.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~~---~~ 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------LKIASEPPP---IR 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-------HHHHHSCCG---GG
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHHcCCCC---ch
Confidence 21 23357999999999999999999999999999999999999999754432211 111111100 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.+ +......+.+++.+||+.||.+|||+.|+++.|..
T Consensus 277 ~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 12223457788889999999999999999987753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=404.93 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=193.9
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec----CCceEEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----GSNRLLVY 578 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 578 (839)
.|.++||+|+||+||+|.. .+++.||||++.... ....+.|.+|++++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4667899999999999976 468999999996432 2234579999999999999999999999864 35679999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCceeecccCcceec
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLM 657 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~ 657 (839)
|||++|+|.++|. +...+++..+..++.||+.||+|||+. .++||||||||+||||+ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999994 345789999999999999999999985 12399999999999998 4799999999999864
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
... ......||+.|||||++.+ .++.++|||||||+||||+||+.||....... .....+..+.. .
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~----~ 248 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVK----P 248 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCC----C
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCC----C
Confidence 332 2345679999999998865 69999999999999999999999996432211 11122222111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111122 34678888999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=415.72 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=197.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..+|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 477788999999999999976 5699999999965432 2345789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
|++|+|.++|... ....+++.+...++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 105 CEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999532 345678889999999999999999995 9999999999999999999999999999876432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.. ......||+.|||||++.+..|+.++|||||||+||||++|+.||......+ ....+..+.. +.+
T Consensus 179 ~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~-----~~~ 245 (350)
T 4b9d_A 179 VE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKIISGSF-----PPV 245 (350)
T ss_dssp HH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC-----CCC
T ss_pred cc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCC-----CCC
Confidence 21 1234569999999999999999999999999999999999999997433211 1111111111 111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122 345778888999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=417.18 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=204.7
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.++||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 366778999999999999976 5699999999976655566779999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++. ...+++.++..++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 232 gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 232 GGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999983 34689999999999999999999995 999999999999999999999999999998754432
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
. .....||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+..+.. +.+..
T Consensus 303 ~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~-----~~~~~ 369 (423)
T 4fie_A 303 R-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLP-----PRLKN 369 (423)
T ss_dssp C-BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC-----CCCSC
T ss_pred c-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCC-----CCCcc
Confidence 2 344579999999999999999999999999999999999999996432211 1111111111 11110
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.......+.+++.+||+.||++|||+.|+++
T Consensus 370 --~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112245678888999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=404.86 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 477889999999999999976 579999999996431 3345679999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.++|. ....+++.+...++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 113 y~~gG~L~~~i~-----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 113 YAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999994 345799999999999999999999995 999999999999999999999999999998754
Q ss_pred CCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......||+.|||||++.+..++.++||||+||+||||++|+.||......+ ....+..+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence 4332 3445679999999999999999999999999999999999999997433211 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVV 774 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~ 774 (839)
.+...+ ...+.+++.+||+.||++|||++|++
T Consensus 252 ~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111222 23567888999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=389.20 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=187.9
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4578889999999999999976 569999999996542 223457899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+ +|+|.++|. ....+++.+...++.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHH-----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 689999884 345799999999999999999999995 99999999999999999999999999998754
Q ss_pred CCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
... ......||+.|||||++.+..+ +.++||||+||++|||++|+.||......+ ..+.+..+..
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~~~----- 229 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNGVY----- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC-----
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence 322 2344679999999999998876 579999999999999999999996432111 1112211111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+...+ ...+.+++.+||+.||++|||++|+++
T Consensus 230 -~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111122 244678888999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=398.20 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=189.8
Q ss_pred hhccccccccCCCceEEEEEe----CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
.|.+.+.||+|+||+||+|+. .+++.||||++++.. ......+.+|++++++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578889999999999999975 247899999996542 22344688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.++|. +...+++.+...++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 mEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 105 LDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ECCCTTCEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEcCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999994 345799999999999999999999995 9999999999999999999999999999865
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
..... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+..
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~----- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKL----- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC-----
Confidence 43222 2334579999999999999999999999999999999999999997533211 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
.+...+ ...+.+++.+||+.||++|||+
T Consensus 244 -~~p~~~----s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -GMPQFL----SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCCCcC----CHHHHHHHHHHcccCHHHCCCC
Confidence 111122 3356788889999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=388.71 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=184.3
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCC--------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-------- 572 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 572 (839)
..|.+.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3467789999999999999976 57899999999654332 3456899999999999999999999986543
Q ss_pred ----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 573 ----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 573 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
..++||||+++|+|.++|... ......++...+.++.||+.||+|||+. +|+||||||+||||+.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 368999999999999999532 1223455667889999999999999995 9999999999999999999999
Q ss_pred cccCcceecCCCCce-----------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc
Q 038743 649 SDFGLAKLMGREHSQ-----------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF 717 (839)
Q Consensus 649 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 717 (839)
+|||+|+.+...... ..+...||+.|||||++.+..|+.++|||||||+||||++ ||....+.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--- 233 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--- 233 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---
Confidence 999999977543221 1233569999999999999999999999999999999996 66421100
Q ss_pred cchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 718 FYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
............ + .........+.+++.+||+.+|++|||+.|+++
T Consensus 234 ---~~~~~~~~~~~~-----p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 ---VRTLTDVRNLKF-----P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHHHTTCC-----C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHhcCCC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111111110 0 011222344567889999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=378.65 Aligned_cols=292 Identities=43% Similarity=0.747 Sum_probs=245.5
Q ss_pred CCCcccchHHHHHHhhcc--ccccccCCCceEEEEEeCCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccc
Q 038743 490 GAPVNFTYRDLQIRTSNF--AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCG 566 (839)
Q Consensus 490 ~~~~~~~~~~l~~~~~~~--~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g 566 (839)
+....+++.++.....++ .+.||+|+||.||+|...+++.||||++..... .....+.+|++++.+++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 344567888888776655 579999999999999988899999999965432 23347899999999999999999999
Q ss_pred eeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCce
Q 038743 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 567 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
++......++||||+++|+|.+++.... .....+++..+..++.||+.||+|||+.+..+|+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999996432 234569999999999999999999999655599999999999999999999
Q ss_pred eecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC--CCCCccchhhhh
Q 038743 647 KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG--DAEDFFYPGWAF 724 (839)
Q Consensus 647 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~--~~~~~~~~~~~~ 724 (839)
||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+... .........|..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999999876555555556679999999999999899999999999999999999999996322 222333445555
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..........+.+..+......+....+.+++.+||+.+|.+|||+.+|+++|++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 5555666667778888888889999999999999999999999999999999987544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=375.30 Aligned_cols=274 Identities=36% Similarity=0.618 Sum_probs=235.5
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNG 584 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 584 (839)
+.+.+.||+|+||.||+|...+++.||||++........+.+.+|++++.+++||||+++++++.+....++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 45567999999999999998889999999987765666778999999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc-e
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS-Q 663 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~ 663 (839)
+|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 121 ~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 121 NLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp BTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred cHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999995431 2234689999999999999999999995 999999999999999999999999999987543222 2
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......|.......+....++++.+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 23345689999999999999999999999999999999999999987665555555556555555566667777777777
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
...+....+.+++.+||+.+|++||++.+|++.|+....
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 888899999999999999999999999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=385.02 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=196.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeec------CCce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE------GSNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 574 (839)
.|.+.+.||+|+||+||+|.. .+|+.||||++++... ...+.+.+|+++|++++|||||++++++.. ....
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 467788999999999999976 5799999999975432 223568899999999999999999998753 4678
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
+||||||+ |+|.++|. ....+++..+..++.||+.||.|||+. +||||||||+|||++.++.+||+|||+|
T Consensus 135 ~ivmE~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 99999996 68999984 346799999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCC---ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh--------h
Q 038743 655 KLMGREH---SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG--------W 722 (839)
Q Consensus 655 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~ 722 (839)
+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||......+...... .
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764322 1223456799999999998875 56999999999999999999999997544221110000 0
Q ss_pred hhhhhccCccccccccc-ccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 AFKEMTNGTPLKVADRR-LEGAVEE-----EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~-l~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+...........+... .....+. .....+.+++.+||+.||.+|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000000 0000010 112456788999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=372.22 Aligned_cols=196 Identities=21% Similarity=0.320 Sum_probs=167.4
Q ss_pred hhccccccccCCCceEEEEEe----CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.|.+.++||+|+||+||+|+. ..++.||||++... ....++.+|++++..+ +|||||++++++.+.++.+|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 477889999999999999964 24789999998653 3345688999999998 6999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-CceeecccCcceec
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLM 657 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~~~ 657 (839)
||+++|+|.+++. .+++.+...++.||+.||+|||+. +|+||||||+||||+.+ +.+||+|||+|+..
T Consensus 100 E~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 100 PYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp ECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999882 488999999999999999999995 99999999999999876 79999999999865
Q ss_pred CCCCc---------------------------eeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 658 GREHS---------------------------QVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 658 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
..... .......||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43211 112345699999999999875 58999999999999999999999996
Q ss_pred CCC
Q 038743 710 MSG 712 (839)
Q Consensus 710 ~~~ 712 (839)
...
T Consensus 249 ~~~ 251 (361)
T 4f9c_A 249 KAS 251 (361)
T ss_dssp CCS
T ss_pred CCC
Confidence 443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=392.74 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=205.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|+.++|||||++++++.+....+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 577889999999999999976 5699999999976544556678999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC--CceeecccCcceecCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN--FCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~--~~~kl~DfGla~~~~~~ 660 (839)
+|+|.++|.. ....+++.+...++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 238 gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 238 GGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999842 345689999999999999999999995 99999999999999854 89999999999987543
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ....+..... -.....
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~--~~~~~~ 379 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDW--NMDDSA 379 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC--CCCSGG
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCC--CCCccc
Confidence 2 3445679999999999999999999999999999999999999997543221 1111111110 001111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+ ...+.+++.+||+.||.+|||+.|+++.
T Consensus 380 ~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 FSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122 2346788899999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=386.10 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=194.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHH---HHHHhhccccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVT---EVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.+.+.++||+|+||+||+++. .+|+.||||++.+.. ........+ ++.++..++|||||++++++.+.+..+|
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 467789999999999999976 469999999996431 222233333 4666777899999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||++||+|.++|. ....+++.....++.||+.||.|||+. +||||||||+||||+.+|.+||+|||+|+.
T Consensus 270 VmEy~~GGdL~~~l~-----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EECCCCSCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999994 345799999999999999999999995 999999999999999999999999999997
Q ss_pred cCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
+.... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||.......... .........
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~----i~~~i~~~~---- 410 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA---- 410 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH----HHHHHHHCC----
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhhcCCC----
Confidence 75433 234579999999999974 579999999999999999999999996432221100 011111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
..+...+ ...+.+++.+||+.||.+|++ ++||++
T Consensus 411 --~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 --VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111222 345678888999999999998 677765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=359.36 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=199.3
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...+.+.+.||+|+||+||+|+. +++.||||++..... ...+++.+|++++.+++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 44567788999999999999987 688999999965432 223578999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe--eeecCCCCCcEEECCCCceeecccCcceec
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR--IIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|+++|+|.+++... .....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 115 YLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp CCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred cCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999532 1223589999999999999999999995 7 999999999999999999999999999865
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-------~~~~~~~------- 254 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-------VAAVGFK------- 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHHS-------
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-------
Confidence 3322 123345699999999999999999999999999999999999999964322110 0000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
......+......+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 255 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 -CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00011112223457788899999999999999999999988655
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.94 Aligned_cols=258 Identities=28% Similarity=0.379 Sum_probs=207.6
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..+.+.++||+|+||+||++.. .+++.||+|++........+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 3456778999999999999977 468999999987655556678999999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++.. ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999953 245689999999999999999999995 99999999999999999999999999998764432
Q ss_pred cee-------------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhc
Q 038743 662 SQV-------------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT 728 (839)
Q Consensus 662 ~~~-------------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 728 (839)
... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+........... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~------ 235 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LN------ 235 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BC------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hh------
Confidence 221 1145699999999999999999999999999999999999999864332211000 00
Q ss_pred cCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 729 NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 729 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.....+..... .....+.+++.+||+.+|++||++.++++.|+...
T Consensus 236 ---~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 ---VRGFLDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---HHHHHHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hhccccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011111111 12234778889999999999999999999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.30 Aligned_cols=270 Identities=26% Similarity=0.340 Sum_probs=204.5
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC----ceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS----NRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 578 (839)
..+.+.++||+|+||+||+|+.. ++.||||++... ......+..|+.++.+++||||+++++++.+.. ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 45667889999999999999884 799999999654 233445677999999999999999999998754 369999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-------CCeeeecCCCCCcEEECCCCceeeccc
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC-------RNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
||+++|+|.+++. ...+++..++.++.||+.||+|||+.+ .++|+||||||+|||++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999993 345899999999999999999999831 229999999999999999999999999
Q ss_pred CcceecCCCCcee-EEeeccccceeCcccccCC-----CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-
Q 038743 652 GLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNR-----PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF- 724 (839)
Q Consensus 652 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~- 724 (839)
|+++.+....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||....+.....+.....
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 9998765433221 2335689999999999873 45678899999999999999999997654432221111100
Q ss_pred ----hhhccCcccccccccccCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 725 ----KEMTNGTPLKVADRRLEGA-VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 725 ----~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+..........+.+... ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000000000011111111 1224566789999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=346.96 Aligned_cols=258 Identities=23% Similarity=0.410 Sum_probs=211.5
Q ss_pred HHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
....+.+.+.||+|+||.||+|+..++..||||++... ....+++.+|++++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34567778899999999999999988889999999754 33456799999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 85 ISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred cCCCcHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999842 234689999999999999999999995 9999999999999999999999999999877655
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.. ...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--~~~-- 226 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHR--LYR-- 226 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC--CCC--
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCC--CCC--
Confidence 4444444557788999999999899999999999999999999 999996433211 0111111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+......+.+++.+||+.+|.+||++.++++.|+...+
T Consensus 227 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 -----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11112357788889999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=360.10 Aligned_cols=261 Identities=23% Similarity=0.434 Sum_probs=206.9
Q ss_pred HHHHHhhccccccccCCCceEEEEEeC----CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
++....+.+.+.||+|+||.||+|... .+..||||++..... ...+.+.+|+.++.+++||||+++++++.+...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 344556777889999999999999873 355699999975432 334679999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp CEEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred cEEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCc
Confidence 9999999999999999942 335689999999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 654 AKLMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 654 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~ 270 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEG 270 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTT
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcC
Confidence 99875433222 223456789999999999999999999999999999999 999996432211 11111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
.....+......+.+++.+||+.+|.+||++.+|+++|+....
T Consensus 271 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 ---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111122234567888999999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=377.86 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=213.8
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeCC-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.++....+.+.+.||+|+||.||+|.... ++.||||+++.. ....++|.+|+.++.+++||||++++++|.+....++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 44555667888999999999999998754 889999999754 3346789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++|+|.++|... ....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 294 v~E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999999532 335689999999999999999999995 999999999999999999999999999997
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.............+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~------ 434 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEK------ 434 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHT------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc------
Confidence 75443332333456789999999999999999999999999999999 999986433211 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
......+......+.+++.+||+.+|.+||+|.+|++.|+....
T Consensus 435 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 ---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11111222334567788899999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=346.29 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=209.7
Q ss_pred cccchHHHHHHhh------------ccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccC
Q 038743 493 VNFTYRDLQIRTS------------NFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM 559 (839)
Q Consensus 493 ~~~~~~~l~~~~~------------~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ 559 (839)
..++++++..++. .+.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.+++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3467777777664 34568999999999999875 7999999999766566667899999999999999
Q ss_pred CcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEE
Q 038743 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENIL 639 (839)
Q Consensus 560 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nil 639 (839)
||+++++++......++||||+++++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999983 34689999999999999999999995 9999999999999
Q ss_pred ECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc
Q 038743 640 LDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719 (839)
Q Consensus 640 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~ 719 (839)
++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---- 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---- 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred ECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 999999999999999876543222 234569999999999999999999999999999999999999996432111
Q ss_pred hhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+..... +.+. ........+.+++.+||+.+|++||++.++++.
T Consensus 249 ---~~~~~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 ---AMKRLRDSPP-----PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHHSSC-----CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHhcCCC-----CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 0000 011123356788889999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=344.33 Aligned_cols=278 Identities=35% Similarity=0.574 Sum_probs=223.4
Q ss_pred CcccchHHHHHHhhccc--------cccccCCCceEEEEEeCCCcEEEEEEecccC----CcchHHHHHHHHHhhccccC
Q 038743 492 PVNFTYRDLQIRTSNFA--------QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSMHHM 559 (839)
Q Consensus 492 ~~~~~~~~l~~~~~~~~--------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~ 559 (839)
...|++.++..++.+|. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++.+++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 35689999999998886 4699999999999987 68899999986532 22346789999999999999
Q ss_pred CcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEE
Q 038743 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENIL 639 (839)
Q Consensus 560 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nil 639 (839)
||+++++++.+....++||||+++|+|.+++... .....+++..++.++.||+.||+|||+. +|+||||||+|||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999998532 2235689999999999999999999995 9999999999999
Q ss_pred ECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc
Q 038743 640 LDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF 718 (839)
Q Consensus 640 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 718 (839)
++.++.+||+|||+++......... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 9999999999999998765433322 234568999999998765 5789999999999999999999999755433211
Q ss_pred chhhhhhhhcc--CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 719 YPGWAFKEMTN--GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 719 ~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+ ...... ......+++.+ ...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 244 -~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 -LDI-KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp -THH-HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHH-HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 111111 11222333333 234567788899999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.05 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=204.2
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..|.+.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 3466778999999999999975 578999999997655556677899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp TTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999983 33688999999999999999999995 99999999999999999999999999998765433
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......+.. .
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~--------~ 235 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP--------E 235 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC--------C
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC--------C
Confidence 32 3345699999999999999999999999999999999999999964322110 0000000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+||+.+|.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01111223457788899999999999999999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=360.50 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=207.0
Q ss_pred HHhhccccccccCCCceEEEEEe--------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL--------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
...+.+.+.||+|+||.||+|.. .++..||||+++.... ...+++.+|+.++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 34567788999999999999975 2356899999975432 2345789999999999 899999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
...++||||+++|+|.++|..... .....+++..++.++.||+.||+|||+. +|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999964321 1234588999999999999999999995 99999999999999
Q ss_pred CCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCcc
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFF 718 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 718 (839)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 99999999999999876543221 1233457889999999999999999999999999999999 999986432211
Q ss_pred chhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 719 YPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+..+. ....+......+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 314 ----~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 ----LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ----HHHHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 11112223345778889999999999999999999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=374.55 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=210.1
Q ss_pred HHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
++....+.+.+.||+|+||.||+|...+++.||||+++.. ....++|.+|++++.+++||||+++++++. ....++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3444566778899999999999999988999999999764 345678999999999999999999999987 56789999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.++|... ....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 999999999999432 234688899999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
...........+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~------- 401 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERG------- 401 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHT-------
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-------
Confidence 432222233446789999999999999999999999999999999 999996432211 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
.....+......+.+++.+||+.+|++||||.+|+++|+....
T Consensus 402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0111122234567888999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=365.62 Aligned_cols=258 Identities=25% Similarity=0.439 Sum_probs=195.6
Q ss_pred HHHHhhccccccccCCCceEEEEEeC----CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.+.||+|+||.||+|+.. ++..||||+++.... ...++|.+|+.++.+++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 33456677889999999999999764 577899999975432 3345799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 122 ~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 999999999999999942 345689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 655 KLMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 655 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
+......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~-- 265 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDE-- 265 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHT--
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc--
Confidence 8765433222 222345778999999999999999999999999999998 999996432111 1111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
......+......+.+++.+||+.+|.+||+|.+|+++|+..
T Consensus 266 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 266 -------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111111223345678899999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.89 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=208.0
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||+|...+++.||||++... ....+++.+|++++.+++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 456778899999999999999988999999999754 3345679999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 89 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999999943 345689999999999999999999995 999999999999999999999999999987654333
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+. .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF---------R 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC---------C
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCc---------c
Confidence 33334457788999999999999999999999999999999 999996432211 111111110 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|.+||++.++++.|++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 011111234577888899999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.33 Aligned_cols=274 Identities=23% Similarity=0.335 Sum_probs=203.7
Q ss_pred HHHHhhccccccccCCCceEEEEEe-----CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec--CC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GS 572 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~ 572 (839)
+....+.+.+.||+|+||+||++++ .+++.||||++........+.+.+|++++.+++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3445677889999999999999984 3688999999976655555779999999999999999999999854 35
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 68999999999999999943 234689999999999999999999995 99999999999999999999999999
Q ss_pred cceecCCCCce--eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 653 LAKLMGREHSQ--VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 653 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
+++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 99876543322 2233457888999999999999999999999999999999999885321100000000000000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+.+........+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00011111111122223345678889999999999999999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=371.06 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=204.3
Q ss_pred HHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+....+.+.+.||+|+||.||+|...++..||||+++... ...++|.+|++++.+++||||+++++++.+ ...++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4445567788999999999999999888899999997543 345689999999999999999999999876 67899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.++|... ....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999421 234689999999999999999999995 999999999999999999999999999987654
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
..........+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~-------- 397 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG-------- 397 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT--------
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC--------
Confidence 33333334457889999999999999999999999999999999 999986432211 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
.....+......+.+++.+||+.+|++|||+.+|++.|+....
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 0111122334567788999999999999999999999998755
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.63 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=198.6
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhc--cccCCcccccceeec----CCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGS--MHHMNLVRLCGYCSE----GSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~ 575 (839)
...+.+.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 34567789999999999999988 7899999998643 34556667776665 799999999998654 34589
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-----CCeeeecCCCCCcEEECCCCceeecc
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC-----RNRIIHCDIKPENILLDENFCPKVSD 650 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~D 650 (839)
+||||+++|+|.+++. ...+++..++.++.||+.||+|||... ..+|+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 9999999999999993 346899999999999999999999211 25999999999999999999999999
Q ss_pred cCcceecCCCCcee---EEeeccccceeCcccccCC------CCCCcccEEehhHHHHHHHhC----------CCCCCCC
Q 038743 651 FGLAKLMGREHSQV---VTMVRGTRGYLAPEWVSNR------PITVKADVYSYGMLLLEIVGG----------RRNLDMS 711 (839)
Q Consensus 651 fGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~DV~S~Gvvl~elltG----------~~p~~~~ 711 (839)
||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765443332 2234699999999999876 455799999999999999999 6666433
Q ss_pred CCCCCccchhhhhhhhccCccccccccccc-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 712 GDAEDFFYPGWAFKEMTNGTPLKVADRRLE-GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...... .... ...... ....+.+. ...+......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 237 ~~~~~~-~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 237 VPNDPS-FEDM-RKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SCSSCC-HHHH-HHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcc-hhhh-hHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 221110 0000 000000 00011111 11223567788999999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.04 Aligned_cols=257 Identities=21% Similarity=0.366 Sum_probs=206.5
Q ss_pred HHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+....+.+.+.||+|+||.||+++..++..||||++... ....+++.+|++++.+++||||+++++++.+....++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 344566778999999999999999988889999999754 3345789999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHC----GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999943 245689999999999999999999995 999999999999999999999999999987644
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+. .
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-----~- 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL-----R- 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC-----C-
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhccc-----C-
Confidence 33222333457788999999999999999999999999999998 999996433211 111111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|.+||++.++++.|+..
T Consensus 240 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011111234577888999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=363.00 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=205.4
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
+....+.+.+.||+|+||.||+|... +++.||||++..... ....+|.+|++++.+++||||+++++++.+....++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 33445677889999999999999885 789999999875432 2235688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 191 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999942 234689999999999999999999995 9999999999999999999999999999865
Q ss_pred CCCCceeE-EeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQVV-TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
........ ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~---- 332 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGG---- 332 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTC----
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC----
Confidence 43221111 12235778999999999999999999999999999998 999986432211 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 333 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111122234577888999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.46 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=203.5
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||++.. .+++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 3567788999999999999975 46899999998543322 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 91 EYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp ECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred eCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999984 334689999999999999999999995 99999999999999999999999999998765
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........... . ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~-~-~~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSVP-N-VTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCCC-C-HHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccCC-C-cch
Confidence 444333445679999999999999999999999999999999999999996433211 11111111100 0 011
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhcCCCCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRP-SMGEVVKMLEGSADI 783 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~~v~~~L~~~~~~ 783 (839)
.... .....+.+++.+|++.+|.+|| +++++.+.|+....-
T Consensus 235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1111 2234577889999999999999 999999999876553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.41 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=198.5
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCc----EEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGT----LVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
+....+.+.++||+|+||+||+|... +++ +||+|.+.... ....+++.+|+.++.+++||||+++++++.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 33455677889999999999999853 444 46888875432 344578999999999999999999999998754
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred eEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcc
Confidence 7899999999999999953 245689999999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 654 AKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 654 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~- 235 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKG- 235 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTT-
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcC-
Confidence 98775443322 334557889999999999999999999999999999999 9999975432210 1111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+......+.+++.+||+.+|.+||+|.+|++.|+..
T Consensus 236 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 --------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111222344678889999999999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.10 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=214.0
Q ss_pred chHHHHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
.-.++....+.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|++++.+++||||+++++++.+....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 334455667778899999999999999875 4889999999754 34456799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 85 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred EEEEEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999999532 345689999999999999999999996 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~---- 227 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEK---- 227 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHT----
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhc----
Confidence 8776555444445567889999999999999999999999999999999 999986433211 0111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
......+......+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 228 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 228 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 011111122235678888999999999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.29 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=192.6
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCC----cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP----HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+|.. .++.||||++..... ...+.+.+|++++..++||||+++++++.+....++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4567788999999999999998 488999999865422 22467899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC--------CCceeecc
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--------NFCPKVSD 650 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--------~~~~kl~D 650 (839)
||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999983 457899999999999999999999962223999999999999986 77899999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . .....
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~-~~~~~- 228 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------A-YGVAM- 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------H-HHHHT-
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-Hhhhc-
Confidence 999986543322 234689999999999999999999999999999999999999964322110 0 00000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.......+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 229 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 -------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 001111122233457788999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=362.52 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=202.0
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC-ceEEEEee
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-NRLLVYEF 580 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~ 580 (839)
...+.+.+.||+|+||.||+|... ++.||||+++... ..+.|.+|++++.+++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 345667789999999999999984 7899999997542 4568999999999999999999999987665 78999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.++|... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999532 233478999999999999999999995 9999999999999999999999999999864322
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~-------- 403 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY-------- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTC--------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC--------
Confidence 122357889999999999999999999999999999998 999996543221 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+......+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111222345677888999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.03 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=206.7
Q ss_pred HHHHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCCc-chHHHHHHHHHhhcc-ccCCcccccceee
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSM-HHMNLVRLCGYCS 569 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 569 (839)
.++....+.+.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 344455677789999999999999963 34689999999754332 345699999999999 8999999999988
Q ss_pred cCCc-eEEEEeeccCCChhhhcccCCCC----------------------------------------------------
Q 038743 570 EGSN-RLLVYEFMKNGSLDKWIFPSYHH---------------------------------------------------- 596 (839)
Q Consensus 570 ~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 596 (839)
+... .++||||+++|+|.+++......
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 7554 89999999999999999643210
Q ss_pred ---------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce-eEE
Q 038743 597 ---------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ-VVT 666 (839)
Q Consensus 597 ---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~ 666 (839)
....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++........ ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 012288999999999999999999995 9999999999999999999999999999876443332 234
Q ss_pred eeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCC
Q 038743 667 MVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745 (839)
Q Consensus 667 ~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 745 (839)
...||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ....+..+.. ...+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~ 318 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR---------MRAP 318 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCC---------CCCC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCC---------CCCC
Confidence 5568999999999999999999999999999999998 9999965432211 1111111110 1111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 746 ~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
......+.+++..||+.+|.+||+|.+|++.|+..
T Consensus 319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11234577888999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=347.74 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=200.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 467788999999999999976 679999999996542 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 96 ASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999984 235689999999999999999999995 9999999999999999999999999999866433
Q ss_pred CceeEEeeccccceeCcccccCCCCC-CcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPIT-VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
. ......||+.|+|||.+.+..+. .++||||||+++|||++|+.||......+ .......+.. .
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------~ 232 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY------R 232 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------C
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------C
Confidence 2 12345699999999999988775 79999999999999999999997432111 1111111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+ +......+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 ~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 11123446788888999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.11 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=207.0
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeec
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 570 (839)
.++....+.+.+.||+|+||.||+|... +++.||||++.... .....++.+|+.++.+++||||+++++++.+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3444566778899999999999999853 46789999996542 3344578999999999999999999999999
Q ss_pred CCceEEEEeeccCCChhhhcccCCC--CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC---c
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYH--HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---C 645 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~ 645 (839)
....++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+||||+.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999964321 1234689999999999999999999995 999999999999999554 5
Q ss_pred eeecccCcceecCCCCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhh
Q 038743 646 PKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWA 723 (839)
Q Consensus 646 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 723 (839)
+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~ 295 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------V 295 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------H
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999986532221 12234557899999999999999999999999999999998 999996433211 1
Q ss_pred hhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 724 FKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+..+.. ...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 296 ~~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 296 LEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111110 111112234577888999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.19 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=199.0
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++..++||||+++++++.+....++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4667889999999999999764 78999999985432 223456899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 88 ~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 88 SGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp TTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999983 345689999999999999999999995 99999999999999999999999999998764332
Q ss_pred ce-eEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 662 SQ-VVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 662 ~~-~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... + ..+..... ...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~-----~~~~~~~~--~~~-- 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKT--YLN-- 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H-----HHHHTTCT--TST--
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHHhcccc--cCC--
Confidence 22 2334579999999999988765 78999999999999999999999754432110 1 11111100 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
........+.+++.+||+.+|.+|||+.|+++.
T Consensus 230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001123456788899999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.87 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=198.2
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..|.+.+.||+|+||+||+|...+++.||||++..... .....+.+|++++.+++||||+++++++.++...++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 45677889999999999999998899999999964422 2245788999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 101 MEK-DLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CSE-EHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 985 78777742 335689999999999999999999995 9999999999999999999999999999876533
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh--------hhhhcc--
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA--------FKEMTN-- 729 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~-- 729 (839)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ +....+
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22 2334568999999999876 56899999999999999999999999765433211000000 000000
Q ss_pred ---CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 ---GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ---~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......................+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000000000112245678899999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.28 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=195.5
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||+|+. .++.||||++... ...+.+.+|++++.+++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4566788999999999999988 4789999998643 345679999999999999999999999874 4899999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc-eeecccCcceecCCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC-PKVSDFGLAKLMGREH 661 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~-~kl~DfGla~~~~~~~ 661 (839)
+|+|.+++... .....+++..++.++.||++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 83 GGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999543 12235788899999999999999999954458999999999999998886 799999999765332
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... .....+. .+.+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~-~~~~~~~-----~~~~~ 226 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIM-WAVHNGT-----RPPLI 226 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHH-HHHHTTC-----CCCCB
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHH-HHHhcCC-----CCCcc
Confidence 2234589999999999999999999999999999999999999974332210 000 0111111 01111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.. ....+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 227 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 227 KN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 12 2345778889999999999999999999997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=362.91 Aligned_cols=254 Identities=19% Similarity=0.217 Sum_probs=199.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.++||+|+||+||+|+.. +++.||||++.+.. ......+.+|+.++..++||||+++++++.+....+||||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4556789999999999999875 47899999996421 2223458899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.++|.. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 155 y~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 155 YYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999943 245789999999999999999999995 999999999999999999999999999987765
Q ss_pred CCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ..+.... ..
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~-~~ 299 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHK-ER 299 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTHH-HH
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-------Hhhhhcc-cc
Confidence 5444444567999999999987 567899999999999999999999999754321110 1110000 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFM--RPSMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~~v~~~ 776 (839)
+.-+...... ...+.+++.+|++.+|++ ||+++|+++.
T Consensus 300 ~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 FQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0001111112 234667788888877777 9999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=374.28 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=209.9
Q ss_pred HHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
++....+.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++.+++||||+++++++.+ ...+|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34455667788999999999999999888899999997643 345689999999999999999999999976 6789999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.++|... ....+++.+++.|+.||+.||+|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 341 e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp CCCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred ehhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999421 234689999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
...........++..|+|||.+....++.++||||||++||||++ |+.||......+ ....+..+.
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~------ 481 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY------ 481 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTC------
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 322222223456789999999999999999999999999999999 999986432211 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
....+......+.+++.+||+.+|++||++.+|+++|+....
T Consensus 482 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111122234457788899999999999999999999998765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.19 Aligned_cols=279 Identities=22% Similarity=0.322 Sum_probs=203.2
Q ss_pred ccchHHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhc--cccCCcccccceeecC
Q 038743 494 NFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGS--MHHMNLVRLCGYCSEG 571 (839)
Q Consensus 494 ~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~ 571 (839)
.....+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34556666778899999999999999999884 899999998532 23445556665555 4999999999999877
Q ss_pred ----CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-----CCeeeecCCCCCcEEECC
Q 038743 572 ----SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC-----RNRIIHCDIKPENILLDE 642 (839)
Q Consensus 572 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~dlk~~Nill~~ 642 (839)
...++||||+++|+|.+++. ...+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 67899999999999999993 346899999999999999999999841 238999999999999999
Q ss_pred CCceeecccCcceecCCCCcee---EEeeccccceeCcccccCCCCCCc------ccEEehhHHHHHHHhCCCCCCCCCC
Q 038743 643 NFCPKVSDFGLAKLMGREHSQV---VTMVRGTRGYLAPEWVSNRPITVK------ADVYSYGMLLLEIVGGRRNLDMSGD 713 (839)
Q Consensus 643 ~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------~DV~S~Gvvl~elltG~~p~~~~~~ 713 (839)
++.+||+|||+++.+....... .....||+.|+|||.+.+.....+ +||||||+++|||++|..|+.....
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998764433222 123469999999999988776665 9999999999999999555432111
Q ss_pred CCCccc----hhhhhhhhccCcccccccccccCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 714 AEDFFY----PGWAFKEMTNGTPLKVADRRLEGA-VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 714 ~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
...... ..................+.+... ...+....+.+++.+||+.+|.+||++.+|++.|+...+
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 100000 000000000000000111111111 122567788999999999999999999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.55 Aligned_cols=272 Identities=18% Similarity=0.228 Sum_probs=209.7
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCC--ceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS--NRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 579 (839)
.|.+.++||+|+||+||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4667889999999999999775 58999999997543 233567889999999999999999999987655 7799999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE----CCCCceeecccCcce
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAK 655 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla~ 655 (839)
|+++++|.+++... .....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 90 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 90 FCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp CCTTCBHHHHHHSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred CCCCCCHHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999543 1223489999999999999999999995 99999999999999 888889999999998
Q ss_pred ecCCCCceeEEeeccccceeCccccc--------CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc-chhhhhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVS--------NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF-YPGWAFKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~ 726 (839)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||.......... ........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 23346999999999886 5788999999999999999999999996543322110 00000000
Q ss_pred hccCccccc---------c--cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 727 MTNGTPLKV---------A--DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 727 ~~~~~~~~~---------~--~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
.....+..+ . +-.............+.+++.+||+.||++||++.|+++...+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 000000000 0 0111224456777788899999999999999999999999876554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.18 Aligned_cols=265 Identities=24% Similarity=0.351 Sum_probs=210.1
Q ss_pred HHHHHhhccccccccCCCceEEEEEe--------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCccccccee
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL--------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYC 568 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 568 (839)
++....+.+.+.||+|+||.||+|+. ..+..||||++..... ....++.+|++++.++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44455677889999999999999975 2346899999975432 2346789999999999 999999999999
Q ss_pred ecCCceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
.+....++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999854321 1234689999999999999999999995 99999999999
Q ss_pred EEECCCCceeecccCcceecCCCCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCC
Q 038743 638 ILLDENFCPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAE 715 (839)
Q Consensus 638 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 715 (839)
|||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654322 22233457889999999999999999999999999999999 999986432111
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
....+..+.. ...+......+.+++.+||+.+|++||++.+|++.|+....
T Consensus 302 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 302 -------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp -------HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 11111223457788899999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.03 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=200.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc------chHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.|.+.+.||+|+||.||++... +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4677889999999999999764 6899999999654322 24678999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC----ceeecccC
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF----CPKVSDFG 652 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG 652 (839)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 93 v~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 93 ILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999993 345789999999999999999999995 999999999999998877 79999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVSY 235 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCC
Confidence 998765432 2234569999999999999999999999999999999999999996533211 1111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
-.++..... ....+.+++.+||+.+|.+|||+.|+++
T Consensus 236 --~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 --DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111111 1245678888999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.91 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=192.8
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--------------------------cchHHHHHHHHHhhc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--------------------------HGEKEFVTEVNTIGS 555 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 555 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 3567788999999999999976 5689999999864321 113568899999999
Q ss_pred cccCCcccccceeec--CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCC
Q 038743 556 MHHMNLVRLCGYCSE--GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDI 633 (839)
Q Consensus 556 l~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 633 (839)
++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||+|||+. +|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 999999999999976 56889999999999998876 335789999999999999999999995 9999999
Q ss_pred CCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCC---CCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 634 KPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP---ITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 634 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
||+|||++.++.+||+|||+++.+..... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233456999999999998765 37889999999999999999999964
Q ss_pred CCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.... . ....+..... ...........+.+++.+||+.+|++||++.|+++
T Consensus 243 ~~~~------~-~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM------C-LHSKIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH------H-HHHHHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH------H-HHHHHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 0 0111111110 00001112345778889999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.44 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=207.7
Q ss_pred HHHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeec
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE 570 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 570 (839)
++....+.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34455677888999999999999985 246689999996542 33456799999999999 89999999999999
Q ss_pred CCceEEEEeeccCCChhhhcccCCCC------------------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecC
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYHH------------------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCD 632 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 632 (839)
....++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999543210 113489999999999999999999995 999999
Q ss_pred CCCCcEEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCC
Q 038743 633 IKPENILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDM 710 (839)
Q Consensus 633 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~ 710 (839)
|||+|||++.++.+||+|||++.......... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999998765443322 334557889999999999999999999999999999998 9999965
Q ss_pred CCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
...... ....+..+ .....+......+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 278 ~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcHHH------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 432211 11111111 1111112223457788899999999999999999999987644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=339.87 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=192.6
Q ss_pred HHHhhccccccccCCCceEEEEEeCC----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
....+.+.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|+.++.+++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34567788999999999999997643 45799999875432 23456899999999999999999999985 46789
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 99999999999999942 234689999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i~~~~~-- 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGER-- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCC--
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHHHcCCC--
Confidence 775543333344557889999999999999999999999999999996 999997543221 1111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122234577888999999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=339.70 Aligned_cols=250 Identities=18% Similarity=0.233 Sum_probs=202.2
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||.||++... +++.||+|.+... ......+.+|+.++..++||||+++++++.+....++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4667889999999999999764 6889999998643 3445568899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC--CCceeecccCcceecCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--NFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~ 660 (839)
+|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 85 g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 85 GLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999942 334689999999999999999999995 9999999999999987 789999999999887543
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+... .+...
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~--~~~~~ 226 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDEEA 226 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCHHH
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCC--CChhh
Confidence 2 3345569999999999999889999999999999999999999996433211 11111111100 00000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
... ....+.+++.+|++.+|.+|||+.|+++.
T Consensus 227 ~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011 23457788999999999999999999984
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=343.36 Aligned_cols=248 Identities=23% Similarity=0.277 Sum_probs=201.2
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEeccc---CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRV---LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+++.. +|+.||||++++. .......+.+|++++..++||||+++++++......++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 35667889999999999999764 6899999999653 2334567889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999884 345789999999999999999999995 99999999999999999999999999998643
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+..+. .
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~------~ 222 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE------I 222 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------C
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------C
Confidence 2222 2334569999999999999999999999999999999999999996432111 111111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
.+... ....+.+++.+||+.+|.+|| ++.+|++.
T Consensus 223 ~~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11112 234567888889999999999 89999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.03 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=207.5
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 345667889999999999999873 348999999975432 2345789999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCC-------------------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCC
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHH-------------------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKP 635 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~ 635 (839)
++||||+++|+|.++|...... ....+++.+++.++.||+.||.|||+. +|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence 9999999999999998643111 125789999999999999999999995 999999999
Q ss_pred CcEEECCCCceeecccCcceecCCCCc-eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCC
Q 038743 636 ENILLDENFCPKVSDFGLAKLMGREHS-QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGD 713 (839)
Q Consensus 636 ~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~ 713 (839)
+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999987643322 22344568999999999999999999999999999999999 9999964321
Q ss_pred CCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 714 AEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
.+ ....+..+... ..+......+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 283 ~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 EE-------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH-------HHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11 11111111111 1111223457788899999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=338.52 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=206.3
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
...+.+.+.||+|+||.||+|...+++.||||.+... ....+.+.+|++++.+++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 3467778899999999999999988889999999754 3346789999999999999999999999864 5689999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 90 ENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp TTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999421 223689999999999999999999995 99999999999999999999999999998875543
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~--------- 227 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGY--------- 227 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhccc---------
Confidence 333333457788999999998899999999999999999999 899986432211 111111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+......+.+++.+|++.+|++||++.++++.|+...
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00111122345778888999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.82 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=207.8
Q ss_pred HHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCc
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 573 (839)
....+.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 345567788999999999999975 3458999999975432 334678999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCC-------------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCC
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYH-------------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIK 634 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 634 (839)
.++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999964321 0124588999999999999999999995 99999999
Q ss_pred CCcEEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCC
Q 038743 635 PENILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSG 712 (839)
Q Consensus 635 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~ 712 (839)
|+|||++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765433322 233457889999999999999999999999999999999 999996443
Q ss_pred CCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 713 DAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
... ....+..+.. ...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 258 ~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PER-------LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGG-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-------HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 211 1111111110 111122334577888999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.18 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=198.9
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcch-------HHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGE-------KEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
..+.+.+.||+|+||.||+|.. .+++.||||++........ +.+.+|++++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 4567788999999999999977 5789999999864432221 57899999999999999999999987655
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe--eeecCCCCCcEEECCCCc-----ee
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR--IIHCDIKPENILLDENFC-----PK 647 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlk~~Nill~~~~~-----~k 647 (839)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +|
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999988843 345789999999999999999999995 7 999999999999988776 99
Q ss_pred ecccCcceecCCCCceeEEeeccccceeCccccc--CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS--NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
|+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||......... . ..
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~-~~ 240 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----F-IN 240 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----H-HH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----H-HH
Confidence 999999985433 234456999999999984 456789999999999999999999999754322110 0 00
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
... ........+......+.+++..||+.+|.+||++.+|++.|++
T Consensus 241 ~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MIR--------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHH--------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHh--------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 000 0111111222233567888899999999999999999999975
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=329.37 Aligned_cols=223 Identities=20% Similarity=0.212 Sum_probs=161.9
Q ss_pred CCCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCC-----CeEEEEecCCc
Q 038743 1 HIGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTK-----DAILELDTTGN 75 (839)
Q Consensus 1 ~~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~-----~~~l~l~~~G~ 75 (839)
+|++|++|.+ +++|||++|+||||||+++ .+|| |+ + .+ |||+|||++||.+ +++|+|+.||+
T Consensus 16 ~l~~g~~l~~--~~~l~S~~g~F~lgf~~~~----~~~l---y~--~-~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 16 VLPAYQTLSA--GQYLLSPNQRFKLLLQGDG----NLVI---QD--N-GA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp EECTTEEBCT--TCEEECTTSSEEEEECTTS----CEEE---EE--T-TE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred EecCCCEecC--CCEEEcCCCcEEEEEECCC----CeEE---EC--C-CC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 3788999877 8999999999999999542 4456 76 4 57 9999999999986 56899999999
Q ss_pred EEE--eC-CCeeEEEecCCC------CceeEEEEeccccEEEecCCCCceeecccCCCccccCCCC----cccceeeccC
Q 038743 76 LVL--ND-GDTTIWASNSSG------AGVELATMSESGNFILYAPNNQPVWQSFLHPSDTLLPNQP----LSVSLELTSP 142 (839)
Q Consensus 76 Lvl--~~-~~~~vWst~~~~------~~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~~----l~~~~~L~s~ 142 (839)
||| .| .+.+||+|+++. ..+++|+|+|+|||||++ +.+|||| ||||||||||| |..+.+|+|.
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L~S~ 158 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSELVQG 158 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEECTT
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCcccccC
Confidence 999 66 456899999754 345679999999999998 7899999 99999999999 6667788664
Q ss_pred CccCCCCcceeeEeecCCCceeEEeecCCCcccCCCCccccccccccCCCCCCcccCceEEeeccCCcceeeeccCCCcc
Q 038743 143 KSLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGA 222 (839)
Q Consensus 143 ~s~~~~g~~s~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~yW~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 222 (839)
.++++|.|++++ ++++ .+.|..+ ...+||+++.|+. ......++.+|.+.+.... +.
T Consensus 159 -~dps~G~fsl~l-~~dG--nlvLy~~---------~~~~yW~Sgt~~~-------~~~~l~l~~dGnLvl~d~~---~~ 215 (276)
T 3m7h_A 159 -VVYGAGASKLVF-QGDG--NLVAYGP---------NGAATWNAGTQGK-------GAVRAVFQGDGNLVVYGAG---NA 215 (276)
T ss_dssp -CEEEETTEEEEE-CTTS--CEEEECT---------TSSEEEECCCTTT-------TCCEEEECTTSCEEEECTT---SC
T ss_pred -CCCCCceEEEee-cCCc--eEEEEeC---------CCeEEEECCCCCC-------ccEEEEEcCCCeEEEEeCC---Cc
Confidence 457789999999 5544 3444221 2345666555542 1134556666666543221 11
Q ss_pred EEEEecCCCccccccccccccccceeEEEEEecCCcEEEEEeecCCCCCCCceeeccccCC
Q 038743 223 VYVYQNDGDYDGLASATNKSTRLTVLRRLILETNGNLRLYRWDNDVNGSRQWVPEWAAVSN 283 (839)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~w~~~~~~~~~W~~~~~~p~d 283 (839)
.+-+ +... ....+|++|+.||+|++|.| ...|..++.+|..
T Consensus 216 ~vWs----------S~t~----~~~~~rl~Ld~dGnLvly~~------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 216 VLWH----------SHTG----GHASAVLRLQANGSIAILDE------KPVWARFGFQPTY 256 (276)
T ss_dssp EEEE----------CSCT----TCTTCEEEECTTSCEEEEEE------EEEEESSSCCTTS
T ss_pred EEEE----------ecCC----CCCCEEEEEcCCccEEEEcC------CCeEEccCccCCc
Confidence 1111 1111 01237999999999999998 2468888888754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=347.10 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=195.9
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.++||+|+||+||+++.. +++.||||++++.. ......+..|..++.++ +||||+++++++.+....++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 45677889999999999999874 58899999997543 22334588999999887 899999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 132 ~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEcCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999884 345789999999999999999999995 9999999999999999999999999999863
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc--cchhhhhhhhccCccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--FYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 735 (839)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+......
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 3222 2234467999999999999999999999999999999999999999754322111 01111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
+ .++......+.+++.+||+.+|.+||++
T Consensus 279 ----~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ----I--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----C--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----c--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 1111223456788889999999999995
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=336.11 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=206.6
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
..+.+.+.||+|+||.||++...+++.||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 3566788999999999999999888999999997653 345689999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 87 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 9999999943 234688999999999999999999995 999999999999999999999999999987643322
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~--------- 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR--------- 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC---------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCc---------
Confidence 22233457789999999998999999999999999999999 899986432111 1111111100
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|.+||++.++++.|+..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111234577888999999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=340.00 Aligned_cols=257 Identities=17% Similarity=0.194 Sum_probs=203.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|++++.++ +||||+++++++......++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 456778999999999999975 678999999986432 234689999999999 9999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc-----eeecccCccee
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC-----PKVSDFGLAKL 656 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~DfGla~~ 656 (839)
+++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 88 -GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred -CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999998432 45799999999999999999999995 9999999999999998887 99999999997
Q ss_pred cCCCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 657 MGREHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 657 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~ 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE----RYQKIGDT 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH----HHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH----HHHHHHhh
Confidence 64433221 234579999999999999999999999999999999999999997543221110 00111000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
... ...+.+... .. .+.+++..|++.+|.+||++.+|++.|+..
T Consensus 236 ~~~-~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 236 KRA-TPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHH-SCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hcc-CCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 000000011 12 688888899999999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.21 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=208.8
Q ss_pred HHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
+....+.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3345677889999999999999974 3578999999975433 2346789999999999 999999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCC-------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYH-------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
...++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999854321 1123589999999999999999999995 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAED 716 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 716 (839)
|++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 99999999999999998775544332 233457889999999999999999999999999999998 9999865432211
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
........ .....+......+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 257 ------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 ------FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ------HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11111111 11111112234577888999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=341.27 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=202.0
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc------chHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...|.+.+.||+|+||.||++... +++.||||++...... ....+.+|+.++.+++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345778899999999999999774 6899999998654321 356799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC----ceeecc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF----CPKVSD 650 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~D 650 (839)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999999993 345689999999999999999999995 999999999999999887 899999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+...
T Consensus 162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~ 232 (326)
T 2y0a_A 162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAV 232 (326)
T ss_dssp CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHT
T ss_pred CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhc
Confidence 99998764322 2234569999999999999999999999999999999999999996432211 00111000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. . ........ ....+.+++.+||+.+|.+|||+.++++.
T Consensus 233 ~~-~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NY-E-FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-C-CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-C-cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 00001111 12456788889999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.03 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=203.8
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 3577888999999999999976 468999999997654445567899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC--CCceeecccCcceecCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--NFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~ 659 (839)
++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 131 ~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 131 SGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999842 344689999999999999999999995 9999999999999974 57899999999998754
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... ..++.
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~~~~~--~~~~~ 272 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDW--EFDED 272 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCC--CCCSS
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--CCCcc
Confidence 332 334569999999999999999999999999999999999999997533211 0011111100 00111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. .......+.+++.+||+.+|.+|||+.++++.
T Consensus 273 ~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 A----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 11223457788999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=340.94 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=194.3
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCC--------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS-------- 572 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 572 (839)
..+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677889999999999999875 79999999996433 334567999999999999999999999986543
Q ss_pred -------------------------------------------------ceEEEEeeccCCChhhhcccCCCCCcccCCh
Q 038743 573 -------------------------------------------------NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDW 603 (839)
Q Consensus 573 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~ 603 (839)
..++||||+++|+|.+++... .......+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~ 163 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--CSLEDREH 163 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--CSGGGSCH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--cCccchhh
Confidence 279999999999999999543 23344566
Q ss_pred hhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce-----------eEEeecccc
Q 038743 604 TTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ-----------VVTMVRGTR 672 (839)
Q Consensus 604 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-----------~~~~~~gt~ 672 (839)
..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999995 9999999999999999999999999999987554221 122346999
Q ss_pred ceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHH
Q 038743 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRA 752 (839)
Q Consensus 673 ~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 752 (839)
.|+|||.+.+..++.++||||||+++|||++|..|+... ............ ..........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~~---------~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLKF---------PLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTCC---------CHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccCC---------CcccccCChhH
Confidence 999999999999999999999999999999987654200 000011111100 01112334556
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 038743 753 MKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 753 ~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+++.+||+.+|.+||++.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 78999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.39 Aligned_cols=252 Identities=20% Similarity=0.253 Sum_probs=200.5
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.++||+|+||+||+++.. +++.||+|++.+.. ......+.+|+.++..++||||+++++++.+....++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34566789999999999999874 58899999996421 223445889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 149 E~~~gg~L~~~l~------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 149 EYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp CCCTTEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999983 23588999999999999999999995 99999999999999999999999999998876
Q ss_pred CCCceeEEeeccccceeCcccccCCC----CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRP----ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
...........||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+. ...+..+.
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~--- 289 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMNHK--- 289 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTHH---
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-------HHHHHhcc---
Confidence 55443444567999999999998765 78999999999999999999999974332110 11111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFM--RPSMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~~v~~~ 776 (839)
..+...........+.+++.+|++.+|.+ ||+++||++.
T Consensus 290 ---~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 ---NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000000112345677888899999988 9999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=339.15 Aligned_cols=256 Identities=21% Similarity=0.271 Sum_probs=181.4
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeeccCCCh
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
+.||+|+||.||++... +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999774 6899999998643 3567889999999996 99999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC---ceeecccCcceecCCCCce
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---CPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DfGla~~~~~~~~~ 663 (839)
.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 94 ~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 94 FERIK-----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99994 335789999999999999999999995 999999999999997665 899999999987644322
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+..+... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 2334568999999999999999999999999999999999999997544321111111112222221110 0000
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCCCC
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGSAD 782 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~~~ 782 (839)
........+.+++.+||+.+|.+||++.++++. +++...
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 001124567788999999999999999999854 444433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.25 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=199.1
Q ss_pred HhhccccccccCCCceEEEEEeC-CCc----EEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGT----LVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
..+.+.+.||+|+||.||+|... +++ .||+|.+.... ......+.+|+.++.+++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 34567789999999999999763 444 38888875432 333456889999999999999999999986 467899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999842 345789999999999999999999995 999999999999999999999999999997
Q ss_pred cCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 657 MGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 657 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
....... ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~- 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERL- 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBC-
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCC-
Confidence 7544332 2345568889999999999999999999999999999999 9999975432211 1111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
..+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 237 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 --------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111224667888999999999999999999997643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=341.60 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=192.6
Q ss_pred HHhhccccccccCCCceEEEEEeCCC----cEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccceeecCCce-
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDG----TLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR- 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~- 574 (839)
...+.+.+.||+|+||.||+|..... ..||||++... .....+++.+|++++.+++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 34567788999999999999987543 27999999654 233456799999999999999999999999877665
Q ss_pred -----EEEEeeccCCChhhhcccCCC-CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 575 -----LLVYEFMKNGSLDKWIFPSYH-HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 575 -----~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 999999999999999853321 1223689999999999999999999995 9999999999999999999999
Q ss_pred cccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhh
Q 038743 649 SDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 649 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------YNY 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-------HHH
Confidence 999999876443222 2234457889999999999999999999999999999999 9999875432211 111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+..+.. ...+......+.+++.+||+.+|.+||++.++++.|++...
T Consensus 252 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 252 LIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111110 01112233457888999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.13 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=200.2
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC--CceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG--SNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 577 (839)
...+.+.+.||+|+||.||+|+. +++.||||++.... ....+++.+|+.++.+++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 34567788999999999999998 48899999997543 22345799999999999999999999999877 788999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe--eeecCCCCCcEEECCCCceeecccCcce
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR--IIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999532 334689999999999999999999985 6 9999999999999999999999988876
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCC---cccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITV---KADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
..... ...||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ........+
T Consensus 162 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-- 227 (271)
T 3kmu_A 162 SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG-- 227 (271)
T ss_dssp TTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC--
T ss_pred eeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC--
Confidence 43222 235899999999998765544 7999999999999999999996432211 001111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.....+......+.+++..||+.+|++||++.++++.|+...
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 -------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111112222345778888999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.74 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=195.2
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||.||+|...+++.||||++..... .....+.+|++++.+++||||+++++++.+....++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 3567789999999999999988899999999964422 22467889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 83 DQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp SE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred CC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 86 89888842 235688999999999999999999995 99999999999999999999999999998764322
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc---Ccc-----
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN---GTP----- 732 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----- 732 (839)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ........ ...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhhc
Confidence 2 2234468999999999876 458999999999999999999999997543211000 00000000 000
Q ss_pred ccccccccc-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLE-------GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~-------~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....++... ..........+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 0001112345678889999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.24 Aligned_cols=267 Identities=27% Similarity=0.443 Sum_probs=196.1
Q ss_pred ccchHHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC
Q 038743 494 NFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG 571 (839)
Q Consensus 494 ~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 571 (839)
.+.-.|+....+.+.+.||+|+||.||+|+... .||||++..... ...+.+.+|+.++.+++||||+++++++ ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 344456667778889999999999999998743 599999965432 2345789999999999999999999965 45
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||+++++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CccEEEEEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence 678999999999999999842 345789999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCC-ceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhh
Q 038743 652 GLAKLMGREH-SQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 652 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
|+++...... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||........ .....
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~ 238 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMV 238 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHH
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHh
Confidence 9998654322 22234456999999999986 56788999999999999999999999965432211 11111
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
..+... +.+ ..........+.+++.+||+.+|.+||++.++++.|+...
T Consensus 239 ~~~~~~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 239 GRGSLS----PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHTSCC----CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccccC----cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111110 000 0111223356788889999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=338.65 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=194.8
Q ss_pred hHHHHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhcc-ccCCcccccceeecCC
Q 038743 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGS 572 (839)
Q Consensus 497 ~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 572 (839)
..++....+.+.++||+|+||+||+|... +++.||||++...... ...++..|+..+.++ +||||+++++++.++.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34556677888899999999999999875 7999999998654322 233455666666555 8999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEA----WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEEEEEecc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 999999999 7799888843 235699999999999999999999995 89999999999999999999999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
++....... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... .+..+..+.
T Consensus 203 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~- 268 (311)
T 3p1a_A 203 LLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGY- 268 (311)
T ss_dssp TCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTC-
T ss_pred eeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccC-
Confidence 998764322 2334569999999998876 78999999999999999999977664211 111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+.+... ....+.+++.+||+.+|++|||+.|+++
T Consensus 269 ---~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 ---LPPEFTAG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCcccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111111 2345788889999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.58 Aligned_cols=260 Identities=17% Similarity=0.210 Sum_probs=205.5
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..+.+.+.||+|+||.||+|.. .+++.||||++... .....+.+|++++.++ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 3567788999999999999975 67999999998643 2345688999999999 899999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc-----eeecccCcce
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC-----PKVSDFGLAK 655 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~DfGla~ 655 (839)
+ +++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 88 ~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 88 L-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp C-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred c-CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9 9999999943 234689999999999999999999985 9999999999999987776 9999999999
Q ss_pred ecCCCCce------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 656 LMGREHSQ------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 656 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----~~~~~~~ 235 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----KYERIGE 235 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----HHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH----HHHHHHh
Confidence 77543321 1234569999999999999999999999999999999999999997543221110 0111100
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
... ....+.+... ....+.+++.+||+.+|++||++.+|++.|+...
T Consensus 236 ~~~-~~~~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 236 KKQ-STPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHH-HSCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hcc-CccHHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 000 0000011111 2346778889999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.61 Aligned_cols=273 Identities=22% Similarity=0.286 Sum_probs=209.7
Q ss_pred CcccchHHHHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhc--cccCCcccccceee
Q 038743 492 PVNFTYRDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGS--MHHMNLVRLCGYCS 569 (839)
Q Consensus 492 ~~~~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~ 569 (839)
...+...+.....+.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344556677778899999999999999999998 5899999998643 35667888888877 79999999999998
Q ss_pred cCC----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-----CCeeeecCCCCCcEEE
Q 038743 570 EGS----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC-----RNRIIHCDIKPENILL 640 (839)
Q Consensus 570 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~dlk~~Nill 640 (839)
... ..++||||+++|+|.+++. ...+++..++.++.||+.||+|||... ..+|+||||||+||||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 776 7899999999999999993 346899999999999999999999310 1599999999999999
Q ss_pred CCCCceeecccCcceecCCCCcee---EEeeccccceeCcccccCCC------CCCcccEEehhHHHHHHHhC-------
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQV---VTMVRGTRGYLAPEWVSNRP------ITVKADVYSYGMLLLEIVGG------- 704 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~s~~~DV~S~Gvvl~elltG------- 704 (839)
+.++.+||+|||+++......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999998765443322 23446999999999997753 33689999999999999999
Q ss_pred ---CCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 705 ---RRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA-VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 705 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+.||........ ....+ ...+... ...+.+... ...+....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 261 ~~~~~p~~~~~~~~~-~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SVEEM-RKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCTTTTTSCSSC-CHHHH-HHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCccccCcCcc-cHHHH-HHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 556543221110 00000 0111111 111111111 1235677889999999999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.15 Aligned_cols=254 Identities=18% Similarity=0.175 Sum_probs=201.5
Q ss_pred HHhhccccccccCCCceEEEEE------eCCCcEEEEEEecccCCcchHHHHHHHHHhhccc---cCCcccccceeecCC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGS------LGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGS 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 572 (839)
...+.+.++||+|+||+||+|. ..+++.||||++... ...++..|++++.+++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3456677899999999999993 456889999999643 4557788888887775 999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC----------
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---------- 642 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---------- 642 (839)
..++||||+++|+|.+++..........+++..++.++.||+.||+|||+. +|+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999999543223456799999999999999999999995 8999999999999998
Q ss_pred -CCceeecccCcceecCCC-CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch
Q 038743 643 -NFCPKVSDFGLAKLMGRE-HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 643 -~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 720 (839)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 899999999999876432 2333455679999999999999999999999999999999999999985322110
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHhcCCCC
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMR-PSMGEVVKMLEGSAD 782 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~R-Pt~~~v~~~L~~~~~ 782 (839)
+ .+...+...... ..+.+++..|++.+|.+| |++.++.+.|+....
T Consensus 293 -~------------~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 -C------------KPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -E------------EECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -e------------eechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0 000111111122 344566667999999998 688999888876544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=341.27 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=201.8
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC-C-------cEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD-G-------TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG 571 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 571 (839)
+....+.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|++++.+++||||+++++++.+.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 344567788999999999999997632 3 57999999776556667899999999999999999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc------
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC------ 645 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~------ 645 (839)
...++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999943 234589999999999999999999995 8999999999999998887
Q ss_pred --eeecccCcceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh
Q 038743 646 --PKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 646 --~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 722 (839)
+||+|||++...... ....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+........
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------ 226 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------ 226 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------
T ss_pred ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------
Confidence 999999999755332 22357899999999987 7799999999999999999996655432211100
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
........ ..+.... ...+.+++.+||+.+|.+||++.++++.|+....
T Consensus 227 ~~~~~~~~-------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 227 KLQFYEDR-------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHTT-------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHhhcc-------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000000 0011111 2346788889999999999999999999998765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.41 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=196.1
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.++||+|+||.||+++. .+++.||||++++.. ......+..|.+++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4455677889999999999999976 468999999996531 22345678899999988 799999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 100 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccce
Confidence 99999999999999984 345689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+..
T Consensus 172 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~-- 241 (353)
T 3txo_A 172 KEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV-- 241 (353)
T ss_dssp BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--
T ss_pred eecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence 854322 222344579999999999999999999999999999999999999997443211 1111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM------GEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~------~~v~~ 775 (839)
.++......+.+++.+|++.+|.+||++ .++++
T Consensus 242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0111123456788889999999999998 66665
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.18 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=201.6
Q ss_pred HHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-----CcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
....|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++..++||||+++++++.+....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345678889999999999999976 468999999985321 22356799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc---eeeccc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC---PKVSDF 651 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Df 651 (839)
++||||+++|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999988874321 1234588999999999999999999995 9999999999999986554 999999
Q ss_pred CcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
|+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....+..+.
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGK 248 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTC
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCC
Confidence 99987754322 22345699999999999999999999999999999999999999964211 0111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. ..+..... ....+.+++.+||+.+|++||++.++++
T Consensus 249 ~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000011 1345778889999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=345.48 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=194.3
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
.+.||+|+||.||+|.. .+|+.||||++........+++.+|++++.+++||||+++++++.+....++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 45799999999999976 56899999999765445567899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE--CCCCceeecccCcceecCCCCcee
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL--DENFCPKVSDFGLAKLMGREHSQV 664 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~ 664 (839)
.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 998842 335689999999999999999999995 99999999999999 6778999999999997654322
Q ss_pred EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCC
Q 038743 665 VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744 (839)
Q Consensus 665 ~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 744 (839)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..... .. .......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~-~~-~~~~~~~- 314 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-------LNNILACRW-DL-EDEEFQD- 314 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCC-CS-CSGGGTT-
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccC-CC-Chhhhcc-
Confidence 2234599999999999999999999999999999999999999975432110 111111100 00 0000111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 745 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+.+++.+||+.+|.+||++.|+++
T Consensus 315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ---ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2345778899999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.20 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=203.7
Q ss_pred ccccccccCCCceEEEEEeC-----CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeec--CCceEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-----DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNRLLV 577 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 577 (839)
.+.+.||+|+||+||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67789999999999998652 688999999975432 334568999999999999999999999987 4678999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 114 ~e~~~~~~L~~~l~------~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 114 MEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp ECCCTTCBHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EecccCCcHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999993 33589999999999999999999995 9999999999999999999999999999987
Q ss_pred CCCCce--eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQ--VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+...........+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence 554332 2334568889999999999999999999999999999999999985321100 0000000000000011111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
+........+......+.+++.+||+.+|.+||++.++++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 222222222333445688899999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.52 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=200.6
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...|.+.+.||+|+||.||++.. .+|+.+|+|++..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45678889999999999999965 5789999999865432 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeecccCcce
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAK 655 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~ 655 (839)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 90 E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 90 DLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp CCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999998843 35689999999999999999999995 999999999999998 56789999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+... .
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~-~ 232 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYD-F 232 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC-C
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCC-C
Confidence 7654322 2234569999999999999999999999999999999999999996433211 11111111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+ ... .....+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 ~~~-~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSP-EWD----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTT-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccc-ccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 001 123456788889999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.46 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=201.3
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...|.+.+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45678889999999999999976 4689999999965422 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC---CceeecccCcce
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN---FCPKVSDFGLAK 655 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DfGla~ 655 (839)
||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++.
T Consensus 108 e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 108 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp CCCCSCBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999884 345689999999999999999999995 99999999999999865 459999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+... .
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~-~ 249 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYD-Y 249 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-C
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-C
Confidence 765332 2234569999999999999999999999999999999999999996432211 11111111100 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...........+.+++.+||+.+|.+||++.++++.
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001123456788889999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.90 Aligned_cols=269 Identities=16% Similarity=0.162 Sum_probs=201.3
Q ss_pred HHHHHhhccccccccCCCceEEEEEeCC------CcEEEEEEecccCCcch-----------HHHHHHHHHhhccccCCc
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLGD------GTLVAVKKLDRVLPHGE-----------KEFVTEVNTIGSMHHMNL 561 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~ni 561 (839)
++....|.+.+.||+|+||.||+|.... ++.||||++........ ..+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 3444567888999999999999998754 47899999865421111 123445566777889999
Q ss_pred ccccceeecC----CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 562 VRLCGYCSEG----SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 562 v~l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
+++++++... ...+|||||+ +++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 9999998764 4589999999 9999999843 235799999999999999999999995 99999999999
Q ss_pred EEEC--CCCceeecccCcceecCCCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 638 ILLD--ENFCPKVSDFGLAKLMGREHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 638 ill~--~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
|||+ .++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 88999999999998765432211 123459999999999999999999999999999999999999997
Q ss_pred CCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 710 MSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....... ......... ...+..++++.+... .....+.+++..||+.+|.+||++.+|++.|+...
T Consensus 263 ~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 263 DNLKDPK--YVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp GGTTCHH--HHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccccCHH--HHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 4332211 111111111 111222333332211 11345677888899999999999999999997653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=345.04 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=189.9
Q ss_pred hccccccccCCCceEEEEEeC--CC--cEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeec-CCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLG--DG--TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~ 578 (839)
+.+.+.||+|+||.||+|... ++ ..||||.+.... ....+++.+|+.++.+++||||+++++++.+ ....++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 456689999999999999763 22 468999986543 2345679999999999999999999998754 55789999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 171 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp ECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999942 345678899999999999999999995 99999999999999999999999999998664
Q ss_pred CCCce---eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 659 REHSQ---VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 659 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. ......+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-------~~~~~~~~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYLLQGRR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-------HHHHHTTCC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-------HHHHHcCCC--
Confidence 33221 1233457889999999999999999999999999999999 6677754332211 011111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
. ..+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 315 ~-------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 L-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 001112345778888999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.14 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=200.5
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
...+.+.+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|++++..++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 34577889999999999999976 458899999986432 33456788999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+
T Consensus 94 ~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ-----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 99999999999994 345689999999999999999999995 9999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... .........
T Consensus 166 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~~~~~~~~~--- 236 (384)
T 4fr4_A 166 PRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----IVHTFETTV--- 236 (384)
T ss_dssp CTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH----HHHHHHHCC---
T ss_pred cCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH----HHHHHhhcc---
Confidence 4332 2344569999999999874 458999999999999999999999997543321110 001110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-MGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-~~~v~~ 775 (839)
...+......+.+++.+||+.+|.+||+ +++|++
T Consensus 237 -------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111122345778888999999999998 777765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=339.68 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=198.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 467788999999999999986 678999999986431 2234578999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+ +|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 90 ~~-~g~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 90 YA-GGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CC-CEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred CC-CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99 789988884 335689999999999999999999996 999999999999999999999999999987643
Q ss_pred CCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... .....+. .
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~~------~ 225 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKVNSCV------Y 225 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCCCSSC------C
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHcCC------C
Confidence 321 234569999999999988776 78999999999999999999999754322111 0000000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+ +......+.+++.+||+.+|.+|||+.|+++.
T Consensus 226 ~~----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VM----PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CC----CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CC----cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01 11123456788899999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=343.96 Aligned_cols=252 Identities=22% Similarity=0.261 Sum_probs=190.6
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..|.+.+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 35677889999999999999775 7899999999654 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc--eeecccCcceecCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC--PKVSDFGLAKLMGR 659 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DfGla~~~~~ 659 (839)
++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 99 ~~~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 99 SGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999984 234689999999999999999999995 9999999999999987765 99999999975322
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCc-ccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVK-ADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
. .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||.......... . ........
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~-~~~~~~~~-------- 237 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--K-TIQRILSV-------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--H-HHHHHHTT--------
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--H-HHHHHhcC--------
Confidence 2 12233469999999999988887655 899999999999999999997544322211 0 00111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.............+.+++.+||+.+|.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000000122456788899999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=366.28 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=196.4
Q ss_pred ccccCCCceEEEEEeC---CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCC
Q 038743 510 LLGTGGFGSVYKGSLG---DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|++++.+++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999763 46689999997643 3346789999999999999999999999976 56899999999999
Q ss_pred hhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCcee-
Q 038743 586 LDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV- 664 (839)
Q Consensus 586 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 664 (839)
|.++|.. ....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 422 L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 9999942 345689999999999999999999995 99999999999999999999999999998765433222
Q ss_pred -EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 665 -VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 665 -~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+..+. ..
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~---------~~ 558 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGK---------RM 558 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTC---------CC
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 223346789999999999999999999999999999998 999997543221 111111111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+......+.+++..||+.+|++||+|.+|++.|+..
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11223345677889999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=342.79 Aligned_cols=277 Identities=19% Similarity=0.269 Sum_probs=207.2
Q ss_pred chHHHHHHhhccccccccCCCceEEEEEe-----CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceee
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 569 (839)
....+....+.+.+.||+|+||.||++++ .+++.||||++.... ......+.+|++++.+++||||+++++++.
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 33444455677889999999999999983 468999999997443 334567999999999999999999999998
Q ss_pred cC--CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 570 EG--SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 570 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
+. ...++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence 76 668999999999999999843 234689999999999999999999995 999999999999999999999
Q ss_pred ecccCcceecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 648 VSDFGLAKLMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
|+|||+++......... .....||..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ..
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~ 245 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT-HG 245 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC-CG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc-cc
Confidence 99999999875543322 2345688899999999999999999999999999999999988642110000000000 00
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..........+........+......+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000000001111111112223345678899999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=343.43 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=192.8
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCC--cchHHHHHHHHHhhcccc--CCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHH--MNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||++...+++.||||++..... ...+.+.+|+.++.+++| |||+++++++.+....++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 4667889999999999999988899999999864422 233678999999999976 999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
+.+++|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 90 -~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 90 -CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp -CCSEEHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred -CCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 57889999994 345789999999999999999999995 999999999999997 57899999999987654
Q ss_pred CCce-eEEeeccccceeCcccccC-----------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhh
Q 038743 660 EHSQ-VVTMVRGTRGYLAPEWVSN-----------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 660 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .. .
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~-~--- 230 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK-L--- 230 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH-H---
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HH-H---
Confidence 3332 2334579999999999865 678999999999999999999999996432110 00 0
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
..++++......+......+.+++.+||+.+|.+|||+.++++.-
T Consensus 231 -----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 011111111111212234567888899999999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=344.45 Aligned_cols=269 Identities=16% Similarity=0.154 Sum_probs=198.5
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeC----CCcEEEEEEecccCCc-----------chHHHHHHHHHhhccccCCcc
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLPH-----------GEKEFVTEVNTIGSMHHMNLV 562 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 562 (839)
.++....|.+.+.||+|+||.||+|... ++..||||++...... ....+.+|+..+..++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 4444566788899999999999999875 5788999998654321 112366788889999999999
Q ss_pred cccceeec----CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 563 RLCGYCSE----GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 563 ~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
++++++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 182 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANL 182 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHE
Confidence 99999987 77899999999 9999999942 33799999999999999999999995 999999999999
Q ss_pred EECCCC--ceeecccCcceecCCCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 639 LLDENF--CPKVSDFGLAKLMGREHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 639 ll~~~~--~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
|++.++ .+||+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998877 99999999998764332111 1334699999999999999999999999999999999999999963
Q ss_pred CCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 711 SGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....... ........... ....+..... .......+.+++..||+.+|++||++.+|++.|+...
T Consensus 263 ~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 263 NLKDPVA--VQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GTTCHHH--HHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccccHH--HHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2211100 00000010000 0000000000 0022345778888999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=347.59 Aligned_cols=272 Identities=22% Similarity=0.303 Sum_probs=208.1
Q ss_pred HhhccccccccCCCceEEEEEe-----CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee--cCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS--EGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 575 (839)
..+.+.+.||+|+||.||++++ .+++.||||++........+.+.+|++++.+++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4567788999999999999984 468899999997665555667999999999999999999999886 456689
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999842 234689999999999999999999995 99999999999999999999999999999
Q ss_pred ecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... .............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHH
Confidence 875443322 2334588889999999999999999999999999999999999853221000000 0000000000001
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+.+........+......+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111222233344567888999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.41 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=200.0
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+++.. +|+.||+|++++.. ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 35677889999999999999774 68999999996432 233456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999994 234688999999999999999999985 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+..+..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------ 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL------ 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------
Confidence 32 223569999999999999999999999999999999999999996432111 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
.+... ....+.+++.+|++.+|.+|| +++++++.
T Consensus 221 ~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 RFPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111 234567888889999999999 88888753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=341.74 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=197.6
Q ss_pred HHhhccccccccCCCceEEEEEeCC-----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD-----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...+.+.+.||+|+||.||+|.... +..||||++..... .....+.+|++++.+++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3445567899999999999997632 24699999975432 23456899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 123 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999843 235689999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 656 LMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 656 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~- 267 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGF- 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC-
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCC-
Confidence 765433222 223446889999999999999999999999999999998 999996432111 111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111123345778899999999999999999999997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.64 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=196.1
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc---chHHHHHHHHHhhcc-ccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+++.. +++.||||++.+.... ....+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 35677889999999999999874 5889999999754322 234578899999887 899999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999984 235689999999999999999999995 9999999999999999999999999999864
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc--cchhhhhhhhccCccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF--FYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 735 (839)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........+.....
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 3222 2234457999999999999999999999999999999999999999753322110 001111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
. ++......+.+++.+||+.+|.+||++
T Consensus 237 ---~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---R----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---C----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---C----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 111223457788889999999999995
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.17 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=195.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.++.+++||||+++++++.+....++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 456778999999999999977 4689999999964432 2246788999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 83 CDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 986 55554422 345689999999999999999999995 9999999999999999999999999999876433
Q ss_pred CceeEEeeccccceeCcccccCCC-CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhc---cCccc---
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT---NGTPL--- 733 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 733 (839)
.. ......||+.|+|||.+.+.. ++.++||||||+++|||++|..|+......... + ........ .....
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~-~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-H-HHHHHHHCCCCTTTCTTGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHHhCCCChhhhhhhc
Confidence 22 223456899999999998765 899999999999999999999886433221100 0 00000000 00000
Q ss_pred cc--------c-cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 734 KV--------A-DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 734 ~~--------~-~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. . ...............+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0 000000111223345678889999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.11 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=201.5
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee----cCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS----EGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv 577 (839)
..|.+.+.||+|+||.||++.. .+++.||||++........+.+.+|++++.+++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 4567788999999999999976 678999999986654455677999999999999999999999986 34578999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999985321 1345789999999999999999999995 9999999999999999999999999998865
Q ss_pred CCCCce--------eEEeeccccceeCcccccCCC---CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 658 GREHSQ--------VVTMVRGTRGYLAPEWVSNRP---ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 658 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... . ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~----~~~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-V----ALA 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-H----HHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-h----hHH
Confidence 321110 012235799999999987654 689999999999999999999998531110000 0 000
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
... .............+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00001111223457888999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=332.32 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=198.4
Q ss_pred HhhccccccccCCCceEEEEEeCC----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+|...+ +..||||.+..... ...+.+.+|+.++.+++||||+++++++.+ ...++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 456678899999999999997532 34699999975432 345678999999999999999999999865 456899
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 91 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 91 MELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999943 234588999999999999999999995 9999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~~~~~~~~~---- 232 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLEKGDR---- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------HHHHHHTCC----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------HHHHhcCCC----
Confidence 5544333445567889999999999999999999999999999998 9999964332110 111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 233 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 001111234577888899999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=332.83 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=202.2
Q ss_pred hcccc-ccccCCCceEEEEEeC---CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 505 SNFAQ-LLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 505 ~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
+.+.+ .||+|+||.||+|... +++.||||++..... ...+++.+|++++.+++||||+++++++ +.+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34444 8999999999999753 578899999976432 3356789999999999999999999999 5567899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 90 MAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp CCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999842 345689999999999999999999995 999999999999999999999999999998754
Q ss_pred CCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 660 EHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 660 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~---- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR---- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCC----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCc----
Confidence 43322 223456899999999998899999999999999999998 999996443211 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++..||+.+|.+||++.+|++.|+..
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222345677888999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=340.68 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=207.1
Q ss_pred HHHHHhhccccccccCCCceEEEEEe--------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCccccccee
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL--------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYC 568 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 568 (839)
++....+.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++.++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34445677889999999999999976 3467899999975432 2345789999999999 899999999999
Q ss_pred ecCCceEEEEeeccCCChhhhcccCCCC-----------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHH-----------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
.+....++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 9999999999999999999999643210 123588999999999999999999995 99999999999
Q ss_pred EEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCC
Q 038743 638 ILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAE 715 (839)
Q Consensus 638 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 715 (839)
||++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999998765433222 233457889999999998899999999999999999999 999986432111
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+..+.. ...+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 268 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 268 -------LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -------HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111110 1111222345778889999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=343.41 Aligned_cols=261 Identities=17% Similarity=0.177 Sum_probs=200.1
Q ss_pred HhhccccccccC--CCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTG--GFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..|.+.++||+| +||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 356778899999 99999999875 699999999965432 2235688899999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++...
T Consensus 105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999998532 235689999999999999999999995 9999999999999999999999999998754
Q ss_pred CCCCce------eEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 658 GREHSQ------VVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 658 ~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .. ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~~-~~ 251 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL------EK-LN 251 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH------HC---
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH-hc
Confidence 322111 1122468999999999987 679999999999999999999999997543322110 00 00
Q ss_pred Cccccccc-----------------------cc-------------ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 038743 730 GTPLKVAD-----------------------RR-------------LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEV 773 (839)
Q Consensus 730 ~~~~~~~~-----------------------~~-------------l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v 773 (839)
+....+.+ .. ............+.+++.+||+.+|.+|||+.|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 00000000 00 0000112234568889999999999999999999
Q ss_pred HHH
Q 038743 774 VKM 776 (839)
Q Consensus 774 ~~~ 776 (839)
++.
T Consensus 332 l~h 334 (389)
T 3gni_B 332 LNH 334 (389)
T ss_dssp TTS
T ss_pred hcC
Confidence 864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.36 Aligned_cols=263 Identities=25% Similarity=0.321 Sum_probs=188.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++.+++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 456678999999999999976 468999999986543 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCC-CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 582 KNGSLDKWIFPSY-HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 582 ~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+ |+|.+++.... ......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 59999885321 11234688999999999999999999995 9999999999999999999999999999876533
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh--------hhhhhhc---
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG--------WAFKEMT--- 728 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~--- 728 (839)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...... ..+....
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 22 2233468999999999876 468999999999999999999999997543221100000 0000000
Q ss_pred ----------cCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 729 ----------NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 729 ----------~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.....+.+.+..... ....+.+++.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000111111111 2245788899999999999999999865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.71 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=161.6
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccc-cCCcccccceeecCC--c
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGS--N 573 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~ 573 (839)
.....|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3445678889999999999999975 5789999999865422 23456789999999997 999999999997544 7
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||++ |+|..++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999998 58988883 34688999999999999999999995 999999999999999999999999999
Q ss_pred ceecCCC--------------------CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 654 AKLMGRE--------------------HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 654 a~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
++.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876321 1112344579999999999986 678999999999999999999999997543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=329.60 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=196.4
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcc---hHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHG---EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
...|.+.+.||+|+||.||++... +++.||||++....... .+.+.+|+.++.+++||||+++++++......++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 345778899999999999999864 68899999996543222 35688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999984 234689999999999999999999995 9999999999999999999999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
............|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..... . .
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~--~ 254 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-R--P 254 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-C--G
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-C--c
Confidence 554333344556999999999999999999999999999999999999999643211 01111111000 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhcCCCCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-SMGEVVKMLEGSADINT 785 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~~v~~~L~~~~~~~~ 785 (839)
... .......+.+++.+||+.+|++|| +++++++.|+.......
T Consensus 255 ~~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 STV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GGT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ccc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 011 112233577888899999999999 99999999998765433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.54 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=196.2
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCc----EEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGT----LVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...+.+.++||+|+||.||+|.. .+++ +||+|.+.... ....+++.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 34567788999999999999976 3444 46788775432 345678999999999999999999999998754 78
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999999853 235689999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~-- 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE-- 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTC--
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCC--
Confidence 765433222 233457889999999999999999999999999999999 9999975432211 11111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111222345778889999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=368.57 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=195.2
Q ss_pred cccccCCCceEEEEEe---CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSL---GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.||+|+||.||+|.+ ..++.||||+++.... ...+++.+|++++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 3467899999975432 235689999999999999999999999964 568899999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.++|. ....+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999994 345689999999999999999999995 9999999999999999999999999999876543322
Q ss_pred --eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 664 --VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 664 --~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+..+.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~--------- 589 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE--------- 589 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 2334457889999999999999999999999999999998 999996443211 111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
....+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111122234567788899999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.14 Aligned_cols=245 Identities=22% Similarity=0.263 Sum_probs=200.6
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|++++..++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45677889999999999999874 68999999985432 233467889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999942 34689999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 193 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------ 255 (350)
T 1rdq_E 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV------ 255 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------
T ss_pred CCc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence 432 23468999999999999999999999999999999999999996432111 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~~ 776 (839)
.+ +......+.+++.+||+.+|.+||+ +++|++.
T Consensus 256 ~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11 1122345778888999999999998 8888753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=346.80 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=193.1
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccc--cCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMH--HMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++ ||||+++++++......++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 467788999999999999998889999999986432 223467899999999996 5999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||||+ ++.+||+|||+++.+..
T Consensus 137 -~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 137 -CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp -CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred -cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 678899999843 34688889999999999999999995 999999999999996 57899999999987654
Q ss_pred CCcee-EEeeccccceeCcccccC-----------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhh
Q 038743 660 EHSQV-VTMVRGTRGYLAPEWVSN-----------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 660 ~~~~~-~~~~~gt~~y~aPE~~~~-----------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . ...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~-~~~-- 278 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S-KLH-- 278 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H-HHH--
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H-HHH--
Confidence 33222 334569999999999865 468999999999999999999999996432110 0 001
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.++++......+......+.+++.+||+.+|.+||++.+|++.
T Consensus 279 ------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111111113457788889999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=342.15 Aligned_cols=246 Identities=22% Similarity=0.204 Sum_probs=186.3
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhc-cccCCcccccceeec----CCceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGS-MHHMNLVRLCGYCSE----GSNRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~e~~~ 582 (839)
++||+|+||+||++.. .+++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....+|||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 6899999999999976 4689999999853 2467788888754 489999999998865 567899999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCcceecCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~~~~~ 659 (839)
+|+|.++|... ....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 143 gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 143 GGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999532 235689999999999999999999995 9999999999999997 78999999999987543
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..+...
T Consensus 217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~------ 285 (400)
T 1nxk_A 217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE------ 285 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCC------
T ss_pred CC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCccc------
Confidence 22 2344568999999999999999999999999999999999999997544322110 011111111100
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+...........+.+++.+||+.+|.+|||+.++++.
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001123457788999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.88 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=197.0
Q ss_pred hccccccccCCCceEEEEEeCC----CcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceee-cCCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCS-EGSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~ 578 (839)
+.+.++||+|+||.||+|...+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++. .+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5667899999999999998643 23689999875433 23467899999999999999999999864 556789999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 107 PYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp ECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred eCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999943 345688999999999999999999995 99999999999999999999999999998765
Q ss_pred CCCce---eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhC-CCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 659 REHSQ---VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGG-RRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 659 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++| ..||........ ......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~-- 250 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYLLQGRR-- 250 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-------HHHHHTTCC--
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhcCCC--
Confidence 43322 23345678899999999999999999999999999999995 455543322110 011111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
. ..+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus 251 ---~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 251 ---L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp ---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 001112245778889999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.56 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=185.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4667789999999999999875 57899999997542 34568899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCcceecCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~~~~~ 659 (839)
+|+|.+++. ....+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 132 ~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 132 GGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp SCBHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999984 345689999999999999999999995 9999999999999975 88999999999987543
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+...... ..
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~~--- 271 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-FI--- 271 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-CC---
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-cC---
Confidence 21 2234568999999999999999999999999999999999999996433211 111111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..........+.+++.+||+.+|++||++.++++.
T Consensus 272 --~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 --SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223457788999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=342.33 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=199.2
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.+.||+|+||.||+|+.. +++.||||++++.. ......+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 33455677889999999999999874 68999999996532 23445678899999887 999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999984 235689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+.
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~--- 234 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN--- 234 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC---
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCC---
Confidence 86432221 2344579999999999999999999999999999999999999996432211 111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMG-EVV 774 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-~v~ 774 (839)
..+... ....+.+++.+||+.+|.+||++. +|+
T Consensus 235 ---~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ---PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 234567888899999999999997 665
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.44 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=205.8
Q ss_pred HHHhhccccccccCCCceEEEEEe-----CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC--c
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL-----GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS--N 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~ 573 (839)
....+.+.+.||+|+||.||++++ .+++.||||++........+.+.+|++++.+++||||+++++++.... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 344567788999999999999984 468899999998765555678999999999999999999999986644 7
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 89999999999999999532 34689999999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC-
Q 038743 654 AKLMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG- 730 (839)
Q Consensus 654 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 730 (839)
++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~ 263 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDK 263 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTC
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhcccc
Confidence 99875543322 12345778899999999888999999999999999999999887532100 00000000
Q ss_pred -------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 731 -------TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 731 -------~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+.+........+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00011111111111223345678889999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=342.21 Aligned_cols=264 Identities=24% Similarity=0.373 Sum_probs=206.3
Q ss_pred HHHHHhhccccccccCCCceEEEEEeCC------CcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeec
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSLGD------GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE 570 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 570 (839)
++....+.+.+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4445566778899999999999997632 24899999975432 2345689999999999 89999999999999
Q ss_pred CCceEEEEeeccCCChhhhcccCCC---------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYH---------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD 641 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~ 641 (839)
....++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 9999999999999999999853210 0134578999999999999999999995 999999999999999
Q ss_pred CCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccc
Q 038743 642 ENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFY 719 (839)
Q Consensus 642 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 719 (839)
.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--- 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--- 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---
Confidence 99999999999998764433322 233457889999999999999999999999999999998 9999865432211
Q ss_pred hhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.......+ .....+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 276 ---~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 ---FYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ---HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 01111111 00111111234577888899999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=334.65 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=194.8
Q ss_pred hcc-ccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeec
Q 038743 505 SNF-AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 505 ~~~-~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
|.+ .+.||+|+||.||++.. .+++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 445 36899999999999975 47899999999766555667899999999885 7999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc---eeecccCcceecC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC---PKVSDFGLAKLMG 658 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DfGla~~~~ 658 (839)
++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 94 ~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 94 RGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp TTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred CCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999943 35689999999999999999999995 9999999999999988776 9999999998653
Q ss_pred CCCc------eeEEeeccccceeCcccccC-----CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch-------
Q 038743 659 REHS------QVVTMVRGTRGYLAPEWVSN-----RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP------- 720 (839)
Q Consensus 659 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~------- 720 (839)
.... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||............
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11223459999999999875 56889999999999999999999999765432211000
Q ss_pred -hhhhhhhccCcccccccccccCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 721 -GWAFKEMTNGTPLKVADRRLEGAVEE----EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 721 -~~~~~~~~~~~~~~~~~~~l~~~~~~----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
......+..+. . ..+. .....+.+++.+||+.+|.+||++.|+++.
T Consensus 246 ~~~~~~~i~~~~--------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGK--------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCC--------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccC--------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00001111110 0 1111 123457889999999999999999999884
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=337.02 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=191.8
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcc---hHHHHHHHHHhhccccCCcccccceeecCCce----
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHG---EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR---- 574 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---- 574 (839)
..|.+.+.||+|+||.||++.. .+++.||||++....... ...+.+|++++.+++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3567788999999999999975 678999999997643322 34688999999999999999999998765543
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++++|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~lv~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred EEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999984 234689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCce--eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 655 KLMGREHSQ--VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 655 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence 876543222 2234568999999999999999999999999999999999999996432211 11111111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH-HHHhcCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEV-VKMLEGS 780 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v-~~~L~~~ 780 (839)
. ...... .....+.+++.+||+.+|.+||++.++ ...|...
T Consensus 238 ~---~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 P---PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp C---HHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C---cccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 000011 123457788899999999999965554 4455443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.41 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=194.4
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHH--HhhccccCCcccccceee-----cCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVN--TIGSMHHMNLVRLCGYCS-----EGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~g~~~-----~~~~~~ 575 (839)
..+.+.+.||+|+||.||+|+. +++.||||++... ....+..|.+ .+..++||||+++++.+. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4567788999999999999987 7899999998643 2334444444 455689999999997543 334678
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc------CCeeeecCCCCCcEEECCCCceeec
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC------RNRIIHCDIKPENILLDENFCPKVS 649 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~dlk~~Nill~~~~~~kl~ 649 (839)
+||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ .++|+||||||+||||+.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHh------hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 9999999999999993 334588999999999999999999842 2289999999999999999999999
Q ss_pred ccCcceecCCCCc-------eeEEeeccccceeCcccccC-------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCC
Q 038743 650 DFGLAKLMGREHS-------QVVTMVRGTRGYLAPEWVSN-------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715 (839)
Q Consensus 650 DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~ 715 (839)
|||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987654321 11223469999999999987 456678999999999999999988774433221
Q ss_pred CccchhhhhhhhccCcc---------cccccccccCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 716 DFFYPGWAFKEMTNGTP---------LKVADRRLEGA--VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~---------~~~~~~~l~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....... ........ .....+.+... ........+.+++.+||+.+|++|||+.||++.|+...
T Consensus 243 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQ--TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTH--HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhh--cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1110000 00000000 00011111111 12235667899999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.16 Aligned_cols=254 Identities=18% Similarity=0.199 Sum_probs=198.7
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.++||+|+||.||+++. .+++.||||++.+.. ......+.+|..++..++||||+++++++.+....++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3456678999999999999987 469999999996431 122345889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.++|.. .+..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 141 E~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 141 EYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp CCCCSCBHHHHHHH----HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 99999999999942 234689999999999999999999995 99999999999999999999999999998876
Q ss_pred CCCceeEEeeccccceeCccccc-------CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVS-------NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ...+....
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~ 286 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-------YGKIVHYK 286 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTHH
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcc
Confidence 54443334457999999999987 45789999999999999999999999964332111 01110000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMR---PSMGEVVKM 776 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~R---Pt~~~v~~~ 776 (839)
..+..+... ......+.+++.+||+ +|.+| |+++|+++.
T Consensus 287 -~~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 -EHLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -cCcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000001111 1223457788888999 99998 689998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.82 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=179.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 466788999999999999976 578999999985432 2224678999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 92 MCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp CCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999842 335789999999999999999999995 999999999999999999999999999987653
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... .+..
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~------~~~~ 230 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVL------ADYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS------SCCC
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhh------cccC
Confidence 3222 22356899999999999999999999999999999999999999754322110 00000 0011
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+... ....+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Cccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 2245678889999999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=337.25 Aligned_cols=258 Identities=24% Similarity=0.258 Sum_probs=196.6
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEeccc-----CCcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV-----LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
...|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++.+++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 35678889999999999999976 56889999998543 2344567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCC-----------------------------------CcccCChhhHHHHHHHHHHHhHHh
Q 038743 576 LVYEFMKNGSLDKWIFPSYHH-----------------------------------RDRVLDWTTRFNIAIATAQGIAYF 620 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~yL 620 (839)
+||||+++|+|.+++...... ....+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421000 122345677889999999999999
Q ss_pred hhccCCeeeecCCCCCcEEECCCC--ceeecccCcceecCCCCce---eEEeeccccceeCcccccC--CCCCCcccEEe
Q 038743 621 HEQCRNRIIHCDIKPENILLDENF--CPKVSDFGLAKLMGREHSQ---VVTMVRGTRGYLAPEWVSN--RPITVKADVYS 693 (839)
Q Consensus 621 H~~~~~~iiH~dlk~~Nill~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S 693 (839)
|+. +|+||||||+|||++.++ .+||+|||+++.+...... ......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 995 999999999999998766 8999999999876432221 2345669999999999875 67899999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 038743 694 YGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEV 773 (839)
Q Consensus 694 ~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v 773 (839)
||+++|||++|+.||......+ .......... ....+. .......+.+++.+||+.+|.+||++.++
T Consensus 262 lG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDAD-------TISQVLNKKL-CFENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-CTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHH-------HHHHHHhccc-ccCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999996443211 0111111100 000000 01123457788889999999999999999
Q ss_pred HH
Q 038743 774 VK 775 (839)
Q Consensus 774 ~~ 775 (839)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.38 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=199.4
Q ss_pred Hhhcccc-ccccCCCceEEEEEe---CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 503 RTSNFAQ-LLGTGGFGSVYKGSL---GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 503 ~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
..+.+.+ .||+|+||.||+|.. .+++.||||++..... ...+++.+|++++..++||||+++++++ +....++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3455566 899999999999954 3468999999975432 2246799999999999999999999999 5677899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999943 34689999999999999999999995 999999999999999999999999999987
Q ss_pred cCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 657 MGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 657 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-
Confidence 75544332 233456789999999998889999999999999999999 999996432211 1111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222344677888999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=332.78 Aligned_cols=242 Identities=23% Similarity=0.249 Sum_probs=198.2
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--------chHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
...|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.+++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 34577788999999999999975 57899999999654211 2345788999999999999999999999999
Q ss_pred ceEEEEeeccCC-ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 573 NRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 573 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
..++||||+.+| +|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH-----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999777 9999984 334689999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
|+++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~~ 239 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------EA 239 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------TT
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------hh
Confidence 99987654322 234569999999999988876 889999999999999999999996321100 00
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.... ... ....+.+++.+||+.+|.+||++.++++.
T Consensus 240 ----~~~~--~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 ----AIHP--PYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----CCCC--SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----ccCC--Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011 12347788889999999999999999885
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=342.83 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=184.5
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceee--------cCC
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCS--------EGS 572 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~~ 572 (839)
..+.+.++||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 3567788999999999999986 478999999986554455667899999999996 999999999983 344
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe--eeecCCCCCcEEECCCCceeecc
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR--IIHCDIKPENILLDENFCPKVSD 650 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlk~~Nill~~~~~~kl~D 650 (839)
..++||||+. |+|.+++... .....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred eEEEEEEecC-CCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 5789999996 7998888432 1234689999999999999999999985 6 99999999999999999999999
Q ss_pred cCcceecCCCCcee-----------EEeeccccceeCcccc---cCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCC
Q 038743 651 FGLAKLMGREHSQV-----------VTMVRGTRGYLAPEWV---SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAED 716 (839)
Q Consensus 651 fGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~ 716 (839)
||+++......... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998765432211 1134589999999998 567789999999999999999999999964322110
Q ss_pred ccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 717 FFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
+...............+.+++.+||+.+|.+||++.++++.|+....
T Consensus 262 -------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 -------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000000001111236678888999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.99 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=199.8
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhcc-ccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.+.||+|+||.||+++.. +++.||||++++.. ......+..|.+++..+ +||||+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34456778899999999999999875 47899999996532 23445688999999988 899999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 97 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 99999999999999984 234689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~-- 238 (353)
T 2i0e_A 169 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV-- 238 (353)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--
T ss_pred cccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC--
Confidence 8643222 12334569999999999999999999999999999999999999996432111 1111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~~ 776 (839)
. ++......+.+++.+||+.+|.+||+ ++++++.
T Consensus 239 ----~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ----A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 11122345778888999999999995 4666643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.04 Aligned_cols=264 Identities=22% Similarity=0.364 Sum_probs=207.0
Q ss_pred HHHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
+....+.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++.+++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34456778899999999999999753 367899999975432 23456899999999999999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCC-----CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSY-----HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
..++||||+++|+|.+++.... ......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence 9999999999999999985321 01124568899999999999999999995 999999999999999999999
Q ss_pred ecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhh
Q 038743 648 VSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 725 (839)
|+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~ 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLR 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------HHH
Confidence 99999998654332211 123346889999999999999999999999999999999 888886432111 111
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
....+... ..+......+.+++.+||+.+|.+||++.++++.|+....
T Consensus 252 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111110 0111223457788889999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=323.01 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=201.0
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..+.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++..++||||+++++++.+....++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45778899999999999999774 68999999986432 23356789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 87 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 87 CSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999983 345689999999999999999999995 9999999999999999999999999999876433
Q ss_pred Cce-eEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 661 HSQ-VVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 661 ~~~-~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .+ ..+...... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~~--~~- 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKTY--LN- 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCTT--ST-
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhcccc--cC-
Confidence 221 2334568999999999987665 7899999999999999999999975443211 01 111111100 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
........+.+++.+||+.+|.+||++.++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00112335678889999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.15 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=198.6
Q ss_pred ccccccccCCCceEEEEEeC-CC---cEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCce-EEEEe
Q 038743 506 NFAQLLGTGGFGSVYKGSLG-DG---TLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR-LLVYE 579 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv~e 579 (839)
.+.++||+|+||+||+|... ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 34578999999999999753 22 3799999975433 2346789999999999999999999999876665 99999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+.+|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 104 YMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred cccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999943 345788999999999999999999995 999999999999999999999999999986543
Q ss_pred CCc---eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 660 EHS---QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 660 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
... .......+++.|+|||.+.+..++.++||||||+++|||++|..|+........ .......+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~~~~~---- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LTHFLAQGRR---- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG------HHHHHHTTCC----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH------HHHHhhcCCC----
Confidence 321 112345688999999999999999999999999999999997666532222111 0111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
...+......+.+++.+|++.+|.+|||+.++++.|+...
T Consensus 247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111122345778889999999999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.17 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=195.0
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||+||+|... +++.||||++...... ..+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4667889999999999999874 5899999998654322 245688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 84 CDHTVLHELDR-----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CSEEHHHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred CCCchHHHHHh-----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999998873 345689999999999999999999995 9999999999999999999999999999876533
Q ss_pred CceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh--------hhhhccCc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA--------FKEMTNGT 731 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 731 (839)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ...+....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2234468999999999876 67899999999999999999999999754422111000000 00000000
Q ss_pred cc---ccccccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 732 PL---KVADRRLEGAV---EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 732 ~~---~~~~~~l~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. .+.++...... .......+.+++.+||+.+|.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00000000000 01123457789999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.44 Aligned_cols=252 Identities=23% Similarity=0.412 Sum_probs=203.9
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec------
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE------ 570 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------ 570 (839)
.......+.+.+.||+|+||.||+|... +++.||||++... ...+.+|++++.+++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4455567788899999999999999875 7999999998643 2467899999999999999999998854
Q ss_pred ----------CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 571 ----------GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 571 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
....++||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEE
Confidence 44579999999999999999532 235789999999999999999999995 99999999999999
Q ss_pred CCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP 720 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 720 (839)
+.++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------- 224 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------- 224 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred cCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence 9999999999999987654322 23345899999999999999999999999999999999999876311
Q ss_pred hhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 721 GWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
......+..+ .+....+ ..+.+++.+||+.+|.+||++.++++.|+....
T Consensus 225 ~~~~~~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 SKFFTDLRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 0011111111 1112222 346678889999999999999999999986544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.51 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=191.9
Q ss_pred HHHhhccccccccCCCceEEEEEe----CCCcEEEEEEecccC----CcchHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
....+.+.+.||+|+||.||+++. .+++.||||++++.. ......+.+|+.++.+++||||+++++++....
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 345677889999999999999976 478999999997542 123456788999999999999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEEEEeCCCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence 9999999999999999984 234688899999999999999999995 99999999999999999999999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.....
T Consensus 167 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~ 238 (327)
T 3a62_A 167 LCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-------TIDKILKCKL 238 (327)
T ss_dssp CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC
T ss_pred cccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCC
Confidence 997543221 12234568999999999999999999999999999999999999996432211 1111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
.+ +......+.+++.+||+.+|.+|| ++.++++.
T Consensus 239 ------~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ------NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11 112234577888899999999999 77788763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.83 Aligned_cols=268 Identities=22% Similarity=0.245 Sum_probs=195.6
Q ss_pred HHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-----CcchHHHHHHHHHhhccc---cCCcccccceee
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-----PHGEKEFVTEVNTIGSMH---HMNLVRLCGYCS 569 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~ 569 (839)
++....|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.++.+++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34455678889999999999999986 578999999986432 112346778888777764 999999999997
Q ss_pred cCC-----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 570 EGS-----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 570 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
... ..++||||+. |+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 755 4789999997 5999998533 234489999999999999999999995 899999999999999999
Q ss_pred ceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh
Q 038743 645 CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 724 (839)
.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||................
T Consensus 158 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp CEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999998664322 2234568999999999999999999999999999999999999997543221100000000
Q ss_pred hhhccCccc---ccccccccC-------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 725 KEMTNGTPL---KVADRRLEG-------AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 725 ~~~~~~~~~---~~~~~~l~~-------~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......... .+....... ....+....+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000000 000000000 001122346778899999999999999999976
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.36 Aligned_cols=203 Identities=25% Similarity=0.315 Sum_probs=174.5
Q ss_pred HHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-----cCCcccccceeecC
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-----HMNLVRLCGYCSEG 571 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~ 571 (839)
.++....|.+.++||+|+||.||+|.. .+++.||||++... ......+..|+.++..++ ||||+++++++...
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 344455677889999999999999977 56899999999643 233456788999999886 99999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---------
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--------- 642 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--------- 642 (839)
+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+||||+.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred CeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 9999999999 99999998533 234588999999999999999999995 9999999999999975
Q ss_pred ----------------CCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC
Q 038743 643 ----------------NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 643 ----------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 7899999999998754322 23468999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 038743 707 NLDMSG 712 (839)
Q Consensus 707 p~~~~~ 712 (839)
||....
T Consensus 258 pf~~~~ 263 (360)
T 3llt_A 258 LFRTHE 263 (360)
T ss_dssp SCCCSS
T ss_pred CCCCCc
Confidence 997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=346.60 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=200.7
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35677889999999999999874 79999999996432 223457899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999994 345689999999999999999999995 99999999999999999999999999998765
Q ss_pred CCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ....+..+..
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~----- 233 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIF----- 233 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCC-----
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCc-----
Confidence 432 2234569999999999988765 689999999999999999999997432211 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...... ...+.+++.+||+.+|.+|||+.++++
T Consensus 234 -~~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -YTPQYL----NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccC----CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 001112 235678888999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.61 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=206.0
Q ss_pred HHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCCc-chHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
+....+.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3445677889999999999999974 35689999999764332 345789999999999 799999999998765
Q ss_pred C-ceEEEEeeccCCChhhhcccCCCC-----------CcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEE
Q 038743 572 S-NRLLVYEFMKNGSLDKWIFPSYHH-----------RDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENIL 639 (839)
Q Consensus 572 ~-~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nil 639 (839)
. ..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence 4 589999999999999999543211 022388999999999999999999995 9999999999999
Q ss_pred ECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCc
Q 038743 640 LDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDF 717 (839)
Q Consensus 640 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 717 (839)
++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~- 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-
Confidence 999999999999999876543332 2334567899999999999999999999999999999998 9999965432211
Q ss_pred cchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 718 FYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+..+.. . ..+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 260 -----~~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 260 -----FCRRLKEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp -----HHHHHHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHhccCcc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111110 0 11111234577888999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=324.95 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=201.3
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
...|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 345778889999999999999764 5779999999776566677899999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccCcceec
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLM 657 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~ 657 (839)
+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++..+
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999884 345689999999999999999999995 99999999999999 78899999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ ....+..+... . .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-~-~ 227 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFT-F-P 227 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-C-C
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-C-C
Confidence 5432 22334689999999988654 8999999999999999999999996432211 11111111100 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..... .....+.+++.+|++.+|.+||++.++++
T Consensus 228 ~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 12345778889999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.58 Aligned_cols=260 Identities=19% Similarity=0.209 Sum_probs=200.4
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCccccccee-ecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC-SEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~ 580 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ...++.+|++++..++|++++..++.+ .+....++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4567789999999999999976 678999999875432 234688999999999988887777766 667788999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccCcceec
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLM 657 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~ 657 (839)
+ +++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 ~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 87 L-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp C-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred c-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9 9999999842 234689999999999999999999995 99999999999999 78999999999999977
Q ss_pred CCCCce------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 658 GREHSQ------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 658 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 236 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc--
Confidence 543321 123456999999999999999999999999999999999999999764433221111100000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
...+.+.... ...+.+++..||+.+|++||++.+|++.|+...
T Consensus 237 ---~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 237 ---TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---SCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---chhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0000011111 346788889999999999999999999997643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.94 Aligned_cols=247 Identities=24% Similarity=0.312 Sum_probs=196.0
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+|.. .+++.||||++...... ..+++.+|++++.+++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3466678999999999999975 67899999999654322 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+. |+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 678777732 235689999999999999999999995 89999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.. ....||+.|+|||++. ...++.++||||||+++|||++|+.||....... ... ....+..
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~-~~~~~~~--- 270 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNES--- 270 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCC---
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHHhcCC---
Confidence 32 2346999999999884 5678999999999999999999999986432111 001 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
+.+. .......+.+++.+||+.+|++|||+.++++..
T Consensus 271 --~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 --PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp --CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred --CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111 111223467788889999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=330.14 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=194.5
Q ss_pred HHHhhccccccccCCCceEEEEEeC----CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCc-
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG----DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN- 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~- 573 (839)
....+.+.+.||+|+||.||+|... .++.||||++..... ...+.+.+|+.++.+++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3445667889999999999999763 345899999865422 234568999999999999999999999977553
Q ss_pred ----eEEEEeeccCCChhhhcccCC-CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 574 ----RLLVYEFMKNGSLDKWIFPSY-HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 574 ----~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
.++||||+++|+|.+++.... ......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 499999999999999984322 12446799999999999999999999995 9999999999999999999999
Q ss_pred cccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhh
Q 038743 649 SDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 649 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~ 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------YDY 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-------HHH
Confidence 999999876443221 2334457889999999999999999999999999999999 8888864332210 111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
...+.. ...+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus 262 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 LLHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111110 0111122345788889999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.62 Aligned_cols=242 Identities=14% Similarity=0.125 Sum_probs=185.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEeccc---CCcchHHHHHHH---HHhhccccCCccccc-------ceee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV---LPHGEKEFVTEV---NTIGSMHHMNLVRLC-------GYCS 569 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~ 569 (839)
.+.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +++++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 455678999999999999986 56999999999643 233456789999 555666899999998 4444
Q ss_pred cCC-----------------ceEEEEeeccCCChhhhcccC--CCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeee
Q 038743 570 EGS-----------------NRLLVYEFMKNGSLDKWIFPS--YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIH 630 (839)
Q Consensus 570 ~~~-----------------~~~lv~e~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 630 (839)
+.+ ..++||||+ +|+|.+++... .......+++..++.|+.||+.||+|||+. +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 432 378999999 68999999532 111123455688899999999999999995 9999
Q ss_pred cCCCCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCC-----------CCCCcccEEehhHHHH
Q 038743 631 CDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR-----------PITVKADVYSYGMLLL 699 (839)
Q Consensus 631 ~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DV~S~Gvvl~ 699 (839)
|||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986432 3344567 999999999887 8999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 700 EIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 700 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
||++|+.||.......... . +... .... ...+.+++.+||+.+|++||++.++++
T Consensus 305 elltg~~Pf~~~~~~~~~~-------~--------~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSE-------W--------IFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCSG-------G--------GGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccchh-------h--------hhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999996543222110 0 0000 0112 245778888999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=341.40 Aligned_cols=269 Identities=19% Similarity=0.260 Sum_probs=208.6
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCC--ceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS--NRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 579 (839)
.|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.. ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4667889999999999999775 58999999997543 233567889999999999999999999987655 7799999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE----CCCCceeecccCcce
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLAK 655 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla~ 655 (839)
|+++|+|.+++... .....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 90 ~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 90 FCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCTTEEHHHHTTSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred cCCCCCHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999532 1223389999999999999999999995 99999999999999 788889999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC--------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN--------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... . .....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~-~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--E-VMYKI 239 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--H-HHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--H-HHHHH
Confidence 7654322 223468999999998865 567889999999999999999999996543222110 0 01111
Q ss_pred ccCcccc----c---------c--cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 728 TNGTPLK----V---------A--DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 728 ~~~~~~~----~---------~--~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+.... + . +.......+......+.+++.+||+.||++||++.++++.++.+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111100 0 0 0111223456777888899999999999999999999999876544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.05 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=200.9
Q ss_pred HhhccccccccCCCceEEEEEe----CCCcEEEEEEecccC----CcchHHHHHHHHHhhcc-ccCCcccccceeecCCc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSN 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 573 (839)
..+.+.+.||+|+||.||+++. .+++.||||+++... ......+.+|++++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4577889999999999999987 478999999986532 12345678899999999 69999999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999942 34689999999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
++.+............||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ... .......
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~-~~~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEI-SRRILKS- 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHH-HHHHHHC-
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHH-HHHHhcc-
Confidence 98765444333444579999999999986 35789999999999999999999999754332211 000 0111000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKML 777 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~L 777 (839)
.+ ..+......+.+++.+||+.+|.+|| ++.++++..
T Consensus 282 -----~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -----EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01 11222234577888999999999999 999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.82 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=202.6
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc------chHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...|.+.+.||+|+||.||++... +++.||||.+...... ..+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456788899999999999999764 6899999999654321 356799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC----ceeecc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF----CPKVSD 650 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~D 650 (839)
++||||+++++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHH-----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999994 335688999999999999999999995 999999999999999888 799999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+...
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~ 233 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSV 233 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTT
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhc
Confidence 999987654321 234468999999999999999999999999999999999999996432111 01111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. ..++..... ....+.+++.+|++.+|.+|||+.++++.
T Consensus 234 ~~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 001111111 12457788999999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=352.02 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=190.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEeccc---CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV---LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.+.||+|+||.||++.. .+++.||||++... .......+.+|++++..++||||+++++++.+.+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 466788999999999999976 56899999999643 23334567899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. .+|+||||||+||||+.++.+||+|||+++....
T Consensus 229 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 229 YANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCSSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999884 345789999999999999999999973 3899999999999999999999999999986432
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.... ..
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~------~~ 367 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE------IR 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CC
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCC------CC
Confidence 22 22344679999999999999999999999999999999999999996432211 011111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
+... ....+.+++.+||+.+|.+|| ++.|+++
T Consensus 368 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111 234577888899999999999 9999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=350.67 Aligned_cols=253 Identities=26% Similarity=0.309 Sum_probs=202.6
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.++||+|+||.||++.. .+|+.||||++.+.. ......+.+|++++.+++||||+++++++.+....++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 3456678999999999999977 469999999996431 234556889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 264 Ey~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 264 TLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp CCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999998532 234589999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~-------- 404 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV-------- 404 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHC--------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcc--------
Confidence 432 233457999999999999999999999999999999999999999754322110 0011111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
...++......+.+++.+||+.+|.+|| ++.||++.
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0111122234577888899999999999 78888753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.74 Aligned_cols=259 Identities=19% Similarity=0.209 Sum_probs=201.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCccccccee-ecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC-SEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~ 581 (839)
.+.+.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+.++..++|++++..+.++ .+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 466778999999999999986 679999999986532 335689999999999998877776665 5667789999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccCcceecC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~~ 658 (839)
+++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 88 -GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999842 234689999999999999999999995 99999999999999 488999999999998765
Q ss_pred CCCce------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 659 REHSQ------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 659 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 236 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 236 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH---
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC---
Confidence 44321 123456999999999999999999999999999999999999999764432211111000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
...+.+.... ...+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 237 --~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 237 --TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp --SCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred --CchHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0000111112 245778889999999999999999999998643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.62 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=194.4
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecC-CceEEEEee
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-SNRLLVYEF 580 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 580 (839)
...+.+.+.||+|+||.||+++. .++.||||+++.. ...+.+.+|++++.+++||||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 34567788999999999999988 5889999999753 3456799999999999999999999987554 578999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999998432 223488999999999999999999995 9999999999999999999999999999865432
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-------- 231 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY-------- 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTC--------
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCC--------
Confidence 123357889999999999999999999999999999998 999986432211 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+......+.+++.+||+.+|.+||++.++++.|+..
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111122234577888899999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.19 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=199.1
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC------cchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP------HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456778899999999999999875 689999999864321 1356799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC----ceeecc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF----CPKVSD 650 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~D 650 (839)
++||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA-----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence 99999999999999984 235689999999999999999999995 999999999999998877 899999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+...
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~ 226 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAV 226 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTT
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhc
Confidence 99998764322 2234468999999999999999999999999999999999999996432211 01111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. ........ .....+.+++.+|++.+|.+||++.++++
T Consensus 227 ~~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NY--DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC--CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc--CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 00011111 12345778899999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=339.20 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=188.8
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHH-hhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNT-IGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+++.. +++.||||++.+... .....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 45678899999999999999874 588999999965432 223456777776 5678999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 118 ~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999984 345688899999999999999999995 9999999999999999999999999999864
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~----- 256 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPL----- 256 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSCC-----
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhccc-----
Confidence 3221 12344579999999999999999999999999999999999999996432111 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVV 774 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~ 774 (839)
.+...+ ...+.+++.+||+.+|.+||++.+.+
T Consensus 257 -~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 -QLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -CCCCCC----CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111122 23567888899999999999986433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.47 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=203.5
Q ss_pred hHHHHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceee
Q 038743 497 YRDLQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCS 569 (839)
Q Consensus 497 ~~~l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 569 (839)
+.++....+.+.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.++.+++||||+++++++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3445566788889999999999999974 347799999996442 234457899999999999999999999999
Q ss_pred cCCceEEEEeeccCCChhhhcccCCC--CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CC
Q 038743 570 EGSNRLLVYEFMKNGSLDKWIFPSYH--HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NF 644 (839)
Q Consensus 570 ~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~ 644 (839)
+....++||||+++|+|.+++..... .....+++..++.++.||+.||.|||+. +|+||||||+|||++. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999964321 1224588999999999999999999995 9999999999999984 45
Q ss_pred ceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 645 CPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
.+||+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------- 253 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------- 253 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------
Confidence 6999999999865332221 2233457899999999999999999999999999999998 999986432111
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+..+.. ...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 254 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 254 VLEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111110 011112234577888999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=339.71 Aligned_cols=251 Identities=10% Similarity=-0.018 Sum_probs=178.1
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhcc--ccCCccccc-------ceeecC
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSM--HHMNLVRLC-------GYCSEG 571 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~ 571 (839)
+.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 56778999999999999986 4789999999976533 2234577785555444 699988754 333222
Q ss_pred -----------------CceEEEEeeccCCChhhhcccCCCCCcccCChhhH------HHHHHHHHHHhHHhhhccCCee
Q 038743 572 -----------------SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTR------FNIAIATAQGIAYFHEQCRNRI 628 (839)
Q Consensus 572 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~i 628 (839)
...++||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||+. +|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 34799999999 8999999532 345566777 88889999999999995 99
Q ss_pred eecCCCCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCC
Q 038743 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 629 iH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876432 224557799999999987 789999999999999999999999
Q ss_pred CCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 707 NLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 707 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
||..........+... .....................+.+++.+||+.+|++||++.++++
T Consensus 292 Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRP--------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTCCCBC--------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccchhhh--------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9976533211110000 000000111111111122345778888999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=325.00 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=196.1
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 34667889999999999999764 57799999985432 123456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 89 e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 89 EYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred ecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999984 235689999999999999999999985 99999999999999999999999999986543
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ........ .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~------~- 223 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRV------E- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHT------C-
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhC------C-
Confidence 22 2234568999999999999999999999999999999999999996432111 11111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+......+.+++.+||+.+|.+||++.|+++.
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111223456788889999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.31 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=195.0
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...+.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35678889999999999999976 468999999986543 3345779999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccCccee
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKL 656 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~ 656 (839)
|+++|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 101 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999884321 1235689999999999999999999995 99999999999999 4568899999999987
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
+.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......+ ..............
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQKATYKEPNYAV 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCCC
T ss_pred cCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHhhhccCCccccc
Confidence 64322 233456899999999875 568999999999999999999999996432111 00000000000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.... ....+.+++.+||+.+|.+||++.||++
T Consensus 247 ---~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ---ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 1245678888999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=339.00 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=190.0
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--------CcchHHHHHHHHHhhccccCCcccccceeec
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--------PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 570 (839)
.....|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3455678889999999999999976 568999999986431 1122358899999999999999999999754
Q ss_pred CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC---Ccee
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN---FCPK 647 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~---~~~k 647 (839)
...++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ ..+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 55899999999999999884 345789999999999999999999995 99999999999999654 4599
Q ss_pred ecccCcceecCCCCceeEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 724 (839)
|+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~------~ 354 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------K 354 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH------H
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH------H
Confidence 9999999876432 22344569999999999853 67889999999999999999999999754322110 1
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+..+... . .+.... .....+.+++.+||+.+|.+||++.++++.
T Consensus 355 ~~i~~~~~~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 355 DQITSGKYN-F-IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHTTCCC-C-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCC-C-Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111110 0 000001 123457788999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.51 Aligned_cols=262 Identities=20% Similarity=0.277 Sum_probs=188.4
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..|.+.+.||+|+||+||+|.. .+++.||||++...... ....+.+|++++.+++||||+++++++.+....++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 4567788999999999999975 57899999999654322 23467899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE-----CCCCceeecccCcc
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL-----DENFCPKVSDFGLA 654 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill-----~~~~~~kl~DfGla 654 (839)
|+++ +|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 114 ~~~~-~L~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 114 YAEN-DLKKYMD-----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp CCSE-EHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred cCCC-CHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9984 9999884 234689999999999999999999995 99999999999999 45566999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch----------hhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP----------GWA 723 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~----------~~~ 723 (839)
+....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||............ .|.
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 87643322 23344689999999999874 5899999999999999999999999754321110000 000
Q ss_pred h----hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 724 F----KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 724 ~----~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. ..+. ..........+...........+.+++.+||+.+|.+|||+.|+++
T Consensus 264 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0000 0000000000000000112345678899999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.34 Aligned_cols=262 Identities=20% Similarity=0.326 Sum_probs=194.7
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++.+....++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4577889999999999999976 578999999997532 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999984321 1245688999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ....+......
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~~----- 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCDYP----- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HH-HHHHHHTTCSC-----
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HH-HHHHhhcccCC-----
Confidence 3322 2233468999999999999999999999999999999999999996432110 00 01111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
.+. .......+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000 11123457788889999999999999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.70 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=203.9
Q ss_pred cccchHHHHHHhhccc-cccccCCCceEEEEEeC-CCcEEEEEEecccCC--cchHHHHHHHHHhhcc-ccCCcccccce
Q 038743 493 VNFTYRDLQIRTSNFA-QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSM-HHMNLVRLCGY 567 (839)
Q Consensus 493 ~~~~~~~l~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~ 567 (839)
..|...+.....|.+. +.||+|+||.||+|... +++.||||++..... ....++.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455556666666666 89999999999999764 689999999865432 2356789999999999 57999999999
Q ss_pred eecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CC
Q 038743 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NF 644 (839)
Q Consensus 568 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~ 644 (839)
+.+....++||||+++|+|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++. ++
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999998432 346789999999999999999999995 9999999999999987 78
Q ss_pred ceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh
Q 038743 645 CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 724 (839)
.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .
T Consensus 172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~ 242 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-------Y 242 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H
T ss_pred cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-------H
Confidence 99999999998764332 22345699999999999999999999999999999999999999964332110 0
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+.... ..............+.+++.+||+.+|.+|||+.++++.
T Consensus 243 ~~i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 243 LNISQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000000 000011111223457788899999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.80 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=202.8
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
...+.+.+.||+|+||.||+++.. +|+.||||++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999764 7899999999765444556789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccCcceec
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLM 657 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~ 657 (839)
+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 88 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999998842 34688999999999999999999995 99999999999999 78899999999999764
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+...
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~---- 225 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE---- 225 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC----
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence 3321 223458999999999999999999999999999999999999996432111 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhcCCCCC
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK--MLEGSADI 783 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~--~L~~~~~~ 783 (839)
............+.+++.+|++.+|.+||++.++++ .+++...+
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (304)
T 2jam_A 226 --FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271 (304)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence 001111122345778899999999999999999987 35554433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=334.22 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=196.9
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEe
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...|.+.+.||+|+||.||++... +++.||||++.+... ...+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345778899999999999999764 689999999965432 345788888887 79999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC----CceeecccCcce
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN----FCPKVSDFGLAK 655 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~ 655 (839)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++
T Consensus 97 ~~~gg~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 97 LMKGGELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCSCBHHHHHH-----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999984 335689999999999999999999995 99999999999998433 359999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+..+...
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~-- 241 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFS-- 241 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCC--
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCcc--
Confidence 7654332 2234568999999999988889999999999999999999999997532211 01111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+...........+.+++.+||+.+|++||++.++++.
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111223457788889999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.24 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=201.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 356678999999999999976 568999999996543 334577999999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 103 ~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 103 GGGSALDLLE------PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp TTEEHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999983 34689999999999999999999995 99999999999999999999999999998765432
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... .+.+.
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~~ 240 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNN-----PPTLE 240 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC-----CCCCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCC-----CCCCc
Confidence 2 1234568999999999999999999999999999999999999986432111 001111111 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
... ...+.+++..||+.+|.+||++.++++.
T Consensus 241 ~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222 2447788889999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.52 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=190.2
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||+||+|... +++.||||++...... ....+.+|++++.+++||||+++++++.+....++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 4567789999999999999874 7899999999644322 1224567999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
+ |+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 83 D-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp S-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred c-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 7 588888843 245689999999999999999999995 99999999999999999999999999998654322
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc---
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD--- 737 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 737 (839)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 22334468999999999876 5789999999999999999999999975432211000000000000000000000
Q ss_pred ------ccccCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 ------RRLEGA----VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ------~~l~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+..... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00112345678899999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.67 Aligned_cols=202 Identities=25% Similarity=0.387 Sum_probs=173.9
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
+....+.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+....++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 33455677889999999999999774 689999999965432 2345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||++...
T Consensus 110 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp ECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999942 34688999999999999999999983 37999999999999999999999999999755
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCC
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMS 711 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~ 711 (839)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 183 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 223356899999999999999999999999999999999999999654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=343.17 Aligned_cols=260 Identities=23% Similarity=0.250 Sum_probs=190.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecC------Cce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 574 (839)
.|.+.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 466788999999999999965 568999999996542 23345788999999999999999999998654 456
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||++++ |.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 143 ~lv~E~~~~~-l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEEeCCCCC-HHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 9999999865 555552 2388999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc---------chhhh--
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF---------YPGWA-- 723 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~---------~~~~~-- 723 (839)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.+.
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8764322 2344579999999999999999999999999999999999999997543211000 00000
Q ss_pred ----hhhhccCc-------ccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 724 ----FKEMTNGT-------PLKVADRRLEGA---VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 724 ----~~~~~~~~-------~~~~~~~~l~~~---~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.....+.. ........+... ........+.+++.+||+.||++|||+.|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000000 011225678899999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=333.25 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=195.1
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcc--hHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHG--EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||.||++... +++.||||++....... .+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4667789999999999999774 58999999985443222 34578999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 106 VDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999988763 334689999999999999999999995 9999999999999999999999999999865433
Q ss_pred CceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhhhccCc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKEMTNGT 731 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~ 731 (839)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+..... ......+....
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 22 23345689999999999875 7899999999999999999999999754322110000 00000000000
Q ss_pred -ccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 -PLKVADRRLEGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 -~~~~~~~~l~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
......+.+..... ......+.+++.+||+.+|.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000111111111 122456888999999999999999999876
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.27 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=196.1
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 577 (839)
...+.+.+.||+|+||.||+|... +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 355778899999999999999875 79999999986542 33456788999999999 999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---------------
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--------------- 642 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--------------- 642 (839)
|||+++++|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999994321 1124689999999999999999999995 9999999999999984
Q ss_pred ----CCceeecccCcceecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc
Q 038743 643 ----NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF 717 (839)
Q Consensus 643 ----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 717 (839)
...+||+|||++........ ..||+.|+|||.+.+. .++.++||||||+++|||++|..++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 44799999999987654332 3489999999999876 66789999999999999999987763211
Q ss_pred cchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 718 FYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....+..+.. +.+... ....+.+++.+||+.+|.+||++.++++.
T Consensus 236 -----~~~~~~~~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -----QWHEIRQGRL-----PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHHHTTCC-----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHHHcCCC-----CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111111111 111112 23457788889999999999999999763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.90 Aligned_cols=266 Identities=18% Similarity=0.213 Sum_probs=196.3
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeec--------C
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--------G 571 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 571 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++.+++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4577788999999999999987 5789999999854432 234578899999999999999999999876 3
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999985 77676632 334689999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCc---eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh-----
Q 038743 652 GLAKLMGREHS---QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW----- 722 (839)
Q Consensus 652 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~----- 722 (839)
|+++.+..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653221 22334568999999998876 5689999999999999999999999975432211000000
Q ss_pred ---hhhhhccCcccccccccccCCCC-HHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 723 ---AFKEMTNGTPLKVADRRLEGAVE-EEE------LMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 723 ---~~~~~~~~~~~~~~~~~l~~~~~-~~~------~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+...........+......... .+. ...+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000000000000000 111 2347789999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.29 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=198.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++.+++||||+++++++.+....++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 466788999999999999976 4689999999865422 2335688999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc---eeecccCcceec
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC---PKVSDFGLAKLM 657 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DfGla~~~ 657 (839)
+++++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++...
T Consensus 87 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 87 VTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999998884 335689999999999999999999995 9999999999999976655 999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+... ...
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~-~~~ 228 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYD-YPS 228 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-CCT
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhcccc-CCc
Confidence 54322 233568999999999999999999999999999999999999996432211 01111111100 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+ ........+.+++.+|++.+|.+||++.++++
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00112245678888999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=332.39 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=201.8
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcE--EEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTL--VAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.+.||+|+||.||+|... ++.. ||||.+.... ....+.+.+|++++.++ +||||+++++++.+....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 33456778899999999999999763 4554 5999986432 33456789999999999 999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCC-----------CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC
Q 038743 575 LLVYEFMKNGSLDKWIFPSY-----------HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN 643 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~ 643 (839)
++||||+++|+|.+++.... ......+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999995431 01234789999999999999999999995 99999999999999999
Q ss_pred CceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhh
Q 038743 644 FCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGW 722 (839)
Q Consensus 644 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 722 (839)
+.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 179 ~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------- 249 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------- 249 (327)
T ss_dssp GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred CeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------
Confidence 999999999997432211 1233457889999999998889999999999999999998 999996432211
Q ss_pred hhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 723 AFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+..+. ....+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus 250 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 250 LYEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111110 00111122345778889999999999999999999987543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=335.33 Aligned_cols=261 Identities=15% Similarity=0.114 Sum_probs=199.3
Q ss_pred HhhccccccccCCCceEEEEEeCC---------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCccc----------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD---------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVR---------- 563 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 563 (839)
..|.+.+.||+|+||.||+|.... ++.||||++... ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 457788999999999999998753 789999998643 46889999999999999998
Q ss_pred -----ccceeec-CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 564 -----LCGYCSE-GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 564 -----l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 4556654 67889999999 99999999532 246799999999999999999999995 99999999999
Q ss_pred EEECCCC--ceeecccCcceecCCCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 638 ILLDENF--CPKVSDFGLAKLMGREHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 638 ill~~~~--~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
||++.++ .+||+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 99999999998765432211 123469999999999999999999999999999999999999997
Q ss_pred CCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 710 MSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
........ ... ....+. .....+.+..... ......+.+++.+||+.+|.+||++.+|+++|+...
T Consensus 270 ~~~~~~~~-~~~-~~~~~~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNTED-IMK-QKQKFV-DKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCHHH-HHH-HHHHHH-HSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCHHH-HHH-HHHhcc-CChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 54311100 000 000000 0111111111000 011245778888899999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.68 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=194.3
Q ss_pred HHhhccccccccCCCceEEEEEeC--CCc--EEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG--DGT--LVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.+.+.||+|+||.||+|+.. +++ .||||+++... ....+.+.+|++++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 345777889999999999999752 333 69999986542 233467899999999999999999999998755 8
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++|+||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHh----ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 899999999999999843 235689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 655 KLMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 655 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~ 241 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEG 241 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-------HHHHHHccC
Confidence 8775443322 234557889999999998889999999999999999999 999996432211 011111100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.....+......+.+++.+||+.+|.+||++.++++.|++..
T Consensus 242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 000111123355788889999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.24 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=193.7
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccCCCh
Q 038743 508 AQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
..+||+|+||.||+|.. .+++.||||.+........+.+.+|+.++..++||||+++++++.+....++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 34899999999999975 56889999999766555567899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccCcceecCCCCceeE
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFGLAKLMGREHSQVV 665 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~ 665 (839)
.+++... .....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 107 ~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~ 180 (295)
T 2clq_A 107 SALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CT 180 (295)
T ss_dssp HHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred HHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cc
Confidence 9998532 1234567888999999999999999995 9999999999999987 89999999999987643221 22
Q ss_pred EeeccccceeCcccccCCC--CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 666 TMVRGTRGYLAPEWVSNRP--ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 666 ~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
....|++.|+|||.+.+.. ++.++||||||+++|||++|+.||......... ...... ....+.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~-----~~~~~~~--- 247 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVGM-----FKVHPEI--- 247 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-----HHHHHH-----HCCCCCC---
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-----HHhhcc-----ccccccc---
Confidence 3456899999999987653 889999999999999999999999632211100 000000 0001111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+......+.+++.+||+.+|++||++.++++
T Consensus 248 -~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 -PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222345778889999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.07 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=193.0
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec----CCceEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----GSNRLLV 577 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 577 (839)
+.+.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 45667899999999999976 468899999986432 2234568999999999999999999998764 4568999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe--eeecCCCCCcEEEC-CCCceeecccCcc
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR--IIHCDIKPENILLD-ENFCPKVSDFGLA 654 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~DfGla 654 (839)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++
T Consensus 108 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 108 TELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEecCCCCHHHHHH-----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999994 235688999999999999999999995 6 99999999999997 7899999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ .......+...
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~- 248 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKP- 248 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCC-
T ss_pred ccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCc-
Confidence 7654332 234568999999998764 589999999999999999999999964332111 11111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...... ....+.+++..||+.+|.+||++.+|++
T Consensus 249 ---~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ---ASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011111 1235778889999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=343.59 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=198.3
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.+.+.++||+|+||.||+++.. +|+.||||++.+.. ......+.+|++++.+++||||+++++++.+....++|||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 4556679999999999999874 69999999996432 2334578899999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.++|.... .....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+..
T Consensus 266 ~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred eccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999985431 2245689999999999999999999995 999999999999999999999999999987654
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQA-------- 409 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHCC--------
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhcc--------
Confidence 3222 23347999999999999999999999999999999999999999754322110 00111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSM 770 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 770 (839)
. ..+......+.+++.+||+.+|.+||++
T Consensus 410 ~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 V--TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred c--CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0 1112223456778888999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.10 Aligned_cols=262 Identities=20% Similarity=0.266 Sum_probs=201.3
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcc-----------------hHHHHHHHHHhhccccCCcccc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-----------------EKEFVTEVNTIGSMHHMNLVRL 564 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 564 (839)
...|.+.+.||+|+||.||+|.. +++.||||++....... ...+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 34577788999999999999998 99999999985432111 1789999999999999999999
Q ss_pred cceeecCCceEEEEeeccCCChhhhcccC---CCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC
Q 038743 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPS---YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD 641 (839)
Q Consensus 565 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~ 641 (839)
++++.+.+..++||||+++|+|.+++... .......+++..+..++.||+.||.|||+. .+|+||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEc
Confidence 99999999999999999999999983210 111256799999999999999999999982 3999999999999999
Q ss_pred CCCceeecccCcceecCCCCceeEEeeccccceeCcccccCC-CCCC-cccEEehhHHHHHHHhCCCCCCCCCCCCCccc
Q 038743 642 ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR-PITV-KADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719 (839)
Q Consensus 642 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~ 719 (839)
.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--- 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--- 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---
Confidence 9999999999999876433 33445699999999999887 6666 99999999999999999999975443110
Q ss_pred hhhhhhhhccCcccc------cccc---cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 720 PGWAFKEMTNGTPLK------VADR---RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 720 ~~~~~~~~~~~~~~~------~~~~---~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+..+.... ...+ .............+.+++.+||+.+|.+||++.++++
T Consensus 261 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 ---LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011111111000 0000 0000001223346778889999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.69 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=200.6
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 34667789999999999999875 588999999865422 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 95 e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 95 ELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp ECCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999883 335789999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~------ 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY------ 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC------
Confidence 3222 2233568999999999999999999999999999999999999996433211 0111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+... ....+.+++.+|++.+|++||++.++++.
T Consensus 233 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKH----INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccc----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 22356788889999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.53 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=198.8
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceee--cCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCS--EGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~ 578 (839)
.|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4667789999999999999774 68999999996432 223456899999999999999999999874 466889999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCe-----eeecCCCCCcEEECCCCceeecccCc
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR-----IIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
||+++++|.+++.... .....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 87 EYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp ECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred eCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999985321 1234589999999999999999999996 5 99999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
++........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+...
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~ 234 (279)
T 2w5a_A 163 ARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR 234 (279)
T ss_dssp HHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC
T ss_pred heeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhcccc
Confidence 9875432211 123458999999999999999999999999999999999999996432110 11111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.+ +......+.+++.+||+.+|.+||++.+|++.+..
T Consensus 235 -----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 -----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 11223457788899999999999999999987754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.64 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=198.7
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc--------chHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH--------GEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
...|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 455777889999999999999875 7999999998654321 134578899999999 799999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CEEEEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999984 235689999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCceeEEeeccccceeCcccccC------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVSN------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
|++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 245 G~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-------~~~ 315 (365)
T 2y7j_A 245 GFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-------MLR 315 (365)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred CcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------HHH
Confidence 9998765432 2234569999999998863 358899999999999999999999996432110 011
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+..+... ...+. ... ....+.+++.+||+.+|.+||++.++++
T Consensus 316 ~i~~~~~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQYQ-FSSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCCC-CCHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCC-CCCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111100 00000 001 1245778889999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.56 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=195.6
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc-----chHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH-----GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
..|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++.+++||||+++++++.+....++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45677889999999999999874 5899999998643221 13468899999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999986 88888842 345689999999999999999999995 899999999999999999999999999987
Q ss_pred cCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhc---cCcc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT---NGTP 732 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 732 (839)
+..... ......||+.|+|||.+.+. .++.++||||||+++|||++|..||......+... ....... ....
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~---~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTS
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHcCCCChhhh
Confidence 643322 22345689999999998764 58999999999999999999999986543211100 0000000 0000
Q ss_pred c------ccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 038743 733 L------KVADRRLEGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVKML 777 (839)
Q Consensus 733 ~------~~~~~~l~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L 777 (839)
. +.+........+ ......+.+++.+||+.+|.+|||+.|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 000000000111 11235678899999999999999999998863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=340.07 Aligned_cols=258 Identities=17% Similarity=0.235 Sum_probs=200.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcccc-CCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH-MNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.++||+|+||.||+|.. .+++.||||++.... ...++..|++++..++| +++..+..++.+....+|||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 467788999999999999975 679999999876432 23468899999999976 55566666677888899999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccCcceecC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfGla~~~~ 658 (839)
+++|.+++.. ....+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++.+.
T Consensus 86 -g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 86 -GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999842 245799999999999999999999995 99999999999999 688999999999999875
Q ss_pred CCCcee------EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 659 REHSQV------VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 659 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
...... .....||+.|+|||.+.+..++.++||||||++||||++|+.||........... ...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~i~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK----YEKISEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH----HHHHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH----HHHHhhccc
Confidence 433221 2245699999999999999999999999999999999999999975443221110 011100000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+ ..+...+ ...+.+++..||+.+|++||++.+|+++|+..
T Consensus 234 ~~~~-~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSI-EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCH-HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccH-HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 0111112 34678888999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.40 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=200.5
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---cchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 34667789999999999999774 578999999865422 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++. ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 121 ELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp CCCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999883 335789999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+.... .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~------~ 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNE------Y 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC------C
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCC------C
Confidence 3322 2234568999999999999999999999999999999999999996432111 011111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+.... ...+.+++.+||+.+|++||++.++++.
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112 2346778889999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.48 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=190.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCC------ce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------NR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 574 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+++++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 466778999999999999976 56999999999654222 2456889999999999999999999987653 46
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 106 ~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp EEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 9999999 889999883 24688999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~ 725 (839)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||........... +.....
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876432 233568999999999887 7899999999999999999999999975432111000 000000
Q ss_pred hhccCccc-------ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGTPL-------KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+...... ......+. .........+.+++.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000 00000000 0111223457788899999999999999999884
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.44 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=182.9
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..+.+.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 4566788999999999999976 468999999986432 23356788999999999999999999999999999999999
Q ss_pred ccCCChhhhcccC---CCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 581 MKNGSLDKWIFPS---YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 581 ~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
+++++|.+++... .......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999998531 111345689999999999999999999995 9999999999999999999999999999865
Q ss_pred CCCCc----eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 658 GREHS----QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 658 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ............
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 248 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQNDPPSLE 248 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTSSCCCTT
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhccCCCccc
Confidence 43221 11234568999999999876 56899999999999999999999999754322110 000000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....++...... ...+.+++.+||+.+|.+||++.++++
T Consensus 249 ~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 249 TGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011111122222 235678888999999999999999976
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=339.56 Aligned_cols=192 Identities=26% Similarity=0.372 Sum_probs=151.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeec-----CCceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-----GSNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 575 (839)
.|.+.++||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 467789999999999999975 4789999999965432 234578899999999999999999999843 35789
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+ +|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 134 lv~e~~-~~~L~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR-----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEECCC-SEEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEecc-ccchhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 999997 578998883 345689999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCc--------------------------eeEEeeccccceeCcccc-cCCCCCCcccEEehhHHHHHHHhC
Q 038743 656 LMGREHS--------------------------QVVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGG 704 (839)
Q Consensus 656 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvvl~elltG 704 (839)
....... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 123445789999999976 566799999999999999999994
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.43 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=199.7
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++.+++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45677889999999999999774 57899999985431 223467899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999842 34689999999999999999999985 99999999999999999999999999997654
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+.... .
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~------~ 229 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVD------L 229 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC------C
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhccc------c
Confidence 322 223468999999999999999999999999999999999999996432111 011111110 1
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+... ....+.+++.+|++.+|.+||++.++++
T Consensus 230 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111 2345678889999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=339.42 Aligned_cols=197 Identities=27% Similarity=0.374 Sum_probs=164.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC-----CceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 575 (839)
.|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.+++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 467788999999999999976 4688999999975432 2345789999999999999999999998765 5789
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+. |+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 107 lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFK-----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEECCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCC-cCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 9999986 59999983 345689999999999999999999995 99999999999999999999999999999
Q ss_pred ecCCCCce---------------------eEEeeccccceeCcccc-cCCCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 656 LMGREHSQ---------------------VVTMVRGTRGYLAPEWV-SNRPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 656 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
........ ......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76543211 23456799999999986 56679999999999999999999766664
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=356.24 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=200.9
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEeccc---CCcchHHHHHHHHHhhcc-ccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV---LPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.++||+|+||.||+|+. .+++.||||++++. .......+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4445677788999999999999976 46889999999643 133455688899999987 799999999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
+|||||+++|+|.++|. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 418 ~lV~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999994 335689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+....... ......||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+.....
T Consensus 490 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~-- 559 (674)
T 3pfq_A 490 KENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV-- 559 (674)
T ss_dssp EECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCC--
T ss_pred eccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC--
Confidence 86433222 2344679999999999999999999999999999999999999997533211 1111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSM-----GEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~-----~~v~~ 775 (839)
.++......+.+++..||+.+|.+||++ +||++
T Consensus 560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111223457788888999999999997 66654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=358.17 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=200.8
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC----CcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
+....+.+.+.||+|+||.||+|.... +..||||++...... ..+.+.+|+.++.+++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 344567788999999999999997632 568999998754332 23678999999999999999999999854 568
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 999999999999999942 234689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
+..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~- 610 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGER- 610 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTCC-
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCC-
Confidence 8775544333444567889999999999999999999999999999997 999986432211 1111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 611 --------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011122234677889999999999999999999999754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.09 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=196.1
Q ss_pred HHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
....+.+.+.||+|+||.||+|.... .||+|++.... ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34456778899999999999998854 49999986432 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999942 345789999999999999999999995 999999999999998 6799999999987653
Q ss_pred CCCc----eeEEeeccccceeCcccccC---------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 659 REHS----QVVTMVRGTRGYLAPEWVSN---------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 659 ~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
.... .......|++.|+|||.+.. ..++.++||||||+++|||++|+.||....... ...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~ 253 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIW 253 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence 2211 11233458999999999864 457899999999999999999999996432211 111
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
....+....... .. ....+.+++.+||+.+|.+||++.+|+++|+....
T Consensus 254 ~~~~~~~~~~~~----~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 254 QMGTGMKPNLSQ----IG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHTTCCCCCCC----SS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HhccCCCCCCCc----CC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111111100 01 12346788889999999999999999999998765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.70 Aligned_cols=256 Identities=17% Similarity=0.243 Sum_probs=196.1
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeec--CCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSE--GSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++.. ...+.+.+|++++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 3466788999999999999975 6789999999863 34567999999999997 9999999999987 66789999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcceec
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLM 657 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~ 657 (839)
||+++++|.+++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999882 478899999999999999999995 999999999999999776 8999999999876
Q ss_pred CCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------hhhhhc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------AFKEMT 728 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~ 728 (839)
..... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... +... ....+.
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHH
Confidence 54322 233468999999999877 67899999999999999999999999543321100 0000 000000
Q ss_pred --------------cCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 729 --------------NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 729 --------------~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.......................+.+++.+||+.+|.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000111111113456788999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=334.30 Aligned_cols=270 Identities=23% Similarity=0.256 Sum_probs=204.1
Q ss_pred cchHHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc--------cCCccccc
Q 038743 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH--------HMNLVRLC 565 (839)
Q Consensus 495 ~~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~ 565 (839)
+...++....|.+.++||+|+||+||+|.. .+++.||||++... ......+.+|++++.+++ |+||++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 444555566788899999999999999975 56889999999643 233567889999999985 88899999
Q ss_pred ceee----cCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC
Q 038743 566 GYCS----EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD 641 (839)
Q Consensus 566 g~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~ 641 (839)
+++. +....++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. .+|+||||||+||||+
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~ 181 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEEC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEe
Confidence 9987 567899999999 56666666432 235689999999999999999999983 2899999999999999
Q ss_pred CCC-------------------------------------------------ceeecccCcceecCCCCceeEEeecccc
Q 038743 642 ENF-------------------------------------------------CPKVSDFGLAKLMGREHSQVVTMVRGTR 672 (839)
Q Consensus 642 ~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~ 672 (839)
.++ .+||+|||+++...... ....||+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~ 257 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTR 257 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCG
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCC
Confidence 775 79999999998765432 2346899
Q ss_pred ceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh---hhhhhh--------ccC-----------
Q 038743 673 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG---WAFKEM--------TNG----------- 730 (839)
Q Consensus 673 ~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~---~~~~~~--------~~~----------- 730 (839)
.|+|||++.+..++.++|||||||++|||++|+.||..........-.. ...... ..+
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 9999999999999999999999999999999999997654322110000 000000 000
Q ss_pred cccccccc-------c--ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADR-------R--LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~-------~--l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
....+.+. . -....+.+....+.+++.+||+.+|++|||+.|+++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 0 011235667788999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=342.21 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=195.5
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456788899999999999999874 68899999996543 333567899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCcce
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGLAK 655 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla~ 655 (839)
||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 116 e~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999884 335688999999999999999999995 9999999999999976 4559999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.+.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||......+ ....+..+... .
T Consensus 188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-~ 256 (494)
T 3lij_A 188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT-F 256 (494)
T ss_dssp ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-C
T ss_pred ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-C
Confidence 765432 223456999999999876 569999999999999999999999997543211 11111111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
....... ....+.+++.+||+.+|.+|||+.++++.
T Consensus 257 -~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 -DSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -Cchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000011 22456788889999999999999998853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=322.68 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=196.8
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.....+.+.+.||+|+||.||+|... +|+.||||.+... ....++.+|+.++.+++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 33455677889999999999999775 5899999999653 34567899999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 104 EYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp ECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred ecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999842 245689999999999999999999995 99999999999999999999999999998765
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .............
T Consensus 177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~-- 246 (314)
T 3com_A 177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------IFMIPTNPPPTFR-- 246 (314)
T ss_dssp TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCCCCCS--
T ss_pred hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCcccC--
Confidence 4322 12334689999999999999999999999999999999999999964321110 0001001000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+......+.+++.+||+.+|.+||++.++++
T Consensus 247 -----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 -----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112345778889999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=321.00 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=194.7
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..+.+.+.||+|+||.||+|... +++.||+|++..........+.+|++++.+++||||+++++++......++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34667889999999999999875 58999999997665666778999999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 99 PGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp TTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999998843 235689999999999999999999995 99999999999999999999999999986432211
Q ss_pred ceeEEeeccccceeCcccc-----cCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWV-----SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
.......|++.|+|||.+ ....++.++||||||+++|||++|+.||....... . .............
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------V-LLKIAKSDPPTLL 243 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H-HHHHHHSCCCCCS
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------H-HHHHhccCCcccC
Confidence 112334689999999988 36778999999999999999999999996432111 0 0111111110000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+......+.+++.+||+.+|.+||++.++++
T Consensus 244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01112345778888999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.73 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=191.9
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 35667889999999999999875 78999999985431 233457889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 91 EYVSGGELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp ECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999842 34688999999999999999999995 99999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ....+..+..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----- 228 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVF----- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCcc-----
Confidence 322 2234468999999999988765 689999999999999999999996432110 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+ +......+.+++.+|++.+|.+||++.++++.
T Consensus 229 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01 11122456788889999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.36 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=182.9
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc-chH-HHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH-GEK-EFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~-~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
...+.+.+.||+|+||.||++.. .+++.||||++...... ... .+.++...+..++||||+++++++.++...++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 34567788999999999999976 57899999999654322 222 3444555678889999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||++ |+|.+++.... .....+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 48877774311 1345789999999999999999999983 389999999999999999999999999998764
Q ss_pred CCCceeEEeeccccceeCcccc----cCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWV----SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... ...........
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-- 231 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPS-- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCC--
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCC--
Confidence 4322 2334689999999996 56678999999999999999999999996432211 00011111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+ ..........+.+++.+|++.+|.+|||+.++++
T Consensus 232 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ---P---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---C---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---C---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 0001122345778888999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.85 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=200.0
Q ss_pred HHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
....|.+.++||+|+||+||++... +++.||||++.... ......+.+|++++.+++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567888999999999999999774 78999999985432 33456789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeecccCcc
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLA 654 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla 654 (839)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999999884 335689999999999999999999995 999999999999995 5668999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+ ....+..+....
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~ 241 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF 241 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCS
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC
Confidence 8664322 2344569999999999876 58999999999999999999999996433211 111111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. .+ ........+.+++.+||+.+|.+|||+.++++.
T Consensus 242 ~-~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D-LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C-SG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-Cc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 001123456788899999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=324.75 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=190.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeec------CCceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE------GSNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~ 575 (839)
.+.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++.++ +||||+++++++.. ....+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 456678999999999999987 57899999998654 34456899999999999 89999999999976 46789
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 104 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred EEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 999999999999998532 345788999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||........ .......
T Consensus 178 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~ 249 (326)
T 2x7f_A 178 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHS
T ss_pred ecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcC
Confidence 7643221 123346899999999987 56789999999999999999999999964321110 0011111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.. +.+. .......+.+++.+||+.+|.+||++.++++
T Consensus 250 ~~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CC-----CCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cc-----ccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0010 1111245778888999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=343.76 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=202.1
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
.....|.+.++||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++.+....+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34556888899999999999999774 78999999985432 334567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---CCCCceeecccC
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL---DENFCPKVSDFG 652 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DfG 652 (839)
+||||+.+|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 103 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEECCCCSCBHHHHHH-----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 9999999999999884 335689999999999999999999995 99999999999999 567899999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+++.+.... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+ ....+..+..
T Consensus 175 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~ 244 (484)
T 3nyv_A 175 LSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKY 244 (484)
T ss_dssp HHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC
T ss_pred eeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 998764332 1233469999999999876 68999999999999999999999997543211 1111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. ...........+.+++.+||+.+|.+|||+.++++.
T Consensus 245 ~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 000001123457788899999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=328.03 Aligned_cols=259 Identities=23% Similarity=0.263 Sum_probs=178.7
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecC------Cce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 574 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 466778999999999999975 5789999999965422 2345788999999999999999999998654 567
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++|+||+ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp EEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEeccc-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 9999998 789988883 24689999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh--------hhhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG--------WAFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~ 725 (839)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............. ....
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 234568999999999887 688999999999999999999999997543211100000 0000
Q ss_pred hhccCcccccccccc-cCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGTPLKVADRRL-EGAVEE-----EELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l-~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+........+.... ...... .....+.+++.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000 000000 112457788999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.67 Aligned_cols=197 Identities=25% Similarity=0.327 Sum_probs=168.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc------ccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM------HHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l 576 (839)
.|.+.++||+|+||.||+|.. .+++.||||++... .....++.+|++++..+ +|+||+++++++......++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 467788999999999999966 45899999999653 22345677888888777 57799999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc--eeecccCcc
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC--PKVSDFGLA 654 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DfGla 654 (839)
||||+. ++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++. +||+|||++
T Consensus 177 v~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999996 6899988533 234589999999999999999999996 9999999999999999887 999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 223468999999999999999999999999999999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.77 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=194.2
Q ss_pred HHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--------cchHHHHHHHHHhhccccCCcccccceeecC
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--------HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG 571 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 571 (839)
....|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++.+++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 345678889999999999999976 4588999999864321 1224588999999999999999999998765
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc---eee
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC---PKV 648 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl 648 (839)
. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence 4 899999999999999884 345789999999999999999999995 9999999999999987654 999
Q ss_pred cccCcceecCCCCceeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 649 SDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 649 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......... ..
T Consensus 159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~ 230 (322)
T 2ycf_A 159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KD 230 (322)
T ss_dssp CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH------HH
T ss_pred ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH------HH
Confidence 9999998764322 122346899999999874 567899999999999999999999999754332110 01
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+..+... ..+.... .....+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111100 0011111 12345778899999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=334.52 Aligned_cols=199 Identities=23% Similarity=0.321 Sum_probs=152.5
Q ss_pred ccccccCCCceEEEEEeC---CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee--cCCceEEEEeecc
Q 038743 508 AQLLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS--EGSNRLLVYEFMK 582 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~ 582 (839)
.++||+|+||+||+|+.. +++.||||++... .....+.+|+.++.+++||||+++++++. .....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 458999999999999864 5789999999653 23457889999999999999999999994 4678999999997
Q ss_pred CCChhhhcccCC----CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE----CCCCceeecccCcc
Q 038743 583 NGSLDKWIFPSY----HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL----DENFCPKVSDFGLA 654 (839)
Q Consensus 583 ~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DfGla 654 (839)
+ +|.+++.... ......+++..+..++.||+.||+|||+. +|+||||||+|||| +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4 7777763210 11223589999999999999999999995 89999999999999 77899999999999
Q ss_pred eecCCCCc--eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 655 KLMGREHS--QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 655 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 87654322 22344679999999999987 458999999999999999999999997544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.80 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=188.8
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcc-----------hHHHHHHHHHhhccccCCcccccceeec-
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHG-----------EKEFVTEVNTIGSMHHMNLVRLCGYCSE- 570 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~~~~- 570 (839)
..|.+.+.||+|+||.||+|...+++.||||++....... .+.+.+|++++.+++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 3456678999999999999998889999999986432221 2678999999999999999999999843
Q ss_pred ----CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCce
Q 038743 571 ----GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCP 646 (839)
Q Consensus 571 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~ 646 (839)
....++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCE
Confidence 346799999998 688887742 345789999999999999999999995 99999999999999999999
Q ss_pred eecccCcceecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 647 KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 647 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ....
T Consensus 174 kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~ 248 (362)
T 3pg1_A 174 TICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN---KIVE 248 (362)
T ss_dssp EECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHH
T ss_pred EEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHH
Confidence 999999998543322 2234568999999999877 678999999999999999999999997543211000 0000
Q ss_pred hhccCc-----------cccccccccc-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGT-----------PLKVADRRLE-------GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~-----------~~~~~~~~l~-------~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...... ........+. ..........+.+++.+||+.+|.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000 0000000000 00011123457789999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.13 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=195.2
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC----CcchHHHHHHHHHhhccccCCccccccee--ecCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSMHHMNLVRLCGYC--SEGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~ 575 (839)
..|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|++++.+++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 3567789999999999999987 468899999996432 23456799999999999999999999998 4556889
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||++++ |.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 85 lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 999999887 66666432 345789999999999999999999995 99999999999999999999999999998
Q ss_pred ecCCCCc-eeEEeeccccceeCcccccCCC--CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 656 LMGREHS-QVVTMVRGTRGYLAPEWVSNRP--ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 656 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
....... .......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCCC
Confidence 7654322 2234556999999999987654 3789999999999999999999997432110 1111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+... ....+.+++.+||+.+|.+||++.++++.
T Consensus 231 ------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11112 23456788889999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=322.27 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=192.1
Q ss_pred HHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccc--cCCcccccceeecCCceEE
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMH--HMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~l 576 (839)
....|.+.+.||+|+||.||++...+++.||||++.... ......+.+|++++.+++ ||||+++++++.+....++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 344567788999999999999998889999999986432 223467899999999996 5999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++ +.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 678899999842 34688999999999999999999995 9999999999999965 8999999999987
Q ss_pred cCCCCcee-EEeeccccceeCcccccC-----------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh
Q 038743 657 MGREHSQV-VTMVRGTRGYLAPEWVSN-----------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF 724 (839)
Q Consensus 657 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-----------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 724 (839)
........ .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... . ..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~-~~ 249 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S-KL 249 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H-HH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----H-HH
Confidence 65433221 234568999999999875 478889999999999999999999996432110 0 00
Q ss_pred hhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.. ++++......+......+.+++.+||+.+|.+||++.++++.
T Consensus 250 ~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 HA--------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH--------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH--------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 01 111111111111113457788889999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.52 Aligned_cols=260 Identities=20% Similarity=0.257 Sum_probs=195.9
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecC-----CceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 576 (839)
.|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 467788999999999999976 46889999999754322 236788999999999999999999998654 46899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+. |+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 v~e~~~-~~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 108 VQDLME-TDLYKLLK------TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEECCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcccC-cCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999997 58998883 34689999999999999999999995 999999999999999999999999999987
Q ss_pred cCCCCcee--EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc-
Q 038743 657 MGREHSQV--VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP- 732 (839)
Q Consensus 657 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 732 (839)
........ .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ..........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCHH
Confidence 65433222 234579999999998754 5589999999999999999999999975443221100 0000000000
Q ss_pred ----------cccccc-cccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 733 ----------LKVADR-RLEGAVE-----EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 733 ----------~~~~~~-~l~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...... ......+ ......+.+++.+||+.+|.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000 1123457789999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.91 Aligned_cols=261 Identities=23% Similarity=0.253 Sum_probs=188.6
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCC------c
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------N 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 573 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 3467788999999999999975 4689999999965322 23456889999999999999999999987654 7
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.++||||+++ +|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 8999999975 7877772 2488899999999999999999995 999999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc---------cchhhhh
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF---------FYPGWAF 724 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~---------~~~~~~~ 724 (839)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.+..
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654321 233456899999999999999999999999999999999999999754321100 0000000
Q ss_pred -------hhhccC------cccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 -------KEMTNG------TPLKVADRRLEGA---VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 -------~~~~~~------~~~~~~~~~l~~~---~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...... ............. ........+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 0000000000000 012235678899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=339.67 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=196.3
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-------------cchHHHHHHHHHhhccccCCccccccee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-------------HGEKEFVTEVNTIGSMHHMNLVRLCGYC 568 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 568 (839)
..|.+.++||+|+||+||+|... +++.||||++..... ...+.+.+|+.++.+++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45677889999999999999764 588999999865321 2345789999999999999999999999
Q ss_pred ecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC---c
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF---C 645 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~---~ 645 (839)
.+....++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EcCCEEEEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999884 335689999999999999999999995 999999999999998775 6
Q ss_pred eeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 646 PKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 646 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
+||+|||+++.+.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+ ...
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIK 257 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence 9999999998765432 223456999999999887 468999999999999999999999997533211 111
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+..+... .+...... ....+.+++.+||+.+|.+|||+.|+++.
T Consensus 258 ~i~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYY--FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC--CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111110 00000011 12457788899999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.85 Aligned_cols=261 Identities=20% Similarity=0.239 Sum_probs=188.6
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceee-------------
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCS------------- 569 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------- 569 (839)
.|.+.+.||+|+||.||+|... +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 4567789999999999999875 48999999987654455677899999999999999999998873
Q ss_pred -cCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCcee
Q 038743 570 -EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPK 647 (839)
Q Consensus 570 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~k 647 (839)
+....++||||++ |+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+|
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE------QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccCceeEEeeccC-CCHHHHhh------cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 69999983 34688999999999999999999995 999999999999997 577999
Q ss_pred ecccCcceecCCCCce--eEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh---
Q 038743 648 VSDFGLAKLMGREHSQ--VVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG--- 721 (839)
Q Consensus 648 l~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--- 721 (839)
|+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432221 1233457899999998865 678999999999999999999999997543211100000
Q ss_pred -----hhhhhhccCccccccccccc-CCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 722 -----WAFKEMTNGTPLKVADRRLE-GAV-----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 722 -----~~~~~~~~~~~~~~~~~~l~-~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.....+.. .....+..... ... .......+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 00000000000 000 0112356788999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.52 Aligned_cols=262 Identities=21% Similarity=0.270 Sum_probs=199.7
Q ss_pred HHhhccccccccCCCceEEEEEe--CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC------cccccceeecCCc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL--GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN------LVRLCGYCSEGSN 573 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~ 573 (839)
...|.+.+.||+|+||.||++.. .+++.||||+++.. ......+.+|++++..++|++ ++++++++.+...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45677889999999999999975 46889999999643 233467889999999987665 9999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-----------
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE----------- 642 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~----------- 642 (839)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 89999998532 234688999999999999999999995 9999999999999987
Q ss_pred --------CCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCC
Q 038743 643 --------NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDA 714 (839)
Q Consensus 643 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~ 714 (839)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 6789999999998754322 2346899999999999999999999999999999999999999754322
Q ss_pred CCcc--------chhhhhhhhccCccc------------------cccccc-ccCCCCHHHHHHHHHHHHhccccCCCCC
Q 038743 715 EDFF--------YPGWAFKEMTNGTPL------------------KVADRR-LEGAVEEEELMRAMKVAFWCIQDEVFMR 767 (839)
Q Consensus 715 ~~~~--------~~~~~~~~~~~~~~~------------------~~~~~~-l~~~~~~~~~~~~~~l~~~Cl~~~p~~R 767 (839)
+... .+............. ....+. -...........+.+++.+||+.+|.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 1100 000000000000000 000000 0011123456778899999999999999
Q ss_pred CCHHHHHH
Q 038743 768 PSMGEVVK 775 (839)
Q Consensus 768 Pt~~~v~~ 775 (839)
||+.||++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.81 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=189.4
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec-----------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----------- 570 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 570 (839)
..+.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4567788999999999999986 47899999998543 3344678999999999999999999998754
Q ss_pred --CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 571 --GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 571 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
....++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999953 235678889999999999999999995 9999999999999999999999
Q ss_pred cccCcceecCCCC-------------ceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCC
Q 038743 649 SDFGLAKLMGREH-------------SQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDA 714 (839)
Q Consensus 649 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~ 714 (839)
+|||+++...... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998764321 1122345689999999999864 78999999999999999998 44311000
Q ss_pred CCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 715 EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
......+... ...+....+......+.+++.+||+.+|.+||++.++++.
T Consensus 235 ------~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 ------VNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ------HHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0011111111 1111122233344567788999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.75 Aligned_cols=262 Identities=20% Similarity=0.208 Sum_probs=190.1
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCC------ceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------NRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv 577 (839)
.|.+.++||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++.... ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4677889999999999999987777799998854322 2337999999999999999999985433 37899
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCceeecccCccee
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKL 656 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~ 656 (839)
|||++++.+....... .....+++..+..++.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+++.
T Consensus 117 ~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 117 LEYVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EECCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eeccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999876544332111 1245788999999999999999999995 999999999999999 799999999999987
Q ss_pred cCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhh--------hhhh-
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGW--------AFKE- 726 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~- 726 (839)
...... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....... ....
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 643322 2334689999999998765 589999999999999999999999975432111000000 0000
Q ss_pred ---hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 ---MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ---~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+.....+....+...+.......+.+++.+||+.+|.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000000000111123467889999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=331.81 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=184.5
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccCCC
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
..++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+. |+
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 35789999999998776678999999998542 245678999999887 89999999999999999999999995 69
Q ss_pred hhhhcccCCCCCc--ccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-------------Cceeecc
Q 038743 586 LDKWIFPSYHHRD--RVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-------------FCPKVSD 650 (839)
Q Consensus 586 L~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-------------~~~kl~D 650 (839)
|.+++........ ....+..++.++.||+.||+|||+. +|+||||||+||||+.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 9999954321111 1224556788999999999999995 99999999999999654 5899999
Q ss_pred cCcceecCCCCce---eEEeeccccceeCcccccC-------CCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccc
Q 038743 651 FGLAKLMGREHSQ---VVTMVRGTRGYLAPEWVSN-------RPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFY 719 (839)
Q Consensus 651 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 719 (839)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence 9999987543322 1234579999999999975 678999999999999999999 999996432211
Q ss_pred hhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+..+.. ..+.+...........+.+++.+||+.+|.+||++.+|++
T Consensus 248 -----~~i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -----SNIIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----HHHHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00000000 0001111123455677889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.95 Aligned_cols=257 Identities=19% Similarity=0.200 Sum_probs=171.4
Q ss_pred hhcc-ccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec----CCceEEE
Q 038743 504 TSNF-AQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----GSNRLLV 577 (839)
Q Consensus 504 ~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 577 (839)
.|.+ .++||+|+||.||+|... +++.||||++... ..........+..++||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 4555 457999999999999775 6899999998542 2222223334566799999999999876 4558999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCcc
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGLA 654 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla 654 (839)
|||+++|+|.+++... ....+++.+++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 105 ~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 105 MECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999532 335799999999999999999999995 9999999999999976 456999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
+...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ........+
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~---- 248 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLG---- 248 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcc----
Confidence 8654322 234568999999999988889999999999999999999999996543221100 000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhcCCCC
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK--MLEGSAD 782 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~--~L~~~~~ 782 (839)
...............+.+++.+||+.+|.+|||+.++++ .+.....
T Consensus 249 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 249 --QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred --ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 000000111122345778888999999999999999998 4454433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.74 Aligned_cols=264 Identities=21% Similarity=0.287 Sum_probs=195.1
Q ss_pred HhhccccccccCCCceEEEEEe--CCCcEEEEEEecccCC--cchHHHHHHHHHhhcc---ccCCcccccceee-----c
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL--GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSM---HHMNLVRLCGYCS-----E 570 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~ 570 (839)
..|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++..+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 3466788999999999999987 4688999999864322 2234577788777766 8999999999987 5
Q ss_pred CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecc
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D 650 (839)
....++||||+. |+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 677899999998 6999998533 234589999999999999999999995 999999999999999999999999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh-----hh
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA-----FK 725 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-----~~ 725 (839)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............... ..
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99998764322 123356899999999999999999999999999999999999999754321100000000 00
Q ss_pred hhccCc--cccccc---ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 726 EMTNGT--PLKVAD---RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 726 ~~~~~~--~~~~~~---~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+.... ...... ..............+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000000 00000011122345678889999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.67 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=197.7
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC---------cchHHHHHHHHHhhccc-cCCcccccceeecC
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP---------HGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEG 571 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 571 (839)
..|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++.++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 35667789999999999999874 689999999864321 11345789999999995 99999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CeEEEEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999994 235689999999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCceeEEeeccccceeCccccc------CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhh
Q 038743 652 GLAKLMGREHSQVVTMVRGTRGYLAPEWVS------NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFK 725 (839)
Q Consensus 652 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 725 (839)
|++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ...
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 239 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHH
Confidence 9998765432 223356899999999885 4568899999999999999999999996432111 111
Q ss_pred hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 726 EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 726 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+..+... ............+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111100 000001122345778889999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.75 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=175.8
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHH-HhhccccCCcccccceeecCCceEEEEe
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVN-TIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..+.+.+.||+|+||.||+|.. .+++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 4456678999999999999987 4689999999965432 22345666666 6777899999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++ +|.+++..........+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 787776421112346789999999999999999999983 3899999999999999999999999999987643
Q ss_pred CCceeEEeeccccceeCcccc----cCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWV----SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.. ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... ......+..
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~--- 247 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDP--- 247 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC---
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCC---
Confidence 22 12334689999999998 4567899999999999999999999999643221100 000001110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+.+...........+.+++.+||+.+|.+||++.+|++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111122345778889999999999999999965
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=323.18 Aligned_cols=269 Identities=21% Similarity=0.227 Sum_probs=201.1
Q ss_pred HHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-----------cCCcccccce
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-----------HMNLVRLCGY 567 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~ 567 (839)
+....|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|++++.+++ ||||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 3455678889999999999999976 57899999999643 233456888999998886 8999999999
Q ss_pred eecCC----ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC--
Q 038743 568 CSEGS----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-- 641 (839)
Q Consensus 568 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-- 641 (839)
+.... ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. .+|+||||||+||||+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEecc
Confidence 87644 789999999 89999998532 234589999999999999999999983 2899999999999994
Q ss_pred ----CCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc
Q 038743 642 ----ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF 717 (839)
Q Consensus 642 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~ 717 (839)
..+.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCCcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 44589999999998765432 2346899999999999999999999999999999999999999754321100
Q ss_pred cchh---hhhhhh--------ccCc----------c------------cccccccccCCCCHHHHHHHHHHHHhccccCC
Q 038743 718 FYPG---WAFKEM--------TNGT----------P------------LKVADRRLEGAVEEEELMRAMKVAFWCIQDEV 764 (839)
Q Consensus 718 ~~~~---~~~~~~--------~~~~----------~------------~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p 764 (839)
.... .....+ ..+. . ..++. -....+......+.+++.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCc
Confidence 0000 000000 0000 0 00000 0113456677889999999999999
Q ss_pred CCCCCHHHHHHH--hcCCC
Q 038743 765 FMRPSMGEVVKM--LEGSA 781 (839)
Q Consensus 765 ~~RPt~~~v~~~--L~~~~ 781 (839)
++|||+.||++. +.+..
T Consensus 323 ~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred cccCCHHHHhhChhhhccc
Confidence 999999999873 44443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.18 Aligned_cols=259 Identities=20% Similarity=0.250 Sum_probs=190.7
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec-----------
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----------- 570 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 570 (839)
..|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 3567788999999999999976 679999999985432 223479999999999999999999843
Q ss_pred ---------------------------CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc
Q 038743 571 ---------------------------GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623 (839)
Q Consensus 571 ---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 623 (839)
....++||||++ |+|.+.+.... .....+++..+..++.||+.||+|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334789999998 58777764211 2345789999999999999999999985
Q ss_pred cCCeeeecCCCCCcEEEC-CCCceeecccCcceecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHH
Q 038743 624 CRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEI 701 (839)
Q Consensus 624 ~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~el 701 (839)
+|+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||.+.+. .++.++||||||+++|||
T Consensus 161 ---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 161 ---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp ---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 999999999999997 689999999999987644322 2334589999999998775 589999999999999999
Q ss_pred HhCCCCCCCCCCCCCccchhhhhhhhcc----------Ccccc-----cccccccCCCCHHHHHHHHHHHHhccccCCCC
Q 038743 702 VGGRRNLDMSGDAEDFFYPGWAFKEMTN----------GTPLK-----VADRRLEGAVEEEELMRAMKVAFWCIQDEVFM 766 (839)
Q Consensus 702 ltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~-----~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~ 766 (839)
++|+.||......+... . ....... ....+ +.........+......+.+++.+||+.+|.+
T Consensus 236 l~g~~pf~~~~~~~~~~--~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLV--R-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHSSCSSCCSSHHHHHH--H-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HhCCCCCCCCChHHHHH--H-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999997543221100 0 0000000 00000 00000000111123345788899999999999
Q ss_pred CCCHHHHHH
Q 038743 767 RPSMGEVVK 775 (839)
Q Consensus 767 RPt~~~v~~ 775 (839)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.61 Aligned_cols=270 Identities=20% Similarity=0.231 Sum_probs=185.7
Q ss_pred HHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCc----
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN---- 573 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 573 (839)
......+.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|++.+..++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 34445677889999999999999987 46899999998554 2334467788888999999999999999865333
Q ss_pred ---eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhh--hccCCeeeecCCCCCcEEECC-CCcee
Q 038743 574 ---RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH--EQCRNRIIHCDIKPENILLDE-NFCPK 647 (839)
Q Consensus 574 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~dlk~~Nill~~-~~~~k 647 (839)
.++||||+++ +|...+... ......+++..+..++.||+.||.||| + .+|+||||||+||||+. ++.+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 444433211 124557888999999999999999999 6 59999999999999996 89999
Q ss_pred ecccCcceecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch------
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP------ 720 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~------ 720 (839)
|+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999987654322 2334689999999998765 4899999999999999999999999754322110000
Q ss_pred --hhhhhhhccC-ccccccc------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 721 --GWAFKEMTNG-TPLKVAD------RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 721 --~~~~~~~~~~-~~~~~~~------~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...+..+... ......+ ..............+.+++.+||+.+|.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 0000000 000111112245678899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=335.12 Aligned_cols=259 Identities=23% Similarity=0.272 Sum_probs=188.5
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecC------CceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG------SNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 576 (839)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3566789999999999999874 68999999985432 2344799999999999999999988432 23678
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC-CceeecccCcce
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAK 655 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DfGla~ 655 (839)
||||+++ +|.+++... ......+++..+..++.||++||+|||+. +|+||||||+||||+.+ +.+||+|||+++
T Consensus 131 v~e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred ehhcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 9999986 555554211 11345789999999999999999999995 99999999999999955 678999999999
Q ss_pred ecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh--------
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE-------- 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-------- 726 (839)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .. ..+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~-i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VE-IIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCCHHH
Confidence 7643322 2334689999999998765 7999999999999999999999999754321110 00 0000
Q ss_pred hc--cCcccccccccccC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 727 MT--NGTPLKVADRRLEG-----AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 727 ~~--~~~~~~~~~~~l~~-----~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+. .....+...+.+.. .+.......+.+++.+||+.+|.+||++.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 00000000011100 0111223567889999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.57 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=193.4
Q ss_pred hhccccccccCCCceEEEEEeC-CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecC-----CceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-----SNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 576 (839)
.+.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++.+++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4667789999999999999874 689999999964322 2345688999999999999999999988654 67899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+. |+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIS------TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EECCCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccC-ccHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 999997 58998883 34689999999999999999999995 999999999999999999999999999987
Q ss_pred cCCCCcee---------EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh-----
Q 038743 657 MGREHSQV---------VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG----- 721 (839)
Q Consensus 657 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~----- 721 (839)
........ .....||+.|+|||.+.. ..++.++||||||+++|||++|+.||.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65322211 123468999999998765 778999999999999999999999997543211000000
Q ss_pred ----hhhhhhccCccccccccc-ccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 722 ----WAFKEMTNGTPLKVADRR-LEGAV-----EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 722 ----~~~~~~~~~~~~~~~~~~-l~~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
............+..... ..... .......+.+++.+||+.+|.+|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000000000 00000 01123457788999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.63 Aligned_cols=258 Identities=22% Similarity=0.265 Sum_probs=191.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCce------
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR------ 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------ 574 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++..++||||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 456678999999999999976 46899999999754322 245788999999999999999999999877655
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 123 ~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp EEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68888772 2489999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~ 725 (839)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... .....
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 865432 234568999999999887 78999999999999999999999999754321100000 00000
Q ss_pred hhccCcccccccc---cccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGTPLKVADR---RLEGA---VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~~~~~~~~---~l~~~---~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+........... ..... ........+.+++.+||+.+|.+|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000000 00000 001123567888999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=320.56 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=191.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeecCCc------e
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN------R 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 574 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++.+++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 466778999999999999976 46899999999654322 23568899999999999999999999987654 4
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp EEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 99999997 58888772 2489999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc-------hhh-hhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY-------PGW-AFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~-------~~~-~~~ 725 (839)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... +.. ...
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 234568999999999887 6789999999999999999999999975432110000 000 000
Q ss_pred hhccCccccc-------ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 726 EMTNGTPLKV-------ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 726 ~~~~~~~~~~-------~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.+........ ..+.+ ..........+.+++.+|++.+|++|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 00000 01112234567888899999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=311.48 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=202.0
Q ss_pred chHHHHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCC
Q 038743 496 TYRDLQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS 572 (839)
Q Consensus 496 ~~~~l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 572 (839)
..+......|.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++.+++||||+++++++.+..
T Consensus 15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 345566678889999999999999999874 68999999985432 234567899999999999999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCC---Cceeec
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDEN---FCPKVS 649 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~---~~~kl~ 649 (839)
..++|+||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEe
Confidence 99999999999999998842 34689999999999999999999995 99999999999999754 479999
Q ss_pred ccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 650 DFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 650 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
|||++........ .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||....... ....+..
T Consensus 167 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~ 236 (287)
T 2wei_A 167 DFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVET 236 (287)
T ss_dssp STTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred ccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHc
Confidence 9999986643321 223458999999998876 48999999999999999999999996432111 1111111
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+.... +...... ....+.+++.+|++.+|.+||++.++++
T Consensus 237 ~~~~~--~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 GKYAF--DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCC--CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC--Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11100 0000011 2345778889999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.78 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=168.7
Q ss_pred HHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccc-cC-----CcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HM-----NLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~ 574 (839)
...|.+.+.||+|+||+||+|... +++.||||+++.. .....++..|++++..++ |+ +|+++++++......
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 346777889999999999999764 6889999999743 233456778888888874 44 499999999999999
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC--CCCceeecccC
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD--ENFCPKVSDFG 652 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DfG 652 (839)
++||||++ |+|.+++... ....+++..+..++.||+.||.|||.+ ..+|+||||||+||||+ .++.+||+|||
T Consensus 132 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999996 5999998543 234589999999999999999999952 25899999999999994 57889999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 223568999999999999999999999999999999999999997543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.64 Aligned_cols=245 Identities=27% Similarity=0.385 Sum_probs=188.8
Q ss_pred HHHHHHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc------chHHHHHHHHHhhcc----ccCCcccccc
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSM----HHMNLVRLCG 566 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~g 566 (839)
.+.....|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344456688889999999999999976 56889999999654321 223466789988888 8999999999
Q ss_pred eeecCCceEEEEee-ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCC
Q 038743 567 YCSEGSNRLLVYEF-MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENF 644 (839)
Q Consensus 567 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~ 644 (839)
++...+..++|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 99999999999999 789999999942 34689999999999999999999995 999999999999999 889
Q ss_pred ceeecccCcceecCCCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh
Q 038743 645 CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA 723 (839)
Q Consensus 645 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 723 (839)
.+||+|||+++...... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 99999999998765432 233458999999999887666 458999999999999999999986321
Q ss_pred hhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 724 FKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...... ..+.. .....+.+++.+||+.+|++||++.++++.
T Consensus 244 --~~~~~~------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 --EILEAE------LHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HHHHTC------CCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --HHhhhc------cCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00111 123456788899999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.53 Aligned_cols=246 Identities=24% Similarity=0.287 Sum_probs=183.0
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
+.+.++||+|+||+|+.....+++.||||++.... ...+.+|++++.++ +||||+++++++.+....++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 45567999999999766655689999999986432 23467899999999 89999999999999999999999996
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-----CCceeecccCcceecC
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-----NFCPKVSDFGLAKLMG 658 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~~~ 658 (839)
|+|.+++... ...+.+..++.++.||+.||+|||+. +|+||||||+||||+. ...+||+|||+++...
T Consensus 102 g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 5999998532 33455667789999999999999995 9999999999999943 3468899999998765
Q ss_pred CCCc--eeEEeeccccceeCccccc---CCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 659 REHS--QVVTMVRGTRGYLAPEWVS---NRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 659 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
.... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||....... .........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~ 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLGACS 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTTCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhccCC
Confidence 3322 2234467999999999997 4667889999999999999999 999985322111 000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.... .........+.+++.+||+.+|.+||++.+|++
T Consensus 247 ~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 011233445678999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=320.62 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=198.5
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeC-CC-cEEEEEEecccCCcchHHHHHHHHHhhccccCC------cccccceee
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLG-DG-TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN------LVRLCGYCS 569 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~ 569 (839)
.+.....|.+.+.||+|+||.||++... ++ +.||||+++.. ......+.+|+.++.+++|++ ++.+++++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3334456788899999999999999763 34 78999999643 233457888999999998766 899999999
Q ss_pred cCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE---------
Q 038743 570 EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL--------- 640 (839)
Q Consensus 570 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill--------- 640 (839)
.....++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred eCCeEEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccc
Confidence 999999999999 66777776432 234689999999999999999999995 99999999999999
Q ss_pred ----------CCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCC
Q 038743 641 ----------DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDM 710 (839)
Q Consensus 641 ----------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~ 710 (839)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 568899999999998754322 234689999999999999999999999999999999999999975
Q ss_pred CCCCCCcc--------chhhhhhhhccCccc--------c------cc----cc-cccCCCCHHHHHHHHHHHHhccccC
Q 038743 711 SGDAEDFF--------YPGWAFKEMTNGTPL--------K------VA----DR-RLEGAVEEEELMRAMKVAFWCIQDE 763 (839)
Q Consensus 711 ~~~~~~~~--------~~~~~~~~~~~~~~~--------~------~~----~~-~l~~~~~~~~~~~~~~l~~~Cl~~~ 763 (839)
....+... .+............. . .. .+ .............+.+++.+||+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 43221100 000000000000000 0 00 00 0000112234567889999999999
Q ss_pred CCCCCCHHHHHH
Q 038743 764 VFMRPSMGEVVK 775 (839)
Q Consensus 764 p~~RPt~~~v~~ 775 (839)
|.+|||+.++++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.60 Aligned_cols=241 Identities=26% Similarity=0.377 Sum_probs=195.0
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc------chHHHHHHHHHhhccc--cCCcccccceeecCC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSMH--HMNLVRLCGYCSEGS 572 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 572 (839)
...|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.+++ |+||+++++++.+..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 44577789999999999999975 57899999999654221 2245778999999996 599999999999999
Q ss_pred ceEEEEeeccC-CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCceeecc
Q 038743 573 NRLLVYEFMKN-GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSD 650 (839)
Q Consensus 573 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~D 650 (839)
..++|+|++.+ ++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred cEEEEEEcCCCCccHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999986 89999984 235689999999999999999999995 999999999999999 789999999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhcc
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 729 (839)
||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ...
T Consensus 194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~ 257 (320)
T 3a99_A 194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIR 257 (320)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHH
T ss_pred Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhc
Confidence 99998765432 223468999999999987665 6889999999999999999999863210 000
Q ss_pred CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 730 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
+.. ...... ...+.+++.+||+.+|++||++.+|++.
T Consensus 258 ~~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011112 2357788889999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.32 Aligned_cols=259 Identities=25% Similarity=0.306 Sum_probs=195.0
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeec------CCc
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE------GSN 573 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 573 (839)
...|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 35678899999999999999976 568999999986542 2334568999999999999999999998765 677
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCc---eeecc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFC---PKVSD 650 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~---~kl~D 650 (839)
.++||||+++|+|.+++... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 89999999999999999543 2234689999999999999999999995 9999999999999987664 99999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhh---
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM--- 727 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 727 (839)
||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .|.....
T Consensus 168 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~ 240 (676)
T 3qa8_A 168 LGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKS 240 (676)
T ss_dssp CCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC---
T ss_pred ccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhccc
Confidence 99998764432 2234568999999999999999999999999999999999999996532110 0000000
Q ss_pred ---------ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 038743 728 ---------TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGE 772 (839)
Q Consensus 728 ---------~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~ 772 (839)
..+.....................+.+++.+|++.+|.+|||+.+
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000000111233445677889999999999999999966
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.03 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=174.2
Q ss_pred HhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCc-chHH-HHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPH-GEKE-FVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~-~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
..+.+.+.||+|+||.||+|... +++.||||++...... ...+ +..+..++..++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 34667789999999999999874 6899999999654322 2223 4445556788899999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+ ++.+..++.. ....+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 4455444421 235688999999999999999999983 2899999999999999999999999999976543
Q ss_pred CCceeEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ........+...
T Consensus 178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~- 248 (318)
T 2dyl_A 178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------EVLTKVLQEEPP- 248 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHHSCCC-
T ss_pred Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------HHHHHHhccCCC-
Confidence 22 223446899999999984 5678899999999999999999999997432211 011111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+.. .......+.+++.+||+.+|.+||++.++++
T Consensus 249 ----~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 ----LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 0012245778888999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=338.96 Aligned_cols=238 Identities=21% Similarity=0.261 Sum_probs=189.5
Q ss_pred HHHhhccccccccCCCceEEEEEeC--CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCc----
Q 038743 501 QIRTSNFAQLLGTGGFGSVYKGSLG--DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSN---- 573 (839)
Q Consensus 501 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 573 (839)
....|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++.+++||||+++++++.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3456788899999999999999874 689999999864322 234568899999999999999999999987665
Q ss_pred -eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 574 -RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 574 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
.+|||||+++++|.+++. ..+++.+++.++.||+.||.|||+. +|+||||||+||||+.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999988762 2689999999999999999999995 99999999999999986 89999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+++..... ....||+.|+|||++.+.. +.++||||||+++|||++|..|+....... ++
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---~~------------ 285 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---LP------------ 285 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---CC------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---cc------------
Confidence 99876543 3346999999999987764 899999999999999999988875321100 00
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhc
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-SMGEVVKMLE 778 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~~v~~~L~ 778 (839)
...........+.+++.+||+.+|.+|| +++++...|.
T Consensus 286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0000112235677899999999999999 5666666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.30 Aligned_cols=229 Identities=21% Similarity=0.203 Sum_probs=174.2
Q ss_pred hccc-cccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHh-hccccCCcccccceeec----CCceEEE
Q 038743 505 SNFA-QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTI-GSMHHMNLVRLCGYCSE----GSNRLLV 577 (839)
Q Consensus 505 ~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lv 577 (839)
+.+. +.||+|+||.||++.. .+++.||||+++. ...+.+|+.++ ..++||||+++++++.. ....++|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4444 6899999999999976 5689999999853 34677888887 55599999999999876 6778999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCcc
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGLA 654 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGla 654 (839)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 94 MECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp ECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999542 334689999999999999999999995 9999999999999998 789999999998
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccc
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (839)
.... +..++.++||||||+++|||++|+.||.......... ........+.. .
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~-~ 220 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY-E 220 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---CSCCSSCTTCC-S
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---HHHHHHhhccc-c
Confidence 7532 2346789999999999999999999996543221100 00000000000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 735 VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 735 ~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
. ...... .....+.+++.+||+.+|.+||++.|+++.
T Consensus 221 ~-~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 221 F-PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp S-CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-Cchhcc----cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 000001 123457788899999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=295.83 Aligned_cols=233 Identities=12% Similarity=0.088 Sum_probs=181.5
Q ss_pred HHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcc---hHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHG---EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
+....|.+.+.||+|+||.||+|... +++.||||++....... .+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44456778899999999999999874 48999999997553322 367899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++++|.+++.. . ....+..+++.||+.||+|||+. +|+||||||+||||+.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred EEEEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---
Confidence 99999999999999832 1 34557888999999999999995 99999999999999999999998543
Q ss_pred ecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
|++| ++.++||||||+++|||++|+.||........... ....... ...
T Consensus 175 ------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~-~~~-- 223 (286)
T 3uqc_A 175 ------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAG-QPI-- 223 (286)
T ss_dssp ------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTS-CBC--
T ss_pred ------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhcc-CCC--
Confidence 4443 68999999999999999999999976543221100 0000000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+.... ...+.+++.+||+.||.+| |+.++++.|+...
T Consensus 224 ~~~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 224 EPADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CHHHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ChhhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000111222 3447788899999999999 9999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=315.02 Aligned_cols=241 Identities=13% Similarity=0.069 Sum_probs=177.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC---cchHHHHHHHHHhhcccc-CCcccccce------------
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP---HGEKEFVTEVNTIGSMHH-MNLVRLCGY------------ 567 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~g~------------ 567 (839)
+.+.++||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++..++| +|...+..+
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 34457899999999999984 5799999999873322 225679999999999977 332222111
Q ss_pred ---------eec-----CCceEEEEeeccCCChhhhcccC--CCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeec
Q 038743 568 ---------CSE-----GSNRLLVYEFMKNGSLDKWIFPS--YHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHC 631 (839)
Q Consensus 568 ---------~~~-----~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 631 (839)
... ....+++|++ .+++|.+++... .......+++..++.++.||++||+|||+. +|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 111 1234566665 468999887311 012356788999999999999999999995 99999
Q ss_pred CCCCCcEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccc----------cCCCCCCcccEEehhHHHHHH
Q 038743 632 DIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV----------SNRPITVKADVYSYGMLLLEI 701 (839)
Q Consensus 632 dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DV~S~Gvvl~el 701 (839)
||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999875432 344567 999999999 555688999999999999999
Q ss_pred HhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 702 VGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 702 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
++|+.||......+.. . .++... ..++ ..+.+++.+||+.+|.+||++.++++
T Consensus 311 ltg~~Pf~~~~~~~~~-------~--------~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 311 WCADLPNTDDAALGGS-------E--------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHSSCCCCTTGGGSCS-------G--------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCcchhhhH-------H--------HHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999644322110 0 011100 1122 45778888999999999999988854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-33 Score=303.65 Aligned_cols=244 Identities=15% Similarity=0.110 Sum_probs=182.2
Q ss_pred HHHHhhccccccccCCCceEEEEEeCCCcEEEEEEecccC--------CcchHHHHHHHHHhhccc--------------
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--------PHGEKEFVTEVNTIGSMH-------------- 557 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~-------------- 557 (839)
+....|.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3356678889999999999999988 78999999996542 222367889999988886
Q ss_pred ------------cCCcccccceeec-------------CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHH
Q 038743 558 ------------HMNLVRLCGYCSE-------------GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612 (839)
Q Consensus 558 ------------h~niv~l~g~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ 612 (839)
||||+++++++.+ ....++||||+++|++.+.+. ...+++..+..++.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQ 169 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHH
Confidence 5666666666554 788999999999998777662 246899999999999
Q ss_pred HHHHhHHhh-hccCCeeeecCCCCCcEEECCCC--------------------ceeecccCcceecCCCCceeEEeeccc
Q 038743 613 TAQGIAYFH-EQCRNRIIHCDIKPENILLDENF--------------------CPKVSDFGLAKLMGREHSQVVTMVRGT 671 (839)
Q Consensus 613 ia~~L~yLH-~~~~~~iiH~dlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt 671 (839)
|+.||+||| +. +|+||||||+||||+.++ .+||+|||+++..... ...||
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt 240 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECC
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEe
Confidence 999999999 74 999999999999999887 8999999999876432 23699
Q ss_pred cceeCcccccCCCCCCcccEEehhHH-HHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCCCCHHHHH
Q 038743 672 RGYLAPEWVSNRPITVKADVYSYGML-LLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELM 750 (839)
Q Consensus 672 ~~y~aPE~~~~~~~s~~~DV~S~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 750 (839)
+.|+|||++.+.. +.++|||||+++ .+++++|..||.... ........+.... ................
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQM---TFKTKCNTPAMKQIKR 310 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTC---CCSSCCCSHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhh---ccCcccchhhhhhcCH
Confidence 9999999998776 899999998777 778888988873100 0000001110000 0000111112234567
Q ss_pred HHHHHHHhccccCCCCCCCHHHHH
Q 038743 751 RAMKVAFWCIQDEVFMRPSMGEVV 774 (839)
Q Consensus 751 ~~~~l~~~Cl~~~p~~RPt~~~v~ 774 (839)
.+.+++.+||+.+ |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 7889999999865 888887
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-30 Score=260.67 Aligned_cols=207 Identities=19% Similarity=0.250 Sum_probs=140.5
Q ss_pred CCCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC
Q 038743 1 HIGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND 80 (839)
Q Consensus 1 ~~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~ 80 (839)
+|.+|++|.+ +++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ..+.|+|+.||||||.|
T Consensus 10 ~i~~g~~L~~--g~~l--~~g~f~l~f~~~gn------l~l-y~~----~~~vW~an~~~~--~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 10 EGSHPQTLHA--AQSL--ELSSFRFTMQSDCN------LVL-FDS----DVRVWASNTAGA--TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp SSCSCSCCCT--TCEE--CSTTEEEEECTTSC------EEE-EES----SSEEECCCCCSC--SCCBCCBCSSSCBCCBC
T ss_pred eeCCCCEECC--CCEE--EcCCEEEEECCCCc------EEE-EEC----CEEEEECCCCCC--CCeEEEEcCCCcEEEEc
Confidence 4889999987 8888 59999999986653 333 432 699999999998 56789999999999999
Q ss_pred -CCeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeecccCCCccc----------cCCCCcccc-eeeccCCccCC
Q 038743 81 -GDTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQSFLHPSDTL----------LPNQPLSVS-LELTSPKSLQN 147 (839)
Q Consensus 81 -~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTl----------Lpg~~l~~~-~~L~s~~s~~~ 147 (839)
.+.+||+|++.. .+...|+|+|+|||||++. ++||||||||||+ +||||++.+ .+|++. ..++
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~-~d~s 148 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHAT-QSLQ 148 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSS-CCCB
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEcC-cEee
Confidence 466899999754 3445799999999999954 8999999998655 777766553 467763 3466
Q ss_pred CCcceeeEeecCCCceeEEeecCCCcccCCCCccccccccccCCCCCCcccCceEEeeccCCcceeeeccCCCccEEEEe
Q 038743 148 GGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPKAYANKSYWSGPDISNVTGDVVAVLDEAGSFGIVYGESSNGAVYVYQ 227 (839)
Q Consensus 148 ~g~~s~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~yW~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 227 (839)
+|.|++++ ++++ .+.|. +. ..+||+++.|+.. ....+.++..|.+.+ |.
T Consensus 149 ~G~~~l~l-~~dG--~LvL~-~~---------~~~~W~s~~~~~~------~~~~~~L~~~Gnl~l------------y~ 197 (236)
T 1dlp_A 149 LSPYRLSM-ETDC--NLVLF-DR---------DDRVWSTNTAGKG------TGCRAVLQPNGRMDV------------LT 197 (236)
T ss_dssp CSSCEEEE-ETTT--EEEEE-BT---------TBCCSCCCCCSSC------SSCEEEEETTTEEEE------------EE
T ss_pred cCcEEEEE-CCCC--cEEEE-cC---------CEeEEeCCCcCCC------CceEEEECCCCcEEE------------Ee
Confidence 89999998 5555 44442 22 1345666666431 112344555554432 22
Q ss_pred cCCCccccccccccccccceeEEEEEecCCcEEEEE
Q 038743 228 NDGDYDGLASATNKSTRLTVLRRLILETNGNLRLYR 263 (839)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 263 (839)
.++.....++... . ...+|++|++||++++|.
T Consensus 198 ~~~~~vw~s~~~~---~-~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 198 NQNIAVWTSGNSR---S-AGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp TTTEEEEECCCCC---S-SSCCEEEECSSSCEEEEC
T ss_pred CCCcEEEEeCCCC---C-CCCEEEEEcCCCcEEEeC
Confidence 2211111111111 1 135799999999999995
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-28 Score=280.43 Aligned_cols=185 Identities=14% Similarity=0.075 Sum_probs=129.0
Q ss_pred cccccCCCceEEEE-EeCCCcEEEEEEecccCC----------cchHHHHHHHHHhhcc-ccCCcccccceeecCCceEE
Q 038743 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLP----------HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (839)
..++.|++|.+..+ ++-.|+.+|||.+.+... ...++|.+|+++|+++ +|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 35677777777765 334588999999964321 1235699999999999 79999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||++|++|.++|.. ...++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.
T Consensus 320 VMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCee
Confidence 9999999999999942 3445543 5889999999999995 999999999999999999999999999987
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~ 706 (839)
....... .....||+.|||||++.+. +..++|+||+|++++++.++..
T Consensus 389 ~~~~~~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 389 TPQDCSW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CC---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCCCCcc-ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 6543322 2345699999999998764 6678999999999988876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=251.95 Aligned_cols=182 Identities=16% Similarity=0.184 Sum_probs=146.5
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCc--------chHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH--------GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.++||+|+||.||+|.. .++.+++|+....... ..+.+.+|++++.+++||||+++..++......+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999965 6788999987432211 12347999999999999999977777778888899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++++|.+++.. +..++.||++||+|||+. +|+||||||+|||++. .+||+|||+++....
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999932 568999999999999995 9999999999999999 999999999998755
Q ss_pred CCcee------EEeeccccceeCcccccC--CCCCCcccEEehhHHHHHHHhCCCCC
Q 038743 660 EHSQV------VTMVRGTRGYLAPEWVSN--RPITVKADVYSYGMLLLEIVGGRRNL 708 (839)
Q Consensus 660 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~~~DV~S~Gvvl~elltG~~p~ 708 (839)
..... .....||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 33221 134579999999999987 66888899999999999988887665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.9e-22 Score=207.99 Aligned_cols=142 Identities=13% Similarity=0.088 Sum_probs=115.9
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEecccCC------------------cchHHHHHHHHHhhccccCCccccccee
Q 038743 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP------------------HGEKEFVTEVNTIGSMHHMNLVRLCGYC 568 (839)
Q Consensus 507 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 568 (839)
+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++.+++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4589999999999999887899999999964321 12356889999999998 5 6777755
Q ss_pred ecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceee
Q 038743 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKV 648 (839)
Q Consensus 569 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl 648 (839)
.. +..++||||+++|+|.+ +. ......++.||+.||.|||+. +|+||||||+|||++ ++.+||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred ec-cceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence 43 56799999999999987 41 133457999999999999985 999999999999999 999999
Q ss_pred cccCcceecCCCCceeEEeeccccceeCcccccC
Q 038743 649 SDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682 (839)
Q Consensus 649 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 682 (839)
+|||+++. +..++|||++..
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHHH
Confidence 99999974 345789998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.79 E-value=5.9e-19 Score=154.66 Aligned_cols=100 Identities=24% Similarity=0.461 Sum_probs=84.0
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|..|++|.+ +++|+| |.|.|.|...++ |.|+. ..++||+|||++|....+.|+|+.||||||.|
T Consensus 4 L~~g~~L~~--g~~L~s--g~y~l~~q~DgN------Lvly~-----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 4 LDNNEGLYA--GQSLDV--EPYHFIMQDDCN------LVLYD-----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp ECTTEEECT--TCEEEE--TTEEEEECTTSC------EEEEE-----TTEEEEECCCCCTTCCSCEEEECTTSCEEEECT
T ss_pred cCCCCEEcC--CCEEEE--CCEEEEECCCCe------EEEEE-----CCEEEEEecCCCCCCccEEEEEeCCccEEEECC
Confidence 567899987 999998 889999987653 66654 25889999999999888899999999999999
Q ss_pred CCeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeec
Q 038743 81 GDTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 81 ~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.+||+|+++. .+..+|+|+|+|||||++. .+|||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 457899999753 4556799999999999964 69998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=156.04 Aligned_cols=102 Identities=19% Similarity=0.362 Sum_probs=85.7
Q ss_pred CCCCCceEEecCCCeEE--eCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEE
Q 038743 1 HIGLGSRLLASQDQAWI--SDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVL 78 (839)
Q Consensus 1 ~~~~~~~~~~~~~~~~v--S~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl 78 (839)
+|..|++|.+ +++|+ |++|.|+|+|+.+++ + +||++ +++||+||++.| ..++.|+|..||||||
T Consensus 10 ~l~~g~~L~~--g~~l~~~S~~g~~~L~~~~dgn----l---vly~~----~~~vW~sn~~~~-~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 10 DDNHPQILHA--TESLEILFGTHVYRFIMQTDCN----L---VLYDN----NNPIWATNTGGL-GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp SSCCCCEEET--TCEEEEEETTEEEEEEECTTSC----E---EEEET----TEEEEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred ccCCCCEEcC--CCEEEEeCCCCCEEEEEecCCC----E---EEEEC----CEEEEeCCCccC-CCceEEEEccCCEEEE
Confidence 4789999988 89999 999999999998763 2 57864 699999999877 3357899999999999
Q ss_pred eC-CCeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeec
Q 038743 79 ND-GDTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 79 ~~-~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.| ++.+||+|++.. .+...++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 98 466899998743 345579999999999997 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.1e-18 Score=151.85 Aligned_cols=105 Identities=20% Similarity=0.424 Sum_probs=86.0
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|..|+.|.+ +++|+ ++|.|+|+|+..++ | ++|+. .++||.||++.|. ..+.++|..||||||.|
T Consensus 4 l~~g~~L~~--g~~l~-~~~~~~l~~~~dGn------l-vl~~~----~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 4 LSSPNSLFT--GHSLE-VGPSYRLIMQGDCN------F-VLYDS----GKPVWASNTGGLG-SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp EETTCEECT--TCEEE-ETTTEEEEECTTSC------E-EEEET----TEEEEECCCTTSC-SSCEEEECTTSCEEEECT
T ss_pred eCCCCEECC--CCEEE-ECCCEEEEEcCCCc------E-EEEEC----CEEEEECCCCCCC-CcEEEEEeCCCCEEEECC
Confidence 557888777 89999 99999999987653 3 67762 6899999998773 35789999999999998
Q ss_pred CCeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecccCCC
Q 038743 81 GDTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLHPS 124 (839)
Q Consensus 81 ~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~PT 124 (839)
++.+||+|++... +...++|+|+|||||++. .+||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 5668999987543 454799999999999975 7999999983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-18 Score=175.65 Aligned_cols=136 Identities=18% Similarity=0.143 Sum_probs=105.2
Q ss_pred ccccccccCCCceEEEEEe-CCCcE--EEEEEecccCCc------------------------chHHHHHHHHHhhcccc
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTL--VAVKKLDRVLPH------------------------GEKEFVTEVNTIGSMHH 558 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h 558 (839)
.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4667999999999999987 78888 999987432111 01257899999999988
Q ss_pred CCc--ccccceeecCCceEEEEeeccC-C----ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhh-hccCCeeee
Q 038743 559 MNL--VRLCGYCSEGSNRLLVYEFMKN-G----SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH-EQCRNRIIH 630 (839)
Q Consensus 559 ~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH 630 (839)
+++ +.++.+ ...+|||||+.+ | +|.+++. ..++.....++.||+.||.||| + .+|+|
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~givH 194 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQE---AELVH 194 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence 865 333332 467899999953 4 5655442 1235577889999999999999 7 49999
Q ss_pred cCCCCCcEEECCCCceeecccCcceecC
Q 038743 631 CDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 631 ~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
|||||.|||++. .++|+|||++....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 89999999998653
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-17 Score=147.39 Aligned_cols=105 Identities=23% Similarity=0.462 Sum_probs=84.9
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|.+|+.|.+ +++|+ +|.|+|+|+..++ +. +|+ ..++||+||++.|. .++.|+|..+|||||.|
T Consensus 5 l~~gq~L~~--g~~L~--~g~~~L~~~~dgn----lv---ly~----~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 5 LLSGQTLHA--DHSLQ--AGAYTLTIQNKCN----LV---KYQ----NGRQIWASNTDRRG-SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp EETTCEEET--TEEEE--ETTEEEEECTTSC----EE---EEE----TTEEEEECSCTTSC-SSCEEEECTTSCEEEECT
T ss_pred eCCCCEECC--CCEEE--CCCEEEEEcCCCc----EE---EEe----CCEEEEeCCCCCCC-CceEEEECCCCcEEEECC
Confidence 567888877 88998 8999999986652 32 364 26899999999884 35789999999999998
Q ss_pred CCeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeecccCCCc
Q 038743 81 GDTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQSFLHPSD 125 (839)
Q Consensus 81 ~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTD 125 (839)
++.+||+|++.. .+...|+|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 466899998753 3455799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.71 E-value=4.5e-17 Score=145.23 Aligned_cols=106 Identities=24% Similarity=0.519 Sum_probs=85.6
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeCC
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDG 81 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~~ 81 (839)
|.+|+.|.+ +++| ++|.|+|+|+.+++ | ++|++ .++||+||++.+ ..++.|+|..+|||||.|.
T Consensus 4 l~~gq~L~~--g~~L--~~~~~~L~~~~dgn------l-vl~~~----~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d~ 67 (112)
T 1xd5_A 4 LNSGHQLDT--GGSL--AEGGYLFIIQNDCN------L-VLYDN----NRAVWASGTNGK-ASGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp EETTEEECT--TCEE--EETTEEEEECTTSC------E-EEEET----TEEEEECCCTTS-CSSEEEEECTTSCEEEEET
T ss_pred CCCCCEECC--CCEE--eCCCEEEEEcCCCc------E-EEEEC----CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEcC
Confidence 567888866 8899 58999999998763 2 35754 589999999864 2347899999999999985
Q ss_pred CeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeecccCC
Q 038743 82 DTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQSFLHP 123 (839)
Q Consensus 82 ~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD~P 123 (839)
+.+||+|++.. .+...++|+++|||||++.++.++||||+|.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 56899998643 3445699999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=135.30 Aligned_cols=99 Identities=23% Similarity=0.483 Sum_probs=78.9
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|-+|+.|.+ +++|+ +|.|+|+|+..++ ++| |+. .++||+||++.+ ...+.|+|..||||||.|
T Consensus 4 L~~gq~L~~--g~~L~--~g~~~L~~q~dGn----Lvl---y~~----~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 4 LYSGETLSP--GEFLN--NGRYVFIMQEDCN----LVL---YDV----DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp EETTEEECT--TCEEE--ETTEEEEECTTSC----EEE---EET----TEEEEECCCTTS-SSSCEEEECTTSCEEEECT
T ss_pred cCCCCEeCC--CCEEE--CCCEEEEEcCCCc----EEE---EeC----CEEEEECCcccC-CCCEEEEEeCCCCEEEECC
Confidence 567888865 88886 7999999987653 323 643 488999999876 335789999999999998
Q ss_pred CCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeec
Q 038743 81 GDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 81 ~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.+||+|++.+.. ..+|+|+|+|||||++. .+|||
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 45689999875443 45799999999999974 89998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7.9e-16 Score=166.09 Aligned_cols=140 Identities=13% Similarity=0.046 Sum_probs=98.6
Q ss_pred hccccccccCCCceEEEEEeCCCcEEEEEEecccCC--------------cchHHHHHHHHHhhccccCCcccccceeec
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLP--------------HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE 570 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 570 (839)
|.+...||+|+||.||+|...+|+.||||+++.... ......+.++++.....|+||++++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 567789999999999999999999999998753210 011122333333333345555544332211
Q ss_pred ------CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC
Q 038743 571 ------GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644 (839)
Q Consensus 571 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~ 644 (839)
....+|||||+++++|..+.. ......++.||+.+|.|||+. +||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred CCeeeeccCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 123369999999999876541 123456889999999999985 899999999999998776
Q ss_pred ----------ceeecccCcceecC
Q 038743 645 ----------CPKVSDFGLAKLMG 658 (839)
Q Consensus 645 ----------~~kl~DfGla~~~~ 658 (839)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-13 Score=122.31 Aligned_cols=101 Identities=17% Similarity=0.334 Sum_probs=78.0
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|-.|+.|.+ +++|.+ |.|.|-|...++ |.++..+ ..++||.+|+..+- ..+.|+|..+|||||.|
T Consensus 9 L~~gq~L~~--g~~L~~--g~~~L~~q~dGN------LvL~~~~---~~~~vWssnt~~~~-~~~~l~l~~dGNLVl~d~ 74 (113)
T 3mez_B 9 LFSSQVMYD--NAQLAT--RDYSLVMRDDCN------LVLTKGS---KTNIVWESGTSGRG-QHCFMRLGHSGELDITDD 74 (113)
T ss_dssp EETTCEEET--TCEEEE--TTEEEEECTTSC------EEEEETT---TTEEEEECCCTTSC-SSCEEEECTTSCEEEECT
T ss_pred eCCCCEECC--CCEeEc--CCEEEEEcCCCE------EEEEECC---CCEEEEECCcccCC-cCEEEEEeCCCcEEEECC
Confidence 346777766 888864 889999976553 6665432 36899999998763 34789999999999998
Q ss_pred CCeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeec
Q 038743 81 GDTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 81 ~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.+||+|++... +..+|+|+|+|||||++ ..+|+|
T Consensus 75 ~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 75 RLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp TSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 4568999998543 44579999999999997 689997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.9e-14 Score=122.90 Aligned_cols=98 Identities=21% Similarity=0.390 Sum_probs=73.6
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|-+|+.|.+ +++|+| |.|.|-|...++ |.| |.. ++||.+|++.. ...+.|+|..+|||||.|
T Consensus 9 L~~gq~L~~--g~~L~s--g~~~L~~q~dGn------Lvl-~~~-----~~vW~snt~~~-~~~~~l~l~~dGNLvl~d~ 71 (110)
T 3r0e_B 9 LFSGQVLYG--DGRLTA--KNHQLVMQGDCN------LVL-YGG-----KYGWQSNTHGN-GEHCFLRLNHKGELIIKDD 71 (110)
T ss_dssp EETTCEEET--TEEEEC--SSCEEEECTTSC------EEE-ECS-----SSCEECCCTTS-SSSCEEEECTTSCEEEECT
T ss_pred ECCCCEecC--CCEEEe--CCEEEEEcCCCe------EEE-ECC-----eEEEECCCcCC-CcCEEEEEeCCCcEEEEeC
Confidence 445666665 889998 458887765442 444 543 46899999863 234689999999999998
Q ss_pred CCeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeec
Q 038743 81 GDTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 81 ~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.+||+|++.+ .+...|+|+|+|||||++ ..+|+|
T Consensus 72 ~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 72 DFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 456899998753 344579999999999997 489987
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=114.73 Aligned_cols=102 Identities=25% Similarity=0.473 Sum_probs=77.2
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeCC
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDG 81 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~~ 81 (839)
|-+|+.|.+ +++| .+|.|.|.|...++ |-+ |.. +|.+|+..+ ...+.|+|..||||||.|.
T Consensus 6 L~~gq~L~~--g~~L--~~g~~~L~~q~dGN------Lvl-~~~-------~Wssnt~~~-~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 6 LLSGQTLDT--EGHL--KNGDFDLVMQDDCN------LVL-YNG-------NWQSNTANN-GRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp EETTCEECT--TCEE--EETTEEEEECTTSC------EEE-ETT-------TEECCCTTS-CSSCEEEECTTSCEEEECT
T ss_pred cCCCCCcCC--CCEe--ECCCEEEEEecCCe------EEE-EeC-------eEEcCCCCC-CCcEEEEEcCCCeEEEEeC
Confidence 456777765 8888 57999999976653 322 431 599998865 3357999999999999984
Q ss_pred -CeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecccCCCccccCC
Q 038743 82 -DTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLHPSDTLLPN 130 (839)
Q Consensus 82 -~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg 130 (839)
+.+||+|++.+. ....|+|+|+|||||++ ..+|+| .|.+||
T Consensus 67 ~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 67 DGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp TSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 568999987543 44579999999999997 689998 566554
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=116.25 Aligned_cols=91 Identities=25% Similarity=0.461 Sum_probs=67.4
Q ss_pred CeEEEEecCCcEEEeCCCeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecccCCCccccCCCCcccceeeccCC
Q 038743 65 DAILELDTTGNLVLNDGDTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLHPSDTLLPNQPLSVSLELTSPK 143 (839)
Q Consensus 65 ~~~l~l~~~G~Lvl~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTDTlLpg~~l~~~~~L~s~~ 143 (839)
..+|.|..||||||.+.+.+||++++... ....|+|+|+|||||++ ++.++||||+.|
T Consensus 20 ~~~L~~~~dgnlvl~~~~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~-------------------- 78 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNR-------------------- 78 (112)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCCC--------------------
T ss_pred CEEEEEcCCCcEEEEECCEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCccC--------------------
Confidence 36899999999999987788999997543 34579999999999999 788999999644
Q ss_pred ccCCCCcceeeEeecCCCceeEEeecCCCcccCCCCccccccccccCC
Q 038743 144 SLQNGGYYSLKMLQQPTSLSLALTYNLPGSYDAANSPKAYANKSYWSG 191 (839)
Q Consensus 144 s~~~~g~~s~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~yW~~ 191 (839)
.+|.|++++ ++++. +.|+.. ...+||+++.|++
T Consensus 79 ---~~g~~~l~l-~~dGn--lvl~~~---------~~~~~W~S~~~~g 111 (112)
T 1xd5_A 79 ---QNGNYYLIL-QRDRN--VVIYDN---------SNNAIWATHTNVG 111 (112)
T ss_dssp ---SCCCCEEEE-CTTSC--EEEECT---------TSCEEEECCCCCC
T ss_pred ---CCCCEEEEE-eCCCc--EEEECC---------CCceEEECCCccC
Confidence 246788888 55553 444321 2345666666654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=114.75 Aligned_cols=58 Identities=29% Similarity=0.529 Sum_probs=50.0
Q ss_pred CCeEEEEecCCcEEEeCCCeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeeccc
Q 038743 64 KDAILELDTTGNLVLNDGDTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFL 121 (839)
Q Consensus 64 ~~~~l~l~~~G~Lvl~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD 121 (839)
...+|.|..||||||.+.+++||++++... ....|+|+|+|||||++.++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT 78 (110)
T ss_dssp TTEEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC
T ss_pred CCEEEEEcCCCcEEEEECCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC
Confidence 457899999999999997788999997543 2357999999999999998999999994
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=8.8e-12 Score=111.33 Aligned_cols=59 Identities=31% Similarity=0.447 Sum_probs=50.4
Q ss_pred CCeEEEEecCCcEEEeCCCeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecccC
Q 038743 64 KDAILELDTTGNLVLNDGDTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 64 ~~~~l~l~~~G~Lvl~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
....|.|..||||||.+.+++||++|+... ....++|+++|||||++.++.++|||||+
T Consensus 20 g~~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~ 79 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW 79 (115)
T ss_dssp TTEEEEECTTSCEEEEETTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC
T ss_pred CCEEEEEcCCCcEEEEeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC
Confidence 346899999999999987778999997533 23569999999999999888999999998
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=108.87 Aligned_cols=98 Identities=21% Similarity=0.362 Sum_probs=74.4
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeCC
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDG 81 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~~ 81 (839)
|-+|+.|.+ +++| .+|.|.|-|...++ |.+ |.. . . ||.+|+..+ ...+.|+|..+|||||.+.
T Consensus 5 l~~gq~L~~--g~~L--~~g~~~L~~q~dGn------Lvl-~~~---~-~-vW~snt~~~-~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 5 LLTGDVIHT--DNQL--SYESAAFVMQGDCN------LVL-YNE---A-G-GFQSNTHGR-GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp EETTCEECT--TCEE--EETTEEEEECTTSC------EEE-ECS---S-C-CEECCCTTS-CSSCEEEECTTSCEEEECS
T ss_pred eCCCCEeCC--CCEE--ecCCEEEEEccCCe------EEE-ECC---C-C-EEECCcccC-CcCEEEEEcCCCcEEEEeC
Confidence 456777766 8888 47899999976553 433 543 2 3 899999876 2357899999999999985
Q ss_pred -Ce-eEEEecCC---CCceeEEEEeccccEEEecCCCCceeec
Q 038743 82 -DT-TIWASNSS---GAGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 82 -~~-~vWst~~~---~~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
+. +||+|++. ..+...|.|+|+|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 34 59999852 2345579999999999997 789987
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.7e-11 Score=109.87 Aligned_cols=57 Identities=33% Similarity=0.531 Sum_probs=49.0
Q ss_pred eEEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeecccC
Q 038743 66 AILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 66 ~~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
.+|.|..||||||.+.+++||++|+...+ ...|+|+|+|||||++.++.++||||..
T Consensus 32 ~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~ 89 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA 89 (119)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCC
T ss_pred EEEEEecCCCEEEEECCEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCCC
Confidence 47899999999999888889999975432 3579999999999999989999999943
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=9.6e-11 Score=121.89 Aligned_cols=142 Identities=13% Similarity=0.022 Sum_probs=112.2
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.+.+...++.|+.+.||+.... ++.+++|+...........+.+|+.++..+. |..+.++++++.+....++||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 3556678888899999999864 6899999986532233456889999999884 6778899999988889999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc---------------------------------------
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ--------------------------------------- 623 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 623 (839)
|.+|.+.+. +......++.+++++|+.||+.
T Consensus 94 G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 94 GVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred CeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999977541 1223457889999999999981
Q ss_pred -----------------cCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 624 -----------------CRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 624 -----------------~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014689999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=4.1e-10 Score=116.78 Aligned_cols=131 Identities=13% Similarity=0.034 Sum_probs=99.2
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC--cccccceeecCCceEEEEeeccCCChh
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--LVRLCGYCSEGSNRLLVYEFMKNGSLD 587 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~ 587 (839)
+.+.|..+.||+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 33466679999998877888999997543 2346889999999886544 456888888777899999999998884
Q ss_pred hhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-------------------------------------------
Q 038743 588 KWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC------------------------------------------- 624 (839)
Q Consensus 588 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------- 624 (839)
.. . .....++.++++.|+.||+..
T Consensus 104 --~~-~----------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SS-H----------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TS-C----------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cC-c----------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 21 0 112357778888888888631
Q ss_pred ------------CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 625 ------------RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 625 ------------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=6.9e-10 Score=114.89 Aligned_cols=99 Identities=16% Similarity=0.390 Sum_probs=71.6
Q ss_pred CCeEEeCCCeEEeeeecCC-CCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeCC-CeeEEEecC
Q 038743 13 DQAWISDNGTFAFGFTPIV-NIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDG-DTTIWASNS 90 (839)
Q Consensus 13 ~~~~vS~~g~F~lGF~~~~-~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~~-~~~vWst~~ 90 (839)
+++|+| ..+++-|+|... .....++ + |++ ..+++|.+++.++- ...|.|..+|+|++.|+ +..+|+|++
T Consensus 152 g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~---~~~~yW~Sgt~~~~--~~~l~l~~dGnLvl~d~~~~~vWsS~t 222 (276)
T 3m7h_A 152 GSELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP---NGAATWNAGTQGKG--AVRAVFQGDGNLVVYGAGNAVLWHSHT 222 (276)
T ss_dssp SEEECT-TCEEEETTEEEEECTTSCEE--E-ECT---TSSEEEECCCTTTT--CCEEEECTTSCEEEECTTSCEEEECSC
T ss_pred Cccccc-CCCCCCceEEEeecCCceEE--E-EeC---CCeEEEECCCCCCc--cEEEEEcCCCeEEEEeCCCcEEEEecC
Confidence 556654 346666655432 1112333 3 433 25789999998773 26899999999999985 468999997
Q ss_pred CCCceeEEEEeccccEEEecCCCCceeecccC
Q 038743 91 SGAGVELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 91 ~~~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
.+.....|+|+++|||||++. +.+||||||
T Consensus 223 ~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 223 GGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 655556899999999999976 689999997
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=6.1e-09 Score=113.56 Aligned_cols=140 Identities=14% Similarity=0.171 Sum_probs=105.6
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEec--ccC-CcchHHHHHHHHHhhccc--cCCcccccceeecC---CceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLD--RVL-PHGEKEFVTEVNTIGSMH--HMNLVRLCGYCSEG---SNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~e~ 580 (839)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..++..+. +..+++++.++.+. ...++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 478999999999998854 678888775 221 122356888999999886 45678888888776 458999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc------------------------------------
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC------------------------------------ 624 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 624 (839)
+++..+.+.. -..++...+..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998875422 123567788899999999999999720
Q ss_pred -------------------CCeeeecCCCCCcEEECCCCc--eeecccCccee
Q 038743 625 -------------------RNRIIHCDIKPENILLDENFC--PKVSDFGLAKL 656 (839)
Q Consensus 625 -------------------~~~iiH~dlk~~Nill~~~~~--~kl~DfGla~~ 656 (839)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987653 68999999875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.89 E-value=4.1e-09 Score=93.04 Aligned_cols=61 Identities=23% Similarity=0.347 Sum_probs=48.5
Q ss_pred CCCCCC-CeEEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCC-ceeecc
Q 038743 59 NFPVTK-DAILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQ-PVWQSF 120 (839)
Q Consensus 59 ~~pv~~-~~~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~-~lWQSF 120 (839)
+.++++ ...|.+..||||||.+.+. +|+|++...+ ...++|+|+|||||++.++. ++|||.
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~-vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~ 77 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYP 77 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC-CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEES
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC-EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEec
Confidence 344443 3589999999999999666 9999985433 35699999999999998776 499998
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.86 E-value=2.6e-09 Score=94.65 Aligned_cols=63 Identities=25% Similarity=0.363 Sum_probs=51.0
Q ss_pred CCCCCCC-CeEEEEecCCcEEEeCC--CeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecc
Q 038743 58 RNFPVTK-DAILELDTTGNLVLNDG--DTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSF 120 (839)
Q Consensus 58 r~~pv~~-~~~l~l~~~G~Lvl~~~--~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSF 120 (839)
.+.|+.+ ...|.+..||||||.+. +.+||+|++... ....|+|+|+|||||++.++.++|||=
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~ 83 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSN 83 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECS
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECC
Confidence 4556654 35899999999999984 578999997543 234699999999999998889999984
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-08 Score=89.98 Aligned_cols=57 Identities=35% Similarity=0.670 Sum_probs=48.7
Q ss_pred CeEEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeeccc
Q 038743 65 DAILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQSFL 121 (839)
Q Consensus 65 ~~~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFD 121 (839)
...|.|..||||||.+.+.+||++++...+ ...++|+|+|||||++.++.++|||..
T Consensus 20 ~~~L~~q~dGnLvly~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t 77 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNT 77 (109)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCC
T ss_pred CEEEEEcCCCcEEEEeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCC
Confidence 468999999999999887899999975432 346999999999999988899999864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.69 E-value=2e-08 Score=88.35 Aligned_cols=56 Identities=27% Similarity=0.469 Sum_probs=47.3
Q ss_pred CeEEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeeccc
Q 038743 65 DAILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQSFL 121 (839)
Q Consensus 65 ~~~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFD 121 (839)
...|.+..||||||.+. .++|++++...+ ...++|+|+|||||++.++.++|||-.
T Consensus 25 ~~~L~~q~dGnLvl~~~-~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t 81 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG-KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRS 81 (110)
T ss_dssp SCEEEECTTSCEEEECS-SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCC
T ss_pred CEEEEEcCCCeEEEECC-eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCC
Confidence 35899999999999887 589999975433 346999999999999998999999864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.62 E-value=5.3e-08 Score=84.81 Aligned_cols=54 Identities=31% Similarity=0.535 Sum_probs=47.3
Q ss_pred eEEEEecCCcEEEeCCCeeEEEecCCC--CceeEEEEeccccEEEecCCCCceeec
Q 038743 66 AILELDTTGNLVLNDGDTTIWASNSSG--AGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 66 ~~l~l~~~G~Lvl~~~~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
-+|.+..||||||.+.+++||++|+.. .....+.|.++|||||+|.+++++|+|
T Consensus 21 y~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss 76 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWAS 76 (105)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEEC
T ss_pred EEEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEe
Confidence 579999999999999889999999743 334569999999999999999999987
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=6.7e-09 Score=110.39 Aligned_cols=182 Identities=17% Similarity=0.198 Sum_probs=118.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCC--cccccceeecCC---ceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMN--LVRLCGYCSEGS---NRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~g~~~~~~---~~~lv~e~~~ 582 (839)
+.++.|....||+.. ..+++|+.... .....+.+|.+++..+ .+.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999863 45888986432 2345688999999887 3333 344444443333 3478999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc---------------------------------------
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ--------------------------------------- 623 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 623 (839)
|.+|..... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 988865331 2355666777888888888888851
Q ss_pred ----------------cCCeeeecCCCCCcEEECC--CCceeecccCcceecCCCCceeEEeeccccce---eCcccccC
Q 038743 624 ----------------CRNRIIHCDIKPENILLDE--NFCPKVSDFGLAKLMGREHSQVVTMVRGTRGY---LAPEWVSN 682 (839)
Q Consensus 624 ----------------~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 682 (839)
....++|+|++|.||++++ ...+.|+||+.+........-. ....+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHH
Confidence 1246899999999999998 5568899999987643211100 00001 12221110
Q ss_pred -----CCC---------CCcccEEehhHHHHHHHhCCCCC
Q 038743 683 -----RPI---------TVKADVYSYGMLLLEIVGGRRNL 708 (839)
Q Consensus 683 -----~~~---------s~~~DV~S~Gvvl~elltG~~p~ 708 (839)
+.. ....+.|+++.++|++.+|..++
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 12257899999999999998654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.54 E-value=2.8e-07 Score=93.54 Aligned_cols=58 Identities=29% Similarity=0.457 Sum_probs=49.7
Q ss_pred CeEEEEecCCcEEEeCCCeeEEEecCCCCceeEEEEeccccEEEecCCCCceeecccC
Q 038743 65 DAILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 65 ~~~l~l~~~G~Lvl~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
.-.|.|..+|+|+|.+++++||.+|+.......++|.++|||||+|.+++++|+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~ 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK 84 (236)
T ss_dssp TEEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC
T ss_pred CEEEEECCCCcEEEEECCEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc
Confidence 3578888999999998888999999754445568999999999999999999999975
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.51 E-value=9.2e-08 Score=84.00 Aligned_cols=59 Identities=27% Similarity=0.468 Sum_probs=47.5
Q ss_pred CCCCCCC-CeEEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeec
Q 038743 58 RNFPVTK-DAILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 58 r~~pv~~-~~~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.|+++ ...|.+..||||||.++ +|+|++...+ ...++|+++|||||++.++.++|+|
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~---~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss 74 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG---NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKS 74 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT---TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEEC
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC---eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcC
Confidence 4455543 35899999999999985 7999985433 3569999999999999888999976
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3.6e-06 Score=87.42 Aligned_cols=135 Identities=15% Similarity=0.103 Sum_probs=95.4
Q ss_pred ccccCCCc-eEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeeccCCCh
Q 038743 510 LLGTGGFG-SVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 510 ~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
.+..|..| .||+.... ++..++||+-.. ....++.+|...|..+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68988664 467889998642 23456888999888873 44467888899888999999999999887
Q ss_pred hhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc------------------------------------------
Q 038743 587 DKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC------------------------------------------ 624 (839)
Q Consensus 587 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------ 624 (839)
.+.... .......++.++++.|+.||...
T Consensus 108 ~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 664411 12233345555666666666311
Q ss_pred -------------CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 625 -------------RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 625 -------------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 22489999999999999887778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=8.7e-06 Score=86.18 Aligned_cols=135 Identities=18% Similarity=0.172 Sum_probs=91.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccC---Ccccccceee-cCCceEEEEeeccCC
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHM---NLVRLCGYCS-EGSNRLLVYEFMKNG 584 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~g 584 (839)
+.++.|....||+. ++.++||+-.. ......+..|.+++..+.+. .+.+++.+.. .....++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899988 56788888532 22345788999999998642 3556666663 445678999999998
Q ss_pred ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhc-----------------------------------------
Q 038743 585 SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ----------------------------------------- 623 (839)
Q Consensus 585 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------- 623 (839)
+|...... .++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88653211 123334444445555555444431
Q ss_pred ----------------cCCeeeecCCCCCcEEECC---CCc-eeecccCccee
Q 038743 624 ----------------CRNRIIHCDIKPENILLDE---NFC-PKVSDFGLAKL 656 (839)
Q Consensus 624 ----------------~~~~iiH~dlk~~Nill~~---~~~-~kl~DfGla~~ 656 (839)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999987 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=7.8e-06 Score=88.67 Aligned_cols=80 Identities=6% Similarity=-0.019 Sum_probs=56.9
Q ss_pred ccc-ccCCCceEEEEEeC-------CCcEEEEEEecccC---CcchHHHHHHHHHhhccc-c--CCcccccceeecC---
Q 038743 509 QLL-GTGGFGSVYKGSLG-------DGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMH-H--MNLVRLCGYCSEG--- 571 (839)
Q Consensus 509 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~--- 571 (839)
+.| +.|....+|+.... +++.+++|+..... ......+..|+.++..+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 88889999998764 26788999865321 111246788998888884 3 3567788877665
Q ss_pred CceEEEEeeccCCChhh
Q 038743 572 SNRLLVYEFMKNGSLDK 588 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~ 588 (839)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=5.5e-05 Score=83.22 Aligned_cols=74 Identities=12% Similarity=0.025 Sum_probs=49.0
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEecccCC-------cchHHHHHHHHHhhcccc--CC-cccccceeecCCceEEE
Q 038743 509 QLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLP-------HGEKEFVTEVNTIGSMHH--MN-LVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~g~~~~~~~~~lv 577 (839)
+.||.|..+.||++... +++.++||....... .....+..|.+++..+.+ +. +.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 47899999999999764 468899998653221 123456788888887742 33 3345543 34567899
Q ss_pred EeeccCC
Q 038743 578 YEFMKNG 584 (839)
Q Consensus 578 ~e~~~~g 584 (839)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.0001 Score=79.19 Aligned_cols=142 Identities=18% Similarity=0.251 Sum_probs=80.9
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcccc--CCcccccc------eeecCCceEEEEeec
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH--MNLVRLCG------YCSEGSNRLLVYEFM 581 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g------~~~~~~~~~lv~e~~ 581 (839)
.|+.|..+.||+....+| .+++|+.... ..++..|..++..|.. -.+++++. +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 566677899999988655 5899988642 2344455665555531 12334443 113456678999999
Q ss_pred cCCChhh--------------hcccCCC----CC-----cccCChhhHH-------------------------------
Q 038743 582 KNGSLDK--------------WIFPSYH----HR-----DRVLDWTTRF------------------------------- 607 (839)
Q Consensus 582 ~~gsL~~--------------~l~~~~~----~~-----~~~l~~~~~~------------------------------- 607 (839)
+|..+.. -|+.... .. .....|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9876531 0111000 00 0111232110
Q ss_pred HHHHHHHHHhHHhhh----------ccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 608 NIAIATAQGIAYFHE----------QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 608 ~i~~~ia~~L~yLH~----------~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
.+...+.+++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345666763 1246899999999999998888899999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00013 Score=76.21 Aligned_cols=74 Identities=22% Similarity=0.268 Sum_probs=54.5
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-c--CCcccccceeecCCceEEEEeeccCCC
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-H--MNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
+.+|.|..+.||+.++.+|+.|+||+...........|..|...|+.|. . --+++++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 5789999999999999999999999876544444456788999888874 2 133444443 23478999998765
Q ss_pred h
Q 038743 586 L 586 (839)
Q Consensus 586 L 586 (839)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00056 Score=72.03 Aligned_cols=139 Identities=16% Similarity=0.183 Sum_probs=91.1
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc---cCCcccccceeecCCceEEEEeeccCCC
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH---HMNLVRLCGYCSEGSNRLLVYEFMKNGS 585 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~gs 585 (839)
+.|+.|....+|+... +++.++||+.... ....+..|...|+.|. ...+++++.++......++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4689999999999987 5678889987532 3456888999888884 3567888888887788999999999986
Q ss_pred hhhh-----------cccCCCCC-----------------cccCChhhHH---HHH--HH--------------HHHH-h
Q 038743 586 LDKW-----------IFPSYHHR-----------------DRVLDWTTRF---NIA--IA--------------TAQG-I 617 (839)
Q Consensus 586 L~~~-----------l~~~~~~~-----------------~~~l~~~~~~---~i~--~~--------------ia~~-L 617 (839)
+..- |+...... ...-+|...+ ++. .+ ++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 5321 22211100 0012343221 111 11 1111 1
Q ss_pred HHhhh-ccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 618 AYFHE-QCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 618 ~yLH~-~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2347899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00064 Score=75.21 Aligned_cols=72 Identities=8% Similarity=0.091 Sum_probs=44.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccC----Cc-----chHHHHHHHHHhhc-cccCCcccccceeecCCceEEEE
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL----PH-----GEKEFVTEVNTIGS-MHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~-----~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
+.||.|..+.||+... +++.++||...... .. ....+..|+..+.. ..+..+.+++.+. ....++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 4689999999999975 56789999542211 11 22234444433322 2234556666554 56779999
Q ss_pred eec-cC
Q 038743 579 EFM-KN 583 (839)
Q Consensus 579 e~~-~~ 583 (839)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=73.49 Aligned_cols=73 Identities=16% Similarity=0.165 Sum_probs=50.9
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEe
Q 038743 509 QLLGTGGFGSVYKGSLGD--------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 579 (839)
+.|+.|....||+...++ ++.+++|+.... .....+..|..++..+...++ +++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467888889999998753 578999987432 112456689999888854444 566666543 28999
Q ss_pred eccCCChh
Q 038743 580 FMKNGSLD 587 (839)
Q Consensus 580 ~~~~gsL~ 587 (839)
|+++.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0018 Score=70.12 Aligned_cols=143 Identities=16% Similarity=0.134 Sum_probs=83.0
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEe
Q 038743 509 QLLGTGGFGSVYKGSLGD--------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 579 (839)
+.|..|-...+|+...++ ++.+++|+.... ......+.+|.++++.+. +.-..++++++.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 457778888999998753 578999986332 233456778999998884 32235666666542 8999
Q ss_pred eccCCChhhh-----------------cccCCCCCcccCC--hhhHHHHHHHHH-------------------HHhHHhh
Q 038743 580 FMKNGSLDKW-----------------IFPSYHHRDRVLD--WTTRFNIAIATA-------------------QGIAYFH 621 (839)
Q Consensus 580 ~~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~yLH 621 (839)
|++|..|..- |+.....-.+... |.++.++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 1111000111122 233333333321 1223332
Q ss_pred h-----ccCCeeeecCCCCCcEEECCC----CceeecccCccee
Q 038743 622 E-----QCRNRIIHCDIKPENILLDEN----FCPKVSDFGLAKL 656 (839)
Q Consensus 622 ~-----~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~ 656 (839)
+ .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123478999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0063 Score=64.53 Aligned_cols=143 Identities=14% Similarity=0.074 Sum_probs=81.8
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC--cccccce-----eecCCceEEEEeecc
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--LVRLCGY-----CSEGSNRLLVYEFMK 582 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lv~e~~~ 582 (839)
.|+ |....||+....+|+.+++|..... ......+..|..++..+.... +++++.. ....+..+++|||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 8888999988777878999998632 123456777888887774222 3444443 112345678999998
Q ss_pred CCChhh-----h---------cccC---C-CCCcccCChhhH-------------------HHHHHHHHHHhHHhhhc--
Q 038743 583 NGSLDK-----W---------IFPS---Y-HHRDRVLDWTTR-------------------FNIAIATAQGIAYFHEQ-- 623 (839)
Q Consensus 583 ~gsL~~-----~---------l~~~---~-~~~~~~l~~~~~-------------------~~i~~~ia~~L~yLH~~-- 623 (839)
|..+.. + |+.. . ......+++... -.+...+.+.++.+.+.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865431 0 1110 0 000111121110 00111111223333221
Q ss_pred --cCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 624 --CRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 624 --~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235789999999999999 4 899999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0039 Score=66.38 Aligned_cols=142 Identities=15% Similarity=0.031 Sum_probs=72.5
Q ss_pred ccccCCCce-EEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcccc--CCcccccceeecCCceEEEEeeccCCCh
Q 038743 510 LLGTGGFGS-VYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH--MNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 510 ~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
.|+.|.... +|+....+++.+++|...... ..++..|+.++..+.. -.+.+++.+..+. -+++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 455554444 677776547778887654321 1334566777666632 2345566554333 3789999977666
Q ss_pred hhhcccC---------------------CCCCcccCChhhHH--------------------HHHHHHHHHhHHhhh---
Q 038743 587 DKWIFPS---------------------YHHRDRVLDWTTRF--------------------NIAIATAQGIAYFHE--- 622 (839)
Q Consensus 587 ~~~l~~~---------------------~~~~~~~l~~~~~~--------------------~i~~~ia~~L~yLH~--- 622 (839)
.+++... ....-..++..... .....+...+..|.+
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 5433110 00000011110000 000111122222211
Q ss_pred ccCCeeeecCCCCCcEEECCC----CceeecccCccee
Q 038743 623 QCRNRIIHCDIKPENILLDEN----FCPKVSDFGLAKL 656 (839)
Q Consensus 623 ~~~~~iiH~dlk~~Nill~~~----~~~kl~DfGla~~ 656 (839)
.....++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123589999999999999874 6789999998865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0037 Score=69.52 Aligned_cols=74 Identities=12% Similarity=0.034 Sum_probs=48.4
Q ss_pred cccccCCCceEEEEEeCC-CcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEeeccCCCh
Q 038743 509 QLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
+.|+.|-...+|+....+ +..+++|+..... ........|..++..|...++ .++++++.. .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 468888889999998865 5788899874322 111123588888888865444 566766632 259999998555
Q ss_pred h
Q 038743 587 D 587 (839)
Q Consensus 587 ~ 587 (839)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0056 Score=64.74 Aligned_cols=145 Identities=11% Similarity=0.089 Sum_probs=80.9
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCC--ccccccee------ecCCceEEEEee
Q 038743 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN--LVRLCGYC------SEGSNRLLVYEF 580 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~e~ 580 (839)
+.|+.|....+|+....+| .+++|..... ....++..|+.++..+.... +.+++... ...+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3577788899999987665 5888988642 12345667777777764222 23333221 123456899999
Q ss_pred ccCCChhhh--------------cccCC---CCCc----ccCChhhHHH------------HHHHHHHHhHHhhhc----
Q 038743 581 MKNGSLDKW--------------IFPSY---HHRD----RVLDWTTRFN------------IAIATAQGIAYFHEQ---- 623 (839)
Q Consensus 581 ~~~gsL~~~--------------l~~~~---~~~~----~~l~~~~~~~------------i~~~ia~~L~yLH~~---- 623 (839)
++|..+... |+... .... ....|...+. +...+.+.++.|++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 998664321 11100 0000 0111222110 111234455555532
Q ss_pred cCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 624 ~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
....++|+|+++.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 235799999999999999876668999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0033 Score=65.97 Aligned_cols=71 Identities=6% Similarity=-0.020 Sum_probs=44.5
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEeec-cCCC
Q 038743 508 AQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYEFM-KNGS 585 (839)
Q Consensus 508 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~gs 585 (839)
.+.|+.|....+|+. +.+++|+...... .......|+.++..+....+ .+++++. .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 357888999999998 5688888754311 11234568877777743333 3555443 34457899999 6555
Q ss_pred h
Q 038743 586 L 586 (839)
Q Consensus 586 L 586 (839)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0046 Score=66.90 Aligned_cols=73 Identities=14% Similarity=0.165 Sum_probs=44.4
Q ss_pred cccccCCCceEEEEEeCC---------CcEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEE
Q 038743 509 QLLGTGGFGSVYKGSLGD---------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~ 578 (839)
+.|+.|....+|+....+ ++.+++|+..... ........|..++..+...++ .++++.. .-.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 467788888999998754 2688888865421 111234678888887754343 4565543 136899
Q ss_pred eeccCCCh
Q 038743 579 EFMKNGSL 586 (839)
Q Consensus 579 e~~~~gsL 586 (839)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.024 Score=60.44 Aligned_cols=32 Identities=22% Similarity=0.333 Sum_probs=28.1
Q ss_pred CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 625 ~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.035 Score=60.80 Aligned_cols=73 Identities=10% Similarity=0.097 Sum_probs=48.1
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEecccCCcchHHHHHHHHHhhccccCC-cccccceeecCCceEEEEe
Q 038743 509 QLLGTGGFGSVYKGSLGD--------GTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMN-LVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e 579 (839)
+.|..|-...+|+...++ ++.+++|+..... .......+|.++++.+...+ ..++++.+. -.+|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456778888999998753 5789999864332 22223467888888874333 345555332 378999
Q ss_pred eccCCCh
Q 038743 580 FMKNGSL 586 (839)
Q Consensus 580 ~~~~gsL 586 (839)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998665
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.62 E-value=0.023 Score=55.26 Aligned_cols=98 Identities=9% Similarity=0.053 Sum_probs=63.3
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
-+|.+.|. ..+.+|++.+.+.++.|.+..|.-+-.. +.. ..+=+.|..|+|..+|.+...+ ..+.
T Consensus 33 vSL~eIL~----~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILR----LYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHH----HcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc--------
Confidence 37888773 3567999999999999999998776221 011 1333457899999999888764 1110
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHH
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIV 702 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ell 702 (839)
.....+.|||... ...+.+.=|||+|++||.-+
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 0123466888753 34467788999999999988
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.32 E-value=0.27 Score=53.45 Aligned_cols=30 Identities=30% Similarity=0.330 Sum_probs=25.5
Q ss_pred eeeecCCCCCcEEE------CCCCceeecccCccee
Q 038743 627 RIIHCDIKPENILL------DENFCPKVSDFGLAKL 656 (839)
Q Consensus 627 ~iiH~dlk~~Nill------~~~~~~kl~DfGla~~ 656 (839)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999998864
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=91.52 E-value=0.16 Score=40.72 Aligned_cols=33 Identities=21% Similarity=0.584 Sum_probs=28.3
Q ss_pred cChHHHHHhhcCCCceeEEEeecCCCCCeEEEeee
Q 038743 369 ATVSKCGDACLSNCQCVASVYGLDDEKPYCWVLRS 403 (839)
Q Consensus 369 ~~~~~C~~~Cl~nCsC~A~~y~~~~~~~~C~~~~~ 403 (839)
.++++|+++|+.+=.|+||.|+ .....|+++..
T Consensus 30 ~sl~~Cq~aC~a~~~C~aFTyN--~~s~~CflKs~ 62 (82)
T 2ll3_A 30 SSLSECRARCQAEKECSHYTYN--VKSGLCYPKRG 62 (82)
T ss_dssp SSHHHHHHHHHHCTTEEEEEEE--TTTTEEEEEES
T ss_pred CCHHHHHHHhhccCCCCeEEec--cCCCceEcccC
Confidence 4899999999999999999997 44578998754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.45 E-value=0.12 Score=35.80 Aligned_cols=29 Identities=7% Similarity=0.055 Sum_probs=13.8
Q ss_pred EEhhhHHHHHHHHHHHHHHHHhhhhhcch
Q 038743 449 VVIPIVLSMTLLIGLLCLLLYYNVHRKRF 477 (839)
Q Consensus 449 ~ii~i~~~~~~l~~l~~~~~~~~~~r~~~ 477 (839)
++.+++++++++++++.++++++++|+++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 44444555555555554444444444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.35 E-value=0.17 Score=35.24 Aligned_cols=27 Identities=15% Similarity=0.156 Sum_probs=13.3
Q ss_pred EEhhhHHHHHHHHHHHHHHHHhhhhhc
Q 038743 449 VVIPIVLSMTLLIGLLCLLLYYNVHRK 475 (839)
Q Consensus 449 ~ii~i~~~~~~l~~l~~~~~~~~~~r~ 475 (839)
++.++++++++++++++++++++++|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444555555555555544444444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.80 E-value=1.5 Score=42.48 Aligned_cols=116 Identities=9% Similarity=0.161 Sum_probs=76.4
Q ss_pred ccCCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCC
Q 038743 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPE 636 (839)
Q Consensus 557 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~ 636 (839)
.||++++. .+-.+++...+.|+.- .+...|- .-+.++...+++++.+|+....+++. -+|--|+|.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~------~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD------NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG------GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH------HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68888765 3445555555555443 3232222 23467888999999999998877764 378889999
Q ss_pred cEEECCCCceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCC
Q 038743 637 NILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLD 709 (839)
Q Consensus 637 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~ 709 (839)
|++++.++.++|.-.|+...+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999988875433 221 01111112345678888998887764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.25 E-value=2.1 Score=41.57 Aligned_cols=84 Identities=13% Similarity=0.091 Sum_probs=59.4
Q ss_pred ccCCcccccceeecCCceEEEEeeccCC-ChhhhcccCCCCCcccCChhhHHHHHHHHHHHhH-HhhhccCCeeeecCCC
Q 038743 557 HHMNLVRLCGYCSEGSNRLLVYEFMKNG-SLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA-YFHEQCRNRIIHCDIK 634 (839)
Q Consensus 557 ~h~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~iiH~dlk 634 (839)
.||.+ -...-.+++...+.|+.-+++ ++. .+ +.++...+++++.+|+.... +++. -+|--|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i--------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI--------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH--------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH--------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEe
Confidence 67777 233345566666666554332 222 12 45778899999999998877 6664 4788899
Q ss_pred CCcEEECCCCceeecccCccee
Q 038743 635 PENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 635 ~~Nill~~~~~~kl~DfGla~~ 656 (839)
|+|+++|.++.++|.-.|+-..
T Consensus 112 P~NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp GGGEEECTTCCEEESCCEETTT
T ss_pred CceEEEeCCCcEEEEEcCCccc
Confidence 9999999999999998886543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=82.76 E-value=0.85 Score=31.55 Aligned_cols=13 Identities=23% Similarity=0.491 Sum_probs=5.1
Q ss_pred EhhhHHHHHHHHH
Q 038743 450 VIPIVLSMTLLIG 462 (839)
Q Consensus 450 ii~i~~~~~~l~~ 462 (839)
+++++++++++++
T Consensus 14 Ia~~vVGvll~vi 26 (44)
T 2jwa_A 14 IISAVVGILLVVV 26 (44)
T ss_dssp HHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHH
Confidence 3344444433333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 839 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-15 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-12 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 8e-12 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-08 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 5e-65
Identities = 64/274 (23%), Positives = 118/274 (43%), Gaps = 23/274 (8%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
Q +G+G FG+VYKG V + + P + F EV + H+N++ GY
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 569 SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRI 628
+ +V ++ + SL + H + + +IA TAQG+ Y H + I
Sbjct: 74 TAP-QLAIVTQWCEGSSLYHHL----HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 629 IHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVTMVRGTRGYLAPEWV---SNRP 684
IH D+K NI L E+ K+ DFGLA + R S + G+ ++APE + P
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 685 ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744
+ ++DVY++G++L E++ G+ + + + G +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLSKVRSNCP 239
Query: 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ ++ C++ + RP +++ +E
Sbjct: 240 KA-----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 5e-63
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 23/272 (8%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+ LG G FG V+ G T VAVK L + F+ E N + + H LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
++ ++ E+M+NGSL ++ L ++A A+G+A+ E+
Sbjct: 76 VVTQE-PIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
IH D++ NIL+ + K++DFGLA+L+ + + APE ++ T
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 687 VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746
+K+DV+S+G+LL EIV R YPG E+ ++ +R +
Sbjct: 189 IKSDVWSFGILLTEIVTHGR----------IPYPGMTNPEV-----IQNLERGYRMVRPD 233
Query: 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
++ C ++ RP+ + +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 2e-62
Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 42/304 (13%)
Query: 495 FTYRDLQIRTSNFA-----------QLLGTGGFGSVYKGSL----GDGTLVAVKKLDR-V 538
FT+ D FA Q++G G FG V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 539 LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRD 598
++F++E + +G H N++ L G ++ + +++ EFM+NGSLD + D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF----LRQND 122
Query: 599 RVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658
+ A G+ Y + +H D+ NIL++ N KVSDFGL++ +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 659 REHSQV----VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDA 714
+ S + + APE + R T +DV+SYG+++ E++
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-------- 231
Query: 715 EDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVV 774
+ +MTN + ++ + ++ C Q + RP G++V
Sbjct: 232 -------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 775 KMLE 778
L+
Sbjct: 285 NTLD 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 9e-62
Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 23/273 (8%)
Query: 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
F Q +G+G FG V+ G + VA+K + E++F+ E + + H LV+L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G C E + LV+EFM++G L + + + T + + +G+AY E C
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDY----LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
+IH D+ N L+ EN KVSDFG+ + + + T + + +PE S
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745
+ K+DV+S+G+L+ E+ + + ++++ G L
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRLY---------KP 224
Query: 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
++ C ++ RP+ +++ L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-61
Identities = 53/273 (19%), Positives = 106/273 (38%), Gaps = 23/273 (8%)
Query: 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
F + LGTG FG V G VA+K + E EF+ E + ++ H LV+L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G C++ ++ E+M NG L ++ + + + Y
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
+ +H D+ N L+++ KVSDFGL++ + + + + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745
+ K+D++++G+L+ EI + ++ TN + + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRP 223
Query: 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ + + C ++ RP+ ++ +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-60
Identities = 62/304 (20%), Positives = 118/304 (38%), Gaps = 36/304 (11%)
Query: 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH 557
R + ++ + +G G FG V++G G VAVK E+ +
Sbjct: 3 RTIVLQ-----ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLR 55
Query: 558 HMNLVRLCGYCSEGSNRL----LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIAT 613
H N++ ++ + LV ++ ++GSL ++ + +A++T
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALST 109
Query: 614 AQGIAYFHEQC-----RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQV---V 665
A G+A+ H + + I H D+K +NIL+ +N ++D GLA +
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 666 TMVRGTRGYLAPEWVSNR------PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
GT+ Y+APE + + +AD+Y+ G++ EI + D + +Y
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 720 ----PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAM-KVAFWCIQDEVFMRPSMGEVV 774
+ +EM + + + E +R M K+ C R + +
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 775 KMLE 778
K L
Sbjct: 290 KTLS 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-60
Identities = 77/284 (27%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 507 FAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
LG G FG V+ G+ T VA+K L + F+ E + + H LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
SE +V E+M GSL ++ + L ++A A G+AY
Sbjct: 80 VVSEE-PIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
+H D++ NIL+ EN KV+DFGLA+L+ + + APE T
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 687 VKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEE 746
+K+DV+S+G+LL E+ R YPG +E+ L +R
Sbjct: 193 IKSDVWSFGILLTELTTKGRV----------PYPGMVNREV-----LDQVERGYRMPCPP 237
Query: 747 EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQ 790
E + C + E RP+ + LE D T PQ
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE---DYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 4e-59
Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 25/290 (8%)
Query: 492 PVNFTYRDLQIRTSNFA--QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVT 548
P + Y ++ ++ LG G +G VY+G VAVK L +EF+
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLK 62
Query: 549 EVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFN 608
E + + H NLV+L G C+ ++ EFM G+L ++ + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLY 119
Query: 609 IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMV 668
+A + + Y + IH D+ N L+ EN KV+DFGL++LM +
Sbjct: 120 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 669 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT 728
+ + APE ++ ++K+DV+++G+LL EI + YPG ++
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------PYPGIDLSQV- 225
Query: 729 NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
++ ++ E + ++ C Q RPS E+ + E
Sbjct: 226 ----YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 34/304 (11%)
Query: 501 QIRTSNF--AQLLGTGGFGSVYKGSLGDGT-----LVAVKKLDR-VLPHGEKEFVTEVNT 552
+I S +++G G FG VYKG L + VA+K L +F+ E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 553 IGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIA 612
+G H N++RL G S+ +++ E+M+NG+LDK+ +D +
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF----LREKDGEFSVLQLVGMLRG 118
Query: 613 TAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRG 670
A G+ Y +H D+ NIL++ N KVSDFGL++++ E + + +
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730
+ APE +S R T +DV+S+G+++ E++ + E++N
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNH 220
Query: 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQ 790
+K + + ++ C Q E RP ++V +L+ I P +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK--LIRAPDSLK 278
Query: 791 TVLE 794
T+ +
Sbjct: 279 TLAD 282
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-58
Identities = 71/271 (26%), Positives = 109/271 (40%), Gaps = 29/271 (10%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYC 568
Q +G G FG V G G VAVK + + F+ E + + + H NLV+L G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 569 SEGSNRL-LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
E L +V E+M GSL ++ VL ++ + + Y N
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
+H D+ N+L+ E+ KVSDFGL +E S + + APE + + +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 688 KADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEE 747
K+DV+S+G+LL EI R +D + G + D E
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPPAVYE-- 231
Query: 748 ELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
V C + MRPS ++ + LE
Sbjct: 232 -------VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-58
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 31/282 (10%)
Query: 506 NFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMN 560
+F +++G G FG VY G+L G AVK L+R+ GE +F+TE + H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 561 LVRLCGYCSEGSNR-LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
++ L G C L+V +MK+G L + + + A+G+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVAKGM-- 143
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE---HSQVVTMVRGTRGYLA 676
+ +H D+ N +LDE F KV+DFGLA+ M + T + ++A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 677 PEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736
E + + T K+DV+S+G+LL E++ + D + G L
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQP 256
Query: 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ + E V C + MRPS E+V +
Sbjct: 257 EYCPDPLYE---------VMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-58
Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 14/239 (5%)
Query: 500 LQIRTSNF--AQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGS 555
++++ +F LG G G V+K G ++A K + + P + + E+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 556 MHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQ 615
+ +V G + E M GSLD+ + + + ++IA +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIK 115
Query: 616 GIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYL 675
G+ Y E +++I+H D+KP NIL++ K+ DFG++ + + GTR Y+
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYM 170
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLK 734
+PE + +V++D++S G+ L+E+ GR + E G + TP +
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (503), Expect = 7e-58
Identities = 67/315 (21%), Positives = 122/315 (38%), Gaps = 47/315 (14%)
Query: 493 VNFTYRDLQIRTSNF--AQLLGTGGFGSVYKG------SLGDGTLVAVKKLDR-VLPHGE 543
+N L+ +N + +G G FG V++ T+VAVK L +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 544 KEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHR------ 597
+F E + + N+V+L G C+ G L++E+M G L++++ H
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 598 -------------DRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF 644
L + IA A G+AY E+ + +H D+ N L+ EN
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 645 CPKVSDFGLAKLM-GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG 703
K++DFGL++ + ++ + ++ PE + T ++DV++YG++L EI
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 704 GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDE 763
E+ Y + +G L E + + C
Sbjct: 238 YGLQPYYGMAHEEVIY------YVRDGNILA---------CPENCPLELYNLMRLCWSKL 282
Query: 764 VFMRPSMGEVVKMLE 778
RPS + ++L+
Sbjct: 283 PADRPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 60/290 (20%), Positives = 112/290 (38%), Gaps = 32/290 (11%)
Query: 498 RDLQIRTSNFAQL---LGTGGFGSVYKG---SLGDGTLVAVKKLDRVLPHGE-KEFVTEV 550
+ L ++ N LG G FGSV +G VA+K L + + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 551 NTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
+ + + +VRL G C + +LV E G L K++ + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELL 115
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV--TMV 668
+ G+ Y +H D+ N+LL K+SDFGL+K +G + S +
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 669 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMT 728
+ + APE ++ R + ++DV+SYG+ + E + + +K+M
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMK 217
Query: 729 NGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ ++ E + C + RP V + +
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 2e-55
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 46/313 (14%)
Query: 511 LGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE---KEFVTEVNTIGSMHHMNLVRLCG 566
+G G FG+VY + + +VA+KK+ ++ + EV + + H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
LV E+ + D + L + QG+AY H +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGLAYLHS---H 134
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV---SNR 683
+IH D+K NILL E K+ DFG A +M +S V GT ++APE +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 684 PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743
K DV+S G+ +E+ + L + N +P + E
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNESPALQSGHWSEYF 243
Query: 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIEEGLDHV 803
+ C+Q RP+ ++K + P +++LI+ D V
Sbjct: 244 ---RNFVD------SCLQKIPQDRPTSEVLLK----HRFVLRERPPTVIMDLIQRTKDAV 290
Query: 804 -------YKAMKR 809
Y+ MK+
Sbjct: 291 RELDNLQYRKMKK 303
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 6e-55
Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 39/295 (13%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSM-HH 558
F + LG G FG V + + VAVK L + ++E+ + + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHR-------------DRVLDWTT 605
MN+V L G C+ G L++ E+ G L ++ + LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV 665
+ + A+G+A+ IH D+ NILL K+ DFGLA+ + + + VV
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 666 -TMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF 724
R ++APE + N T ++DV+SYG+ L E+ + + FY
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY----- 258
Query: 725 KEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779
K+ E + C + RP+ ++V+++E
Sbjct: 259 ---------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-55
Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 31/275 (11%)
Query: 511 LGTGGFGSVYKGSL---GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLC 565
LG+G FG+V KG VAVK L P + E + E N + + + +VR+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
G C E + +LV E + G L+K++ ++R + + + G+ Y
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM--VRGTRGYLAPEWVSNR 683
+ +H D+ N+LL K+SDFGL+K + + + + + APE ++
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 684 PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743
+ K+DV+S+G+L+ E + ++ M + ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ C +V RP V L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 62/274 (22%), Positives = 114/274 (41%), Gaps = 25/274 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDR--VLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+GTG +G K DG ++ K+LD + ++ V+EVN + + H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 566 GYCSEGSNRLL--VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
+ +N L V E+ + G L I R LD + + H +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 128
Query: 624 --CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVS 681
+ ++H D+KP N+ LD K+ DFGLA+++ + + GT Y++PE ++
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMN 187
Query: 682 NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741
K+D++S G LL E+ E ++ G ++ R +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIPYRYSD 240
Query: 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
E++ + + + RPS+ E+++
Sbjct: 241 ELN---EIIT------RMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-54
Identities = 67/305 (21%), Positives = 120/305 (39%), Gaps = 36/305 (11%)
Query: 506 NFAQLLGTGGFGSVYKGSL---GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMN 560
F ++G G FG V K + G A+K++ ++F E+ + + HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 561 LVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRFNI 609
++ L G C L E+ +G+L ++ F + L +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 610 AIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVR 669
A A+G+ Y + + IH D+ NIL+ EN+ K++DFGL++ + TM R
Sbjct: 133 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 670 GTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTN 729
++A E ++ T +DV+SYG+LL EIV Y G E+
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----------PYCGMTCAEL-- 235
Query: 730 GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMP 789
+ + + C +++ + RPS +++ L + +
Sbjct: 236 ---YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292
Query: 790 QTVLE 794
T+ E
Sbjct: 293 TTLYE 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-53
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 33/296 (11%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
LG G FG VYK + L A K +D ++++ E++ + S H N+V+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+N ++ EF G++D + +R L + + T + Y H+ N+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLHD---NK 130
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV-----SN 682
IIH D+K NIL + K++DFG++ R + + + GT ++APE V +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKD 189
Query: 683 RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742
RP KADV+S G+ L+E+ ++ P +A
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPS-RW 241
Query: 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADINTPPMPQTVLELIEE 798
+ ++ ++ C++ V R + ++++ + D N P + ELI E
Sbjct: 242 SSNFKDFLK------KCLEKNVDARWTTSQLLQHPFVTVDSNKP-----IRELIAE 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 59/277 (21%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 507 FAQLLGTGGFGSVYKG-SLGDGTLVAVKKLD--RVLPHGEKEFVTEVNTIGSMHHMNLVR 563
F +G G F +VYKG VA +L ++ + F E + + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 564 LCGYC----SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
+LV E M +G+L ++ R +V+ + +G+ +
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQF 127
Query: 620 FHEQCRNRIIHCDIKPENILL-DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
H + IIH D+K +NI + K+ D GLA L + V GT ++APE
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPE 183
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
+ DVY++GM +LE+ + ++ +T+G
Sbjct: 184 -MYEEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVK------ 230
Query: 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
+ ++ + ++ CI+ R S+ +++
Sbjct: 231 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-52
Identities = 67/299 (22%), Positives = 109/299 (36%), Gaps = 44/299 (14%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLPHGEKE-FVTEVNTIGSM-HH 558
F ++LG+G FG V + G VAVK L E+E ++E+ + + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIF------------------PSYHHRDRV 600
N+V L G C+ L++E+ G L ++ V
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 601 LDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK-LMGR 659
L + A A+G+ + +H D+ N+L+ K+ DFGLA+ +M
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
+ V R ++APE + T+K+DV+SYG+LL EI N + FY
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 720 PGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
K+ + + C + RPS + L
Sbjct: 278 --------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 32/271 (11%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRL 564
+ LG G FG+VY ++A+K L + E + EV + H N++RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
GY + + L+ E+ G++ + + + D A ++Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHSK- 125
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
R+IH DIKPEN+LL K++DFG + + GT YL PE + R
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRM 180
Query: 685 ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744
K D++S G+L E + G+ + + E +K ++ V
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF------TFPDFV 227
Query: 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
E A + ++ RP + EV++
Sbjct: 228 TEG----ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-52
Identities = 60/277 (21%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTL----VAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLV 562
++LG+G FG+VYKG + +G VA+K+L P KE + E + S+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
RL G C L+ + M G L + + N + A+G+ Y
Sbjct: 75 RLLGICLTS-TVQLITQLMPFGCLLDY----VREHKDNIGSQYLLNWCVQIAKGMNYL-- 127
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM-VRGTRGYLAPEWVS 681
R++H D+ N+L+ K++DFGLAKL+G E + + ++A E +
Sbjct: 128 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 682 NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741
+R T ++DV+SYG+ + E++ + + + ++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGER 231
Query: 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ + C + RP E++
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-52
Identities = 62/275 (22%), Positives = 102/275 (37%), Gaps = 28/275 (10%)
Query: 509 QLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVLPHGEKE-FVTEVNTIGSMHHMNLVR 563
+ +G G FG V++G VA+K +E F+ E T+ H ++V+
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
L G +E ++ E G L + R LD + A + +AY
Sbjct: 73 LIGVITEN-PVWIIMELCTLGELRSF----LQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
R +H DI N+L+ N C K+ DFGL++ M + + ++APE ++ R
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 684 PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743
T +DV+ +G+ + EI+ D + NG L +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNCPPTL 238
Query: 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
LM C + RP E+ L
Sbjct: 239 ---YSLMT------KCWAYDPSRRPRFTELKAQLS 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 63/279 (22%), Positives = 101/279 (36%), Gaps = 31/279 (11%)
Query: 509 QLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNL 561
+ LG G FG V +G G VAVK L + P +F+ EVN + S+ H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
+RL G ++ V E GSL T A+ A+G+ Y
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDR----LRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAPEW 679
R IH D+ N+LL K+ DFGL + + +H + + + APE
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739
+ R + +D + +G+ L E+ + + + + K+
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--------------KIDKEG 231
Query: 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
E+ V C + RP+ + L
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 68/271 (25%), Positives = 107/271 (39%), Gaps = 26/271 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD-RVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
Q LG G +G V + VAVK +D + + E+ ++H N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+ EG+ + L E+ G L I D + G+ Y H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVTMVRGTRGYLAPEWVSNRPI 685
I H DIKPEN+LLDE K+SDFGLA + +++ + GT Y+APE + R
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 686 -TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAV 744
DV+S G++L ++ G D D Y W K+ K+
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSD-SCQEYSDWKEKKTYLNPWKKIDS------- 234
Query: 745 EEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
L+ + + R ++ ++ K
Sbjct: 235 APLALLH------KILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-50
Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 25/268 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ +G G G+VY + G VA+++++ ++ + E+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
G +V E++ GSL + + D + Q + + H N+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHS---NQ 136
Query: 628 IIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITV 687
+IH DIK +NILL + K++DFG + E S+ TMV GT ++APE V+ +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 688 KADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEE 747
K D++S G++ +E++ G + TNGTP +L
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPELQNPEKLSAIF--R 247
Query: 748 ELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
+ + C+ +V R S E+++
Sbjct: 248 DFLN------RCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-49
Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 38/291 (13%)
Query: 509 QLLGTGGFGSVYKG------SLGDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSM-HHMN 560
+ LG G FG V + VAVK L H E + ++E+ + + HH+N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 561 LVRLCGYCSEGSNRL-LVYEFMKNGSLDKWIFPSYHHRD-----------RVLDWTTRFN 608
+V L G C++ L ++ EF K G+L ++ + L
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 609 IAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV-TM 667
+ A+G+ + + IH D+ NILL E K+ DFGLA+ + ++ V
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 668 VRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEM 727
R ++APE + +R T+++DV+S+G+LL EI + ++ + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRL 250
Query: 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
GT ++ D + C E RP+ E+V+ L
Sbjct: 251 KEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-49
Identities = 62/289 (21%), Positives = 116/289 (40%), Gaps = 31/289 (10%)
Query: 507 FAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSMHHM 559
++ LG G FG VY+G T VA+K ++ EF+ E + + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRV-----LDWTTRFNIAIATA 614
++VRL G S+G L++ E M G L ++ + +A A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR-EHSQVVTMVRGTRG 673
G+AY + N+ +H D+ N ++ E+F K+ DFG+ + + ++ +
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733
+++PE + + T +DV+S+G++L EI E + + G L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLL 254
Query: 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782
D + ++ C Q MRPS E++ ++ +
Sbjct: 255 DKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 40/292 (13%)
Query: 509 QLLGTGGFGSVYKG--------SLGDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSM-HH 558
+ LG G FG V T VAVK L + ++E+ + + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI-----------FPSYHHRDRVLDWTTRF 607
N++ L G C++ ++ E+ G+L +++ + H+ + L
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 608 NIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM 667
+ A A+G+ Y + + IH D+ N+L+ E+ K++DFGLA+ + T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 668 V-RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726
R ++APE + +R T ++DV+S+G+LL EI + YPG +E
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----------PYPGVPVEE 245
Query: 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+ K+ + C RP+ ++V+ L+
Sbjct: 246 L-----FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (434), Expect = 8e-48
Identities = 62/320 (19%), Positives = 120/320 (37%), Gaps = 28/320 (8%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ LGTG FG V++ G A K + ++ E+ T+ + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ + +++YEFM G L + + + +G+ + HE
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 628 IIHCDIKPENILL--DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
+H D+KPENI+ + K+ DFGL + + S + GT + APE +P+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPV 202
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745
D++S G+L ++ G D E M + +++ +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-------D 255
Query: 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVK---MLEGSADINTPPMPQTVLELIEEGLDH 802
++ +R + + R ++ + ++ + G+A +P + I + +
Sbjct: 256 GKDFIR------KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 309
Query: 803 VYKAMKRDFNQFSSFTINSS 822
Y A + SS
Sbjct: 310 KYDAWPEPLPPLGRISNYSS 329
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-46
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 501 QIRTSNFA--QLLGTGGFGSVYKG-SLGDGTLVAVKKLDR---VLPHGEKEFVTEVNTIG 554
+ R +F ++LG G F +V L A+K L++ + + E + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 555 SMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATA 614
+ H V+L + + KNG L K+I + D T TA
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETC---TRFYTA 115
Query: 615 QGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVV-TMVRGTRG 673
+ ++ IIH D+KPENILL+E+ +++DFG AK++ E Q GT
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 674 YLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
Y++PE ++ + +D+++ G ++ ++V G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (418), Expect = 1e-45
Identities = 64/302 (21%), Positives = 120/302 (39%), Gaps = 27/302 (8%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ LG+G FG V++ G + K ++ P + E++ + +HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
+ +L+ EF+ G L I D + N +G+ + HE +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 628 IIHCDIKPENILLDENFCP--KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
I+H DIKPENI+ + K+ DFGLA + ++V + T + APE V P+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745
D+++ G+L ++ G D E + + D + E
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAFSSVSPE 258
Query: 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGSADINTPPMPQTVLELIEEGLDHV 803
++ ++ +Q E R ++ + ++ L+G T +P + I + +
Sbjct: 259 AKDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312
Query: 804 YK 805
Y
Sbjct: 313 YA 314
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 2e-41
Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 19/215 (8%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDR---VLPHGEKEFVTEVNTIGSMH---HMNL 561
+++G GGFG VY G + A+K LD+ + GE + E + + +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
V + + + M G L + + V A G+ + H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 622 EQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE-WV 680
+ +++ D+KP NILLDE+ ++SD GLA ++ GT GY+APE
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQ 178
Query: 681 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAE 715
AD +S G +L +++ G +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 2e-41
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 495 FTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL---PHGEKEFVTEV 550
++ +D QI + LGTG FG V+ S +G A+K L + + + E
Sbjct: 1 YSLQDFQIL-----RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 551 NTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIA 610
+ + H ++R+ G + ++ ++++ G L + S
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--------PNPVAK 107
Query: 611 IATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRG 670
A+ II+ D+KPENILLD+N K++DFG AK + + G
Sbjct: 108 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----G 163
Query: 671 TRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
T Y+APE VS +P D +S+G+L+ E++ G
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 3e-41
Identities = 67/315 (21%), Positives = 127/315 (40%), Gaps = 33/315 (10%)
Query: 506 NFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDR-VLPHGEKEFVTEVNTIGSMHHMNLVR 563
+F +LGTG F V LVA+K + + L E E+ + + H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
L G + L+ + + G L I + + Y H+
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 624 CRNRIIHCDIKPENILL---DENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
I+H D+KPEN+L DE+ +SDFGL+K+ V++ GT GY+APE +
Sbjct: 127 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVL 181
Query: 681 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740
+ +P + D +S G++ ++ G DA+ F+++ +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYEFDSPYWD 234
Query: 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGSADINTPPMPQTVLELIEE 798
+ + ++ +R ++ + R + + ++ + G ++ + Q+V E I++
Sbjct: 235 DISDSAKDFIR------HLMEKDPEKRFTCEQALQHPWIAGDTALD-KNIHQSVSEQIKK 287
Query: 799 GLDHVYKAMKRDFNQ 813
K+ FN
Sbjct: 288 NFAK--SKWKQAFNA 300
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 7e-41
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 32/281 (11%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRL 564
++LG GG V+ L VAVK L L P F E +++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 565 CGYC----SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
G +V E++ +L + H + + + Q + +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFS 127
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM--VRGTRGYLAPE 678
+N IIH D+KP NI++ KV DFG+A+ + + V V GT YL+PE
Sbjct: 128 ---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 679 WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738
+ ++DVYS G +L E++ G + P+ + R
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPPSAR 237
Query: 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRP-SMGEVVKMLE 778
+ + + ++ + R + E+ L
Sbjct: 238 HEGLSADLDAVVL------KALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 44/270 (16%), Positives = 100/270 (37%), Gaps = 26/270 (9%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ LG G FG V++ K + +V + E++ + H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNR 627
++++EF+ + + I + L+ + + + + H +
Sbjct: 70 FESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 628 IIHCDIKPENILLD--ENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
I H DI+PENI+ + K+ +FG A+ + + ++ Y APE + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVE 745
+ D++S G L+ ++ G + + + + N + E ++E
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTFDEEAFKEISIE 233
Query: 746 EEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
+ + + E R + E ++
Sbjct: 234 AMDFVD------RLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 1e-40
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLD---------RVLPHGEKEFVTEVNTIGSMH- 557
++LG G V + AVK +D + + + EV+ + +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 558 HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
H N+++L + LV++ MK G L ++ L I A + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLEVI 123
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
H+ I+H D+KPENILLD++ K++DFG + + + + + V GT YLAP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 178
Query: 678 EWVS------NRPITVKADVYSYGMLLLEIVGGR 705
E + + + D++S G+++ ++ G
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE---FVTEVNTIG-SMHHMNLVR 563
++LG G FG V+ A+K L + + + + + E + + H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 564 LCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQ 623
+ N V E++ G L I D + A G+ + H
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 624 CRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNR 683
I++ D+K +NILLD++ K++DFG+ K ++ T GT Y+APE + +
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 684 PITVKADVYSYGMLLLEIVGGRR 706
D +S+G+LL E++ G+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE-----FVTEVNTIGSMHHMNLV 562
LG G F +VYK +VA+KK+ K+ + E+ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 563 RLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
L SN LV++FM+ VL + + T QG+ Y H+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 623 QCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN 682
I+H D+KP N+LLDEN K++DFGLAK G + + T TR Y APE +
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFG 174
Query: 683 -RPITVKADVYSYGMLLLEIVGGR 705
R V D+++ G +L E++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-39
Identities = 67/336 (19%), Positives = 118/336 (35%), Gaps = 43/336 (12%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIG-SMHHMNLVRLCG 566
Q+LG G G V + + A+K L + EV + ++VR+
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 567 YC----SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHE 622
+ L+V E + G L I D+ I + + I Y H
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 623 QCRNRIIHCDIKPENILLDENFCP---KVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
I H D+KPEN+L K++DFG AK +S T T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEV 184
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739
+ D++S G+++ ++ G + K + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQYEFPNPE 240
Query: 740 LEGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVK---MLEGSADINTPPMPQTVL-- 793
EE + L+R ++ E R ++ E + +++ + TP VL
Sbjct: 241 WSEVSEEVKMLIR------NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294
Query: 794 -----ELIEEGLDHVYKAMKRDFNQFSSFTINSSTH 824
E ++E + M+ D+ Q I +++
Sbjct: 295 DKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 7e-39
Identities = 50/282 (17%), Positives = 90/282 (31%), Gaps = 32/282 (11%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ +G+G FG +Y G + G VA+K + E M + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 568 C-SEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
C +EG ++V E + D + + R T +A I Y H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLF-----NFCSRKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 627 RIIHCDIKPENIL---LDENFCPKVSDFGLAKLMGREHSQVV------TMVRGTRGYLAP 677
IH D+KP+N L + + DFGLAK + + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
+ + D+ S G +L+ G A ++ ++ +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERISEKKMSTPIE 238
Query: 738 RRLEGAVEE-EELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
+G E + +C +P + ++
Sbjct: 239 VLCKGYPSEFATYLN------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (360), Expect = 2e-38
Identities = 49/283 (17%), Positives = 91/283 (32%), Gaps = 32/283 (11%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCG 566
+ +G G FG +++G +L + VA+K R + E T + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+ EG + +LV + + D R T A + HE+
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEK--- 120
Query: 627 RIIHCDIKPENILLDENFCP-----KVSDFGLAKLMGREHSQVVTM------VRGTRGYL 675
+++ DIKP+N L+ V DFG+ K ++ + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 676 APEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735
+ R + + D+ + G + + + G A E TPL+
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-KAATNKQKYERIGEKKQSTPLRE 239
Query: 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778
EE + M + P + +
Sbjct: 240 LCAGF-----PEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 13/218 (5%)
Query: 509 QLLGTGGFGSVYKG--SLGDGTLVAVKKL-----DRVLPHGEKEFVTEVNTIGSMHHMNL 561
+G G +G V+K G VA+K++ + +P V + + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHH-RDRVLDWTTRFNIAIATAQGIAYF 620
VRL C+ + +D+ + + + T ++ +G+ +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
H +R++H D+KP+NIL+ + K++DFGLA++ + + T V T Y APE +
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 681 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF 718
D++S G + E+ + S D +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 3e-38
Identities = 45/199 (22%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVRLCG 566
+ +G G +G VYK G A+KK+ ++ + E++ + + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+LV+E + + + L+ T + + GIAY H+
Sbjct: 68 VIHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPIT 686
R++H D+KP+N+L++ K++DFGLA+ G + + + ++ +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 687 VKADVYSYGMLLLEIVGGR 705
D++S G + E+V G
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-38
Identities = 44/202 (21%), Positives = 85/202 (42%), Gaps = 10/202 (4%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE-KEFVTEVNTIGSMHHMNLVRLCG 566
+G G +G V + VA+KK+ + + E+ + H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 567 YCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRN 626
+ + ++ + ++ + + L +G+ Y H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKYIHS---A 128
Query: 627 RIIHCDIKPENILLDENFCPKVSDFGLAKLM--GREHSQVVTMVRGTRGYLAPEWVSN-R 683
++H D+KP N+LL+ K+ DFGLA++ +H+ +T TR Y APE + N +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 684 PITVKADVYSYGMLLLEIVGGR 705
T D++S G +L E++ R
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNR 210
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 65/278 (23%), Positives = 99/278 (35%), Gaps = 44/278 (15%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKL------DRVLPHGEKEFVTEVNTIGSMH--HM 559
LLG+GGFGSVY G + D VA+K + D EV + +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
++RL + + +L+ E + + L + + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFD----FITERGALQEELARSFFWQVLEAVRH 125
Query: 620 FHEQCRNRIIHCDIKPENILLDEN-FCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPE 678
H ++H DIK ENIL+D N K+ DFG L+ T GTR Y PE
Sbjct: 126 CHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPE 179
Query: 679 WVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
W+ A V+S G+LL ++V G P +E+ G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIRGQVF---- 222
Query: 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
V E + WC+ RP+ E+
Sbjct: 223 --FRQRVSSE----CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+ +G G +G VYK + G +VA+KK+ D + E++ + ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
+ LV+EF+ + + QG+A+ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFM----DASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
++H D+KP+N+L++ K++DFGLA+ G V + +
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 686 TVKADVYSYGMLLLEIVGGRR 706
+ D++S G + E+V R
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 54/278 (19%), Positives = 103/278 (37%), Gaps = 34/278 (12%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE------KEFVTEVNTIGSMHHMNL 561
+ LG+G F V K G A K + + ++ EV+ + + H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 562 VRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFH 621
+ L ++ +L+ E + G L + L G+ Y H
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDF-----LAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 622 EQCRNRIIHCDIKPENILLDENFCP----KVSDFGLAKLMGREHSQVVTMVRGTRGYLAP 677
I H D+KPENI+L + P K+ DFGLA + + + GT ++AP
Sbjct: 131 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAP 185
Query: 678 EWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737
E V+ P+ ++AD++S G++ ++ G E E + +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775
++ +R + + R ++ + ++
Sbjct: 246 -------LAKDFIR------RLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 13/202 (6%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRL 564
+LLG G FG V G A+K L + + + E VTE + + H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 565 CGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC 624
V E+ G L + R+RV A+ ++
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYG---AEIVSALEYLH 122
Query: 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRP 684
+++ DIK EN++LD++ K++DFGL K + + + T GT YLAPE + +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 685 ITVKADVYSYGMLLLEIVGGRR 706
D + G+++ E++ GR
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-36
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 26/223 (11%)
Query: 492 PVNFTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEV 550
P +Y D ++ +G G FG VY+ G LVA+KK+ + ++ E+
Sbjct: 17 PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL 64
Query: 551 NTIGSMHHMNLVRLCGYCSEGSNR------LLVYEFMKNGSLDKWIFPSYHHRDRVLDWT 604
+ + H N+VRL + + LV +++ Y + L
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVI 122
Query: 605 TRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQ 663
+ +AY H I H DIKP+N+LLD + K+ DFG AK +
Sbjct: 123 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEP 178
Query: 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
V+ + T DV+S G +L E++ G+
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 44/214 (20%), Positives = 83/214 (38%), Gaps = 11/214 (5%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+ +G G +G+V+K + +VA+K++ D + E+ + + H N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
LV+EF + + + LD + Q +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHS 119
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI 685
++H D+KP+N+L++ N K+++FGLA+ G V +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 686 TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
+ D++S G + E+ R L D +D
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 3e-34
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 19/236 (8%)
Query: 475 KRFLKRAVENSLIVCGAPVNFTYRDLQIRTSNFAQLLGTGGFGSVYKG-SLGDGTLVAVK 533
K FL +A E+ L P T Q+ + + LGTG FG V G A+K
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNT---AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 534 KLDRVLPHGEKE---FVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI 590
LD+ K+ + E + +++ LV+L + SN +V E++ G + +
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 591 FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650
R A Y H +I+ D+KPEN+L+D+ +V+D
Sbjct: 133 -----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 706
FG AK + + GT LAPE + ++ D ++ G+L+ E+ G
Sbjct: 185 FGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-33
Identities = 45/213 (21%), Positives = 78/213 (36%), Gaps = 23/213 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKL--DRVLPHGEKEFVTEVNTIGSMHHMNLVRLC 565
+G G FG V+K G VA+KK+ + + E+ + + H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 566 GYCSEGSNR--------LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGI 617
C ++ LV++F ++ L R +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRV-----MQMLL 127
Query: 618 AYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR---EHSQVVTMVRGTRGY 674
+ RN+I+H D+K N+L+ + K++DFGLA+ T T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 675 LAPEWVSN-RPITVKADVYSYGMLLLEIVGGRR 706
PE + R D++ G ++ E+
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 49/201 (24%), Positives = 80/201 (39%), Gaps = 12/201 (5%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLC 565
Q +G+G +G+V G VA+KKL R K E+ + M H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 566 GYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCR 625
+ +F + L + +G+ Y H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 626 NRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSN-RP 684
H D+KP N+ ++E+ K+ DFGLA+ E + V R Y APE + N
Sbjct: 143 I---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT----RWYRAPEVILNWMR 195
Query: 685 ITVKADVYSYGMLLLEIVGGR 705
T D++S G ++ E++ G+
Sbjct: 196 YTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 1e-31
Identities = 46/236 (19%), Positives = 91/236 (38%), Gaps = 27/236 (11%)
Query: 495 FTYRDLQIRTSN-----FAQLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVT 548
+ Y + N + LG G + V++ ++ + V VK L P +K+
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKR 78
Query: 549 EVNTIGSM-HHMNLVRLCGYCSEGSNRL--LVYEFMKNGSLDKWIFPSYHHRDRVLDWTT 605
E+ + ++ N++ L + +R LV+E + N + + L
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYD 130
Query: 606 RFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMGREHSQV 664
+ + Y H I+H D+KP N+++D E+ ++ D+GLA+ Q
Sbjct: 131 IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQE 185
Query: 665 VTMVRGTRGYLAPE-WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY 719
+ +R + PE V + D++S G +L ++ + D D
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 19/221 (8%)
Query: 509 QLLGTGGFGSVYKG----SLGDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSM-HHM 559
++LGTG +G V+ G L A+K L + + TE + +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 560 NLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
LV L + L+ +++ G L + + + I + +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH--------EVQIYVGEIVLA 141
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
+ II+ DIK ENILLD N ++DFGL+K + ++ GT Y+AP+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 680 V--SNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF 718
V + D +S G+L+ E++ G + G+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 51/206 (24%), Positives = 80/206 (38%), Gaps = 22/206 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLC 565
+ +G+G G V VA+KKL R K E+ + ++H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 566 GYCS------EGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAY 619
+ E + LV E M D + GI +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 620 FHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEW 679
H IH D+KP NI++ + K+ DFGLA+ G S ++T TR Y APE
Sbjct: 135 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEV 189
Query: 680 VSNRPITVKADVYSYGMLLLEIVGGR 705
+ D++S G ++ E+V +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-28
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 22/206 (10%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGE--KEFVTEVNTIGSMHHMNLVRLC 565
+G+G +GSV G VAVKKL R K E+ + M H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 566 GYCSEGS-----NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYF 620
+ N + + + L+ + + L + +G+ Y
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNI------VKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 621 HEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWV 680
H IIH D+KP N+ ++E+ K+ DFGLA+ E T TR Y APE +
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIM 190
Query: 681 SN-RPITVKADVYSYGMLLLEIVGGR 705
N D++S G ++ E++ GR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 4e-27
Identities = 43/211 (20%), Positives = 82/211 (38%), Gaps = 17/211 (8%)
Query: 509 QLLGTGGFGSVYKG-SLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGY 567
+ LG G F +V+ + + T VA+K + + E+ + ++ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 568 CSEGSNRLL-VYEFMKNGSLDKWIFPSYH----------HRDRVLDWTTRFNIAIATAQG 616
+ +LL + + + + R + I+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 617 IAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLMG-REHSQVVTMVRGTRGY 674
+ Y H +C IIH DIKPEN+L++ + + +A L + + T TR Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 675 LAPEWVSNRPITVKADVYSYGMLLLEIVGGR 705
+PE + P AD++S L+ E++ G
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 2e-22
Identities = 39/204 (19%), Positives = 70/204 (34%), Gaps = 30/204 (14%)
Query: 509 QLLGTGGFGSVYKGSLGDGTLVAVK----------KLDRVLPHGEKEFVTEVNTIGSMHH 558
+L+G G +V+ VK K+ +G+ F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIA 618
L +L G VY + N L + I +R RV + + + +A
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEVA 117
Query: 619 YFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQVVTM--VRGTRGYLA 676
F+ + I+H D+ N+L+ E + DF + +G E + + VR Y
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYF- 172
Query: 677 PEWVSNRPITVKADVYSYGMLLLE 700
+R + D+ S +L+
Sbjct: 173 -----SRTYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 69.2 bits (169), Expect = 6e-15
Identities = 29/120 (24%), Positives = 49/120 (40%), Gaps = 20/120 (16%)
Query: 5 GSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTK 64
G L A Q D + F Q+ L ++ + T VW++N K
Sbjct: 7 GEGLYAGQ----SLDVEPYHFIM------QEDCNLVLYDH-----STSVWASNTGILGKK 51
Query: 65 DAILELDTTGNLVLNDGD-TTIWASNSS-GAGVELATMSESGNFILYAPNNQPVWQSFLH 122
L + GN V+ D + ++WAS+S G G + + E GN ++Y +W + +
Sbjct: 52 GCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---GSDIWSTGTY 108
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.7 bits (160), Expect = 1e-13
Identities = 21/85 (24%), Positives = 34/85 (40%), Gaps = 2/85 (2%)
Query: 41 IWFNELPGDRTVVWSANRNFPVT-KDAILELDTTGNLVLNDGDTTIWASNSSGAGVELAT 99
I F L + + + + + + + NLVL D D +WASN++GA A
Sbjct: 3 ILFG-LSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAV 61
Query: 100 MSESGNFILYAPNNQPVWQSFLHPS 124
+ G ++ N W S S
Sbjct: 62 LQSDGLLVILTAQNTIRWSSGTKGS 86
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 62.6 bits (152), Expect = 2e-12
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 41 IWFNELPGDRTVVWSANRNFPVT-KDAILELDTTGNLVLNDGDTTIWASNSSGAGVEL-A 98
I ++ + + + + L ++T NLVL D D +W++N++G G A
Sbjct: 12 ILYSTQG-NDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRA 70
Query: 99 TMSESGNFILYAPNNQPVWQSF--LHPSDTLLPNQP 132
+ +G + N VW S + QP
Sbjct: 71 VLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQP 106
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.6 bits (100), Expect = 2e-05
Identities = 13/74 (17%), Positives = 23/74 (31%), Gaps = 6/74 (8%)
Query: 48 GDRTVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGA-GVELATMSESGN 105
VWS N L G + + +W S +S + G + + N
Sbjct: 51 DRDDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109
Query: 106 FILYAPNNQPVWQS 119
+Y +W +
Sbjct: 110 LAIYGG---ALWTT 120
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 60.6 bits (146), Expect = 8e-12
Identities = 20/107 (18%), Positives = 41/107 (38%), Gaps = 13/107 (12%)
Query: 20 NGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLN 79
G + F N+ L + VW++ N + +L++ GNLV+
Sbjct: 18 EGGYLFIIQNDCNLV-----------LYDNNRAVWASGTNGKAS-GCVLKMQNDGNLVIY 65
Query: 80 DGDTTIW-ASNSSGAGVELATMSESGNFILYAPNNQPVWQSFLHPSD 125
G IW ++ + G + N ++Y +N +W + + +
Sbjct: 66 SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.0 bits (119), Expect = 5e-08
Identities = 19/53 (35%), Positives = 26/53 (49%), Gaps = 1/53 (1%)
Query: 68 LELDTTGNLVLNDGDTTIWASNSSGAGVEL-ATMSESGNFILYAPNNQPVWQS 119
+ T NLVL D + IWA+N+ G G A + G ++ N VWQS
Sbjct: 34 FIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQS 86
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.6 bits (118), Expect = 7e-08
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 51 TVVWSANRNFPVTKDAILELDTTGNLVLNDGD-TTIWASNSSGAGVE-LATMSESGNFIL 108
+W+ N + L G LV+ + T+W S +G + + N ++
Sbjct: 49 NPIWATNTG-GLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 109 YAPNNQPVWQS 119
Y +W +
Sbjct: 108 YGD---ALWAT 115
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 46.5 bits (110), Expect = 5e-07
Identities = 18/106 (16%), Positives = 36/106 (33%), Gaps = 17/106 (16%)
Query: 19 DNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVL 78
+ G+F F N+ L +W+ N L + T GNLV+
Sbjct: 17 NYGSFVFIMQEDCNLV-----------LYDVDKPIWATNTGGLSR-SCFLSMQTDGNLVV 64
Query: 79 NDGDTTIWASNSSGAGVE--LATMSESGNFILYAPNNQPVWQSFLH 122
+ ++++G + + + N ++Y W + H
Sbjct: 65 YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 839 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.8 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.75 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.72 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.42 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.38 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.11 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.76 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.7 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.69 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.65 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.4 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.82 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.38 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 82.37 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.46 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.24 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=413.31 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=196.6
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.+.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||+++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 35677899999999999999988999999999754 44567899999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++.. ....+++..++.++.|||.||+|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 85 g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 85 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999843 345789999999999999999999995 9999999999999999999999999999887655444
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccCC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEGA 743 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 743 (839)
......||+.|||||++.+..++.++|||||||++|||+|+..|+....... .....+..+. ...
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~---------~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGF---------RLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH------HHHHHHHHTC---------CCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH------HHHHHHHhcC---------CCC
Confidence 4445679999999999999999999999999999999999654443221110 0111111111 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 744 VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 744 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.+......+.+++.+||+.+|++||||++|++.|+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1112234577889999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=413.47 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=206.9
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
...+.+.+.||+|+||+||+|.+++++.||||+++.. ....++|.+|++++.+++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3456778899999999999999988899999999754 3456789999999999999999999998865 5679999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++... ....+++..+++|+.||++||.|||+. +|+||||||+||||++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999987432 334699999999999999999999995 99999999999999999999999999999876554
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
........||+.|||||++.+..++.++|||||||++|||+||..|+....... .....+..+. .+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i~~~~-----~~--- 229 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGY-----RM--- 229 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTC-----CC---
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcC-----CC---
Confidence 444445678999999999999999999999999999999999766654222111 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
..+......+.+++.+||+.+|++||||++|+++|+.
T Consensus 230 -~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111223457788999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-49 Score=415.24 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=215.4
Q ss_pred HHHHHHhhccccccccCCCceEEEEEeC-CCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 498 RDLQIRTSNFAQLLGTGGFGSVYKGSLG-DGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 498 ~~l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.|+....+.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3455566778899999999999999874 5889999999754 3456789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++|+|.++|... ....+++..++.++.|||.||+|||+. +|+||||||+||||++++.+||+|||+++.
T Consensus 91 v~E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EeecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999998543 346789999999999999999999995 999999999999999999999999999998
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
.............|++.|||||++.+..++.++|||||||++|||++|..|+....+... ..+.+..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~------- 231 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEK------- 231 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHT-------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhc-------
Confidence 766555555556689999999999999999999999999999999998777643222110 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
......+......+.+++.+||+.+|++||||.+|++.|+...
T Consensus 232 --~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 232 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111222223456788999999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-48 Score=411.42 Aligned_cols=263 Identities=27% Similarity=0.470 Sum_probs=199.3
Q ss_pred cchHHHHHHhhcc-----------ccccccCCCceEEEEEeCC-C---cEEEEEEecccCC-cchHHHHHHHHHhhcccc
Q 038743 495 FTYRDLQIRTSNF-----------AQLLGTGGFGSVYKGSLGD-G---TLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHH 558 (839)
Q Consensus 495 ~~~~~l~~~~~~~-----------~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h 558 (839)
++|+|+..++.+| .++||+|+||+||+|.+.. + ..||||++..... ...++|.+|++++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 5566666655544 4689999999999998742 3 3699999865433 334679999999999999
Q ss_pred CCcccccceeecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcE
Q 038743 559 MNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENI 638 (839)
Q Consensus 559 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Ni 638 (839)
||||+++|++.+.+..++||||+++|+|.+++.. ....+++.+++.++.|||+||+|||+. +|+||||||+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NI 159 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNI 159 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceE
Confidence 9999999999999999999999999999998842 345699999999999999999999995 999999999999
Q ss_pred EECCCCceeecccCcceecCCCCcee----EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCC
Q 038743 639 LLDENFCPKVSDFGLAKLMGREHSQV----VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGD 713 (839)
Q Consensus 639 ll~~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~ 713 (839)
||+.++.+||+|||+++.+....... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999775433222 123458999999999999999999999999999999998 8999864322
Q ss_pred CCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 714 AEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.+ ....+..+ .....+.+....+.+++.+||+.+|++||||.||++.|+..
T Consensus 240 ~~-------~~~~i~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 240 QD-------VINAIEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HH-------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HH-------HHHHHHcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11111111 11112223345677889999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=398.42 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=210.6
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
.+.|.++||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|+|.+....++||||+++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 34678899999999999999988999999999765 44567899999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++.. ....+++..+.+++.|||+||+|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 84 g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 84 GCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999998742 345788999999999999999999994 9999999999999999999999999999877655444
Q ss_pred eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 664 VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ ....+..+. ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~---------~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL---------RL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTC---------CC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCC---------CC
Confidence 4445679999999999999999999999999999999998 899986443221 111122111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
..+......+.+++.+||+.+|++||||+++++.|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1112223467788999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=405.23 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=198.4
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
..+.+.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|+.++.+++|||||+++|++.+ ...++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 34667889999999999999874 359999986442 3445689999999999999999999999865 568999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+++|+|.++|.. ....+++..++.++.|||+||+|||+. +||||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 85 CEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999953 345699999999999999999999994 9999999999999999999999999999876543
Q ss_pred Cc-eeEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 661 HS-QVVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 661 ~~-~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
.. .......||+.|||||++.+ ..++.++|||||||+||||+||+.||........ .......+. .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~----~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGY----L 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTS----C
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCC----C
Confidence 32 23455679999999999864 4589999999999999999999999974332111 111111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.+.+ ..........+.+++.+||+.+|++||||.+|++.|+..
T Consensus 228 ~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 228 SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1110 011122334677889999999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=406.03 Aligned_cols=259 Identities=26% Similarity=0.365 Sum_probs=203.7
Q ss_pred HHhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
...+.+.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3467888999999999999999988889999999754 4456789999999999999999999999865 5689999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|..++... ....++|.+++.++.||+.||+|||+. +|+||||||+||||+.++++||+|||+++......
T Consensus 94 ~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999988532 335699999999999999999999995 89999999999999999999999999998775544
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLE 741 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 741 (839)
........||+.|+|||++..+.++.++||||||+++|||++|..|+........ ....+..+. .
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~------~~~~i~~~~---------~ 232 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY---------R 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTC---------C
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC---------C
Confidence 4444556799999999999999999999999999999999997776643222110 111111111 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCCC
Q 038743 742 GAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSADI 783 (839)
Q Consensus 742 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~~ 783 (839)
...+......+.+++.+||+.+|++||+|++|+++|+.....
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 112222334678899999999999999999999999986653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=395.54 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=199.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|++++++++|||||++++++.+++..+|||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 467788999999999999976 569999999986542 233457899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.++|. ....+++.++..++.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+......
T Consensus 86 ~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 86 SGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999994 345799999999999999999999995 99999999999999999999999999999775433
Q ss_pred ce-eEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 662 SQ-VVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 662 ~~-~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ......||+.|||||++.+..+ +.++|||||||++|||++|+.||......... ...........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~~~~~~~~~~----- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYL----- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH------HHHHHTTCTTS-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCCCCC-----
Confidence 22 2345679999999999988876 67899999999999999999999754332110 01111111000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.........+.+++.+||+.+|++|||++|+++
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111234667888999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=401.43 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=197.8
Q ss_pred hhccccccccCCCceEEEEEeCCC-----cEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDG-----TLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
.+.+.++||+|+||+||+|.+... ..||||++...... ...+|.+|++++.+++|||||+++|++.+....++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 455678999999999999987432 47999999654332 345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+.+|+|.+++.. ....+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+
T Consensus 88 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 88 TEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999988742 345799999999999999999999995 9999999999999999999999999999976
Q ss_pred CCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... .....||+.|||||++.++.++.++|||||||++|||++|..|+....... .....+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~----- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDG----- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHHHhcc-----
Confidence 5433222 334568999999999999999999999999999999999776654322111 011111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
.....+......+.+++.+||+.+|++||||.||+++|+...
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111222233456788999999999999999999999997654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=398.25 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=196.3
Q ss_pred cccccCCCceEEEEEeC---CCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 509 QLLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
++||+|+||+||+|.+. .++.||||+++.... ...++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999763 356899999965432 234679999999999999999999999965 567899999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 92 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHh-----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999984 345699999999999999999999995 8999999999999999999999999999987554433
Q ss_pred e--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 664 V--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 664 ~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. .....||+.|||||.+.+..++.++|||||||++|||++ |+.||......+ ....+..+..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~-------- 228 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER-------- 228 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC--------
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 3 334579999999999999999999999999999999998 899997432211 1112222111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+......+.+++.+||+.+|++||||++|+++|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11122223457788999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=398.93 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=201.4
Q ss_pred ccc-ccccCCCceEEEEEeC---CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 507 FAQ-LLGTGGFGSVYKGSLG---DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 507 ~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
+.+ +||+|+||+||+|.+. ++..||||+++.... ...++|.+|++++.+++|||||+++|++.. +..+|||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 445 4999999999999763 355899999975433 334679999999999999999999999865 5689999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.+++.. ....+++..++.++.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 91 ~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 91 GGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp TTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred CCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999998842 345799999999999999999999994 99999999999999999999999999999876543
Q ss_pred cee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 662 SQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 662 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... .....||+.|||||++.+..++.++|||||||++|||+| |+.||......+ ....+..+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~------ 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR------ 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCC------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence 332 234568999999999999999999999999999999998 899997543221 1112222211
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
...+......+.+++.+||+.+|++||||.+|++.|+.
T Consensus 231 ---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122233457788999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=395.62 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=203.7
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 467778999999999999976 5799999999976555556789999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
+|+|.+++. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 101 gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 101 GGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999873 34689999999999999999999995 999999999999999999999999999998754332
Q ss_pred eeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccccC
Q 038743 663 QVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRLEG 742 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 742 (839)
......||+.|||||++.+..++.++|||||||++|||++|+.||........ .......+.. . .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~-~-------~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-E-------L 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-C-------C
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCC-C-------C
Confidence 23445699999999999999999999999999999999999999964322110 0111111110 0 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 743 AVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 743 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+......+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122345778889999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=404.79 Aligned_cols=261 Identities=24% Similarity=0.367 Sum_probs=205.0
Q ss_pred HHHHhhccccccccCCCceEEEEEeCC------CcEEEEEEecccC-CcchHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLGD------GTLVAVKKLDRVL-PHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
+....+.+.++||+|+||+||+|+... ...||||++.... ......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 344566788999999999999997632 2379999986432 33456789999999998 899999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCC------------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCC
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYH------------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDI 633 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 633 (839)
+..++||||+++|+|.++|..... .....+++..++.++.||++||+|||+. +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999964321 1124589999999999999999999995 9999999
Q ss_pred CCCcEEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCC
Q 038743 634 KPENILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMS 711 (839)
Q Consensus 634 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~ 711 (839)
||+|||++.++.+||+|||+|+......... .....||+.|||||.+.++.++.++|||||||+||||++ |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765544332 334568999999999999999999999999999999997 89999754
Q ss_pred CCCCCccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 038743 712 GDAEDFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLE 778 (839)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~ 778 (839)
..... ..+.+..+ .....+......+.+++.+||+.+|++||||+||+++|.
T Consensus 271 ~~~~~------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH------HHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33211 01111111 111122223346788899999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=389.10 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=202.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 477889999999999999977 468999999985421 3345678999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.++|. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 y~~~g~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 87 YAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred ecCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999984 345789999999999999999999995 999999999999999999999999999986543
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+..... .
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~------~ 222 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF------T 222 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC------C
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC------C
Confidence 22 234579999999999999999999999999999999999999996432111 1111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+ +......+.+++.+||+.+|++|||++|+++
T Consensus 223 ~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 F----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 1112345677888999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=393.72 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=202.2
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeeccC
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMKN 583 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 583 (839)
|.+.+.||+|+||+||+|+. .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 56778999999999999976 56899999999776666678899999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCce
Q 038743 584 GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHSQ 663 (839)
Q Consensus 584 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 663 (839)
|+|.+++.. ....+++.++..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.......
T Consensus 94 g~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 94 GAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 999998742 235699999999999999999999995 999999999999999999999999999986543211
Q ss_pred eEEeeccccceeCccccc-----CCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 664 VVTMVRGTRGYLAPEWVS-----NRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 664 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
......||+.|||||++. ...++.++|||||||++|||++|+.||......+ ....+..+....+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~~~--- 235 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTL--- 235 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCCCC---
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCC---
Confidence 122356999999999984 4568999999999999999999999997543221 1111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122345778888999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=391.70 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=190.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeec--CCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--GSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 578 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++.+++|||||++++++.+ ....++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 467789999999999999976 5789999999965432 234568899999999999999999999865 45679999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc--CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC--RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||+++|+|.+++.... .....+++..++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 85 Ey~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 85 EYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp ECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred ecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999984321 12357999999999999999999999852 13599999999999999999999999999997
Q ss_pred cCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...... .....+..+...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~~~--- 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCC---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCC---
Confidence 654322 234467999999999999999999999999999999999999999643211 111122222111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+...+ ...+.+++.+||+.||.+|||+.|+++
T Consensus 233 --~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111122 335778888999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=385.84 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=193.4
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeec----CCceEEEE
Q 038743 506 NFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE----GSNRLLVY 578 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 578 (839)
.|.++||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4667899999999999976 468899999986542 2234568999999999999999999999854 45679999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC-CCCceeecccCcceec
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD-ENFCPKVSDFGLAKLM 657 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DfGla~~~ 657 (839)
||+++|+|.+++. ....+++..+..++.||++||+|||+. ..+|+||||||+||||+ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHh-----ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999994 345789999999999999999999985 12399999999999996 5789999999999865
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVAD 737 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (839)
.... .....||+.|||||++.+ .++.++|||||||++|||++|+.||....... ...+.+..+.. .
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~----~ 231 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVK----P 231 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCC----C
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCC----C
Confidence 4332 234579999999998865 59999999999999999999999996432211 11122221111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 738 RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 738 ~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..+.... ...+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111112 234678888999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=399.87 Aligned_cols=201 Identities=25% Similarity=0.394 Sum_probs=175.6
Q ss_pred HHhhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
...|.+.++||+|+||+||+|.. .+|+.||+|+++... .....++.+|+.++++++|||||++++++.+..+.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34566778999999999999976 578999999996543 3334678999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. +...+++..+..++.||+.||.|||+. ++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999994 335689999999999999999999973 3899999999999999999999999999987643
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCC
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSG 712 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~ 712 (839)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||....
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 234579999999999999999999999999999999999999997543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=389.92 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=199.9
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHH--HHHHHHhhccccCCcccccceeecCC----ceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEF--VTEVNTIGSMHHMNLVRLCGYCSEGS----NRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv 577 (839)
++-+.+.||+|+||.||+|++ +|+.||||+++.. ..+++ ..|+..+.+++|||||+++|+|.+.. ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455678999999999999998 6899999999643 23333 44555667789999999999997643 57899
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc-----CCeeeecCCCCCcEEECCCCceeecccC
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC-----RNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
|||+++|+|.++|. ...++|..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecccCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999994 346899999999999999999999732 4699999999999999999999999999
Q ss_pred cceecCCCCcee---EEeeccccceeCcccccCCC------CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch---
Q 038743 653 LAKLMGREHSQV---VTMVRGTRGYLAPEWVSNRP------ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--- 720 (839)
Q Consensus 653 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--- 720 (839)
+++......... .....||+.|||||++.+.. ++.++|||||||+||||+||..|+............
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 999875433322 34567999999999987643 577899999999999999999888654432211100
Q ss_pred -hhhhhhhccCcccccccccccCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 721 -GWAFKEMTNGTPLKVADRRLEGAV-EEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 721 -~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...............+++.+.... +.+....+.+++.+||+.+|++||||.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 000011110001111122221111 234667788999999999999999999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=383.34 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=194.8
Q ss_pred HhhccccccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecC-CceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEG-SNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~ 581 (839)
..+.+.+.||+|+||.||+|++ .|+.||||++++. ...++|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3456788999999999999998 5789999999653 3456799999999999999999999998654 5689999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
++|+|.++|... ....+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp TTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 999999999532 23468999999999999999999999 49999999999999999999999999999865432
Q ss_pred ceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+......+ ....+..+.
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~--------- 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY--------- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTC---------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 233458899999999999999999999999999999998 677775432211 111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
....+......+.+++.+||+.||++||||.+|+++|+.+
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1112222335677889999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=386.34 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=199.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 477889999999999999976 578999999986431 3344678999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+.+..
T Consensus 89 y~~gg~L~~~~~-----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 89 YAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ccCCCCHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999884 345799999999999999999999995 999999999999999999999999999998754
Q ss_pred CCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 660 EHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 660 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+..+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~------ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY------ 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCC------
Confidence 4332 2345679999999999999999999999999999999999999997432111 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVV 774 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~ 774 (839)
.+...+ ...+.+++.+||+.||.+|||++|++
T Consensus 228 ~~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 DFPEKF----FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 111122 34567889999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=391.71 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=205.8
Q ss_pred hhccccccccCCCceEEEEEeC------CCcEEEEEEecccCCc-chHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLPH-GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.+.+.+.||+|+||+||+|+.. +++.||||+++..... ..++|.+|++++++++||||++++++|.+....++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4567889999999999999763 4578999999754333 34679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCC-------------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 577 VYEFMKNGSLDKWIFPSYH-------------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
||||+++|+|.++|..... .....+++..++.|+.||+.||+|||+. +||||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 9999999999999853211 1224589999999999999999999995 99999999999
Q ss_pred EEECCCCceeecccCcceecCCCCce-eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCC-CCCCCCCCCC
Q 038743 638 ILLDENFCPKVSDFGLAKLMGREHSQ-VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR-RNLDMSGDAE 715 (839)
Q Consensus 638 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~-~p~~~~~~~~ 715 (839)
||||.++.+||+|||+++.+...... ......|++.|+|||.+.+..++.++|||||||++|||++|. +||......+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 99999999999999999876443332 334567899999999999999999999999999999999996 4665332211
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
....+.++... ..+......+.+++.+||+.+|++||||.||+++|+.+.
T Consensus 251 -------~~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 -------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -------HHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11122222211 112222346788999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=388.31 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=197.5
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcc---hHHHHHHHHHhhccccCCcccccceeecCCceEEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHG---EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
..|...+.||+|+||+||+|+. .+++.||||++....... .+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3466778999999999999975 578999999996543322 346889999999999999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 95 E~~~~g~l~~~~~-----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHH-----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 9999999987663 345799999999999999999999995 99999999999999999999999999998654
Q ss_pred CCCceeEEeeccccceeCcccccC---CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSN---RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
.. ....||+.|||||++.+ ..++.++|||||||++|||++|+.||......+ .......+..
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i~~~~~--- 231 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES--- 231 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC---
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCC---
Confidence 32 23469999999999864 468999999999999999999999996432111 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+.+. +......+.+++.+||+.+|.+|||+.|+++
T Consensus 232 --~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 --PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 1112345778888999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=388.27 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=200.6
Q ss_pred hccccccccCCCceEEEEEeCCC----cEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeec-CCceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSLGDG----TLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE-GSNRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~ 578 (839)
.+|.++||+|+||+||+|.+.++ ..||||+++... ....++|.+|++++++++||||++++|++.+ +...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 45678999999999999987442 369999997543 3344679999999999999999999999875 45789999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.+++.. ....+++..++.++.|+|.||.|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 109 E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp ECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEeecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 99999999998843 345677889999999999999999994 99999999999999999999999999999765
Q ss_pred CCCcee---EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 659 REHSQV---VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 659 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
...... .....||+.|+|||.+....++.++||||||+++|||++|+.||........ . ...+..+...
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~----~~~i~~g~~~-- 253 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I----TVYLLQGRRL-- 253 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCCC--
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--H----HHHHHcCCCC--
Confidence 433222 2235689999999999999999999999999999999998888764332211 1 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+......+.+++.+||+.+|++||+|.||++.|+.+
T Consensus 254 -------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01112234577889999999999999999999999765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=384.06 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=193.5
Q ss_pred HhhccccccccCCCceEEEEEeCC----CcEEEEEEecccCCcc-hHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLGD----GTLVAVKKLDRVLPHG-EKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
..+.+.+.||+|+||.||+|.+.. +..||||+++...... .+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 457788999999999999997643 3579999986544333 4569999999999999999999999964 678999
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 ~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999998743 345789999999999999999999995 9999999999999999999999999999987
Q ss_pred CCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcccccc
Q 038743 658 GREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVA 736 (839)
Q Consensus 658 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (839)
............||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....+..+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~--- 228 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC---
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 6554444556678999999999999999999999999999999998 888886543321 11122222111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 737 DRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 737 ~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
..+......+.+++.+||+.+|++||||.||++.|+.+
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222334577888999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-45 Score=386.56 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=189.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC-CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL-PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++|||||++++++.++...+|||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 477889999999999999976 468999999996543 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeecccCcceecC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~~~ 658 (839)
++|+|.++|. ....+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++...
T Consensus 90 ~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 90 SGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CSCBHHHHHH-----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCcHHHhhh-----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999994 345799999999999999999999995 999999999999994 57899999999998754
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+..+..
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~------ 226 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEY------ 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCC------
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCC------
Confidence 322 2334569999999999999999999999999999999999999996432211 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCC
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGS 780 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~ 780 (839)
.............+.+++.+||+.+|++|||+.|+++. +.+.
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00111111223457788899999999999999999883 5543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-44 Score=389.38 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=207.6
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||.||+|.. .+|+.||||+++.........+.+|++++++++|||||++++++.++...+|||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 477889999999999999976 5799999999976554555678899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC--CCCceeecccCcceecCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD--ENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DfGla~~~~~~ 660 (839)
+|+|.+++. .....+++.++..|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 110 gg~L~~~~~----~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 110 GGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CChHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999988773 2345799999999999999999999985 999999999999998 6789999999999987543
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+..+.. ..
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~------~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDW------EF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCC------CC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------CC
Confidence 3 3445679999999999999999999999999999999999999996433211 1111111110 01
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCC
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGS 780 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~ 780 (839)
...........+.+++.+||+.+|.+|||+.|+++. |++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 111111223456788999999999999999999874 5543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-44 Score=389.96 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=205.6
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
..|.+.+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3678889999999999999976 579999999997665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC--CCCceeecccCcceecCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD--ENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DfGla~~~~~ 659 (839)
++|+|.++|.. ....+++..+..++.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+++.+..
T Consensus 106 ~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 106 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999842 345699999999999999999999995 999999999999995 467899999999998754
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+...... ....
T Consensus 179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~~~ 247 (350)
T d1koaa2 179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN--MDDS 247 (350)
T ss_dssp TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--SCCG
T ss_pred cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CCcc
Confidence 33 2345679999999999999999999999999999999999999996442211 11111111100 0011
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
... .....+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFS----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 122456788899999999999999999984
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=381.74 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=193.2
Q ss_pred HhhccccccccCCCceEEEEEeC--CC--cEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceE
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSLG--DG--TLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRL 575 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 575 (839)
..+.+.+.||+|+||.||+|++. ++ ..||||++.+.. ....++|.+|++++++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 34677889999999999999763 23 379999986532 2334679999999999999999999999976 4678
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
+||||+++|+|.+++.. ....+++..++.++.|||+||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhc----ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 99999999999988742 345699999999999999999999994 89999999999999999999999999999
Q ss_pred ecCCCCcee--EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 656 LMGREHSQV--VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 656 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
......... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+ ........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~-- 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG-- 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC--
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCC--
Confidence 875544333 334568899999999999999999999999999999998 899996433211 011111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
.....+......+.+++.+||+.+|++||||.+|++.|++
T Consensus 232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111112223457789999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=386.94 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=197.6
Q ss_pred hhccccccccCCCceEEEEEeC-CCc----EEEEEEeccc-CCcchHHHHHHHHHhhccccCCcccccceeecCCceEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLG-DGT----LVAVKKLDRV-LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 577 (839)
.|.+.++||+|+||+||+|.+. +|+ +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 3677789999999999999763 444 6899988643 344567899999999999999999999999874 56788
Q ss_pred EeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceec
Q 038743 578 YEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLM 657 (839)
Q Consensus 578 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~ 657 (839)
+||+.+|+|.+++.. ....+++..++.++.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 89 TQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 999999999998743 356789999999999999999999995 9999999999999999999999999999987
Q ss_pred CCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 658 GREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 658 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
....... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||......+ ....+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC----
Confidence 5544332 344568999999999999999999999999999999998 788886443221 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcC
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEG 779 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~ 779 (839)
....+......+.+++.+||+.+|.+||||.||++.|+.
T Consensus 231 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 111122233557789999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=379.34 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=201.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC------cchHHHHHHHHHhhccccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP------HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.|.+.+.||+|+||+||+|.. .+|+.||||++++... ...+.+.+|+.++++++|||||++++++.+....+|
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 477889999999999999986 5799999999864321 234679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC----ceeecccC
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF----CPKVSDFG 652 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DfG 652 (839)
||||+++|+|.++|. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 v~E~~~gg~L~~~i~-----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 91 ILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEcCCCccccchhc-----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999984 335799999999999999999999995 999999999999998776 49999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTP 732 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (839)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY 233 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCC
Confidence 998764332 2234568999999999999999999999999999999999999997433211 1111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 733 LKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 733 ~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. ........ ....+.+++.+||+.+|++|||++|+++
T Consensus 234 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001111 2345678899999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=385.04 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=209.2
Q ss_pred HHHHHhhccccccccCCCceEEEEEe------CCCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeec
Q 038743 499 DLQIRTSNFAQLLGTGGFGSVYKGSL------GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE 570 (839)
Q Consensus 499 ~l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 570 (839)
|+....+.+.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.++.++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 45556778899999999999999975 3467999999975433 2345789999999999 79999999999999
Q ss_pred CCceEEEEeeccCCChhhhcccCCC-------------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCc
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYH-------------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPEN 637 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~N 637 (839)
....++||||+++|+|.++|..... .....+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999864321 1234689999999999999999999996 89999999999
Q ss_pred EEECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCC-CCCCCCCC
Q 038743 638 ILLDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRN-LDMSGDAE 715 (839)
Q Consensus 638 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p-~~~~~~~~ 715 (839)
||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+|+..| +......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999999876544333 3446789999999999999999999999999999999995544 43322211
Q ss_pred CccchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 716 DFFYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
. ..+.+ ........+......+.+++.+||+.+|.+||||.+|+++|++.
T Consensus 256 ~------~~~~i---------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 K------FYKMI---------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp H------HHHHH---------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H------HHHHH---------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 11111 11111112222345678899999999999999999999999753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=384.66 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=195.6
Q ss_pred HHHHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 500 LQIRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 500 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
+....+.+.++||+|+||.||+|... +++.||||+++.... ...+++..|...+.++ +|+||+++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 44456778899999999999999752 356899999965433 3345688888888877 789999999988654
Q ss_pred -CceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEE
Q 038743 572 -SNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENIL 639 (839)
Q Consensus 572 -~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nil 639 (839)
...++||||+++|+|.++|..... .....+++..++.++.||++||+|||+. +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 568999999999999999854311 1234689999999999999999999995 9999999999999
Q ss_pred ECCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCC-CCCCCCCCCCCc
Q 038743 640 LDENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR-RNLDMSGDAEDF 717 (839)
Q Consensus 640 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~ 717 (839)
|++++.+||+|||+|+......... .....||+.|||||.+.+..++.++|||||||++|||++|. .||......+
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998765433322 33457999999999999999999999999999999999875 5665332221
Q ss_pred cchhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 718 FYPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+..+.. ...+......+.+++.+||+.+|++||||.||+++|+.+
T Consensus 245 ----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 ----EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ----HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111211111 111122234578889999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=383.37 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=200.3
Q ss_pred hhccccccccCCCceEEEEEeCC-Cc--EEEEEEeccc-CCcchHHHHHHHHHhhcc-ccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGD-GT--LVAVKKLDRV-LPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.+.+.++||+|+||+||+|.+.+ |. .||||+++.. .....++|.+|++++.++ +|||||+++|+|.+++..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 45677899999999999998743 43 5888988543 234456799999999998 7999999999999999999999
Q ss_pred eeccCCChhhhcccCC-----------CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 579 EFMKNGSLDKWIFPSY-----------HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
||+++|+|.++|.... ......+++..+++++.|||.||.|||+. +|+||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceE
Confidence 9999999999995431 12346799999999999999999999995 999999999999999999999
Q ss_pred ecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCC-CCCCCCCCCCccchhhhhhh
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR-NLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~ 726 (839)
|+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ ....
T Consensus 168 l~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~~ 238 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK 238 (309)
T ss_dssp ECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHH
T ss_pred Ecccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHHH
Confidence 999999986543222 233468999999999999999999999999999999999765 554322111 1111
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCC
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSA 781 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~ 781 (839)
+..+. ....+......+.+++.+||+.+|++||+|+||++.|+.+.
T Consensus 239 i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 11112223346788899999999999999999999987653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=382.57 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=207.3
Q ss_pred HHhhccccccccCCCceEEEEEeC------CCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCCce
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLG------DGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 574 (839)
...+.+.++||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++|+|......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 345667889999999999999763 357899999975432 2334689999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcccCC-----CCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeec
Q 038743 575 LLVYEFMKNGSLDKWIFPSY-----HHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVS 649 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~ 649 (839)
++||||+++|+|.+++.... ......+++..+++++.|||+||.|||+. +|+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999985321 11223578899999999999999999995 89999999999999999999999
Q ss_pred ccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCC-CCCCCCCCCCCccchhhhhhhh
Q 038743 650 DFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGR-RNLDMSGDAEDFFYPGWAFKEM 727 (839)
Q Consensus 650 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 727 (839)
|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||+||. .|+......+ ....+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 999998765443322 23345899999999999999999999999999999999985 5554322111 11111
Q ss_pred ccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCCCC
Q 038743 728 TNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGSAD 782 (839)
Q Consensus 728 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~~~ 782 (839)
..+... ..+......+.+++.+||+.+|++||||.+|+++|++..+
T Consensus 249 ~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 121111 1112223468889999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=381.73 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=202.8
Q ss_pred HHhhccccccccCCCceEEEEEeCC--------CcEEEEEEecccCC-cchHHHHHHHHHhhcc-ccCCcccccceeecC
Q 038743 502 IRTSNFAQLLGTGGFGSVYKGSLGD--------GTLVAVKKLDRVLP-HGEKEFVTEVNTIGSM-HHMNLVRLCGYCSEG 571 (839)
Q Consensus 502 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 571 (839)
...+.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3456778999999999999997522 34799999976543 3346788999999888 899999999999999
Q ss_pred CceEEEEeeccCCChhhhcccCCC-----------CCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEE
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYH-----------HRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILL 640 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill 640 (839)
...++||||+++|+|.++|..... .....+++.+++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999964321 1235689999999999999999999995 99999999999999
Q ss_pred CCCCceeecccCcceecCCCCcee-EEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHh-CCCCCCCCCCCCCcc
Q 038743 641 DENFCPKVSDFGLAKLMGREHSQV-VTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG-GRRNLDMSGDAEDFF 718 (839)
Q Consensus 641 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 718 (839)
+.++.+||+|||+++......... .....|++.|+|||.+.++.++.++||||||+++|||++ |+.||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 999999999999999775433322 334568999999999999999999999999999999998 68887633221
Q ss_pred chhhhhhhhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 719 YPGWAFKEMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.....+..+. ....+......+.+++.+||+.+|.+||||.||+++|+.+
T Consensus 245 ---~~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1112222211 1111122234578899999999999999999999999765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=378.44 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=202.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 467889999999999999976 579999999996432 3345678999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|.+++. ....+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+....
T Consensus 86 y~~gg~L~~~~~-----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 86 YANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ccCCCchhhhhh-----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999984 445788999999999999999999995 999999999999999999999999999987543
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ..+....+.+ .
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~------~ 223 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------R 223 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------C
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCC------C
Confidence 322 2344579999999999999999999999999999999999999997543211 1111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
+...++ ..+.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112223 34677888999999999995 778876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-43 Score=373.32 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=200.7
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 467889999999999999986 569999999996431 3345678999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+++|+|..++. ....+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+....
T Consensus 85 ~~~gg~l~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 85 YIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred ecCCcccccccc-----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999884 445678888899999999999999995 999999999999999999999999999997654
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ....||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....+..+.. .
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~------~ 219 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL------R 219 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC------C
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC------C
Confidence 32 34579999999999999999999999999999999999999997432211 1111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVKM 776 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~~ 776 (839)
+...+ ...+.+++.+||+.+|.+|| +++++++.
T Consensus 220 ~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11122 23467888899999999996 89998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-43 Score=367.96 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=195.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---chHHHHHHHHHhhccccCCcccccceeecCC----ceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS----NRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 575 (839)
.|.+.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+|++++++++|||||++++++.... ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 367889999999999999975 57999999999754332 2346899999999999999999999987643 378
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
|||||+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+||||+.++..+|+|||.++
T Consensus 88 lvmE~~~g~~L~~~~~-----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEECCCCCEehhhhc-----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 9999999999999884 345799999999999999999999985 99999999999999999999999999998
Q ss_pred ecCCCCce--eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 656 LMGREHSQ--VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 656 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
........ ......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCC
Confidence 66433222 2345679999999999999999999999999999999999999996432211 111111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhcC
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-SMGEVVKMLEG 779 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~~v~~~L~~ 779 (839)
.......+ ...+.+++.+|++.||.+|| +++++++.|..
T Consensus 234 ---~~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 ---PSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---GGGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---CchhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 00111122 24577888899999999999 89999888754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=370.88 Aligned_cols=251 Identities=22% Similarity=0.211 Sum_probs=194.9
Q ss_pred hhccc-cccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcc-ccCCcccccceeec----CCceEE
Q 038743 504 TSNFA-QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSM-HHMNLVRLCGYCSE----GSNRLL 576 (839)
Q Consensus 504 ~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~l 576 (839)
.|.+. +.||+|+||+||+|.. .+++.||||+++. ...+.+|+.++.++ +|||||++++++.+ ....++
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 45554 5699999999999976 6789999999854 34678899987665 89999999999865 467899
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC---CCceeecccCc
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE---NFCPKVSDFGL 653 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DfGl 653 (839)
|||||++|+|.++|... ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 87 vmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 99999999999999532 345799999999999999999999995 9999999999999975 56799999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPL 733 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (839)
++....... .....||+.|||||++.+..++.++|||||||+||||++|+.||.......... ........+.
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~-- 233 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ-- 233 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC--
Confidence 987654322 344569999999999999999999999999999999999999996543322110 0000000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 734 KVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 734 ~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
..+...........+.+++.+||+.+|++|||+.|+++.
T Consensus 234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000111111234567888999999999999999999883
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=369.10 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=194.3
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEecccCCc-----chHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 509 QLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH-----GEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6899999999999986 46899999998643221 13468899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCCc
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREHS 662 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 662 (839)
++++..++ .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 84 TDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred chHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877665 3456789999999999999999999995 999999999999999999999999999987654332
Q ss_pred eeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh-----hhhhccC-ccccc
Q 038743 663 QVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA-----FKEMTNG-TPLKV 735 (839)
Q Consensus 663 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~ 735 (839)
. .....||+.|+|||.+.. ..++.++|||||||++|||++|+.||....+.+........ ...+... .....
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2 233468999999998865 46799999999999999999999999654321110000000 0000000 00000
Q ss_pred ccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HhcC
Q 038743 736 ADRRLEGAVEE-----EELMRAMKVAFWCIQDEVFMRPSMGEVVK--MLEG 779 (839)
Q Consensus 736 ~~~~l~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~--~L~~ 779 (839)
.........+. .....+.+++.+||+.||++|||++|+++ .|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00000000111 12345788899999999999999999987 3654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-42 Score=362.12 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=199.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc---------chHHHHHHHHHhhccc-cCCcccccceeecCC
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH---------GEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGS 572 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 572 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 467788999999999999976 57899999999654321 1235889999999996 999999999999999
Q ss_pred ceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccC
Q 038743 573 NRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFG 652 (839)
Q Consensus 573 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfG 652 (839)
..+|||||+++|+|.++|. ....+++.++..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 84 ~~~ivmE~~~~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEcCCCchHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999994 345789999999999999999999985 99999999999999999999999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccC------CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhh
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSN------RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKE 726 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 726 (839)
+++...... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||...... .....
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~ 226 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRM 226 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHH
Confidence 999875432 2244579999999998863 45788999999999999999999999744321 11122
Q ss_pred hccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 727 MTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 727 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
+..+... ............+.+++.+||+.+|++||++.||++
T Consensus 227 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222111 001111122345778899999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=365.27 Aligned_cols=249 Identities=18% Similarity=0.245 Sum_probs=200.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeecc
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFMK 582 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 582 (839)
.|.+.+.||+|+||+||+|.. .+++.||||+++.. ......+.+|++++.+++|||||++++++.+....+|||||++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 467788999999999999976 46889999999754 3334568899999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC--CCceeecccCcceecCCC
Q 038743 583 NGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE--NFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 583 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DfGla~~~~~~ 660 (839)
+|+|.++|.. ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 85 gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 85 GLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999942 234689999999999999999999995 9999999999999985 458999999999876443
Q ss_pred CceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccccc
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRRL 740 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 740 (839)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..+... .+...
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~~~~ 226 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDEEA 226 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCHHH
T ss_pred C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CChhh
Confidence 2 3344568999999999999999999999999999999999999997443211 11111111100 00111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 741 EGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 741 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
...+ ...+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112 234678899999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-42 Score=374.42 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=194.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHH---HHHHhhccccCCcccccceeecCCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVT---EVNTIGSMHHMNLVRLCGYCSEGSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~~l 576 (839)
.|.+.++||+|+||.||+|+. .+|+.||||++.+.. ......+.+ |+++++.++|||||++++++.+.+..++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 467788999999999999976 469999999985421 122233444 4667777889999999999999999999
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
||||+++|+|.++|. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.
T Consensus 85 vmE~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 85 ILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EECCCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHH-----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999994 345688899999999999999999995 999999999999999999999999999997
Q ss_pred cCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccc
Q 038743 657 MGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKV 735 (839)
Q Consensus 657 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (839)
+.... .....||+.|||||++.. ..++.++|||||||+||||++|+.||......... .........
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~~----- 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTM----- 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSSSC-----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcccC-----
Confidence 65432 234569999999999875 56899999999999999999999999754322111 000110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 038743 736 ADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPS-----MGEVVK 775 (839)
Q Consensus 736 ~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~~v~~ 775 (839)
...+...+ ...+.+++.+||+.||.+||| ++|+++
T Consensus 225 -~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111122 234678888999999999999 688865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-42 Score=371.95 Aligned_cols=243 Identities=22% Similarity=0.268 Sum_probs=200.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 579 (839)
.|.+.+.||+|+||.||+|+. .+|+.||||++.+.. ....+.+.+|+++++.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 577788999999999999976 579999999986421 2334578999999999999999999999999999999999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGR 659 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~ 659 (839)
|+.+|+|..++. ....+++..+..++.||+.||.|||+. +||||||||+||||+.++.+||+|||+|+.+..
T Consensus 122 ~~~~g~l~~~l~-----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 122 YVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccchhhhHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999984 335789999999999999999999995 999999999999999999999999999998754
Q ss_pred CCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCccccccccc
Q 038743 660 EHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADRR 739 (839)
Q Consensus 660 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (839)
.. ....||+.|||||++.+..++.++|||||||++|||++|+.||...... .....+..+.. .
T Consensus 194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~------~ 256 (350)
T d1rdqe_ 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKV------R 256 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------C
T ss_pred cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-------HHHHHHhcCCC------C
Confidence 32 2356999999999999999999999999999999999999999643211 11111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 740 LEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 740 l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
.... ....+.+++.+||+.||.+|+ |++++++
T Consensus 257 ~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCcc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112 234567888899999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=370.57 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=198.8
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC---CcchHHHHHHHHHhh-ccccCCcccccceeecCCceEEEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL---PHGEKEFVTEVNTIG-SMHHMNLVRLCGYCSEGSNRLLVY 578 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~ 578 (839)
.|.+.++||+|+||+||+|+. .+++.||||++++.. ....+.+..|..++. .++|||||++++++.+++..+|||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 467889999999999999976 468999999996432 233456777777765 589999999999999999999999
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
||+++|+|.++|. ....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 83 Ey~~~g~L~~~i~-----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 83 EYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp ECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred eecCCCcHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999994 345688999999999999999999995 99999999999999999999999999998654
Q ss_pred CCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCcccccccc
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGTPLKVADR 738 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (839)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+. +
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~------~ 220 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN------P 220 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------C
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------C
Confidence 3322 2344579999999999999999999999999999999999999997543211 112221111 1
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 038743 739 RLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMG-EVVK 775 (839)
Q Consensus 739 ~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-~v~~ 775 (839)
.+...+ ...+.+++.+||+.+|++||++. ++++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111122 34467888899999999999996 6753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-41 Score=357.35 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=196.7
Q ss_pred hhccccccccCCCceEEEEEeCCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.++++++|||||++++++...+..++++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 356678999999999999999899999999996543 223567999999999999999999999999999999999999
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCCC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGREH 661 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 661 (839)
.++.+..+. .....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 83 ~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 83 DQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp SEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 988777766 3456799999999999999999999995 99999999999999999999999999998765433
Q ss_pred ceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc----------chhhhhh-hhcc
Q 038743 662 SQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF----------YPGWAFK-EMTN 729 (839)
Q Consensus 662 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~----------~~~~~~~-~~~~ 729 (839)
. ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+... ...|... ....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 2233458999999999876 457999999999999999999999997543211000 0000000 0000
Q ss_pred -CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 730 -GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 730 -~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
........+.............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000011112245678889999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=357.74 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=197.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.++||+|+||+||+|.. .+|+.||||+++... .....++.+|++++++++|||||++++++.++...++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 456678999999999999976 679999999996432 22356799999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+.++.+. ++.. .....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~~-~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 83 LHQDLKK-FMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CSEEHHH-HHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred cCCchhh-hhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9765444 3321 2345799999999999999999999995 8999999999999999999999999999876443
Q ss_pred CceeEEeeccccceeCcccccCCC-CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc--------hhhhhhhhccC-
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY--------PGWAFKEMTNG- 730 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~~~~~~- 730 (839)
.. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||........... ....+......
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 22 233346999999999887655 58899999999999999999999975432110000 00000000000
Q ss_pred cccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCC
Q 038743 731 TPLKVADRRLEGA---VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGS 780 (839)
Q Consensus 731 ~~~~~~~~~l~~~---~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~ 780 (839)
............. ........+.+++.+||+.||++|||++|+++. |++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000000000 001122456778889999999999999999885 5543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=357.36 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=192.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc------chHHHHHHHHHhhccc--cCCcccccceeecCCce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH------GEKEFVTEVNTIGSMH--HMNLVRLCGYCSEGSNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 574 (839)
.|.+.++||+|+||+||+|+. .+|+.||||++.+.... ...++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 467889999999999999976 57899999998643211 1234778999999986 99999999999999999
Q ss_pred EEEEeeccC-CChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-CCceeecccC
Q 038743 575 LLVYEFMKN-GSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-NFCPKVSDFG 652 (839)
Q Consensus 575 ~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DfG 652 (839)
++||||+.+ +++.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~lv~e~~~~~~~l~~~~~-----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeccCcchHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 999999976 67777773 345789999999999999999999995 9999999999999985 5799999999
Q ss_pred cceecCCCCceeEEeeccccceeCcccccCCCC-CCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 653 LAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPI-TVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 653 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....+.
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~ 220 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ 220 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC
T ss_pred cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc
Confidence 998764432 234569999999999987765 677999999999999999999996321 010110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
. .+...++ ..+.+++.+||+.||++|||++|+++
T Consensus 221 ~------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 1111222 34678888999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=355.13 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=192.7
Q ss_pred HhhccccccccCCCceEEEEEe-CC-CcEEEEEEecccC--CcchHHHHHHHHHhhcc---ccCCcccccceeec-----
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GD-GTLVAVKKLDRVL--PHGEKEFVTEVNTIGSM---HHMNLVRLCGYCSE----- 570 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----- 570 (839)
..|.+.++||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 3567788999999999999976 34 6789999985432 22234577888877766 79999999999853
Q ss_pred CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecc
Q 038743 571 GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSD 650 (839)
Q Consensus 571 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~D 650 (839)
....+++|||+.++.+..... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346799999999887765442 2445788999999999999999999995 999999999999999999999999
Q ss_pred cCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch----------
Q 038743 651 FGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP---------- 720 (839)
Q Consensus 651 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~---------- 720 (839)
||+++...... ......||+.|||||++.+..++.++||||+||++|||++|+.||......+.....
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 99998654322 234456999999999999999999999999999999999999999754321110000
Q ss_pred hhhhhhhccCc-ccc---cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 721 GWAFKEMTNGT-PLK---VADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 721 ~~~~~~~~~~~-~~~---~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.|......... ... ...+.+.... ...+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDI----DELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSC----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccC----CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 000 0000111122 2346678889999999999999999763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=349.64 Aligned_cols=266 Identities=17% Similarity=0.188 Sum_probs=192.8
Q ss_pred HhhccccccccCCCceEEEEEe-CCCcEEEEEEeccc--CCcchHHHHHHHHHhhccccCCcccccceeec--------C
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRV--LPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE--------G 571 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 571 (839)
..|.+.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 4567788999999999999986 57999999998543 23334678999999999999999999998855 3
Q ss_pred CceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeeccc
Q 038743 572 SNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDF 651 (839)
Q Consensus 572 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df 651 (839)
...++||||+.++.+..+. .....+....+..++.||+.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 4679999999988776555 2445688889999999999999999995 9999999999999999999999999
Q ss_pred CcceecCCCCcee---EEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh---
Q 038743 652 GLAKLMGREHSQV---VTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF--- 724 (839)
Q Consensus 652 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--- 724 (839)
|+++.+....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+.+.........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998765432221 2234699999999998765 68999999999999999999999997543221110000000
Q ss_pred -----hhhccCcccccccccccCCCCH-H------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 725 -----KEMTNGTPLKVADRRLEGAVEE-E------ELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 725 -----~~~~~~~~~~~~~~~l~~~~~~-~------~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
...................... + ....+++++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000000000000011 1 12345678999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-39 Score=344.32 Aligned_cols=257 Identities=20% Similarity=0.204 Sum_probs=193.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCccccc-ceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLC-GYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||++... ....++..|+++++.++|+|++..+ ++..+....++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 367889999999999999976 56899999998653 2334688999999999877665554 4557778889999998
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEEC---CCCceeecccCcceecC
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLD---ENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DfGla~~~~ 658 (839)
+++|...+. .....+++..+..++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 86 -~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 86 -GPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred -CCchhhhhh----hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 456655553 2345789999999999999999999995 999999999999985 45679999999999875
Q ss_pred CCCce------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch-hhhhhhhccCc
Q 038743 659 REHSQ------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP-GWAFKEMTNGT 731 (839)
Q Consensus 659 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 731 (839)
..... ......||+.|||||.+.+..++.++|||||||++|||++|+.||............ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--- 234 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 234 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence 43321 223457999999999999999999999999999999999999999754432211110 00000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
...+.+...+ ...+.+++..|++.+|++||++.++.+.|+..
T Consensus 235 ---~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 ---TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---SCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---CChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0011111222 24467788889999999999999998888753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=354.72 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=191.3
Q ss_pred hccccccccCCCceEEEEEe-CCCcEEEEEEecccCC-cchHHHHHHHHHhhccccCCcccccceeecCC----ceEEEE
Q 038743 505 SNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP-HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS----NRLLVY 578 (839)
Q Consensus 505 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 578 (839)
|.+.++||+|+||+||+|.. .+|+.||||++.+... ...+.+++|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 56778999999999999965 6799999999975432 23457889999999999999999999986543 335566
Q ss_pred eeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecC
Q 038743 579 EFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMG 658 (839)
Q Consensus 579 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~ 658 (839)
+|+.+|+|.+++. ...+++..+..++.||+.||+|||+. +||||||||+||||+.++.+||+|||+++...
T Consensus 90 ~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 90 THLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 7788999999983 34689999999999999999999995 99999999999999999999999999998765
Q ss_pred CCCcee--EEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhh-----hhhcc-
Q 038743 659 REHSQV--VTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAF-----KEMTN- 729 (839)
Q Consensus 659 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~- 729 (839)
...... .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||................ .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 433221 344569999999999854 567899999999999999999999996543211100000000 00000
Q ss_pred ------------CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 730 ------------GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 730 ------------~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
.......-..+.... ...+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000011111 2357789999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=350.04 Aligned_cols=261 Identities=23% Similarity=0.255 Sum_probs=189.0
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcccccceeec------CCceEE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLVRLCGYCSE------GSNRLL 576 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~l 576 (839)
+|...++||+|+||+||+|+. .+|+.||||++.... ..+.+|++++++++||||+++++++.. ....+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 455668999999999999987 469999999996542 223479999999999999999999843 335789
Q ss_pred EEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcce
Q 038743 577 VYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAK 655 (839)
Q Consensus 577 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~ 655 (839)
||||++++.+..+.... .....+++..+..++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999876544433211 2345789999999999999999999985 999999999999999775 89999999998
Q ss_pred ecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch--------hhhhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP--------GWAFKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~ 726 (839)
.+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..... ...+..
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 7654322 233569999999998775 57899999999999999999999999654321110000 000000
Q ss_pred hcc----CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 727 MTN----GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 727 ~~~----~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
... ......................+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000000111122345778888999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=350.20 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=190.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeecCC------ce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGS------NR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 574 (839)
.|.+.++||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 466678999999999999975 5699999999975432 22356889999999999999999999997654 56
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+ +.+|..++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 99 ~lv~e~~-~~~l~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLM------KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp EEEEECC-SEEHHHHH------HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecc-cccHHHHH------HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 9999999 55777766 234699999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccC-CCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCcc--------chhhhhh
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSN-RPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFF--------YPGWAFK 725 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~ 725 (839)
+...... +...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......... .+.....
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 8765432 34569999999999876 457999999999999999999999997543211100 0000000
Q ss_pred hhccC-------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hcCCC
Q 038743 726 EMTNG-------TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM--LEGSA 781 (839)
Q Consensus 726 ~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~--L~~~~ 781 (839)
..... ...+.....+. .........+.+++.+||+.||.+|||+.|+++. |++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000 00000000000 0011112346788889999999999999999985 66543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-39 Score=339.00 Aligned_cols=258 Identities=17% Similarity=0.220 Sum_probs=200.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhcccc-CCcccccceeecCCceEEEEeec
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH-MNLVRLCGYCSEGSNRLLVYEFM 581 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 581 (839)
.|.+.+.||+|+||+||+|+. .+|+.||||++.... ...++.+|++.+..++| +|++.+++++.+....++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 467889999999999999986 468999999985432 23457889999999865 89999999999999999999998
Q ss_pred cCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECC-----CCceeecccCccee
Q 038743 582 KNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDE-----NFCPKVSDFGLAKL 656 (839)
Q Consensus 582 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DfGla~~ 656 (839)
+++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||||+. ++.+||+|||+|+.
T Consensus 84 -~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 84 -GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred -CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 6899988742 345789999999999999999999995 9999999999999974 57899999999998
Q ss_pred cCCCCce------eEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccC
Q 038743 657 MGREHSQ------VVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNG 730 (839)
Q Consensus 657 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 730 (839)
+...... ......||+.|||||.+.+..++.++||||||+++|||++|+.||.......... ....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~----~~~~i~~~ 231 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----KYERIGEK 231 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----HHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH----HHHHHHhc
Confidence 7543221 1234579999999999999999999999999999999999999997544322110 01111100
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcCC
Q 038743 731 TPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKMLEGS 780 (839)
Q Consensus 731 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~L~~~ 780 (839)
.. ....+.+...++ ..+.+++..|++.+|++||+++.+.+.|++.
T Consensus 232 ~~-~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 232 KQ-STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HH-HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cC-CCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 000111222222 3466777789999999999999998888653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-38 Score=340.09 Aligned_cols=256 Identities=18% Similarity=0.257 Sum_probs=192.5
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeec--CCceEEEEe
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSE--GSNRLLVYE 579 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~e 579 (839)
.|.+.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+.+|.+++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 577889999999999999976 57999999998643 3567899999999995 9999999999874 456899999
Q ss_pred eccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-ceeecccCcceecC
Q 038743 580 FMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF-CPKVSDFGLAKLMG 658 (839)
Q Consensus 580 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DfGla~~~~ 658 (839)
|+.+++|..+. +.+++..+..++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||+++...
T Consensus 113 ~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 113 HVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred ecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999997654 3588999999999999999999995 999999999999998654 69999999998765
Q ss_pred CCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccc-----------hhhhhh-
Q 038743 659 REHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFY-----------PGWAFK- 725 (839)
Q Consensus 659 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~-----------~~~~~~- 725 (839)
.... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||....+...... ..+...
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 2345689999999998765 579999999999999999999999965443211000 000000
Q ss_pred ---------hhccCcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 726 ---------EMTNGTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 726 ---------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
..........................+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000011111112335678889999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=346.22 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=199.5
Q ss_pred HhhccccccccCCCceEEEEEe----CCCcEEEEEEecccC----CcchHHHHHHHHHhhcccc-CCcccccceeecCCc
Q 038743 503 RTSNFAQLLGTGGFGSVYKGSL----GDGTLVAVKKLDRVL----PHGEKEFVTEVNTIGSMHH-MNLVRLCGYCSEGSN 573 (839)
Q Consensus 503 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 573 (839)
..|.+.+.||+|+||+||+|.. .+|+.||||++++.. ....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4588899999999999999965 248899999986432 1234568899999999966 899999999999999
Q ss_pred eEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCc
Q 038743 574 RLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGL 653 (839)
Q Consensus 574 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGl 653 (839)
.+++|||+.+|+|.+++. ....+.......++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~-----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHH-----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999984 344667888899999999999999995 899999999999999999999999999
Q ss_pred ceecCCCCceeEEeeccccceeCcccccCC--CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhhhhhhccCc
Q 038743 654 AKLMGREHSQVVTMVRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWAFKEMTNGT 731 (839)
Q Consensus 654 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 731 (839)
++.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||.......... .........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~- 251 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKS- 251 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHC-
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcccC-
Confidence 998765444444556799999999998764 46889999999999999999999997654332111 011111000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 038743 732 PLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRP-----SMGEVVK 775 (839)
Q Consensus 732 ~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~~v~~ 775 (839)
....+......+.+++.+||+.+|++|| |++|+++
T Consensus 252 ---------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0111222345677788899999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=335.76 Aligned_cols=263 Identities=20% Similarity=0.258 Sum_probs=198.4
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccC--CcchHHHHHHHHHhhccccCCcccccceeecCCceEEEEee
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVL--PHGEKEFVTEVNTIGSMHHMNLVRLCGYCSEGSNRLLVYEF 580 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 580 (839)
.|.+.++||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 356778999999999999976 578999999985433 23356789999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcceecCCC
Q 038743 581 MKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAKLMGRE 660 (839)
Q Consensus 581 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~~~~~ 660 (839)
+.+++|..++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++.....
T Consensus 83 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 83 CDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSEEHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ccccccccccc-----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999988773 345788999999999999999999995 9999999999999999999999999999986543
Q ss_pred CceeEEeeccccceeCcccccCCC-CCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccch-----------hhhh-hhh
Q 038743 661 HSQVVTMVRGTRGYLAPEWVSNRP-ITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYP-----------GWAF-KEM 727 (839)
Q Consensus 661 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-----------~~~~-~~~ 727 (839)
... .....+++.|+|||.+.... ++.++|||||||++|||++|+.||....+....... .|.. ...
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 322 23345788999999887665 699999999999999999999997433221110000 0000 000
Q ss_pred ccCccccccc-ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 038743 728 TNGTPLKVAD-RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK 775 (839)
Q Consensus 728 ~~~~~~~~~~-~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~ 775 (839)
.+........ ..-...........+.+++.+|++.||.+|||++||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 00001111222345678888999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=333.85 Aligned_cols=260 Identities=23% Similarity=0.239 Sum_probs=186.1
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCC--cchHHHHHHHHHhhccccCCcccccceeec------CCce
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLP--HGEKEFVTEVNTIGSMHHMNLVRLCGYCSE------GSNR 574 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 574 (839)
.|.+.++||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++++++|||||++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 366778999999999999976 4699999999965432 223468899999999999999999999853 4688
Q ss_pred EEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcc
Q 038743 575 LLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLA 654 (839)
Q Consensus 575 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla 654 (839)
++||||+.++.+.. +. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 98 ~iv~Ey~~~~l~~~-~~-------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 98 YLVMELMDANLCQV-IQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEECCSEEHHHH-HT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeccchHHHHh-hh-------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 99999997765543 31 3578999999999999999999995 9999999999999999999999999999
Q ss_pred eecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCc---------cchhhh--
Q 038743 655 KLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDF---------FYPGWA-- 723 (839)
Q Consensus 655 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~---------~~~~~~-- 723 (839)
+...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||......... ..+.+.
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8654322 234456899999999999999999999999999999999999999654311100 000000
Q ss_pred ----hhhhccCc-------ccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 038743 724 ----FKEMTNGT-------PLKVADRRLEGA---VEEEELMRAMKVAFWCIQDEVFMRPSMGEVVKM 776 (839)
Q Consensus 724 ----~~~~~~~~-------~~~~~~~~l~~~---~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~~ 776 (839)
........ ............ ........+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000111111111 122345678889999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-38 Score=339.48 Aligned_cols=263 Identities=22% Similarity=0.257 Sum_probs=191.2
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCc--chHHHHHHHHHhhccccCCcccccceeec-----CCceE
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPH--GEKEFVTEVNTIGSMHHMNLVRLCGYCSE-----GSNRL 575 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 575 (839)
.|.+.++||+|+||+||+|.. .+|+.||||++++.... ..+++.+|++++++++|||||++++++.. ....+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 366778999999999999975 67999999999754322 33568899999999999999999999863 33457
Q ss_pred EEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 576 LVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 576 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
++++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++.
T Consensus 99 ~i~~~~~gg~L~~~~~------~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEEECCSEEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeecCCchhhhcc------cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 7788889999999983 34699999999999999999999995 99999999999999999999999999997
Q ss_pred ecCCCCceeEEeeccccceeCcccccCC-CCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchh--------hhhhh
Q 038743 656 LMGREHSQVVTMVRGTRGYLAPEWVSNR-PITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPG--------WAFKE 726 (839)
Q Consensus 656 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~ 726 (839)
...... ....|++.|+|||.+.+. .++.++|||||||++|||++|+.||............. .....
T Consensus 170 ~~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 654322 234589999999987765 56899999999999999999999997543211100000 00000
Q ss_pred hcc-------CcccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhcCC
Q 038743 727 MTN-------GTPLKVADRRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGEVVK--MLEGS 780 (839)
Q Consensus 727 ~~~-------~~~~~~~~~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~v~~--~L~~~ 780 (839)
... ..........+.. ........+.+++.+||+.||.+|||+.|+++ .|.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000 0000000000000 00011234678889999999999999999997 45544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-33 Score=308.04 Aligned_cols=267 Identities=21% Similarity=0.194 Sum_probs=190.3
Q ss_pred hhccccccccCCCceEEEEEe-CCCcEEEEEEecccCCcchHHHHHHHHHhhccc-----------cCCcccccceeec-
Q 038743 504 TSNFAQLLGTGGFGSVYKGSL-GDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-----------HMNLVRLCGYCSE- 570 (839)
Q Consensus 504 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~- 570 (839)
.|.+.++||+|+||+||+|+. .+|+.||||++++. ....+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 477889999999999999976 57999999999754 222456788998888775 5789999988754
Q ss_pred -CCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCC-----
Q 038743 571 -GSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENF----- 644 (839)
Q Consensus 571 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~----- 644 (839)
....+++++++..+........ ......+.+..+..++.||+.||+|||+. .+|+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 3456677777665543332211 12456778889999999999999999984 4899999999999998655
Q ss_pred -ceeecccCcceecCCCCceeEEeeccccceeCcccccCCCCCCcccEEehhHHHHHHHhCCCCCCCCCCCCCccchhhh
Q 038743 645 -CPKVSDFGLAKLMGREHSQVVTMVRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSGDAEDFFYPGWA 723 (839)
Q Consensus 645 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 723 (839)
.+||+|||.+....... ....||+.|+|||.+....++.++||||+||+++||++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 38999999998654322 3356999999999999999999999999999999999999999754322110000000
Q ss_pred h-----------hhhccC--------------cccccc----c--ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 038743 724 F-----------KEMTNG--------------TPLKVA----D--RRLEGAVEEEELMRAMKVAFWCIQDEVFMRPSMGE 772 (839)
Q Consensus 724 ~-----------~~~~~~--------------~~~~~~----~--~~l~~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~~ 772 (839)
. ...... ...... . ..............+.+++.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 000000 000000 0 00122344567788999999999999999999999
Q ss_pred HHHH--hcC
Q 038743 773 VVKM--LEG 779 (839)
Q Consensus 773 v~~~--L~~ 779 (839)
+++. |++
T Consensus 325 ~L~Hp~f~~ 333 (362)
T d1q8ya_ 325 LVNHPWLKD 333 (362)
T ss_dssp HHTCGGGTT
T ss_pred HhcCcccCC
Confidence 9874 543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=192.12 Aligned_cols=163 Identities=15% Similarity=0.164 Sum_probs=120.2
Q ss_pred ccccccccCCCceEEEEEeCCCcEEEEEEecccCCc------------------chHHHHHHHHHhhccccCCcccccce
Q 038743 506 NFAQLLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPH------------------GEKEFVTEVNTIGSMHHMNLVRLCGY 567 (839)
Q Consensus 506 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~g~ 567 (839)
.+.++||+|+||+||+|...+|+.||||+++..... .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999889999999987531100 01234568888999999999887765
Q ss_pred eecCCceEEEEeeccCCChhhhcccCCCCCcccCChhhHHHHHHHHHHHhHHhhhccCCeeeecCCCCCcEEECCCCcee
Q 038743 568 CSEGSNRLLVYEFMKNGSLDKWIFPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQCRNRIIHCDIKPENILLDENFCPK 647 (839)
Q Consensus 568 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk~~Nill~~~~~~k 647 (839)
. ..+++|||+++..+.. ++......++.|++++|+|||+. +|+||||||+|||+++++ ++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EE
Confidence 3 2379999998866533 34455678999999999999995 999999999999999765 89
Q ss_pred ecccCcceecCCCCceeEEeeccccceeC------cccccCCCCCCcccEEehhHHH
Q 038743 648 VSDFGLAKLMGREHSQVVTMVRGTRGYLA------PEWVSNRPITVKADVYSYGMLL 698 (839)
Q Consensus 648 l~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~~DV~S~Gvvl 698 (839)
|+|||+|.....+.... |.. .|. ..+.|..++||||..--+
T Consensus 143 liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99999998765432211 111 011 135678899999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.80 E-value=1.6e-19 Score=158.81 Aligned_cols=108 Identities=24% Similarity=0.493 Sum_probs=90.8
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeCC
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLNDG 81 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~~ 81 (839)
|.+|+.|.+ +++|+| |.|+|+|+..++ |.|+.. .++||.||++.|.. .+.|.|+.||+|||.++
T Consensus 4 L~~gq~L~~--g~~l~~--g~~~l~~q~DGN------Lvly~~-----~~~vW~s~~~~~~~-~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 4 LNSGHQLDT--GGSLAE--GGYLFIIQNDCN------LVLYDN-----NRAVWASGTNGKAS-GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp EETTEEECT--TCEEEE--TTEEEEECTTSC------EEEEET-----TEEEEECCCTTSCS-SEEEEECTTSCEEEEET
T ss_pred ecCCCEecC--CCEEEE--CCEEEEEcCCCC------EEEEcC-----CcEEEEccCccCCC-CcEEEEeccccEEEEec
Confidence 567888888 999975 999999998764 666542 57899999998854 46899999999999998
Q ss_pred CeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecccCCCc
Q 038743 82 DTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLHPSD 125 (839)
Q Consensus 82 ~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~PTD 125 (839)
+..+|+|++... +...|+|+|+|||||++.++.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 888998886443 45579999999999999999999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.75 E-value=4e-18 Score=148.06 Aligned_cols=103 Identities=27% Similarity=0.454 Sum_probs=84.9
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|..|+.|.+ ++.|+ +|.|.|+|...++ |.|+. ..++||+||++.|+...+.|.|+.||+|||.|
T Consensus 4 L~~g~~L~~--g~~l~--~g~~~l~~q~dgn------Lvl~~-----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 4 LTNGEGLYA--GQSLD--VEPYHFIMQEDCN------LVLYD-----HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp EETTCEEET--TCEEE--ETTEEEEECTTSC------EEEEE-----TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS
T ss_pred ccCCCEEeC--CCEEE--eCCEEEEecCCCe------EEEEe-----CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC
Confidence 568898987 88886 4889999987653 55553 25789999999999888899999999999999
Q ss_pred CCeeEEEecCC-CCceeEEEEeccccEEEecCCCCceeecccC
Q 038743 81 GDTTIWASNSS-GAGVELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 81 ~~~~vWst~~~-~~~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
.+.+||+|+++ +.+..+|.|+|+|||||++ ..+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~---~~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---SDIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEEC---CEEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEEC---CCEecCCCc
Confidence 56789999875 3456679999999999996 369999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.72 E-value=1.1e-17 Score=145.18 Aligned_cols=102 Identities=25% Similarity=0.470 Sum_probs=82.1
Q ss_pred CCCCceEEecCCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-
Q 038743 2 IGLGSRLLASQDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND- 80 (839)
Q Consensus 2 ~~~~~~~~~~~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~- 80 (839)
|..|+.|.+ ++.|. +|.|.|.|+..++ |.|+.. .++||.||++.|. ..+.|.|..+|+|+|.+
T Consensus 4 L~~g~~L~~--G~~l~--ng~~~l~~q~DGN------Lvly~~-----~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 4 LYSGETLST--GEFLN--YGSFVFIMQEDCN------LVLYDV-----DKPIWATNTGGLS-RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp EETTEEECT--TCEEE--ETTEEEEECTTSC------EEEEET-----TEEEEECCCTTSC-SSCEEEECTTSCEEEECT
T ss_pred ccCCCEecC--CCEEE--cCCEEEEECCCCe------EEEEeC-----CceeeEeCCCCCC-CccEEEEeccceEEEECC
Confidence 456888855 88885 6999999998774 667652 4779999999884 34689999999999998
Q ss_pred CCeeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeecccC
Q 038743 81 GDTTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFLH 122 (839)
Q Consensus 81 ~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD~ 122 (839)
.+.+||+|++... ...+|+|+|+|||||++. .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 5678999987543 444689999999999953 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=6.9e-16 Score=136.01 Aligned_cols=80 Identities=24% Similarity=0.363 Sum_probs=69.6
Q ss_pred EEeccCCCCCcEEEeeCCCCCCCCCe-EEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceee
Q 038743 41 IWFNELPGDRTVVWSANRNFPVTKDA-ILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQ 118 (839)
Q Consensus 41 Iw~~~i~~~~tvVW~ANr~~pv~~~~-~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQ 118 (839)
|||.+++ +++.+|++|++.|++... +|.+..||||||.+.+.+||++++...+ ...|+|+++|||||++.++.++||
T Consensus 12 il~~~~~-~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 12 ILYSTQG-NDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp ECCCC---CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred EEEcCCC-CCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 8999875 789999999999998654 8999999999999988899999976543 457999999999999999999999
Q ss_pred ccc
Q 038743 119 SFL 121 (839)
Q Consensus 119 SFD 121 (839)
||.
T Consensus 91 S~t 93 (120)
T d1dlpa2 91 SGN 93 (120)
T ss_dssp CCC
T ss_pred eCC
Confidence 984
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.42 E-value=2.9e-14 Score=124.03 Aligned_cols=96 Identities=24% Similarity=0.337 Sum_probs=79.9
Q ss_pred EEeccCCCCCcEEEeeCCCCCCCCC-eEEEEecCCcEEEeCCCeeEEEecCCCCceeEEEEeccccEEEecCCCCceeec
Q 038743 41 IWFNELPGDRTVVWSANRNFPVTKD-AILELDTTGNLVLNDGDTTIWASNSSGAGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 41 Iw~~~i~~~~tvVW~ANr~~pv~~~-~~l~l~~~G~Lvl~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
|||.- +.+.+..|..+.+.++.+. .+|.|..||||||.+++.+||++++.+.....|.|+|+|||||++.++.++|||
T Consensus 3 ~~~~~-~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGL-SHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCS-SSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEec-CCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 67764 4467888999999999865 489999999999999888999999876667779999999999999999999999
Q ss_pred ccCCCccccCCCCcccceeeccCCccCCCCcceeeEeecCCC
Q 038743 120 FLHPSDTLLPNQPLSVSLELTSPKSLQNGGYYSLKMLQQPTS 161 (839)
Q Consensus 120 FD~PTDTlLpg~~l~~~~~L~s~~s~~~~g~~s~~~~~~~~~ 161 (839)
+.. .+.|.|.+.+ ++++.
T Consensus 82 ~t~-----------------------~~~g~y~l~L-q~DGN 99 (115)
T d1dlpa1 82 GTK-----------------------GSIGNYVLVL-QPDRT 99 (115)
T ss_dssp CCC-----------------------CCSSCCEEEE-CSSSC
T ss_pred CCC-----------------------CCCCCEEEEE-CCCCc
Confidence 742 2358888988 55553
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.38 E-value=1.4e-12 Score=114.12 Aligned_cols=99 Identities=19% Similarity=0.384 Sum_probs=75.9
Q ss_pred ceEEecCCCeE--EeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-CC
Q 038743 6 SRLLASQDQAW--ISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND-GD 82 (839)
Q Consensus 6 ~~~~~~~~~~~--vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~-~~ 82 (839)
..|.+ +|.| ++.+|.|.|.|...+| |.+ |+ ..++||.||+..|.. .+.|.|..||+|+|.| .+
T Consensus 15 ~~l~~--~q~l~~~~~~~~y~l~mQ~DGN------LVL-y~----~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHA--TESLEILFGTHVYRFIMQTDCN------LVL-YD----NNNPIWATNTGGLGN-GCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEET--TCEEEEEETTEEEEEEECTTSC------EEE-EE----TTEEEEECCCTTSCS-SCEEEECTTSCEEEECTTC
T ss_pred CEEeC--CCeEEEecCCceEEEEECCCCc------EEE-EE----CCeEEEEecCCCCCc-ceEEEEEeCCCEEEECCCC
Confidence 34444 4554 6789999999988764 444 43 257899999987743 4689999999999999 45
Q ss_pred eeEEEecCCCC-ceeEEEEeccccEEEecCCCCceeeccc
Q 038743 83 TTIWASNSSGA-GVELATMSESGNFILYAPNNQPVWQSFL 121 (839)
Q Consensus 83 ~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFD 121 (839)
..||++++.+. +..+|+|+|+|||||++ ..+|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 68999987543 44568999999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.11 E-value=4.8e-11 Score=103.34 Aligned_cols=92 Identities=22% Similarity=0.370 Sum_probs=71.3
Q ss_pred CCCeEEeCCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-CCeeEEEecC
Q 038743 12 QDQAWISDNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND-GDTTIWASNS 90 (839)
Q Consensus 12 ~~~~~vS~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~-~~~~vWst~~ 90 (839)
.++.| .+|.|.|.|...++ |.|+. . .++||.+|...+ ..+.+.|..+|||||.| .+.+||+|.+
T Consensus 19 ~~~~l--~~g~~~l~~q~DGN------LvL~~-~----~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~~~~~vWsS~t 83 (115)
T d1dlpa1 19 AAQSL--ELSSFRFTMQSDCN------LVLFD-S----DVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIRWSSGT 83 (115)
T ss_dssp TTCEE--CSTTEEEEECTTSC------EEEEE-S----SSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCSCCCCC
T ss_pred CCCcE--EcCCEEEEECCCCe------EEEEc-C----CeeEEEcccCCC--CceEEEEeccCCEEEEccCCCEEEEcCC
Confidence 37877 57899999988774 66754 2 467899996542 34689999999999998 5678999987
Q ss_pred CC-CceeEEEEeccccEEEecCCCCceeeccc
Q 038743 91 SG-AGVELATMSESGNFILYAPNNQPVWQSFL 121 (839)
Q Consensus 91 ~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFD 121 (839)
.. .+..+++|+++|||||++ ..+|+|-.
T Consensus 84 ~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 84 KGSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred CCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 53 455569999999999994 47999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.76 E-value=1.2e-08 Score=88.92 Aligned_cols=86 Identities=19% Similarity=0.362 Sum_probs=62.7
Q ss_pred CCCeEEeeeecCCCCCCcEEEEEEeccCCCCCcEEEeeCCCCCCCCCeEEEEecCCcEEEeC-CCeeEEEecCCC-Ccee
Q 038743 19 DNGTFAFGFTPIVNIQDRFQLGIWFNELPGDRTVVWSANRNFPVTKDAILELDTTGNLVLND-GDTTIWASNSSG-AGVE 96 (839)
Q Consensus 19 ~~g~F~lGF~~~~~~~~~~~lgIw~~~i~~~~tvVW~ANr~~pv~~~~~l~l~~~G~Lvl~~-~~~~vWst~~~~-~~~~ 96 (839)
..|.|.|.|...++ |.|+-. ..+||.+|-... ...+.+.|..+|||||.| .+..||+|++.. .+..
T Consensus 33 ~~g~y~L~~q~DGN------LvL~~~-----~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~ 100 (120)
T d1dlpa2 33 QLSPYRLSMETDCN------LVLFDR-----DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRY 100 (120)
T ss_dssp BCSSCEEEEETTTE------EEEEBT-----TBCCSCCCCCSS-CSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCC
T ss_pred EcCCEEEEEcCCCc------EEEecC-----CcEEEEEccccC-CCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcE
Confidence 36778888875552 666531 356799985332 234689999999999998 567899999743 3455
Q ss_pred EEEEeccccEEEecCCCCceeec
Q 038743 97 LATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 97 ~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.+.|.++|||||++ ..+|.|
T Consensus 101 ~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 101 VFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp EEEECSSSCEEEEC---CCCCBC
T ss_pred EEEECCCCcEEEeC---CCcccC
Confidence 68999999999994 468875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.70 E-value=2.6e-08 Score=86.39 Aligned_cols=54 Identities=35% Similarity=0.567 Sum_probs=47.2
Q ss_pred EEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeecc
Q 038743 67 ILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQSF 120 (839)
Q Consensus 67 ~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSF 120 (839)
.|.+..||||||.+++.+||++++.+.+ ...+.|.++|||||++.++.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP 87 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS
T ss_pred EEEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC
Confidence 6888999999999988899999975443 45699999999999999999999864
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.69 E-value=3.2e-08 Score=84.62 Aligned_cols=54 Identities=37% Similarity=0.766 Sum_probs=47.6
Q ss_pred eEEEEecCCcEEEeCCCeeEEEecCCCCc-eeEEEEeccccEEEecCCCCceeec
Q 038743 66 AILELDTTGNLVLNDGDTTIWASNSSGAG-VELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 66 ~~l~l~~~G~Lvl~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
-+|.+..||||||.+.+.+||++++.+.+ ...+.|.++|||||++.++.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS 75 (108)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC
T ss_pred EEEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc
Confidence 47899999999999988999999975543 3469999999999999999999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.65 E-value=4.7e-08 Score=83.59 Aligned_cols=54 Identities=31% Similarity=0.548 Sum_probs=47.0
Q ss_pred eEEEEecCCcEEEeCCCeeEEEecCCC--CceeEEEEeccccEEEecCCCCceeec
Q 038743 66 AILELDTTGNLVLNDGDTTIWASNSSG--AGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 66 ~~l~l~~~G~Lvl~~~~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
-.|.+..||||||...+.+||++++.. .....+.|.++|||||+++++.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS 76 (109)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC
T ss_pred EEEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE
Confidence 578899999999999888999998743 334569999999999999999999997
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=1.3e-06 Score=87.73 Aligned_cols=134 Identities=13% Similarity=0.033 Sum_probs=93.2
Q ss_pred ccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccc-cCCcccccceeecCCceEEEEeeccCCChhhhc
Q 038743 512 GTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMH-HMNLVRLCGYCSEGSNRLLVYEFMKNGSLDKWI 590 (839)
Q Consensus 512 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l 590 (839)
+.++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+..
T Consensus 23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 3344568999875 56678889886554444556788888887773 444667788888888899999999998876543
Q ss_pred ccCCCCCcccCChhhHHHHHHHHHHHhHHhhhcc----------------------------------------------
Q 038743 591 FPSYHHRDRVLDWTTRFNIAIATAQGIAYFHEQC---------------------------------------------- 624 (839)
Q Consensus 591 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------- 624 (839)
.. ......++.++++.|+.||+..
T Consensus 102 ~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 102 ED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp TT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred cc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 21 1122334455555555555311
Q ss_pred ----------CCeeeecCCCCCcEEECCCCceeecccCccee
Q 038743 625 ----------RNRIIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 625 ----------~~~iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
...++|+|+.|.|||++++..+-|.||+.+..
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 23489999999999999877677999998864
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.20 E-value=2.4e-06 Score=73.27 Aligned_cols=54 Identities=30% Similarity=0.653 Sum_probs=43.7
Q ss_pred CeEEEEecCCcEEEeCCCeeEEEecCCC-CceeEEEEeccccEEEecCCCCceeec
Q 038743 65 DAILELDTTGNLVLNDGDTTIWASNSSG-AGVELATMSESGNFILYAPNNQPVWQS 119 (839)
Q Consensus 65 ~~~l~l~~~G~Lvl~~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQS 119 (839)
.-.|.+..||||||...+.+||++++.. ...+.+.|..+|||||++. +..+|-|
T Consensus 20 ~~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS 74 (112)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC
T ss_pred CEEEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE
Confidence 3589999999999999889999998643 3345699999999999986 4566754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=1.1e-05 Score=80.38 Aligned_cols=76 Identities=13% Similarity=0.055 Sum_probs=54.7
Q ss_pred ccccCC-CceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhcccc--CCcccccceeecCCceEEEEeeccCCCh
Q 038743 510 LLGTGG-FGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHH--MNLVRLCGYCSEGSNRLLVYEFMKNGSL 586 (839)
Q Consensus 510 ~lG~G~-fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL 586 (839)
.+..|. -+.||+....++..+++|..... ....+..|+..+..+.. -.+.+++.+..+....++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 36799999888888999986543 23346778887777642 3356778888888889999999998766
Q ss_pred hh
Q 038743 587 DK 588 (839)
Q Consensus 587 ~~ 588 (839)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00067 Score=71.60 Aligned_cols=75 Identities=15% Similarity=0.083 Sum_probs=47.8
Q ss_pred cccccCCCceEEEEEeCC-CcEEEEEEecccC-------CcchHHHHHHHHHhhccc-c--CCcccccceeecCCceEEE
Q 038743 509 QLLGTGGFGSVYKGSLGD-GTLVAVKKLDRVL-------PHGEKEFVTEVNTIGSMH-H--MNLVRLCGYCSEGSNRLLV 577 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lv 577 (839)
+.||.|....||+....+ ++.|+||.-.... +........|.+.|..+. + ..+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 6789999753211 112334566887777652 2 234555544 45567899
Q ss_pred EeeccCCC
Q 038743 578 YEFMKNGS 585 (839)
Q Consensus 578 ~e~~~~gs 585 (839)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00042 Score=71.25 Aligned_cols=138 Identities=14% Similarity=0.079 Sum_probs=79.7
Q ss_pred CceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcc-----cccc--eeecCCceEEEEeeccCCChhh
Q 038743 516 FGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLV-----RLCG--YCSEGSNRLLVYEFMKNGSLDK 588 (839)
Q Consensus 516 fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-----~l~g--~~~~~~~~~lv~e~~~~gsL~~ 588 (839)
--.||+.+.++|+.+++|..+.. ....+++..|...+..|....+. ..-+ ........+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999999999999998643 33456788898888887433322 1111 1233456788999988744321
Q ss_pred h--------------ccc----CCCCCcccCC-------------------hhhHHHHHHHHHHHhHHhhh----ccCCe
Q 038743 589 W--------------IFP----SYHHRDRVLD-------------------WTTRFNIAIATAQGIAYFHE----QCRNR 627 (839)
Q Consensus 589 ~--------------l~~----~~~~~~~~l~-------------------~~~~~~i~~~ia~~L~yLH~----~~~~~ 627 (839)
. ++. ........++ ...+-.+...+.+.+..+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 000 0000111111 11111122222233333322 23457
Q ss_pred eeecCCCCCcEEECCCCceeecccCccee
Q 038743 628 IIHCDIKPENILLDENFCPKVSDFGLAKL 656 (839)
Q Consensus 628 iiH~dlk~~Nill~~~~~~kl~DfGla~~ 656 (839)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.40 E-value=0.0081 Score=63.03 Aligned_cols=73 Identities=18% Similarity=0.200 Sum_probs=50.1
Q ss_pred cccccCCCceEEEEEeCCC--------cEEEEEEecccCCcchHHHHHHHHHhhccccCCc-ccccceeecCCceEEEEe
Q 038743 509 QLLGTGGFGSVYKGSLGDG--------TLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNL-VRLCGYCSEGSNRLLVYE 579 (839)
Q Consensus 509 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 579 (839)
+.|+.|-.-.+|+...+++ +.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678888899999987543 4677776643 2334456788888888853344 567777654 68899
Q ss_pred eccCCChh
Q 038743 580 FMKNGSLD 587 (839)
Q Consensus 580 ~~~~gsL~ 587 (839)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99875543
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.38 E-value=0.0031 Score=38.92 Aligned_cols=33 Identities=27% Similarity=0.620 Sum_probs=27.3
Q ss_pred CCCCcccccccccccccCCCCCCCceeecCCCCcC
Q 038743 282 SNPCNIAGICGKGICNLDRSKTKASCTCLPGDSKI 316 (839)
Q Consensus 282 ~d~Cd~yg~CG~g~C~~~~~~~~~~C~Cl~Gf~~~ 316 (839)
.|+|.+-..||+|-|..- .+.-.|.|-.||+|.
T Consensus 1 tdECsignpCGnGTCtNv--iGgFec~C~~GFepg 33 (39)
T d1emoa2 1 TDECSVGNPCGNGTCKNV--IGGFECTCEEGFEPG 33 (39)
T ss_dssp CCGGGTTCSSSSSCEEEC--SSSEEECCSSSSCCC
T ss_pred CCccccCCccCCceeeec--ccceEEeecCCcCCC
Confidence 378999999999999743 246789999999985
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.82 E-value=0.088 Score=52.69 Aligned_cols=143 Identities=10% Similarity=-0.009 Sum_probs=73.3
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEecccCCcchHHHHHHHHHhhccccCCcc--cccce------eecCCceEEEEeec
Q 038743 510 LLGTGGFGSVYKGSLGDGTLVAVKKLDRVLPHGEKEFVTEVNTIGSMHHMNLV--RLCGY------CSEGSNRLLVYEFM 581 (839)
Q Consensus 510 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~g~------~~~~~~~~lv~e~~ 581 (839)
.|..|---+.|+.+.++|+ +++|+..... ...+...|++++..|...++. ..+-. .........++.+.
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 3556767888999886665 8899886431 234555667777776433221 11111 11234455666666
Q ss_pred cCCChhhhc--------------c---cC-CCCCc------------------ccCChhhHHHHHHHHHHHhHHhhh-cc
Q 038743 582 KNGSLDKWI--------------F---PS-YHHRD------------------RVLDWTTRFNIAIATAQGIAYFHE-QC 624 (839)
Q Consensus 582 ~~gsL~~~l--------------~---~~-~~~~~------------------~~l~~~~~~~i~~~ia~~L~yLH~-~~ 624 (839)
.+......- + .. ..... ...........+..+...+.-.+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 654332210 0 00 00000 001111112222222222222221 23
Q ss_pred CCeeeecCCCCCcEEECCCCceeecccCcce
Q 038743 625 RNRIIHCDIKPENILLDENFCPKVSDFGLAK 655 (839)
Q Consensus 625 ~~~iiH~dlk~~Nill~~~~~~kl~DfGla~ 655 (839)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999998877899999885
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.38 E-value=0.12 Score=34.35 Aligned_cols=32 Identities=25% Similarity=0.388 Sum_probs=24.7
Q ss_pred CCCcccccccccccccCCCCCCCceeecCCCCcC
Q 038743 283 NPCNIAGICGKGICNLDRSKTKASCTCLPGDSKI 316 (839)
Q Consensus 283 d~Cd~yg~CG~g~C~~~~~~~~~~C~Cl~Gf~~~ 316 (839)
|+|.....|..+.|.... ++-.|.|++||...
T Consensus 4 dEC~~~~~~c~~~C~Nt~--G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLDPTTCISGNCVNTP--GSYICDCPPDFELN 35 (43)
T ss_dssp CGGGSTTSSBTSEEEEET--TEEEEECCTTCEEC
T ss_pred cccCCCCcCcCCEeECCC--CCEEEecCCCCEEC
Confidence 678876666578997443 57899999999864
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.37 E-value=0.3 Score=31.52 Aligned_cols=30 Identities=30% Similarity=0.716 Sum_probs=21.0
Q ss_pred CCCcccccccc-cccccCCCCCCCceeecCCCCc
Q 038743 283 NPCNIAGICGK-GICNLDRSKTKASCTCLPGDSK 315 (839)
Q Consensus 283 d~Cd~yg~CG~-g~C~~~~~~~~~~C~Cl~Gf~~ 315 (839)
|+|. ...|-+ |.|.... ....|.|++||.-
T Consensus 1 D~C~-~~PC~ngg~C~~~~--~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGL--GEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCS--SSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCC--CCEEEECCCCCCc
Confidence 3455 356885 8887543 3678999999964
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.46 E-value=0.2 Score=33.04 Aligned_cols=32 Identities=25% Similarity=0.689 Sum_probs=22.6
Q ss_pred CCCc-ccccccccccccCCCCCCCceeecCCCCcC
Q 038743 283 NPCN-IAGICGKGICNLDRSKTKASCTCLPGDSKI 316 (839)
Q Consensus 283 d~Cd-~yg~CG~g~C~~~~~~~~~~C~Cl~Gf~~~ 316 (839)
|+|. ..+.|..|.|.... ++-.|.|++||...
T Consensus 3 dEC~~~~~~C~~~~C~Nt~--Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRDPLLCRGGVCHNTE--GSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHCSSTTTTSEEEEET--TEEEEESCTTSCCC
T ss_pred cccCCCCCCCCCCEeECCC--CCeEEeCCCCCeEC
Confidence 4453 34567678887443 57899999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.24 E-value=0.32 Score=32.03 Aligned_cols=31 Identities=29% Similarity=0.692 Sum_probs=22.8
Q ss_pred CCCcc-cccccc-cccccCCCCCCCceeecCCCCc
Q 038743 283 NPCNI-AGICGK-GICNLDRSKTKASCTCLPGDSK 315 (839)
Q Consensus 283 d~Cd~-yg~CG~-g~C~~~~~~~~~~C~Cl~Gf~~ 315 (839)
|+|.. ...|.+ |.|.... ++..|.|++||.-
T Consensus 4 deC~~~~~pC~n~g~C~n~~--g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTL--GSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECS--SSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCC--CCEEeECCCCCcC
Confidence 56764 467884 8997543 4789999999963
|